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Allosteric	   regulation	   of	   important	   enzymes	   is	   a	   mechanism	   frequently	   employed	   by	   organisms	   to	  
exert	  control	  over	  their	  metabolism.	  The	  work	  presented	  in	  this	  thesis	  focused	  on	  further	  developing	  
our	  understanding	  of	  the	  sophisticated	  synergistic	  regulation	  of	  the	  3-­‐deoxy-­‐D-­‐arabino-­‐heptulosonate	  
7-­‐phosphate	  synthase	  (DAH7PS)	  from	  Mycobacterium	  tuberculosis.	  
	  
The	  shikimate	  pathway	   is	  ultimately	  responsible	   for	  the	  biosynthesis	  of	   the	  aromatic	  amino	  acids	   in	  
plants,	   microorganisms	   and	   apicomplexans.	   DAH7PS	   catalyses	   the	   first	   committed	   step	   of	   the	  
shikimate	  pathway.	  Chorismate	  mutase	  (CM)	   is	  positioned	  at	  a	  critical	  branch	  point	  of	   the	  aromatic	  
amino	  acid	  biosynthetic	  pathway	  and	  is	  the	  first	  committed	  step	  toward	  the	  biosynthesis	  of	  Phe	  and	  
Tyr.	  Due	  to	  the	  critical	  position	  of	  these	  two	  enzymes,	  the	  activity	  of	  DAH7PS	  and	  CM	  are	  often	  tightly	  
feedback	   regulated	   in	  order	   to	   control	   the	   flux	  of	  metabolites	   through	   the	  pathway.	   The	   shikimate	  
pathway	   is	   absent	   in	   mammals	   making	   the	   enzymes	   of	   the	   pathway	   excellent	   targets	   for	   the	  
development	  of	  novel	  antimicrobial	  drugs	  for	  pathogens	  such	  as	  M.	  tuberculosis,	  the	  causative	  agent	  
of	  tuberculosis.	  	  
	  
The	   kinetic	   and	   biophysical	   characterisation	   of	   the	   DAH7PS	   from	   M.	   tuberculosis	   (MtuDAH7PS)	  
described	   in	   Chapter	   2	   of	   this	   thesis,	   revealed	   for	   the	   first	   time	   that	  MtuDAH7PS	   is	   subject	   to	  
synergistic	   feedback	   regulation	   by	   all	   three	   aromatic	   amino	   acids.	   Structural	   characterisation	   of	  
MtuDAH7PS	   revealed	   that	   MtuDAH7PS	   exists	   as	   a	   mixture	   of	   oligomeric	   species	   with	   the	  
homotetrameric	  species	  favoured	  as	  the	  protein	  concentration	  increases.	  	  
	  
The	   feedback	   regulation	   of	   the	   MtuDAH7PS	   is	   highly	   sophisticated;	   MtuDAH7PS	   activity	   is	   only	  
inhibited	   when	   Trp	   is	   present	   in	   combination	   with	   either	   Phe	   or	   Tyr.	   Crystallographic	   studies	   of	  
MtuDAH7PS	   have	   shown	   the	   aromatic	   amino	   acids	   bind	   to	   three	   distinct	   allosteric	   binding	   sites.	  
Designated	  here	  as	  the	  Trp	  site,	  site	  1	  and	  site	  2.	  Trp	  has	  only	  been	  observed	  to	  occupy	  the	  Trp	  site,	  
but	   Phe	   and	   Tyr	   have	   been	   observed	   to	   occupy	   both	   site	   1	   and	   site	   2.	   Site-­‐directed	   mutagenesis	  
(SDM)	  was	  used	  to	  generate	  two	  MtuDAH7PS	  variants	  with	  an	  amino	  acid	  substitution	  at	  either	  site	  1	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(Arg171Ala)	   or	   site	   2	   (Arg256Ala),	   in	   order	   to	   disrupt	   ligand	   binding.	   The	   results	   of	   the	   functional	  
analysis	  of	  these	  two	  variants	  are	  described	  in	  Chapter	  3.	  Kinetic	  analysis	  revealed	  Phe	  binding	  to	  site	  
1	  was	  required	  for	  the	  regulatory	  response	  of	  MtuDAH7PS	  to	  Trp	  and	  Phe,	  and	  that	  Tyr	  binding	  to	  site	  
2	  was	   required	   for	   the	  proper	   regulatory	   response	   to	   Trp	   and	  Tyr.	   Biophysical	   analysis	   showed	  Tyr	  
could	   bind	   to	   both	   site	   1	   and	   site	   2,	   but	   Tyr	   had	   a	   greater	   affinity	   for	   site	   2.	   Phe	   only	   displayed	   a	  
significant	   affinity	   for	   site	   1.	   These	   observations	   have	   lead	   to	   the	   designation	   of	   site	   1	   as	   the	   Phe-­‐
selective	  binding	  site	  and	  site	  2	  as	  the	  Tyr	  selective	  binding	  site.	  
	  
MtuDAH7PS	  can	  form	  a	  non-­‐covalent	  complex	  with	  MtuCM,	  boosting	  MtuCM	  activity	  by	  more	  than	  
100-­‐fold	   and	   endowing	  MtuCM	  with	   regulatory	   sensitivity	   to	   Phe	   and	   Tyr.	   Chapter	   4	   describes	   the	  
functional	  and	  structural	  characterisation	  of	  the	  interaction	  of	  MtuDAH7PS	  with	  MtuCM.	  MtuDAH7PS	  
was	   also	   found	   to	   endow	  MtuCM	   with	   synergistic	   regulatory	   sensitivity	   when	   Trp	   was	   added	   in	  
combination	  with	   Phe	   or	   Tyr.	   The	   functional	   and	   biophysical	   characterisation	   of	   the	   interaction	   of	  
MtuCM	  with	  the	  two	  MtuDAH7PS	  variants	  used	  in	  the	  studies	  presented	  in	  Chapter	  3	  were	  also	  used	  
to	  show	  that	  the	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  were	  responsible	  for	  the	  synergistic	  regulation	  
of	   MtuCM.	   The	   results	   from	   analytical	   ultracentrifugation	   (AUC),	   native	   polyacrylamide	   gel	  
electrophoresis	   (PAGE)	   and	   kinetic	   analysis	   found	   that	   the	   binding	   of	   Phe	   lowered	   the	   affinity	   of	  
MtuDAH7PS	  for	  MtuCM	  and	  resulted	  in	  poorer	  activation	  of	  MtuCM	  activity.	  	  
	  
Crystallographic	  studies	  have	  shown	  the	  binding	  of	  the	  aromatic	  amino	  acids	  to	  MtuDAH7PS	  do	  not	  
cause	  a	  significant	  change	  in	  the	  conformation	  of	  MtuDAH7PS.	  Molecular	  dynamics	  (MD)	  simulations	  
reveal	   the	  synergistic	   regulation	  of	  MtuDAH7PS	  by	  Trp	  and	  Phe	   is	   likely	   to	  be	  primarily	  entropically	  
driven,	  mediated	  by	  subtle	  changes	  in	  the	  molecular	  dynamics	  of	  the	  substrate	  and	  allosteric	  binding	  
sites	   to	   facilitate	   aromatic	   acid	   binding	   at	   other	   allosteric	   binding	   sites	   or	   disfavour	   erythrose	   4-­‐
phosphate	  (E4P)	  binding	  at	  the	  active	  site.	  Statistical	  coupling	  analysis	  (SCA)	  was	  combined	  with	  MD	  
simulations	   to	   predict	   a	   cluster	   of	   residues	   that	  may	   be	   involved	   in	   transmitting	   ligand	   occupancy	  
between	   allosteric	   binding	   sites	   and	   to	   the	   active	   site.	   Four	   of	   these	   residues	   were	   selected	   for	  
substitution	   via	   SDM.	   The	   structural	   and	   functional	   characterisation	   of	   these	   four	   MtuDAH7PS	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variants,	   described	   in	   chapter	   5,	   found	   that	   all	   four	   residues	   play	   a	   role	   in	   the	   transmission	   of	  
regulatory	  signals	  of	  MtuDAH7PS	  validating	  the	  computational	  studies.	  	  
	  
SDM	  was	  also	  used	   to	  produce	   two	  MtuDAH7PS	  variants	   that	  contained	  an	  amino	  acid	  substitution	  
(Lys123Met	  or	  Asn237Ala)	  at	   the	  Trp	  site	  as	  described	   in	  Chapter	  6.	  These	  modifications	   to	   the	  Trp	  
site	   were	   found	   to	   disrupt	   the	   quaternary	   structure	   equilibrium	   of	   MtuDAH7PS.	   Kinetic	   and	  
biophysical	  analysis	  found	  that	  the	  synergistic	  regulation	  of	  MtuDAH7PS	  had	  been	  disrupted	  but	  that	  
sensitivity	  to	  Phe	  and	  Tyr	  had	  been	  enhanced.	  	  
	  
The	   substitution	   of	   several	   residues	   resulted	   in	   the	   disruption	   of	   the	   homotetrameric	   structure	   of	  
MtuDAH7PS,	  providing	  a	  serendipitous	  opportunity	  to	  study	  the	  structural	  and	  functional	  properties	  
of	   the	  MtuDAH7PS	   dimer.	   The	   kinetic	   characterisation	   described	   in	   Chapter	   7	   found	   the	   catalytic	  
efficiency	  and	  regulation	  of	  the	  dimeric	  MtuDAH7PS	  variants	  was	  severely	  compromised.	  
	  
All	   the	  results	  presented	   in	  this	  thesis	  are	  discussed	   in	  Chapter	  8.	  Overall	   this	  work	  has	  emphasised	  
the	   remarkable	   complexity	   by	   which	  MtuDAH7PS	   is	   regulated	   and	   its	   unusual	   ability	   to	   share	   its	  




Table	  of	  contents	  
Acknowledgements	  .........................................................................................................................	  i	  
Abstract	  ..........................................................................................................................................	  iii	  
Table	  of	  contents	  ...........................................................................................................................	  vii	  
List	  of	  abbreviations	  ....................................................................................................................	  xvii	  
Index	  of	  figures	  .............................................................................................................................	  xxi	  
Index	  of	  tables	  ...........................................................................................................................	  xxvii	  
Publications	  ................................................................................................................................	  xxix	  
1.	   Introduction	  ............................................................................................................................	  1	  
	   Allostery	  ...........................................................................................................................	  1	  1.1.
	   Monod-­‐Wyman-­‐Changeux	  (MWC)	  model	  ................................................................	  2	  1.1.1.
	   Koshland-­‐Némethy-­‐Filmer	  (KNF)	  model	  ...................................................................	  3	  1.1.2.
	   Morpheein	  model	  .....................................................................................................	  4	  1.1.3.
	   Dynamic	  energy	  landscape	  model	  ............................................................................	  4	  1.1.4.
	   Allostery	  and	  drug	  discovery	  ....................................................................................	  8	  1.1.5.
	   Mycobacterium	  tuberculosis	  ............................................................................................	  9	  1.2.
	   The	  shikimate	  pathway	  and	  aromatic	  amino	  acid	  biosynthesis	  ....................................	  10	  1.3.
	   3-­‐Deoxy-­‐D-­‐arabino-­‐heptulosonate	  7-­‐phosphate	  synthase	  (DAH7PS)	  ...........................	  12	  1.4.
	   M.	  tuberculosis	  DAH7PS	  .........................................................................................	  15	  1.4.1.
	   Chorismate	  mutase	  (CM)	  ...............................................................................................	  15	  1.5.
	   M.	  tuberculosis	  CM	  .................................................................................................	  17	  1.5.1.
	   Outline	  of	  this	  thesis	  ......................................................................................................	  18	  1.6.
2.	   Characterisation	  of	  MtuDAH7PS	  ...........................................................................................	  21	  
	   Introduction	  ...................................................................................................................	  21	  2.1.
	   Chapter	  aims	  ..................................................................................................................	  22	  2.2.
	   Preparation,	  expression	  and	  purification	  ......................................................................	  23	  2.3.
	   Construct	  details	  .....................................................................................................	  23	  2.3.1.
	  viii	  
	   Expression,	  lysis	  and	  purification	  ............................................................................	  23	  2.3.2.
	   Kinetic	  characterisation	  .................................................................................................	  25	  2.4.
	   Kinetic	  parameters	  ..................................................................................................	  25	  2.4.1.
	   Feedback	  regulation	  by	  individual	  aromatic	  amino	  acids	  .......................................	  25	  2.4.2.
	   Feedback	  regulation	  ...............................................................................................	  26	  2.4.3.
	   Biophysical	  characterisation	  ..........................................................................................	  28	  2.5.
	   Thermal	  stability	  .....................................................................................................	  28	  2.5.1.
	   Binding	  affinities	  .....................................................................................................	  29	  2.5.2.
	   Structural	  characterisation	  ............................................................................................	  32	  2.6.
	   SAXS	  analysis	  ...........................................................................................................	  32	  2.6.1.
	   Native	  PAGE	  ............................................................................................................	  35	  2.6.1.
	   Analytical	  ultracentrifugation	  (AUC)	  analysis	  .........................................................	  36	  2.6.2.
	   Chapter	  summary	  ..........................................................................................................	  39	  2.7.
3.	   MtuDAH7PS	  has	  a	  Phe-­‐selective	  site	  and	  a	  Tyr-­‐selective	  site	  ..............................................	  41	  
3.1.	   Introduction	  ...................................................................................................................	  41	  
	   Architecture	  of	  site	  1	  ..............................................................................................	  41	  3.1.1.
	   Architecture	  of	  site	  2	  ..............................................................................................	  44	  3.1.2.
	   Chapter	  aims	  ..................................................................................................................	  46	  3.2.
	   Preparation	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  ..................................................	  46	  3.3.
	   Selection	  of	  residues	  for	  mutagenesis	  ....................................................................	  46	  3.3.1.
	   Mutagenesis,	  expression	  and	  purification	  ..............................................................	  47	  3.3.2.
	   Confirmation	  of	  product	  .........................................................................................	  47	  3.3.3.
	   Structural	  analysis	  ..........................................................................................................	  48	  3.4.
	   Comparison	  of	  secondary	  structure	  .......................................................................	  48	  3.4.1.
	   Quaternary	  structure	  analysis	  in	  solution	  ...............................................................	  49	  3.4.2.
	   Determination	  of	  kinetic	  parameters	  ............................................................................	  52	  3.5.
	   Assessment	  of	  ligand	  binding	  ........................................................................................	  53	  3.6.
	   Thermal	  stability	  .....................................................................................................	  53	  3.6.1.
	   Binding	  affinities	  .....................................................................................................	  54	  3.6.2.
	  ix	  
	   Disruption	  of	  feedback	  regulation	  .................................................................................	  58	  3.7.
	   Chapter	  summary	  ..........................................................................................................	  60	  3.8.
4.	   Interaction	  of	  MtuCM	  with	  MtuDAH7PS	  ..............................................................................	  63	  
	   Introduction	  ...................................................................................................................	  63	  4.1.
	   Interface	  of	  the	  non-­‐covalent	  complex	  ..................................................................	  65	  4.1.1.
	   Proposed	  mechanism	  of	  MtuCM	  activation	  ...........................................................	  65	  4.1.2.
	   Chapter	  aims	  ...........................................................................................................	  67	  4.1.3.
	   Preparation	  of	  MtuCM	  ...................................................................................................	  67	  4.2.
	   Construct	  details	  .....................................................................................................	  67	  4.2.1.
	   Expression	  and	  lysis	  ................................................................................................	  68	  4.2.2.
	   Purification	  .............................................................................................................	  68	  4.2.3.
	   Determination	  of	  concentration	  .............................................................................	  71	  4.2.4.
	   Confirmation	  of	  product	  .........................................................................................	  71	  4.2.5.
	   Basic	  characterisation	  of	  MtuCM	  ..................................................................................	  72	  4.3.
	   Kinetic	  parameters	  ..................................................................................................	  72	  4.3.1.
	   Absence	  of	  feedback	  regulation	  .............................................................................	  73	  4.3.2.
	   Thermal	  stability	  .....................................................................................................	  74	  4.3.3.
	   Activation	  of	  MtuCM	  activity	  by	  MtuDAH7PSWT	  ............................................................	  75	  4.4.
	   Kinetic	  assay	  development	  .....................................................................................	  75	  4.4.1.
	   MtuCM•MtuDAH7PSWT	  kinetic	  parameters	  ...........................................................	  77	  4.4.2.
	   Evidence	  of	  MtuCM•MtuDAH7PSWT	  complex	  in	  solution	  ..............................................	  78	  4.5.
	   Regulation	  of	  the	  MtuCM•MtuDAH7PSWT	  complex	  ......................................................	  81	  4.6.
	   Feedback	  regulation	  ...............................................................................................	  81	  4.6.1.
	   Effect	  of	  Phe	  and	  Tyr	  on	  kinetic	  parameters	  of	  MtuCM•MtuDAH7PSWT	  ................	  83	  4.6.2.
	   Determination	  of	  the	  apparent	  dissociation	  constant	  between	  MtuCM	  and	  MtuDAH7PS	   84	  4.7.
	   Evidence	  of	  complex	  dissociation	  in	  solution	  ................................................................	  86	  4.8.
	   Native	  PAGE	  ............................................................................................................	  86	  4.8.1.
	   IMAC	  pull	  down	  assay	  .............................................................................................	  88	  4.8.2.
	   AUC	  analysis	  ............................................................................................................	  89	  4.8.3.
	  x	  
	   Effect	  of	  complex	  formation	  on	  MtuDAH7PS	  ................................................................	  91	  4.9.
	   Effect	  on	  kinetic	  parameters	  ...................................................................................	  91	  4.9.1.
	   Effect	  of	  MtuCM	  on	  MtuDAH7PSWT	  regulation	  .......................................................	  92	  4.9.2.
	   Allosteric	  sites	  of	  MtuDAH7PS	  regulate	  MtuCM	  activity	  ...............................................	  94	  4.10.
	   Activation	   of	  MtuCM	   activity	   in	   the	   presence	   of	  MtuDAH7PSR171A	  or	  MtuDAH7PSR256A4.10.1.
	  ..............................................................................................................................	  94	  
	   Regulation	  of	  MtuCM	  activity	  by	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  ............	  96	  4.10.2.
	   Effect	  of	  MtuCM	  on	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  kinetic	  parameters	  .	  99	  4.10.3.
	   Effect	   of	   the	  MtuDAH7PS	   polyhistidine	   tag	   on	   the	   interaction	   of	  MtuDAH7PS	   and	  MtuCM4.11.
	  .....................................................................................................................................	  100	  
	   Feedback	  regulation	  of	  MtuDAH7PSH6	  ...............................................................	  100	  4.11.1.
	   Activation	  of	  MtuCM	  by	  MtuDAH7PSH6	  ..............................................................	  102	  4.11.2.
	   Feedback	  regulation	  of	  the	  MtuCM	  activity	  .......................................................	  103	  4.11.3.
	   Chapter	  summary	  ........................................................................................................	  105	  4.12.
5.	   Residues	  potentially	  pivotal	  to	  the	  allosteric	  regulation	  of	  MtuDAH7PS	  ...........................	  111	  
	   Introduction	  .................................................................................................................	  111	  5.1.
	   Residues	  chosen	  for	  investigation	  ........................................................................	  112	  5.1.1.
	   Successful	  MtuDAH7PS	  SCA	  variants	  ....................................................................	  113	  5.1.2.
	   Chapter	  aims	  .........................................................................................................	  116	  5.1.3.
	   Preparation	  of	  MtuDAH7PS	  variants	  ...........................................................................	  116	  5.2.
	   Mutagenesis,	  expression	  and	  purification	  ............................................................	  116	  5.2.1.
	   Confirmation	  of	  product	  .......................................................................................	  117	  5.2.2.
	   Structural	  analysis	  ........................................................................................................	  118	  5.3.
	   Comparison	  of	  secondary	  structure	  .....................................................................	  118	  5.3.1.
	   Quaternary	  structure	  in	  solution	  ..........................................................................	  119	  5.3.2.
	   The	  flexibility	  of	  Gly190	  is	  essential	  to	  communicating	  allosteric	  regulation	  ..............	  124	  5.4.
	   Kinetic	  parameters	  ................................................................................................	  124	  5.4.1.
	   Disruption	  of	  feedback	  regulation	  ........................................................................	  124	  5.4.2.
	   Thermal	  stability	  ...................................................................................................	  125	  5.4.3.
	  xi	  
	   Binding	  affinities	  ...................................................................................................	  127	  5.4.4.
	   Activation	  of	  MtuCM	  by	  MtuDAH7PSG190P	  ............................................................	  129	  5.4.5.
	   Regulation	  of	  MtuCM	  by	  MtuDAH7PSG190P	  ...........................................................	  130	  5.4.1.
	   Summary	  of	  findings	  for	  MtuDAH7PSG190P	  ............................................................	  133	  5.4.2.
	   Investigating	  the	  role	  of	  Val103	  ...................................................................................	  134	  5.5.
	   Kinetic	  parameters	  ................................................................................................	  134	  5.5.1.
	   Disruption	  of	  feedback	  regulation	  ........................................................................	  135	  5.5.2.
	   Thermal	  stability	  ...................................................................................................	  136	  5.5.3.
	   Activation	  of	  MtuCM	  ............................................................................................	  137	  5.5.4.
	   Regulation	  of	  MtuCM	  by	  MtuDAH7PSV103A	  ...........................................................	  138	  5.5.5.
	   Summary	  of	  findings	  for	  MtuDAH7PSV103A	  ............................................................	  140	  5.5.1.
	   Investigating	  the	  role	  of	  Tyr131	  ...................................................................................	  142	  5.6.
	   Kinetic	  parameters	  ................................................................................................	  142	  5.6.1.
	   Disruption	  of	  feedback	  regulation	  ........................................................................	  142	  5.6.2.
	   Thermal	  stability	  ...................................................................................................	  144	  5.6.3.
	   Binding	  affinities	  ...................................................................................................	  145	  5.6.4.
	   Activation	  of	  MtuCM	  ............................................................................................	  146	  5.6.5.
	   Regulation	  of	  MtuCM	  by	  MtuDAH7PSY131A	  ...........................................................	  147	  5.6.6.
	   Summary	  of	  findings	  for	  MtuDAH7PSY131A	  ............................................................	  150	  5.6.7.
	   Investigating	  the	  role	  of	  Asn175	  ..................................................................................	  152	  5.7.
	   Kinetic	  parameters	  ................................................................................................	  152	  5.7.1.
	   Disruption	  of	  feedback	  regulation	  ........................................................................	  153	  5.7.2.
	   Thermal	  stability	  in	  the	  presence	  of	  ligand	  ..........................................................	  154	  5.7.3.
	   Activation	  of	  MtuCM	  ............................................................................................	  155	  5.7.4.
	   Regulation	  of	  MtuCM	  activity	  by	  MtuDAH7PSN237A	  ..............................................	  156	  5.7.5.
	   Summary	  of	  findings	  for	  MtuDAH7PSN175A	  ............................................................	  158	  5.7.6.
	   Summary	  ......................................................................................................................	  160	  5.8.
6.	   MtuDAH7PS	  variants	  used	  to	  examine	  Trp	  site	  residues.	  ...................................................	  163	  
6.1.	   Introduction	  .................................................................................................................	  163	  
	  xii	  
6.1.1.	   Formation	  of	  the	  Trp	  site	  ......................................................................................	  163	  
6.1.2.	   Chapter	  aims	  .........................................................................................................	  166	  
6.2.	   Preparation	  of	  variants	  ................................................................................................	  167	  
6.2.1.	   Selection	  of	  residues	  for	  mutagenesis	  ..................................................................	  167	  
6.2.2.	   Mutagenesis,	  expression	  and	  purification	  ............................................................	  167	  
6.2.3.	   Confirmation	  of	  product	  .......................................................................................	  168	  
6.2.4.	   Comparison	  of	  secondary	  structure	  .....................................................................	  169	  
6.3.	   Kinetic	  parameters	  .......................................................................................................	  169	  
6.4.	   Feedback	  Regulation	  ...................................................................................................	  171	  
6.4.1.	   Disruption	  to	  feedback	  regulation	  ........................................................................	  171	  
6.4.2.	   Effect	  of	  ligand	  on	  kinetic	  parameters	  ..................................................................	  173	  
6.5.	   Thermal	  stability	  ..........................................................................................................	  175	  
6.6.	   Binding	  affinities	  ..........................................................................................................	  176	  
6.7.	   Quaternary	  Structure	  ...................................................................................................	  179	  
6.7.1.	   SAXS	  analysis	  .........................................................................................................	  179	  
6.7.2.	   Native	  PAGE	  ..........................................................................................................	  184	  
6.7.3.	   AUC	  analysis	  ..........................................................................................................	  185	  
6.8.	   Activation	  of	  MtuCM	  ...................................................................................................	  186	  
6.9.	   Regulation	  of	  MtuCM	  ..................................................................................................	  187	  
6.10.	   Effect	  of	  MtuCM	  on	  the	  E4P	  kinetics	  of	  MtuDAH7PSK123M	  ...........................................	  190	  
6.11.	   Chapter	  summary	  ........................................................................................................	  191	  
7.	   The	  regulatory	  consequences	  of	  disrupting	  the	  quaternary	  structure	  of	  MtuDAH7PS.	  .....	  197	  
	   Introduction	  .................................................................................................................	  197	  7.1.
	   Subunit	  interfaces	  .................................................................................................	  197	  7.1.1.
	   Serendipitous	  dimeric	  MtuDAH7PS	  variants	  ........................................................	  201	  7.1.2.
	   Chapter	  aims	  .........................................................................................................	  202	  7.1.3.
	   Preparation	  of	  variants	  ................................................................................................	  203	  7.2.
	   Choice	   of	   aromatic	   amino	   acid	   substitution	   to	   disrupt	   the	   MtuDAH7PS	   tetramer	  7.2.1.
interface	  ................................................................................................................	  203	  
	  xiii	  
	   Preparation,	  expression	  and	  purification	  .............................................................	  204	  7.2.2.
	   Confirmation	  of	  product	  .......................................................................................	  205	  7.2.3.
	   Comparison	  of	  secondary	  structure	  ............................................................................	  205	  7.3.
	   Quaternary	  structure	  analysis	  .....................................................................................	  206	  7.4.
	   SAXS	  analysis	  .........................................................................................................	  207	  7.4.1.
	   Native	  PAGE	  ..........................................................................................................	  209	  7.4.2.
	   AUC	  analysis	  ..........................................................................................................	  210	  7.4.3.
	   Kinetic	  parameters	  .......................................................................................................	  212	  7.5.
	   Feedback	  regulation	  of	  dimeric	  MtuDAH7PS	  variants	  .................................................	  215	  7.6.
	   Disruption	  of	  feedback	  inhibition	  .........................................................................	  215	  7.6.1.
	   Effect	  of	  ligand	  on	  dimeric	  MtuDAH7PS	  kinetic	  parameters	  ................................	  217	  7.6.2.
	   Thermal	  stability	  ..........................................................................................................	  219	  7.7.
	   Binding	  affinities	  ..........................................................................................................	  221	  7.8.
	   Activation	  of	  MtuCM	  activity	  .......................................................................................	  225	  7.9.
	   Regulation	  of	  MtuCM	  ..................................................................................................	  226	  7.10.
	   Chapter	  summary	  ........................................................................................................	  227	  7.11.
8.	   Thesis	  summary	  and	  future	  directions	  ...............................................................................	  233	  
	   MtuDAH7PS	  is	  subject	  to	  ternary	  synergistic	  allostery	  ................................................	  233	  8.1.
	   The	   synergistic	   allosteric	   regulation	   of	  MtuDAH7PS	   involves	   a	   highly	   evolved	   network	   of	  8.2.
residues	  to	  communicate	  between	  remote	  sites	  ........................................................	  235	  
	   The	  MtuDAH7PS	  tetramer	  is	  the	  regulated	  quaternary	  structure	  ..............................	  237	  8.3.
	   CM	  complex	  and	  dissociation	  ......................................................................................	  240	  8.4.
	   Future	  directions	  .........................................................................................................	  244	  8.5.
	   Does	  a	  twist	  at	  the	  dimer	  interface	  of	  MtuDAH7PS	  occur?	  ..................................	  244	  8.5.1.
	   How	   is	   the	   allosteric	   regulation	   of	   MtuDAH7PS	   transmitted	   across	   the	  8.5.2.
MtuCM•MtuDAH7PS	  interface	  to	  MtuCM?	  .......................................................................	  245	  
	   Is	  the	  highly	  sophisticated	  allostery	  of	  MtuDAH7PS	  a	  common	  feature	  of	  microbial	  type	  8.5.3.
II	  DAH7PS’s?	  ..........................................................................................................	  245	  
	   Concluding	  remarks	  .....................................................................................................	  247	  8.6.
	  xiv	  
9.	   Experimental	  details	  ...........................................................................................................	  249	  
	   General	  experimental	  ..................................................................................................	  249	  9.1.
	   Water	  ....................................................................................................................	  249	  9.1.1.
	   pH	  measurement	  ..................................................................................................	  249	  9.1.2.
	   Centrifugation	  .......................................................................................................	  249	  9.1.3.
	   Culture	  media	  .......................................................................................................	  249	  9.1.4.
	   Antibiotic	  stocks	  ....................................................................................................	  250	  9.1.5.
	   Generation	  of	  protein	  structure	  figures	  ...............................................................	  250	  9.1.6.
	   Experimental	  for	  site-­‐directed	  mutagenesis	  and	  transformations	  ..............................	  251	  9.2.
	   Primers	  ..................................................................................................................	  251	  9.2.1.
	   Site-­‐directed	  mutagenesis	  ....................................................................................	  251	  9.2.2.
	   Agarose	  gel	  electrophoresis	  .................................................................................	  252	  9.2.3.
	   Chemical	  transformation	  of	  E.	  coli	  cells	  ................................................................	  252	  9.2.1.
	   Preparation	  of	  chemically	  competent	  cells	  ..........................................................	  253	  9.2.2.
	   Electroporation	  of	  BL21	  (DE3)	  pGroESL	  cells	  ........................................................	  253	  9.2.1.
	   Preparation	  of	  BL21	  (DE3)	  pGroESL	  electro-­‐competent	  cells	  ...............................	  254	  9.2.2.
	   Plasmid	  preparation	  and	  isolation	  ........................................................................	  254	  9.2.3.
	   DNA	  sequencing	  ....................................................................................................	  255	  9.2.4.
	   Glycerol	  stocks	  ......................................................................................................	  255	  9.2.5.
	   E.	  coli	  cell	  growth,	  induction	  and	  harvesting	  ...............................................................	  255	  9.3.
	   Growth	  of	  E.	  coli	  cells	  ...........................................................................................	  255	  9.3.1.
	   Induction	  of	  protein	  expression	  ............................................................................	  256	  9.3.2.
	   Cell	  harvesting	  ......................................................................................................	  256	  9.3.3.
	   General	  purification	  experimental	  ...............................................................................	  256	  9.4.
	   Fast	  protein	  liquid	  chromatography	  (FPLC)	  ..........................................................	  256	  9.4.1.
	   Preparation	  of	  TEV	  protease	  .................................................................................	  257	  9.4.2.
	   Determination	  of	  MtuDAH7PS	  concentration	  ......................................................	  258	  9.4.3.
	   Determination	  of	  MtuCM	  concentration	  ..............................................................	  258	  9.4.4.
	   SDS-­‐PAGE	  ..............................................................................................................	  259	  9.4.5.
	  xv	  
	   Visualisation	  of	  PAGE	  gels	  .....................................................................................	  259	  9.4.6.
	   Protein	  concentration	  and	  buffer	  exchange	  .........................................................	  260	  9.4.7.
	   Purification	  of	  MtuDAH7PS	  and	  MtuDAH7PS	  variants	  ................................................	  260	  9.5.
	   Cell	  lysis	  ................................................................................................................	  260	  9.5.1.
	   Immobilised	  metal	  affinity	  chromatography	  (IMAC)	  ............................................	  261	  9.5.2.
	   Cleavage	  of	  the	  polyhistidine	  tag	  ..........................................................................	  262	  9.5.3.
	   Size	  exclusion	  chromatography	  (SEC)	  ...................................................................	  262	  9.5.4.
	   Storage	  of	  purified	  MtuDAH7PS	  ...........................................................................	  263	  9.5.5.
	   Purification	  of	  MtuCM	  .................................................................................................	  263	  9.6.
	   Cell	  lysis	  ................................................................................................................	  263	  9.6.1.
	   Affinity	  chromatography	  .......................................................................................	  264	  9.6.2.
	   Cleavage	  of	  GST-­‐tag	  ..............................................................................................	  265	  9.6.3.
	   SEC	  ........................................................................................................................	  266	  9.6.4.
	   Desalting	  ...............................................................................................................	  266	  9.6.5.
	   Storage	  of	  purified	  MtuCM	  ...................................................................................	  267	  9.6.6.
	   Structural	  characterisation	  ..........................................................................................	  267	  9.7.
	   Mass	  spectrometry	  ...............................................................................................	  267	  9.7.1.
	   Blue	  native	  PAGE	  of	  MtuDAH7PS	  .........................................................................	  267	  9.7.2.
	   Native	  PAGE	  of	  the	  MtuCM•MtuDAH7PS	  complex	  ..............................................	  268	  9.7.3.
	   Circular	  dichroism	  (CD)	  .........................................................................................	  268	  9.7.4.
	   Small	  angle	  X-­‐ray	  spectroscopy	  (SAXS)	  data	  collection	  ........................................	  268	  9.7.5.
	   SAXS	  data	  analysis	  ................................................................................................	  269	  9.7.6.
	   Analytical	  ultracentrifugation	  (AUC)	  .....................................................................	  270	  9.7.7.
	   IMAC	  pull	  down	  assay	  ...........................................................................................	  271	  9.7.8.
	   Biophysical	  characterisation	  ........................................................................................	  273	  9.8.
	   Differential	  scanning	  fluorimetry	  (DSF)	  ................................................................	  273	  9.8.1.
	   Isothermal	  titration	  calorimetry	  (ITC)	  ...................................................................	  273	  9.8.2.
	   Kinetic	  analysis	  .............................................................................................................	  275	  9.9.
	   Standard	  kinetic	  assays	  .........................................................................................	  275	  9.9.1.
	  xvi	  
	   Determination	  of	  substrate	  concentrations	  .........................................................	  276	  9.9.2.
	   Inhibition	  studies	  ..................................................................................................	  277	  9.9.3.
	   Kinetic	  determination	  of	  dissociation	  constant	  between	  MtuCM	  and	  MtuDAH7PS278	  9.9.4.
Appendix	  I	  –	  Michaelis-­‐Menten	  plots	  of	  kinetic	  data	  .............................................................	  279	  
Appendix	  II	  –	  AUC	  distribution	  and	  residual	  data	  ...................................................................	  287	  
Appendix	  III	  –	  Protein-­‐Protein	  interface	  interactions	  .............................................................	  295	  
Appendix	  IV	  –	  Examples	  of	  ITC	  HOD	  experiments	  ..................................................................	  299	  
Appendix	  V	  –	  Statistical	  analysis	  of	  DSF	  and	  kinetic	  data	  .......................................................	  301	  
Bibliography	  ................................................................................................................................	  311	  
	  
	  xvii	  
List	  of	  abbreviations	  
ACT	   aspartate	  kinase-­‐chorismate-­‐mutase-­‐tyrA	  	  
Ala	  (A)	   Alanine	  
AMP	   Ampicillin	  
Arg	  (R)	   Arginine	  
Asn	  (N)	   Asparagine	  
Asp	  (D)	   Aspartic	  acid	  
AUC	   Analytical	  ultracentrifugation	  
bp	   Base	  pairs	  
BSA	   Bovine	  serum	  albumin	  
BTP	   1,3-­‐bis(tris(hydroxymethyl)methylamino)propane	  
CAM	   Chloramphenicol	  
CD	   Circular	  dichroism	  
CM	   chorismate	  mutase	  
Cys	  (C)	   Cysteine	  
DAH7P	   3-­‐deoxy-­‐D-­‐arbino-­‐heptulosonate	  7-­‐phosphate	  
DAH7PS	   3-­‐deoxy-­‐D-­‐arbino-­‐heptulosonate	  7-­‐phosphate	  synthase	  
DNA	   Deoxy-­‐ribose	  nucleic	  acid	  
DSF	   Differential	  scanning	  fluorimetry	  
E4P	   D-­‐Erythrose	  4-­‐phosphate	  
EDTA	   Ethylenediamine	  tetra-­‐acetic	  acid	  
ESI-­‐MS	   Electrospray	  ionisation	  mass	  spectrometry	  
FPLC	   Fast	  protein	  liquid	  chromatography	  
Gln	  (Q)	   Glutamine	  
Glu	  (E)	   Glutamic	  acid	  
Gly	  (G)	   Glycine	  
GST	   glutathione	  S-­‐transferase	  
	  xviii	  
HCl	   Hydrochloric	  acid	  
His	  (H)	   Histidine	  
Ile	  (I)	   Isoleucine	  
IMAC	   Immobilised	  metal	  affinity	  chromatography	  
IPTG	   Isopropyl-­‐1-­‐thio-­‐β-­‐D-­‐galactopyranoside	  
ITC	   Isothermal	  titration	  calorimetry	  
kcat	   Turnover	  number	  
KDO8PS	   3	  Deoxy-­‐D-­‐manno-­‐octulosonate	  8-­‐phosphate	  
Km	   Michaelis-­‐Menten	  constant	  
KNF	   Koshland-­‐Nemethy-­‐Filmer	  
LB	   Lysogeny	  broth	  
Leu	  (L)	   Leucine	  
Lys	  (K)	   Lysine	  
MD	   Molecular	  dynamics	  
MDR-­‐TB	   Multidrug	  resistant	  TB	  
Met	   Methionine	  
MnSO4	   Manganese	  sulphate	  
MW	   Molecular	  weight	  
MWC	   Monod-­‐Wyman-­‐Changeux	  
MWCO	   Molecular	  weight	  cut-­‐off	  
NaCl	   Sodium	  chloride	  
NaOH	   Sodium	  hydroxide	  
NMR	   Nuclear	  magnetic	  resonance	  
OD	   Optical	  density	  
PAGE	   Polyacrylamide	  gel	  electrophoresis	  
PCR	   Polymerase	  chain	  reaction	  
PDB	   Protein	  Data	  Bank	  
PEP	   Phosphoenolpyruvate	  
Phe	  (F)	   Phenylalanine	  
	  xix	  
Pro	  (P)	   Proline	  
RMSD	   Root-­‐mean	  square	  deviation	  
RNA	   Ribonucleic	  acid	  
RPM	   Revolutions	  per	  minute	  
SAXS	   Small	  angle	  X-­‐ray	  scattering	  
SCA	   Statistical	  coupling	  analysis	  
SDM	   Site-­‐directed	  mutagenesis	  
SDS	   Sodium	  dodecyl	  sulphate	  
SEC	   Size	  exclusion	  chromatography	  
Ser	  (S)	   Serine	  
SOC	   Super	  optimal	  broth	  
TAE	   Tris	  base-­‐acetic	  acid-­‐EDTA	  
TB	   Tuberculosis	  
TCEP	   Tris(2-­‐carboxyethyl)phosphine	  	  
TEV	   Tobacco	  etch	  virus	  
Thr	  (T)	   Threonine	  
TIM	   Triose	  phosphate	  isomerase	  
Trp	  (W)	   Tryptophan	  
Tyr	  (Y)	   Tyrosine	  
UV	   Ultraviolet	  
Val	  (V)	   Valine	  
WAXS	   Wide	  angle	  X-­‐ray	  scattering	  
WHO	   world	  health	  organisation	  
XDR-­‐TB	   Extensively	  drug	  resistant	  T

	  xxi	  
Index	  of	  figures	  
Figure	  1.1	  Schematic	  of	  MWC	  model	  of	  allostery..	  ........................................................................	  2	  
Figure	  1.2	  Schematic	  of	  the	  KNF	  model	  of	  allostery	  .......................................................................	  3	  
Figure	  1.3	  Schematic	  of	  the	  morpheein	  model	  of	  allostery.	  ..........................................................	  4	  
Figure	  1.4	  Schematic	  of	  a	  dynamic	  energy	  landscape	  of	  a	  protein	  ................................................	  6	  
Figure	  1.5	  Schematic	  representation	  of	  the	  molecular	  communication	  pathways.	  .......................	  7	  
Figure	  1.6	  The	  shikimate	  pathway	  and	  aromatic	  amino	  acid	  biosynthesis.	  .................................	  11	  
Figure	  1.7	  Cartoon	  depeiction	  of	  the	  subunits	  of	  the	  	  different	  types	  of	  DAH7PS	  enzymes.	  .......	  15	  
Figure	  1.8	  Cartoon	  depeiction	  of	  the	  dimeric	  or	  trimeric	  	  chorismate	  mutase	  structures	  ...........	  16	  
Figure	  2.1	  The	  subunit	  structure	  of	  MtuDAH7PS	  soaked	  with	  Trp	  and	  Phe	  .................................	  21	  
Figure	  2.2	  Sequence	  of	  the	  pProEx-­‐HTa	  His6-­‐tag	  ..........................................................................	  23	  
Figure	  2.3	  A.	  An	  outline	  of	  the	  standard	  purification	  protocol	  for	  MtuDAH7PS.	  .........................	  24	  
Figure	  2.4	  Response	  of	  MtuDAH7PSWT	  activity	  to	  increasing	  concentrations	  of	  	  Trp,	  Phe	  or	  Tyr	   26	  
Figure	  2.5	  Remaining	  activity	  of	  MtuDAH7PSWT	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids.	  .......................................................................	  27	  
Figure	  2.6	  The	  effect	  of	  the	  aromatic	  amino	  acids	  on	  the	  thermal	  stability	  of	  MtuDAH7PSWT..	  ..	  29	  
Figure	  2.7	  ITC	  data	  for	  MtuDAH7PSWT	  ..........................................................................................	  31	  
Figure	  2.8	  SAXS	  scattering	  profiles	  for	  MtuDAH7PSWT	  with	  and	  without	  Trp,	  Phe	  and	  Tyr	  .	  ........	  34	  
Figure	  2.9	  Blue	  native	  PAGE	  of	  MtuDAH7PSWT.	  ............................................................................	  36	  
Figure	  2.10	  AUC	  distribution	  data	  for	  MtuDAH7PSWT	  with	  Phe	  and	  Trp	  ......................................	  38	  
Figure	  3.1	  Critical	  residues	  involved	  in	  ligand	  binding	  at	  site	  1.	  ...................................................	  42	  
Figure	  3.2	  Critical	  residues	  involved	  in	  ligand	  binding	  at	  site	  2..	  ..................................................	  45	  
Figure	  3.3	  SDS-­‐PAGE	  gel	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A.	  ............................................	  48	  
Figure	  3.4	  CD	  spectra	  for	  MtuDAH7PSWT,	  MtuDAH7PSR171A	  	  and	  MtuDAH7PSR256A	  ......................	  49	  
Figure	  3.5	  SAXS	  scattering	  profiles	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  .............................	  50	  
Figure	  3.6	  Blue	  native	  PAGE	  of	  MtuDAH7PSR171A	  and.	  MtuDAH7PSR256A	  ......................................	  51	  
	  xxii	  
Figure	  3.7	  Thermal	  stability	  of	  MtuDAH7PSR171A	  	  and	  MtuDAH7PSR256A	  in	  the	  presence	  of	  single,	  binary	  
and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  ...................................................	  53	  
Figure	  3.8	  ITC	  data	  for	  MtuDAH7PSR171A	  and	  MtuDAH7R256A.	  .......................................................	  57	  
Figure	  3.9	  Remaining	  activity	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  in	  the	  presence	  of	  various	  
single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  ..............................	  59	  
Figure	  3.10	  The	  subunit	  structure	  of	  MtuDAH7PS	  soaked	  with	  Trp	  and	  Phe	  ...............................	  61	  
Figure	  4.1	  Heterooctamer	  structure	  of	  MtuCM•MtuDAH7PS	  complex	  .......................................	  64	  
Figure	  4.2	  Alignment	  of	  MtuCM	  active	  site	  residues	  from	  the	  non-­‐complexed	  MtuCM	  and	  the	  
MtuCM•MtuDAH7PS	  complex	  ....................................................................................	  66	  
Figure	  4.3	  Sequence	  of	  the	  pDEST	  ™	  15	  GST-­‐tag.	  .........................................................................	  68	  
Figure	  4.4	  A.	  An	  outline	  of	  the	  standard	  purification	  protocol	  for	  MtuCM	  ..................................	  69	  
Figure	  4.5	  SDS-­‐PAGE	  gel	  of	  purified	  MtuCM.	  ...............................................................................	  72	  
Figure	  4.6	  Remaining	  activity	  of	  MtuCM	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids..	  ......................................................................	  73	  
Figure	  4.7	  The	  effect	  of	  the	  aromatic	  amino	  acids	  on	  the	  thermal	  stability	  of	  MtuCM	  ...............	  74	  
Figure	  4.8	  Effect	  or	  increasing	  MtuDAH7PSWT	  and	  NaCl	  concentration	  on	  MtuCM	  activity	  ........	  76	  
Figure	  4.9	  AUC	  distribution	  data	  for	  mixtures	  of	  MtuDAH7PSWT	  and	  MtuCM.	  ............................	  80	  
Figure	  4.10	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  for	  MtuCM	  aloneor	  with	  a	  ten-­‐fold	  excess	  of	  
MtuDAH7PSWT.	  ............................................................................................................	  82	  
Figure	  4.11	  Response	  of	  MtuCM	  catalytic	  efficiency	  (kcat/Km)	  to	  increasing	  concentrations	  of	  
MtuDAH7PSWT	  with	  and	  without	  Phe	  ..........................................................................	  85	  
Figure	  4.12	  A.	  Native	  PAGE	  of	  MtuCM•MtuDAH7PSWT	  	  with	  and	  without	  Phe	  and	  B.	  SDS-­‐PAGE	  analysis	  
of	  IMAC	  pull	  down	  assay	  fractions	  ..............................................................................	  87	  
Figure	  4.13	  AUC	  distribution	  data	  for	  mixtures	  of	  	  MtuDAH7PSWT	  andMtuCM	  with	  and	  without	  Phe
	  .....................................................................................................................................	  90	  
Figure	  4.14	  Remaining	  MtuDAH7PS	  activity	  for	  MtuDAH7PSWT	  with	  a	  ten-­‐fold	  molar	  excess	  of	  MtuCM	  
in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.
	  .....................................................................................................................................	  93	  
	  xxiii	  
Figure	  4.15	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSWT,	  MtuDAH7PSR171A	  and	  
MtuDAH7PSR256A	  ..........................................................................................................	  96	  
Figure	  4.16	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  for	  MtuCM	  with	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT,	  	  
MtuDAH7PSR171A	  or	  MtuDAH7PSR256A	  ...........................................................................	  97	  
Figure	  4.17	  Native	  PAGE	  of	  mixtures	  of	  MtuCM	  and	  MtuDAH7PSR171A	  or	  MtuDAH7PSR256A	  with	  and	  
without	  Phe.	  ................................................................................................................	  98	  
Figure	  4.18	  Remaining	  activity	  of	  MtuDAH7PSH6	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids.	  .....................................................................	  101	  
Figure	  4.19	  The	  activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSH6	  ....................................	  102	  
Figure	  4.20	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  for	  MtuCM	  with	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSH6
	  ...................................................................................................................................	  104	  
Figure	  4.21	  The	  interaction	  of	  the	  β0-­‐strand	  of	  adjacent	  subunits	  at	  the	  dimer	  interface,	  located	  
between	  subunits	  of	  the	  crystallographic	  asymmetric	  unit	  ......................................	  109	  
Figure	  5.1	  Structure	  of	  tetrameric	  MtuDAH7PS	  soaked	  with	  Trp	  and	  Phe	  highlighting	  the	  locations	  of	  
residues	  targeted	  for	  substitution	  .............................................................................	  115	  
Figure	  5.2	  SDS-­‐PAGE	  gel	  of	  purified	  MtuDAH7PSG190P,	  MtuDAH7PSV103A,	  MtuDAH7PSY131A	  and	  
MtuDAH7PSN175A.	  .......................................................................................................	  117	  
Figure	  5.3	  CD	  spectra	  for	  MtuDAH7PSG190,	  MtuDAH7PSV103A,	  MtuDAH7PSY131A	  and	  MtuDAH7PSN175A
	  ...................................................................................................................................	  118	  
Figure	  5.4	  SAXS	  profiles	  of	  MtuDAH7PSG190P,	  MtuDAH7PSV103A,	  MtuDAH7PSY131A	  and	  MtuDAH7PSN175A
	  ...................................................................................................................................	  120	  
Figure	  5.5	  Blue	  native	  PAGE	  of	  MtuDAH7PSG190P,	  MtuDAH7PSN175A,	  ,MtuDAH7PSV103A	  and	  
MtuDAH7PSY131A.	  .......................................................................................................	  121	  
Figure	  5.6	  AUC	  	  distributation	  data	  for	  MtuDAH7PSG190P	  and	  MtuDAH7PSV103A	  ........................	  123	  
Figure	  5.7	  Remaining	  activity	  of	  MtuDAH7PSG190P	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids.	  .....................................................................	  125	  
	  xxiv	  
Figure	  5.8	  The	  effect	  of	  individual,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  on	  the	  
thermal	  stability	  of	  MtuDAH7PSG190P	  	  ........................................................................	  126	  
Figure	  5.9	  ITC	  data	  for	  MtuDAH7PSG190P	  .....................................................................................	  128	  
Figure	  5.10	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSG190P	  .......................................	  130	  
Figure	  5.11	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSG190P	  ...	  131	  
Figure	  5.12	  Native	  PAGE	  of	  MtuCM	  mixed	  with	  MtuDAH7PSG190P	  with	  and	  without	  Phe.	  ........	  132	  
Figure	  5.13	  Remaining	  activity	  of	  MtuDAH7PSV103A	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids.	  .....................................................................	  136	  
Figure	  5.14	  The	  effect	  of	  individual,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  on	  the	  
thermal	  stability	  of	  MtuDAH7PSV103A	  .........................................................................	  137	  
Figure	  5.15	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSV103A	  .......................................	  138	  
Figure	  5.16	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSV103A	  ...	  140	  
Figure	  5.17	  Remaining	  activity	  of	  MtuDAH7PSY131A	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids.	  .....................................................................	  143	  
Figure	  5.18	  The	  effect	  of	  individual,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  on	  the	  
thermal	  stability	  of	  MtuDAH7PSY131A	  .........................................................................	  144	  
Figure	  5.19	  ITC	  data	  for	  MtuDAH7PSY131A	  ...................................................................................	  146	  
Figure	  5.20	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSY131A	  .......................................	  147	  
Figure	  5.21	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSY131A.	  ..	  149	  
Figure	  5.22	  Native	  PAGE	  of	  a	  mixture	  of	  	  MtuDAH7PSY131A	  with	  and	  without	  Phe.	  ...................	  150	  
Figure	  5.23	  Remaining	  activity	  of	  MtuDAH7PSN175A	  	  in	  the	  presence	  of	  various	  single,	  binary	  and	  
ternary	  combinations	  of	  aromatic	  amino	  acids.	  .....................................................	  153	  
Figure	  5.24	  The	  effect	  of	  individual,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  on	  the	  
thermal	  stability	  of	  MtuDAH7PSN175A	  ......................................................................	  154	  
Figure	  5.25	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSN175A	  .......................................	  155	  
	  xxv	  
Figure	  5.26	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSN175A	  157	  
Figure	  5.27	  Native	  PAGEof	  a	  mixture	  of	  MtuCM	  and	  MtuDAH7PSY131A	  with	  and	  without	  Phe.	  .	  158	  
Figure	  6.1	  Critical	  residues	  involved	  in	  ligand	  binding	  at	  the	  Trp	  site	  ........................................	  165	  
Figure	  6.2	  SDS-­‐PAGE	  gel	  of	  purified	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M.	  ............................	  168	  
Figure	  6.3	  CD	  spectra	  for	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  .............................................	  169	  
Figure	  6.4	  E4P-­‐dependent	  kinetic	  data	  for	  MtuDAH7PSN237A.	  ....................................................	  171	  
Figure	  6.5	  Remaining	  activity	  of	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  	  in	  the	  presence	  of	  various	  
single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  ........................	  172	  
Figure	  6.6	  E4P-­‐dpendent	  kinetic	  data	  for	  MtuDAH7PSN237A	  with	  with	  out	  Phe	  .........................	  175	  
Figure	  6.7	  The	  effect	  of	  individual,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  on	  the	  
thermal	  stability	  of	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  ...................................	  176	  
Figure	  6.8	  ITC	  data	  for	  MtuDAH7PSN237A	  ....................................................................................	  178	  
Figure	  6.9	  SAXS	  scattering	  profile	  of	  MtuDAH7PSN237A	  withand	  with	  out	  Trp	  and	  MtuDAH7PSK123M	  with	  	  
and	  without	  Phe.	  ....................................................................................................	  180	  
Figure	  6.10	  Blue	  native	  PAGE	  of	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  ..................................	  184	  
Figure	  6.11	  AUC	  distribution	  data	  for	  MtuDAH7PSK123M	  ............................................................	  186	  
Figure	  6.12	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSN237A	  or	  MtuDAH7PSK123M.	  .....	  187	  
Figure	  6.13	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  ofMtuDAH7PSN237A	  or	  
MtuDAH7PSK123M	  .....................................................................................................	  189	  
Figure	  7.1	  The	  dimer	  present	  in	  the	  crystallographic	  asymmetric	  unit,	  with	  schematic	  of	  the	  dimer	  
interface	  interactions	  ................................................................................................	  199	  
Figure	  7.2	  The	  tetramer	  interface	  formed	  by	  the	  interaction	  between	  chain	  A	  of	  the	  adjacent	  
assymeteric	  dimers.	  ...................................................................................................	  201	  
Figure	  7.3	  Interactions	  of	  Gly190	  and	  Gly232	  ............................................................................	  202	  
Figure	  7.4	  Hydrophobic	  grove	  located	  on	  tetramer	  interface	  of	  MtuDAH7PS	  ...........................	  204	  
Figure	  7.5	  SDS-­‐PAGE	  gel	  of	  purified	  MtuDAH7PSF227D,	  MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P.	  205	  
Figure	  7.6	  CD	  spectra	  of	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  ...........	  206	  
	  xxvi	  
Figure	  7.7	  SAXS	  profiles	  of	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  .......	  207	  
Figure	  7.8	  Blue	  native	  PAGE	  gel	  of	  MtuDAH7PSF227D;	  MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P210	  
Figure	  7.9	  AUC	  distribution	  dara	  for	  MtuDAH7PSG232P	  with	  and	  with	  out	  Trp	  and	  Phe	  .............	  211	  
Figure	  7.10	  Ternary	  complex	  kinetics	  used	  to	  determine	  the	  Km
PEP	  for	  MtuDAH7PSG232P,	  	  
MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D.	  .............................................................	  214	  
Figure	  7.11	  Remaining	  activity	  of	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  	  in	  the	  
presence	  of	  various	  single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids216	  
Figure	  7.12	  E4P-­‐dependent	  kinetic	  data	  of	  MtuDAH7PSG190P/G232P	  in	  the	  presence	  Trp	  and	  Phe.218	  
Figure	  7.13	  The	  effect	  of	  individual,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids	  on	  the	  
thermal	  stability	  of	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  	  and	  MtuDAH7PSF227D	  .	  220	  
Figure	  7.14	  ITC	  data	  for	  MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P	  ........................................	  223	  
Figure	  7.15	  (Figure	  7.14	  cont.)	  ITC	  data	  for	  MtuDAH7PSF227D	  ....................................................	  224	  
Figure	  7.16	  A.	  Activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  and	  
MtuDAH7PSF227D.	  .......................................................................................................	  225	  
Figure	  7.17	  Remaining	  MtuCM	  activity	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  
combinations	  of	  aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSG232P	  or	  
MtuDAH7PSF227D	  ......................................................................................................	  227	  
Figure	  7.18	  Cartoon	  and	  surface	  depiction	  of	  the	  MtuCM	  bound	  MtuDAH7PS	  .........................	  230	  
Figure	  8.1	  The	  change	  in	  position	  of	  the	  antiparallel	  β-­‐sheet	  formed	  between	  the	  β0-­‐strands	  of	  the	  




Index	  of	  tables	  
Table	  2.1	  A	  comparison	  of	  MtuDAH7PSWT	  kinetic	  parameters	  ....................................................	  25	  
Table	  2.2	  Dissociation	  constants	  determined	  for	  MtuDAH7PSWT	  by	  ITC	  ......................................	  31	  
Table	  2.3	  SAXS	  paramaters	  of	  MtuDAH7PSWT	  with	  and	  without	  Trp,	  Phe	  and	  Tyr	  ......................	  34	  
Table	  3.1	  Molecular	  masses	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  determined	  by	  MS	  ........	  47	  
Table	  3.2	  SAXS	  Parameters	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  ........................................	  50	  
Table	  3.3	  kinetic	  parameters	  of	  MtuDAH7PSWT,	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A.	  ...........	  52	  
Table	  3.4	  Dissociation	  constants	  determined	  for	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  by	  ITC..55	  
Table	  4.1	  A	  comparison	  of	  MtuCM	  Kinetic	  parameters	  ...............................................................	  73	  
Table	  4.2	  Comparison	  of	  MtuCM	  Kinetic	  parameters	  determined	  with	  and	  without	  MtuDAH7PSWT	  77	  
Table	  4.3	  Kinetic	  parameters	  for	  MtuCM	  in	  the	  presence	  of	  ten-­‐fold	  molar	  excess	  of	  MtuDAH7PSWT	  
and	  ligands	  .....................................................................................................................	  84	  
Table	  4.4	  Kinetic	  parameters	  determined	  for	  MtuDAH7PSWT	  with	  and	  without	  the	  presence	  of	  a	  ten-­‐
fold	  excess	  of	  MtuCM..	  ...................................................................................................	  91	  
Table	  4.5	  Kinetic	  parameters	  for	  MtuCM	  activity	  determined	  for	  MtuCM	  with	  or	  without	  a	  ten-­‐fold	  
excess	  of	  MtuDAH7PSR171A	  or	  MtuDAH7PSR256A	  ..............................................................	  95	  
Table	  4.6	  Kinetic	  parameters	  determined	  for	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  with	  and	  without	  
the	  presence	  of	  a	  ten-­‐fold	  excess	  of	  MtuCM	  ...............................................................	  100	  
Table	  5.1	  List	  of	  residues	  considered	  as	  mutagenesis	  targets.	  ...................................................	  112	  
Table	  5.2	  Molecular	  masses	  of	  MtuDAH7PS	  variants	  determined	  by	  MS.	  .................................	  117	  
Table	  5.3	  SAXS	  parameters	  determined	  for	  MtuDAH7PS	  variants.	  ............................................	  120	  
Table	  5.4	  Kinetic	  parameters	  determined	  for	  MtuDAH7PSG190P	  .................................................	  124	  
Table	  5.5	  Dissociation	  constants	  determined	  for	  MtuDAH7PSG190P	  by	  ITC..	  ...............................	  128	  
Table	  5.6	  Kinetic	  parameters	  determined	  for	  MtuDAH7PSV103A	  .................................................	  135	  
Table	  5.7	  Kinetic	  parameters	  determined	  from	  for	  MtuDAH7PSY131A.	  .......................................	  142	  
Table	  5.8	  Dissociation	  constants	  determined	  for	  MtuDAH7PSY131A	  by	  ITC	  .................................	  146	  
Table	  5.9	  Kinetic	  parameters	  determined	  from	  MtuDAH7PSN175A.	  ............................................	  152	  
	  xxviii	  
Table	  6.1	  Kinetic	  parameters	  for	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M.	  ................................	  170	  
Table	  6.2	  The	  kinetic	  parameters	  determined	  for	  the	  E4P-­‐dependent	  kinetics	  of	  MtuDAH7PSN237A	  and	  
MtuDAH7PSK123M	  ..........................................................................................................	  174	  
Table	  6.3	  Dissociation	  constants	  determined	  for	  MtuDAH7PSN237A	  by	  ITC.	  ...............................	  177	  
Table	  6.4	  SAXS	  parameters	  determined	  for	  MtuDAH7PSN237A	  with	  and	  without	  Trp,	  and	  
MtuDAH7PSK123M	  with	  and	  without	  Phe.	  ......................................................................	  181	  
Table	  6.5	  SAXS	  parameters	  determined	  for	  MtuDAH7PSK123M	  by	  OLIGOMER	  ...........................	  183	  
Table	  6.6	  E4P-­‐dependent	  kinetic	  parameters	  for	  MtuDAH7PSK123M	  with	  and	  without	  a	  ten-­‐fold	  molar	  
excess	  of	  MtuCM..	  ........................................................................................................	  190	  
Table	  7.1	  SAXS	  parameters	  determined	  for	  dimeric	  MtuDAH7PS	  variants	  ................................	  209	  
Table	  7.2	  Kinetic	  parameters	  of	  dimeric	  MtuDAH7PS	  variants	  ..................................................	  212	  
Table	  7.3	  E4P-­‐dependent	  kinetic	  parameters	  for	  MtuDAH7PSG190P/G232P	  with	  and	  without	  Trp	  and	  Phe
	  ......................................................................................................................................	  219	  
Table	  7.4	  Dissociation	  constants	  for	  the	  dimeric	  MtuDAH7PS	  variants	  determined	  by	  ITC.	  .....	  224	  
Table	  9.1	  Sequence	  of	  primers	  designed	  for	  site-­‐directed	  mutagenesis.	  ..................................	  251	  
Table	  9.2	  Molar	  extinction	  coefficients	  determined	  for	  MtuDAH7PS	  and	  MtuCM	  ....................	  258	  
Table	  9.3	  Frictional	  coefficient	  ratios	  (f/f0)	  .................................................................................	  271	  






• Blackmore,	  N.	  J.;	  Reichau,	  S.;	  Jiao,	  W.;	  Hutton,	  R.	  D.;	  Baker,	  E.	  N.;	  Jameson,	  G.	  B.;	  Parker,	  E.	  J.,	  
Three	  sites	  and	  you	  are	  out:	  ternary	  synergistic	  allostery	  controls	  aromatic	  amino	  acid	  
biosynthesis	  in	  Mycobacterium	  tuberculosis.	  J.	  Mol.	  Biol.	  2013,	  425	  (9),	  1582-­‐1592.	  	  
• Webby,	  C.	  J.,	  Jiao,	  W.,	  Hutton,	  R.	  D.,	  Blackmore,	  N.	  J.,	  Baker,	  H.	  M.,	  Baker,	  E.	  N.,	  Jameson,	  G.	  
B.,	  and	  Parker,	  E.	  J.	  Synergistic	  allostery,	  a	  sophisticated	  regulatory	  network	  for	  the	  control	  of	  
aromatic	  amino	  acid	  biosynthesis	  in	  Mycobacterium	  tuberculosis,	  J.	  Biol.	  Chem.	  2010	  285,	  
30567-­‐30576.	  
	   	  





All	   living	   cells	   are	   dependent	   on	   the	   wide	   range	   of	   enzyme-­‐catalysed	   chemical	   reactions	   for	   their	  
survival.	   Biological	   pathways	   are	   a	   series	   of	   chemical	   reactions	   responsible	   for	   the	   formation	   of	   a	  
particular	   product	   or	   which	   lead	   to	   a	   specific	   cellular	   change.	   Typically	   biological	   pathways	   are	  
responsible	   for	   the	  biosynthesis	  of	  necessary	  metabolites	  or	   the	  degradation	  of	  potentially	  harmful	  
chemicals.	  Every	  living	  cell	  possesses	  a	  huge	  array	  of	  integrated	  biological	  pathways,	  which	  need	  to	  be	  
tightly	  controlled	  to	  ensure	  that	  the	  rates	  of	  these	  chemical	  reactions	  are	  appropriate	  to	  meet	  cellular	  
needs.	   Regulation	  of	   these	  biological	   pathways	   is	   achieved	   chiefly	   by	   either	   directly	   controlling	   the	  
enzymatic	   activity	   of	   critical	   enzymes	   along	   the	   pathways	   or	   by	   controlling	   the	   expression	   of	   the	  
genes	  that	  encode	  the	  enzymes.	  Regulation	  of	  enzymatic	  activity	  is	  commonly	  accomplished	  by	  either	  
covalent	  modification	  of	  the	  enzyme,	  the	  use	  of	  inactive	  enzymatic	  precursors,	  called	  zymogens,	  or	  by	  
allosteric	  regulation	  of	  the	  enzyme.1-­‐3	  
 Allostery	  1.1.
Allosteric	  regulation	  is	  generally	  defined	  as	  the	  activation	  or	  inhibition	  of	  protein	  functionality	  by	  non-­‐
covalent	   interactions	  with	  an	  effector	  molecule(s).	  The	  term	  allostery	   is	  derived	  from	  allos	  meaning	  
“other”	   and	   stereos	  meaning	   “solid”,	   in	   reference	   to	   an	   effector	  molecule	   binding	   to	   a	   site	   on	   the	  
enzyme	  remote	   from	  the	  active	  site.2,4	   In	  general	   terms	  the	  binding	  of	   the	  effector	  molecule	  to	  the	  
allosteric	  binding	  site	  of	  an	  enzyme	  confers	  some	  change	  that	  affects	  enzyme	  activity	  at	  the	  remote	  
active	   site.2,4	   Allostery	   is	   a	   general	   property	   of	   proteins	   and	   non-­‐enzyme	   proteins,	   such	   as	   cell	  
receptors,	  and	  metabolite	  binding	  proteins	  can	  also	  display	  allostery	  with	  the	  binding	  of	  an	  allosteric	  
effector	   conferring	   some	   change	   that	   affects	   another	   site	   responsible	   for	   protein	   function.	   The	  
concept	  of	  allostery	  can	  also	  be	  broadened	  to	  include	  the	  interactions	  between	  the	  similar	  sites	  on	  a	  
multisubunit	  protein,	  which	  is	  sometimes	  referred	  to	  as	  cooperativity.2	  There	  are	  two	  classical	  models	  
used	   to	  describe	  allostery:	   the	  MWC	  model	  and	  the	  KNF	  model.	  These	  models	  have	  evolved	  and	   in	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some	  cases	  merged	  as	  our	  understanding	  of	  allostery	  has	  grown	  leading	  to	  new	  models	  such	  as	  the	  
morpheein	  and	  dynamic	  energy	  landscape	  models	  of	  allostery.5,6	  
 Monod-­‐Wyman-­‐Changeux	  (MWC)	  model	  1.1.1.
The	  first	  proposed	  model	  of	  allostery	  was	  put	  forward	  by	  Monod	  Wyman	  and	  Changeux,	  after	  whom	  
it	  was	  named.7	  The	  model	  was	  proposed	  based	  on	  correlating	  the	  structural	  organisation	  of	  a	  protein	  
with	  observed	  cooperativity.7,8	  The	  model	  states	  that	   in	  the	  absence	  of	   ligand	  an	  oligomeric	  protein	  
exists	  as	  an	  equilibrium	  between	  two	  conformational	  states	  usually	  referred	  to	  as	  the	  relaxed	  (R)	  and	  
tense	   (T)	   states.4,7,8	   The	   addition	   of	   an	   effector	   molecule	   perturbs	   this	   equilibrium	   to	   favour	   a	  
particular	  state	  with	  a	  higher	  affinity	  for	  the	  effector	  (Figure	  1.1).	  	  
	  
	  
Figure	  1.1	  Schematic	  of	  MWC	  model	  of	  allostery.	  A	  symmetric	  oligomeric	  protein	  can	  either	  exist	  in	  a	  relaxed	  (R)	  
or	   tense	   (T)	   conformational	   state.	   These	   two	   conformational	   states	  may	  vary	   in	   their	   affinity	   for	   the	  allosteric	  
effector.	  
	  
This	  model	  also	  assumes	  the	  subunits	  of	  a	  protein	  are	  arranged	  together	  so	  as	  the	  oligomeric	  state	  of	  
the	   protein	   possesses	   at	   least	   one	   axis	   of	   symmetry.	   The	  model	   also	   assumes	   all	   (or	   none)	   of	   the	  
subunits	  of	   the	  protein	  undergo	   the	   transition	  between	   the	  R	   and	  T	   states	   in	   a	   concerted	  manner,	  
thus	  conserving	  the	  symmetry	  of	  the	  enzyme	  (Figure	  1.1).	  Consequently	  this	  model	  is	  also	  referred	  to	  
as	  the	  concerted	  model.	  
Allosteric	  Effector	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 Koshland-­‐Némethy-­‐Filmer	  (KNF)	  model	  1.1.2.
A	   year	   after	   the	   MWC	   was	   proposed	   the	   KNF	   model	   of	   allostery	   was	   put	   forward	   by	   Koshland,	  
Némethy	   and	   Filmer.9	   This	   model	   was	   derived	   from	   the	   concept	   of	   induced	   fit	   theory,	   where	   the	  
binding	   of	   an	   effector	   molecule	   causes	   a	   change	   in	   the	   protein’s	   structure	   to	   accommodate	   the	  
effector	   molecule.4,9,10	   In	   the	   KNF	   model	   the	   binding	   of	   an	   effector	   to	   a	   protein	   subunit	   induces	  
conformational	   change	   to	   that	   subunit	   to	   enable	   the	   effector	   to	   bind	   (Figure	   1.2).	   4,9,10	   This	  
conformational	   change	   that	   occurs	   at	   the	   subunit	   to	   which	   the	   effector	   bound	   can	   also	   induce	  
changes	  to	  other	  subunits,	  which	  affect	  effector	  binding	  at	  those	  subunits.	  1,4,9,10	  For	  this	  reason	  the	  
KNF	  model	  is	  commonly	  referred	  to	  as	  the	  sequential	  model	  of	  allostery.1,4,10	  
	   	  
Figure	   1.2	   Schematic	   of	   the	   KNF	   model	   of	   allostery.	   The	   subunit	   of	   an	   oligomeric	   enzyme	   undergoes	  
conformational	   change	   to	   facilitate	   the	   binding	   of	   an	   allosteric	   effector.	   This	   conformational	   change	   induces	  
changes	  in	  other	  subunits	  affecting	  effector	  binding	  and/or	  substrate	  binding	  at	  other	  subunits.	  
	  
The	   KNF	  model	   assumes	   that	   one	   conformation	  will	   only	   exist	   in	   the	   absence	   of	   ligand	   and	   that	   a	  
second	   conformation	  will	   only	   exist	  when	   an	   effector	  molecule	   binds	   to	   the	   protein	   and	   induces	   a	  
change	  to	  the	  structure	  of	  the	  protein	  (Figure	  1.2).1,4,9,10	  The	  change	  that	  occurs	  at	  one	  subunit	  due	  to	  
effector	  binding	  can	  make	  changes	  to	  other	  subunits	   take	  place	  more	  readily	  but	  this	  change	   is	  not	  
propagated	   to	  all	  associated	  subunits	  as	  proposed	   in	   the	  MWC	  model.	  Furthermore	   the	  KNF	  model	  
does	  not	  require	  all	  the	  subunits	  of	  an	  protein	  to	  adopt	  the	  same	  conformation,	  thus	  the	  protein	  does	  
not	  need	  to	  be	  symmetrical.1,2	  Moreover	  the	  KNF	  model	  introduces	  the	  idea	  that	  a	  protein	  can	  occupy	  
different	  conformations	  between	  the	  initial	  and	  final	  states	  of	  a	  conformational	  equilibrium.11	  
	  
The	  KNF	  model	  allows	  for	  both	  positive	  and	  negative	  heterotropic	  and	  homotropic	  effects	  on	  effector	  
(and	   substrate)	   binding.1	   Molecules	   that	   influence	   the	   binding	   of	   different	   molecules	   to	   a	   protein	  
have	  a	  heterotropic	  effect,	  whereas	  molecules	   that	   influence	   the	  binding	  of	   the	  same	  molecules	   to	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the	   protein	   have	   a	   homotropic	   effect.	   This	   is	   particularly	   advantageous	  when	   considering	   negative	  
cooperativity,	  which	  is	  when	  the	  binding	  of	  an	  effector	  to	  one	  protein	  subunit	  may	  cause	  changes	  in	  
other	  subunits	  that	  decrease	  the	  affinity	  of	  the	  protein	  for	  the	  effector,	  encumbering	  effector	  binding.	  
1,4,9,10	  
 Morpheein	  model	  1.1.3.
The	  morpheein	  model	   of	   allostery	   can	   be	   viewed	   as	   an	   extension	   of	   the	  MWC	  and	   KNF	  models	   of	  
allostery	  and	  proposes	  that	  an	  oligomeric	  protein	  dissociates	   into	  smaller	  subunits.	   Jaffe	  coined	  the	  
term	  morpheein	   in	  2005	  to	  describe	  homooligomeric	  proteins	   that	  reversibly	  dissociate	  and	  change	  
conformation	  in	  their	  dissociated	  state.5,12	  The	  morpheein	  model	  of	  allostery	  requires	  the	  dissociated	  
state	   of	   the	   homooligomeric	   protein	   to	   undergo	   a	   conformational	   change	   and	  may	   reassemble	   to	  
form	  another	  structurally	  and	  functionally	  distinct	  oligomer	  (Figure	  1.3).5,12	   In	  the	  morpheein	  model	  
of	  allostery	  all	  subunit	  forms	  are	  accessible	  in	  the	  presence	  and	  absence	  of	  an	  allosteric	  effector,	  but	  
the	   allosteric	   effector	   may	   shift	   the	   position	   of	   the	   dynamic	   equilibrium	   between	   the	   different	  




Figure	  1.3	  Schematic	  of	  the	  morpheein	  model	  of	  allostery.	  A	  homooligomeric	  enzyme	  reversibly	  dissociates	  into	  
smaller	   subunits	   that	   may	   undergo	   conformational	   change	   in	   their	   dissociated	   state.	   These	   subunits	   with	   an	  
altered	  conformation	  can	  then	  reassemble	  to	  form	  an	  alternative	  structurally	  and	  functionally	  distinct	  oligomeric	  
structure.	  The	  addition	  of	  an	  allosteric	  effector	  may	  shift	  the	  equilibrium	  to	  favour	  a	  particular	  homo-­‐oligomer.	  
 Dynamic	  energy	  landscape	  model	  1.1.4.
The	  MWC	  and	  KNF	  models	  of	  allostery	  were	  originally	  proposed	  as	  conceptual	  models	  to	  explain	  the	  
observed	   cooperative	   binding	   of	   oxygen	   to	   haemoglobin.3,7,9	   Many	   authors	   have	   noted	   these	   two	  
models	  could	  be	  considered	  as	  special	  cases	  of	  more	  general	  models	   in	  which	  neither	  induced	  fit	  or	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conformational	   symmetry	  are	  conserved.4,6,10,13-­‐15	   In	   recent	  years	   the	  concepts	  of	  allostery	  provided	  
by	   these	  models	  and	   their	  application	  have	  been	  expanded	   to	  encompass	  monomeric	  proteins	   (i.e.	  
chemotaxis	   protein	   Y,	   and	   trypsin-­‐like	   proteases),	   unstructured	   allosteric	   proteins	   (i.e.	   glucokinase	  
and	  protein	   kinase	  A)	   and	   allosteric	   proteins	   that	   show	  no	  evidence	  of	   conformational	   change	   (i.e.	  
catabolite	  activator	  protein).8,10,16-­‐19	  It	  should	  also	  be	  noted	  that	  the	  concept	  of	  the	  allosteric	  effector	  
has	  also	  developed	  as	  the	  study	  of	  allosteric	  proteins	  has	  grown,	  the	  allosteric	  effector	   is	  no	   longer	  
constrained	  to	  being	  a	  small	  molecule;	  the	  effector	  can	  be	  as	  large	  as	  another	  protein.16	  	  
	  
The	  current	  understanding	  of	  allostery	  is	  based	  on	  the	  premise	  that	  proteins	  exist	  as	  an	  ensemble	  of	  
possible	   conformational	   states	   populated	   according	   to	   their	   Boltzmann	   distribution.11,20-­‐22	   Proteins	  
are	  considered	  to	  populate	  a	  dynamic	  energy	  landscape	  with	  multiple	  energy	  minima	  (Figure	  1.4).6,15	  
The	  protein	  can	  sample	  these	  minima	  via	  its	  natural	  molecular	  dynamic	  fluctuations,	  but	  will	  primarily	  
occupy	  the	  lowest	  energy	  state.6,15	  Effector	  binding	  to	  the	  protein	  changes	  the	  energy	  landscape	  and	  
the	  protein	  population	  is	  redistributed	  favouring	  the	  new	  lowest	  energy	  state.11,20	  Okazaki	  proposed	  
that	   both	   induced-­‐fit	   and	   population	   shift	   (derived	   from	   the	   KNF	   and	   MWC	   models	   of	   allostery	  
respectively)	   can	  allow	  proteins	   to	   jump	  between	   the	  unbound	  protein	   and	  effector-­‐bound	  protein	  
energy	  landscapes.6	  	  





Figure	  1.4	  Schematic	  of	  a	  dynamic	  energy	  landscape	  of	  a	  protein.	  On	  top	  is	  the	  energy	  landscape	  populated	  by	  a	  
protein	   with	   no	   effector	   bound	   (unbound	   protein)	   and	   below	   the	   energy	   landscape	   of	   the	   effector-­‐bound	  
protein.	   The	   ligand	   can	   jump	   between	   the	   two	   energy	   landscapes	   by	   effector	   binding	   or	   unbinding.	   Both	   an	  
induced-­‐fit	   or	   population	   shift	   model	   of	   allostery	   can	   represent	   the	   jump	   between	   the	   energy	   landscapes.	  
Schematic	  adapted	  from	  Okazaki	  et	  al..6	  
	  
The	  MWC	  and	  KNF	  models	  of	  allostery,	  are	  phenomenological	  and	  do	  not	  directly	  address	  how	  the	  
binding	   of	   an	   effector	   causes	   the	   observed	   allosteric	   effect	   in	   atomic	   detail.4,10	   The	   classic	   view	   of	  
allostery,	  which	  considered	  allostery	  in	  terms	  of	  two	  distinct	  conformations,	  sought	  one	  well-­‐defined	  
communication	  pathway	  between	  the	  allosteric	  binding	  site	  and	  the	  active	  site	  (Figure	  1.5A).16,23	  The	  
binding	   signal	   of	   an	   allosteric	   effector	   is	   transmitted	   along	   this	  molecular	   communication	   pathway	  
and	  alters	  the	  conformation	  of	  the	  active	  site	  to	  better	  facilitate	  or	  impede	  catalysis.	  Communication	  
pathways	   refer	   to	   a	   set	   of	   residues	   that	   dynamically	   contact,	   creating	   a	   structural	   pathway	   that	  
















Figure	   1.5	   Schematic	   representation	   of	   the	   molecular	   communication	   pathways	   that	   connect	   the	   allosteric	  
effector	   binding	   site	   and	   the	   active	   site.	   In	   this	   scenario	   the	   effector	   acts	   as	   an	   inhibitor;	   the	   binding	   of	   the	  
effector	  at	  the	  allosteric	  binding	  site	  is	  communicated	  to	  the	  active	  site	  preventing	  substrate	  binding.	  According	  
the	   classic	   view	   (A)	   a	   single	   pathway	   exists	   between	   the	   active	   site	   and	   the	   allosteric	   binding	   site,	   whereas	  
multiple	  connected	  pathways	  link	  the	  two	  sites	  in	  the	  current	  view	  (B).	  
	  
Overtime	  this	  view	  has	  evolved	  to	  the	  current	  view	  that	  enzymes	  exist	  as	  ensembles	  thus	  permitting	  
networks	   of	   communication	   pathways	   to	   exist.16,23	   The	   binding	   of	   the	   allosteric	   effector	   can	   be	  
transmitted	   along	  multiple	   pathways,	   each	   pathway	   contributing	   to	   the	   changes	   that	   occur	   at	   the	  
active	   site	   (Figure	   1.5B).	   The	   changes	   that	   occur	   at	   the	   active	   site	   are	   not	   restricted	   to	   detectable	  
conformational	   changes.	   16,23	   Alternatively,	   effector	   binding	   may	   change	   the	   flexibility	   or	   dynamic	  
motion	   of	   an	   enzyme,	   which	   thermodynamic	   affects	   the	   affinity	   of	   an	   enzyme	   for	   its	   substrate	  
without	   changing	   the	   average	   conformation	   of	   the	   enzyme.16,22-­‐24	   The	   catabolite	   activator	   protein	  
(CAP)	  is	  the	  most	  prominent	  example	  of	  an	  allosteric	  enzyme	  that	  does	  not	  undergo	  conformational	  
change.8,22,25	   The	   binding	   of	   cyclic	   adenosine	  monophosphate	   (cAMP)	   to	   CAP	   switches	   the	   enzyme	  
from	   inactive	   to	   active	   without	   any	   evidence	   of	   structural	   change.8,25	   Nuclear	  magnetic	   resonance	  
analysis	  revealed	  the	  intrinsic	  motion	  of	  the	  unliganded	  CAP	  was	  strongly	  affected	  by	  the	  addition	  of	  
cyclic	   adenosine	   monophosphate	   (cAMP).8,16,25	   CAP	   was	   one	   of	   the	   first	   examples	   of	   an	   allosteric	  
mechanism	  that	  is	  entropically	  driven.	  8,16,25	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 Allostery	  and	  drug	  discovery	  1.1.5.
In	  the	  past	  drug	  development	  has	  almost	  exclusively	  focused	  on	  developing	  compounds	  that	  bind	  to	  
the	   orthosteric	   site	   of	   a	   protein	   to	   effectively	   inhibit	   protein	   function.3,16	  More	   recently	   drugs	   that	  
bind	  to	  the	  allosteric	  binding	  site	  of	  a	  protein	  are	  being	  more	  actively	  pursued.	  3,16	  There	  is	  a	  range	  of	  
allosteric	   drugs	   currently	   available	  on	   the	  market	   including	  Valium	  and	   the	  benzodiazepines,	  which	  
target	  the	  ionotropic	  γ-­‐aminobutyric	  acid	  (GABA)	  receptor.3,26	  	  
	  
One	   advantage	   of	   drugs	   developed	   based	   on	   allosteric	   ligands	   is	   that	   they	   can	   either	   activate	   or	  
inactivate	   their	   target	   protein	   opening	   up	   a	   new	   range	   of	   novel	   therapeutic	   drug	   targets.	   3,16	   One	  
example	   of	   a	   potential	   drug	   target	  where	   activation	   of	   the	   target	   enzyme	  may	  be	   beneficial	   is	   the	  
sirtuins.	  The	  sirtuins	  are	  a	  class	  of	  deacetylases	  being	  explored	  as	  potential	  therapeutic	  targets	  for	  the	  
treatment	  of	  age-­‐related	  diseases	  such	  as	  type-­‐2	  diabetes.27,28	  The	  activation	  of	  the	  silent	  information	  
regulator	   protein	   2	   (Sir2p)	   from	   yeast	   has	   been	   correlated	   to	   increased	   longevity	   in	   response	   to	  
calorie	   restriction.28	   Investigation	   into	   the	   human	   orthologue	   of	   Sir2p,	   SIRT1,	   has	   identified	   small	  
molecules,	  which	  activate	  SIRT1	  and	  may	  mimic	  the	  beneficial	  effects	  of	  calorie	  restriction.27,28	  
	  
Allosteric	  drugs	  have	  other	  potential	  advantages	  over	  orthosteric	  drugs.	  Allosteric	  drugs	  are	  typically	  
highly	  specific	  as	   the	  allosteric	  binding	  sites	  are	   less	  conserved	  across	  protein	   families	  compared	   to	  
the	  active	  site.	  3,26	  Higher	  specificity	  in	  turn	  can	  also	  lead	  to	  a	  lower	  risk	  of	  side	  effects.3,26	  Allosteric	  
drugs	  tend	  to	  modulate	  enzyme	  activity	  rather	  than	  eliminating	  it	  completely.3	  Allosteric	  drugs	  do	  not	  
necessarily	  need	  to	  bind	  to	  the	  target	  protein	  directly	  to	  affect	  the	  protein’s	  function.	  The	  effect	  of	  an	  
allosteric	   drug	  may	   be	   propagated	   along	   different	   proteins	   or	   receptors	   often	   by	   altering	   protein-­‐
protein	   interfaces.3	   A	   phenomena	   illustrated	   by	   the	   indirect	   allosteric	  modulation	   of	   the	  G-­‐protein	  
coupled	  receptor	  (GPCR).	  Ligand	  binding	  reduces	  the	  interactions	  between	  different	  combinations	  of	  
receptors	  in	  the	  glucagon	  receptor	  family	  (GPCR	  class	  B).3,29	  An	  increase	  in	  the	  interactions	  between	  
the	   gastric-­‐inhibitory-­‐peptide-­‐receptor	   (GIPR)	   and	   the	   glucagon-­‐like-­‐peptide-­‐1-­‐receptor	   (GLP	   1R)	   is	  
observed	  upon	  binding	  of	  GLP-­‐1	  to	  the	  GLP	  1R.	  The	  binding	  of	  GIP	  to	  GIPR-­‐GLP	  reverses	  this	  effect.	  3,29	  
Although	   this	   allosteric	   propagation	  may	  broaden	   the	   range	  of	   available	   therapeutic	   targets	   it	  may	  
Introduction	   1	  
	  
9	  
also	  make	  it	  more	  difficult	  to	  predict	  the	  possible	  side	  effects	  of	  an	  allosteric	  drug.	  Moreover,	  it	  must	  
be	  remembered	  that	  drug	  development	  targets	  a	  population	  of	  patients	  and	  this	  population	  may	  have	  
significant	  variance	  in	  their	  metabolism	  and	  genetics	  due	  to	  factors	  such	  as	  age,	  ethnicity	  and	  health.3	  
This	   variance	   may	   prevent	   some	   allosteric	   drugs	   working	   on	   individual	   patients	   due	   to	   different	  
propagation	  pathways	  operating	  within	  the	  metabolism	  of	  different	  patients.	  
	  
Another	  complication	  that	  may	  arise	  in	  the	  development	  of	  allosteric	  drugs	  is	  the	  difficulty	  to	  identify	  
the	   allosteric	   binding	   sites	   of	   a	   protein.	   The	   exact	   effect	   of	   an	   effector	   can	   also	   be	   difficult	   to	  
predict.3,26	  Unlike	  orthosteric	   sites,	   the	   allosteric	   binding	   sites	   of	   a	   protein	   are	  more	   likely	   to	  differ	  
widely	  between	  organisms.	  Thus	  allosteric	  drugs	  that	  work	  in	  a	  rat	  model	  may	  not	  work	  in	  the	  human	  
homologue.3	  Furthermore	  allosteric	  drugs	  are	  not	  immune	  to	  the	  development	  of	  drug	  resistance	  as	  
observed	   by	   melanoma	   cells	   becoming	   resistant	   to	   B-­‐RAF	   (V600E)	   inhibition	   by	   allosteric	   MEK	  
inhibitors	  by	  up	  regulating	  receptor	  tyrosine	  kinases.3,30	  
	  
The	   pursuit	   of	   allosteric	   drugs	   offers	   new	   opportunities	   for	   the	   development	   of	   novel	   drugs	   if	   the	  
target	   proteins	   are	   carefully	   considered	   in	   an	   effort	   to	  mitigate	   the	   additional	   challenges	   allosteric	  
drugs	   can	   pose.	   Perhaps	   one	   of	   the	   greatest	   potential	   benefits	   of	   pursuing	   allosteric	   drugs	   is	   the	  
possibility	   of	   developing	   treatment	   plans	   to	   combat	   drug	   resistance	   by	   using	   a	   combination	   of	  
allosteric	  and	  orthosteric	  drugs.3	  	  
	  
 Mycobacterium	  tuberculosis	  1.2.
Mycobacterium	  tuberculosis	   (M.	   tuberculosis)	   is	  a	   contagious	  airborne	  pathogen	   that	   is	   the	  primary	  
causative	  agent	  of	  tuberculosis	  (Tb).	  In	  2012,	  8.3	  million	  people	  contracted	  Tb,	  the	  infection	  proving	  
fatal	   in	   1.4	  million	   of	   those	   cases,	   making	   Tb	   the	   second	   leading	   cause	   of	  mortality	   from	   a	   single	  
infectious	  agent.31,32	  It	   is	  believed	  that	  Tb	  affects	  more	  than	  one	  third	  of	  the	  world’s	  population	  and	  
although	  incidence	  is	  reported	  throughout	  the	  world,	  prevalence	  is	  greatest	  in	  developing	  nations.31	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Inadequate	  diagnostics	  and	  the	  long	  (6-­‐9	  month)	  treatment	  plans	  for	  Tb	  have	  lead	  to	  the	  emergence	  
of	  multi-­‐drug	  resistant	  Tb	  (MDR-­‐Tb),	  which	  is	  defined	  as	  resistant	  to	  two	  types	  of	  the	  first-­‐line	  anti-­‐Tb	  
drugs,	  isoniazid	  and	  rifampin.31,33	  In	  2006,	  the	  World	  Health	  Organisation	  (WHO)	  and	  the	  US	  Centers	  
for	   Disease	   Control	   and	   Prevention	   (CDC)	   classified	   a	   new	   extensively	   drug-­‐resistant	   Tb	   (XDR-­‐Tb)	  
strain.34	   XDR-­‐Tb	   is	   defined	   as	   resistance	   to	   flouroquinolone	   and	   at	   least	   one	   other	   second-­‐line	  
injectable	  anti-­‐Tb	  drug	  (kanamycin,	  amikacin	  or	  capreomycin)	  in	  addition	  to	  isoniazid	  and	  rifampin.33-­‐
36	  Incidences	  of	  MDR-­‐	  or	  XDR-­‐Tb	  have	  been	  reported	  worldwide	  and	  treatment	  for	  both	  requires	  the	  
use	  of	  less	  effective	  and	  more	  expensive	  second-­‐line	  drugs	  for	  at	  least	  20	  months.31,33,34,36	  
	  
Alarmingly	   in	   2009	   a	   new	   strain	   of	   totally	   drug-­‐resistant	   Tb	   (TDR-­‐Tb)	   was	   announced,	   possibly	  
resistant	  to	  all	  first-­‐	  and	  second-­‐line	  anti-­‐Tb	  drugs.37	  WHO	  is	  yet	  to	  recognise	  the	  emergence	  of	  TDR-­‐
Tb,	  mainly	  due	  to	  ambiguity	  in	  defining	  and	  testing	  the	  antibiotic	  resistance	  of	  all	  first	  and	  second-­‐line	  
drugs.38	   Several	   countries	   (Iran,	   India,	   South	   Africa	   and	   Italy)	   have	   reported	   incidents	   of	   TDR-­‐Tb,	  
making	  the	  possibility	  of	  potentially	  untreatable	  Tb	  outbreaks	   increasingly	   likely.37,39,40	   41	  To	  counter	  
the	  threat	  that	  MDR-­‐,	  XDR-­‐	  and	  potentially	  TDR-­‐Tb	  pose	  to	  global	  health	  there	   is	  a	  need	  to	  develop	  
new	  and	  novel	  anti-­‐Tb	  drugs.	  
 The	   shikimate	   pathway	   and	   aromatic	   amino	   acid	  1.3.
biosynthesis	  
	  
Ideal	  targets	  for	  novel	  drug	  development	  are	  biosynthetic	  pathways	  present	  in	  the	  target	  pathogen,	  
such	  as	  M.	  tuberculosis,	  but	  absent	  in	  the	  human	  host.	  The	  shikimate	  pathway,	  ultimately	  responsible	  
for	   aromatic	   amino	   acid	   biosynthesis,	   is	   only	   found	   in	   bacteria,	   plants	   and	   apicomplexan	   parasites	  
(Figure	   1.6).42-­‐44	   Furthermore	   gene	   disruption	   studies	   have	   shown	   the	   operation	   of	   the	   shikimate	  
pathway	  is	  essential	  for	  the	  viability	  of	  M.	  tuberculosis.45	  Thus	  the	  enzymes	  of	  this	  pathway	  are	  ideal	  
candidates	  for	  exploration	  as	  a	  potential	  anti-­‐Tb	  drug	  targets.	  
	  
The	   shikimate	   pathway	   is	   responsible	   for	   the	   conversion	   of	   D-­‐erythrose	   4-­‐phosphate	   (E4P)	   and	  
phosphoenolpyruvate	  (PEP)	  to	  chorismate	  via	  a	  set	  of	  seven	  enzyme-­‐catalysed	  reactions.	  Chorismate	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can	   either	   then	   be	   directed	   toward	   the	   formation	   of	   Tryptophan	   (Trp)	   by	   anthranilate	   synthase	   or	  
toward	  the	  biosynthesis	  of	  Phenylalanine	  (Phe)	  and	  Tyrosine	  (Tyr)	  via	  chorismate	  mutase.	  Chorismate	  
is	  also	  a	  precursor	   for	  other	  essential	  metabolites	   including	  vitamins	  E	  and	  K,	   folic	  acid	  and	  various	  
quinones.46	  	  
	  	  
Figure	   1.6	   The	   seven	   enzyme-­‐catalysed	   reactions	   of	   the	   shikimate	   pathway	   leading	   to	   the	   formation	   of	  
chorismate.	   Chorismate	   is	   then	   directed	   toward	   the	   aromatic	   amino	   acid	   biosynthesis	   by	   either	   anthranilate	  
synthase	  or	   chorismate	  mutase.	  The	   reactions	   catalysed	  by	  DAH7PS	  and	  chorismate	  mutase	  are	  highlighted	   in	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 3-­‐Deoxy-­‐D-­‐arabino-­‐heptulosonate	   7-­‐phosphate	  1.4.
synthase	  (DAH7PS)	  
	  
The	  first	  committed	  step	  of	   the	  shikimate	  pathway	   is	   the	  aldol-­‐like	  condensation	  of	  E4P	  and	  PEP	  to	  
produce	   the	   seven-­‐carbon	   sugar	   3-­‐deoxy-­‐D-­‐arabino-­‐heptulosonate	   7-­‐phosphate	   (DAH7P).	   This	  
reaction	   is	   catalysed	  by	  3-­‐deoxy-­‐D-­‐arabino-­‐heptulosonate	  7-­‐phosphate	   synthase	   (DAH7PS).	  DAH7PS	  
enzymes,	   located	   at	   the	   start	   of	   the	   shikimate	   pathway,	   have	   been	   found	   to	   be	   tightly	   feedback	  
regulated	  in	  many	  organisms	  due	  to	  the	  need	  to	  control	  the	  entry	  of	  metabolites	  into	  the	  pathway.	  47-­‐
51	  
	  
DAH7PS	   enzymes	   have	   been	   classified	   into	   two	   types	   based	   primarily	   on	  molecular	  mass.52	   Type	  I	  
DAH7PS	  enzymes	  are	  less	  than	  40	  kDa	  in	  mass	  whilst	  Type	  II	  DAH7PS	  enzymes	  typically	  have	  a	  mass	  of	  
about	   54	  kDa.53,54	   Type	   I	   DAH7PS	   enzymes	   have	   been	   very	   well	   characterised	   structurally	   and	  
functionally,	  and	  have	  been	  further	  divided	  into	  two	  sub-­‐families,	  Type	  Iα	  and	  Type	  Iβ,	  based	  mainly	  
on	   sequence	   similarity.	   Type	   Iβ	   share	   less	   than	   18	   %	   sequence	   identity	   with	   the	   Type	   Iα	   DAH7PS	  
enzymes	   and	   are	   more	   closely	   related	   to	   3-­‐deoxy-­‐D-­‐manno-­‐octulosonate	   8-­‐phosphate	   synthase	  
(KDO8PS).55	  KDO8PS	  enzymes	  catalyse	  the	  aldol-­‐like	  condensation	  of	  PEP	  and	  arabinose	  5-­‐phosphate	  
to	   produce	   the	   eight-­‐carbon	   sugar	   3-­‐deoxy-­‐D-­‐manno-­‐octulosonate	   8-­‐phosphate.54	   Type	   II	   DAH7PS	  
enzymes	   share	   less	   than	  10%	  sequence	   similarity	  with	  Type	   I	  DAH7PS	  enzymes	  and	  have	  been	   less	  
well	  characterised.53	  	  
	  
All	  available	  crystal	  structures	  of	  DAH7PS	  enzymes	  to	  date	  show	  Type	  Iα,	  Type	  Iβ	  and	  Type	  II	  share	  the	  
same	  core	  structure	  (Figure	  1.7);	  a	  (β/α)8	  barrel	  fold	  with	  the	  active	  site	  located	  at	  the	  C-­‐terminal	  end	  
of	   the	  barrel.47-­‐49,51,56-­‐65	   Variation	   amongst	  DAH7PS	  enzymes	   generally	   arises	   due	   to	   extensions	   and	  
additions	  to	  the	  core	  barrel	  structure	  sometimes	  referred	  to	  as	  decorations	  to	  the	  barrel.	  The	  more	  
extensive	   decorations	   often	   contribute	   to	   the	   formation	   of	   the	   allosteric	   sites	   responsible	   for	   the	  
feedback	   regulation	   of	   DAH7PS	   enzymes.47-­‐51	   The	   unregulated	   Pyrococcus	   furiosus	   and	   Aeropyrum	  
pernix	  enzymes	  possess	  only	  small	  additions	  to	  the	  N-­‐terminus	  of	  the	  core	  (β/α)8	  barrel.
60,65	  The	  Type	  
1α	  DAH7PS	  enzymes	   from	  Escherichia	   coli,	   Saccharomyces	   cerevisiae	  and	  Neissseria	  meningitidis	   all	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possess	  similar	  structures	  and	  are	  all	  feedback	  regulated	  by	  selected	  aromatic	  amino	  acids.49,51,59	  The	  
N-­‐terminal	   extension	   and	   the	   inserted	  β-­‐sheets	   both	   contribute	   to	   the	   formation	  of	   their	   allosteric	  
sites	   and	   no	   significant	   changes	   in	   structure	   are	   observed	   on	   effector	   binding.	   The	   N-­‐terminal	  
extension	   to	   the	   core	   structure	   of	   the	   DAH7PS	   from	   Thermotoga	  maritima	   (TmaDAH7PS)	   is	   more	  
elaborate	  and	  includes	  an	  ferredoxin-­‐like	  domain	  which	  shares	  structural	  homology	  with	  known	  ACT	  
domains.62,66	  This	  ferredoxin-­‐like	  domain	  has	  been	  shown	  to	  be	  involved	  in	  formation	  of	  the	  allosteric	  
binding	   sites	   responsible	   for	   the	   feedback	   regulation	   of	   TmaDAH7PS	   by	   undergoing	   a	   detectable	  
conformational	   change	   that	   effectively	   blocks	   the	   active	   site.47	   DAH7PS	   enzymes	   from	   other	  
organisms	  such	  as	  Listeria	  monocytogenes,	  Bacillus	  subtilis	  and	  Porphyromonas	  gingivalis	  possess	  N-­‐	  
or	   C-­‐terminal	   extensions	   which	   contain	   a	   functional	   chorismate	   mutase-­‐like	   domain,	   are	   also	  
responsible	  for	  the	  regulation	  of	  DAH7PS	  activity	  by	  binding	  chorismate	  or	  prephenate.61,67,68	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Figure	   1.7	   Cartoon	   depiction	   of	   the	   subunits	   of	   the	   Type	   Iα	   DAH7PSs	   from	   Escherichia	   coli	   (PDB	   code:	   1KFL),	  
Saccharomyces	  cerevisiae	  (1OF6)	  and	  Neisseria	  meningitidis	  (4HSN);	  the	  Type	  Iβ	  DAH7PSs	  from	  Aeropyrum	  pernix	  
(1VS1)	   Pyrococcus	   furiosus	   (1ZCO),	   Listeria	   monocytogenes	   (3NVT)	   and	   Thermotoga	  maritima	   (3PG9)	   and	   the	  
Type	  II	  DAH7PS	  Mycobacterium	  tuberculosis	  (3KGF).	  The	  core	  (β/α)8	  barrel	  structure	  is	  coloured	  blue,	  N-­‐terminal	  
additions	  are	  coloured	  red	  and	   insertions	  to	  the	  core	  structure	  are	  coloured	  yellow.	  The	  functional	  chorismate	  
mutase	  domain	  of	  L.	  monomcytogenes	  DAH7PS	   is	  coloured	  olive.	  Allosteric	   ligands	  Trp,	  Phe	  and	  Tyr	  have	  been	  
shown	   in	   green,	   orange	   and	   purple	   sticks	   respectively.	   The	   allosteric	   binding	   sites	   of	  MtuDAH7PS	   have	   been	  
highlighted.	  
 M.	  tuberculosis	  DAH7PS	  1.4.1.
The	  M.	  tuberculosis	  genome	  encodes	  for	  a	  single	  DAH7PS	  classified	  as	  a	  type	  II	  DAH7PS.	  The	  DAH7PS	  
from	  M.	   tuberculosis	   (MtuDAH7PS)	   is	   the	   only	   structurally	   characterised	   Type	   II	   DAH7PS	   to	   date.	  	  
MtuDAH7PS	   subunits	   have	   the	   same	   (β/α)8	   barrel	   core	   structure	   and	   are	   decorated	   by	   two	  major	  
additions	   (Figure	  1.7).69,70	  A	  β-­‐strand	  and	   three	  helices	   form	  an	  N-­‐terminal	   extension	   to	   the	  barrel,	  
whilst	  two	  α-­‐helices	  have	  been	  inserted	  between	  the	  α2-­‐helix	  and	  β3-­‐sheet	  of	  the	  barrel.	  MtuDAH7PS	  
has	  been	  shown	  to	  be	  synergistically	  feedback	  regulated	  by	  Trp	  in	  combination	  with	  either	  Phe	  or	  Tyr,	  
whereas	  no	  single	  aromatic	  amino	  acid	  elicits	  a	  significant	  inhibitory	  response.48,69	  The	  decorations	  to	  
the	  core	  barrel	  structure	  of	  MtuDAH7PS	  contribute	  to	  the	  formation	  of	  the	  allosteric	  binding	  sites	  of	  
the	   aromatic	   amino	   acids	   and	   the	   structure	   does	   not	   undergo	   any	   significant	   structural	   change	   on	  
ligand	  binding.48,71	  Three	  allosteric	  binding	  sites	  have	  been	  identified	  (Figure	  1.7).	  One	  site	  has	  been	  
observed	   to	   bind	   Trp	   primarily	   and	   designated	   the	   Trp	   site.	   The	   remaining	   two	   sites	   have	   been	  
designated	  as	   sites	   1	   and	  2	   and	  have	  both	  been	  observed	   to	  bind	  both	  Phe	  and	  Tyr.	   The	  allosteric	  
binding	  sites	  are	  discussed	  in	  greater	  detail	  in	  the	  relevant	  chapters	  (Sections	  3.1	  and	  6.1).	  	  
 Chorismate	  mutase	  (CM)	  1.5.
Chorismate	  mutase	  (CM)	  catalyses	  the	  Claisen	  rearrangement	  of	  chorismate	  to	  prephenate	  and	   is	  a	  
rare	  example	  of	  an	  enzyme-­‐catalysed	  pericyclic	   reaction.72	  The	   reaction	  catalysed	  by	  CM	   is	   the	   first	  
committed	  step	  toward	  the	  biosynthesis	  of	  Phe	  and	  Tyr.72,73	  	  
	  
CM	  enzymes	  have	  also	  been	  divided	   into	  distinct	  unrelated	   families,	  AroH	   (or	  Type	   I)	   and	  AroQ	   (or	  
Type	  II).74	  The	  AroH	  class	  are	  characterised	  by	  their	  trimeric	  pseudo	  α/β-­‐barrel	  structure,	  exemplified	  
by	  the	  monofunctional	  B.	  subtilis	  CM	  (BsuCM)	  and	  is	  relatively	  rare	  (Figure	  1.8).75	  The	  AroQ	  class	  are	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generally	  characterised	  by	  CM	  enzymes	  with	  a	  dimeric	  α-­‐helical	  structure	  and	  often	  accompanied	  by	  
another	  enzyme	  for	  optimal	  activity.76,77	  
	  
Figure	   1.8	   Cartoon	   depiction	   of	   the	   dimeric	   or	   trimeric	   	   chorismate	  mutase	   structures	   of	   E.	   coli,	   S.cerevisiae,	  
M.	  tuberculosis	  encoded	  by	  the	  open	  reading	  frames	  Rv1885c	  and	  Rv0948c	  and	  B.	  subtilis.	  The	  structures	  show	  
each	  subunit	  as	  olive	  and	  purple	  for	  all	  dimeric	  CMS	  and	  olive,	  purple	  and	  orange	  for	  the	  trimeric	  BsuCM.	  
The	  AroQ	  class	  has	  been	  further	  divided	  into	  four	  subfamilies	  ΑroQα-­‐AroQδ	  The	  AroQα	  subclass	  of	  CM	  
enzymes	  is	  exemplified	  by	  the	  structure	  of	  E.	  coli	  CM	  (EcoCM).	  The	  EcoCM	  subunit	  consists	  of	  three	  α-­‐
helices	  folded	  to	  resemble	  the	  number	  4	  (Figure	  1.8).76	  Two	  active	  sites	  are	  created	  on	  formation	  of	  
the	  EcoCM	  dimer	  with	   residues	  contributed	  by	  both	  subunits.78	  Most	  bacterial	  CM	  enzymes	   fit	   into	  
the	   AroQα	   subclass	   including	   those	   belonging	   to	   bifunctional	   or	   fusion	   enzymes.	   These	   CM	   fusion	  
E.	  coli	  CM	  
AroQα	  
S.	  cerevisiae	  CM	  
AroQβ	  
M.	  tuberculosis	  (Rv1885c)	  CM	  
AroQγ	  
M.	  tuberculosis	  (Rv0948c)	  CM	  
AroQδ	  
B.	  subtilis	  CM	  
AroH	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enzymes	   are	   also	   grouped	   into	   subfamilies	   based	   on	   the	   fusion	   partner;	   AroQp	   have	   CM	   enzymes	  
fused	   to	  prephenate	  dehydratase;	  AroQt	  have	  CMs	   fused	   to	  prephenate	  dehydrogenase	   and	  AroQd	  
have	  CMs	  fused	  to	  DAH7PSs.78-­‐80	  
	  
The	  structure	  of	  S.	  cerevisiae	  CM	  (SceCM)	  is	  representative	  of	  the	  subclass	  AroQβ.	  The	  AroQβ	  subclass	  
typically	   includes	   the	   CM	   enzymes	   from	   most	   eukaryotes	   and	   usually	   has	   a	   regulatory	   domain.78	  
SceCM	  has	  a	  more	  complicated	  subunit	  structure	  with	  12	  helices	  and	  the	  topology	  of	  the	  fold	  said	  to	  
resemble	  the	  antiparallel	  α	  domain	  of	  Greek	  key	  helix	  bundles	  (Figure	  1.8).78,81	  The	  active	  site	  is	  fully	  
contained	  within	   the	   subunit.78	   The	   SceCM	  protomer	   consists	   of	   a	   catalytic	   domain	   very	   similar	   to	  
EcoCM	  and	   a	   regulatory	   domain	   responsible	   for	   the	   formation	   of	   allosteric	   binding	   sites	   for	   Trp	   or	  
Tyr.78,82	  
 M.	  tuberculosis	  CM	  1.5.1.
The	   genome	   for	  M.	   tuberculosis	   encodes	   reading	   frames	   for	   two	   CM	   with	   novel	   AroQ	   folds.	   One	  
highly	  active	  CM	   is	   secreted	  by	  M.	  tuberculosis	  and	   is	  encoded	  by	   the	  open	  reading	   frame	  Rv1885c	  
(*MtuCM).78,83	  The	  subunit	  structure	  of	  *MtuCM	  is	  similar	  to	  EcoCM,	  but	  with	  some	  key	  differences	  
leading	  to	  it	  being	  assigned	  to	  a	  new	  AroQγ	  subclass	  (Figure	  1.8).
78	  The	  subunit	  of	  *MtuCM	  consists	  of	  
three	  α-­‐helices,	  the	  first	  much	  shorter	  than	  the	  one	  found	  in	  EcoCM,	  and	  like	  SceCM	  the	  active	  site	  is	  
fully	   contained	  within	   each	   subunit.78	   All	   CMs	   known	   to	   date	   belong	   to	   the	   AroQγ	   subclass	   are	   all	  
exported	  CMs.84	  
	  
The	   second	   intracellular	   CM	   from	  M.	   tuberculosis	   (MtuCM)	   encoded	   by	   the	   open	   reading	   frame	  
Rv0948c	  and	  was	  originally	  found	  to	  have	  very	  poor	  activity.78,83,85-­‐87	  MtuCM	  also	  has	  a	  novel	  topology	  
not	  seen	  in	  other	  AroQ	  subclasses	  and	  was	  assigned	  the	  new	  AroQδ	  subclass.
78	  The	  subunit	  structure	  
of	  MtuCM	  contains	  six	  α-­‐helices	  and	  forms	  a	  dimeric	  quaternary	  structure	  with	  a	  active	  site	  located	  in	  
each	  subunit	  (Figure	  1.8).85,86	  So	  far	  the	  CM	  enzymes	  belonging	  to	  the	  AroQδ	  subclass	  have	  only	  been	  
found	  in	  Gram-­‐positive	  genera.78,83,84	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Interestingly	  MtuCM	  was	  shown	  to	  form	  a	  non-­‐covalent	  complex	  with	  MtuDAH7PS,	  boosting	  MtuCM	  
activity	   by	   over	   a	   100-­‐fold	   and	   endowing	   the	  MtuCM	  with	   regulatory	   sensitivity	   to	   Phe	   and	   Tyr.85	  
Sasso	  et	  al.	  showed	  the	  activity	  boost	  in	  MtuCM	  was	  due	  to	  the	  rearrangement	  of	  MtuCM	  active	  site	  
residues	   on	   formation	   of	   the	   non-­‐covalent	   complex.85	   The	   interaction	   between	   MtuCM	   and	  
MtuDAH7PS	  is	  discussed	  in	  greater	  detail	  in	  chapter	  4.	  	  
	  
In	  2013	  kinetic	  analysis	  by	  Li	  et	  al.	  discovered	  the	  CM	  of	  Corynebacterium	  glutamicum	  (CglCM)	  alters	  
the	   properties	   of	   DAH7PS	   of	   C.	   glutamicum	   (CglDAH7PS),	   this	   in	   combination	   with	   homology	  
modelling	   lead	   the	   authors	   to	   propose	   the	   two	   enzymes	   form	   a	   non-­‐covalent	   complex	   similar	   to	  
MtuCM	   and	   MtuDAH7PS.88	   Complex	   formation	   had	   no	   effect	   on	   CglCM	   activity	   but	   instead	  
significantly	   enhanced	   the	   activity	   of	  CglDAH7PS.88,89	  CglDAH7PS	   alone	   shows	   only	   slight	   sensitivity	  
and	  to	  Trp	  and	  is	  insensitive	  to	  Tyr	  and	  Phe,	  in	  the	  presence	  of	  CM,	  CglDAH7PS	  activity	  is	  regulated	  by	  
prephenate.88,90	   This	   endowed	   regulatory	   sensitivity	   to	   prephenate	   draws	   parallels	   to	   the	   DAH7PS	  
from	  B.	  subtilis,	  which	  is	  regulated	  by	  chorismate	  and	  prephenate	  via	  a	  fused	  CM	  domain.67	  Evidence	  
of	   the	   complex	   formation	   between	   CglCM	   and	   CglDAH7PS	   has	   relied	   on	   biophysical	   and	   kinetic	  
characterisation	   and	   as	   yet	   there	   is	   no	   structural	   characterisation	   available	   of	   the	   non-­‐covalent	  
complex	  for	  structural	  comparison	  to	  the	  complex	  formed	  between	  MtuDAH7PS	  and	  MtuCM	  or	  other	  
CM	  enzymes	  covalently	  fused	  to	  DAH7PS	  enzymes.	  
 Outline	  of	  this	  thesis	  1.6.
The	  primary	  goal	  of	   this	   thesis	   is	   to	   carry	  out	   a	  detailed	  examination	  of	   the	  allosteric	   regulation	  of	  
MtuDAH7PS.	  A	  more	  comprehensive	  understanding	  of	  how	  MtuDAH7PS	  regulates	  its	  own	  activity	  and	  
the	   activity	   of	  MtuCM	  may	   contribute	   to	  more	   efficient	   research	   into	   the	   development	   of	   anti-­‐TB	  
drugs	  that	  target	  MtuDAH7PS	  and/or	  MtuCM.	  
	  
Chapter	   2	   presents	   a	   comprehensive	   kinetic,	   biophysical	   and	   solution	   structural	   analysis	   of	  
MtuDAH7PS	   and	   provides	   data	   that	   acts	   as	   a	   point	   of	   comparison	   for	   later	   chapters.	   Chapter	   3	  
describes	   the	   investigation	   into	   the	   specificity	   of	   the	   allosteric	   binding	   sites	   of	  MtuDAH7PS,	   sites	  1	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and	  2,	   and	   the	  occupancy	  of	   these	   two	   sites	   required	   for	   regulation.	  Chapter	  4	  details	   studies	   that	  
explored	   the	   interactions	   between	  MtuCM	  and	  MtuDAH7PS,	  with	   an	   emphasis	   on	   determining	   the	  
mechanism	   by	  which	  MtuDAH7PS	   regulates	  MtuCM	   activity.	   Chapter	   5	   describes	   the	   inspection	   of	  
residues	   believed	   to	   be	   part	   of	   the	   allosteric	   communication	   network	   responsible	   for	   signal	  
transmission	   between	   the	   allosteric	   binding	   sites	   or	   between	   the	   allosteric	   binding	   sites	   and	   the	  
active	  sites	  of	  MtuDAH7PS.	  Chapter	  6	  presents	  work	  that	  probed	  the	  Trp	  binding	  site	  of	  MtuDAH7PS	  
to	   identify	   residues	   that	   are	   critical	   to	   Trp	   binding	   and	   the	   effect	   of	   disrupting	   Trp	   binding	   on	  
MtuDAH7PS.	   Chapter	   7	   details	   studies	   that	   examined	   the	   catalytic	   and	   regulatory	   properties	   of	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2. Characterisation	  of	  MtuDAH7PS	  
 Introduction	  2.1.
Previous	  work	  has	   shown	  MtuDAH7PS	   is	  only	   subject	   to	   synergistic	   feedback	   inhibition	  when	  Trp	   is	  
present	   in	   combination	  with	  either	  Phe	  or	   Tyr.48,69,70	  Also	  prior	   to	   the	   start	   of	   this	   research	   several	  
crystal	  structures	  of	  MtuDAH7PS	  had	  been	  solved	   including	  one	  structure	  with	  Trp	  bound,	  one	  with	  
Phe	  bound	  and	  one	  with	  Trp	  and	  Phe	  bound.48	  The	  Trp	  and	  Phe	  soaked	  crystal	  structure	  (PDB	  code:	  
3KGF)	  revealed	  that	  MtuDAH7PS	  has	  three	  distinct	  allosteric	  binding	  sites	  present	  in	  each	  MtuDAH7PS	  
subunit	  (Figure	  2.1).	  One	  molecule	  of	  Trp	  was	  observed	  to	  bind	  per	  subunit	  at	  a	  site	  designated	  here	  
as	  the	  Trp	  site,	  whereas	  Phe	  was	  observed	  to	  bind	  at	  two	  different	  sites,	  designated	  site	  1	  and	  site	  2.	  
Site	  1	  is	  occupied	  by	  Phe	  in	  all	  subunits,	  whereas	  site	  2	  was	  occupied	  in	  only	  one	  of	  the	  subunits	  of	  the	  
dimer	   that	   is	   in	   the	   asymmetric	   unit,	   thus	   in	   two	   subunits	   of	   the	   homotetramer.	   Later	   work	  
demonstrated	  Tyr	  was	  also	  able	  to	  bind	  at	  site	  1	  and	  site	  2.48,91	  Since	  there	  are	  three	  distinct	  allosteric	  
binding	   sites	   per	  MtuDAH7PS	   subunit	   and	   three	   aromatic	   amino	   acids,	   the	  next	   logical	   question	   to	  
consider	  was	  whether	  all	  three	  aromatic	  amino	  acids	  could	  bind	  simultaneously.	  
	  	  
	   	  
Figure	   2.1	   The	   subunit	   structure	   of	  MtuDAH7PS	   soaked	  with	   Trp	   and	   Phe	   (PDB	   code:	   3KGF).	   The	   core	   (β/α)8	  
barrel	   structure	   is	   coloured	  blue,	   the	  N-­‐terminal	  extension	   is	   coloured	   red,	   the	  additional	  helices	   to	   the	  α2-­‐β3	  
loop	  are	  coloured	  yellow	  and	  the	  metal	  ion	  (Mn2+)	  is	  shown	  in	  purple.	  Trp	  is	  shown	  in	  orange	  bound	  to	  the	  Trp	  





2	   MtuDAH7PS	  
	  
22	  
Previous	  structural	  characterisation	  of	  MtuDAH7PS	  has	  relied	  heavily	  on	  crystallography,	  and	  reveals	  
MtuDAH7PS	  as	  a	  homotetramer	   in	   the	  crystalline	   form.48,64,69,70	  However,	   some	  proteins	  exist	  as	  an	  
equilibrium	  of	   a	   number	  of	   oligomeric	   states	   in	   solution	  or	   an	   ensemble	  of	   various	   conformational	  
states.92-­‐97	  The	  position	  of	  this	  equilibrium	  is	  subject	  to	  any	  changes	  to	  the	  external	  conditions,	  such	  
as	   temperature	  or	  concentration.	  As	  crystallisation	  typically	  occurs	  under	  conditions	  of	  high	  protein	  
concentrations,	   these	   conditions	  may	   favour	  higher	  oligomeric	   states.	  Analysis	   of	  MtuDAH7PSWT	  by	  
structural	   techniques	   that	   analyse	   proteins	   in	   solution	   such	   as	   small	   angle	   X-­‐ray	   scattering	   (SAXS),	  
analytical	   ultracentrifugation	   (AUC)	   and	   native	   polayacrylamide	   gel	   electrophoresis	   (PAGE),	   can	   be	  
carried	  out	  at	  a	  range	  of	  protein	  concentrations,	  and	  can	  reveal	  alternative	  conformers	  or	  oligomers.	  
By	  complimenting	  the	  known	  crystallographic	  data	  on	  MtuDAH7PS	  with	  solution	  phase	  techniques	  a	  
better	  understanding	  of	  the	  in	  vivo	  structure	  of	  MtuDAH7PS	  may	  be	  developed.	  	  
	  
Crystallographic	  studies	  also	  showed	  the	  binding	  of	  the	  aromatic	  amino	  acids	  to	  the	  allosteric	  binding	  
sites	  of	  MtuDAH7PSWT	  did	  not	  result	  in	  any	  significant	  change	  in	  protein	  conformation.	  However,	  the	  
possibility	   that	   crystal	   packing	   effects	   mask	   changes	   in	   conformation	   have	   yet	   to	   be	   eliminated.	  
Furthermore	   the	   binding	   of	   the	   aromatic	   amino	   acids	   may	   also	   alter	   the	  MtuDAH7PS	   quaternary	  
structure	   equilibrium	   in	   solution.	   Both	   possibilities	   need	   to	   be	   explored	   through	   analysis	   of	  
MtuDAH7PS	  structure	  using	  range	  of	  solution	  phase	  structural	  techniques	  i.e.	  SAXS	  and	  AUC.	  
 Chapter	  aims	  2.2.
The	   primary	   aim	   of	   this	   chapter	   was	   to	   establish	   a	   thorough	   and	   robust	   characterisation	   of	  
MtuDAH7PSWT	  to	  serve	  as	  a	  point	  of	  comparison	  for	  work	  described	  in	  later	  chapters	  of	  this	  thesis.	  As	  
a	  part	  of	  this	  goal	  efforts	  were	  made	  to	  expand	  upon	  previous	  knowledge	  of	  the	  allosteric	  regulation	  
of	  MtuDAH7PS	   by	   better	   understanding	   the	   contribution	   of	   Tyr.	   Studies	   were	   also	   conducted	   to	  
establish	   the	   quaternary	   structure	   of	  MtuDAH7PSWT	   in	   solution	   and	   to	   determine	   if	   the	   aromatic	  
amino	  acids	  caused	  any	  detectable	  changes.	  	  
MtuDAH7PS	   2	  
	  
23	  
 Preparation,	  expression	  and	  purification	  2.3.
 Construct	  details	  2.3.1.
Shaun	  Lott	  (University	  of	  Auckland)	  had	  previously	  cloned	  the	  gene	  for	  MtuDAH7PS	  into	  a	  pProEx-­‐HTa	  
vector.	  This	  vector	  contained	  an	  ampicillin	   resistance	  gene,	  T7	  promoter	   regions	   for	   the	   lac	  operon	  
and	  N-­‐terminal	   tobacco	  etch	   virus	   (TEV)	  protease	   cleavable	  His6-­‐tag.	   The	  ampicillin	   resistance	   gene	  
allowed	   selection	   for	   cells	   that	   contain	   the	   plasmid,	   whilst	   the	   incorporation	   of	   T7	   promoter	  
permitted	   induction	   of	   protein	   expression	   in	   the	   presence	   of	   isopropyl-­‐𝛽-­‐D-­‐thiogalactopyranoside	  
(IPTG).	   The	   inclusion	   of	   a	   TEV	   protease	   cleavable	   polyhistidine	   tag	   (His6-­‐tag)	   permitted	   the	   use	   of	  
immobilised	   metal	   affinity	   chromatography	   (IMAC)	   techniques	   for	   simpler	   and	   faster	   purification	  
procedures.	  The	  sequence	  for	  this	  tag	  is	  shown	  below	  (Figure	  2.2).	  
	  
Figure	  2.2	  Sequence	  of	  the	  pProEx-­‐HTa	  His6-­‐tag.	  Highlighted	  are	  the	  polyhistidine	  metal	  binding	  site	  (blue),	  the	  
TEV	  protease	  recognition	  site	  (purple)	  and	  the	  residues	  retained	  at	  the	  N-­‐terminus	  post	  cleavage	  (pink).	  
	  
The	  pProEx-­‐HTa	  vector	  containing	  the	  MtuDAH7PS	  gene	  was	  electroporated	  into	  BL21(DE3)	  pGroESL	  
cells.	  Contained	  in	  this	  cell	  line	  was	  a	  pGroESL	  plasmid	  for	  the	  production	  of	  chaperonins	  pGroES	  and	  
pGroEL,	   which	   assist	   protein	   folding.	   Previous	   work	   showed	   these	   chaperonins	   were	   essential	   for	  
soluble	  expression	  of	  MtuDAH7PS.70	  The	  pGroESL	  plasmid	  also	  carried	  a	  chloramphenicol	   resistance	  
gene.	  Consequently	  colonies	  were	  selected	  for	  ampicillin	  and	  chloramphenicol	  resistance.	  
 Expression,	  lysis	  and	  purification	  2.3.2.
Protein	  expression	  was	  carried	  out	  as	  outlined	   in	  Section	  9.5,	  and	  resulted	   in	   the	  overexpression	  of	  
MtuDAH7PS	  as	  confirmed	  by	  sodium-­‐dodecyl	  sulphate	  polyacrylamide	  gel	  elect	  (SDS-­‐PAGE).	  The	  SDS-­‐
PAGE	  gel	  showed	  an	  overexpressed	  protein	  band	  of	  ~55	  kDa	  which	  matched	  the	  expected	  molecular	  
mass	  of	  the	  His6-­‐tagged	  MtuDAH7PS	  (Figure	  2.3B).	  Plasmid	  sequencing	  and	  mass	  spectrometry	  were	  
used	  to	  confirm	  there	  were	  no	  unintended	  alterations	  to	  the	  amino	  acid	  sequence.	  
MSYYHHHHHHDYDIPTTENLYFQGA	  




Cells	  were	   lysed	  using	  either	  sonication	  or	  preferentially	  cell	  disruption	  and	  the	  resulting	   lysate	  was	  
clarified	   by	   centrifugation	   to	   remove	   insoluble	   cell	   debris.	   The	   lysis	   of	   cells	   by	   cell	   disruption	   was	  
quicker	   and	  more	   reliably	   achieved	   complete	   cell	   lysis	   than	   sonication,	  with	  purifications	  using	   this	  
method	  frequently	  resulting	   in	  higher	  yields.	  The	  MtuDAH7PS	   in	  the	   lysed	  supernatant	  was	  purified	  
utilising	  IMAC	  and	  size	  exclusion	  chromatography	  (SEC).	  The	  procedure	  is	  outlined	  in	  Figure	  2.3A	  and	  
presented	   with	   an	   SDS-­‐PAGE	   (Figure	   2.3B)	   illustrating	   protein	   purity	   achieved	   at	   each	   step.	   The	  
purification	  procedure	  is	  detailed	  in	  Section	  9.5	  and	  largely	  followed	  the	  protocol	  set	  out	  by	  Richard	  
Hutton,	  who	  himself	  had	  improved	  upon	  the	  original	  protocol	  developed	  by	  Celia	  Webby.48,70	  
	  
Figure	   2.3	  A.	  An	  outline	  of	   the	   standard	  purification	  protocol	   for	  MtuDAH7PS.	  B.	   SDS-­‐PAGE	  gel.	   Lane	  M	   is	   the	  
molecular	  weight	  maker;	  lane	  1	  whole	  lysate;	  lane	  2	  soluble	  fraction	  of	  the	  cell	  lysate;	  lane	  3	  insoluble	  fraction	  of	  
the	   cell	   lysate;	   lane	   4	   protein	   isolated	   from	   IMAC	   gradient;	   lane	   5	   TEV	   protease	   treated	  MtuDAH7PS	   (TEV	  
protease	  removed)	  and	   lane	  6	  pooled	  fractions	  after	  SEC	  overexpressed	  protein	  bands	  can	  be	  observed	  at	  ~50	  
kDa,	   ~55	   kDa	   and	   ~60	   kDa	   which	   correspond	   to	  MtuDAH7PSWT,	   His6-­‐tagged	  MtuDAH7PS	   and	   the	   chaperonin	  
proteins	  respectively.	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 Kinetic	  characterisation	  2.4.
 Kinetic	  parameters	  2.4.1.
Previous	  work	  had	  established	  optimal	  conditions	  for	  the	  kinetic	  assays69.	  Assays	  were	  conducted	  at	  
37	  °C	  in	  50	  mM	  Bis-­‐tris	  propane	  (BTP)	  buffer	  at	  pH	  7.5	  and	  required	  a	  divalent	  metal	  ion	  (Mn2+)	  and	  
reducing	  agent	  tris(2-­‐carboxyethyl)phosphine	  (TCEP)	  for	  efficient	  catalysis.	  The	  procedure	  is	  described	  
in	  Section	  9.9.1.	  The	  kinetic	  parameters	  of	  MtuDAH7PSWT,	  determined	  using	  steady-­‐state	  Michaelis-­‐
Menten	  kinetics,	  were	  compared	  with	  previously	  published	  results	  (Table	  2.1).69	  
	  
Table	   2.1	   A	   comparison	   of	   kinetic	   parameters	   for	   MtuDAH7PSWT	   from	   this	   study	   and	   those	   published	  
previously.70	  Michaelis-­‐Menten	  kinetic	  plots	  supplied	  in	  Appendix	  I.	  
MtuDAH7PS	   Km
E4P	   Km
PEP	   kcat	   Catalytic	  Efficiency	  
	   	   	   	   kcat/Km
E4P	   kcat/Km
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (mM-­‐1s-­‐1)	   (mM-­‐1s-­‐1)	  
This	  study	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
Webby69	   25	  ±	  1	   37	  ±	  3	   3.1	  ±	  0.1	   124	  ±	  9	   80	  ±	  10	  
	  
 Feedback	   regulation	   by	   individual	   aromatic	  2.4.2.
amino	  acids	  
	  
Kinetic	  assays	  were	  conducted	  under	  standard	  assay	  conditions	  for	  MtuDAH7PS,	  including	  150	  µM	  of	  
E4P	  and	  PEP	  and	  are	  outlined	  in	  Section	  9.9.3.	  This	  study	  found	  that	  when	  present	  at	  a	  concentration	  
of	  200	  µM	  the	  individual	  aromatic	  amino	  acids	  only	  caused	  a	  small	  reduction	  in	  activity	  (Figure	  2.4),	  
results	   consistent	   with	   previous	   work.48	   When	   the	   aromatic	   amino	   acid	   concentration	   exceeded	  
~1	  mM	   substantial	   inhibition	   of	   MtuDAH7PS	   activity	   was	   observed.	   Phe	   and	   Tyr	   reduced	  
MtuDAH7PSWT	  activity	  by	  up	  to	  ~40	  %	  and	  Trp	  up	  to	  ~50	  %.	  	  
	  




Figure	   2.4	  Response	  of	  MtuDAH7PSWT	  activity	   to	   increasing	  concentrations	  of	   individual	  aromatic	  amino	  acids;	  
tryptophan	   (Trp)(dark	   blue);	   phenylalanine	   (Phe)	   (red)	   and	   tyrosine	   (Tyr)	   (green).	   E4P	   and	   PEP	   concentrations	  
were	  held	  constant	  at	  150	  µM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  
	  
 Feedback	  regulation	  2.4.3.
Kinetic	  assays	  were	  conducted	  under	  the	  standard	  assay	  conditions	  used	  for	  all	   inhibition	  studies	  as	  
outlined	  in	  Section	  9.9.3.	  Each	  aromatic	  amino	  acid	  was	  added	  to	  the	  assay	  conditions	  to	  give	  a	  final	  
concentration	   of	   200	   µM,	   unless	   stated	   otherwise.	   In	   agreement	   with	   previous	   work,	   Trp	   in	  
combination	  with	  either	  Phe	  or	  Tyr	  dramatically	  reduced	  MtuDAH7PSWT	  activity	  (Figure	  2.5).48,71	  The	  
most	  potent	  binary	  combination	  was	  Trp	  and	  Phe,	  which	  reduced	  MtuDAH7PSWT	  activity	   to	  ~6	  %	  of	  
the	  observed	  activity	  of	   the	  unliganded	  enzyme.	  The	   inhibition	  achieved	  by	   the	  combination	  of	  Trp	  
and	  either	  Phe	  or	  Tyr	  was	  more	  than	  the	  ~20-­‐30	  %	   inhibition	  expected	  of	  an	  additive	  effect	   for	   the	  
two	  aromatic	  amino	  acids	  and	  clear	  evidence	  of	  synergy.	  
	  
	  




Figure	  2.5	  Remaining	  activity	  of	  MtuDAH7PSWT	  in	  the	  presence	  of	  various	  single,	  binary	  and	  ternary	  combinations	  
of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  
Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  amino	  acid.	  E4P	  and	  PEP	  concentrations	  
were	   held	   constant	   at	   150	   µM.	   Error	   bars	   depict	   the	   standard	   deviation	   of	   triplicate	  measurements.	   P-­‐values	  
provided	  in	  appendix	  V.	  
	  
The	   combination	   of	   all	   three	   aromatic	   amino	   acids	   almost	   completely	   inhibited	   MtuDAH7PSWT,	  
reducing	  enzyme	  activity	  to	  ~0.6	  %.	  This	  was	  a	   level	  of	   inhibition	  that	  was	  not	  achieved	  by	  using	  an	  
equivalent	   total	   concentration	   of	   only	   two	   aromatic	   amino	   acids	   (i.e.	   200	   µM	   Trp	   and	   400	   µM	   or	  
either	  Phe	  or	  Tyr)	   (Figure	  2.5).	  The	   inhibition	  of	  MtuDAH7PSWT	  was	  found	  to	  be	  more	  complex	  than	  
first	   proposed;	   this	   study	   showed	   all	   three	   aromatic	   amino	   acids	   contribute	   to	   the	   synergistic	  
regulation	  of	  the	  enzyme.	  Each	  amino	  acid	  makes	  a	  contribution	  that	  could	  not	  be	  compensated	  for	  
by	  simply	  increasing	  the	  concentration	  of	  the	  alternative	  amino	  acids,	  making	  this,	  to	  the	  best	  of	  our	  
knowledge,	   the	   first	   reported	   example	   of	   enzyme	   regulation	   by	   ternary	   synergy	   found	   in	   the	  
literature.	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 Biophysical	  characterisation	  2.5.
 Thermal	  stability	  2.5.1.
Differential	  scanning	  fluorimetry	  (DSF)	  is	  a	  technique	  commonly	  used	  to	  measure	  the	  thermal	  stability	  
of	  a	  protein.	  The	  protein	  is	  incubated	  with	  a	  dye,	  which	  fluoresces	  upon	  binding	  hydrophobic	  residues	  
of	   the	   protein.	   The	   temperature	   is	   incrementally	   increased	   causing	   the	   protein	   to	   denature	   and	  
exposing	   more	   hydrophobic	   residues	   for	   the	   dye	   to	   bind,	   thus	   increasing	   the	   fluorescence.	   The	  
melting	  temperature	  (Tm)	  reported	  corresponds	  to	  the	  maximum	  increase	  in	  measured	  fluorescence.	  
The	  standard	  SEC	  buffer	  (10	  mM	  BTP	  pH	  7.5	  plus	  150	  mM	  NaCl	  and	  200	  µM	  each	  of	  PEP,	  MnSO4	  and	  
TCEP)	  was	  used	  for	  all	  DSF	  assays.	  The	  protocol	  is	  described	  in	  Section	  9.8.1.	  
	  
Ligand	   binding	   alters	   the	   thermal	   stability	   of	   MtuDAH7PSWT	   (Figure	   2.6A).	   Trp	   has	   the	   greatest	  
influence	   on	   the	   thermal	   stability	   of	  MtuDAH7PSWT.	   Trp	   (200	  µM)	   increased	   the	   Tm	   by	   8.6	  ±	  0.9	  ˚C.	  
Addition	   of	   200	   µM	   of	   Tyr	   or	   Phe	   caused	   a	   more	   modest	   increases	   in	   the	   thermal	   stability	   of	  
MtuDAH7PSWT	  of	  1	  ±	  0.2	  ˚C	  and	  2.6	  ±	  0.6	  ˚C	  respectively.	  Further	  increases	  in	  the	  concentration	  of	  Trp	  
or	  Phe	  resulted	  in	  even	  greater	  increases	  in	  thermal	  stability	  (Figure	  2.6B).	  Trp	  (1000	  µM)	  caused	  the	  
greatest	  increase	  in	  Tm	  for	  MtuDAH7PS
WT	  of	  15.0	  ±	  0.2	  ˚C.	  Increasing	  the	  concentration	  of	  Tyr	  resulted	  
in	  a	  decrease	  in	  thermal	  stability.	  	  
	  




Figure	  2.6	  The	  effect	  of	  A.	  increasing	  concentrations	  of	  individual	  aromatic	  amino	  acids	  and	  B.	  individual,	  binary	  
and	  ternary	  combinations	  on	  the	  thermal	  stability	  of	  MtuDAH7PSWT.	  The	  aromatic	  amino	  acids	  are	  represented	  
by	   their	   one	   letter	   code;	   Trp,	  W;	   Phe,	   F	   and	   Tyr,	   Y.	   Each	   letter	   also	   represents	   200	   µM	  of	   the	   corresponding	  
aromatic	  amino	  acids,	  except	  where	  500,	  and	  1000	  are	  stated	  and	  represent	  their	  respective	  concentrations	   in	  
µM.	  Assays	  conducted	   in	  10	  mM	  BTP	  buffer	  pH	  7.5	   in	   the	  presence	  of	  NaCl,	  MnSO4,	  TCEP	  and	  PEP.	  Error	  bars	  
depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	   ternary	   combination	  of	  Trp,	  Phe	  and	  Tyr	   caused	   the	   largest	   increase	   in	   the	   thermal	   stability	  of	  
MtuDAH7PSWT	  observed	  for	  any	  ligand	  combination,	  10.6	  ±	  0.7	  ˚C	  (Figure	  2.6B).	  The	  binding	  of	  each	  
different	   aromatic	   amino	   acid	   appeared	   to	   make	   a	   separate	   contribution	   toward	   improving	   the	  
thermal	   stability	   of	  MtuDAH7PSWT.	   It	   is	   possible	   at	   the	   higher	   concentrations	   of	   Trp	   and	   Phe,	   the	  
amino	  acids	  start	  to	  occupy	  all	  the	  available	  binding	  sites,	  not	  just	  their	  preferential	  binding	  sites.	  	  
 Binding	  affinities	  2.5.2.
Isothermal	   titration	   calorimetry	   (ITC)	  was	   used	   to	   assess	   the	   affinity	  MtuDAH7PS	   displays	   for	   each	  
aromatic	  amino	  acid	  under	  specific	  conditions.	  ITC	  measures	  the	  change	  in	  heat	  caused	  by	  a	  series	  of	  
small	   injections	   of	   a	   ligand	   (in	   this	   case	   aromatic	   amino	   acids)	   into	   a	   cell	   containing	   the	  
macromolecule	  (MtuDAH7PS).98-­‐100	  Origin®	  software	  then	  uses	  the	  resulting	  thermogram	  to	  iteratively	  
fit	   a	   binding	   model,	   permitting	   determination	   of	   the	   dissociation	   constant	   (Kd),	   a	   measure	   of	   the	  
affinity	  MtuDAH7PS	   has	   for	   the	   ligand.	   The	   experimental	   protocol	   is	   described	   in	   Section	   9.8.2,	  
including	  the	  experimental	  setup	  for	  each	  experiment.	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The	   affinity	   of	   MtuDAH7PS	   for	   the	   individual	   aromatic	   amino	   acids	   has	   previously	   been	  
determined.71,91	  Previous	  work	  established	   that	  pre-­‐incubation	  of	  MtuDAH7PSWT	  with	  Trp	   improved	  
the	  affinity	  of	  the	  protein	  for	  Phe	  and	  vice	  versa.71	  The	  intention	  of	  this	  study	  was	  to	  investigate	  how	  
Tyr	  binding	  affects	  and	  is	  affected	  by	  the	  binding	  of	  Trp	  or	  Phe.	  
	  
Trp	  binding	  to	  MtuDAH7PSWT	  became	  tighter	  when	  MtuDAH7PS	  was	  incubated	  with	  Tyr	  as	  illustrated	  
by	   the	   lower	   Kd	   (Figure	   2.7B,	   Table	   2.2).	   However,	   the	   Kd	   between	   Tyr	   and	  MtuDAH7PS
WT	   was	  
unaffected	  by	  the	  incubation	  of	  MtuDAH7PSWT	  with	  Trp	  prior	  to	  the	  titration	  of	  Tyr	  (Figure	  2.7A,	  Table	  
2.2).	  
	  
The	  binding	  of	  Tyr	  to	  MtuDAH7PSWT	  at	  either	  site	  1	  or	  site	  2	   is	  communicated	  across	  the	  protein	  to	  
whichever	   site	   (or	   sites)	   Tyr	   binds,	   causing	   the	   Trp	   site(s)	   to	   bind	   Trp	  more	   tightly.	   The	  means	   of	  
communication	   is	   likely	   a	   subtle	   change	   of	   the	  molecular	   dynamics	   of	   the	   enzyme,	   similar	   to	   that	  
suggested	   for	   communication	   between	   the	   Trp	   and	   Phe	   sites.71	   Molecular	   dynamics	   simulations	  
attributed	   the	  enhancement	  of	   ligand	  binding	   to	   the	  alternate	  allosteric	  binding	   sites	   to	  changes	   in	  
local	   flexibility	  within	   the	   binding	   pockets,	  making	   ligand	   binding	   entropically	  more	   favourable.71	   A	  
similar	  mechanism	  is	   likely	  responsible	  for	  the	  enhancement	  of	  Trp	  binding	  to	  MtuDAH7PS	  once	  Tyr	  
has	  bound.	  




Figure	  2.7	   ITC	  data	  for	  the	   interaction	  of	  A.	  38	  µM	  MtuDAH7PSWT	  preincubated	  with	  20	  µM	  Trp	  and	  3	  mM	  Tyr	  
titrant;	   B.	   49	  µM	   of	  MtuDAH7PSWT	   preincubated	   with	   400	   µM	   Tyr	   and	   250	   µM	   Trp	   titrant	   and	   C.	   40	   µM	  
MtuDAH7PSWT	  preincubated	  with	  400	  µM	  Tyr	  and	  1	  mM	  Phe	  titrant.	  
	  
Table	   2.2	   A	   complete	   list	   of	   dissociation	   constants	   determined	   by	   ITC	   for	  MtuDAH7PSWT.	   *	   Denotes	   values	  
determined	   by	   Richard	   Hutton.71,91	  —	   Indicates	   no	   background	   ligand	   present.	   Values	   are	   determined	   from	   a	  
single	  ITC	  experiment.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  squares	  fit.	  




Phe	   —	   21	  ±	  1*	  
	   Trp	   5	  ±	  1*	  
	   Tyr	   3.2	  ±	  0.1	  
Tyr	   —	   39	  ±	  1*	  
	   Trp	   40	  ±	  2	  
	   Phe	   12	  ±	  1*	  
Trp	   —	   4.7	  ±	  0.1*	  
	   Phe	   1.08	  ±	  0.03*	  
	   Tyr	   1.0	  ±	  0.1	  
	  
The	  inability	  of	  Trp	  to	  enhance	  Tyr	  binding	  suggests	  the	  communication	  pathway	  is	  only	  one	  way	  and	  
is	   a	   curious	   result.	   It	   may	   suggest	   either,	   Phe	   and	   Tyr	   do	   not	   bind	   to	   the	   same	   binding	   sites	   or	  
alternatively	   that	   the	   changes	   at	   sites	   1	   and/or	   2	   are	   optimised	   for	   Phe	   binding	   and	   not	   for	   Tyr	  
binding.	  The	  only	  difference	  between	  Phe	  and	  Tyr	  is	  the	  hydroxyl	  group	  of	  the	  Tyr.	  So	  enhancement	  of	  
Phe	  binding	  whilst	   leaving	  Tyr	  binding	  unaffected	  would	  most	   likely	   require	   the	   ‘optimised’	  binding	  
C.	  B.	  A
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site	   to	   encourage	   the	  burying	  of	   the	  hydrophobic	   phenyl	   group	  of	   Phe,	   to	  make	  Phe	  binding	  more	  
favourable.	  The	  optimisation	  of	  the	  hydrophobic	  contacts	  for	  the	  phenyl	  group	  of	  Phe	  may	  not	  affect	  
Tyr	  binding	  due	  to	  a	  hydrogen	  bond	  that	  forms	  between	  the	  Tyr	  hydroxyl	  group	  and	  the	  residues	  of	  
the	  core	  barrel	  structure	  at	  either	  site	  1	  or	  site	  2.	  This	  polar	  contact	  would	  most	  probably	  prevent	  the	  
tyrosyl	  group	  from	  repositioning	  itself	  in	  the	  binding	  pocket.	  
	  
This	   study	   also	   showed	   incubation	   of	  MtuDAH7PSWT	   with	   Tyr	   prior	   to	   titration	   of	   Phe	   resulted	   in	  
tighter	   Phe	   binding	   (Figure	   2.7C,	   Table	   2.2).	   Previous	   work	   had	   already	   established	   a	   background	  
presence	   of	   Phe	   decreased	   the	   Kd	   between	   MtuDAH7PS
WT	   and	   Tyr.48	   This	   cooperative	   binding	  
suggested	  a	  binding	  event	  at	  either	  site	  1	  or	  site	  2	  maybe	  transmitted	  to	  the	  other	  site.	  The	  enhanced	  
binding	   affinity	   at	   the	   other	   site	   is	   again	   probably	   due	   to	   subtle	   changes	   in	   local	   flexibility	   of	   the	  
binding	  site(s)	   that	   facilitate	   ligand	  binding.	  Alternatively	  the	  decrease	   in	  Kd	  between	  MtuDAH7PS
WT	  
and	   either	   Phe	   or	   Tyr	   with	   MtuDAH7PSWT	   pre-­‐incubated	   with	   the	   other	   amino	   acid	   could	   have	  
resulted	  from	  the	  elimination	  of	  weaker	  binding	  event	  due	  to	  the	  weaker	  binding	  site	  being	  occupied	  
by	   the	  alternative	   amino	  acid.	   If	   for	   example	   site	  1	  binds	  Phe	  more	   tightly	   than	   site	  2,	   then	   the	  Kd	  
determined	   between	   Phe	   and	   MtuDAH7PSWT	   is	   an	   average	   of	   the	   two	   binding	   events.	   When	  
MtuDAH7PS	  is	  incubated	  with	  Tyr,	  Tyr	  occupies	  site	  2	  and	  only	  the	  tighter	  binding	  of	  Phe	  to	  site	  1	  is	  
measured	  giving	  a	  lower	  Kd.	  
	  
 Structural	  characterisation	  2.6.
 SAXS	  analysis	  2.6.1.
The	   quaternary	   structure	   of	  MtuDAH7PS	   in	   solution	   was	   studied	   by	   small	   angle	   X-­‐ray	   scattering	  
(SAXS).	  This	  technique	  uses	  the	  elastic	  scattering	  of	  X-­‐rays	  at	  low	  angles	  to	  discern	  information	  about	  
a	  macromolecule’s	   size	   and	   shape.	   The	   SAXS	   scattering	  profile	  of	  MtuDAH7PSWT	  was	   analysed	  with	  
PRIMUS101,	  GNOM102,	  CRYSOL103	  and	  SAXS	  MoW104	  to	  determine	  the	  relevant	  SAXS	  parameters	  which	  
are	   tabulated	  below	   (Table	  2.3).	  The	  experimental	  and	  analytical	  protocols	  are	  described	   in	  Section	  
MtuDAH7PS	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9.7.5	  and	  9.7.6.	  Parameters	  of	  interest	  include	  the	  radius	  of	  gyration	  (Rg),	  the	  maximum	  particle	  size	  
(Dmax)	  and	  the	  Porod	  volume	  (Vp).	  The	  Rg	  is	  defined	  as	  the	  root	  mean	  square	  distance	  of	  atoms	  from	  
the	   centre	   of	   gravity	   of	   the	   macromolecule,	   and	   is	   an	   indication	   of	   the	   overall	   compactness	   of	   a	  
molecule.	  Dmax	  as	  its	  name	  implies,	  gives	  the	  distance	  of	  the	  macromolecules	  longest	  dimension.	  Vp	  is	  
the	  estimated	  particle	  volume	  as	  determined	  by	  the	  application	  of	  Porod’s	  Law.	  
	  
The	   theoretical	   scattering	  patterns	   for	   both	   a	   tetramer	   and	  dimer	  were	  modelled	  by	  CRYSOL	  using	  
MtuDAH7PS	   crystal	   coordinates	   (PDB	   code:	   3NV8).	   The	   experimental	   scattering	   profile	   of	  
MtuDAH7PSWT	  fitted	  more	  closely	  to	  the	  theoretical	  scattering	  of	  an	  MtuDAH7PS	  tetramer	  than	  the	  
dimer	  (Figure	  2.8).	  The	  fit	  was	  reflected	  in	  the	  𝜒2	  values,	  which	  is	  a	  measure	  of	  goodness	  of	  fit	  (Table	  
2.3).	  SAXS	  MoW	  is	  an	  online	  server	  that	  uses	  the	  GNOM	  output	  to	  calculate	  the	  molecular	  mass	  of	  a	  
protein	   and	   the	   number	   of	   subunits	   present.	   SAXS	  MoW	   estimated	   at	   the	   concentration	   analysed	  
(~5.6	  mg/mL)	  MtuDAH7PSWT	  exists	  as	  a	  tetramer	  in	  solution.	  The	  Dmax	  of	  127	  Å	  was	  determined	  from	  
the	   pair	   wise	   distribution	   analysis	   performed	   by	   GNOM.	   A	  Dmax	   of	   122	   Å	   was	   estimated	   from	   the	  
tetrameric	  MtuDAH7PS	  crystal	  structure	  (PDB	  code:	  3NV8).	  	  
	  
	  




Figure	  2.8	  SAXS	  scattering	  profiles	  for	  MtuDAH7PSWT	  (blue)	  and	  MtuDAH7PSWT	  in	  the	  presence	  of	  Trp,	  Phe	  and	  
Tyr	  (WFY)	  (orange)	  each	  ligand	  at	  a	  concentration	  of	  200	  µM.	  Also	  shown	  are	  the	  theoretical	  scattering	  profiles	  
for	   an	  MtuDAH7PS	   tetramer	   (solid	   black)	   and	   dimer	   (dash	   black)	   as	   predicted	   by	   CRYSOL	   using	   the	   crystal	  
coordinates	   PDB	   code:	   3NV8.	   Concentration	   of	   MtuDAH7PS	   was	   ~5.6	   mgmL-­‐1.	   Inset	   shows	   the	   pair	   wise	  
distribution	  from	  analysis	  by	  GNOM.	  
Table	   2.3	   SAXS	   parameters	   from	  MtuDAH7PSWT	  with	   and	  without	   Trp,	   Phe	   and	   Tyr	   (WFY)	   present	   (each	   at	   a	  
concentration	  of	  200	  µM).	  SAXS	  profiles	  were	  analysed	  with	  PRIMUS,	  GNOM,	  SAXS	  MoW	  and	  CRYSOL.	  Values	  are	  
results	  from	  a	  single	  experminent.	  
MtuDAH7PS	  	   Wild	  type	   Wild	  type	  WFY	  
Guinier	  Analysis	  
Rg	  (Å)	   41.6	  ±	  0.3	   41.9	  ±	  0.2	  
I	  (0)	  (cm-­‐1)	   0.168	  ±	  0.001	   0.048	  ±	  0.001	  
Pair	  Distribution	  Analysis	  
Real	  Space	  Rg	  (Å)	   40.9	  ±	  0.2	   41.0	  ±	  0.2	  
Dmax	  (Å)	   127	   125	  
Vp,	  (Da)	   282700	   311707	  
Molecular	  Weight	  Estimates	  from	  SAXS	  MoW	  Analysis	  
Mw	  from	  Vp	  (Da)	   199	  100	   206	  800	  
Nō	  of	  Subunits	   4	   4	  
CRYSOL	  Analysis	  with	  Tetrameric	  3NV8	  
RgE	  (Å)	   42.4	  ±	  0.2	   41.3	  ±	  0.2	  
RgT	  (Å)	   40.6	   41.0	  
𝜒2	   0.996	   0.425	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The	  scattering	  profile	  of	  MtuDAH7PSWT	  determined	  in	  the	  presence	  of	  200	  µM	  each	  of	  Trp,	  Phe	  and	  
Tyr	   was	   almost	   identical	   to	  MtuDAH7PSWT	  alone	   (Figure	   2.8).	   This	   implies	   that	   the	   binding	   of	   the	  
allosteric	  ligands	  does	  not	  cause	  a	  detectable	  change	  in	  conformation	  or	  oligomeric	  state	  in	  solution,	  
which	   agrees	   with	   the	   comparison	   of	   ligand	   bound	   and	   non-­‐ligand	   bound	  MtuDAH7PSWT	   crystal	  
structures.48,71	  
 Native	  PAGE	  2.6.1.
Native	  polyacrylamide	  gel	  electrophoresis	  (PAGE)	  was	  conducted	  using	  blue	  native	  PAGE	  (detailed	  in	  
Section	  9.7.2).	  Blue	  native	  PAGE	  complexes	  the	  protein	  with	  Coomassie®	  G-­‐250,	  making	  it	  negatively	  
charged,	   so	   the	   protein	   will	   migrate	   toward	   the	   anode	   at	   the	   neutral	   pH	   of	   7.5	   regardless	   of	   its	  
isoelectric	   point.	  MtuDAH7PS	   has	   a	   predicted	   isoelectric	   point	   of	   5.5	   from	   ProtParam	   tool	   on	   the	  
ExPASy	   proteomics	   server105.	   Results	   showed	   two	   oligomers	   were	   separated	   out	   at	   the	   low	  
concentration	  of	  ~0.2	  mg/mL	  at	  which	  MtuDAH7PS	  was	  applied	  to	  the	  gel	   (Figure	  2.9).	  One	  band	   is	  
observed	  with	  a	  mass	  of	  ~50	  kDa	  and	  a	  second	  with	  a	  mass	  of	  ~100	  kDa	  consistent	  with	  the	  molecular	  
mass	  of	  an	  MtuDAH7PSWT	  monomer	  and	  dimer	  respectively.	  	  
	  
It	  is	  possible	  the	  Coomassie®	  G-­‐250	  dye	  may	  disrupt	  protein-­‐protein	  interactions	  so	  caution	  must	  be	  
taken	   to	   ensure	   the	   results	   of	   the	   blue	   native	   PAGE	   are	   not	   over	   interpreted.	   Consequently	   it	  was	  
prudent	  to	  compliment	  these	  findings	  with	  further	  structural	  analysis	  of	  MtuDAH7PSWT	  by	  analytical	  
ultracentrifugation.	  
	  




Figure	  2.9	  Blue	  native	  PAGE;	  Lane	  M	  displays	  the	  molecular	  weight	  marker	  and	  Lane	  1	  MtuDAH7PSWT.	  
 Analytical	  ultracentrifugation	  (AUC)	  analysis	  2.6.2.
	  
Sedimentation	   velocity	   experiments	   were	   carried	   out	   to	   assess	   the	   quaternary	   structure	   of	  
MtuDAH7PSWT	  in	  solution.	  Ali	  Nazmi	  conducted	  the	  AUC	  experiments	  and	  assisted	  with	  the	  analysis	  of	  
the	   collected	   data.	   During	   centrifugation	   a	   centrifugal	   force	   is	   applied	   to	   the	   samples	   causing	   the	  
molecules	   to	   separate	   into	   layers	   based	   on	   their	   size	   and	   shape.106-­‐108	   These	   layers	   result	   in	  
boundaries	  and	  their	  movement	  can	  be	  monitored	  by	  UV	  absorbance.	  The	  rate	  of	  movement	  of	  the	  
boundaries	   is	   used	   to	   calculate	   the	   sedimentation	   coefficient,	   a	   parameter	   used	   to	   define	   a	  
molecule’s	   behaviour	   during	   sedimentation.106,107	   The	   sedimentation	   coefficient	   (s)	   is	   more	   strictly	  
defined	  as	   the	   ratio	  of	  a	  molecules	   sedimentation	  velocity	   to	   the	   force	  applied	   to	   it.106	   The	   sample	  
preparation,	  experimental	  setup	  and	  analysis	  are	  described	  in	  Section	  9.7.7.	  
	  
The	  MtuDAH7PSWT	  data	  for	  each	  concentration	  was	  fitted	  to	  a	  continuous	  size	  distribution	  model	  to	  
determine	  the	  sedimentation	  coefficients	  and	  calculated	  molecular	  mass	  (Figure	  2.10A).	  At	  1.0	  mg/mL	  
a	  single	  boundary	  was	  observed	  with	  a	  sedimentation	  coefficient	  of	  ~8.8	  S.	  The	  calculated	  mass	  of	  this	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the	  boundary	  had	  a	  slightly	  lower	  sedimentation	  coefficient	  of	  ~8.5	  S,	  giving	  a	  mass	  of	  ~164	  kDa,	  less	  
than	  expected	  for	  an	  MtuDAH7PS	  tetramer.	  The	  lowest	  concentration	  (0.2	  mg/mL)	  data	  revealed	  two	  
boundaries	  were	  present.	  The	  major	  species	  had	  a	  sedimentation	  coefficient	  of	  ~8.6	  S	  and	  again	  most	  
likely	  corresponds	  to	  a	  tetramer.	  The	  second	  boundary	  has	  a	  lower	  sedimentation	  coefficient	  of	  ~5.7	  S	  
with	   a	   calculated	   molecular	   mass	   of	   81	   kDa,	   less	   than	   102	   kDa	   molecular	   mass	   predicted	   for	   an	  
MtuDAH7PS	  dimer.	  
	  
Presence	  of	  multiple	  boundaries	  in	  the	  0.2	  mg/mL	  sample	  indicated	  there	  was	  a	  mixture	  of	  dimer	  and	  
tetramer	   in	  solution.	   If	   the	   interconversion	  between	  the	  dimer	  and	  tetramer	   is	   rapid	  relative	  to	  the	  
time	  scale	  of	  the	  experiment	  the	  distribution	  of	  the	  boundaries	  will	  depend	  on	  concentration	  as	  seen	  
here	  for	  MtuDAH7PS.109	  At	  concentrations	  greater	  than	  0.2	  mg/mL	  the	  equilibrium	  was	  driven	  almost	  
entirely	  toward	  the	  MtuDAH7PSWT	  tetramer	  whereas	  at	  0.2	  mg/mL	  and	  below	  the	  proportion	  of	  dimer	  
present	   increased.	   The	   variation	   of	   the	   quaternary	   structure	   of	  MtuDAH7PSWT	   with	   concentration	  
observed	  by	  AUC	  correlates	  well	  with	  the	  SAXS	  and	  native	  PAGE	  analyses	  previously	  described.	  




Figure	  2.10	  Normalised	  c(s)	  distribution	  functions	  from	  AUC	  data	  for	  MtuDAH7PSWT	  A.	  alone,	  B.	  plus	  100	  µM	  Phe,	  
C.	  plus	  100	  µM	  Trp	  and	  D.	  plus	  100	  µM	  Trp	  and	  100	  µM	  Phe,	  analysed	  at	  0.2	  mg/mL	  (violet),	  0.4	  mg/mL	  (purple)	  
and	  1.0	  mg/mL	  (pink).	  AUC	  data,	  fits	  and	  residuals	  are	  provided	  in	  Appendix	  II.	  	  
	  
The	   most	   remarkable	   finding	   from	   the	   analytical	   ultracentrifugation	   (AUC)	   studies	   was	   how	   the	  
presence	  of	  100	  µM	  of	  Trp	  and/or	  Phe	  resulted	   in	  single	  predominant	  species	  being	  detected	  at	  all	  
concentrations	  (Figure	  2.10B-­‐D).	  The	  sedimentation	  coefficient	  for	  each	  set	  of	  experiments,	  with	  Trp,	  
Phe	   or	   both	   were	   all	   ~8.6	   S	   and	   gave	   a	   calculated	   molecular	   mass	   of	   ~174	   kDa,	   the	   expected	  
molecular	  mass	  of	  204	  kDa	  for	  the	  MtuDAH7PS	  tetramer.	  The	  allosteric	  binding	  sites	  are	  all	  located	  in	  






+ 100 µM Trp 
MtuDAH7PSWT 
+ 100 µM Phe 
MtuDAH7PSWT 
+ 100 µM Trp  
+ 100 µM Phe 
MtuDAH7PSWT 
MtuDAH7PS	   2	  
	  
39	  
plausible	   ligand	  binding	   could	   stabilise	   the	  MtuDAH7PSWT	   tetramer,	   as	   suggested	  by	   these	   findings.	  
The	  MtuDAH7PS	  tetramer	  may	  in	  all	  likelihood	  be	  the	  functional	  regulatory	  species.	  
 Chapter	  summary	  2.7.
	  
Successful	   expression	   and	   purification	   of	   MtuDAH7PSWT	   gave	   an	   active	   enzyme	   with	   kinetic	  
parameters	   comparable	   to	   those	   previously	   reported.48,70	   In	   agreement	   with	   previous	   work	  
synergistic	  regulation	  of	  MtuDAH7PSWT	  was	  also	  observed.48	  Addition	  of	  Trp	  and	  either	  Phe	  or	  Tyr	  to	  
MtuDAH7PSWT	  resulted	  in	  a	  huge	  reduction	  in	  enzymatic	  activity,	  which	  could	  not	  be	  achieved	  by	  any	  
single	  aromatic	  amino	  acid	  even	  at	  very	  high	  concentrations.	  For	  the	  first	  time	  this	  study	  showed	  the	  
regulation	   of	  MtuDAH7PSWT	   activity	  was	   subject	   to	   ternary	   synergy,	  with	   the	   presence	   of	   all	   three	  
aromatic	  amino	  acids	  almost	  completely	  abolishing	  enzymatic	  activity.	  	  
	  
Biophysical	   characterisation	   by	   DSF	   indicated	   each	   aromatic	   amino	   acid	   makes	   a	   separate	  
contribution	  to	  the	  overall	  thermal	  stability	  of	  the	  enzyme.	  ITC	  studies	  revealed	  the	  binding	  of	  Tyr	  to	  
MtuDAH7PSWT	  enhances	  the	  affinity	  of	  MtuDAH7PSWT	  for	  Trp	  and	  Phe.	  Similarly	  Phe	  binding	  enhances	  
MtuDAH7PSWT	  affinity	  for	  Tyr	  and	  Trp	  yet	  Trp	  binding	  will	  only	  enhance	  the	  affinity	  of	  MtuDAH7PSWT	  
for	  Phe	  and	  not	  Tyr.	  	  
	  
Evaluation	  of	  MtuDAH7PSWT	  by	  SAXS,	  AUC	  and	  native	  PAGE	  revealed	  the	  concentration	  dependence	  
of	   the	  observed	  quaternary	  structure.	  At	  high	  concentrations	  AUC	  and	  SAXS	  showed	  MtuDAH7PSWT	  
exists	   primarily	   as	   a	   tetramer.	   As	   the	   concentration	   was	   reduced,	   the	   proportion	   of	   dimer	   (and	  
possibly	  even	  monomer	  if	  the	  native	  PAGE	  is	  believed)	  increases,	  indicating	  MtuDAH7PSWT	  exists	  in	  a	  
dynamic	  equilibrium.	  Furthermore	  the	  addition	  of	  ligand	  (Trp	  or	  Phe)	  drives	  the	  equilibrium	  towards	  
the	  tetrameric	  MtuDAH7PS	  species	  as	  shown	  by	  AUC,	  suggesting	  the	  tetramer	  may	  be	  the	  functionally	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3. MtuDAH7PS	   has	   a	   Phe-­‐selective	   site	   and	   a	  
Tyr-­‐selective	  site	  
3.1. Introduction	  
MtuDAH7PS	   is	   subject	   to	   a	   highly	   sophisticated	   feedback	   regulatory	  mechanism	   in	  which	   all	   three	  
aromatic	  amino	  acids	  contribute	  to	  the	  total	   inhibition	  observed	  (Section	  2.4.3)	  Analysis	  of	  multiple	  
ligand	   bound	   crystal	   structures	   clearly	   shows	   the	   presence	   of	   three	   distinct	   allosteric	   binding	  
sites.48,71,91	  These	  have	  been	  designated	  the	  Trp	  site,	  and	  sites	  1	  and	  2.	  Trp	  has	  only	  been	  observed	  to	  
occupy	  the	  Trp	  site,	  in	  the	  crystal	  structures	  reported	  to	  date.	  The	  binding	  preference	  of	  sites	  1	  and	  2	  
is	  more	   ambiguous,	   as	   both	   sites	   have	   been	   observed	   to	   bind	   Phe	   and	   Tyr	   in	   the	   various	   liganded	  
crystal	   structures.48,71,91	   The	   work	   described	   in	   this	   chapter	   has	   investigated	   the	   specificity	   and	  
selectivity	  of	  sites	  1	  and	  2	  for	  Phe	  and	  Tyr	  in	  order	  to	  establish	  the	  role	  and	  function	  of	  each	  site.	  This	  
was	  achieved	  by	  disrupting	  ligand	  binding	  at	  each	  site	  through	  site-­‐directed	  mutagenesis	  to	  substitute	  
key	  binding	   site	   residues.	   The	  properties	  of	   the	  enzyme	  variants	  and	   the	   impact	  of	   the	   changes	  on	  
MtuDAH7PS	  regulation	  were	  monitored	  by	  kinetic	  and	  biophysical	  techniques.	  
 Architecture	  of	  site	  1	  3.1.1.
Site	  1	  is	  located	  at	  the	  tight	  dimer	  interface	  ~23	  Å	  from	  the	  active	  site	  and	  has	  been	  shown	  to	  be	  occupied	  in	  
each	   chain	   of	   the	   homotetrameric	   MtuDAH7PS	   structure.	   The	   analysis	   of	   several	   ligand	   bound	   crystal	  






Figure	  3.1A).48,71,91	   Phe	  binds	   to	   site	  1	   through	  contacts	   formed	  between	   the	   carboxyl	   group	  of	   the	  
bound	  amino	  acid	  with	  the	  side	  chains	  of	  residues	  Arg171,	  Asn175	  (α2	  helix)	  and	  the	  α-­‐amino	  group	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of	  the	  bound	  ligand	  hydrogen	  bonding	  to	  the	  main	  chain	  carbonyl	  oxygen	  of	  Phe91	  (β1-­‐α1	  loop).	  The	  
benzyl	  group	  of	  the	  ligand	  is	  tucked	  into	  a	  hydrophobic	  pocket	  created	  by	  Val51*	  (α0b	  helix),	  Val55*,	  
Pro56*	  (α0b-­‐α0c),	  Tyr173*,	  Ala174*,	  Ala174	  and	  Ala178	  (α2	  helix),	  Residues	  from	  the	  β0	  strand	  from	  
the	  N-­‐terminal	  extension	  of	  the	  adjacent	  chain	  cap	  the	  binding	  pocket.	  Asp6*	  forms	  a	  hydrogen	  bond	  
to	   a	   water	   molecule	   which	   coordinates	   to	   the	   carbonyl	   of	   the	   bound	   ligand.	   Trp3*	   is	   positioned	  
between	  two	  adjacent	  site	  1	  binding	  sites,	  one	  from	  each	  subunit	  (Phe	   ligands	  bind	  ~8	  Å	  apart)	  and	  
contributes	  to	  both.	  The	  architecture	  of	  site	  1	  is	  similar	  in	  all	  subunits.	  
	  
Alignment	   of	   non-­‐ligand	   bound	   (PDB	   code:	   3NV8)	   and	   Trp-­‐	   and	   Phe-­‐bound	   tetrameric	  MtuDAH7PS	   crystal	  
structures	  (PDB	  code:	  3KGF)	  gives	  a	  RMSD	  of	  0.271	  Å	  between	  equivalent	  Cα	  atoms,	  revealing	  little	  change	  in	  






Figure	   3.1B).	   Close	   inspection	   of	   the	   site	  1	   binding	   site	   reveals	   that	   although	   the	   critical	   residues	  
retain	   similar	   positions,	   the	   cap	   provided	   by	   β0	   strand	   is	   positioned	   differently	   in	   the	   unliganded	  
structure,	   resulting	   in	   residues	   Trp3*	   to	   Asp6*	   being	   moved	   along	   by	   ~10	   Å.	   In	   the	   absence	   of	  
allosteric	  ligands	  Asp6*	  no	  longer	  coordinates	  to	  a	  water	  molecule	  (the	  water	  is	  not	  observed	  at	  all)	  
and	  its	  side	  chain	  carboxyl	  group	  is	  orientated	  away	  from	  the	  binding	  site.	  Trp3*	  has	  also	  moved,	  its	  
side	  chain	  no	  longer	  contributing	  to	  the	  site	  1	  binding	  site	  of	  either	  chain.	  
	  
Alignment	  of	   the	   Trp	   and	  Phe	   ligand	  bound	   crystal	   structure	   (PDB	   code:	   3KGF)	  with	   the	   crystal	   structure	   in	  
which	  Phe	  only	  occupies	  site	  1	  (PDB	  code:	  2YPO)	  shows	  the	  there	  is	  very	  little	  difference	  in	  the	  structures	  (Cα	  
RMSD	   0.232	   Å).	   The	   Phe	   ligand	   is	   found	   in	   the	   exact	   same	   orientation	   in	   both	   of	   these	   structures	   and	   all	  










Further	  comparison	  of	  the	  tetrameric	  Trp	  and	  Phe	  ligand	  bound	  structure	  with	  a	  Tyr	  soaked	  crystal	  structure	  	  
(PDB	   code:	   2YPP)	   shows	   Tyr	   bound	   at	   site	   1,	   forming	   contacts	   that	   are	   remarkably	   similar	   to	   when	   Phe	   is	  






Figure	  3.1D).	  The	  benzyl	  ring	  of	  the	  Tyr	  is	  slightly	  repositioned	  in	  the	  hydrophobic	  binding	  pocket	  to	  
allow	   the	   hydroxyl	   group	   of	   the	   side	   chain	   to	   coordinate	   via	   a	   water	   molecule	   to	   the	  main	   chain	  









*	  Indicates	  residues	  contributed	  to	  the	  site	  by	  the	  adjacent	  subunit	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Figure	   3.1	   Critical	   residues	   involved	   in	   ligand	   binding	   at	   site	   1.	   A.	  MtuDAH7PSWT	   Trp	   and	   Phe	   soaked	   crystal	  
structure	  (PDB	  code:	  3KGF,	  2.00	  Å	  resolution).	  Backbone	  carbons	  are	  shown	  in	  cartoon	  form	  with	  the	  core	  barrel	  
and	  N-­‐terminal	  extension	  coloured	  blue	  and	  red	  respectively	  and	  key	  residues	  shown	  in	  stick	  form.	  The	  carbons	  
of	  the	  bound	  Phe	  ligand	  are	  shown	  in	  light	  green,	  coordinated	  waters	  are	  shown	  as	  red	  spheres	  and	  the	  dashed	  
grey	   lines	  represent	  hydrogen	  bonding	   interactions.	  B.	  Alignment	  of	  A.	  with	  non-­‐ligand	  bound	  crystal	  structure	  
(PDB	  code:	  3NV8,	  2.25	  Å	  resolution,	  Cα	  RMSD	  0.271	  Å).	  Key	  residues	  of	  3NV8	  are	  shown	  as	  sticks	  in	  light	  blue	  and	  
light	  pink	  (coloured	  by	  core	  and	  N-­‐terminal	  extension	  respectively).	  C.	  Alignment	  of	  A.	  with	  the	  low	  concentration	  
Phe	   soaked	   crystal	   structure	   (PDB	   code:	   2YP0,	   2.00	   Å	   resolution,	   Cα	   RMSD	   0.232Å).	   Key	   residues	   of	   2YP0	   are	  
shown	  as	  sticks	  in	  grey	  and	  mustard	  (coloured	  by	  core	  and	  N-­‐terminal	  extension	  respectively),	  carbons	  of	  the	  Phe	  
ligand	  are	  coloured	  teal	  and	  hydrogen	  bonds	  are	  shown	   in	   red.	  D.	  Alignment	  of	  A.	  with	   the	  Tyr	   soaked	  crystal	  
structure	   (PDB	   code:	   2YPP,	   2.30	   Å	   resolution,	   Cα	   RMSD	   0.287Å).	   Key	   residues	   of	   2YPP	   are	   shown	   as	   sticks	   in	  
orange	  and	  dark	  green	  (coloured	  by	  core	  and	  N-­‐terminal	  extension	  respectively),	  carbons	  of	  the	  bound	  Tyr	  ligand	  
are	  coloured	  deep	  purple	  and	  hydrogen	  bonds	  are	  shown	  in	  red	  
 Architecture	  of	  site	  2	  3.1.2.
This	  site	   is	   located	  ~20	  Å	   from	  site	  1	  and	  ~35	  Å	   from	  the	  active	  site.	  Phe	  or	  Tyr	  has	  only	  ever	  been	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the	  tetrameric	  unit.48,71,91	  It	  is	  unclear	  if	  crystal	  packing	  restricts	  or	  alters	  ligand	  access	  to	  site	  2	  at	  the	  
remaining	   unoccupied	   sites	   of	   the	   subunit.	   In	   the	   Tyr-­‐bound	   crystal	   structure	   Tyr	   occupies	   two	  
different	  allosteric	  binding	  sites	  (PDB	  code:	  2YPP).91	  The	  first	  Tyr	  is	  found	  bound	  at	  Site	  1,	  as	  described	  
in	  Section	  3.1.1,	   the	  second	  Tyr	  at	  site	  2.	  The	  carboxyl	  group	  of	  the	  bound	  Tyr	   forms	  two	  hydrogen	  
bonds	  to	  each	  guanidinium	  group	  of	  the	  side	  chains	  of	  Arg256	  and	  Arg23	  (from	  the	  α0a	  and	  α3	  helices	  
respectively)	   (Figure	  3.2A).	   In	  addition	   the	  α-­‐amino	  group	  of	   the	  bound	  Tyr	  hydrogen	  bonds	   to	   the	  
backbone	  carbonyl	  oxygen	  of	  Arg256,	  the	  side	  chain	  of	  Glu53	  (α0b	  helix)	  and	  coordinates	  via	  a	  water	  
molecule	  to	  Leu259	  (α3-­‐β4	  loop).	  The	  residues	  Leu18	  (β0-­‐α0a	  loop),	  Leu259,	  Leu261,	  and	  Leu271	  (α3-­‐
β4	   loop)	   form	   the	   hydrophobic	   pocket	   for	   the	   benzyl	   ring.	   The	   hydroxyl	   group	   of	   the	   Tyr	   forms	   a	  
hydrogen	  bond	  to	  the	  main	  chain	  carbonyl	  oxygen	  of	  Leu261.	  The	  backbone	  amide	  nitrogen	  group	  of	  
Pro16	  (β0-­‐α0a	  loop)	  coordinates	  directly	  to	  the	  hydroxyl	  group	  of	  the	  ligand.	  
	  
Alignment	   of	   the	   tetrameric	   Tyr-­‐bound	   structure	  with	   the	   non-­‐ligand	   bound	   crystal	   structure	   (PDB	  
code:	   3NV8)	   reveals	  only	   small	   changes	   in	   the	   conformation	  of	   site	  2	  due	   to	   ligand	  binding	   (Figure	  
3.2B).	  Most	  notably	  the	  positions	  of	  Pro16	  and	  Leu18	  have	  been	  altered	  due	  to	  the	  movement	  of	  the	  
β0-­‐α0a	  loop	  to	  allow	  coordination	  of	  the	  amide	  nitrogen	  of	  Pro16	  to	  the	  hydroxyl	  group	  of	  the	  bound	  
Tyr.	  
	  
The	  binding	  of	  Trp	  at	  the	  Trp	  site	  in	  the	  Trp-­‐	  and	  Tyr-­‐bound	  crystal	  structure	  (PDB	  code:	  2YPQ)	  does	  
not	  alter	  Tyr	  binding	  at	  site	  2	  (Figure	  3.2C).	  Only	  minor	  movements	  in	  residues	  contributing	  to	  site	  2	  
are	  observed	  when	  the	  Trp-­‐	  and	  Tyr-­‐bound	  tetrameric	  structure	  is	  compared	  to	  the	  Tyr	  soaked	  crystal	  
structure	  (Cα	  RMSD	  0.529	  Å).	  
3	   Sites	  1	  and	  2	  
	  
46	  
Alignment	  of	   the	  Trp	  and	  Phe	   soaked	  crystal	   structure	   (PDB	  code:	  3KGF),	  with	  Phe	  bound	  at	   site	  2,	  
shows	  how	  Phe	  can	  not	  form	  a	  hydrogen	  bond	  to	  Pro16	  leaving	  the	  β0-­‐α0a	  loop	  in	  a	  similar	  position	  
for	  site	  2	  as	  is	  observed	  in	  the	  absence	  of	  ligand	  (Figure	  3.2D).	  
	  
Figure	  3.2	  Critical	  residues	  involved	  in	  ligand	  binding	  at	  site	  2.	  A.	  MtuDAH7PS	  Tyr	  soaked	  crystal	  structure	  (PDB	  
code:	  2YPP,	  2.30	  Å	  resolution).	  Backbone	  carbons	  are	  shown	  in	  cartoon	  form	  with	  the	  core	  barrel	  and	  N-­‐terminal	  
extension	  coloured	  orange	  and	  dark	  green	  respectively	  and	  key	  residues	  shown	  in	  stick	  form.	  The	  carbons	  of	  the	  
bound	  Tyr	  ligand	  are	  shown	  in	  deep	  purple,	  coordinated	  waters	  are	  shown	  as	  red	  spheres	  and	  the	  dashed	  grey	  
lines	  represent	  hydrogen	  bonding	   interactions.	  B.	  Alignment	  of	  A.	  with	  unliganded	  crystal	  structure	  (PDB	  code:	  
3NV8,	  2.25	  Å	  resolution,	  Cα	  RMSD	  0.208	  Å).	  Key	  residues	  of	  3NV8	  are	  shown	  as	  sticks	  in	  light	  blue	  and	  light	  pink	  
(coloured	  by	  core	  and	  N-­‐terminal	  extension	  respectively).	  C.	  Alignment	  of	  A.	  with	  the	  Tyr	  soaked	  crystal	  structure	  
(PDB	  code:	  2YPQ,	  2.76	  Å	  resolution,	  Cα	  RMSD	  0.529	  Å).	  Key	  residues	  of	  2YPQ	  are	  shown	  as	  sticks	  in	  yellow	  and	  
light	  purple	  (coloured	  by	  core	  and	  N-­‐terminal	  extension	  respectively),	  carbons	  of	  the	  Tyr	  ligand	  are	  coloured	  pink	  
and	  hydrogen	  bonds	  are	   shown	   in	   red.	  D.	  Alignment	  of	  A.	  with	   the	  Trp	  and	  Phe	  soaked	  crystal	   structure	   (PDB	  
code:	   3KGF,	   2.00	   Å	   resolution,	   Cα	   RMSD	   0.287Å).	   Key	   residues	   of	   3KGF	   are	   shown	   as	   sticks	   in	   blue	   and	   red	  
(coloured	   by	   core	   and	  N-­‐terminal	   extension	   respectively),	   carbons	   of	   the	   bound	   Phe	   ligand	   are	   coloured	   light	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 Chapter	  aims	  3.2.
The	  aim	  of	  the	  work	  described	  in	  this	  chapter	  was	  to	  differentiate	  the	  roles	  that	  sites	  1	  and	  2	  play	  in	  
the	   ternary	   synergistic	   inhibition	   observed	   for	  MtuDAH7PS.	   Site-­‐directed	  mutagenesis	  was	   used	   to	  
generate	  two	  MtuDAH7PS	  variants	  with	  ligand	  binding	  hindered	  at	  either	  site	  1	  or	  site	  2,	  leaving	  the	  
alternate	   site	   available	   for	   ligand	   binding.	   Theoretically	   these	   variants	   allow	   sites	   1	   and	   2	   to	   be	  
investigated	   separately,	   albeit	   still	   in	   combination	  with	   the	  Trp	   site.	   This	   approach	  has	  enabled	   the	  
investigation	  into	  the	  ligand	  preferences	  of	  each	  site	  and	  the	  relationship	  between	  the	  occupancy	  of	  
each	  site	  and	  the	  inhibitory	  response.	  
 Preparation	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  3.3.
 Selection	  of	  residues	  for	  mutagenesis	  3.3.1.
The	  primary	  goal	  of	  the	  site-­‐directed	  mutagenesis	  was	  to	  generate	  MtuDAH7PS	  variants	  incapable	  of	  
binding	   ligands	  at	  either	   site	  1	  or	   site	  2.	  To	  start	   residues	  were	   identified	  which	  make	  a	  number	  of	  
stabilising	   contacts	   to	   the	   bound	   ligand	   through	   their	   side	   chain.	   Replacement	   of	   the	   identified	  
residue	  with	  an	  Ala	  effectively	  removes	  the	  side	  chain	  and	  its	  functional	  group,	  whilst	  preserving	  the	  
rigidity	  of	  the	  backbone	  conformation	  to	  maintain	  the	  secondary	  structure.	  
	  
When	  Tyr	  or	  Phe	  binds	  to	  site	  1	  Arg171	  forms	  two	  hydrogen	  bonds	  between	  the	  nitrogen’s	  of	  its	  guanidinium	  






Figure	   3.1A).	   Thus	   the	   substitution	   of	   Arg171	   to	   Ala	   is	   an	   excellent	   candidate	   for	   mutagenesis.	  
Similarly,	   the	  guanidinium	  group	  of	  Arg256	  forms	  two	  hydrogen	  bonds	  to	  the	  carboxyl	  group	  of	  the	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bound	   ligand	   (either	   Tyr	   or	   Phe)	   at	   site	   2	   (Figure	   3.2A).	   Thus	   substitution	   of	   Arg256	   to	   Ala	   would	  
prevent	  these	  contacts,	  and	  so	  would	  be	  expected	  to	  significantly	  attenuate	  ligand	  binding	  at	  site	  2.	  
 Mutagenesis,	  expression	  and	  purification	  3.3.2.
SDM	   was	   performed	   using	   the	   QuikChange®	   Lightning	   Site-­‐Directed	   Mutagenesis	   Kit	   (Stratagene).	  
Primers	   were	   designed	   using	   the	   QuikChange®	   Primer	   Design	   tool	   (Agilent	   technologies)	   to	  
incorporate	   the	  desired	  mutations	  and	   the	  pProEx-­‐Hta	  vector	   containing	   the	  MtuDAH7PS	  gene	  was	  
used	  as	  the	  template	  for	  the	  PCR	  detailed	  in	  Section	  9.2.	  	  
	  
Once	  DNA	  sequencing	  confirmed	  the	  incorporation	  of	  the	  correct	  mutations	  the	  SDM	  products	  were	  
electroporated	   into	   BL21(DE3)	   pGroESL	   cells.	   Expression	   and	   protein	   purification	   followed	   the	  
methodology	  previously	  detailed	  for	  MtuDAH7PSWT	  in	  Section	  9.5.	  
 Confirmation	  of	  product	  3.3.3.
SDS-­‐PAGE	  analysis	  of	  the	  final	  purified	  MtuDAH7PS	  variants	  showed	  both	  were	  highly	  pure,	  producing	  
a	  single	  protein	  band	  at	  ~50	  kDa	  in	  agreement	  with	  the	  expected	  molecular	  mass	  of	  an	  MtuDAH7PS	  
monomer	   (Figure	  3.3).	  Mass	  spectrometry	  confirmed	  the	   final	  purified	  proteins	  were	  of	   the	  correct	  
molecular	  mass.	  Both	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  had	  experimental	  masses	  that	  perfectly	  
matched	  their	  expected	  mass	  of	  50,699	  Da	  (Table	  3.1).	  
	  
Table	   3.1	   Calculated	  molecular	  masses	   determine	   from	   amino	   acid	   sequence	   and	   empirical	  molecular	  masses	  
determined	  from	  mass	  spectroscopy	  for	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A.	  




MtuDAH7PSR171A	   50699	   50699	  
MtuDAH7PSR256A	   50699	   50699	  




Figure	  3.3	  SDS-­‐PAGE	  gel	   illustrating	  the	  size	  and	  purity	  of	  each	  purified	  MtuDAH7PS	  variant.	  Lane	  M	  molecular	  
weight	  marker;	  Lane	  1	  MtuDAH7PSR171A	  and	  Lane	  2	  MtuDAH7PSR256A.	  
 Structural	  analysis	  3.4.
 Comparison	  of	  secondary	  structure	  3.4.1.
CD	   spectrophotometry	   permits	   assessment	   of	   protein	   secondary	   structure	   by	   using	   the	   uneven	  
absorption	  of	  left-­‐	  and	  right-­‐handed	  circularly	  polarised	  light	  to	  detect	  secondary	  structural	  elements	  
within	  proteins.110,111	  The	  CD	  spectra	  were	  measured	  in	  20	  mM	  Tris	  buffer	  at	  pH	  7.5,	  and	  the	  protocol	  
is	  detailed	  in	  Section	  9.7.4.	  
	  
Comparison	   of	   the	   CD	   spectra	   of	   the	   MtuDAH7PS	   variants	   with	   MtuDAH7PSWT	   confirmed	   the	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Figure	  3.4	  CD	  spectra	  for	  MtuDAH7PSWT	  (blue),	  MtuDAH7PSR171A	  (red)	  and	  MtuDAH7PSR256A	  (green).	  
	  
 Quaternary	  structure	  analysis	  in	  solution	  3.4.2.
The	   SAXS	  was	   used	   to	   assess	   the	   quaternary	   structure	   of	  MtuDAH7PSR171A	   and	  MtuDAH7PSR256A	   in	  
solution.	  The	  experimental	  SAXS	  scattering	  profiles	  of	  both	  variant	  enzymes	  were	  almost	  identical	  to	  
MtuDAH7PSWT,	  correlating	  well	  with	  the	  theoretical	  scattering	  profile	  predicted	  by	  CRYSOL103	  for	  the	  
MtuDAH7PS	   tetramer	   from	   the	   crystal	   coordinates	   PDB	   code:	   3NV8	   (Figure	   3.5).	   Furthermore	   the	  
parameters	   derived	   from	   the	   scattering	   profiles	   of	  MtuDAH7PSR171A	   and	  MtuDAH7PSR256A	   were	   in	  
good	   agreement	   with	   the	   parameters	   of	   MtuDAH7PSWT	   (Figure	   3.5,	   Table	   3.2).	   Thus	   at	   high	  
concentrations	   (>4.5	   mg/mL)	   MtuDAH7PSR171A	   and	   MtuDAH7PSR256A	   adopt	   the	   same	   quaternary	  
structure	  as	  MtuDAH7PSWT	  in	  solution.	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Figure	  3.5	  SAXS	  scattering	  profiles	  of	  MtuDAH7PSWT	  (blue),	  MtuDAH7PSR171A	  (red)	  and	  MtuDAH7PSR256A	  (green).	  
Also	   shown	   is	   the	   theoretical	   scattering	   for	   the	   tetrameric	   (black)	   and	   dimeric	   (black	   dash)	   species	   from	   PDB	  
code:	  3NV8.	  Inset	  pair-­‐wise	  distribution	  profiles.	  
Table	  3.2	  SAXS	  parameters	  determined	  from	  the	  SAXS	  scattering	  profile	  of	  MtuDAH7PSWT,	  MtuDAH7PSR171A	  and	  
MtuDAH7PSR256A.	  SAXS	  profiles	  were	  analysed	  with	  PRIMUS,	  GNOM,	  SAXS	  MoW	  and	  CRYSOL.	  Values	  determined	  
from	  a	  single	  SAXS	  experiment.	  
MtuDAH7PS	   Wild	  type	   R171A	   R256A	  
Guinier	  Analysis	   	   	   	  
Rg	  (Å)	   41.6	  ±	  0.3	   42.8	  ±	  0.2	   53.2	  ±	  0.3	  
I	  (0)	  (cm-­‐1)	   0.168	  ±	  0.001	   0.188	  ±	  0.001	   0.071	  ±	  0.001	  
Pair	  Distribution	  Analysis	  
Real	  Space	  Rg	  (Å)	   40.9	  ±	  0.2	   41.7	  ±	  0.2	   41.80	  ±	  0.07	  
Dmax	  (Å)	   127	   126	   125	  
Vp,	  (Da)	   282700	   327700	   291600	  
Molecular	  Weight	  Estimates	  from	  SAXS	  MoW	  Analysis	  
Mw	  from	  Vp	  (Da)	   199	  100	   204300	   198700	  
Nō	  of	  Subunits	   4	   4	   4	  
CRYSOL	  Analysis	  with	  Tetrameric	  3NV8	  
RgE	  (Å)	   42.4	  ±	  0.2	   42.3	  ±	  0.2	   42.4	  ±	  0.2	  
RgT	  (Å)	   40.6	   40.6	   40.6	  
𝜒2	   0.996	   0.966	   0.939	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Unfortunately,	  due	  to	  the	  tendency	  for	  MtuDAH7PS	  to	  aggregate,	  all	  SAXS	  analysis	  was	  conducted	  by	  
passing	   the	   sample	   through	   a	   size	   exclusion	   chromatography	   column	   just	   prior	   to	   analysis,	   limiting	  
analysis	  of	  MtuDAH7PS	  to	  concentrations	  above	  4.5	  mg/mL.	  As	  an	  alternative	  means	  of	  probing	  the	  
quaternary	   structure	   at	   very	   low	   concentrations	   blue	   native	   polyacrylamide	   electrophoresis	   (PAGE)	  
was	  used.	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  were	  applied	  to	  the	  gel	  at	  	  ~	  0.2	  mg/mL	  and	  found	  to	  
exist	   as	   two	   species	   in	   solution.	   One	   band	   at	   ~50	   kDa,	   and	   another	   at	   ~100	   kDa,	   consistent	   with	  
expected	  molecular	  masses	   of	   the	  MtuDAH7PS	  monomer	   and	   dimer	   respectively	   (Figure	   3.6).	   The	  
ratio	  of	  intensity	  between	  the	  two	  bands	  for	  the	  two	  MtuDAH7PS	  variants	  is	  similar	  to	  MtuDAH7PSWT.	  
The	  results	  of	  the	  blue	  native	  PAGE	  and	  SAXS	  imply	  the	  Arg	  to	  Ala	  substitution	  introduced	  into	  each	  
MtuDAH7PS	  variant	  has	  not	  caused	  any	  changes	  to	  the	  quaternary	  structure.	  
	  
	  
Figure	   3.6	   Blue	   native	   PAGE;	   Lane	   M	   displays	   the	   molecular	   weight	   marker;	   Lane	   1	  MtuDAH7PSWT;	   Lane	   2	  
MtuDAH7PSR256A	  and	  Lane	  3	  MtuDAH7PSR171A.	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 Determination	  of	  kinetic	  parameters	  3.5.
The	   kinetic	   assays	   for	   MtuDAH7PSR171A	   and	   MtuDAH7PSR256A	   were	   determined	   under	   the	   same	  
conditions	  as	  MtuDAH7PSWT	   (detailed	   in	  Section	  9.9.1)	  and	  fitted	  to	  the	  Michaelis-­‐Menten	  equation	  
to	   derive	   the	   kinetic	   parameters.	   The	   kinetic	   parameters	   showed	   some	   variation	   to	   those	   of	  
MtuDAH7PSWT	  (Table	  3.3).	  These	  results	  showed	  the	  substitutions	  introduced	  to	  MtuDAH7PSR171A	  and	  
MtuDAH7PSR256A	  have	  no	  significant	  adverse	  effects	  on	  the	  	  catalytic	  abilities	  of	  the	  enzymes.	  	  
	  
Table	   3.3	   Comparison	   of	   kinetic	   parameters	   determined	   from	   a	   single	   set	   of	   Michaelis-­‐Menten	   kinetics	   for	  
MtuDAH7PSWT,	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A.	  For	  Michaelis-­‐Menten	  plots	  refer	  to	  Appendix	  I.	  Error	  bars	  
represent	  the	  error	  of	  fit	  of	  the	  equation	  to	  the	  data	  as	  determined	  by	  least	  squares	  fit.	  	  










E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
R171A	   35	  ±	  3	   60	  ±	  6	   7.0	  ±	  0.3	   200	  ±	  30	   120	  ±	  20	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 Assessment	  of	  ligand	  binding	  3.6.
 Thermal	  stability	  3.6.1.
DSF	  of	  MtuDAH7PSWT	  demonstrated	   the	  melting	   temperature	   (Tm)	   increased	   in	   the	  presence	  of	   the	  
aromatic	  amino	  acids	  (Section	  2.5.1).	  Thus	  DSF	  can	  be	  used	  as	  a	  tool	  to	  quickly	  evaluate	  whether	  the	  
aromatic	  amino	  acids	  are	  likely	  to	  bind	  to	  the	  proteins	  by	  monitoring	  the	  increase	  in	  thermal	  stability	  
of	   the	  MtuDAH7PS	   variants.	   DSF	   assay	   conditions	   and	   experimental	   setup	   are	   described	   in	   Section	  
9.8.1.	  
	  
Figure	   3.7	   Thermal	   melting	   points	   determined	   by	   DSF	   for	  MtuDAH7PSWT	   (blue),	  MtuDAH7PSR171A	   (red)	   and	  
MtuDAH7PSR256A	  (green).	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  
in	  appendix	  V.	  
	  
Unlike	  wild	  type	  enzyme,	  MtuDAH7PSR171A	  displayed	  no	  increase	  in	  thermal	  stability	  in	  the	  presence	  of	  
Phe	  (Figure	  3.7).	  As	  the	  substitution	  of	  Arg171Ala	  is	  designed	  to	  disrupt	  ligand	  binding	  at	  site	  1,	  these	  
results	  offer	  evidence	  Phe	  must	  be	  able	   to	  bind	   to	   site	  1	   to	   improve	  MtuDAH7PS	   thermal	   stability.	  
Likewise	   the	   thermal	   stability	   of	  MtuDAH7PSR256A	  was	   unaffected	   by	   Tyr.	   Recalling	  MtuDAH7PSR256A	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has	   been	   engineered	   to	   disrupt	   ligand	   binding	   at	   site	   2,	   the	   inability	   of	   Tyr	   to	   stabilise	  
MtuDAH7PSR256A	   indicates	   Tyr	   binding	   to	   site	   2	   plays	   an	   integral	   part	   in	   the	   stabilisation	   of	  
MtuDAH7PS	  by	  Tyr.	  	  
	  
Both	  MtuDAH7PSR171A	   and	  MtuDAH7PSR256A	   were	   significantly	   stabilised	   by	   Trp	   in	   accordance	   with	  
what	   was	   observed	   for	   the	   wild	   type	   enzyme,	   suggesting	   Trp	   binding	   does	   take	   place.	   Careful	  
inspection	   also	   revealed	   the	   change	   in	   Tm	   for	  MtuDAH7PS
R171A	   in	   the	  presence	  of	   Trp	   and	  Phe	  was	  
equivalent	   to	   that	   observed	   for	   Trp	   alone.	   Similarly	   the	   presence	   of	   Trp,	   Phe	   and	   Tyr	   yielded	   an	  
increase	  in	  Tm	  of	  MtuDAH7PS
R171A	  equivalent	  to	  the	  increase	  observed	  for	  Trp	  and	  Tyr.	  Together	  these	  
findings	  suggest	  the	  Arg171Ala	  substitution	  disrupted	  Phe	  binding	  at	  site	  1.	  
	  
Likewise	  MtuDAH7PSR256A	  displayed	  almost	  an	  identical	  increase	  in	  Tm	  in	  the	  presence	  of	  Trp	  and	  Tyr,	  
but	  in	  the	  presence	  of	  all	  three	  aromatic	  acids	  the	  Tm	  was	  0.5	  ˚C	  less	  than	  in	  the	  presence	  of	  Trp	  and	  
Phe.	  	  
	  
Furthermore	  both	  MtuDAH7PS	  variants	  demonstrated	  an	   increase	   in	  their	  thermal	  stability	  equal	  to	  
the	  additive	  affect	  of	  each	  component	  when	  multiple	  aromatic	  amino	  acids	  were	  present.	  This	  was	  
consistent	   with	   results	   for	  MtuDAH7PSWT	   and	   indicates	   multiple	   ligands	   are	   still	   able	   to	   bind	   the	  
MtuDAH7PS	  variants	  simultaneously.	  	  
 Binding	  affinities	  	  3.6.2.
	  
Although	  DSF	  can	  detect	  ligand	  binding	  by	  changes	  in	  thermal	  stability	  it	  does	  not	  absolutely	  prove	  a	  
ligand	  has	  not	  bound	  simply	  because	  no	  change	   is	  observed.	  A	   ligand	   that	  binds	   to	  an	  MtuDAH7PS	  
variant	   but	   is	   unable	   to	   elicit	   an	   increase	   in	   thermal	   stability	   would	   not	   increase	   the	   determined	  
melting	   temperature.	   ITC	  directly	  measures	   the	  enthalpy	   changes	  associated	  with	   ligand	  binding	   to	  
MtuDAH7PS.	   This	   provides	   definitive	   and	   quantitative	   information	   about	   the	   ability	   of	   each	  
MtuDAH7PS	  variant	   to	  bind	  a	  particular	   ligand.	  Preparation,	  experimental	   conditions	  and	   setup	  are	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detailed	  in	  Section	  9.8.2.	  The	  Kd	  are	  determined	  by	  iteratively	  fitting	  the	  appropriate	  model	  (either	  a	  
one	  or	  two	  site	  binding	  model)	  to	  the	  ITC	  data	  using	  Origin®	  software.	  	  
	  
The	  isotherm	  for	  binding	  of	  Phe	  to	  MtuDAH7PSR171A	  displayed	  very	  weak	  binding	  with	  a	  Kd	  in	  excess	  of	  
1	  mM	   and	   beyond	   the	   detection	   limit	   of	   the	   VP	   ITC	   system	   (Figure	   3.8A).	   Recalling	   the	   Arg171Ala	  
substitution	  of	  MtuDAH7PSR171A	  was	  intended	  to	  disrupt	  Tyr	  or	  Phe	  binding	  at	  site	  1,	  and	  given	  the	  Kd	  
of	  ~21	  µM	  between	  MtuDAH7PSWT	  and	  Phe	  this	  result	  confirmed	  Phe	  does	  not	  bind	  to	  site	  2	  (or	  the	  
Trp	   site)	   of	  MtuDAH7PSR171A	   with	   any	   significant	   affinity.	   Furthermore	   the	   Kd	   determined	   for	   the	  
binding	   of	   Phe	   to	  MtuDAH7PSR256A	   was	   very	   similar	   to	  MtuDAH7PSWT	   (Figure	   3.8E,	   Table	   3.4).	   As	  
MtuDAH7PSR256A	  was	  the	  variant	  with	  impaired	  ability	  to	  bind	  ligands	  at	  site	  2	  this	  was	  further	  proof	  
Phe	  preferentially	  binds	  to	  site	  1.	  
	  
Table	  3.4	  Dissociation	  constants	  determined	  for	  MtuDAH7PSWT,	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  by	  ITC.	  A	  
background	   Phe	   concentration	   of	   50	   µM	   was	   used.	   *	   Denotes	   values	   determined	   by	   Richard	   Hutton.71,91	   —	  
Indicates	   no	   background	   ligand	   is	   present.	   Values	   were	   determined	   from	   a	   single	   ITC	   experiment.	   Error	  









Wild	  Type	   R171A	   R256A	  
Kd	  (µM)	   Kd	  (µM)	   Kd	  (µM)	  
Phe	   —	   21	  ±	  1*	   >>1000	   17	  ±	  1	  
Tyr	   —	   39	  ±	  1*	   19	  ±	  2	   54	  ±	  4	  
Tyr	   Phe	   12	  ±	  1*	   40	  ±	  3	   120	  ±	  20	  
Trp	   —	   4.7	  ±	  0.1*	   1	  ±	  8	  and	  1	  ±	  3	   3.4	  ±	  0.4	  
	  
Tyr	  was	  able	  to	  bind	  reasonably	  well	  to	  MtuDAH7PSR256A	  with	  a	  Kd	  higher	  than	  that	  observed	  for	  the	  
wild	   type	  enzyme	   (Figure	  3.8F,	   Table	  3.4).	   Tyr	  has	  only	  ever	  been	  observed	   to	   concurrently	  occupy	  
sites	  1	  and	  2	  crystallographically.91	  The	  substitution	   introduced	  to	  MtuDAH7PSR256A	  was	  designed	  to	  
impair	   binding	   at	   site	   2.	   Hence	   the	   Kd	   determined	   between	   Tyr	   and	   MtuDAH7PS
R256A	   could	   be	  
considered	  primarily	  a	  measure	  of	  how	  tightly	  Tyr	  binds	   to	  site	  1.	   Interestingly,	   the	  Kd	  between	  Tyr	  
and	  MtuDAH7PSR171A	  showed	  that	  Tyr	  binds	  more	  tightly	  to	  this	  variant	  than	  MtuDAH7PSR256A	  (Figure	  
3.8B,	  Table	  3.4).	  Although	  Tyr	  can	  bind	  to	  both	  sites	  it	  binds	  more	  tightly	  to	  site	  2	  than	  site	  1.	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The	  Kd	  between	  Tyr	  and	  MtuDAH7PS
R256A	  was	  shown	  to	  increase	  markedly	  when	  the	  variant	  enzyme	  
was	   incubated	   with	   Phe	   prior	   to	   the	   titration	   of	   Tyr	   (Figure	   3.8G,	   Table	   3.4).	   A	   similar	   result	   was	  
observed	  for	  MtuDAH7PSR171A	  preincubated	  with	  Phe	  (Figure	  3.8C),	  but	  with	  a	  less	  significant	  increase	  
in	   Kd.	   This	   suggests	   there	  may	   be	   strong	   competition	   between	   Tyr	   and	   Phe	   to	   occupy	   site	   1,	   and	  
despite	  the	  very	  weak	  binding	  of	  Phe	  to	  site	  2,	  Tyr	  also	  competes	  with	  Phe	  somewhat	  to	  occupy	  site	  2.	  
In	   contrast	   the	  Kd	  between	  MtuDAH7PS
WT	   and	  Tyr	  decreased	   if	   the	  enzyme	  was	  preincubated	  with	  
Phe.	  	  
	  
The	   Kd	   between	   Trp	   and	   MtuDAH7PS
R256A	   was	   approximately	   that	   same	   as	   for	   MtuDAH7PSWT	  
suggesting	  Trp	  binding	  is	  unaffected	  by	  the	  substitution	  (Figure	  3.8H,	  Table	  3.4).	  The	  ITC	  data	  for	  both	  
MtuDAH7PSWT	  and	  MtuDAH7PSR256A	  fitted	  nicely	  to	  a	  single	  site	  binding	  model.	  On	  the	  other	  hand	  the	  
isotherm	  for	  the	  titration	  of	  Trp	  into	  a	  cell	  containing	  MtuDAH7PSR171A	  produced	  an	  isotherm	  with	  the	  
distinctive	   shape	  of	  a	   two	  site	  binding	  model	   (Figure	  3.8D).	  Two	  separate	  and	   independent	  binding	  
events	  for	  Tyr	  to	  MtuDAH7PS	  were	  recorded	  with	  the	  same	  Kd	  but	  opposite	  enthalpies.	   Intriguingly,	  
Trp	   binding	   to	   MtuDAH7PSR171A	   was	   tighter,	   for	   both	   binding	   events,	   than	   MtuDAH7PSWT	   so	  
fortunately	  Trp	  binding	  has	  not	  been	  compromised.	  
	  




Figure	   3.8	   ITC	   data	   for	   the	   interaction	   of	   A.	  30	  µM	   MtuDAH7PSR171A	   with	   2	   mM	   Phe	   titrant,	   B.	   30	  µM	   of	  
MtuDAH7PSR171A	  with	  3	  mM	  Tyr	  titrant;	  C.	  30	  µM	  MtuDAH7PSR171A	  preincubated	  with	  50	  µM	  Phe	  and	  3	  mM	  Tyr	  
titrant;	  D.	  70	  µM	  MtuDAH7PSR171A	  with	  3	  mM	  Trp	  titrant;	  E.	  30	  µM	  MtuDAH7PSR256A	  with	  900	  µM	  Phe	  titrant,	  F.	  
60	  µM	  MtuDAH7PSR256A	  with	  2	  mM	  Tyr	   titrant;	  G.	  50	  µM	  MtuDAH7PSR256A	  preincubated	  with	  50	  µM	  Phe	  and	  3	  
mM	  Tyr	  titrant	  and	  H.	  30	  µM	  MtuDAH7R256A	  with	  300	  µM	  Trp	  titrant.	  
H.	  
A.	   B.	   C.	  
D.	   E.	   F.	  
G.	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 Disruption	  of	  feedback	  regulation	  3.7.
Previously	   inhibition	   studies	   were	   used	   to	   show	   binary	   and	   ternary	   combinations	   of	   the	   aromatic	  
amino	  acids	  that	  included	  Trp	  inhibited	  MtuDAH7PSWT	  (Section	  2.4.3).	  The	  loss	  of	  ligand	  binding	  to	  site	  
1	  or	  site	  2	  should	  perturb	  this	  feedback	  regulation	  of	  MtuDAH7PS	  if	  the	  affected	  site	  contributes	  to	  
the	  regulatory	  function	  of	  MtuDAH7PS.	  Kinetic	  assays	  were	  conducted	  under	  the	  standard	  inhibition	  
assay	  conditions	  used	  to	  study	  the	  wild	  type	  enzyme	  detailed	  in	  Section	  9.9.3.	  
	  
MtuDAH7PSR171A	  displayed	  a	  huge	  reduction	  in	  sensitivity	  to	  the	  combination	  of	  Trp	  and	  Phe	  relative	  
to	  the	  wild	  type	  protein,	  yet	  retained	  sensitivity	  to	  the	  combination	  of	  Trp	  and	  Tyr	  (Figure	  3.9).	  In	  the	  
presence	   of	   all	   three	   aromatic	   amino	   acids	   the	   level	   of	   inhibition	   achieved	   was	   equivalent	   to	   the	  
inhibition	  achieved	  by	  Trp	  and	  Tyr.	  MtuDAH7PSR171A	  was	  designed	  to	  hinder	   ligand	  binding	  at	  site	  1,	  
thus	  only	  site	  2	  is	  available	  for	  Tyr	  and	  Phe	  binding.	  These	  results	  demonstrate	  Phe	  must	  occupy	  site	  1	  
to	  elicit	  any	  inhibitory	  response	  in	  combination	  with	  Trp.	  As	  MtuDAH7PSR171A	  was	  still	  sensitive	  to	  Trp	  
and	  Tyr,	  site	  1	  is	  not	  essential	  for	  regulatory	  sensitivity	  to	  Tyr,	  however	  it	  should	  be	  noted	  Trp	  and	  Tyr	  
inhibition	  was	  ~20	  %	  less	  effective	  than	  observed	  for	  MtuDAH7PSWT.	  




Figure	  3.9	  Remaining	  activity	  of	  MtuDAH7PSWT	  (blue),	  MtuDAH7PSR171A	  (red)	  and	  MtuDAH7PSR256A	  (green)	  in	  the	  
presence	  of	  various	  single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  
are	   represented	  by	   their	  one	   letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	   letter	  also	   represents	  200	  µM	  of	   the	  
corresponding	   aromatic	   amino	   acid.	   Error	   bars	   depict	   the	   standard	   deviation	   of	   triplicate	   measurements.	   P-­‐
values	  provided	  in	  appendix	  V.	  
	  
Conversely,	  MtuDAH7PSR256A	  was	  strongly	   inhibited	  by	  the	  combination	  of	  Trp	  and	  Phe,	  but	  had	  lost	  
the	   sensitivity	   to	   the	   combination	   of	   Trp	   and	   Tyr	   (Figure	   3.9).	   The	   inhibitory	   response	   of	  
MtuDAH7PSR256A	   in	   the	  presence	  of	  all	   three	  amino	  acids	  was	  equivalent	   to	   the	  combination	  of	  Trp	  
and	  Phe.	   The	   substitution	   introduced	   to	  MtuDAH7PSR256A	  was	   intended	   to	  disrupt	   ligand	  binding	   at	  
site	  2,	  only.	  The	  sensitivity	  displayed	  to	  the	  presence	  of	  Trp	  and	  Phe	  by	  MtuDAH7PSR256A	  is	  evidence	  
Phe	  binding	  at	  site	  2	  was	  nonessential	  for	  the	  regulatory	  response.	  The	  complete	  loss	  of	  sensitivity	  of	  
MtuDAH7PSR256A	  to	  the	  combination	  of	  Trp	  and	  Tyr	  revealed	  Tyr	  binding	  to	  site	  2	  was	  essential	  for	  Tyr	  
to	   inhibit	  MtuDAH7PS	  activity.	   The	  combination	  of	  Trp,	  Phe	  and	  Tyr	   failed	   to	   reduce	   the	  activity	  of	  
MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  to	  less	  than	  1	  %	  as	  observed	  for	  MtuDAH7PSWT.	  This	  indicates	  
all	  three	  allosteric	  ligand	  binding	  sites	  must	  be	  occupied	  for	  the	  greatest	  inhibitory	  effect.	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 Chapter	  summary	  3.8.
The	   preparation	   and	   purification	   of	   both	   MtuDAH7PSR171A	   and	   MtuDAH7PSR256A	   was	   successful.	  
Structural	   analysis	   by	   SAXS,	   native	   PAGE	   and	   CD	   showed	   both	   variants	   had	   similar	   structures	   to	  
MtuDAH7PSWT	   in	   solution.	   Furthermore	   the	   kinetic	   parameters	   determined	   from	   the	  
Michaelis-­‐Menten	   kinetics	   of	   each	  MtuDAH7PS	   variant	   showed	   no	   adverse	   affects	   to	   the	   catalytic	  
efficiency	  of	  variant	  enzymes	  as	  a	  result	  of	  the	  introduced	  substitutions.	  	  
	  
MtuDAH7PS	   contains	   three	   distinct	   allosteric	   binding	   sites	   per	   subunit	   (Figure	   3.10).	   Through	  
crystallography	   one	   site	   has	   been	   shown	   to	   selectively	   bind	   Trp,	   even	   in	   the	   presence	   of	   Tyr	   or	  
Phe.48,69,71,91	   Tyr	   and	   Phe	   have	   been	   shown	   to	   occupy	   both	   sites	   1	   and	   2	   in	   various	   crystal	  
structures.48,71,91	   The	   introduction	   of	   the	   Arg171Ala	   substitution	   to	   site	   1	   of	  MtuDAH7PSR171A	   has	  
prevented	  ligand	  binding	  to	  site	  1,	   leaving	  only	  site	  2	  available	  for	  Phe	  and	  Tyr	  binding.	  Similarly,	  by	  
mutating	  Arg256	  to	  Ala	  ligand	  binding	  to	  site	  2	  has	  been	  prevented	  and	  Phe	  and	  Tyr	  can	  only	  bind	  to	  
site	  1.	  This	  allowed	  sites	  1	  and	  2	  to	  be	  investigated	  independently	  of	  each	  other.	  ITC	  and	  DSF	  studies	  
demonstrated	   that	  Phe	  binds	   very	  poorly	   to	  MtuDAH7PSR171A.	   Inhibition	   studies	  of	  MtuDAH7PSR171A	  
showed	   the	   enzyme	   activity	   was	   insensitive	   to	   the	   presence	   of	   Phe	   and	   only	   responded	   to	   the	  
presence	  of	  Trp	  and	  Tyr.	   In	  conjunction	  with	   ITC	  and	  DSF,	   the	   inhibition	  studies	   illustrated	  that	  Phe	  
does	  not	  bind	  readily	  to	  site	  2	  of	  MtuDAH7PS.	  
	  
Investigation	   of	   Phe	   binding	   to	  MtuDAH7PSR256A	   by	   ITC	   and	   DSF,	   showed	   that	   Phe	   binding	   to	   the	  
enzyme	   is	   unaffected	   by	   the	   Arg256Ala	   substitution.	   Furthermore	   inhibition	   studies	   showed	  
MtuDAH7PSR256A	  activity	  retained	  sensitivity	  to	  the	  combination	  of	  Trp	  and	  Phe.	  Thus	  Phe	  only	  needs	  
to	  bind	  to	  site	  1	  to	  elicit	  an	  inhibitory	  response.	  
	  




Figure	   3.10	   The	   subunit	   structure	  of	  MtuDAH7PS	   soaked	  with	   Trp	   and	  Phe	   (PDB	   code:	   3KGF).	   The	   core	   (β/α)8	  
barrel	   structure	   is	   coloured	  blue,	   the	  N-­‐terminal	  extension	   is	   coloured	   red,	   the	  additional	  helices	   to	   the	  α2-­‐β3	  
loop	  are	  coloured	  yellow	  and	  the	  metal	  ion	  (Mn2+)	  is	  shown	  in	  purple.	  Trp	  is	  shown	  in	  orange	  bound	  to	  the	  Trp	  
site.	  Phe	  bound	  to	  site	  1	  is	  shown	  in	  green	  and	  Phe	  bound	  to	  site	  2	  is	  shown	  in	  limon.	  
	  
ITC	  and	  DSF	  studies	  showed	  MtuDAH7PSR171A	  was	  responsive	  to	  the	  presence	  of	  Tyr.	  This	  was	  further	  
supported	  by	   the	   inhibition	  studies	  showing	  MtuDAH7PSR171A	   is	   inhibited	  by	   the	  combination	  of	  Trp	  
and	  Tyr,	  but	  not	  quite	  as	  effectively	  as	  observed	  for	  MtuDAH7PSWT.	  These	  findings	  show	  Tyr	  is	  able	  to	  
bind	  to	  site	  2	  and	  elicit	  an	  inhibitory	  response.	  
	  
Remarkably	   ITC	   and	  DSF	   studies	  of	  MtuDAH7PSR256A	   revealed	   Tyr	   can	  bind	   to	  MtuDAH7PSR256A	  with	  
considerable	  affinity,	  however	  the	  inhibition	  studies	  showed	  Trp	  and	  Tyr	  are	  ineffective	  at	   inhibiting	  
MtuDAH7PSR256A	  activity.	  Overall	  these	  results	  suggested	  Tyr	  can	  also	  bind	  to	  site	  1,	  although	  it	  does	  
not	  provide	  an	  inhibitory	  response	  by	  binding	  in	  this	  position.	  How	  MtuDAH7PS	  is	  able	  to	  distinguish	  
between	   Phe	   and	   Tyr	   binding	   at	   site	   1,	   given	   their	   structural	   similarity	   and	   similar	   binding	  modes,	  
presents	  a	  new	  conundrum,	  worthy	  of	  further	  investigation.	  	  
	  
Collectively	   these	   findings	   reveal	   site	   1	   can	   bind	   both	   Phe	   and	   Tyr.	   All	   kinetic	   and	   biophysical	  
characterisation	   carried	   out	   in	   this	   chapter	   suggests	   Phe	   preferentially	   binds	   to	   site	   1.	   Most	  
importantly	  Tyr	  cannot	  regulate	  MtuDAH7PS	  very	  well	  by	  occupying	  site	  1	  alone	  (in	  the	  presence	  of	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run	   in	   parallel	   to	   this	   research	   by	   Sebastian	   Reichau	  which	   show	   the	   soaking	   of	   an	  MtuDAH7PSWT	  
crystal	  in	  a	  low	  concentration	  solution	  of	  Phe	  results	  in	  Phe	  only	  being	  observed	  to	  occupy	  site	  1.91	  	  
	  
Site	  2	  is	  exclusively	  a	  Tyr	  binding	  site	  and	  Tyr	  must	  bind	  to	  site	  2	  for	  an	  inhibitory	  response	  involving	  
Trp	  to	  be	  observed.	  These	  observations	  indicate	  site	  2	  is	  a	  Tyr-­‐selective	  site.	  There	  was	  little	  evidence	  
to	  suggest	  Phe	  had	  a	  significant	  affinity	   for	   this	  site.	  However	   it	   should	  be	  noted,	   that	  although	  Tyr	  
binding	  was	  required	  at	  site	  2	  for	  an	  inhibitory	  response	  involving	  Tyr,	  a	  greater	  level	  of	  inhibition	  was	  
observed	  when	  Tyr	  was	  able	  occupy	  both	  site	  1	  and	  site	  2.	  Curiously,	  all	  crystallographic	  data	  to	  date	  
has	  only	  ever	  shown	  Tyr	  to	  occupy	  both	  sites	  1	  and	  2.48,71,91	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4. Interaction	  of	  MtuCM	  with	  MtuDAH7PS	  
 Introduction	  4.1.
Early	  investigations	  of	  chorismate	  mutase	  (Rv0948c)	  from	  M.	  tuberculosis	  had	  reported	  MtuCM	  as	  an	  
unusually	   poor	   catalyst,	   with	   no	   known	   regulatory	   control.78,83,84,86	   In	   2009	   two	   articles	   were	  
published	  describing	   the	   first	   crystal	   structure	  of	  a	  non-­‐covalent	   complex	  between	   two	  enzymes	  of	  
the	   shikimate	   pathway,	  MtuDAH7PS	   and	  MtuCM	   (PDB	   code:	   2W19)	   (Figure	   4.1A).85,112	   The	   authors	  
demonstrated	   that	   the	   non-­‐covalent	   complex	   between	  MtuDAH7PS	   and	  MtuCM	   boosted	  MtuCM	  
activity	  by	  two	  orders	  of	  magnitude,	  but	  left	  the	  MtuDAH7PS	  activity	  unaffected.85	  Additionally,	  and	  
most	   excitingly,	  MtuCM	   activity	   developed	   sensitivity	   to	   the	   presence	   of	   Tyr	   or	   Phe	   on	   complex	  
formation.	  	  




Figure	   4.1	  Heterooctamer	   structure	   of	  MtuCM•MtuDAH7PS	   complex	   (PDB	   code:	   2W19,	   2.15	  Å	   resolution).	   A.	  
MtuDAH7PS	  shown	  with	  the	  core	  (β/α)8	  barrel	  structure	   is	  coloured	  blue,	  the	  N-­‐terminal	  extension	   is	  coloured	  
red,	   the	  additional	  helices	   to	   the	  α2-­‐β3	   loop	  coloured	  yellow	  and	  the	  metal	   ion	   (Mn2+)	   is	   shown	   in	  purple	  and	  
MtuCM	  with	  subunit	  A	  and	  subunit	  B	  coloured	  grey	  and	  magenta	  respectively.	  B.	  Interface	  between	  MtuCM	  and	  
MtuDAH7PS	  and	  the	  dashed	  black	  lines	  represent	  hydrogen	  bonds.*	  indicate	  residues	  contributed	  from	  MtuCM	  








Arg213	   Glu392	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 Interface	  of	  the	  non-­‐covalent	  complex	  4.1.1.
Approximately	  855	  Å2	  of	  the	  MtuDAH7PS	  subunit	  surface	  area	  (5	  %	  of	  the	  total	  subunit	  surface	  area	  
of	  a	  single	  subunit)	  is	  estimated	  to	  be	  buried	  at	  the	  interface	  of	  MtuCM	  and	  MtuDAH7PS,	  formed	  via	  a	  
combination	  of	  polar	  and	  non-­‐polar	   interactions	   (Figure	  4.1B).85	   In	  comparison	  ~10%	  of	   the	  surface	  
area	  of	  each	  MtuDAH7PS	  chain	  is	  buried	  at	  the	  dimer	  interface,	  that	  forms	  between	  the	  two	  subunits	  
of	  the	  crystallographic	  asymmetric	  dimer	  and	  ~5	  %	  of	  the	  surface	  area	  is	  buried	  by	  the	  formation	  of	  
the	  tetramer	   interface.	  The	  major	  contributions	   from	  MtuDAH7PS	  to	   form	  the	  MtuCM•MtuDAH7PS	  
interface	  are	  from	  the	  inserted	  α2b	  helix	  and	  its	  preceding	  loop,	  and	  the	  α7	  and	  α8	  helices	  of	  the	  core	  
barrel	  of	  MtuDAH7PS.	  MtuCM	  contributes	  residues	  from	  the	  H1-­‐H2	  loop	  and	  the	  H1	  and	  H2	  helices.	  A	  
list	  of	  the	  polar	  and	  nonpolar	  interactions	  that	  form	  the	  MtuCM•MtuDAH7PS	  interface	  is	  provided	  in	  
Appendix	   III.	   The	   most	   notable	   interactions	   are	   contributed	   by	   the	   C-­‐terminal	   of	  MtuCM	   are	   the	  
residues	   Leu88*,	   Gly89*	   and	   His90*.	   These	   residues	   pack	   into	   a	   shallow	   grove	   on	   the	   surface	   of	  
MtuDAH7PS	  forming	  numerous	  hydrophobic	   interactions	  with	  the	  residues	  of	  the	  α7	  and	  α8	  helices	  
of	   MtuDAH7PS	   and	   with	   additional	   polar	   interactions	   forming	   between	   His90*	   and	   Glu392	  
(MtuDAH7PS	  α7	  helix)	  and	  also	  Gly89*	  and	  both	  Glu392	  and	  Arg399	  (MtuDAH7PS	  α7	  helix).	  
 Proposed	  mechanism	  of	  MtuCM	  activation	  4.1.2.
Complex	   formation	   causes	   the	   C-­‐terminus	   and	   H1-­‐H2	   loop	   of	   MtuCM	   to	   undergo	   substantial	  
conformational	   change.	   Key	   active	   site	   residues	   are	   located	   along	   the	   C-­‐terminus	   and	  H1-­‐H2	   loop,	  
thus	  the	  conformational	  change	  of	  these	  regions	  repositions	  these	  key	  residues	  and	  this	  is	  likely	  to	  be	  
responsible	  for	  the	  improved	  MtuCM	  catalytic	  efficiency	  (Figure	  4.2).	  Alignment	  of	  the	  MtuCM	  dimer	  
(PDB	  code:	  2BQV)	  with	  the	  MtuCM	  bound	  to	  MtuDAH7PS	  (PDB	  code:	  2W19,	  Cα	  RMSD	  0.568)	  reveals	  
a	  residue	  previously	  shown	  to	  be	  critical	  to	  catalysis,	  Arg46*,	  has	  moved	  considerably	  upon	  formation	  
of	  the	  complex.85	  The	  guanidinium	  group	  of	  Arg46*	  is	  orientated	  for	  more	  efficient	  interaction	  with	  an	  
incoming	  ligand.	  The	  movement	  of	  Arg46*	  is	  caused	  by	  a	  dramatic	  shift	  in	  the	  position	  of	  the	  H1-­‐H2	  
loop,	  shifting	  Arg53*	  from	  coordinating	  to	  Glu59*	  in	  the	  unbound	  MtuCM	  structure	  to	  coordinate	  the	  
guanidinium	   group	   of	   Arg46*	   in	   the	  MtuCM•MtuDAH7PS	   complex	   structure.	   Furthermore	   residues	  
*	  Indicates	  residues	  belong	  to	  MtuCM	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Leu54*,	  Val55*	  and	  His56,	  also	  located	  in	  the	  H1-­‐H2	  loop,	  have	  shifted	  along	  by	  one	  residue	  enabling	  
Leu54*	  to	  contact	  Leu88*	  in	  the	  MtuCM•MtuDAH7PS	  complex	  structure,	  whereas	  these	  two	  residues	  
are	   20	   Å	   apart	   in	   the	  MtuCM	   structure.	   The	   formation	   of	   the	   complex	   also	   causes	   a	   shift	   of	   the	  
C-­‐terminal	  tail	  of	  MtuCM	  facilitating	  the	  formation	  of	  two	  hydrogen	  bonds	  between	  the	  guanidinium	  
group	  of	  Arg85*	  and	  the	  carboxylate	  of	  Glu59*.	  
	  
	  
Figure	  4.2	  Alignment	  of	  MtuCM	  active	  site	  residues	  from	  the	  non-­‐complexed	  MtuCM	  (PDB	  code:	  2BQV,	  2.00	  Å	  
resolution)	  and	  MtuCM•MtuDAH7PS	  complex	  (PDB	  code:	  2W19,	  2.15	  Å	  resolution	  and	  RMSD	  of	  0.568).	  Unbound	  
MtuCM	   shown	  with	   residues	   from	   subunit	   A	   coloured	   olive	   and	   subunit	   B	   deep	   purple.	   Backbone	   cartoon	   is	  
depicted	   from	   the	   structure	   with	  MtuCM	   bound	   to	  MtuDAH7PS	   and	   is	   shown	  with	   subunit	   A	   and	   subunit	   B	  
coloured	  grey	  and	  magenta	  respectively.	  
	  
Sasso	  et	  al.	  proposed	  that	  on	  complex	  formation	  the	  residues	  of	  the	  H1-­‐H2	  loop	  and	  the	  C-­‐terminal	  
tail	   are	  brought	   into	  a	  more	  catalytically	  beneficial	   conformation.85	  To	   support	   their	  hypothesis	   the	  
authors	  investigated	  the	  importance	  of	  the	  last	  four	  C-­‐terminal	  residues	  (Arg87*,	  Leu88*,	  Gly89*	  and	  
His90*)	   for	  catalysis	  and	  showed	  that	  although	  they	  are	  not	  essential	   for	  basal	  MtuCM	  activity,	   the	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 Chapter	  aims	  4.1.3.
One	  significant	  limitation	  of	  the	  work	  conducted	  to	  characterise	  the	  MtuCM•MtuDAH7PS	  complex	  by	  
Sasso	  et	  al.	  was	  the	  use	  of	  a	  polyhistidine	  tagged	  MtuDAH7PS	  (MtuDAH7PSH6)	  to	  conduct	  the	  kinetic	  
characterisation.	  Prior	  work	  by	  the	  Parker	  research	  group	  has	  found	  retention	  of	  the	  polyhistidine	  tag	  
adversely	  effects	  crystallisation	  of	  MtuDAH7PS,	  so	  it	  may	  also	  affect	  other	  properties	  of	  the	  enzyme.70	  
Consequently	   the	  studies	  described	   in	   this	  chapter	  aimed	  to	  assess	   the	  activation	  and	  regulation	  of	  
the	  MtuCM•MtuDAH7PS	  complex	  when	  untagged	  MtuDAH7PSWT	  was	  used	  to	  form	  the	  complex.	  This	  
work	  was	  complemented	  by	  a	  detailed	   investigation	   into	  the	  regulatory	  properties	  of	  MtuDAH7PSH6	  
itself.	  
	  
This	  work	  also	  aimed	  to	  prove	  unequivocally	  the	  allosteric	  sites	  of	  MtuDAH7PS	  (site	  1	  and	  site	  2)	  were	  
responsible	   for	   the	   regulation	  of	  MtuCM	  by	  utilising	   the	  binding	   site	   variants,	  MtuDAH7PSR171A	   and	  
MtuDAH7PSR256A,	  generated	  as	  described	  in	  Chapter	  3.	  	  
	  
Finally,	  all	   structural	  evidence	  of	   complex	   formation	  between	  MtuCM	  and	  MtuDAH7PS	   thus	   far	  has	  
relied	  on	  crystallography	  and	  native	  PAGE.	  This	  work	  aimed	  to	  observe	  the	  formation	  of	  the	  complex	  
in	  solution.	  Formation	  of	  the	  complex	  in	  solution	  would	  suggest	  the	  complex	  may	  form	  in	  vivo	  and	  is	  
more	   likely	   to	   be	   biologically	   relevant.	   Fortuitously	   by	   studying	   the	   complex	   formation	   in	   solution,	  
these	  studies	  also	  permitted	  an	  insight	  into	  the	  mechanism	  of	  the	  inhibition	  of	  MtuCM	  activity	  by	  the	  
MtuCM•MtuDAH7PS	  complex.	  
 Preparation	  of	  MtuCM	  4.2.
 Construct	  details	  4.2.1.
A	   synthetic	  MtuCM	   gene	   optimised	   for	   E.	   coli	   codon	   usage	   was	   obtained	   from	   GeneArt.	   Richard	  
Hutton	   transferred	   the	   synthetic	   gene	   into	   pDEST™	   15	   vector	   using	   Gateway	   cloning	   technology	  
(Invitrogen).	  The	  pDEST™	  15	  vector	  allows	  production	  of	  a	  N-­‐terminal	  glutathione	  S-­‐transferase	  (GST)-­‐
tagged	   recombinant	   protein	   for	   purification	   via	   affinity	   chromatography.	   The	   GST-­‐tag	   was	   TEV	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protease	  cleavable.	  The	  pDEST™	  15	  vector	  also	  encoded	  the	  T7	  promoter	  regions	  to	  allow	  induction	  
of	  protein	  expression	  by	  addition	  of	  IPTG	  and	  an	  ampicillin	  resistance	  gene	  to	  allow	  for	  selection	  in	  E.	  
coli.	  The	  tag	  sequence	  is	  shown	  in	  Figure	  4.3.	  
	  
	  
Figure	  4.3	  Sequence	  of	  the	  pDEST	  ™	  15	  GST-­‐tag.	  Highlighted	  are	  the	  GST	  fusion	  protein	  (blue),	  the	  TEV	  protease	  
recognition	  site	  (purple)	  and	  the	  residues	  retained	  at	  the	  N-­‐terminus	  post	  cleavage	  (pink).	  
	  
The	  pDEST™	  15	  vector	  containing	  the	  synthetic	  MtuCM	  gene	  was	  transformed	  into	  BL21	  Star™	  (DE3)	  
(Life	  technologies)	  and	  colonies	  bearing	  the	  plasmid	  were	  selected	  for	  ampicillin	  resistance.	  
	  
 Expression	  and	  lysis	  	  4.2.2.
Protein	   expression	   was	   conducted	   as	   outlined	   in	   Section	   9.3.	   Overexpression	   of	   MtuCM	   was	  
confirmed	  by	   SDS-­‐PAGE	   gel.	  Mass	   spectrometry	   and	  plasmid	   sequencing	   confirmed	   the	   amino	   acid	  
sequence	  was	  unaltered	  and	  as	  expected.	  Cells	  were	  resuspended	  in	  10	  mM	  phosphate	  buffer	  pH	  7.5	  
and	  lysed	  by	  sonication.	  The	  whole	  lysate	  was	  then	  clarified	  by	  centrifugation	  and	  insoluble	  fraction	  
discarded.	  	  
 Purification	  4.2.3.
The	  purification	  procedure	  is	  outlined	  in	  Figure	  4.4A	  and	  detailed	  in	  Section	  9.6.	  The	  progress	  of	  the	  
purification	  is	  shown	  by	  the	  SDS-­‐PAGE	  (Figure	  4.4B).	  Initially	  the	  soluble	  crude	  lysate	  was	  purified	  by	  
affinity	   chromatography	   using	   a	   GSTrap	   (GE	   healthcare).	   The	   GSTrap	   uses	   a	   reduced	   glutathione	  
ligand	  covalently	  attached	  to	  the	  solid	  phase	  of	  the	  column	  to	  bind	  the	  GST-­‐tag	  of	  the	  fusion	  protein.	  
The	  GSTrap	  retains	  the	  fusion	  protein,	  and	  any	  other	  protein	  with	  an	  affinity	  for	  reduced	  glutathione,	  
as	  all	  the	  other	  proteins	  in	  the	  crude	  lysate	  pass	  through	  the	  column	  as	  it	  is	  washed	  with	  phosphate	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buffer.	   The	   fusion	   protein	   was	   eluted	   from	   the	   GSTrap	   with	   an	   increasing	   gradient	   of	   reduced	  
glutathione.	   The	   fractions	   containing	   MtuCM	   were	   collected	   and	   the	   GST-­‐tag	   cleaved	   with	   TEV	  




Figure	   4.4	   A.	   An	   outline	   of	   the	   standard	   purification	   protocol	   for	  MtuCM.	   B.	   SDS-­‐PAGE	   gel.	   Lane	   M	   is	   the	  
molecular	  weight	  maker;	  lane	  1	  pooled	  MtuCM	  post	  SEC;	  lane	  2	  second	  iteration	  of	  GST-­‐tag	  removal;	  lane	  3	  first	  
iteration	   of	  GST-­‐tag	   removal;	   lane	   4	  GST-­‐tag	   removed	   in	   the	   second	   iteration	   of	  GST-­‐tag	   removal;	   lane	   5	   TEV	  
protease	   treated	  MtuCM;	   lane	   6	  MtuCM	   fusion	   protein	   isolated	   by	   reduced	   glutathione	   gradient	   and	   lane	   7	  
soluble	  fraction	  of	  the	  cell	  lysate.	  Overexpressed	  fusion	  protein	  band	  can	  be	  observed	  at	  ~35	  kDa,	  the	  GST-­‐tag	  at	  
~26	  kDa	  and	  MtuCM	  at	  ~10	  kDa.	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Usually	   passing	   the	   TEV	   protease	   treated	   protein	   back	   through	   a	   GSTrap	   would	   be	   expected	   to	  
separate	  the	  GST-­‐tag	  from	  the	  cleaved	  protein.	  Unfortunately,	  MtuCM	  had	  significant	  affinity	  for	  the	  
cleaved	  GST-­‐tag.	  Although	  a	  good	  portion	  of	  the	  GST-­‐tag	  bound	  the	  GSTrap,	  a	  significant	  proportion	  
was	   eluted	   in	   the	   flow-­‐through	   with	   the	  MtuCM.	   The	   collected	  MtuCM	   fractions	   were	   iteratively	  
applied	  to	  four	  GSTraps	  in	  series	  in	  an	  effort	  to	  quickly	  separate	  the	  GST-­‐tag.	  After	  each	  application	  to	  
the	   four	  columns	   in	  series	   the	  eluted	  MtuCM	  was	  assessed	  by	  SDS-­‐PAGE	  gel.	  Once	  the	  MtuCM	  was	  
shown	  to	  be	  pure	  and/or	  a	  significant	  portion	  of	  MtuCM	  was	  starting	  to	  be	  lost	  with	  the	  eluted	  the	  
GST-­‐tag	  the	  MtuCM	  fractions	  were	  collected	  pooled	  and	  concentrated.	  MtuCM	  has	  a	   low	  extinction	  
coefficient	  (1490	  cm-­‐1	  mol-­‐1),	  making	  it	  difficult	  to	  monitor	  the	  purification	  process	  by	  UV	  absorption	  
at	   280	   nm.	   Consequently	   SDS-­‐PAGE	   gels	   were	   essential	   for	   monitoring	   and	   evaluating	   each	  
purification	  step	  post	  GST-­‐tag	  cleavage.	  
	  
The	   initial	   purification	   required	   more	   than	   eight	   applications	   of	   the	  MtuCM	   to	   the	   series	   of	   four	  
GSTrap	  columns	  to	  remove	  enough	  GST-­‐tag	  to	  continue	  with	  SEC	  and	  the	  entire	  purification	  took	  up	  
to	  five	  days	  to	  complete.	  To	  reduce	  the	  affinity	  between	  MtuCM	  and	  the	  GST-­‐tag	  glycerol	  (1	  %)	  was	  
added	   to	   the	   binding	   buffer	   after	   TEV	   protease	   cleavage.	   The	   glycerol	   was	   added	   to	   discourage	  
protein-­‐protein	  interactions.	  It	  has	  been	  proposed	  glycerol	  stabilises	  proteins	  in	  solution	  through	  the	  
preferential	  interaction	  of	  glycerol	  with	  the	  hydrophobic	  surface	  regions	  of	  the	  protein.113	  When	  the	  
purification	   was	   repeated	   using	   glycerol	   only	   two	   to	   three	   passes	   through	   the	   four	   GSTraps	   were	  
required,	   allowing	   the	   purification	   to	   be	   completed	   in	   two	   to	   three	   days.	   Unfortunately	   glycerol	  
interfered	  with	  the	  kinetic	  assays	  and	  had	  to	  be	  completely	  removed	  by	  either	  SEC	  or	  by	  application	  
to	  a	  desalting	  column	  before	  the	  purified	  MtuCM	  could	  be	  used.	  	  
	  
The	  MtuCM	  was	  concentrated	  and	  applied	   to	  a	  SEC	  column	  to	  separate	  any	  remaining	  GST-­‐tag	  and	  
any	  other	  contaminants	   including	  any	  glycerol	  present.	  Fractions	  were	  collected	  either	   to	  maximise	  
purity	  or	  yield	  depending	  on	  the	  intended	  use.	  Fractions	  identified	  as	  pure	  by	  SDS-­‐PAGE	  were	  pooled,	  
concentrated	   and	   flash	   frozen	   in	   small	   aliquots	   (~50	   µL).	   In	   order	   maximise	   yield,	   fractions	   that	  
contained	  GST-­‐tag	   contamination	  were	   reapplied	   to	   the	   four	  GSTraps	   in	   series	   to	   remove	   as	  much	  
GST-­‐tag	  as	  possible.	  Generally	  most	  batches	  of	  purified	  MtuCM	  were	  contaminated	  by	  a	  small	  amount	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of	  GST-­‐tag,	  but	  the	  amount	  of	  contamination	  varied	  between	  batches.	  The	  glycerol	  introduced	  during	  
this	   final	   step	   was	   removed	   by	   a	   PD10	   desalting	   column	   before	   the	   protein	   was	   flash	   frozen	   and	  
stored	  at	  -­‐80	  ˚C.	  
 Determination	  of	  concentration	  4.2.4.
MtuCM	  contains	  only	  a	  single	  Tyr	  residue	  and	  accordingly	  has	  a	  very	  low	  extinction	  coefficient	  of	  1490	  
cm-­‐1	   mol-­‐1	   at	   280	   nm.	   Thus	   measurement	   of	   concentration	   by	   direct	   spectrophotometry	   was	  
imprecise.	  Concentration	  determination	  was	   further	   complicated	  by	   the	  presence	  of	   any	   remaining	  
GST-­‐tag	   that	   gave	   misleading	   results	   when	   either	   directs	   protein	   spectrophotometry	   or	   Bradford	  
assays	   were	   used	   to	   determine	   concentration.	   Fortunately	   a	   highly	   pure	   batch	   of	   MtuCM	   was	  
purified.	  Bradford	  assay	  was	  used	  to	  determine	  the	  concentration	  of	  this	  highly	  pure	  MtuCM	  and	  its	  
kinetic	  activity,	  with	  and	  without	  MtuDAH7PS	  was	  recorded.	  This	  highly	  pure	  MtuCM	  was	  used	  as	  a	  
standard	  for	  determining	  the	  concentration	  and	  purity	  of	  every	  other	  batch	  of	  MtuCM	  purified.	  Even	  
if	  MtuCM	  batches	  were	  contaminated	  by	  a	  small	  amount	  of	  GST-­‐tag	  only	  active	  and	  available	  MtuCM	  
could	   contribute	   to	   the	   activity	   determined.	   This	   method	   does	   assume	   that	   the	   GST-­‐tag	   does	   not	  
significantly	  affect	  to	  the	  overall	  CM	  activity	  of	   the	  protein	  sample.	  Thus	  based	  on	  the	  total	  protein	  
concentration	  determined	  through	  Bradford	  assay	  and	  the	  relative	  activity	  of	  each	  batch	  compared	  to	  
the	   standard	   a	   consistent	   and	   reproducible	   method	   of	  MtuCM	   concentration	   determination	   was	  
developed.	  
 Confirmation	  of	  product	  4.2.5.
SDS-­‐PAGE	  gel	  displayed	  a	  band	  just	  under	  10	  kDa	  and	  this	  size	  is	  comparable	  with	  the	  predicted	  10.4	  
kDa	  molecular	  mass	  of	  MtuCM	  monomer	  (Figure	  4.5).	  Analysis	  by	  mass	  spectrometry	  yielded	  a	  mass	  
of	  10361	  Da	  in	  close	  agreement	  with	  the	  expected	  molecular	  mass	  of	  10362	  Da	  for	  MtuCM.	  
	  




Figure	  4.5	  SDS-­‐PAGE	  gel	  of	  Lane	  M	  the	  molecular	  weight	  maker	  and	  lane	  1	  purified	  MtuCM.	  
 Basic	  characterisation	  of	  MtuCM	  4.3.
 Kinetic	  parameters	  4.3.1.
The	   activity	   of	  MtuCM	   was	   assessed	   under	   conditions	   similar	   to	  MtuDAH7PS	   and	   is	   described	   in	  
Section	  9.9.1.	  Assays	  were	  conducted	  at	  30	  °C	  in	  BTP	  buffer	  pH	  7.5.	  Assays	  were	  also	  conducted	  in	  the	  
presence	   of	   a	   divalent	   metal	   ion	   (Mn2+),	   reducing	   agent	   (TCEP)	   and	   PEP,	   which	   would	   later	   be	  
required	   to	   stabilise	  MtuDAH7PS,	   as	   the	  MtuCM	   activity	   of	   the	  MtuCM•MtuDAH7PS	   complex	   was	  
assessed.	   Kinetic	   assays	  monitored	   the	   loss	   of	   chorismic	   acid	   at	   274	   nm.	   Kinetic	   parameters	   were	  
determined	   using	   continuous	   steady-­‐state	   Michaelis-­‐Menten	   kinetics.	  MtuCM	   was	   found	   to	   have	  
poor	  activity,	  and	  has	  been	  compared	  with	  previously	  published	  results	  (Table	  4.1).78,83-­‐86	  The	  MtuCM	  
from	  this	  study	  has	  four	  additional	  residues	  at	  the	  N-­‐terminus	  (GlySerGlyAla),	  whereas	  Sasso	  et	  al.	  did	  
not	  utilise	  an	  affinity	  tag	  to	  purify	  MtuCM,	  consequently	  their	  protein	  had	  no	  additional	  residues	  at	  
the	   N-­‐terminus.85	   The	   purification	   by	   Kim	   et	   al.	   purified	  MtuCM	   via	   a	   subtilisin-­‐prodomain	   fusion	  

















Table	  4.1	  Comparison	  of	  MtuCM	  Kinetic	  parameters	  determined	  from	  a	  single	  set	  of	  Michaelis-­‐Menten	  kinetics	  
compared	  to	  previously	  published	  results.	  Chorismic	  acid	  is	  abbreviated	  to	  CA.	  For	  Michaelis-­‐Menten	  plot	  refer	  to	  
Appendix	  I.	  Error	  bars	  represent	  the	  error	  of	  fit	  of	  the	  equation	  to	  the	  data	  as	  determined	  by	  least	  squares	  fit.	  	  





	  (M-­‐1	  s-­‐1)	  
This	  study	   500	  ±	  30	   0.42	  ±	  0.02	   840	  ±	  90	  
Sasso85	   1140	  ±	  20	   2.0	  ±	  0.1	   1750	  ±	  90	  
Kim86	   1500	  ±	  100	   5.5	  ±	  0.2	   3700	  ±	  400	  
	  
 Absence	  of	  feedback	  regulation	  4.3.2.
Inhibition	   studies	   carried	   out	   on	   MtuCM	   showed	   the	   addition	   of	   any	   single,	   binary	   or	   ternary	  
combination	   of	   the	   three	   aromatic	   amino	   acids,	   Trp,	   Phe	   or	   Tyr	   had	   no	   effect	   on	  MtuCM	   activity	  
(Figure	   4.6).	   Assays	   were	   conducted	   in	   the	   standard	   assay	   conditions	   used	   to	   determine	   the	  
Michaelis-­‐Menten	   kinetics	  of	  MtuCM	  and	   initiated	  with	  150	  µM	  of	   chorismic	   acid	   (detailed	   Section	  
9.9.3).	  Each	  amino	  acid	  was	  added	  at	  a	  concentration	  of	  200	  µM.	  
	  
Figure	   4.6	   Remaining	  activity	  of	  MtuCM	   in	   the	  presence	  of	   various	   single,	   binary	   and	   ternary	   combinations	  of	  
aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  
Y.	   Each	   letter	   also	   represents	   200	   µM	   of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	  
presence	  of	  150	  µM	  chorismic	  acid.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	  P-­‐values	  
provided	  in	  appendix	  V.	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 Thermal	  stability	  4.3.3.
Although	  the	  aromatic	  amino	  acids	  did	  not	  affect	  MtuCM	  activity,	  DSF	  showed	  the	  amino	  acids	  had	  a	  
measurable	  influence	  on	  the	  thermal	  stability	  of	  MtuCM.	  DSF	  Assays	  were	  conducted	  under	  the	  same	  
conditions	  as	  MtuDAH7PSWT	  and	  are	  described	  in	  Section	  9.8.1.	  
	  
The	  greatest	  difference	  in	  the	  recorded	  Tm	  of	  MtuCM	  was	  a	  ~6	  ˚C	  drop	  caused	  by	  the	  addition	  of	  200	  
µM	  Tyr	  (Figure	  4.7).	  Trp	  and	  Phe	  (200	  µM	  each)	  caused	  smaller	  losses	  in	  MtuCM	  thermal	  stability	  of	  ~	  
2.7	   ˚C.	  These	   findings	  suggest	  despite	  the	   ligands	  generating	  no	   inhibitory	  effect	  on	  MtuCM	  activity	  
they	   are	   still	   able	   to	   interact	  with	  MtuCM.	   Interestingly	   the	   loss	   in	   thermal	   stability	   caused	   by	   the	  
addition	  of	  Tyr	  could	  be	  partially	  recovered	  by	  adding	  Phe	  or	  Trp	  and	  Phe.	  	  
	  
	  
Figure	   4.7	   Effect	   of	   individual,	   binary	   and	   ternary	   combinations	   of	   allosteric	   amino	   acids	   on	   thermal	  melting	  
temperature.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  
letter	   also	   represents	   200	   µM	   of	   the	   corresponding	   aromatic	   amino	   acids.	   Error	   bars	   depict	   the	   standard	  
deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	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 Activation	  of	  MtuCM	  activity	  by	  MtuDAH7PSWT	  4.4.
 Kinetic	  assay	  development	  4.4.1.
Initial	  work	  sought	  to	  develop	  the	  kinetic	  assay	  conditions	  to	  be	  used	  for	  monitoring	  MtuCM	  activity	  
of	  the	  MtuCM•MtuDAH7PS	  complex.	  More	  specifically	  the	  ratio	  of	  MtuCM	  to	  MtuDAH7PS	  to	  be	  used	  
for	  the	  assays	  had	  to	  be	  determined.	  
	  
Assays	  were	  conducted	  under	  the	  standard	  assay	  conditions	  for	  measuring	  MtuCM	  activity	  and	  were	  
initiated	  by	  the	  addition	  of	  150	  µM	  MtuCM.	  The	  concentration	  of	  MtuCM	  was	  held	  constant	  at	  10	  nM	  
and	  the	  concentration	  of	  MtuDAH7PS	  was	  varied	  between	  0	  and	  8	  µM.	  	  In	  the	  absence	  of	  MtuDAH7PS	  
the	  concentration	  of	  MtuCM	  was	  adjusted	  to	  90	  nM	  and	  normalised	  in	  order	  to	  detect	  the	  very	  low	  
MtuCM	  activity.	  
	  
As	  may	  have	  been	   intuitively	  expected,	   increasing	   the	  molar	   concentration	  of	  MtuDAH7PSWT	   in	   the	  
presence	   of	   a	   constant	   amount	   of	  MtuCM	   increased	  MtuCM	   activity.	   This	   increase	   in	   activity	   was	  
hyperbolic;	   initially	   displaying	   a	   rapid	   boost	   in	   activation	   of	   MtuCM	   activity	   with	   increasing	  
MtuDAH7PS	   concentration,	   and	   plateauing	   as	   the	   concentration	   of	  MtuDAH7PS	   exceeded	   2	   µM	   (a	  
200-­‐fold	   molar	   excess	   of	   MtuDAH7PS)	   (Figure	   4.8A).	   The	   maximum	   MtuCM	   activity	   of	  
103	  ±	  3	  µMmin-­‐1mg-­‐1	  was	   found	   when	   8	   µM	  MtuDAH7PS	   was	   present	   which	   was	   a	   142	   ±	   3	   -­‐fold	  
activation	  of	  MtuCM	  activity	  compared	  to	  MtuCM	  alone	  (0.73	  µMmin-­‐1mg-­‐1).	  	  
	  
Given	   these	   finding	   a	   molar	   ratio	   of	   1:10	   MtuCM:MtuDAH7PSWT	   was	   chosen	   for	   all	   further	  
characterisation	   of	   the	  MtuCM•MtuDAH7PSWT	   complex.	   The	  MtuCM	   activity	   of	   this	   ratio	   allowed	  
changes	  in	  the	  affinity	  between	  the	  two	  enzymes	  that	  may	  result	  in	  increases	  or	  decreases	  in	  activity.	  
An	   important	  consideration	   in	  choosing	   the	  molar	   ratio	  of	  1:10	  MtuCM:MtuDAH7PSWT	  was	   that	   the	  
amount	  of	  enzyme	  consumed	   in	  each	  kinetic	  assay	  was	  economical,	  and	  would	  not	  quickly	  exhaust	  
proteins	   stocks.	   The	   ratio	   of	   1:10	   (MtuCM:MtuDAH7PSWT)	  was	   an	   economical	   choice,	  which	  would	  
permit	  a	  concise	  investigation	  of	  any	  MtuDAH7PS	  variant	  required.	  




The	   interface	   of	   the	  MtuCM•MtuDAH7PS	   complex	   is	   formed	   through	   a	   considerable	   number	   of	  
hydrophobic	   interactions.	   To	   study	   if	   these	  hydrophobic	   interactions	  were	  primarily	   responsible	   for	  
the	   interaction	   between	  MtuCM	   and	  MtuDAH7PS	   the	   effect	   of	   increasing	   NaCl	   concentration	   on	  
MtuCM	  activity	  was	  monitored.	  Assays	  were	  conducted	  under	  standard	  assay	  conditions	  outlined	  in	  
Section	  9.9.1,	  using	  a	  molar	   ratio	  of	  1:10	  MtuCM:MtuDAH7PSWT,	   a	   concentration	  of	  10	  nM	  MtuCM	  
and	  150	  µM	  chorismic	  acid.	  
	  
Figure	   4.8	   Change	   in	  MtuCM	   activity	   caused	   by	   A.	   the	   increased	   molar	   concentration	   of	  MtuDAH7PS	   or	   B.	  
increasing	  concentration	  of	  NaCl.	  For	  A.	  assays	  were	  conducted	  under	  standard	  MtuCM	  assay	  conditions,	  with	  10	  
nM	   MtuCM	   except	   in	   the	   absence	   of	   MtuDAH7PSWT	   where	   90	   nM	   of	   MtuCM	   was	   used	   and	   the	   activity	  
normalised.	  For	  B.	  assays	  conducted	  under	  standard	  MtuCM	  assay	  conditions	  with	  10	  nM	  of	  MtuCM	  and	  100	  nM	  
of	  MtuDAH7PSWT.Reactions	  for	  both	  A	  and	  B	  were	  initiated	  with	  150	  µM	  chorismic	  acid.	  
	  
Addition	  of	  the	  NaCl	  to	  the	  assay	  conditions	  increases	  the	  ionic	  strength	  of	  the	  buffer	  and	  encourages	  
the	   association	   of	   hydrophobic	   (or	   non-­‐polar)	   areas	   between	   proteins.	   If	   this	   strengthened	   the	  
interaction	  between	  MtuCM	  and	  MtuDAH7PS	  it	  should	  be	  reflected	  in	  an	  increase	  in	  MtuCM	  activity,	  
but	  this	  was	  not	  observed.	  Instead	  the	  addition	  of	  salt	  appeared	  to	  be	  detrimental	  to	  MtuCM	  activity	  
(Figure	  4.8B).	  The	  reduced	  activity	  is	  either	  a	  result	  of	  the	  NaCl	  affecting	  the	  MtuCM	  directly	  or	  it	  may	  
hint	   the	   hydrophobic	   contacts	   between	   MtuCM	   and	   MtuDAH7PS	   are	   not	   the	   most	   significant	  
contributions	  to	  the	  interface.	  The	  activity	  of	  MtuCM	  alone	  in	  the	  presence	  of	  a	  NaCl	  (>	  1mM)	  needs	  
to	  be	  determined	  to	  identify	  if	  MtuCM	  activity	  is	  directly	  harmed.	  	  
A.	   B.	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 MtuCM•MtuDAH7PSWT	  kinetic	  parameters	  	  4.4.2.
The	  Michaelis-­‐Menten	   kinetics	   for	   the	  MtuCM	   activity	   of	   the	   complex	   was	   determined	   under	   the	  
same	  experimental	  conditions	  as	  for	  MtuCM	  alone	  but	  with	  the	  addition	  of	  a	  ten-­‐fold	  molar	  excess	  of	  
MtuDAH7PS	  as	  described	  in	  Section	  9.9.1.	  For	  all	  assays	  the	  MtuCM	  and	  MtuDAH7PS	  were	  added	  to	  
the	   assay	   condition	   and	   allowed	   to	   incubate	   together	   for	   10	  min	   at	   30	   °C	   prior	   to	   initiation	   of	   the	  
reaction	  with	   chorismic	   acid.	   This	   data	  was	   used	   for	   comparison	  with	  MtuDAH7PS	   variants	   in	   later	  
work.	   To	   obtain	   data	   comparable	   to	   previously	   published	   work	   by	   Sasso	   et	   al.	   a	   second	   set	   of	  
Michaelis-­‐Menten	   kinetics	   was	   obtained	   with	   a	   200-­‐fold	   molar	   excess	   of	  MtuDAH7PS	   and	   using	   a	  
concentration	  of	  10	  nM	  MtuCM.	  	  
	  
Table	   4.2	   Comparison	   of	  MtuCM	   Kinetic	   parameters	   determined	   from	   a	   single	   set	   of	   kinetic	   data	   with	   and	  
without	   MtuDAH7PSWT	   by	   Michaelis-­‐Menten	   kinetics	   with	   previously	   published	   results85.	   *Activation	   factor	  
determined	  by	  the	  ratio	  of	  the	  kcat/Km	  with	  and	  without	  MtuDAH7PS
WT,–	  indicates	  not	  applicable.	  Chorismic	  acid	  
is	  abbreviated	  to	  CA,	  MtuCM	  to	  CM	  and	  MtuDAH7PS	  to	  D.	  For	  this	  study	  the	  concentration	  of	  MtuCM	  used	  for	  
assays	  with	  a	  ten-­‐fold	  molar	  excess	  of	  MtuDAH7PS	  was	  30nM,	  and	  10	  nM	  MtuCM	  for	  assays	  with	  200-­‐fold	  molar	  
excess	  of	  MtuDAH7PS.	  For	  work	  by	  Sasso	  et	  al.	  MtuCM	  activity	  was	  determined	  with	  2	  µM	  MtuDAH7PSH6	  and	  
10	  nM	  MtuCM.	  For	  Michaelis-­‐Menten	  plots	  refer	  to	  Appendix	  I.	  Error	  represents	  the	  fit	  of	  the	  data	  to	  the	  model	  
as	  determined	  by	  a	  least	  squares	  fit.	  






CA	   Activation	  
factor*	  
	   (CM:D)	   (µM)	   (s-­‐1)	   (mM-­‐1s-­‐1)	   	  
This	  study	   	   	   	   	   	  
MtuCM	   1:0	   500	  ±	  30	   0.42	  ±	  0.02	   0.84	  ±	  0.09	   –	  
MtuCM•MtuDAH7PSWT	   1:10	   52	  ±	  4	   5.4	  ±	  0.1	   104	  ±	  9	   120	  ±	  20	  
MtuCM•MtuDAH7PSWT	   1:200	   38	  ±	  6	   10.5	  ±	  0.4	   280	  ±	  50	   330	  ±	  90	  
Sasso	  et	  al.85	   	   	   	   	   	  
MtuCM	   1:0	   1140	  ±	  20	   2.0	  ±	  0.1	   1.75	  ±	  0.09	   –	  
MtuCM•MtuDAH7PSH6	   1:200	   34	  ±	  3	   8	  ±	  2	   240	  ±	  60	   140	  ±	  40	  
	  
A	  ten-­‐fold	  molar	  excess	  of	  MtuDAH7PSWT	  enhanced	  the	  catalytic	  efficiency	  of	  MtuCM	  from	  less	  than	  1	  
to	   over	   100	   mM-­‐1s-­‐1,	   a	   120-­‐fold	   increase	   (Table	   4.2).	   A	   200-­‐fold	   molar	   excess	   of	  MtuDAH7PSWT	  
enhanced	  the	  catalytic	  efficiency	  of	  MtuCM	  by	  ~330-­‐fold.	  Both	  sets	  of	  data	  displayed	  a	  huge	  drop	  in	  
the	  Michaelis	  constant	  for	  chorismic	  acid	  (Km
CA)	  and	  an	  increase	  in	  the	  turnover	  number	  (kcat),	  which	  
contributed	   to	   the	   enhanced	   catalytic	   efficiency	   of	   MtuCM	   in	   presence	   of	   MtuDAH7PSWT.	   This	  
enhancement	  in	  the	  catalytic	  efficiency	  is	  most	  likely	  attributed	  to	  the	  rearrangement	  of	  the	  MtuCM	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active	   site	   residues	   on	   formation	   of	   the	  MtuCM•MtuDAH7PSWT	   complex.85	   Rearrangement	   of	   the	  
MtuCM	   active	   site	   may	   better	   facilitate	   interaction	   with	   the	   substrate	   whilst	   also	   optimising	   the	  
residues	  to	  perform	  catalysis.	  
	  
The	  kinetic	  parameters	  for	  MtuCM	  activity	  determined	  in	  the	  presence	  of	  a	  200-­‐fold	  molar	  excess	  of	  
MtuDAH7PS	   were	   consistent	   with	   those	   previously	   reported	   by	   Sasso	   et	   al.85	   using	   polyhistidine	  
tagged	  MtuDAH7PS.	   However,	   the	   calculated	   activation	   of	  MtuCM	   activity	   by	  MtuDAH7PSWT	   was	  
found	  to	  be	  about	   three	   times	  higher	   than	  previously	   reported;	  yet	   the	  catalytic	  efficiency	   for	  both	  
studies	  was	  in	  good	  agreement.	  The	  similar	  catalytic	  efficiency	  was	  because	  the	  activation	  of	  MtuCM	  
is	   calculated	   using	   the	   catalytic	   efficiency	   of	   MtuCM	   alone,	   and	   this	   varied	   for	   each	   study.	  
Furthermore	   no	   investigation	   has	   previously	   been	   made	   to	   assess	   if	   the	   polyhistidine	   tag	   of	  
MtuDAH7PS	   affects	   the	   interaction	   between	  MtuCM	   and	  MtuDAH7PS.	   Hence	   no	   conclusion	   could	  
definitively	  be	  drawn	  with	  regard	  to	  whether	  the	  reduced	  activation	  of	  MtuCM	  activity	  was	  due	  to	  the	  
use	  of	  polyhistidine	  tagged	  MtuDAH7PS	  by	  Sasso	  et	  al.	  or	  simply	  due	  to	  variation	   in	  the	  purification	  
and	  analysis	  of	  MtuCM.	  	  
 Evidence	  of	  MtuCM•MtuDAH7PSWT	  complex	  in	  4.5.
solution	  
	  
Numerous	  techniques	  were	  trialled	  in	  an	  attempt	  to	  obtain	  unequivocal	  evidence	  of	  the	  formation	  of	  
the	  MtuCM•MtuDAH7PS	  complex	  in	  solution.	  Efforts	  were	  continually	  hampered	  by	  the	  low	  yield	  and	  
instability	  of	  the	  MtuCM	  protein	  or	  its	  poor	  extinction	  coefficient	  at	  280	  nM	  (1490	  cm-­‐1mol-­‐1).	  SAXS,	  
light	   scattering	   techniques	   and	   analytical	   SEC	   were	   attempted	   without	   success.	   Eventually	   AUC	  
proved	   to	   be	   the	   only	   technique	   to	   enable	   visualisation	   of	   the	   complex	   formation	   between	  
MtuDAH7PSWT	  and	  MtuCM	  at	  a	  range	  of	  concentrations	  in	  solution.	  
	  
Sedimentation	   velocity	   experiments	   were	   carried	   out	   under	   the	   same	   conditions	   used	   to	   analyse	  
MtuDAH7PSWT	  and	  these	  conditions	  are	  described	  in	  Section	  9.7.7.	  AUC	  experiments	  were	  carried	  out	  
by	   Ali	   Nazmi.	   The	   proteins	   were	   combined	   at	   the	   stated	   molar	   ratio	   (either	   4:1,	   1:1	   or	   1:2;	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MtuCM:MtuDAH7PSWT)	   and	   dialysed	   for	   2-­‐3	   hours	   prior	   to	   being	   analysed	   by	   AUC.	   Analysis	   was	  
carried	  out	   at	   three	  MtuDAH7PSWT	   concentrations	   0.2,	   0.4	   and	  0.6	  mg/mL.	  AUC	  was	   attempted	  on	  
MtuCM	   alone,	   but	   was	   unsuccessful	   due	   to	   the	   instability	   of	  MtuCM	   over	   the	   time	   course	   of	   the	  
analysis,	   and	   the	   analysis	   of	   these	   experiments	   was	   further	   hampered	   by	   the	   low	   extinction	  
coefficient	  of	  the	  enzyme.	  
	  
The	  sedimentation	  coefficient	  (s)	  determined	  in	  the	  presence	  for	  a	  4:1	  MtuCM:MtuDAH7PSWT	  mixture	  
was	   ~9.3	   S	   at	   all	   three	  MtuDAH7PSWT	   concentrations	   and	   corresponded	   to	   a	   molecular	   mass	   of	  
~220	  kDa	   (Figure	   4.9A).	   The	   expected	   molecular	   mass	   of	   the	   heterooctameric	   complex	   between	  
MtuCM	   and	   MtuDAH7PS	   is	   ~244	  kDa.	   This	   was	   ~1	  S	   greater	   than	   sedimentation	   coefficient	   of	  
MtuDAH7PS	  alone	  (~8.4	  S)	  (Figure	  4.9D).	  	  




Figure	   4.9	   Normalised	   continuous	   size	   c(s)	   distribution	   of	   sedimentation	   velocity	   data:	   A.	  MtuDAH7PS	   and	   a	  
four-­‐fold	  molar	  excess	  of	  MtuCM;	  B.	  MtuDAH7PSWT	  and	  equal	  molar	  amount	  of	  MtuCM;	  C.	  MtuDAH7PSWT	  and	  
half	   the	   molar	   concentration	   of	  MtuCM	   and	   D.	   	  MtuDAH7PSWT	   alone.	   Analyses	   conducted	   at	  MtuDAH7PSWT	  
concentrations	  of	  0.2	  mg/mL,	  0.4	  mg/mL	  or	  0.6	  mg/mL	  coloured	  mustard,	  red	  and	  wine	  respectively	  for	  mixtures	  
of	  MtuCM	  and	  MtuDAH7PSWT	  and	  violet,	  purple	  and	  pink	  for	  MtuDAH7PS	  alone.	  Note	  that	  the	  molar	  extinction	  
coefficient	  of	  MtuCM	  is	  1490	  cm-­‐1mol-­‐1,	  whereas	  that	  of	  MtuDAH7PSWT	  is	  41160	  cm-­‐1mol-­‐1	  at	  a	  wavelength	  of	  280	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Analysis	  of	   the	  1:1	  and	  0.5:1	  mixtures	  of	  MtuCM	  and	  MtuDAH7PSWT	   revealed	  a	   single	  peak	  at	  each	  
concentration	  with	  a	  sedimentation	  coefficient	  of	  ~	  8.8	  S	  and	  ~8.5	  S	  respectively	   (Figure	  4.9B-­‐C).	  As	  
the	  molar	   ratio	   of	  MtuCM	   to	  MtuDAH7PS	   decreased,	   the	   sedimentation	   coefficient	   tended	   toward	  
that	   of	   MtuDAH7PS	   alone,	   whilst	   the	   peaks	   of	   the	   continuous	   size	   distribution	   model	   became	  
broader.	   The	   broadened	   peaks	   indicated	   the	   boundary	   layers	   were	   less	   defined	   and	   were	   most	  
probably	  a	  result	  of	  a	  broader	  range	  of	  molecular	  weight	  species	  being	  present	  in	  solution,	  such	  as	  the	  
MtuDAH7PS	  tetramer	  with	  a	  single	  MtuCM	  dimer	  bound.	  
	  
The	   1:1	   and	   0.5:1	  mixtures	   of	  MtuCM	   and	  MtuDAH7PS	  were	   conducted	  with	  MtuCM	  with	   a	   small	  
amount	  of	  GST-­‐tag	  contamination.	  Consequently	   there	   is	  a	   small	  peak	  at	  ~3.6	  S	  corresponding	   to	  a	  
molecular	   mass	   of	   ~41	   kDa.	   The	   expected	   mass	   for	   a	   GST	   dimer	   is	   ~52	  kDa.	   Due	   to	   the	   very	   low	  
extinction	  coefficient	  of	  MtuCM	  at	  280	  nm	  (1490	  cm-­‐1mol-­‐1)	  a	  peak	  for	  MtuCM	  is	  not	  clearly	  observed	  
at	   the	  wavelength	   of	   analysis.	  Note	   the	  MtuCM	  extinction	   coefficient	   is	  much	   smaller	   than	   that	   of	  
MtuDAH7PS	  (41160	  cm-­‐1mol-­‐1).	  	  
	  
Another	   striking	   observation	   from	   the	   sedimentation	   velocity	   experiments	   was	   the	   quaternary	  
structure	  equilibrium	  of	  MtuDAH7PS	  shifted	  in	  the	  presence	  of	  MtuCM	  toward	  the	  formation	  of	  the	  
tetramer	   (Figure	  4.9A-­‐C).	  Even	  at	  a	   ratio	  of	  0.5:1	  MtuCM:MtuDAH7PS	   there	  was	  no	  hint	  of	  a	  dimer	  
peak	  at	  0.2	  mg/mL	  unlike	  MtuDAH7PSWT	  which	  shows	  a	  sizeable	  peak	  at	  ~	  5.7	  S.	  
 Regulation	  of	  the	  MtuCM•MtuDAH7PSWT	  complex	  4.6.
 Feedback	  regulation	  4.6.1.
Inhibition	   studies	   were	   carried	   out	   using	   a	   ten-­‐fold	   molar	   excess	   of	  MtuDAH7PS	   relative	   to	   the	  
concentration	  of	  MtuCM	  (30	  nM),	  and	  the	  two	  components	  were	   incubated	  for	  10	  min	   in	  the	  assay	  
conditions	  prior	   to	   initiation	  with	  substrate.	  Assays	   for	   the	   inhibition	  studies	  were	  conducted	  under	  
the	   standard	  assay	   conditions	  used	   to	  determine	   the	  Michaelis-­‐Menten	  kinetics	  of	  MtuCM	  and	  are	  
described	  in	  Section	  9.9.3.	  Each	  amino	  acid	  was	  added	  at	  a	  concentration	  of	  200	  µM.	  




The	  addition	  of	  MtuDAH7PSWT	   to	   the	  MtuCM	   inhibition	  assays	   resulted	   in	   the	   regulation	  of	  MtuCM	  
activity	  by	  the	  aromatic	  amino	  acids.	  The	  effectiveness	  of	  the	  inhibition	  was	  shown	  to	  be	  dependent	  
on	  substrate	  concentration,	  with	  MtuCM	  activity	  at	   lower	  chorismic	  acid	  concentrations	  being	  more	  
responsive	   to	   the	   addition	   of	   the	   aromatic	   amino	   acids	   (Figure	   4.10).	   In	   agreement	   with	   previous	  
work,	   Phe	  was	   found	   to	  be	   the	  most	   potent	   inhibitor,	   followed	  by	   Tyr	   reducing	  MtuCM	  activity	   by	  
~85	  %	  and	  ~40	  %	  respectively,	  in	  the	  presence	  of	  25	  µM	  chorismic	  acid.85	  The	  addition	  of	  Trp	  had	  no	  
effect	  on	  the	  MtuCM	  activity	  even	  in	  the	  presence	  of	  MtuDAH7PSWT.	  	  
	  
Figure	   4.10	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  for	  MtuCM	  alone	  (burgundy)	  or	  with	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  	  initiated	  by	  either	  
150	  µM	  (blue	  hash)	  or	  25	  µM	  (blue	  stripe)	  chorismic	  acid.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  
letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  amino	  
acids.	  Assays	  conducted	  in	  the	  presence	  of	  150	  µM	  chorismic	  acid	  unless	  otherwise	  stated.	  Error	  bars	  depict	  the	  
standard	  deviation	  of	  at	   least	  duplicate	  measurements.	  MtuCM	  concentrations	  was	  3	  µM	  or	  60	  nM	  for	  MtuCM	  
alone	  or	  in	  combination	  with	  MtuDAH7PS	  respectively.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
Previous	   work	   stated	   Phe	   and	   Tyr	   synergistically	   inhibit	   MtuCM	   activity	   in	   the	   presence	   of	  
MtuDAH7PS.85	  This	  study	  found	  the	  remaining	  activity	  determined	  in	  the	  presence	  of	  Phe	  and	  Tyr	  was	  
~6	  %,	  and	  it	  is	  not	  clear	  whether	  Tyr	  and	  Phe	  act	  synergistically	  or	  additively	  to	  inhibit	  MtuCM	  activity.	  
However,	   synergistic	   inhibition	   of	  MtuCM	   activity	   (in	   the	   presence	   of	  MtuDAH7PS)	   was	   observed	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when	  Trp	  was	  added	  in	  combination	  with	  either	  Phe	  or	  Tyr.	  The	  combination	  of	  Trp	  with	  either	  Tyr	  or	  
Phe	   reduced	   the	   remaining	  MtuCM	  activity	   to	  ~25%	  or	  ~2	  %,	  making	   the	  Trp	  and	  Phe	   combination	  
more	  potent	   than	  Phe	  and	  Tyr.	  The	  combination	  of	  all	   three	  aromatic	  amino	  acids	   reduced	  MtuCM	  
activity	   slightly	  more	   the	  combination	  of	  Trp	  and	  Phe.	  The	  activity	   loss	  with	  combinations	   including	  
Trp	  has	  not	  previously	  been	  observed.85	  
	  
The	  observed	  pattern	  of	  synergistic	  inhibition	  of	  MtuCM	  activity	  in	  the	  presence	  of	  MtuDAH7PS	  was	  
reminiscent	  of	  the	  synergistic	  inhibition	  reported	  for	  MtuDAH7PSWT	  itself	  in	  response	  to	  the	  aromatic	  
amino	   acids.	   Hence,	   it	   is	   highly	   plausible	   the	   allosteric	   binding	   sites	   of	   the	  MtuDAH7PS	   are	   also	  
responsible	  for	  the	  regulation	  of	  MtuCM	  activity.	  
 Effect	  of	  Phe	  and	  Tyr	  on	  kinetic	  parameters	  of	  4.6.2.
MtuCM•MtuDAH7PSWT	  
	  
The	   determination	   of	   the	  Michaelis-­‐Menten	   kinetic	   parameters	   for	  MtuCM	   activity	  was	   conducted	  
under	  standard	  assay	  conditions,	  with	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  and	  addition	  of	  either	  Phe,	  
Tyr	   or	   both	   ligands	   at	   either	   100	  µM	   or	   200	   µM.	   The	   experimental	   protocol	   is	   detailed	   in	   Section	  
9.9.1.	  	  
	  
The	  addition	  of	  Phe	  and	  or	  Tyr	  altered	  the	  kinetic	  parameters	  determined	  for	  MtuCM	  activity	  in	  the	  
presence	  of	  MtuDAH7PSWT	   (Table	  4.3).	   In	   the	  presence	  of	   either	   Tyr	   or	   Phe	   the	  Michaelis	   constant	  
determined	   for	   chorismic	  acid	   (Km
CA)	  increased,	  whilst	   the	  kcat	   remained	   relatively	  unaffected	   (Table	  
4.3).	   Therefore	   a	   higher	   concentration	   of	   chorismic	   acid	  was	   required	   for	   effective	   catalysis	   in	   the	  
presence	  of	  either	  Phe	  or	  Tyr.	  Thus	  Phe	  and	  Tyr	  act	  primarily	  to	  reduce	  the	  affinity	  of	  MtuCM	  for	  its	  
substrate,	  chorismic	  acid,	  making	   them	  K-­‐type	   inhibitors.	  Although	  Tyr	  was	  a	   less	  effective	   inhibitor	  
than	   Phe,	   Tyr	   significantly	   augments	   the	   inhibitory	   response	   to	   Phe	   resulting	   in	   a	   greater	   overall	  
inhibition	  of	  MtuCM	  than	  either	  amino	  acid	  alone.	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Table	  4.3	  Kinetic	  parameters	  determined	  from	  the	  Michaelis-­‐Menten	  kinetics	  for	  a	  single	  set	  of	   	  MtuCM	  in	  the	  
presence	   of	   ten-­‐fold	   excess	   of	  MtuDAH7PSWT	   and	   ligand	   as	   indicated.	   Michaelis-­‐Menten	   plots	   are	   shown	   in	  
Appendix	  I.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  squares	  fit.	  






kcat/Km	  CA	   Relative	  
activity	  
	   (µM)	   (s-­‐1)	   (mM-­‐1s-­‐1)	   (%)	  
none	   52	  ±	  4	   5.4	  ±	  0.1	   104	  ±	  9	   100	  ±	  20	  
Phe(200	  µM)	   220	  ±	  20	   6.3	  ±	  0.2	   29	  ±	  3	   28	  ±	  5	  
Phe(100	  µM)	  Tyr(100	  µM)	   340	  ±	  30	   6.0	  ±	  0.3	   18	  ±	  2	   17	  ±	  4	  
Phe(200	  µM)	  Tyr(200	  µM)	  	   480	  ±	  40	   8.0	  ±	  0.3	   17	  ±	  5	   16	  ±	  7	  
Tyr(200	  µM)	  	   84	  ±	  5	   5.0	  ±	  0.1	   60	  ±	  5	   58	  ±	  9	  
	  
 Determination	  of	   the	  apparent	  dissociation	   constant	  4.7.
between	  MtuCM	  and	  MtuDAH7PS	  
	  
The	  dissociation	  constant	  of	  MtuCM	  and	  MtuDAH7PSWT	  could	  not	  be	  measured	  directly	  by	  ITC	  due	  to	  
the	   instability	   of	  MtuCM	   and	   high	   concentration	   of	   protein	   that	   this	   technique	   demands.	   As	   an	  
alternative,	  kinetic	  analysis	  was	  used	  to	  estimate	  the	  apparent	  dissociation	  constant	  (Kd,app)	  between	  
MtuCM	  and	  MtuDAH7PSWT.	  	  
	  
This	  method	  has	  been	  previously	  established	  and	  is	  detailed	  in	  Section	  9.9.4	  and	  assumes	  the	  physical	  
association	  of	  MtuCM	  and	  MtuDAH7PSWT	  is	  correlated	  to	  the	  enhancement	  in	  the	  MtuCM	  specificity	  
constant.85	   Duplicate	   independent	   MtuCM	   Michaelis-­‐Menten	   kinetics	   were	   determined	   for	   each	  
concentration	  of	  MtuDAH7PSWT.	  The	  concentration	  of	  MtuCM	  was	  kept	  at	  10	  nM	  MtuCM,	  except	   in	  
the	  absence	  of	  MtuDAH7PSWT	  where	  90	  nM	  was	  used	  and	  the	  data	  normalised.	  The	  MtuCM	  catalytic	  
efficiencies	   were	   calculated	   from	   these	   data	   and	   plotted	   against	  MtuDAH7PSWT	   concentration	   to	  
derive	  the	  Kd,app	  between	  MtuCM	  and	  MtuDAH7PS
WT	  (Figure	  4.11).	  Equation	  4.1	  was	  fitted	  to	  the	  data,	  
using	   the	   catalytic	   efficiency	   of	   the	   complex	   (υCM•DS)	   and   Kd,app	   as	   the	   fitting	   parameters,	   by	   the	  
iterative	  curve	   fitting	  software	  KaleidaGraph	   (Synergy	  Software).	  Sasso	  et	  al.	  adapted	  work	  by	  Taira	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and	   Benkovic	   to	   derive	   this	   equation	   allowing	   the	   determination	   of	   the	   apparent	  
MtuCM•MtuDAH7PSWT	  dissociation	  constant	  for	  a	  1:1	  stoichiometry.114	  	  
	  
𝜐 = 𝜐!" + CM ! + DS ! + 𝐾!,!"" − ( CM ! + DS ! + 𝐾!,!"")! − 4 CM ! DS ! •
!!"•!"!!!"
![!"]!
	  	  	  	  	  	  
	  
Equation	  4.1  υ,  υCM  and  υCM•DS  are  the  corresponding  catalytic  efficiencies,  [CM]0  and  [DS]0  are	  the	  total	  concentrations	  
of	  MtuCM	  and	  MtuDAH7PSWT	  respectively.	  Kd,app	  is	  the	  apparent	  dissociation	  constant	  of	  the	  complex.	  
	  
Figure	  4.11	  Response	  of	  MtuCM	  catalytic	  efficiency	  (kcat/Km)	  to	  increasing	  concentrations	  of	  MtuDAH7PS
WT	  in	  the	  
absence	  (blue	  dot)	  and	  presence	  (pink	  dot)	  of	  200	  µM	  Phe.	  All	  assays	  conducted	  with	  10	  nM	  MtuCM.	  Error	  bars	  
represent	  the	  standard	  deviation	  of	  duplicate	  independent	  Michaelis-­‐Menten	  measurements	  with	  at	  least	  seven	  
points.	  
	  
The	  Kd,app	  between	  MtuCM	  and	  MtuDAH7PS
WT	  was	  found	  to	  be	  700	  ±	  200	  nM	  greater	  than	  the	  value	  
of	   140	   ±	   30	   nM	   determined	   by	   previously	   under	   similar	   conditions	   (Figure	   4.11).85	   The	   difference	  
between	  the	  values	  is	  in	  part	  due	  to	  the	  difficulty	  of	  accurately	  determining	  the	  catalytic	  efficiencies	  
of	   the	   lower	   ratios	   of	  MtuCM	   and	  MtuDAH7PSWT,	   which	   help	   define	   the	   shape	   at	   the	   start	   of	   the	  
curve.	   Both	   studies	   give	  Kd,apps	   in	   the	   nM	   range	   and	   indicate	   a	  moderate	   affinity	   between	   the	   two	  
proteins.	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The	  Kd,app	  between	  MtuCM	  and	  MtuDAH7PS
WT	  was	  also	  determined	  in	  the	  presence	  of	  200	  µM	  Phe.	  
Phe	   reduced	   the	   maximum	   activation	   of	  MtuCM	   activity	   by	   ~68	   %	   (Figure	   4.11).	   The	   Kd,app	   was	  
determined	  to	  be	  3.0	  ±	  0.9	  µM	  and	  indicated	  Phe	  had	  reduced	  the	  affinity	  between	  the	  two	  proteins	  
by	  more	  than	  three-­‐fold.	  	  
	  
Molecular	   dynamic	   simulations	   that	   modelled	   Phe	   binding	   to	  MtuDAH7PSWT	   found	   the	   β7-­‐α7	   and	  
β8-­‐α8	  loops	  of	  MtuDAH7PS	  became	  highly	  flexible	  upon	  ligand	  binding.71	  This	  increased	  flexibility	  of	  
these	   loops	  may	   reflect	   a	   subtle	   change	   in	   conformation	   or	  molecular	   dynamics	   in	   the	   local	   area,	  
including	  the	  interface	  between	  MtuDAH7PSWT	  and	  MtuCM.	  Any	  changes	  at	  the	  interface	  are	  likely	  to	  
negatively	  affect	  the	  contacts	  between	  the	  MtuCM	  and	  MtuDAH7PSWT,	  reducing	  the	  affinity	  between	  
the	  two	  proteins.	  The	  binding	  of	  Phe	  to	  MtuDAH7PS	  may	  shift	  the	  average	  species	  of	  the	  population	  
ensemble	  of	  the	  protein	  toward	  a	  species	  that	  has	  a	  lower	  affinity	  for	  MtuCM	  and/or	  is	  less	  suited	  to	  
activating	  MtuCM	   activity.	   By	   changing	   the	   affinity	   of	   the	  MtuDAH7PS	   population	   ensemble	   for	  
MtuCM	  it	   is	  possible	  the	  rates	  at	  which	  the	  enzymes	  associate	  and	  dissociate	  has	  also	  changed	  and	  
could	  be	  responsible	  for	  the	  change	  in	  the	  apparent	  Kd,app.	  
 Evidence	  of	  complex	  dissociation	  in	  solution	  4.8.
 Native	  PAGE	  4.8.1.
Native	   PAGE	   to	   observe	   the	   formation	   of	   the	   complex	   between	   MtuCM	   and	   MtuDAH7PS	   was	  
conducted	   using	   horizontal	   Amersham	   ECL	   12%	   gels	   with	   a	   Tris-­‐Alanine	   running	   buffer	   at	   pH	   9.2	  
(detailed	   in	   Section	  9.7.3).	   Samples	   are	   loaded	   at	   an	  MtuDAH7PSWT	   concentration	  of	   ~6	  µM.	   Initial	  
attempts	  were	  conducted	  under	  the	  blue	  native	  PAGE	  conditions	  used	  to	  analyse	  the	  MtuDAH7PSWT	  
in	  Section	  9.7.2	  but	  were	  unsuccessful.	   It	  was	  thought	  the	  coomassie®	  G250	  dye	  used	  to	  negatively	  
charge	  the	  protein	  interfered	  with	  or	  blocked	  the	  interface	  preventing	  MtuCM	  from	  binding.	  
	  
The	   sample	   of	  MtuDAH7PSWT	   analysed	   by	   native	   PAGE	   under	   the	   Tris-­‐Alanine	   conditions	   yielded	   a	  
single	  band,	  with	  a	  molecular	  mass	  of	  ~240	  kDa.	  The	  expected	  mass	  of	   the	  MtuDAH7PS	  tetramer	   is	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204	   kDa	   (Figure	   4.12A).	   This	   differs	   from	   the	   results	   reported	   for	  MtuDAH7PSWT	   analysed	   by	   blue	  
native	   PAGE	   in	   Section	   2.6.1,	   which	   showed	   a	  mixture	   of	   monomer	   and	   dimer	   were	   present.	   The	  
discrepancy	  in	  results	  is	  most	  likely	  due	  to	  the	  difference	  in	  pH	  of	  the	  two	  running	  buffers.	  The	  blue	  
native	   PAGE	   buffer	   is	   neutral	   and	   the	   Tris-­‐Alanine	   buffer	   is	   basic.	   However,	   more	   thorough	  
investigation	  is	  required	  to	  before	  it	  can	  be	  assumed	  the	  quaternary	  structure	  of	  MtuDAH7PSWT	  is	  pH	  
dependent.	  	  
	  
The	  MtuDAH7PSWT	  sample	  analysed	  in	  the	  presence	  of	  a	  four-­‐fold	  molar	  excess	  of	  MtuCM	  displayed	  a	  
second	  higher	  molecular	  weight	  band	  (~300	  kDa).	  The	  expected	  mass	  of	  the	  heterooctameric	  complex	  
is	  244	  kDa.	  The	  difference	  in	  mass	  between	  the	  two	  bands	  is	  ~60	  kDa,	  similar	  to	  the	  change	  in	  mass	  
expected	   on	   the	   formation	   of	   the	   heterooctameric	   complex	   of	   ~40	   kDa.	   Thus	   the	   second	   band	   is	  
believed	  to	  correspond	  to	   the	   formation	  of	  MtuCM•MtuDAH7PSWT	  complex.	  MtuCM	  alone,	  with	  an	  
expected	  molecular	  mass	  of	  ~10	  kDa,	  does	  not	  migrate	  toward	  the	  anode	  under	   these	  native	  PAGE	  
conditions.	  
	  
Figure	  4.12	  A.	  Native	  PAGE	  of	  MtuDAH7PS	  alone	  (Lane	  1),	  with	   four-­‐fold	  molar	  excess	  of	  MtuCM	  (Lane	  2)	  and	  
with	   four-­‐fold	   molar	   excess	   of	  MtuCM	   and	   1	   mM	   Phe	   (Lane	   3).	   Lane	   M	   native	   molecular	   mass	   marker.	   B.	  
SDS-­‐PAGE	   gel	   of	   fractions	   eluted	   with	   elution	   buffer	   from	   IMAC.	   Lane	   M	   molecular	   mass	   marker;	   Lane	   1	  
MtuDAH7PSH6;	  Lane	  2	  MtuDAH7PSH6	  with	  a	  four-­‐fold	  molar	  excess	  of	  MtuCM;	  Lane	  3	  MtuDAH7PSH6	  with	  a	  four-­‐
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More	  excitingly,	  the	  second	  higher	  molecular	  weight	  band	  present	  for	  a	  sample	  containing	  a	  mixture	  
of	  MtuCM	  and	  MtuDAH7PSWT	  diminished	  with	   the	  addition	  of	  1	  mM	  Phe	   to	   the	  sample.	  This	   result	  
suggested	   the	   addition	   of	   Phe	   prevented	   the	   formation	   of	   the	   heterooctameric	  
MtuCM•MtuDAH7PSWT	  complex;	  supporting	  the	  hypothesis	  Phe	  binding	  to	  MtuDAH7PS	  weakens	  the	  
association	  of	  the	  two	  proteins.	  
 IMAC	  pull	  down	  assay	  4.8.2.
Although	  exciting,	  the	  evidence	  of	  MtuCM•MtuDAH7PS	  complex	  formation	  and	  dissociation	  obtained	  
from	   the	   Tris-­‐Alanine	   native	   PAGE	   required	   such	   precise	   conditions	   the	   results	   needed	   further	  
corroboration,	  preferably	  at	  a	  more	  biologically	   relevant	  pH.	  To	   this	  end	  a	  pull	  down	  assay	  utilising	  
the	  His6-­‐tagged	  MtuDAH7PSs	   (MtuDAH7PS
H6)	   inherent	  affinity	   for	   the	   IMAC	  column	  was	  developed,	  
Section	  9.7.8.	  	  
 
To	  enable	  MtuDAH7PS	  to	  bind	  an	   IMAC	  column	  the	  protein	  was	  purified	  retaining	  the	  polyhistidine	  
tag	   (MtuDAH7PS-­‐H6).	  MtuCM	  was	  purified	   as	   previously	   stated,	   and	  has	   no	   inherent	   affinity	   for	   an	  
IMAC	   column.	   The	   proteins	   were	   applied	   to	   an	   IMAC	   column	   and	   the	   column	   washed	   with	   wash	  
buffer	   to	   remove	   all	   unbound	   protein.	   Any	   bound	   protein	  was	   then	   eluted	   from	   the	   column	   using	  
elution	  buffer.	  SDS-­‐PAGE	  of	  the	  protein	  containing	  fractions	  showed	  MtuDAH7PSH6	  eluted	  as	  a	  single	  
band	  of	  ~55	  kDa	  in	  agreement	  with	  its	  expected	  monomeric	  mass	  (Figure	  4.12B).	  After	  incubation	  of	  
MtuDAH7PSH6	  with	  a	  four-­‐fold	  molar	  excess	  of	  MtuCM	  for	  5	  min,	  SDS-­‐PAGE	  revealed	  two	  bands	  were	  
present	  in	  the	  protein	  bound	  fraction,	  one	  at	  ~	  55kDa	  corresponding	  to	  MtuDAH7PSH6	  and	  a	  second	  at	  
~10	  kDa,	   the	  expected	  monomeric	  mass	  of	  MtuCM.	  Finally	   the	  preincubation	  of	  MtuDAH7PSH6	  with	  
both	  MtuCM	  and	  1	  mM	  Phe	  (and	  addition	  of	  1	  mM	  Phe	  to	  the	  buffers),	  resulted	  in	  a	  single	  band	  at	  ~	  
55	  kDa	  corresponding	  to	  the	  presence	  of	  MtuDAH7PSH6.	  
	  
The	  coelution	  of	  MtuCM	   in	   the	  protein	  bound	   fraction	  with	  MtuDAH7PSH6	   indicates	   the	  association	  
between	  the	  two	  proteins	  was	  great	  enough	  to	  prevent	  the	  MtuCM	  from	  being	  washed	  off	  the	  IMAC	  
column	   with	   the	   wash	   buffer.	   The	   addition	   of	   Phe	   directly	   to	   the	   mixture	   of	   MtuCM	   and	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MtuDAH7PSH6	   resulted	   in	   the	   elution	   of	   MtuDAH7PSH6	   in	   the	   bound	   fraction	   alone.	   This	   result	  
indicates	  Phe	  sufficiently	  weakened	  the	  association	  between	  MtuDAH7PSH6	  and	  MtuCM	  to	  allow	  the	  
MtuCM	  to	  be	  washed	  off	  the	  column	  by	  the	  wash	  buffer.	  
 AUC	  analysis	  4.8.3.
Sedimentation	   velocity	   experiments	   were	   carried	   out	   under	   the	   same	   conditions	   used	   to	   analyse	  
MtuDAH7PSWT	   and	   are	   described	   in	   Section	   9.7.7.	   Ali	   Nazmi	   carried	   out	   the	   AUC	   experiments	   and	  
assisted	  with	   the	  analysis.	  The	  proteins	  were	  combined	   in	   the	  stated	  molar	   ratio	   (either	  4:1	  or	  1:1;	  
MtuCM:MtuDAH7PSWT)	   and	   dialysed	   for	   2-­‐3	   hours.	   Just	   prior	   to	   AUC	   analysis	   samples	   (and	   the	  
reference	   buffer)	  were	   spiked	   by	   100	   µM	  Phe.	   Analysis	  was	   carried	   out	   at	   three	   concentrations	   of	  
MtuDAH7PSWT	  0.2,	  0.4	  and	  0.6	  mg/mL.	  
	  
In	   Section	   4.5	   AUC	   of	   samples	   containing	   a	   mixture	   of	  MtuDAH7PSWT	   and	  MtuCM	   identified	   the	  
formation	   of	   the	   heteroctameric	   MtuCM•MtuDAH7PSWT	   complex	   in	   solution.	   Formation	   of	   the	  
complex	  was	   identified	   by	   an	   increase	   in	   the	   sedimentation	   coefficient	   in	   the	   presence	   of	  MtuCM	  
(Figure	  4.13A-­‐C).	  	  
	  
A	   four-­‐fold	  molar	  excess	  of	  MtuCM	  resulted	   in	  a	  sedimentation	  coefficient	   (s)	  of	  ~9.2	  S,	  and	  gave	  a	  
calculated	  molecular	  mass	  of	  220	  kDa	  (Figure	  4.13A).	  For	  MtuDAH7PS	  in	  the	  presence	  of	  100	  µM	  Phe	  
and	  a	  four-­‐fold	  molar	  excess	  of	  MtuCM	  s	  decreased	  to	  ~8.8	  S,	  and	  gave	  a	  calculated	  molecular	  mass	  
of	  ~190	  kDa,	  in	  good	  agreement	  with	  the	  expected	  tetrameric	  mass	  of	  MtuDAH7PS	  of	  ~204	  kDa.	  The	  
change	  in	  calculated	  mass	  of	  ~30	  kDa	  is	  similar	  to	  the	  expected	  change	  in	  mass	  caused	  by	  the	  loss	  of	  
four	  MtuCM	  monomers	   (~40	   kDa)	   and	   strongly	   supports	   a	   dissociative	  mechanism	  of	   inhibition	   for	  
the	  MtuCM•MtuDAH7PS	  complex.	  




Figure	  4.13	  Continuous	  size	  c(s)	  distribution	  plots	  from	  sedimentation	  velocity	  experiments	  of	  A.	  MtuDAH7PSWT	  
alone	  (purple),	  with	  a	  four-­‐fold	  molar	  excess	  of	  MtuCM	  (red)	  and	  four	  fold-­‐molar	  excess	  of	  MtuCM	  plus	  100	  µM	  
Phe	   (blue)	   all	   analysed	   at	   an	   MtuDAH7PSWT	   concentration	   of	   0.4	   mg/mL;	   B.	   An	   equimolar	   mixture	   of	  
MtuDAH7PSWT	  in	  the	  presence	  of	  100	  µM	  Phe	  analysed	  at	  MtuDAH7PSWT	  concentrations	  of	  0.2	  (orange),	  0.4	  (red)	  
and	  0.6	  mg/mL	  (wine)	  and	  for	  comparison	  C.	  An	  equimolar	  mixture	  of	  MtuDAH7PSWT	  analysed	  at	  MtuDAH7PSWT	  
concentrations	  of	  0.2	  (orange),	  0.4	  (red)	  and	  0.6	  mg/mL	  (wine).	  Experimental	  data	  and	  fits	  are	  shown	  in	  Appendix	  
II.	  
	  
An	  equimolar	   concentration	  of	  MtuCM	  gave	  an	  s	   value	  of	  ~8.6	  S,	   in	   the	  presence	  of	  100	  µM	  Phe	  s	  
value	  was	  ~8.5	  S,	  but	  the	  peaks	  of	  the	  distribution	  plot	  have	  become	  much	  broader	  (Figure	  4.13B-­‐C).	  
A	   lower	  s	   value	   is	   an	   indication	  of	  a	   lower	  average	  molecular	  mass	  of	   the	  proteins	   in	   solution.	  The	  
broadening	   of	   the	   continuous	   size	   distribution	   peaks	   indicated	   the	   sedimentation	   boundaries	  were	  
less	  well	  defined	  and	  a	  greater	  range	  of	  molecular	  masses	  being	  sampled	  by	  the	  proteins	  in	  solution.	  
Thus	   the	  broadening	  of	   the	   peaks	   is	   likely	   due	   to	   a	   larger	   proportion	  of	   unbound	  MtuDAH7PS	   and	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These	   results	   showed	   the	   addition	   of	   Phe	   shifted	   the	   determined	   sedimentation	   coefficient	   for	   a	  
mixture	  of	  MtuCM	  and	  MtuDAH7PS	  toward	  that	  of	  MtuDAH7PSWT	  alone.	  This	  would	  indicate	  the	  peak	  
represents	   two	   or	   more	   close	   boundaries	   due	   to	   a	   mixture	   of	   MtuDAH7PSWT	   and	  
MtuCM•MtuDAH7PSWT	   complex	   being	   present	   in	   solution.	   The	   addition	   of	   Phe	   promoted	   the	  
dissociation	   of	   the	   complex,	   which	   in	   turn	   increased	   the	   proportion	   of	   lower	   molecular	   weight	  
MtuDAH7PSWT	   in	   solution	   and	   resulted	   in	   the	   observed	   decrease	   in	   sedimentation	   coefficient	   and	  
broadening	  of	  the	  distribution	  peaks.	  
 Effect	  of	  complex	  formation	  on	  MtuDAH7PS	  	  4.9.
 Effect	  on	  kinetic	  parameters	  4.9.1.
The	   activity	   of	  MtuDAH7PSWT	   (60	   nM)	   in	   the	   presence	   of	   a	   ten-­‐fold	   molar	   excess	   of	  MtuCM	   was	  
determined	   using	   the	   steady-­‐state	   kinetic	   assays	   developed	   for	  MtuDAH7PSWT	   and	   are	   detailed	   in	  
Section	  9.9.1.	  The	  data	  was	  fitted	  to	  the	  Michaelis-­‐Menten	  equation	  to	  derive	  the	  kinetic	  parameters.	  
	  
The	  presence	  of	  MtuCM	   increased	   the	  kcat	  and	  decreased	   the	  Michaelis	   constants	   for	  both	  PEP	  and	  
E4P	   resulting	   in	   the	   catalytic	   efficiency	   of	   both	   substrates	   improving	   compared	   to	  MtuDAH7PSWT	  
alone	   (Table	   4.4).	   The	   modest	   increase	   in	   catalytic	   efficiency	   of	   MtuDAH7PSWT	   indicates	   the	  
interaction	   of	  MtuCM	   and	  MtuDAH7PS	   has	   favourable	   effect	   on	   both	   enzymes,	   albeit	   overall	   the	  
interaction	  is	  far	  more	  beneficial	  to	  MtuCM.	  
	  
Table	  4.4	  Kinetic	  parameters	  determined	  from	  a	  single	  set	  of	  Michaelis-­‐Menten	  kinetic	  data	  for	  MtuDAH7PSWT	  
with	  and	  without	  the	  presence	  of	  a	  ten-­‐fold	  excess	  of	  MtuCM.	  Michaelis-­‐Menten	  plots	  are	  shown	  in	  Appendix	  I.	  
Stated	  errors	  determined	  by	  least	  squares	  fit	  of	  the	  data	  to	  the	  model.	  










E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
MtuDAH7PSWT	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
MtuCM•	  MtuDAH7PSWT	   20	  ±	  2	   27	  ±	  2	   7.1	  ±	  0.1	   360	  ±	  40	   260	  ±	  20	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 Effect	  of	  MtuCM	  on	  MtuDAH7PSWT	  regulation	  4.9.2.
	  
Inhibition	   of	   MtuDAH7PS	   activity	   in	   the	   presence	   of	   a	   ten-­‐fold	   molar	   excess	   of	   MtuCM	   was	  
investigated	   using	   the	   standard	   kinetic	   assays	   for	   the	   inhibition	   studies	   of	  MtuDAH7PSWT,	   except	  
MtuDAH7PSWT	  (40	  nM)	  and	  MtuCM	  were	  allowed	  to	  incubate	  for	  10	  min	  prior	  to	  initiation	  with	  E4P.	  
The	  experimental	  procedure	  is	  detailed	  in	  Section	  9.9.3.	  
	  
There	  were	  marked	  changes	   in	  the	  regulatory	  profile	  of	  MtuDAH7PSWT	   in	  the	  presence	  of	  a	  ten-­‐fold	  
molar	  excess	  of	  MtuCM.	  Most	  notably	  the	  addition	  of	  Phe,	  Tyr	  or	  Trp	  activated	  MtuDAH7PS	  activity	  in	  
the	  presence	  of	  MtuCM	  (Figure	  4.14).	  Trp	  increased	  MtuDAH7PSWT	  activity	  to	  ~225	  %,	  relative	  to	  the	  
MtuDAH7PS	   activity	   in	   the	   presence	   of	   just	   MtuCM.	   MtuDAH7PSWT	   in	   the	   presence	   of	   MtuCM	  
displayed	   slightly	   better	   activity	   than	  MtuDAH7PSWT	   alone	   as	   supported	   by	   the	   kinetic	   parameters	  
determined	  in	  4.9.1.	  Thus	  Trp	  genuinely	  activated	  MtuDAH7PS	  activity	  in	  the	  presence	  of	  MtuCM.	  
	  
It	  seems	  contradictory	  that	  the	  presence	  of	  Phe	  or	  Tyr	  was	  able	  to	  activate	  MtuDAH7PS	  activity	  of	  a	  
mixture	   of	   MtuDAH7PSWT	   and	   MtuCM	   given	   the	   proposed	   mechanism	   of	   Phe	   binding	   to	  
MtuDAH7PSWT	   weakening	   the	   association	   between	   MtuDAH7PSWT	   and	   MtuCM.	   However,	   the	  
inhibition	  studies	  were	  conducted	  using	  a	  ten-­‐fold	  molar	  excess	  of	  MtuCM	  present	  in	  this	  experiment,	  
whereas	  AUC	   and	  native	   PAGE	  used	   to	   show	   the	   dissociation	   of	   the	   complex	  were	   conducted	   at	   a	  
four-­‐fold	  molar	  excess	  of	  MtuCM.	  Also	  Phe	  was	  shown	  to	  be	  the	  least	  activating	  of	  the	  three	  aromatic	  
amino	  acids,	  increasing	  activity	  to	  ~140	  %.	  




Figure	   4.14	   Remaining	  MtuDAH7PS	   activity	   for	  MtuDAH7PSWT	   (blue)	   and	  MtuDAH7PSWT	  with	   a	   ten-­‐fold	  molar	  
excess	   of	  MtuCM	   (blue	   hash)	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	   aromatic	  
amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  
letter	  also	   represents	  200	  µM	  of	   the	  corresponding	  aromatic	  amino	  acid.	  Assays	  conducted	   in	   the	  presence	  of	  
150	  µM	  E4P	  and	  PEP.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  
appendix	  V.	  
	  
The	  activation	  of	  MtuDAH7PS	  by	  Phe	  and	  Tyr	  indicates	  the	  dissociation	  of	  MtuCM	  from	  MtuDAH7PS	  is	  
not	  straightforward.	  In	  chapter	  2	  AUC	  showed	  MtuDAH7PS	  consists	  of	  a	  mixture	  of	  oligomeric	  states	  
in	  solution,	  but	   the	  addition	  of	  Trp	  and/or	  Phe	  stabilise	   the	  tetramer	  species	   (Section	  2.6.2).	  As	   the	  
MtuCM•MtuDAH7PS	  interface	  is	  located	  across	  the	  MtuDAH7PS	  tetramer	  interface	  it	  would	  be	  logical	  
to	  assume	  that	  the	  MtuDAH7PS	  tetramer	  would	  have	  a	  stronger	  interaction	  with	  MtuCM	  than	  a	  lower	  
oligomeric	   state.	   Thus	   the	  aromatic	  amino	  acids	  probably	  activate	  MtuDAH7PS	  activity	  primarily	  by	  
stabilising	  the	  MtuDAH7PS	  tetramer.	  The	  binding	  of	  Phe	  and	  Tyr	  to	  MtuDAH7PS	  may	  shift	  the	  position	  
of	   the	  MtuDAH7PS	   population	   ensemble	   toward	   a	   tetramer	   species	   that	   has	   a	   lower	   affinity	   for	  
MtuCM.	  When	  the	  complex	  does	  form	  between	  Phe-­‐bound	  MtuDAH7PS	  and	  MtuCM	  it	  is	  beneficial	  to	  
MtuDAH7PS	  activity.	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The	   activation	   of	  MtuDAH7PS	   (in	   the	   presence	   of	  MtuCM)	   activity	   by	   a	   single	   ligand	   is	   practically	  
eliminated	  in	  the	  presence	  of	  multiple	  aromatic	  amino	  acids.	  The	  addition	  of	  multiple	  aromatic	  amino	  
acids	   to	   the	   mixture	   of	   MtuDAH7PSWT	   and	   MtuCM	   resulted	   in	   similar	   inhibitory	   behaviour	   as	  
MtuDAH7PSWT	  alone	   (Figure	   4.14).	   This	   result	   shows	   that	   the	   association	  between	  MtuDAH7PS	   and	  
MtuCM	  does	  not	  adversely	  affect	  the	  synergistic	  regulatory	  network	  of	  MtuDAH7PS.	  	  
	  
In	  the	  absence	  of	  MtuCM	  a	  single	  ligand	  cannot	  activate	  MtuDAH7PS.	  AUC	  demonstrated	  that	  when	  
MtuCM	   or	   an	   aromatic	   amino	   acid	   binds	   to	  MtuDAH7PS	   the	   quaternary	   structure	   equilibrium	   of	  
MtuDAH7PS	   is	   shifted	   in	   favour	   of	   the	   tetramer	   (Section	   4.5).	   It	   is	   likely	   the	   tetramer	   is	   both	   the	  
regulated	  MtuDAH7PS	  species	  and	  the	  species	  that	  interacts	  with	  MtuCM.	  The	  single	  aromatic	  amino	  
acids	  appear	  to	  enhance	  MtuDAH7PS	  activity	   in	  the	  presence	  of	  MtuCM.	  MtuDAH7PS	  activity	   in	  the	  
presence	  of	  MtuCM	  remained	  subject	   to	   synergistic	   inhibition	  by	  binary	  or	   ternary	  combinations	  of	  
aromatic	  amino	  acids	  that	  included	  Trp	  were	  present.	  	  	  
	  
 Allosteric	  sites	  of	  MtuDAH7PS	  regulate	  MtuCM	  4.10.
activity	  	  
	  
To	   demonstrate	   that	   the	   binding	   sites	   of	  MtuDAH7PS	  were	   responsible	   for	   allosteric	   regulation	   of	  
MtuCM	  inhibition	  studies	  were	  conducted	  utilising	  the	  MtuDAH7PS	  variants	  described	   in	  Chapter	  3.	  
The	  two	  variants	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  were	  shown	  to	  have	  impaired	  binding	  at	  the	  
site	  of	  the	  substitution,	  site	  1	  and	  site	  2	  respectively.	  
 Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  4.10.1.
MtuDAH7PSR171A	  or	  MtuDAH7PSR256A	  
	  
The	   standard	   kinetic	   assays	   used	   to	   measure	  MtuCM	   activity	   in	   the	   presence	   of	   a	   ten-­‐fold	   molar	  
excess	  of	  MtuDAH7PSWT	  were	  also	  used	  to	  determine	  the	  kinetic	  parameters	  of	  MtuCM	  activity	  in	  the	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presence	   of	   a	   ten-­‐fold	   molar	   excess	   of	  MtuDAH7PSR171A	   or	  MtuDAH7PSR256A.	   The	   concentration	   of	  
MtuCM	  was	  held	  constant	  at	  30	  nM.	  The	  experimental	  methodology	  is	  detailed	  in	  Section	  9.9.1.	  	  
	  
The	  kinetic	  parameters	  for	  MtuCM	  activity	  derived	  from	  the	  Michaelis-­‐Menten	  kinetics	  for	  MtuCM	  in	  
the	   presence	   of	   either	  MtuDAH7PSR171A	   or	  MtuDAH7PSR256A	   were	   compared	   to	   those	   for	  MtuCM	  
activity	   in	   the	   presence	   of	  MtuDAH7PSWT	   (Table	   4.5).	  MtuDAH7PSWT	   and	   the	  MtuDAH7PS	   variants	  
were	  all	  able	   to	  activate	  MtuCM	  activity	  by	  ~120-­‐fold.	  Based	  on	  the	  determined	  kinetic	  parameters	  
the	  substitutions	  introduced	  to	  the	  allosteric	  biding	  sites	  of	  MtuDAH7PS	  did	  not	  adversely	  affect	  the	  
ability	  of	  the	  MtuDAH7PS	  variants	  to	  activate	  MtuCM	  activity.	  
	  
	  
Table	  4.5	  Kinetic	  parameters	  for	  MtuCM	  activity	  determined	  from	  a	  single	  set	  of	  Michaelis-­‐Menten	  kinetic	  data	  
of	  MtuCM	  with	  or	  without	  a	  ten-­‐fold	  excess	  of	  variant	  MtuDAH7PS.	  –	  indicates	  not	  applicable.	  *	  activation	  factor	  
determined	  as	   the	   ratio	  of	   the	  MtuCM•MtuDAH7PSvariant	   catalytic	  efficiency	   to	  MtuCM	  catalytic	  efficiency.	  The	  
Michaelis-­‐Menten	  plots	  are	   shown	   in	  Appendix	   I.	   Errors	   represent	   the	  error	  of	   fit	  of	   the	  data	   to	   the	  model	  as	  
determine	  by	  a	  least	  squares	  fit.	  




kcat/Km	  CA	   Activation	  
factor*	  
	   (µM)	   (s-­‐1)	   (mM-­‐1s-­‐1)	   	  
MtuCM	   500	  ±	  30	   0.42	  ±	  0.02	   0.84	  ±	  0.09	   –	  
MtuCM•MtuDAH7PSWT	   52	  ±	  4	   5.4	  ±	  0.1	   104	  ±	  9	   120	  ±	  20	  
MtuCM•MtuDAH7PSR171A	   64	  ±	  6	   6.5	  ±	  0.2	   100	  ±	  1	   120	  ±	  20	  
MtuCM•MtuDAH7PSR256A	   53	  ±	  4	   5.5	  ±	  0.1	   104	  ±	  9	   120	  ±	  20	  
	  
To	   gain	  more	   insight	   into	   the	   ability	   of	   the	  MtuDAH7PS	   variants	   to	   activate	  MtuCM	   the	   activity	   of	  
MtuCM	  was	   determined	   with	   three	   different	   ratios	   of	  MtuCM	   to	  MtuDAH7PS:	   1:1,	   1:10	   or	   1:200.	  
Assays	  were	   conducted	   using	   the	   standard	   assay	   conditions	   previously	   used	   for	  measuring	  MtuCM	  
activity	   in	   the	   presence	   of	  MtuDAH7PS	   and	   is	   detailed	   in	   Section	   9.9.1.	   Assays	  were	   initiated	  with	  
150	  µM	  chorismic	  acid.	  	  
	  
The	   activation	   profile	   of	  MtuCM	   activity	  with	   increasing	  MtuDAH7PSR171A	   concentration	  was	   nearly	  
identical	   to	   MtuDAH7PSWT	   (Figure	   4.15).	   Although	   this	   study	   found	   the	   activation	   profile	   with	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increasing	  MtuDAH7PSR256A	  concentration	  was	  similar	  to	  MtuDAH7PSWT,	  MtuDAH7PSR256A	  was	  able	  to	  
better	  enhance	  MtuCM	  activity	  when	  present	  at	  a	  200-­‐fold	  excess.	  Further	  investigation	  is	  required	  to	  
verify	  the	  result,	  but	   if	  confirmed	  it	  suggests	  the	  Arg256Ala	  substitution	  may	  have	  slightly	   improved	  
the	  interaction	  between	  the	  two	  proteins.	  
	  
Figure	   4.15	   Three	   point	   activation	   profile	   for	   the	   activation	   of	  MtuCM	   activity	   by	  MtuDAH7PSWT	   (blue	   hash)	  
MtuDAH7PSR171A	   (red	   hash)	   and	  MtuDAH7PSR256A	   (green	   hash).	   Error	   bars	   depict	   the	   standard	   deviation	   of	  
duplicate	  measurements.	  	  
	  
 Regulation	  of	  MtuCM	  activity	  by	  4.10.2.
MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  
	  
MtuDAH7PSR171A	  or	  MtuDAH7PSR256A	  were	  added	   to	   the	  assay	  conditions	   in	  a	   ten-­‐fold	  excess	  of	   the	  
molar	   concentration	   of	  MtuCM	   (60	   nM).	   Assays	   for	  MtuCM	   activity	  were	   conducted	   as	   previously	  
stated	  for	  MtuCM	  and	  MtuDAH7PSWT	  and	  detailed	  in	  Section	  9.9.3.	  Assays	  were	  initiated	  with	  25	  µm	  
chorismic	  acid	  to	  observe	  the	  maximum	  inhibition	  possible.	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  The	  MtuCM	  activity	  of	  a	  mixture	  of	  MtuDAH7PSR171A	  and	  MtuCM	  was	   insensitive	  to	  the	  addition	  of	  
any	   single	   or	   multiple	   combinations	   of	   aromatic	   amino	   acids	   (Figure	   4.16).	   The	   substitution	   of	  
MtuDAH7PSR171A	  was	  introduced	  to	  disrupt	  binding	  at	  site	  1,	  the	  Phe-­‐selective	  binding	  site	  (Section	  3).	  
The	   inability	  of	  MtuDAH7PSR171A	   to	  regulate	  MtuCM	  activity	  suggests	  site	  1	  plays	  a	  vital	   role	   in	  both	  
the	  Phe	  and	  Tyr	  regulation	  of	  MtuCM	  activity.	  	  
	  
Figure	   4.16	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  for	  MtuCM	  with	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  	  (blue	  hash)	  MtuDAH7PSR171A	  (red	  hash)	  
or	  MtuDAH7PSR256A	  	   (green	  hash).	   The	  aromatic	   amino	  acids	  are	   represented	  by	   their	  one	   letter	   code;	  Trp,	  W;	  
Phe,	   F	   and	   Tyr,	   Y.	   Each	   letter	   also	   represents	   200	   µM	   of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	  
conducted	  with	  25	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	   the	   standard	  deviation	  of	   at	   least	  
duplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	   activity	   of	  MtuCM	  with	   a	   ten-­‐fold	  molar	   excess	   of	  MtuDAH7PSR256A	   was	   insensitive	   to	   Tyr	   but	  
retained	  sensitivity	  to	  Phe.	  MtuCM	  activity	  was	  also	  insensitive	  to	  the	  combination	  of	  Trp	  and	  Phe	  in	  
the	  presence	  of	  MtuDAH7PSR256A.	  Remember,	   the	  Arg256Ala	   substitution	  was	   introduced	   to	  disrupt	  
binding	  at	  site	  2,	  the	  Tyr-­‐selective	  binding	  site.	  Hence,	  Phe	  only	  needs	  to	  bind	  to	  site	  1	  of	  MtuDAH7PS	  
to	  inhibit	  MtuCM	  activity.	  On	  the	  other	  hand	  Tyr	  must	  bind	  to	  both	  site	  1	  and	  site	  2	  of	  MtuDAH7PS	  to	  
inhibit	   MtuCM	   activity.	   Like	   MtuDAH7PSWT,	   MtuDAH7PSR256A	   was	   able	   to	   synergistically	   regulate	  
MtuCM	  activity	  in	  the	  presence	  of	  Trp	  and	  Phe	  or	  Trp,	  Phe	  and	  Tyr.	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Native	  PAGE	  analysis	  was	  also	  conducted	  on	  both	  MtuDAH7PS	  variants	  under	  the	  same	  conditions	  as	  
MtuDAH7PSWT	  (as	  outlined	  in	  Section	  9.7.3)	  in	  order	  to	  observe	  formation	  of	  the	  MtuCM•MtuDAH7PS	  
variant	   complexes.	   Samples	   were	   prepared	   with	   ~6-­‐10	   µM	  MtuDAH7PS	   and	   In	   the	   presence	   of	   a	  
four-­‐fold	  molar	  excess	  of	  MtuCM.	  Samples	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	  ran	  on	  the	  gel	  as	  
a	  single	  band	  of	  ~240	  kDa	  as	  seen	  previously	  for	  the	  wild	  type	  enzyme	  (Figure	  4.17).	  Both	  MtuDAH7PS	  
variants	  formed	  two	  bands	  in	  the	  presence	  of	  MtuCM,	  the	  first	  at	  ~240	  kDa	  and	  the	  second	  at	  higher	  
molecular	  mass	   of	   ~300	   kDa.	   This	   indicated	   both	  MtuDAH7PS	   variants	   are	   able	   to	   form	   a	   complex	  
with	  MtuCM.	  	  
	  
Figure	  4.17	  Native	  PAGE	  of	  MtuDAH7PSR171A	  alone	  (Lane	  1),	  with	  four-­‐fold	  molar	  excess	  of	  MtuCM	  (Lane	  2)	  and	  
with	  four-­‐fold	  molar	  excess	  of	  MtuCM	  and	  1	  mM	  Phe	  (Lane	  3)	  and	  MtuDAH7PSR256A	  alone	  (Lane	  4),	  with	  four-­‐fold	  
molar	   excess	   of	  MtuCM	   (Lane	  5)	   and	  with	   four-­‐fold	  molar	   excess	   of	  MtuCM	  and	  1	  mM	  Phe	   (Lane	  6).	   Lane	  M	  
native	  molecular	  mass	  marker.	  
	  
The	  addition	  of	  1	  mM	  Phe	  to	  a	  mixture	  of	  MtuDAH7PSR256A	  and	  MtuCM	  diminish	  the	  intensity	  of	  the	  
higher	  molecular	  mass	  band	  as	  seen	  previously	   for	  MtuDAH7PSWT.	  The	   loss	  of	   the	  higher	  molecular	  
mass	   band	   suggests	   the	  MtuCM•MtuDAH7PSR256A	   complex	   is	   able	   to	   dissociate	   in	   the	   presence	   of	  
Phe.	   This	   finding	   is	   consistent	   with	   the	   previous	   inhibition	   studies	   that	   showed	  
MtuCM•MtuDAH7PSR256A	  was	  sensitive	  to	  Phe	  (Section	  4.10.2).	  Of	  greater	  interest,	  was	  the	  failure	  of	  
1	   mM	   Phe	   to	   diminish	   the	   second	   higher	   molecular	   mass	   band	   in	   the	   presence	   of	   a	   mixture	  
MtuDAH7PSR171A	   and	  MtuCM.	   This	   observation	   is	   also	   consistent	  with	   the	   inhibition	   studies,	   as	   the	  
addition	   of	   Phe	   to	  MtuCM•MtuDAH7PSR171A	   does	   not	   appear	   to	   affect	   the	  MtuCM	   activity	   of	   the	  
complex.	   Overall,	   these	   results	   reveal	   the	   addition	   of	   Phe	   changes	   the	   nature	   of	   the	   interaction	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between	  MtuDAH7PS	  and	  MtuCM,	  causing	  dissociation	  under	  the	  right	  conditions.	  This	  change	  may	  
be	  a	  very	  important	  part	  of	  the	  regulatory	  mechanism.	  
	  
Both	   the	   inhibition	   studies	   and	   native	   PAGE	   conducted	  with	  MtuDAH7PSR171A	   and	  MtuDAH7PSR256A	  
indisputably	   showed	   the	   allosteric	   binding	   sites	   of	   MtuDAH7PS	   were	   responsible	   for	   observed	  
regulation	  of	  MtuCM	  activity	  of	  the	  MtuCM•MtuDAH7PS	  complex.	  Site	  1	  of	  MtuDAH7PS	  was	  found	  to	  
be	  primarily	  responsible	  for	  the	  regulatory	  sensitivity	  of	  MtuCM	  activity	  to	  Phe.	  For	  MtuCM	  to	  show	  
significant	  sensitivity	  to	  Tyr	  both	  sites	  1	  and	  2	  of	  MtuDAH7PS	  had	  to	  be	  available	  for	  ligand	  binding.	  
 Effect	   of	   MtuCM	   on	   MtuDAH7PSR171A	   and	  4.10.3.
MtuDAH7PSR256A	  kinetic	  parameters	  
	  
The	  activities	  of	  MtuDAH7PSR171A	  and	  MtuDAH7PSR256A	   in	  the	  presence	  of	  a	  ten-­‐fold	  molar	  excess	  of	  
MtuCM	   was	   measured	   using	   the	   steady-­‐state	   kinetic	   assays	   developed	   for	  MtuDAH7PSWT	   and	   are	  
detailed	  in	  Section	  9.9.1.	  The	  concentration	  of	  MtuDAH7PS	  was	  held	  constant	  at	  60	  nM.	  The	  data	  was	  
fitted	  to	  the	  Michaelis-­‐Menten	  equation	  to	  derive	  the	  kinetic	  parameters.	  
	  
The	  kinetic	  parameters	  determined	  for	  MtuDAH7PSR256A	  in	  the	  presence	  of	  MtuCM	  were	  compared	  to	  
MtuDAH7PSWT	   in	   the	   presence	   of	   MtuCM	   (Table	   4.6).	   MtuCM	   activated	   both	   MtuDA7PSWT	   and	  
MtuDAH7PSR256A	   by	   approximately	   two-­‐fold,	   suggesting	   the	   Arg256Ala	   substitution	   has	   had	   no	  
adverse	  affect	  on	  the	  activation	  of	  MtuDAH7PS	  by	  MtuCM.	  
	  
There	  was	  some	  variation	   in	  the	  kinetic	  parameters	  of	  MtuDAH7PSR171A	  compared	  to	  MtuDAH7PSWT	  
when	  determined	  in	  the	  presence	  of	  MtuCM	  (Table	  4.6).	  The	  catalytic	  efficiency	  with	  respect	  to	  PEP	  
of	  MtuDAH7PSR171A	   is	   higher.	   Thus	   the	   introduction	   of	   the	   Arg171Ala	   substitution	   into	   site	   1	   of	  
MtuDAH7PS	  has	  perturbed	  the	  interaction	  between	  MtuCM	  and	  MtuDAH7PSR171A,	  but	  not	  necessarily	  
to	  the	  disadvantage	  of	  either	  enzyme.	  Whether	  a	  change	  has	  occurred	  at	  the	  interface	  of	  MtuCM	  and	  
MtuDAH7PSR171A	  or	  along	  a	  signal	  transmission	  pathway	  is	  unclear.	  These	  findings	  do	  however	  suggest	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site	   1	   is	   able	   to	   interact	  with	  both	  MtuCM	  MtuDAH7PS	   interface	   and	   the	   active	   site,	   in	   agreement	  
with	  the	  inhibition	  studies.	  
	  
Table	  4.6	  Kinetic	  parameters	  determined	  from	  a	  single	  set	  of	  Michaelis-­‐Menten	  kinetics	  for	  MtuDAH7PS	  activity	  
of	  variant	  MtuDAH7PSs	  with	  and	  without	  the	  presence	  of	  a	  ten-­‐fold	  excess	  of	  MtuCM.	  –	  Indicates	  not	  applicable.	  
The	  Michaelis-­‐Menten	  plots	  are	  shown	  in	  Appendix	  I.	  Error	  represents	  the	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  
least	  squares	  fit.	  








Catalytic	  efficiency	   Activation	  factors	  
kcat/Km	  
E4P	   kcat	  /Km	  
PEP	   E4P	   PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	   	  
MtuDAH7PSWT	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	   –	   –	  
MtuCM•	  MtuDAH7PSWT	   20	  ±	  2	   27	  ±	  2	   7.1	  ±	  0.1	   360	  ±	  40	   260	  ±	  20	   2.1	  ±	  0.5	   2.1	  ±	  0.5	  
MtuDAH7PSR171A	   35	  ±	  3	   60	  ±	  6	   7.0	  ±	  0.3	   200	  ±	  30	   120	  ±	  20	   –	   –	  
MtuCM•	  MtuDAH7PSR171A	   48	  ±	  4	   15	  ±	  1	   10.1	  ±	  0.2	   210	  ±	  20	   670	  ±	  60	   1.1	  ±	  0.2	   5	  ±	  1	  
MtuDAH7PSR256A	   33	  ±	  1	   16	  ±	  2	   5.5	  ±	  0.1	   170	  ±	  10	   340	  ±	  50	   –	   –	  
MtuCM•	  MtuDAH7PSR256A	   23	  ±	  1	   10	  ±	  1	   6.4	  ±	  0.1	   280	  ±	  20	   640	  ±	  70	   1.7	  ±	  0.2	   1.9	  ±	  0.5	  
	  
 Effect	   of	   the	   MtuDAH7PS	   polyhistidine	   tag	   on	   the	  4.11.
interaction	  of	  MtuDAH7PS	  and	  MtuCM	  
	  
All	  MtuDAH7PS	  variants	  characterised	  in	  this	  thesis	  have	  had	  their	  polyhistidine	  tag	  removed,	  unless	  
expressly	   stated	   otherwise.	   This	   was	   necessary	   to	   increase	  MtuDAH7PS	   stability	   and	   purification	  
yields.	   Previously	   published	   work	   appears	   to	   have	   been	   conducted	   using	   polyhistidine	   tagged	  
MtuDAH7PS	   for	   all	   kinetic	   analysis.85	   No	   studies	   were	   conducted	   to	   show	   if	   the	   polyhistidine	   tag	  
affected	  the	  characterisation	  of	  the	  MtuCM•MtuDAH7PS	  complex.	  This	  section	  of	  work	  investigated	  if	  
the	   retention	   of	   the	   MtuDAH7PS	   polyhistidine	   tag	   (MtuDAH7PSH6)	   affects	   the	   regulation	   of	  
MtuDAH7PS	  directly	  or	  the	  activation	  and	  regulation	  of	  MtuCM	  activity.	  
 Feedback	  regulation	  of	  MtuDAH7PSH6	  4.11.1.
To	  understand	  the	  impact	  retention	  of	  the	  polyhistine	  tag	  on	  MtuDAH7PSH6	  has	  on	  the	  activation	  and	  
regulation	  of	  MtuCM	  activity	  the	  effect	  on	  the	  feedback	  regulation	  of	  MtuDAH7PS	  itself	  needs	  to	  be	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established.	   Kinetic	   assays	  were	   conducted	   under	   the	   standard	   inhibition	   assay	   conditions	   used	   to	  
study	  the	  wild	  type	  enzyme	  detailed	  in	  Section	  9.9.3.	  
	  
The	  regulation	  of	  MtuDAH7PSH6	  was	  less	  sensitive	  to	  the	  presence	  of	  multiple	  aromatic	  amino	  acids.	  
The	  addition	  of	   Trp	   and	  Phe	   resulted	   in	   ~15	  %	  more	  activity	   than	  MtuDAH7PSWT	   (Figure	  4.18).	   The	  
addition	  of	  Trp	  and	  Tyr	  was	  even	  less	  effective,	  with	  a	  total	  reduction	  of	  MtuDAH7PS	  activity	  of	  ~35	  %,	  
much	  less	  than	  the	  ~75	  %	  achieved	  by	  MtuDAH7PSWT.	  Similarly,	  the	  ternary	  combination	  of	  aromatic	  
amino	   acids	  was	   less	   effective,	   reducing	  MtuDAH7PS	   activity	   to	   ~7	  %.	   The	   regulatory	   behaviour	   of	  
MtuDAH7PS	   is	   adversely	   affected	   by	   the	   retention	   of	   the	   polyhistidine	   tag	   used	   for	   affinity	  
purification.	  
	  
Figure	   4.18	  Remaining	  activity	  of	  MtuDAH7PSWT	   (blue),	  MtuDAH7PSH6	   (cyan)	   in	   the	  presence	  of	   various	   single,	  
binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  
letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  amino	  
acid.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
Residues	   Trp3	   and	   Asp6,	   located	   on	   the	   N-­‐terminal	   tail	   of	   MtuDAH7PS,	   were	   shown	  
crystallographically	   to	   contribute	   to	   the	   formation	   of	   site	   1,	   and	   move	   on	   Phe	   or	   Tyr	   binding.48,69	  
Therefore	  the	  addition	  of	  the	  polyhistidine	  tag	  at	  the	  N-­‐terminal	  end	  of	  MtuDAH7PS	  may	  disrupt	  the	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interactions	  these	  residues	  are	  responsible	  for	  at	  site	  1.	  Furthermore	  the	  added	  bulk	  at	  the	  end	  of	  the	  
N-­‐terminal	   extension	   by	   the	   polyhistidine	   tag	   may	   alter	   the	   flexibility	   of	   the	   N-­‐terminal	   residues,	  
limiting	  the	  movement	  of	  the	  residues	  involved	  in	  signalling	  ligand	  binding	  at	  site	  1	  to	  other	  allosteric	  
binding	  sites.	  Alternatively	  the	  steric	  bulk	  created	  by	  the	  additional	  residues	  of	  the	  polyhistidine	  tag	  
may	  physically	  block	  either	  or	  both	  site	  1	  or	  site	  2,	  preventing	  ligand	  access.	  
	  
 Activation	  of	  MtuCM	  by	  MtuDAH7PSH6	  4.11.2.
A	   three	   point	   activation	   profile	   to	   quickly	   determine	   how	  well	  MtuDAH7PSH6	   can	   activate	  MtuCM	  
activity	   in	   comparison	   to	  MtuDAH7PSWT	   was	   carried	   out	   as	   detailed	   in	   Section	   9.9.1.	   The	  MtuCM	  
activity	  was	  determined	   for	  1:1,	  1:10	  and	  1:200	   (MtuCM:MtuDAH7PS)	  mixtures	  of	   the	   two	  proteins	  
and	   initiated	  with	   150	  µM	   chorismic	   acid.	  MtuDAH7PSH6	  was	   found	   to	   activate	  MtuCM	   slightly	   less	  
effectively	   than	   the	  wild	   type	  enzyme	  when	  MtuDAH7PS	  was	  present	   in	  a	   ten-­‐fold	  molar	  excess	  or	  
more	  (Figure	  4.19).	  	  
	  
	  	  
Figure	   4.19	  The	  activation	  of	  MtuCM	  activity	   in	   the	  presence	  of	  with	  either	  an	  equimolar,	   ten-­‐fold	  or	  200-­‐fold	  
excess	   of	  MtuDAH7PSWT	   (blue	   hash)	   or	  MtuDAH7PSH6	   (cyan	   hash).	   The	   burgundy	   line	   indicates	   the	   activity	   of	  
MtuCM	  alone.	  Assays	  conducted	  with	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  for	  reactions	  requiring	  a	  
200-­‐fold	   excess	   of	  MtuDAH7PS	  where	   10	   nM	   of	  MtuCM	   and	  MtuCM	   alone	  where	   90	   nM	  were	   used	   and	   the	  
results	  normalised.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements	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 Feedback	  regulation	  of	  the	  MtuCM	  activity	  	  4.11.3.
	  
Inhibition	   studies	  were	   conducted	   to	   determine	   the	   regulatory	   sensitivity	   of	  MtuCM	  activity	   in	   the	  
presence	  of	  ten-­‐fold	  excess	  of	  MtuDAH7PSH6.	  Assays	  were	  conducted	  as	  detailed	  in	  Section	  9.9.3.	  
	  
MtuCM	  activity	   retained	   similar	   sensitivity	   to	  Phe	  or	  Tyr	   in	   the	  presence	  of	  either	  MtuDAH7PSWT	  or	  
MtuDAH7PSH6.	   Nevertheless,	   there	   were	   striking	   differences	   in	   the	   feedback	   inhibition	   of	  MtuCM	  
activity	  in	  the	  presence	  of	  excess	  MtuDAH7PSWT	  compared	  to	  MtuDAH7PSH6.	  The	  MtuCM	  activity	  of	  a	  
mixture	  of	  MtuCM	  and	  MtuDAH7PSH6	  was	  sensitive	  to	  the	  addition	  of	  Trp,	  reducing	  activity	  to	  ~50	  %	  
(Figure	   4.20).	   Intriguingly,	   despite	   the	   increased	   sensitivity	   to	   Trp,	   the	   addition	   of	   Trp	   and	   Phe	  
resulted	  in	  less	  effective	  inhibition	  of	  MtuCM	  activity	  in	  the	  presence	  of	  MtuDAH7PSH6.	  The	  acquired	  
sensitivity	  of	  MtuCM	  activity	  to	  Trp	  was	  unexpected	  and	  had	  not	  previously	  been	  reported85.	  MtuCM	  
activity	   to	   combinations	   of	   Trp	   and	   Tyr	   or	   Trp,	   Phe	   and	   Tyr,	   were	   slightly	   more	   sensitive	   in	   the	  
presence	   of	  MtuDAH7PSH6.	   This	   work	   demonstrated	   the	   polyhistidine	   tag	   of	   the	  MtuDAH7PS	   does	  








Figure	   4.20	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	   amino	   acids	   for	  MtuCM	  with	   a	   ten-­‐fold	   excess	   of	  MtuDAH7PSWT	  (blue	   hash)	   or	  MtuDAH7PSH6	   (cyan	  
hash).	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  
also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  amino	  acids.	  Assays	  conducted	  in	  the	  presence	  of	  150	  µM	  
chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  at	  least	  duplicate	  measurements.	  
P-­‐values	  provided	  in	  appendix	  V.	  
	  
Prior	   work	   has	   shown	   the	   Trp	   and	   Phe	   site	   are	   intimately	   connected	   through	   subtle	   changes	   in	  
molecular	  dynamics.71,115	  Movement	  of	  the	  N-­‐terminal	  residues	  (Trp	  3	  through	  to	  Asp	  6)	  are	  the	  only	  
crystallographically	   detectable	   changes	   that	   occur	   upon	   ligand	   binding	   to	   site	   1.48,69	   The	   inhibition	  
studies	  of	  MtuDAH7PSH6	  hinted	  the	  polyhistidine	  tail	  had	  affected	  the	  ability	  of	  site	  1	  to	  bind	  or	  signal	  
binding	  to	  other	  allosteric	  binding	  sites	  and	  the	  active	  site.	  It	  has	  also	  been	  shown	  Phe	  must	  bind	  to	  
site	   1	   of	  MtuDAH7PS	   in	   order	   to	   elicit	   a	   regulatory	   response	   from	   both	  MtuDAH7PS	   activity	   (in	  
combination	   with	   Trp)	   and	  MtuCM	   activity.	   As	   the	   regulation	   of	  MtuCM	   activity	   for	   Phe	   alone	   is	  
unaffected	  by	  the	  polyhistidine	  tag	  of	  MtuDAH7PSH6,	  site	  1	  cannot	  be	  physically	  blocked	  by	  the	  tag.	  
Instead	  it	  suggests	  that	  the	  polyhistidine	  tag	  of	  MtuDAH7PSH6	  disrupts	  the	  binding	  contacts	  and	  or	  the	  
changes	   in	   flexibility	   that	   signal	   to	   the	   Trp	   site	   ligand	   binding	   has	   occurred	   at	   site	   1.	   The	   acquired	  
sensitivity	  of	  MtuCM	  activity	  to	  Trp	  binding	  and	  decreased	  sensitivity	  to	  the	  combination	  of	  Trp	  and	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Phe	   also	   support	   disruption	   of	   the	   communication	   network	   between	   the	   Trp	   site	   and	   site	   1	   of	  
MtuDAH7PS.	  	  
 Chapter	  summary	  4.12.
	  
The	   expression	   and	   purification	   protocol	   developed	  was	   successful,	   yielding	  MtuCM	   of	   the	   correct	  
molecular	  mass	  and	  with	   comparable	  kinetic	  properties	   to	  previous	   studies85,86.	  MtuCM	  showed	  no	  
regulatory	  sensitivity	  to	  any	  combination	  of	  aromatic	  amino	  acids,	  but	  DSF	  studies	  showed	  the	  amino	  
acids	  affected	  the	  thermal	  stability	  of	  MtuCM.	  
	  
The	   formation	   of	   the	   MtuCM•MtuDAH7PS	   complex	   in	   solution	   was	   identified	   by	   AUC.	   The	  
sedimentation	   coefficient	   of	  MtuDAH7PS	   increased	   in	   the	   presence	   of	   a	   four-­‐fold	  molar	   excess	   of	  
MtuCM	  to	  ~9.4	  S	  and	  corresponded	  to	  a	  molecular	  mass	  ~	  220	  kDa,	  in	  the	  close	  agreement	  with	  the	  
expected	   244	   kDa	  molecular	  mass	   of	   the	   heterooctameric	  MtuCM•MtuDAH7PS	   complex.	   AUC	   also	  
showed	  the	  amount	  of	  the	  MtuCM•MtuDAH7PS	  complex	  formed	  in	  solution	  was	  proportional	  to	  the	  
ratio	   of	   the	   two	   components.	   For	   a	   fixed	   concentrations	   of	  MtuDAH7PS,	   as	   the	   molar	   excess	   of	  
MtuCM	  was	  increased	  so	  too	  did	  the	  amount	  of	  MtuCM•MtuDAH7PS	  complex	  formed.	  	  
	  
MtuDAH7PS	   was	   modestly	   activated	   (two-­‐fold	   activation)	   by	   the	   presence	   of	   a	   ten-­‐fold	   excess	   of	  
MtuCM.	  As	  previously	  reported	  MtuDAH7PS	  greatly	  enhances	  MtuCM	  activity;	  this	  study	  found	  a	  ten-­‐
fold	  molar	  excess	  enhanced	  catalytic	  efficiency	  by	  ~120-­‐fold.85	  MtuCM	  catalytic	  efficiency	  showed	  a	  
hyperbolic	  response	  to	  increasing	  MtuDAH7PSWT	  concentration,	  plateauing	  when	  the	  molar	  excess	  of	  
MtuDAH7PSWT	   exceeded	   200-­‐fold.	   The	   increase	   in	  MtuCM	   catalytic	   efficiency	   in	   the	   presence	   of	  
MtuDAH7PSWT	  was	  attributed	   to	  a	  huge	  decrease	   in	   the	  Michaelis	   constant	  of	   chorismic	  acid	  and	  a	  
large	  increase	  in	  the	  turnover	  number.	  Comparison	  of	  crystal	  coordinates	  of	  MtuCM	  with	  and	  without	  
MtuDAH7PS	   bound	   revealed	   significant	   rearrangement	   of	   the	   H1-­‐H2	   loop	   and	   C-­‐terminal	   tail	   of	  
MtuCM.85	  These	  changes	  were	  accompanied	  by	  significant	  rearrangement	  of	  the	  MtuCM	  active	  site,	  
arguably	   better	   positioning	   the	   residues	   for	   interaction	   with	   the	   substrate.	   These	   conformational	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adjustments	  may	   account	   for	   the	   improved	   kinetic	   parameters	  when	  MtuCM	   is	   in	   the	   presence	   of	  
MtuDAH7PSWT.	  
	  
Most	  surprisingly	  the	  presence	  of	  any	  single	  aromatic	  amino	  acids	  was	  found	  to	  activate	  MtuDAH7PS	  
activity	   in	   the	   presence	   of	   a	   ten-­‐fold	  molar	   excess	   of	  MtuCM.	   However,	   combinations	   of	   aromatic	  
amino	   acids	   including	   Trp	   were	   found	   to	   synergistically	   regulate	  MtuDAH7PS	   activity,	   as	   seen	   for	  
MtuDAH7PS	  alone.	  In	  E.	  coli	  cells	  the	  concentration	  of	  Trp,	  Phe	  and	  Tyr	  have	  been	  reported	  to	  be	  12,	  
18	   and	   29	   µM	   respectively.116	   Intriguingly,	   these	   relative	   cellular	   concentrations	   of	   the	   aromatic	  
amino	  acids	  correlate	  with	  their	  ability	  to	  activate	  the	  MtuDAH7PS	  activity	  in	  the	  presence	  of	  MtuCM.	  	  
	  
At	   the	   end	   of	   the	   shikimate	   pathway	   chorismate	   is	   either	   directed	   toward	   the	   synthesis	   of	   Trp	   by	  
anthranilate	   synthase	   or	   toward	   the	   synthesis	   of	   Phe	   and	   Tyr	   via	   chorismate	   mutase.	   When	  
MtuDAH7PS	  was	  in	  the	  presence	  of	  two	  aromatic	  amino	  acids	  (the	  end	  products	  of	  the	  pathway),	  one	  
from	   each	   branch	   of	   the	   aromatic	   amino	   acid	   biosynthetic	   pathway	   (i.e.	   Trp	   in	   combination	   with	  
either	   Phe	   or	   Tyr),	   MtuDAH7PS	   activity	   was	   inhibited	   whether	   or	   not	  MtuCM	   was	   present.	   Thus	  
excess	  product	  from	  a	  single	  branch	  of	  the	  aromatic	  amino	  acid	  biosynthetic	  pathway	  will	  not	  prevent	  
synthesis	  of	  the	  end	  products	  of	  another	  branch,	  until	  the	  cellular	  requirements	  of	  both	  branches	  are	  
met.	   Thus	   the	   regulation	   of	  MtuDAH7PS	   is	   incredibly	   sophisticated	   and	   highly	   efficient	   allowing	  
aromatic	  amino	  acid	  biosynthesis	  to	  be	  finely	  tuned	  to	  meet	  cellular	  demands.	  
	  
Furthermore	  the	  addition	  of	  MtuDAH7PSWT	  endows	  MtuCM	  not	  only	  with	  sensitivity	  to	  Phe	  and	  Tyr	  as	  
first	  reported	  by	  Sasso	  et	  al.	  but	  also	  showed	  for	  the	  first	  time	  MtuCM	  activity	  became	  synergistically	  
regulated	   by	   the	   binary	   and	   ternary	   combinations	   including	   Trp.85	   Examination	   of	   the	   MtuCM	  
Michaelis-­‐Menten	  kinetics	  of	  a	  mixture	  of	  MtuCM	  and	  MtuDAH7PSWT	  with	  the	  addition	  of	  Phe	  and	  or	  
Tyr	  revealed	  the	  ligands	  act	  primarily	  as	  K-­‐type	  inhibitors,	  radically	  increasing	  the	  Km	  of	  chorismic	  acid.	  
The	   complex	   synergistic	   regulation	   of	   MtuCM	   activity	   was	   reminiscent	   of	   the	   regulation	   of	  
MtuDAH7PSWT	   itself.	   Thus	   it	   seems	   logical	   the	   allosteric	   binding	   sites	   of	   MtuDAH7PS	   may	   be	  
responsible	  for	  conveying	  regulation	  to	  MtuCM.	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To	   establish	   if	   the	   allosteric	   binding	   sites	  were	   responsible	   for	   regulating	  MtuCM	   activity,	   the	   two	  
allosteric	   binding	   site	  MtuDAH7PS	   variants	   described	   in	   chapter	   3	  were	  used.	  MtuDAH7PSR171A	  was	  
designed	   to	   eliminate	   ligand	   binding	   at	   site	   1,	   leaving	   site	   2	   available	   for	   Phe	   and	   Tyr	   binding.	  
MtuDAH7PSR256A	  was	  designed	  to	  eliminate	  binding	  at	  site	  2,	   leaving	  site	  1	  available	  for	  Phe	  and	  Tyr	  
binding.	  Inhibition	  studies	  showed	  MtuCM	  activity	  in	  the	  presence	  of	  excess	  of	  MtuDAH7PSR171A	  was	  
insensitive	  to	  Phe	  and	  Tyr,	  whereas	  inhibition	  studies	  conducted	  with	  excess	  MtuDAH7PSR256A	  showed	  
MtuCM	  activity	  was	  insensitive	  to	  Tyr	  but	  had	  retained	  sensitivity	  to	  Phe.	  Phe	  must	  bind	  to	  site	  1	  of	  
MtuDAH7PS	   to	   inhibit	  MtuCM	   activity.	   Tyr	  must	   bind	   to	   both	   site	   1	   and	   site	   2.	   Thus	   the	   allosteric	  
binding	  sites	  of	  MtuDAH7PS	  are	  essential	  to	  the	  allosteric	  regulation	  of	  MtuCM	  activity.	  	  
	  
In	  an	  effort	  to	  understand	  the	  mechanism	  by	  which	  the	  MtuCM	  activity	  of	  the	  MtuCM•MtuDAH7PS	  
complex	  was	   regulated	   the	   apparent	   dissociation	   constant	   between	  MtuCM	  and	  MtuDAH7PS	  were	  
kinetically	   determined	   in	   the	   presence	   and	   absence	   of	   Phe.	   	   The	   Kd,app	   between	   MtuCM	   and	  
MtuDAH7PS	  was	  ~720	  nM,	  but	  in	  the	  presence	  of	  200	  µM	  Phe	  this	  increased	  by	  approximately	  four-­‐
fold	   to	   3	   µM.	   Therefore	   the	   binding	   of	   Phe	   to	   the	   MtuCM•MtuDAH7PS	   complex	   weakens	   the	  
interaction	  between	  the	  two	  proteins.	  AUC	  supplemented	  with	  additional	  evidence	  from	  native	  PAGE	  
and	  a	  pull	  down	  assay	  provided	  additional	  proof	  Phe	  sufficiently	  weakened	  the	  interaction	  between	  
the	  two	  proteins	   to	  cause	  dissociation	  of	   the	  MtuCM•MtuDAH7PS	  complex	  under	   these	  conditions.	  
Molecular	  dynamic	  studies	  show	  the	  β7-­‐α7	  and	  β8-­‐α8	  loops	  near	  the	  MtuCM•MtuDAH7PS	  interface	  
are	   expected	   to	   become	  more	   flexible	   on	   Phe	   binding.71	   The	   change	   in	   the	  molecular	   dynamics	   of	  
MtuDAH7PS	   due	   to	   ligand	   binding	   implies	   ligand	   binding	   changes	   the	   average	   amplitude	   of	   the	  
molecular	  dynamic	  fluctuations	  about	  a	  mean	  conformation	  of	  the	  MtuDAH7PS	  population	  ensemble.	  
If	   the	  MtuCM•MtuDAH7PS	   interface	  were	   to	   become	  more	   flexible	   on	   Phe	  binding	   the	   association	  
between	   the	   two	   proteins	   may	   become	   entropically	   unfavourable	   and	   encourage	   dissociation.	  
Unfortunately	   molecular	   modelling	   does	   not	   predict	   the	   same	   change	   in	   flexibility	   of	   the	  
MtuCM•MtuDAH7PS	   interface	  region	  when	  Trp	  and	  Phe	  are	  bound	  which	  does	  cast	  some	  doubt	  on	  
this	  mechanism	  of	  action.	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An	  alternative	  theory	  for	  the	  dissociation	  which	  is	  far	  more	  difficult	  to	  prove,	  is	  the	  possibility	  that	  on	  
binding	  an	  aromatic	  amino	  acid	  at	  any	  of	  the	  allosteric	  binding	  sites	  MtuDAH7PS	  undergoes	  a	  subtle	  
twist	   across	   the	   weak	   dimer	   interface	   effectively	   changing	   the	   average	   conformation	   of	   the	  
MtuDAH7PS	   population	   ensemble.	   At	   the	   dimer	   interface	   the	   β0-­‐strand	   of	   one	   subunit	   forms	  
antiparallel	  β-­‐sheet	  with	   the	  β0-­‐strand	  of	  adjacent	   subunit	   (Figure	  4.21A).	   In	   the	  absence	  of	   ligand,	  
Trp3	  is	  located	  on	  the	  N-­‐terminal	  tail	  just	  prior	  to	  the	  start	  of	  the	  β0-­‐strand	  in	  both	  subunits	  (Figure	  
4.21B-­‐C).	  When	  Phe	  binds,	  Trp3	  of	  one	  subunit	  moves	  to	  towards	  the	  Phe	  binding	  site	  and	  is	  located	  
in	  the	  middle	  of	  the	  β0-­‐strand.	  The	  Trp3	  located	  on	  the	  adjacent	  subunit	  has	  not	  moved	  and	  is	  located	  
on	  the	  N-­‐terminal	  tail	  just	  prior	  to	  the	  β0-­‐strand.	  This	  movement	  of	  the	  residues	  belonging	  to	  one	  β0-­‐
strand	   relative	   to	   the	  other	  may	   cause	   a	   slight	   twist	   in	   the	  plane	  of	   the	   tetramer.	   This	   twist	   is	   not	  
enough	   to	   cause	   an	   obvious	   change	   in	   the	   shape	   of	   the	   protein,	   and	   could	   be	   masked	   by	   crystal	  
packing,	  but	  it	  may	  be	  enough	  to	  alter	  the	  interactions	  between	  MtuCM	  and	  MtuDAH7PS.	  This	  change	  
to	  the	  interactions	  may	  result	   in	  an	  MtuDAH7PS	  species	  that	  poorly	  activates	  MtuCM	  and/or	  lowers	  
the	   affinity	  of	  MtuDAH7PS	   for	  MtuCM.	  The	   stabilisation	  of	   loops	   via	   site	  directed	  mutagenesis	   and	  
molecular	  dynamic	  simulations	  have	  been	  shown	  to	  increase	  the	  propensity	  of	  a	  neuraminidase	  from	  
the	   influenza	   virus	   and	   the	   photoswitching	   Dronpa	   from	   Pectinidae	   to	   form	   higher	   order	  
olgiomers.117,118	  
	  




Figure	   4.21	   The	   interaction	   of	   the	   β0-­‐strand	   of	   adjacent	   subunits	   at	   the	   dimer	   interface,	   located	   between	  
subunits	  of	  the	  crystallographic	  asymmetric	  unit.	  The	  unliganded	  MtuDAH7PS	  crystal	  structure	  (PDB	  code:	  3NV8)	  
is	   shown	   with	   one	   subunit	   shown	   in	   blue	   and	   the	   second	   subunit	   shown	   in	   red.	   The	   Trp-­‐	   and	   Phe-­‐bound	  
MtuDAH7PS	  crystal	  structure	  (PDB	  code:	  3KGF)	  is	  shown	  with	  one	  subunit	  colour	  orange	  and	  the	  other	  coloured	  
purple.	  A.	  Close-­‐up	  of	  the	  MtuDAH7PS	  dimer	   interface	  with	  the	  β0-­‐strands	  of	  the	  unliganded	  and	  the	  Trp-­‐	  and	  
Phe-­‐bound	   MtuDAH7PS	   crystal	   structures	   structure	   aligned.	   B.	   Schematic	   of	   the	   β0-­‐strands	   that	   form	   the	  
antiparallel	  β-­‐sheet	  at	  the	  dimer	  interface	  showing	  the	  relative	  position	  of	  Trp3	  on	  each	  strand.	  C.	  An	  alignment	  
of	  the	  antiparallel	  β-­‐sheet	  from	  the	  unliganded	  and	  Trp-­‐	  and	  Phe-­‐bound	  MtuDAH7PS	  crystal	  structures	  shown	  in	  
cartoon	  form	  with	  the	  Trp3	  shown	  as	  sticks.	  The	  functional	  group	  of	  Trp3	  on	  the	  blue	  subunit,	  shown	  in	  teal,	  was	  
unrefined	  in	  the	  3NV8	  crystal	  structure	  and	  has	  been	  modelled	  in	  by	  PyMol.	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Previous	   kinetic	   studies	   conducted	   by	   Sasso	   et	   al.	   used	   polyhistidine	   tagged	  MtuDAH7PS,	   but	   no	  
investigation	  had	  been	  made	  into	  whether	  the	  polyhistidine	  tag	  affected	  the	  activation	  or	  regulation	  
of	  MtuCM.85	   A	   brief	   investigation	   found	   there	  was	   no	   reason	   to	   suspect	   the	   polyhistidine	   tag	  was	  
detrimental	  the	  ability	  of	  MtuDAH7PS	  to	  activate	  MtuCM	  activity.	  The	  polyhistidine	  tag	  did	  alter	  the	  
regulatory	   sensitivity	   of	   MtuDAH7PS.	   MtuDAH7PS	   activity	   was	   less	   sensitive	   to	   combinations	   of	  
aromatic	   amino	   acids.	   The	   polyhistidine	   tag	   also	   adversely	   affected	   the	   synergistic	   regulation	   of	  
MtuCM	  activity	  in	  the	  presence	  of	  excess	  MtuDAH7PSH6.	  Trp	  alone	  was	  able	  to	  inhibit	  MtuCM	  activity,	  
yet	  when	  Trp	  was	  combined	  with	  Phe	  inhibition	  was	  less	  effective.	  Crystal	  coordinates	  with	  Phe	  and	  
Tyr	   bound	   showed	   the	   N-­‐terminal	   tail	   of	  MtuDAH7PS	   is	   repositioned	   on	   Phe	   or	   Tyr	   binding.	   Trp3	  
moves	  to	  cap	  site	  1	  when	  ligand	  is	  bound,	  and	  Asp	  6	  coordinates	  to	  the	  ligand	  via	  a	  water	  molecule.	  
The	   addition	   of	   the	   polyhistidine	   tag	   to	   the	   N-­‐terminus	   of	  MtuDAH7PS	   would	   likely	   reduce	   the	  
flexibility	  of	  the	  N-­‐terminal	  region,	  which	   interacts	  with	  site	  1,	  preventing	  or	  at	   least	  hampering	  the	  
capping	  of	   the	  binding	   site.	   The	  movement	  of	   the	  N-­‐terminal	   tail	  may	  be	   an	   important	  part	   of	   the	  
signalling	  pathway	  between	  allosteric	  sites,	  hampering	  the	  movement	  of	  the	  N-­‐terminal	  tail	  may	  then	  
result	  in	  the	  observed	  disruption	  of	  synergistic	  regulation.	  
	  
In	   summary,	  MtuCM	   and	  MtuDAH7PS	   have	   a	   synergistic	   relationship	   where	   the	   activity	   of	   both	  
enzymes	   is	   improved	   on	   formation	   of	   the	   non-­‐covalent	   heterooctameric	   complex.	  MtuCM	   activity	  
was	   found	   to	   have	   a	   similarly	   sophisticated	   synergistic	   feedback	   regulation	   as	  MtuDAH7PS.	   Thus	   it	  
was	  unsurprising	  to	  find	  the	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  were	  directly	  responsible	  for	  the	  
regulation	   of	  MtuCM.	   The	   binding	   of	   the	   aromatic	   amino	   acids	   of	  MtuDAH7PS	   change	   either	   the	  
average	   MtuDAH7PS	   tetramer	   conformation	   or	   the	   amplitude	   or	   frequency	   of	   the	   dynamic	  
fluctuations	   of	   the	   tetramer	   conformation	   about	   the	   mean	   tetramer	   conformation	   resulting	   in	   a	  
tetramer	  species	  that	  displays	  a	  lower	  affinity	  for	  MtuCM	  and	  poorly	  activates	  MtuCM	  activity.	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5. Residues	  potentially	  pivotal	  to	  the	  allosteric	  
regulation	  of	  MtuDAH7PS	  
 Introduction	  5.1.
Allosteric	  regulation	  is	  when	  an	  effector	  molecule	  binds	  to	  a	  protein	  at	  a	  site	  remote	  from	  the	  active	  
site	  and	  alters	   the	   functionality	  of	   the	  protein.	  The	  effector	  molecule	  may	  alter	   the	   functionality	  of	  
the	   protein	   by	   changing	   the	   average	   conformation	   of	   a	   protein	   ensemble	   or	   by	   changing	   the	  
amplitude	   or	   frequency	   of	   fluctuations	   from	   the	   average	   conformation	   of	   a	   protein	   ensemble.	  
Allosteric	   regulation	   has	   most	   frequently	   been	   characterised	   in	   enzymes	   that	   undergo	   detectable	  
conformational	   changes	   associated	   with	   ligand	   binding	   such	   as	   haemoglobin,	   E.	   coli	   aspartase	  
transcarbomoylase	   and	   even	   examples	   amongst	   the	   DAH7PS	   family,	   including	   T.	   maritima	  
DAH7PS.3,47,119,120	   More	   recently,	   enzymes	   that	   undergo	   very	   subtle	   changes	   to	   their	   flexibility	   or	  
molecular	   dynamics	   due	   to	   effector	   binding	   have	   been	   uncovered,	   such	   as	   the	   catabolite	   activator	  
protein	   and	   PDZ	   domains.8,25,121	   Allostery	   mediated	   by	   larger	   conformational	   changes	   is	   largely	  
considered	   to	   be	   enthalpy	   driven,	   whereas	   fluctuations	   about	   a	   mean	   conformation	   mediated	   by	  
protein	  dynamics	  delivers	  primarily	  entropically	  driven	  allostery.22	  Computational	  techniques	  such	  as	  
statistical	  coupling	  analysis	  (SCA)	  and	  molecular	  dynamic	  (MD)	  simulations	  are	  more	  frequently	  being	  
used	   to	   investigate	   systems	   that	   do	   not	   undergo	   major	   conformational	   change	   in	   an	   effort	   to	  
understand	  signal	  transmission	  between	  binding	  sites.25,115,122-­‐124	  
	  
Kinetic	   and	   biophysical	   studies	   provide	   clear	   evidence	   that	   Trp,	   Phe	   and	   Tyr	   regulate	  MtuDAH7PS	  
synergistically.48,91	  However,	  comparison	  of	  MtuDAH7PS	  structure	  with	  ligands	  bound	  at	  the	  allosteric	  
binding	   sites	   with	   the	   structure	   of	   the	   non-­‐liganded	   protein	   provides	   no	   evidence	   of	   significant	  
structural	   change.48,91	  A	  detailed	   investigation	   into	   the	  synergistic	   regulation	  of	  MtuDAH7PS	  using	  a	  
combination	   of	   MD	   simulations	   and	   SCA	   was	   used	   to	   illuminate	   the	   role	   of	   protein	   dynamics	   in	  
MtuDAH7PS	  regulation.115	  SCA	  is	  used	  to	  measure	  coupling	  between	  positions	  on	  a	  multiple	  sequence	  
alignment	  of	   a	  protein	   family.125	  A	   cluster	  of	   39	   residues	  was	   identified,	  which,	  may	  be	   involved	   in	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signal	   transmission	   between	   active	   sites	   of	   MtuDAH7PS.71,115	   The	   MD	   simulations	   predict	   the	  
flexibility	  of	  residues	  in	  the	  presence	  and	  absence	  of	  allosteric	  ligands	  and	  can	  identify	  residues	  that	  
display	  either	  correlated	  or	  anticorrelated	  movements.	  The	  residues	  identified	  by	  SCA	  were	  weighted	  
by	  the	  MD	  analysis,	  effectively	  correlating	  the	  motion	  from	  the	  MD	  simulations	  with	  the	  evolutionary	  
conservation	  of	  the	  type	  II	  DAH7PS	  family	  determined	  from	  SCA	  in	  order	  to	  identify	  the	  29	  residues	  of	  
greatest	  interest	  for	  experimental	  investigation	  from	  the	  cluster	  of	  39	  residues	  originally	  identified.	  
 Residues	  chosen	  for	  investigation	  5.1.1.
The	   focus	   of	   this	   study	   was	   to	   identify	   residues	   critical	   to	   communication	   between	   the	   allosteric	  
binding	   sites	   and	   the	   active	   site.	   Of	   the	   29	   potential	   residues	   identified	   as	   important,	   eight	   were	  
considered	   for	   analysis	   in	   this	   chapter	   (Table	   5.1).	   Residues	   located	   directly	   at	   the	   active	   site	   or	  
subunit	   interfaces	   were	   not	   investigated	   here,	   as	   they	   were	   likely	   to	   directly	   disrupt	   catalysis,	  
substrate	   binding	   or	   quaternary	   structure.	   Residues	   that	   make	   contacts	   through	   their	   peptide	  
functionality	   were	   also	   eliminated	   due	   to	   the	   difficulty	   in	   finding	   an	   appropriate	   substitution	   to	  
disrupt	   the	   interactions.	   SDM	  was	   attempted	   on	   all	   eight	   residues,	   however	   for	   only	   four,	   soluble	  
protein	  was	  successfully	  produced	  without	  disruption	  to	  the	  quaternary	  structure.	  These	  variants	  are	  
discussed	  within	  this	  chapter.	  
	  
Table	  5.1	  List	  of	  residues	  considered	  as	  targets	  for	  mutagenesis.	  
Residue	   Location	   Substitution	   Comments	  
Thr114	   Trp	  site	   Thr114Val	   Disrupted	  quaternary	  structure,	  not	  
pursued	  due	  similarity	  to	  other	  
variants	  
Gly190	   2nd	  shell	  Trp	  site	   Gly190Pro	   Successful,	  discussed	  Chapter	  5	  
Gly232	   2nd	  shell	  Trp	  site	   Gly232Pro	   Disrupted	  quaternary	  structure,	  
discussed	  Chapter	  7	  
Asn175	   Site	  1	   Asn171Ala	   Successful,	  discussed	  Chapter	  5	  
Tyr131	   2nd	  shell	  site	  1	   Tyr131Ala	   Successful,	  discussed	  Chapter	  5	  
Asn94	   2nd	  shell	  site	  1	   Asn94Ala	   Difficulty	  solubilising,	  abandoned	  
Val103	   2nd	  shell	  Trp	  site	   Val103Ala	   Successful,	  discussed	  Chapter	  5	  
Thr240	   Near	  Tetramer	  
interface	  
Thr240Ala	   Difficulty	  solubilising,	  abandoned	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 MtuDAH7PS	  SCA	  variants	  	  5.1.2.
The	   four	   variants,	   which	   were	   successfully	   purified	   without	   disruption	   to	   the	   quaternary	   structure,	   were	  
MtuDAH7PS	  Gly190Pro,	  Tyr131Ala,	  Val103Ala	  and	  Asn175Ala.	  Gly190	  is	  positioned	  along	  the	  loop	  between	  α2	  
and	  α2a	  helices	  (	  
Figure	   5.1B).	   The	   flexibility	   of	   α2-­‐α2a	   loop	   allows	   the	   loop	   to	   bend	   permitting	   the	   formation	   of	   a	  
hydrogen	  bond	  between	  the	  Trp	  ligand	  the	  backbone	  carbonyl	  Ala192.	  Interestingly	  another	  residue	  
considered	   for	   substitution	   was	   Gly232	   (Chapter	   7),	   also	   located	   on	   the	   α2b-­‐β3	   loop	   on	   the	  
succeeding	  the	  α2a	  and	  α2b	  helices.	  These	  Gly	  residues	  afford	  these	  helices	  greater	  movement	  than	  
other	   secondary	   structure	   elements	  within	   the	   tetramer.	   SCA	   identified	   several	   residues	   along	   the	  
α2a	   and	   α2b	   helices,	   plus	   MD	   simulations	   showed	   the	   flexibility	   of	   the	   loops	   changed	   on	   ligand	  
binding.71,115	  Thus	  the	  flexibility	  of	  the	  inserted	  α2a	  and	  α2b	  helices	  may	  play	  a	  critical	  role	   in	  signal	  
transmission	  between	  binding	  sites.	  Gly	  is	  unique	  as	  it	  allows	  the	  peptide	  backbone	  greater	  flexibility	  
than	  other	  residues	  due	  to	  the	  side	  chain	  being	  a	  hydrogen	  atom.	  Pro	  consists	  of	  a	  pyrrollidine	  ring	  
which	   includes	   the	  β	   carbon	  of	   the	  amide	   linkage	  enforcing	  a	  dihedral	  backbone	  angle	  of	  ~60˚	  and	  
therefore	  rigidity	  on	  the	  protein	  backbone.	  In	  order	  to	  probe	  the	  importance	  of	  the	  flexibility	  of	  the	  
α2-­‐α2a	  loop,	  Gly190	  was	  targeted	  for	  substitution	  to	  Pro.	  	  
	  
Asn175	  is	  located	  at	  site	  1	  and	  makes	  direct	  contacts	  with	  the	  carbonyl	  group	  of	  the	  bound	  ligand	  via	  its	  amide	  
side	  chain	  (	  
Figure	  5.1A).	  Asn175	  also	  makes	  polar	  contacts	  to	  Asn94	  and	  Arg171	  a	  residue	  shown	  to	  be	  essential	  
for	   strong	   ligand	   binding	   (Chapter	   3).	   Multiple	   sequence	   alignment	   conducted	   as	   part	   of	   the	   SCA	  
identified	  this	  position	  to	  be	  occupied	  by	  either	  Asn	  or	  Gln,	  conserving	  the	  side	  chain	  functionality.115	  
Despite	   Asn175	   being	   located	   at	   site	   1	   and	   interacting	   with	   the	   bound	   ligand,	   it	   was	   chosen	   for	  
investigation	   as	   it	   had	   also	   been	  highlighted	   as	   a	   critical	   residue	   in	  previous	  work.126	   It	  was	   shown	  
both	   D-­‐	   and	   L-­‐Phe	   were	   able	   to	   bind	   in	   site	   1,	   but	   only	   the	   presence	   of	   the	   L-­‐amino	   acid	   was	  
communicated	  to	  other	  allosteric	  sites	  and	  the	  active	  site.	  Crystallographic	  studies	  revealed	  the	  only	  
notable	  difference	  between	  the	  binding	  modes	  of	  the	  D-­‐	  and	  L-­‐Phe	  was	  the	  hydrogen	  bond	  formed	  
between	  Asn175	   and	   L-­‐Phe.	  Asn175	  was	   substituted	   for	  Ala	   to	   remove	   the	   side	   chain	   functionality	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without	   compromising	   the	   integrity	   of	   the	   secondary	   structure.	   This	   variant	   would	   allow	   the	  
importance	  of	  the	  amide	  side	  chain	  for	  allosteric	  communication	  to	  be	  investigated.	  	  
	  
Tyr131	   is	   in	  close	  proximity	  but	  does	  not	  make	  any	  polar	  contacts	   to	  Phe91	  or	  Asn175,	  both	  of	  which	  make	  
direct	  contacts	  with	  the	  bound	  ligand	  at	  site	  1	  (	  
Figure	  5.1C).	  Tyr	  131	  is	  ~13	  Å	  from	  site	  1.	  SCA	  on	  multiple	  sequences,	  found	  the	  position	  was	  usually	  
occupied	   by	   either	   Tyr	   or	   Phe,	   both	   aromatic	   amino	   acids.115	   Substitution	   of	   Tyr131	   to	   Ala	   would	  
effectively	   remove	   the	   aromatic	   side	   chain,	   whilst	   causing	   the	   least	   disruption	   to	   the	   secondary	  
structure.	   This	   would	   allow	   the	   importance	   of	   the	   aromatic	   side	   chain	   of	   Tyr131	   to	   allosteric	  
regulation	  to	  be	  investigated.	  





Figure	  5.1	  Structure	  of	  tetrameric	  MtuDAH7PS	  soaked	  with	  Trp	  and	  Phe	  (PDB	  code:	  3KGF).	  The	  core	  (β/α)8	  barrel	  
structure	  is	  coloured	  blue,	  the	  N-­‐terminal	  extension	  is	  coloured	  red,	  the	  additional	  helices	  to	  the	  α2-­‐β3	  loop	  are	  
coloured	  yellow	  Trp	   is	   shown	   in	  orange	  bound	   to	   the	  Trp	  site.	  Phe	  bound	   to	  site	  1	   is	   shown	   in	  green	  and	  Phe	  
bound	   to	   site	   2	   is	   shown	   in	   limon.	   Residues	   of	   interest	   as	   identified	   by	   SCA	   and	   MD	   simulations	   shown	   in	  
magenta.	   	  Close	  up	  view	  to	  show	  the	   interactions	  of	  A.	  Asn175;	  B.	  Gly190;	  C.	  Tyr131	  and	  D.	  Val103.	  Hydrogen	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Val103	  is	  in	  close	  proximity	  to	  the	  Trp	  site	  (~14	  Å),	  and	  forms	  hydrophobic	  interactions	  with	  the	  surrounding	  
hydrophobic	   residues	   Ile99,	   Leu186,	   Leu191	   and	   most	   importantly	   Leu107,	   which	   helps	   to	   form	   the	  
hydrophobic	  pocket	  for	  Trp	  binding	  (	  
Figure	  5.1D).	  Substitution	  of	  Val103	   to	  a	  polar	  or	   charged	  side	  chain	  would	   risk	  disrupting	   the	   local	  
secondary	  structure,	  as	  it	  may	  rearrange	  to	  move	  the	  polar	  residue	  into	  a	  position	  where	  it	  could	  be	  
stabilised	   by	   making	   polar	   contacts.	   Instead	   Val103	   was	   mutated	   to	   Ala	   to	   remove	   the	   branched	  
carbon	   side	   chain	   and	   allow	   the	   interactions	   of	   the	   branched	   side	   chain	   with	   the	   surrounding	  
hydrophobic	  residues	  to	  be	  investigated.	  	  
 Chapter	  aims	  5.1.3.
The	  combination	  of	  SCA	  and	  MD	  simulations	  identified	  a	  network	  of	  residues	  that	  may	  be	  involved	  in	  
the	   signal	   transmission	  between	  allosteric	   binding	   sites	   and	   to	   the	   active	   site,	   but	   as	   yet	   there	  has	  
been	  no	  experimental	  work	  to	  support	  these	  findings.	  The	  main	  aim	  of	  the	  studies	  described	  in	  this	  
chapter	  was	  to	  experimentally	  validate	  the	  findings	  from	  the	  SCA	  and	  MD	  analyses	  and	  show	  whether	  
the	   substitutions	   at	   the	   positions	   identified	   would	   disrupt	   or	   alter	   the	   allosteric	   regulation	   of	  
MtuDAH7PS.	  	  
 Preparation	  of	  MtuDAH7PS	  variants	  5.2.
 Mutagenesis,	  expression	  and	  purification	  5.2.1.
SDM	  was	  performed	  using	  the	  QuikChange®	  Lightning	  Site-­‐Directed	  Mutagenesis	  Kit	  (Stratagene).	  The	  
QuikChange®	  Primer	  Design	  tool	  (Agilent	  technologies)	  was	  used	  to	  design	  the	  primers	  incorporating	  
the	  desired	  mutations.	  Protocols	  are	  detailed	  in	  Section	  9.2.	  	  
	  
DNA	  sequencing	  confirmed	  the	  incorporation	  of	  the	  correct	  mutations	  before	  the	  SDM	  products	  were	  
electroporated	   into	   BL21(DE3)	   PGroESL	   cells.	   Expression	   and	   protein	   purification	   followed	   the	  
procedures	  outlined	  for	  MtuDAH7PSWT,	  Section	  9.5.	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 Confirmation	  of	  product	  5.2.2.
The	  purification	  products	   for	  each	  MtuDAH7PS	  variant	  were	  analysed	  by	  SDS-­‐PAGE	  gel	   (Figure	  5.2).	  
Each	   variant	   was	   shown	   to	   be	   pure	   and	   their	   bands	  matched	   the	   expected	  monomeric	  molecular	  
mass	   of	   ~50	   kDa.	   Molecular	   masses	   determined	   by	   mass	   spectrometry	   were	   consistent	   with	   the	  
expected	  mass	  of	  each	  variant	  (Table	  5.2).	  
	  
Table	  5.2	  Comparison	  of	  the	  calculated	  and	  empirical	  molecular	  weight	  (Mw)	  for	  MtuDAH7PS	  variants.	  




MtuDAH7PSG190P	   50825	   50823	  
MtuDAH7PSV103A	   50756	   50756	  
MtuDAH7PSY131A	   50692	   50690	  
MtuDAH7PSN175A	   50741	   50742	  
	  
Figure	  5.2	  SDS-­‐PAGE	  gel	   illustrating	  the	  size	  and	  purity	  of	  each	  purified	  MtuDAH7PS	  variant.	  Lane	  M	  molecular	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 Structural	  analysis	  5.3.
 Comparison	  of	  secondary	  structure	  5.3.1.
The	   secondary	   structure	   of	   each	  MtuDAH7PS	   variant	  was	   inspected	   by	   CD	   as	   described	   previously	  
(Section	   9.7.4).	   Overlay	   of	   the	   CD	   spectra	  with	  MtuDAH7PSWT	   indicated	   little	   variance	   (Figure	   5.3).	  
Therefore,	   it	   was	   unlikely	   any	   of	   the	   substitution	   caused	   significant	   alterations	   to	   the	   secondary	  





Figure	   5.3	   CD	   spectra	   for	  MtuDAH7PSWT	   (blue),	  MtuDAH7PSG190P	   (dusty	   pink),	  MtuDAH7PSV103A	   (lime	   green),	  
MtuDAH7PSY131A	  (orange)	  and	  MtuDAH7PSN175A	  (yellow).	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 Quaternary	  structure	  in	  solution	  5.3.2.
SAXS	   was	   used	   to	   determine	   the	   quaternary	   structure	   of	   each	  MtuDAH7PS	   variant	   in	   solution	   as	  
described	   in	  Section	  9.7.5.	  Comparison	  of	   the	  scattering	  profiles	  and	  pairwise	  distribution	  curves	  of	  
the	  MtuDAH7PS	  variants	  and	  MtuDAH7PSWT	  show	  they	  are	  similar	  (Figure	  5.4).	  	  
	  
Inspection	   of	   the	   SAXS	   parameters	   of	   the	   MtuDAH7PS	   variants	   determined	   from	   analyses	   with	  
GNOM102,	  PRIMUS101	  and	  CRYSOL103	  showed	  small	  variances	  from	  the	  parameters	  calculated	  for	  the	  
wild	   type	   enzyme	   (Table	   5.3).	   The	   𝜒2,	   a	   measure	   of	   goodness	   of	   fit,	   for	   MtuDAH7PSG190P	   and	  
MtuDAH7PSN175A	  were	  reasonably	  close	  to	  1	  and	  are	  a	  good	  fit	  with	  the	  theoretical	  scattering	  profile	  
of	   the	   tetrameric	  MtuDAH7PS	   crystal	   coordinates	   (PDB	   cod:	   3NV8).	  However,	  MtuDAH7PSV103A	  and	  
MtuDAH7PSY131A	   gave	   𝜒2	   values	   of	   2.6	   and	   3.4	   respectively,	   an	   indication	   that	   the	   theoretical	  
scattering	  of	  the	  tetrameric	  MtuDAH7PS	  crystal	  coordinates	  cannot	  fully	  account	  for	  the	  experimental	  
scattering	   of	   these	   two	   enzymes.	   This	   variation	   could	   suggest	   minor	   changes	   in	   the	   quaternary	  










Figure	   5.4	   SAXS	   profiles	   of	  MtuDAH7PSWT(blue),	  MtuDAH7PSG190P	   (dusty	   pink),	  MtuDAH7PSV103A	   (lime	   green),	  
MtuDAH7PSY131A	   (orange)	   and	   MtuDAH7PSN175A	   (yellow).	   Also	   shown	   is	   the	   theoretical	   scattering	   for	   the	  
tetrameric	   (black)	   and	   dimeric	   (black	   dash)	   MtuDAH7PS	   from	   PDB	   code	   3NV8.	   Inset	   pair-­‐wise	   distribution	  
profiles.	  
	  
Table	   5.3	   SAXS	  parameters	  determined	   from	  a	   single	   sample	  analysis	  of	   the	   scattering	  profiles	  of	  MtuDAH7PS	  
variants	  using	  PRIMUS,	  GNOM,	  MoW,	  and	  CRYSOL.	  
MtuDAH7PS	   Wild	  type	   G190P	   V103A	   Y131A	   N175A	  
Guinier	  analysis	  
Rg	  (Å)	   41.6	  ±	  0.3	   41.5	  ±	  0.1	   42.3	  ±	  0.3	   42.8	  ±	  0.2	   42.3	  ±	  0.3	  
I	  (0)	  (cm-­‐1)	   0.168	  ±	  0.001	   0.065	  ±	  0.001	   0.138	  ±	  0.001	   0.188	  ±	  0.001	   0.138	  ±	  0.001	  
Pair	  distribution	  analysis	  
Real	  Space	  Rg	  (Å)	   40.9	  ±	  0.2	   41.07	  ±	  0.06	   42.09	  ±	  0.2	   41.7	  ±	  0.2	   42.09	  ±	  0.2	  
Dmax	  	  (Å)	   127	   124	   126	   126	   126	  
Vp,	  (Da)	   282700	   303800	   338300	   327700	   338300	  
Molecular	  weight	  estimates	  from	  SAXS	  MoW	  analysis	  
Mw	  from	  Vp	  (Da)	   199	  100	   203800	   200900	   214800	   208300	  
Nō	  of	  Subunits	   4	   4	   4	   4	   4	  
CRYSOL	  analysis	  with	  tetrameric	  3NV8	   	  
RgE	  (Å)	   42.4	  ±	  0.2	   41.5	  ±	  0.2	   41.9	  ±	  0.2	   42.2	  ±	  0.2	   42.2	  ±	  0.2	  
RgT	  (Å)	   40.6	   41.2	   40.9	   41.4	   40.6	  
𝜒2	   0.996	   0.446	   2.58	   3.37	   0.612	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The	  quaternary	  structures	  of	  MtuDAH7PS	  variants	  were	  also	  analysed	  at	   low	  protein	  concentrations	  
(6-­‐10	  µM)	   by	   blue	   native	   PAGE,	   as	   described	   in	   Section	   9.7.2.	   The	   native	   PAGE	   showed	   two	  bands	  
were	   produced	   by	  MtuDAH7PSN175A	   one	   at	   ~50	   kDa	   and	   a	   second	   at	   ~100	  kDa	   and	   are	   in	   good	  
agreement	   with	   the	   expected	   monomeric	   and	   dimeric	  MtuDAH7PS	   molecular	   masses	   respectively	  
(Figure	   5.5).	   Furthermore	  MtuDAH7PSWT	   produced	   two	   bands	   of	   the	   same	   molecular	   weight	   and	  
intensities	   as	   MtuDAH7PSN175A,	   providing	   further	   evidence	   MtuDAH7PSN175A	   has	   a	   very	   similar	  
quaternary	   structure	   to	   MtuDAH7PSWT.	   MtuDAH7PSV103A	   generated	   one	   strong	   protein	   band	   at	  
~100	  kDa	  and	  only	  a	  faint	  band	  at	  ~50	  kDa	  suggesting	  the	  distribution	  of	  MtuDAH7PSV103A	  monomer	  
and	  dimer	  has	  been	  altered	  to	  favour	  the	  dimer.	  The	  native	  PAGE	  showed	  MtuDAH7PSG190P	  produced	  
a	  strong	  band	  at	  ~200	  kDa	  and	  consistent	  with	  the	  molecular	  mass	  of	  an	  MtuDAH7PS	  tetramer,	  and	  
only	  faint	  bands	  at	  ~100	  and	  ~50	  kDa	  suggesting	  MtuDAH7PSG190P	  exists	  primarily	  as	  a	  tetramer	  even	  
at	  low	  concentrations.	  The	  bands	  produced	  by	  MtuDAH7PSY131A	  were	  quite	  faint.	  There	  was	  a	  band	  at	  
~100	  kDa	  and	  a	  weaker	  band	  at	  ~200	  kDa	  which	  suggests	  at	  low	  concentrations	  MtuDAH7PSY131A	  may	  
exist	  primarily	  as	  a	  mixture	  of	  dimer	  and	  tetramer	  as	  opposed	  to	  the	  mixture	  of	  monomer	  and	  dimer	  
observed	  for	  MtuDAH7PSWT.	  
	  
Figure	   5.5	   Blue	   native	   PAGE;	   Lane	   M	   displays	   the	   molecular	   weight	   marker;	   Lane	   1	  MtuDAH7PSG190P;	   Lane2	  
MtuDAH7PSN175A;	  Lane	  3	  MtuDAH7PSWT;	  Lane	  4	  MtuDAH7PSV103A	  and	  Lane	  5	  MtuDAH7PSY131A.	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The	   sedimentation	   velocity	   experiments	   for	  MtuDAH7PSG190P	   were	   conducted	   at	   concentrations	   of	  
0.1,	  0.25	  and	  1	  mg/mL	  and	  the	  experimental	  conditions	  are	  detailed	   in	  Section	  9.7.7.	  Ali	  Nazmi	   ran	  
the	  AUC	  experiments	  and	  assisted	  in	  with	  data	  analysis.	  At	  all	  concentrations	  the	  AUC	  data	  fitted	  to	  
the	   continuous	   size	   distribution	   model	   determined	   a	   sedimentation	   coefficient	   (s)	   of	   ~8.3	   S	   for	  
MtuDAH7PSG190P	  and	  gives	  a	  calculated	  molecular	  mass	  of	  ~185	  kDa	  (Figure	  5.6A).	  The	  expected	  mass	  
of	  tetrameric	  MtuDAH7PS	  is	  204	  kDa.	  There	  is	  no	  evidence	  of	  a	  significant	  amount	  of	  monomeric	  or	  
dimeric	  MtuDAH7PSG190P	  being	  present	  even	  at	  the	  lowest	  concentration	  of	  0.1	  mg/mL.	  These	  results	  
are	  in	  agreement	  with	  the	  results	  of	  the	  native	  PAGE,	  which	  suggests	  the	  MtuDAH7SG190P	  is	  primarily	  
present	  as	  a	  tetramer	  in	  solution	  at	  all	  assessable	  concentrations	  (>0.1	  mg/mL).	  
	  
The	   AUC	   data	   for	   MtuDAH7PSV103A	   was	   collected	   at	   concentrations	   of	   0.1,	   0.3	   and	   1	   mg/mL.	  
Unfortunately	   the	   MtuDAH7PSV103A	   was	   unstable	   and	   aggregated	   throughout	   the	   sedimentation	  
velocity	   experiments	   resulting	   in	   data	   that	   did	   not	   fit	   well	   to	   the	   model	   (AUC	   data	   displayed	   in	  
Appendix	   II).	   The	   AUC	   data	   for	  MtuDAH7PSV103A	   revealed	   that	   there	   are	   two	   oligomers	   present	   in	  
solution	   at	   all	   concentrations,	   one	   with	   a	   sedimentation	   coefficient	   of	   ~8.3	   S,	   representing	   the	  
tetramer	  and	  one	  at	  ~5	  S	   representing	   the	  dimer	   (Figure	  5.6B).	  Notwithstanding	   the	   less	   than	   ideal	  
quality	  of	  data,	  the	  sedimentation	  velocity	  experiments	  were	  able	  to	  reveal	  the	  quaternary	  structure	  
equilibrium	  of	  MtuDAH7PSV103A	  has	  shifted	  to	  include	  a	  greater	  portion	  of	  MtuDAH7PS	  dimer	  than	  the	  













Figure	  5.6	  Normalised	  c(s)	  distribution	  functions	  from	  AUC	  	  data	  for	  A.	  MtuDAH7PSG190P,	  analysed	  at	  0.1	  mg/mL	  
(violet),	  0.25	  mg/mL	  (purple)	  and	  1.0	  mg/mL	  (pink).	  And	  B.	  MtuDAH7PSV103A,	  analysed	  at	  0.1	  mg/mL	  (violet),	  0.3	  
mg/mL	  (purple)	  and	  1.0	  mg/mL	  (pink).	  AUC	  data,	  fits	  and	  residuals	  are	  provided	  in	  Appendix	  II.	  
	  
Overall,	  the	  results	  from	  the	  native	  gel	  electrophoresis	  and	  SAXS	  experiments	  indicate	  the	  quaternary	  
structure	  of	  MtuDAH7PSN175A	   is	  unaffected	  by	   the	   introduced	  substitution.	  For	  MtuDAH7PSV103A	  and	  
MtuDAH7PSY131A	  both	  the	  SAXS	  analysis	  and	  native	  gels	  suggest	  the	  quaternary	  structure	  equilibrium	  
varies	   slightly	   compared	   to	  MtuDAH7PSWT.	   For	  MtuDAH7PSV103A	   AUC	   data	   confirms	   the	   Val103Ala	  
substitution	   has	   perturbed	   the	   quaternary	   structure	   equilibrium,	   resulting	   in	   a	   greater	   portion	   of	  
dimer	   present	   at	   all	   concentrations.	   Any	   variance	   in	   quaternary	   structure	   equilibrium	   of	   the	  
MtuDAH7PSY131A	  compared	  to	  the	  wild	  type	  enzyme	  could	  be	  verified	  by	  AUC.	  At	  high	  concentrations	  
SAXS	  showed	  MtuDAH7PSG190P	  had	  a	  tetrameric	  structure	  very	  similar	  to	  the	  MtuDAH7PSWT	  but	  native	  
PAGE	   and	   AUC	   showed	   MtuDAH7PSG190P	   was	   almost	   solely	   tetrameric	   in	   solution	   at	   low	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 The	  flexibility	  of	  Gly190	  is	  essential	  to	  communicating	  5.4.
allosteric	  regulation	  
 Kinetic	  parameters	  5.4.1.
Kinetic	  analysis	  was	  conducted	  under	  standard	  conditions	  as	  outlined	  in	  Section	  9.9.1.	  The	  conversion	  
of	  Gly190	  to	  a	  Pro	  had	  an	  unexpected	  positive	  effect	  on	   the	  variant	  catalytic	  ability	  of	   the	  enzyme.	  
The	  kcat	  of	  MtuDAH7PS
G190P	  is	  almost	  double	  that	  of	  MtuDAH7PSWT	  and	  there	  are	  some	  change	  to	  the	  
determined	  Km	  for	  both	  substrates.	  The	  overall	  result	  is	  the	  catalytic	  efficiency	  for	  both	  E4P	  and	  PEP	  
has	  increased	  compared	  to	  the	  wild	  type	  enzyme	  (Table	  5.4).	  This	  effect	  on	  the	  kinetic	  parameters	  is	  
even	  more	   surprising	   given	   the	   distance,	   ~29	   Å,	   of	   the	   site	   of	   substitution	   from	   the	   active	   site	   (as	  
measured	  between	  the	  Cα	  of	  Gly190	  and	  the	  Mn
2+	  ion	  at	  the	  active	  site).	  	  
	  
Table	   5.4	   Kinetic	   parameters	   determined	   from	   a	   single	   set	   of	  Michaelis-­‐Menten	   kinetics	   for	  MtuDAH7PSG190P.	  
Michaelis-­‐Menten	  plots	  are	  displayed	  in	  Appendix	  I.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  
squares	  fit.	  










E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
G190P	   35	  ±	  2	   47	  ±	  3	   9.0	  ±	  0.1	   260	  ±	  20	   190	  ±	  10	  
	  
 Disruption	  of	  feedback	  regulation	  5.4.2.
Inhibition	   studies	   of	  MtuDAH7PSG190P	   were	   conducted	   under	   standard	   assay	   conditions	   detailed	   in	  
Section	  9.9.3.	  The	  presence	  of	  200	  µM	  of	  any	  single,	  binary	  or	  ternary	  combination	  of	  aromatic	  amino	  
acids	  had	  little	  effect	  on	  the	  activity	  of	  MtuDAH7PSG190P	  (Figure	  5.7).	  Astonishingly	  the	  single	  residue	  
substitution	  of	  Gly190Pro	  appears	  to	  disable	  communication	  between	  the	  allosteric	  binding	  sites	  and	  
the	  active	  site,	  preventing	  inhibition.	  




Figure	   5.7	   Remaining	  activity	  of	  MtuDAH7PSWT	   (blue)	  MtuDAH7PSG190P	   (dusky	  pink)	   in	   the	  presence	  of	   various	  
single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  Assays	  conducted	  in	  the	  presence	  of	  150	  µM	  E4P	  and	  PEP.	  Error	  bars	  depict	  the	  standard	  deviation	  
of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
 Thermal	  stability	  5.4.3.
Having	  established	  that	  the	  addition	  of	  any	  combination	  of	  Trp,	  Phe	  or	  Tyr	  to	  MtuDAH7PSG190P	  could	  
not	   elicit	   any	   significant	   inhibitory	   response	   observable	   in	   kinetic	   assays,	   the	   next	   question	   to	   be	  
addressed	   was	   whether	   the	   ligands	   were	   still	   able	   to	   bind	   at	   the	   allosteric	   binding	   sites.	   The	  
MtuDAH7PSWT	  thermal	  melting	  temperature	  (Tm)	  was	  shown	  to	  increase	  in	  the	  presence	  of	  Trp	  and	  to	  
a	  lesser	  extent	  Phe	  (Section	  9.8.1).	  Consequently	  DSF	  was	  used	  as	  an	  initial	  probe	  to	  assess	  binding	  of	  
aromatic	  amino	  acids	  to	  the	  MtuDAH7PS	  variants.	  	  
	  
The	   melting	   temperatures	   determined	   for	  MtuDAH7PSG190P	   largely	   follow	   the	   trend	   observed	   for	  
MtuDAH7PSWT	  (Figure	  5.8).	  This	  observation	  indicates	  that	  all	  three	  aromatic	  amino	  acids	  are	  still	  able	  
to	   bind	   at	   the	   allosteric	   binding	   sites	   of	  MtuDAH7PSG190P.	   It	   should	   also	   be	   noted	   that	   the	   Tm	   of	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MtuDAH7PSG190P	   in	   the	   absence	   of	   ligand	   is	   ~	   1	   ˚C	   greater	   than	   MtuDAH7PSWT,	   hinting	   that	  
MtuDAH7PSG190P	   may	   be	   slightly	   more	   stable	   than	   the	   wild	   type	   enzyme.	   The	   change	   in	   Tm	   for	  
MtuDAH7PSG190P	   in	   the	   presence	   of	   200	   µM	   Trp	   was	   ~4	   ˚C	   lower	   than	   that	   observed	   for	  
MtuDAH7PSWT.	  When	  the	  concentration	  of	  Trp	  was	   increased	  to	  over	  500	  µM	  the	  changes	   in	  Tm	  for	  
MtuDAH7PSG190P	  and	  MtuDAH7PSWT	  were	  much	  more	  similar.	  The	  similarity	  of	  the	  Tm	  values	  suggests	  
that	  at	  sufficiently	  high	  concentrations	  Trp	   is	  able	  to	  bind	  effectively	  to	  MtuDAH7PSG190P	  and	  induce	  
similar	  changes	  in	  the	  thermal	  stability	  of	  MtuDAH7PSG190P	  as	  observed	  for	  MtuDAH7PSWT.	  
	  
	  
Figure	   5.8	   The	   effect	   of	   individual,	   binary	   and	   ternary	   combinations	   of	   aromatic	   amino	   acids	   on	   the	   thermal	  
stability	  of	  MtuDAH7PSWT	  (blue)	  and	  MtuDAH7PSG190P	  (dusky	  pink).	  The	  aromatic	  amino	  acids	  are	  represented	  by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids,	  except	  where	  500,	  and	  1000	  are	  stated	  and	  represent	  their	  respective	  concentrations	  in	  µM.	  Error	  
bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	   change	   in	   Tm	   for	  MtuDAH7PS
G190P	   in	   the	  presence	  of	  Phe	  was	  ~5.9	   ˚C,	  which	   is	   ~3.3	   ˚C	   greater	  
than	  observed	  for	  MtuDAH7PSWT.	  The	  addition	  of	  Phe	  and	  Tyr	  also	  produced	  a	  large	  increase	  in	  the	  Tm	  
for	  MtuDAH7PSG190P	  of	  ~9	   ˚C,	  5	   ˚C	  greater	   than	  MtuDAH7PSWT.	   Yet	   the	  addition	  of	   combinations	  of	  
aromatic	  amino	  acids	  that	  included	  Trp	  to	  MtuDAH7PSG190P	  resulted	  in	  similar	  increases	  in	  the	  Tm	  for	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MtuDAH7PSG190P	  as	  observed	  for	  MtuDAH7PSWT.	  The	  dramatic	  increases	  in	  Tm	  only	  in	  the	  absence	  of	  
Trp	  hint	  the	  Gly190Pro	  substitution	  has	  partially	  mimicked	  Trp	  binding,	  possibly	  signalling	  Trp	  binding	  
to	  site	  1,	   the	  Phe-­‐selective	  site.	  Signal	  transmission	  to	  site	  1	  might	  result	   in	  tighter	  Phe	  binding	  and	  
hence	  greater	  thermal	  stability	  as	  a	  greater	  portion	  of	  enzyme	  is	  bound	  with	  Phe.	  
 Binding	  affinities	  5.4.4.
ITC	  was	   used	   to	   quantify	   the	   binding	   affinity	   of	  MtuDAH7PSG190P	   for	   Trp	   and	   Phe.	   ITC	   experiments	  
were	   conducted	   under	   similar	   conditions	   as	   for	  MtuDAH7PSWT,	   as	   detailed	   in	   the	  methods	   Section	  
9.8.2.	  	  
	  
There	   is	  a	   remarkable	  difference	  between	   the	   interactions	  MtuDAH7PSG190P	  and	  MtuDAH7PSWT	  with	  
Trp.	   Titration	   of	   MtuDAH7PSWT	   with	   Trp	   displays	   a	   single	   tight	   binding	   event	   with	   Trp.48	   The	  
interaction	  of	  MtuDAH7PSG190P	  with	  Trp,	  with	  or	  without	  the	  pre-­‐incubation	  of	  the	  protein	  with	  Phe,	  
results	   in	  a	  distinctive	   isotherm	  that	   fits	  a	   two	  site	  binding	  model	   (Figure	  5.9A	  and	  C).	  The	   two-­‐site	  
binding	   site	   model	   assumes	   the	   two	   binding	   events	   are	   independent.	   The	   first	   binding	   event	   is	  
endothermic	  and	  the	  second	  is	  exothermic,	  as	  each	  binding	  event	  has	  an	  opposite	  enthalpy	  change	  it	  
allows	   the	   two	  binding	   events	   to	   be	   distinguished	   despite	   having	   similar	  Kd	  values	   (Table	   5.5).	  One	  
binding	  event	  has	  a	  Kd	  of	  ~20	  µM	  whilst	  the	  second	  binding	  event	  has	  a	  Kd	  of	  ~10	  µM.	  	  
	  
	  




Figure	   5.9	   ITC	   data	   for	   the	   interaction	   of	   A.	   81	   µM	  MtuDAH7PSG190P	   with	   1	   mM	   Trp	   titrant;	   B.	   49	   µM	   of	  
MtuDAH7PSG190P	  with	  2mM	  Phe	  titrant	  and	  C.	  38	  µM	  MtuDAH7PSG190P	  and	  a	  background	  of	  100	  µM	  Phe	  present	  
in	  the	  cell	  with	  a	  1	  mM	  Trp	  titrant	  
	  
Table	   5.5	   Dissociation	   constants	   determined	   by	   ITC	   for	   MtuDAH7PSG190P.	   *	   Indicates	   results	   determined	  
previously	  by	  Richard	  Hutton	  and	  —	  Indicates	  no	  background	  ligand	  present.	  Values	  are	  determined	  from	  a	  single	  









Wild	  type	   G190P	  
Kd	  (µM)	   Kd	  (µM)	  
Trp	   —	   4.7	  ±	  0.1*	   20	  ±	  80	  and	  10	  ±	  10	  
Phe	   	   —	   21	  ±	  1*	   47	  ±	  6	  
Trp	   Phe	   1.08	  ±	  0.03*	   14.8	  ±	  0.8	  and	  3	  ±	  1	  
	  
The	  Kd	  values	  between	  Trp	  and	  MtuDAH7PS
G190P	  appear	  to	  be	  lower	  in	  the	  presence	  of	  Phe,	  but	  the	  
high	  error	  associated	  with	  the	  determined	  Kd	  values	  in	  the	  presence	  of	  Trp	  mean	  no	  conclusion	  can	  be	  
drawn	  until	   the	  error	   is	   reduced	   (Table	  5.5).	   The	  Kd	   determined	  between	  MtuDAH7PS
G190P	   and	  Phe	  
was	   more	   than	   twice	   the	   value	   determined	   for	  MtuDAH7PSWT	   (Table	   5.5,	   Figure	   5.9B),	   indicating	  
MtuDAH7PSG190P	  has	  a	  poorer	  affinity	  for	  Phe	  than	  MtuDAH7PSWT.	  
	  
Overall	  the	  binding	  affinities	  determined	  for	  MtuDAH7PSG190P	   indicate	  the	  substitution	  of	  Gly190	  for	  
Pro	  does	  not	  prevent	  communication	  of	  ligand	  binding	  between	  the	  Trp	  site	  and	  site	  1.	  However,	  the	  
A.	   B.	   C.	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substitution	  has	  correlated	  with	  a	  decrease	  in	  the	  binding	  affinity	  of	  MtuDAH7PSG190P	  for	  Trp	  and	  Phe.	  
The	   Gly190Pro	   substitution	   was	   intended	   to	   reduce	   the	   flexibility	   of	   the	   α2-­‐α2a	   loop.	   A	   loss	   in	  
flexibility	  of	  the	  α2-­‐α2a	  loop	  may	  explain	  the	  changes	  in	  allosteric	  communication	  by	  preventing	  the	  
molecular	  dynamic	  changes	  from	  being	  transmitted	  between	  allosteric	  binding	  sites	  and	  between	  the	  
allosteric	  binding	  sites	  and	  the	  active	  site.	  
 Activation	  of	  MtuCM	  by	  MtuDAH7PSG190P	  5.4.5.
Assays	   were	   conducted	   under	   standard	   conditions	   and	   initiated	   with	   150	   µM	   chorismic	   acid	   as	  
described	   in	   Section	   9.9.1.	  MtuDAH7PSG190P	   adequately	   boosts	  MtuCM	  activity,	   but	   is	   less	   effective	  
than	  MtuDAH7PSWT	   at	  molar	   excess	   ≥	   ten-­‐fold	   (Figure	   5.10).	   The	   reduced	   activation	   of	  MtuCM	   by	  
MtuDAH7PSG190P	  at	  200	  fold	  excess	  MtuDAH7PSG190P	  concentrations	  suggests	  the	  interaction	  between	  
MtuDAH7PSG190P	  with	  MtuCM	  is	  weaker	  than	  MtuDAH7PSWT.	  The	   less	  effective	  activation	  of	  MtuCM	  
activity	   may	   be	   due	   to	   a	   less	   favourable	   arrangement	   of	   residues	   in	   the	   vicinity	   of	   the	   interface	  
between	  MtuDAH7PSG190P	  and	  MtuCM.	  	  




Figure	  5.10	  Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  either	  equimolar,	  ten-­‐fold	  or	  200-­‐fold	  molar	  excess	  of	  
MtuDAH7PSWT	   (blue	   hash)	   and	  MtuDAH7PSG190P	   (dusky	   pink	   hash).	   The	   burgundy	   line	   indicates	   the	   activity	   of	  
MtuCM	  alone.	  Assays	  conducted	  with	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  for	  reactions	  requiring	  a	  
200-­‐fold	   excess	   of	  MtuDAH7PS	  where	   10	   nM	   of	  MtuCM	   and	  MtuCM	   alone	  where	   90	   nM	  were	   used	   and	   the	  
results	  normalised.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	  
	  
 Regulation	  of	  MtuCM	  by	  MtuDAH7PSG190P	  5.4.1.
The	   interaction	   of	   MtuCM	   with	   MtuDAH7PS	   was	   used	   to	   probe	   whether	   ligand	   binding	   to	  
MtuDAH7PSG190P	   was	   communicated	   effectively	   to	   MtuCM.	   Assays	   were	   conducted	   under	   the	  
standard	  conditions	  and	  initiated	  with	  25	  µM	  chorismic	  acid	  as	  outlined	  in	  Section	  9.9.3.	  The	  addition	  
of	  Phe	  or	   a	   combination	  of	  Phe	  and	  Tyr	   to	   a	  mixture	  of	  MtuDAH7PSG190P	   and	  MtuCM	   inhibited	   the	  
MtuCM	   activity	   and	   caused	   a	   similar	   reduction	   in	   the	   MtuCM	   activity	   as	   was	   observed	   for	  
MtuDAH7PSWT	   (Figure	   5.11).	   The	   inhibition	   of	   MtuCM	   activity	   in	   a	   mixture	   of	   MtuCM	   and	  
MtuDAH7PSG190P	   by	   the	   addition	   of	   Tyr	   was	   less	   effective	   compared	   to	   a	   mixture	   of	  MtuCM	   and	  
MtuDAH7PSWT.	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The	   similar	   inhibition	   of	   MtuCM	   activity	   by	   Phe	   in	   the	   presence	   of	   either	   MtuDAH7PSG190P	   or	  
MtuDAH7PSWT	   indicates	  that	  the	  substitution	  of	  Gly190	  for	  Pro	  has	  not	  affected	  the	  communication	  
of	  Phe	  binding	  at	  site	  1,	  the	  Phe-­‐selective	  site,	  to	  the	  MtuCM•MtuDAH7PS	  interface.	  The	  Gly190Pro	  
substitution	   has	   resulted	   in	   the	   relatively	   poor	   inhibition	   of	  MtuCM	   activity	   by	   Tyr.	   This	   suggests	  
Gly190	  plays	  a	  role	  in	  the	  signalling	  of	  Tyr	  binding	  to	  the	  MtuCM•MtuDAH7PS	  interface.	  However,	  a	  
dramatic	   reduction	   in	   the	   affinity	   of	  MtuDAH7PSG190P	   for	   Tyr	   could	   also	   explain	   this	   result,	   and	   no	  
quantitative	  assessment	  has	  yet	  been	  made	  of	  the	  affinity	  between	  MtuDAH7PSG190P	  and	  Tyr.	  
	  
	  
Figure	   5.11	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  (blue	  hash)	  or	  MtuDAH7PSG190P	  (dusky	  pink	  hash).	  
The	  aromatic	  amino	  acids	  are	   represented	  by	   their	  one	   letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	   letter	  also	  
represents	   200	   µM	  of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	   presence	   of	   150	   µM	  
chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  at	  least	  duplicate	  measurements.	  
P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	  most	  remarkable	  finding	  from	  the	  inhibition	  studies	  was	  the	  observation	  that	  MtuDAH7PSG190P	  in	  
the	  presence	  of	  Trp	  activated	  MtuCM	  activity.	  The	  absolute	  MtuCM	  activity	  in	  the	  presence	  of	  Trp	  and	  
MtuDAH7PSG190P	   (10.8	   ±	   0.7	   µMmin-­‐1mg-­‐1)	   was	   greater	   than	   that	   determined	   for	   MtuCM	   in	   the	  
presence	   of	   Trp	   and	  MtuDAH7PSWT	   (7.9	   ±	   0.6	   µMmin-­‐1mg-­‐1).	   The	   difference	   in	   absolute	  MtuCM	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activity	   indicates	  that	  Trp	  binding	  has	   improved	  MtuCM	  activation	  beyond	  what	  can	  be	  achieved	  by	  
the	  wild	  type	  enzyme.	  Furthermore	  Phe	  or	  Tyr	  did	  not	  effectively	  supress	  this	  activation	  and	  even	  the	  
ternary	   combination	   of	   aromatic	   amino	   acids	   failed	   to	   reduce	  MtuCM	   activity	   below	   50	   %.	   These	  
findings	   suggest	   that	  Trp	  may	   shift	   the	  MtuDAH7PSG190P	  protein	  ensemble	   further	   toward	  a	   species	  
that	  favours	  the	  interaction	  and	  more	  importantly	  activation	  of	  MtuCM.	  
	  
Native	   PAGE	   provides	   further	   evidence	   that	  MtuDAH7PSG190P	   can	   form	   a	   complex	  with	  MtuCM.	   As	  
seen	  for	  a	  mixture	  of	  MtuDAH7PSWT	  and	  MtuCM	  (Section	  9.7.3)	  the	  native	  PAGE	  gel	  shows	  two	  bands	  
for	  a	  mixture	  of	  MtuDAH7PSG190P	  and	  MtuCM.	  One	  band	   is	  at	  ~240	  kDa	   (according	  to	   the	  molecular	  
mass	  marker)	  and	  corresponds	   to	   the	  presence	  of	   tetrameric	  MtuDAH7PS.	  The	   second	  band	   is	  of	  a	  
higher	   molecular	   mass	   ~300	   kDa	   and	   is	   evidence	   of	   the	   formation	   of	   the	   MtuCM•MtuDAH7PS	  
complex	   (Figure	   5.12).	  More	   importantly	   the	   native	   PAGE	   showed	   the	   band	   at	   ~300	   kDa	   becomes	  
much	  weaker	  if	  1	  mM	  Phe	  was	  added	  to	  the	  mixture	  of	  MtuCM	  and	  MtuDAH7PSG190P.	  The	  results	  from	  
the	  Native	  PAGE	  suggest	  that	  Phe	  alters	  the	  affinity	  of	  MtuDAH7PSG190P	  for	  MtuCM.	  
	  
	  
Figure	   5.12	   Amersham	   ECL	   native	   PAGE	   with	   50	   mM	   Tris-­‐	   175	   mM	   Alanine	   running	   buffer	   pH	   9.2;	   Lane	   M	  
molecular	   weight	   marker;	   Lane	   1	   MtuDAH7PSG190P;	   Lane	   2	   MtuDAH7PSG190Pwith	   MtuCM	   and	   Lane	   3	  
MtuDAH7PSG190P	  with	  MtuCM	  and	  1	  mM	  Phe.	  The	  concentration	  of	  MtuCM	  is	  at	  an	  approximate	  four-­‐fold	  molar	  
excess	  of	  MtuDAH7PS.	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 Summary	  of	  findings	  for	  MtuDAH7PSG190P	  5.4.2.
The	  quaternary	  structure	  of	  MtuDAH7PSG190P	  was	  shown	  to	   favour	   the	   tetrameric	   form	  at	  all	   concentrations	  
analysed.	  Gly190	   is	   located	  on	   the	  α2-­‐α2a	   loop,	   just	  before	   the	   first	   inserted	  helix	   (α2a)	  and	  near	   the	  weak	  
dimer	  interface	  (	  
Figure	  5.1).	  The	  Gly190Pro	  substitution	  was	  intended	  to	  reduce	  the	  flexibility	  of	  the	  α2-­‐α2a	  loop	  and	  
possibly	   the	   inserted	  helices	   at	   the	  dimer	   interface.	   Such	  a	   reduction	   in	   flexibility	  may	   stabilise	   the	  
formation	   of	   the	   tetramer.	   Interestingly	  MtuDAH7PSG190P	  was	   also	  more	   active	   than	  MtuDAH7PSWT.	  
Whether	   the	   increased	   catalytic	   efficiency	   is	   due	   to	   the	   stabilisation	   of	   the	   tetrameric	   form	   of	  
MtuDAH7PS	  or	  the	  Gly190Pro	  substitution	  directly	  is	  unclear.	  	  
	  
The	   inhibition	   studies	   revealed	   MtuDAH7PSG190P	   was	   no	   longer	   susceptible	   to	   inhibition	   by	   any	  
combination	  of	  aromatic	  amino	  acids.	  ITC	  results	  showed	  that	  Trp	  and	  Phe	  can	  bind	  MtuDAH7PSG190P	  
thus;	   the	   loss	   of	   feedback	   regulation	   of	   MtuDAH7PSG190P	   must	   be	   attributed	   to	   the	   Gly190Pro	  
substitution.	   If	   this	  substitution	  restricted	  the	  flexibility	  of	  the	   inserted	  helical	  region	  as	   intended,	   it	  
would	  imply	  the	  flexibility	  of	  the	  region	  is	  required	  for	  allosteric	  signal	  transfer	  between	  the	  allosteric	  
sites	  and	  the	  active	  site.	  Alternatively,	   the	  substitution	  of	  Gly190	  for	  Pro	  may	  restrict	  the	  accessible	  
conformations	  of	  the	  α2-­‐α2a	  loop	  preventing	  the	  nearby	  Ala192	  from	  interacting	  with	  the	  bound	  Trp	  
ligand.	  This	  interaction	  of	  Ala192	  may	  be	  a	  critical	  contact	  for	  the	  transmission	  of	  the	  allosteric	  signal	  
from	   the	  Trp	   site	   to	   the	  active	   site	  and	  other	  allosteric	  binding	   sites.	   Furthermore	   the	   inhibition	  of	  
MtuCM	  activity	  by	  Phe-­‐bound	  MtuDAH7PG190P	   shows	   that	  allosteric	   communication	   from	  site	  1,	   the	  
Phe-­‐selective	  binding	  site,	  has	  not	  been	  adversely	  affected	  by	  the	  Gly190Pro	  substitution.	  	  
	  
MtuDAH7PSG190P	  retained	  the	  ability	  to	  regulate	  MtuCM	  activity.	  Phe	  and	  Tyr	  inhibited	  MtuCM	  activity	  
for	   a	  mixture	  of	  MtuDAH7PSG190P	   and	  MtuCM	  almost	   as	   effectively	   as	   for	   a	  mixture	  of	  MtuCM	  and	  
MtuDAH7PSWT.	   Thus	   the	   Gly190Pro	   substitution	   has	   not	   disrupted	   the	   allosteric	   communication	  
network	  and/or	  mechanism	  that	  operate	  between	  MtuCM	  and	  site	  1	  of	  MtuDAH7PS.	  The	  response	  of	  
a	   mixture	   of	   MtuDAH7PSG190P	   and	   MtuCM	   to	   Trp	   was	   more	   peculiar,	   resulting	   in	   even	   greater	  
activation	   of	  MtuCM	   activity.	   It	   is	   highly	   likely	   that	   Trp	   binding	   shifts	   the	   average	   species	   of	   the	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MtuDAH7PSG190P	   population	   ensemble	   to	   favour	   a	   species	   that	   optimises	   the	   interactions	   between	  
MtuCM	   and	  MtuDAH7PS.	   This	   improved	   interaction	   between	   the	   two	   enzymes	   results	   in	   greater	  
activation	  of	  MtuCM	  activity	  and/or	  a	  higher	  affinity	  of	  MtuDAH7PSG190P	   for	  MtuCM.	  Moreover,	  Trp	  
binding	   to	  MtuDAH7PSG190P	   has	   also	   prevented	   effective	   inhibition	   by	   Phe	   and	   Tyr.	   This	   impaired	  
inhibition	   of	  MtuCM	   activity	   may	   be	   due	   to	   the	   Gly190Pro	   substitution	   disrupting	   the	   allosteric	  
communication	  network	  between	  the	  allosteric	  binding	  sites	  of	  MtuDAH7PSG190P.	  	  
	  
Overall	  structural	  characterisation	  carried	  out	  on	  MtuDAH7PSG190P	  showed	  the	  Gly190Pro	  substitution	  
has	   shifted	   the	   quaternary	   structure	   equilibrium	   of	   MtuDAH7PS,	   stabilising	   tetramer	   formation.	  
Kinetic	  analysis	  showed	  MtuDAH7PSG190P	  was	  unregulated	  and	  thereby	  suggests	  that	  Gly190	  is	  critical	  
for	  signal	  transmission	  from	  the	  Trp	  site	  to	  the	  active	  site	  of	  MtuDAH7PS.	  ITC	  studies	  showed	  Gly190	  
was	   not	   critical	   for	   proper	   signal	   transmission	   from	   site	  1,	   the	   Phe-­‐selective	   site,	   to	   the	   Trp	   site.	  
However	   the	   impaired	   synergistic	   regulation	   of	   MtuCM	   suggests	   the	   communication	   network	  
between	  the	  Trp	  site	  and	  the	  other	  allosteric	  binding	  sites	  may	  not	  be	  completely	  intact	  	  
 Investigating	  the	  role	  of	  Val103	  5.5.
 Kinetic	  parameters	  5.5.1.
Michaelis-­‐Menten	   kinetic	   assays	  were	   conducted	   under	   standard	   conditions	   (Section	   9.9.1)	   for	   the	  
determination	  of	   the	  kinetic	  parameters	  of	  MtuDAH7PSV103A.	   The	  change	   in	   the	  Km	   for	  PEP	  was	   the	  
most	   notable	   difference	   between	   MtuDAH7PSV103A	   and	   MtuDAH7PSWT	   (Table	   5.6).	   Although	  
MtuDAH7PSV103	  displayed	  a	  reduced	  affinity	  for	  PEP	  this	  was	  not	  of	  great	  detriment	  to	  the	  ability	  of	  
the	  enzyme	  to	  catalyse	  the	  formation	  of	  DAH7P	  due	  to	  the	  accompanying	  increase	  in	  the	  kcat.	  The	  Km	  
for	   E4P	   was	   similar	   for	   both	   MtuDAH7PSV103A	   and	   MtuDAH7PSWT.	   The	   catalytic	   efficiency	   of	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Table	   5.6	   Kinetic	   parameters	   determined	   from	   a	   single	   set	   of	  Michaelis-­‐Menten	   kinetics	   of	  MtuDAH7PSV103A.	  
Michaelis-­‐Menten	  plots	  are	  located	  in	  Appendix	  I.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  
squares	  fit.	  










E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
V103A	   26	  ±	  4	   80	  ±	  5	   6.5	  ±	  0.1	   290	  ±	  50	   96	  ±	  8	  
	  
 Disruption	  of	  feedback	  regulation	  5.5.2.
Inhibition	   studies	   were	   conducted	   under	   the	   standard	   conditions	   outlined	   in	   Section	   9.9.3.	  
MtuDAH7PSV103A	   showed	   no	   sensitivity	   to	   Tyr	   alone	   and	   only	   slight	   sensitivity	  with	   the	   addition	   of	  
both	  Tyr	  and	  Trp	  (activity	  was	  reduced	  to	  ~80	  %)	  (Figure	  5.13).	  The	  combinations	  of	  Trp	  and	  Phe	  or	  
Trp,	  Phe	  and	  Tyr	  reduced	  MtuDAH7PSV103A	  activity	  to	  ~20	  %	  and	  ~5	  %	  respectively,	  but	  this	  reduction	  
in	  activity	  was	  less	  effective	  than	  observed	  for	  the	  wild	  type	  enzyme.	  
	  	  
The	   loss	   of	   sensitivity	   of	  MtuDAH7PSV103A	   activity	   to	   the	   combination	   of	   Trp	   and	   Tyr	   means	   the	  
hydrophobic	  contacts	  provided	  by	  Val103	  may	  be	  important	  for	  signal	  transmission	  of	  ligand	  binding	  
between	  the	  Trp	  site	  and	  site	  2,	  the	  Tyr-­‐selective	  site,	  or	  perhaps	  between	  the	  site	  2	  and	  the	  active	  
site.	  The	   former	  option	  seems	  most	   likely	  as	  Val103	   forms	  hydrophobic	  contacts	  with	   residues	   that	  
contribute	   to	   the	   formation	  of	   the	  Trp	  binding	   site.	  As	  MtuDAH7PSV103A	  maintained	  a	  good	   level	  of	  
sensitivity	   to	   the	   combination	   of	   Trp	   and	   Phe,	   Val103	   probably	   does	   not	   play	   a	   direct	   role	   in	   the	  
allosteric	  network	  that	  communicates	  Phe	  binding	  at	  Site	  1,	  the	  Phe-­‐selective	  site,	  or	  Trp	  binding	  at	  
the	   Trp	   site	   to	   the	   active	   site.	   ITC	   could	   be	   used	   to	   verify	   whether	   Phe	   and	   Trp	   binding	   (and	   the	  
synergistic	   binding	   between	   them)	   has	   been	   affected	   by	   the	   substitution	   of	   Val103.	  Use	   of	   an	   E4P	  
analogue	   may	   also	   allow	   ITC	   to	   be	   used	   to	   probe	   the	   effect	   ligand	   binding	   has	   on	   the	   affinity	   of	  
MtuDAH7PS	  for	  its	  substrate.	  




Figure	  5.13	  Remaining	  activity	  of	  MtuDAH7PSWT	  (blue)	  MtuDAH7PSV103A	  (lime	  green)	   in	  the	  presence	  of	  various	  
single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  Assays	  conducted	  in	  the	  presence	  of	  150	  µM	  E4P	  and	  PEP.	  Error	  bars	  depict	  the	  standard	  deviation	  
of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
 Thermal	  stability	  	  5.5.3.
Due	  to	  constraints	  on	  time	  and	  protein	  availability	  it	  was	  not	  practical	  to	  determine	  the	  ligand	  binding	  
dissociation	   constants	   of	   every	   MtuDAH7PS	   variant	   by	   isothermal	   titration	   calorimetry.	   As	   an	  
alternative	   DSF	   was	   used	   to	   gauge	   if	   ligands	   could	   bind	   the	  MtuDAH7PS	   variants	   by	   monitoring	  
whether	   the	  addition	  of	   ligand	  altered	   the	  Tm.	  An	  unfortunate	   limitation	  of	   this	   technique	   is	   ligand	  
binding	  must	   induce	  a	  change	   in	  thermal	  stability	  to	  be	  detected.	  The	  DSF	  assays	  of	  all	  MtuDAH7PS	  
were	  conducted	  under	  equivalent	  conditions	  as	  outlined	  in	  Section	  9.8.1.	  
	  
The	  substitution	  of	  Val103Ala	  showed	  decreased	  thermal	  stability	  of	  the	  enzyme,	  as	  reflected	  by	  the	  	  
~11	   ˚C	   drop	   in	   Tm	   for	   MtuDAH7PS
V103A	   compared	   to	   MtuDAH7PSWT	   (Figure	   5.14).	   The	   Tm	   of	  
MtuDAH7PSV103A	   increased	   by	   ~11	   ˚C	   and	   ~4	   ˚C	   respectively,	   in	   the	   presence	   of	   Trp	   or	   Phe.	   The	  
addition	   of	   Trp	   or	   Phe	   caused	   similar	   changes	   in	   thermal	   stability	   for	   both	  MtuDAH7PSV103A	   and	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MtuDAH7PSWT.	  	  Tyr	  causes	  an	  ~8	  ˚C	  increase	  in	  the	  Tm	  of	  MtuDAH7PS
V103A,	  an	  increase	  ~7	  ˚C	  greater	  
than	  observed	   for	  MtuDAH7PSWT.	  Thus	  Tyr	  must	  be	  able	   to	  bind	   to	  MtuDAH7PSV103A.	   In	  accordance	  
with	  the	   findings	   for	  MtuDAH7PSWT	  the	  addition	  of	  multiple	  aromatic	  amino	  acids	  results	   in	  greater	  
increases	  in	  the	  Tm	  of	  MtuDAH7PS
V103A.	  Therefore	  each	  ligand	  must	  make	  a	  separate	  contribution	  to	  
the	  overall	  thermal	  stabilisation	  of	  MtuDAH7PSV103A.	  These	  findings	  showed	  all	  three	  aromatic	  amino	  
acids	  are	  still	  able	  to	  bind	  to	  MtuDAH7PSV103A.	  	  
	  
	  
Figure	   5.14	   The	   effect	   of	   individual,	   binary	   and	   ternary	   combinations	  of	   aromatic	   amino	   acids	   on	   the	   thermal	  
stability	  of	  MtuDAH7PSWT	  (blue)	  and	  MtuDAH7PSV103A	  (lime	  green).	  The	  aromatic	  amino	  acids	  are	  represented	  by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  
V.	  
	  
 Activation	  of	  MtuCM	  5.5.4.
Kinetic	   assays	   conducted	   to	   determine	   the	   activation	   of	   MtuCM	   activity	   in	   the	   presence	   of	  
MtuDAH7PSV103A	   were	   carried	   out	   under	   the	   standard	   conditions	   defined	   in	   Section	   9.9.1.	   The	  
activation	   profile	   of	   MtuCM	   activity	   by	   MtuDAH7PSV103A	   increased	   with	   excess	   MtuDAH7PS	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concentration	   in	   a	   similar	   fashion	   to	  MtuDAH7PSWT	   (Figure	   5.15).	   However,	   the	   maximal	   activity	  
achieved	  with	   a	   200-­‐fold	  molar	   excess	   of	  MtuDAH7PSV103A,	   ~90	  mMmin-­‐1mg-­‐1,	   was	   better	   than	   the	  
activation	  achieved	  by	  MtuDAH7PSWT.	  Overall	  the	  substitution	  of	  Val103	  for	  Ala	  may	  have	  improved	  
the	   activation	   of	  MtuCM	   possibly	   by	   optimising	   the	   interactions	   across	   the	  MtuDAH7PS•MtuCM	  
interface	  MtuCM	  catalysis.	  
	  
Figure	  5.15	  Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  either	  equimolar,	  ten-­‐fold	  or	  200-­‐fold	  molar	  excess	  of	  
MtuDAH7PSWT	   (blue	   hash)	   and	  MtuDAH7PSV103A	   (lime	   green	   hash).	   The	   burgundy	   line	   indicates	   the	   activity	   of	  
MtuCM	  alone.	  Assays	  conducted	  with	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  for	  reactions	  requiring	  a	  
200-­‐fold	   excess	   of	  MtuDAH7PS	  where	   10	   nM	   of	  MtuCM	   and	  MtuCM	   alone	  where	   90	   nM	  were	   used	   and	   the	  
results	  normalised.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	  
 Regulation	  of	  MtuCM	  by	  MtuDAH7PSV103A	  5.5.5.
Kinetic	  assays	  were	  conducted	  under	   the	  standard	  conditions	  detailed	   in	  Section	  9.9.3.	  The	  MtuCM	  
activity	   of	   a	  mixture	   of	  MtuCM	   and	  MtuDAH7PSV103A	   was	   insensitive	   to	   Tyr.	   Phe	   inhibited	  MtuCM	  
activity	   in	   the	   presence	   of	  MtuDAH7PSV103A	   but	   this	   inhibition	  was	   less	   effective	   than	   observed	   for	  
MtuDAH7PSWT	   (Figure	   5.16).	   The	   MtuCM	   activity	   in	   the	   presence	   of	   MtuDAH7PSV103A	   was	   less	  
responsive	  to	  the	  presence	  of	  Tyr	  and	  Phe,	  retaining	  approximately	  30	  %	  more	  activity	  than	  MtuCM	  in	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the	   presence	   of	  MtuDAH7PSWT.	   This	   loss	   in	   sensitivity	   to	   Phe	   and	   Tyr	   may	   imply	   Val103	   plays	   an	  
important	   part	   in	   signalling	   the	   binding	   of	   Phe	   or	   Tyr	   at	   sites	   1	   and/or	   2	   to	   the	   interface	   of	  
MtuCM•MtuDAH7PS	   and	   across	   to	   the	   associated	  MtuCM.	   Interestingly,	   Phe	   and	   Tyr	   appeared	   to	  
synergistically	   inhibit	   MtuCM	   activity	   when	   added	   together	   to	   a	   mixture	   of	   MtuCM	   and	  
MtuDAH7PSV103A.	  The	  inhibition	  achieved	  by	  adding	  double	  the	  concentration	  of	  Phe	  or	  Tyr	  (400	  µM)	  
also	  needs	   to	  be	  measured	  to	  confirm	  the	   inhibition	   in	   the	  presence	  of	  Phe	  and	  Tyr	   is	  not	  simply	  a	  
response	  to	  an	  increase	  in	  the	  total	  concentration	  of	  Phe	  and	  Tyr.	  	  
	  
Trp	  did	  not	   inhibit	  MtuCM	  activity	   in	   the	  presence	  of	  MtuDAH7PSV103A.	   The	  combination	  of	  Trp	  and	  
Phe	  did	  not	  synergistically	  inhibit	  the	  MtuCM	  activity	  of	  a	  mixture	  of	  MtuCM	  and	  MtuDAH7PSV103A.	  It	  
is	   interesting	   to	   note	   that	   the	   MtuDAH7PSV103A	   activity	   was	   synergistically	   inhibited	   by	   the	  
combination	  of	  Trp	  and	  Tyr	  (Section	  5.5.2).	  These	  observations	  suggest	  that	  the	  substitution	  of	  Val103	  
for	  Ala	  has	  not	  seriously	  disrupted	  the	  allosteric	  communication	  network	  between	  site	  1,	  the	  Trp	  site	  
and	   the	  MtuDAH7PS	  active	   site,	  but	   some	  change	  has	  occurred	   that	  prevents	   this	   regulatory	   signal	  
from	  being	  transmitted	  to	  MtuCM.	  	  
	  




Figure	   5.16	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  (blue	  hash)	  or	  MtuDAH7PSV103A	  (lime	  green	  hash).	  
The	  aromatic	  amino	  acids	  are	   represented	  by	   their	  one	   letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	   letter	  also	  
represents	   200	   µM	  of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	   presence	   of	   150	   µM	  
chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  at	  least	  duplicate	  measurements.	  
P-­‐values	  provided	  in	  appendix	  V.	  
 Summary	  of	  findings	  for	  MtuDAH7PSV103A	  5.5.1.
AUC	  and	  native	  PAGE	  (Section	  5.3.2)	  showed	  the	  quaternary	  structure	  equilibrium	  of	  MtuDAH7PSV103A	  
has	   shifted	   permitting	   a	   greater	   proportion	   of	   dimeric	   MtuDAH7PSV103A	   to	   be	   present	   at	  
concentrations	   up	   to	   1	  mg/mL.	   SAXS	   showed	   the	   tetramer	   formed	   at	   very	   high	   concentrations	   (>5	  
mg/mL)	  (Section	  5.3.2),	  but	  also	  that	  its	  structure	  in	  solution	  may	  not	  be	  identical	  to	  MtuDAH7PSWT.	  
The	  introduced	  substitution	  has	  not	  seriously	  affected	  the	  activity	  of	  MtuDAH7PSV103A	  or	  the	  ability	  of	  
the	  enzyme	  to	  boost	  the	  activity	  of	  MtuCM.	  
	  
Analysis	   by	   DSF	   showed	   all	   three	   aromatic	   amino	   acids	   could	   bind	  MtuDAH7PSV103A,	   as	   they	   all	  
increased	   the	   thermal	   stability	   of	   the	   enzyme.	   Hence	   the	   substitution	   of	   Val103	   for	   Ala	   did	   not	  
prevent	   Trp,	   Phe	   or	   Tyr	   from	   binding	   MtuDAH7PSV103A.	   Somewhat	   surprisingly	   the	   loss	   of	   the	  
branched	  side	  chain	  of	  Val103	  disrupted	  the	  synergistic	   inhibition	  by	  Trp	  and	  Tyr	  of	  MtuDH7PSV103A.	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MtuDAH7PSV103A	  maintained	   sensitivity	   to	   Trp	   and	   Phe.	   Similarly,	  MtuDAH7PSV103A	   is	   able	   to	   inhibit	  
MtuCM	   activity	   in	   the	   presence	   of	   Phe	   but	   not	   Tyr.	   Synergistic	   inhibition	   of	  MtuCM	   activity	   by	  
MtuDAH7PSV103A	  by	  Trp	  in	  combination	  with	  Phe	  or	  Tyr	  has	  also	  been	  adversely	  affected.	  
	  
In	  chapter	  3	  it	  was	  shown	  Tyr	  (in	  combination	  with	  Trp	  binding	  at	  the	  Trp	  site)	  must	  bind	  to	  site	  2	  to	  
inhibit	  MtuDAH7PS	  activity,	  but	  better	   inhibition	   is	   achieved	  when	  Tyr	  occupies	  both	   sites	  1	  and	  2.	  
Chapter	  3	  also	  showed	  site	  1	  was	  a	  Phe-­‐selective	  site.	  As	  both	  MtuDAH7PSV103A	  activity	  and	  MtuCM	  
activity	  (in	  the	  presence	  of	  MtuDAH7PSV103A)	  remain	  sensitive	  to	  the	  presence	  of	  Phe,	  Val103	  is	  most	  
likely	  responsible	  for	  communication	  of	  Tyr	  binding	  from	  site	  2	  of	  MtuDAH7PS	  to	  the	  active	  site	  and	  
the	  Trp	   site.	  The	   less	  effective	   synergistic	   inhibition	  of	  MtuCM	  activity	  by	  MtuDAH7PSV103A	   suggests	  
Val103	  may	   also	  play	   a	   role	   in	   communicating	   Trp	  binding	   from	   the	  Trp	   site	   to	   the	  other	   allosteric	  
binding	  sites	  and	  to	  MtuCM.	  
	  
The	   branched	   side	   chain	   of	   Val103	   fits	   into	   a	   hydrophobic	   pocket,	   forming	   hydrophobic	   contacts	   with	   the	  
surrounding	  residues	  and	  must	  impose	  some	  restriction	  of	  the	  molecular	  motion	  of	  the	  α1	  helix	  on	  which	  it	  is	  
located	  (	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Figure	   5.1D).	   The	   loss	   of	   hydrophobic	   contacts	   with	   the	   surrounding	   residues	   may	   impede	  
transmission	  of	   changes	   in	  molecular	  motion	  upon	  Tyr	  binding	   to	  other	  allosteric	  binding	   sites,	   the	  
active	   site	   and	   the	   MtuCM•MtuDAH7PS	   interface.	   Val103	   forms	   hydrophobic	   interactions	   with	  
Leu107,	  which	  is	  part	  of	  the	  Trp	  site.	  The	  loss	  of	  this	  interaction	  may	  contribute	  to	  the	  disruption	  of	  
the	   communication	  between	   the	  Trp	   site	   and	   the	  other	   allosteric	   sites	   and	   to	  MtuCM.	  Val103	  may	  
also	  help	  to	  position	  residues	  of	  the	  α2-­‐α2a	  loop	  via	  hydrophobic	  interactions	  with	  Leu191,	  thus	  also	  
controlling	  the	  molecular	  dynamics	  of	  the	  loop	  to	  some	  extent.	  The	  loss	  of	  the	  branched	  side	  chain	  of	  
Val103	  by	  substitution	  for	  Ala	  probably	  reduces	  the	  number	  of	  hydrophobic	  contacts	  made	  by	  Leu191	  
and	  may	  allow	  the	  α2	  α2a	   loop	  a	  greater	  range	  of	  movement.	  Ala192	   is	  also	   located	  on	  the	  α2-­‐α2a	  
loop	  and	  form	  a	  hydrogen	  bond	  with	  the	  bound	  Trp	   ligand,	  thus	  changes	  to	  the	   loop	  flexibility	  may	  
also	  cause	  disrupt	  an	  allosteric	  signal	  being	  transmitted	  to	  or	  from	  the	  Trp	  site.	  
	  
 Investigating	  the	  role	  of	  Tyr131	  5.6.
 Kinetic	  parameters	  5.6.1.
The	  standard	  assay	  conditions	  described	  in	  Section	  9.9.1	  were	  used	  to	  carry	  out	  the	  Michaelis-­‐Menten	  
kinetics	   of	  MtuDAH7PSY131A.	   The	   removal	   of	   the	   tyrosyl	   side	   chain	   has	   negatively	   impacted	   on	   the	  
catalytic	   turnover	   of	   MtuDAH7PSY131A	   reducing	   kcat	   to	   ~1.6	   s
-­‐1	   (Table	   5.7).	   In	   addition	   the	  
MtuDAH7PSY131A	   Km	   for	   PEP	   also	   increased,	   signifying	  MtuDAH7PS
Y131A	   has	   a	   decreased	   affinity	   for	  
PEP.	   The	   consequence	   is	   a	   drop	   in	   PEP	   catalytic	   efficiency	   of	   the	   enzyme	   to	   ~	   18	   s-­‐1mM-­‐1.	   The	  
decrease	   in	   the	   E4P	   Km	   helped	   to	   mitigate	   the	   affect	   of	   the	   low	   kcat	   resulting	   in	   an	   E4P	   catalytic	  
efficiency	   of	   ~130.	   Overall	   the	   Tyr131Ala	   substitution	   has	   harmed	   the	   	   catalytic	   efficiency	   of	   the	  
enzyme	  especially	  with	  respect	  to	  PEP.	  	  
	  
Table	   5.7	   Kinetic	   parameters	   determined	   from	   a	   single	   set	   of	   Michaelis-­‐Menten	   kinetic	   data	   from	  
MtuDAH7PSY131A.	  Michaelis-­‐Menten	  plots	  are	  displayed	   in	  Appendix	   I.	  Error	   represents	  error	  of	   curve	   fitting	   to	  
the	  data	  set	  by	  least	  squares	  fit.	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   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
Y131A	   13.0	  ±	  0.9	   91	  ±	  4	   1.63	  ±	  0.03	   130	  ±	  10	   18	  ±	  1	  
	  
 Disruption	  of	  feedback	  regulation	  5.6.2.
Inhibition	   studies	   were	   conducted	   under	   the	   standard	   experimental	   conditions	   detailed	   in	   Section	  
9.9.3.	  The	  final	  MtuDAH7PS	  concentration	  used	  for	  the	  inhibition	  studies	  was	  kept	  between	  0.01	  and	  
0.02	  mg/mL	  for	  all	  MtuDAH7PS	  variants.	  Similarly	  all	   inhibition	  assays	  were	  conducted	  with	  150	  µM	  
E4P	  and	  PEP.	  As	  a	  consequence	  of	  keeping	  both	  the	  concentration	  of	  enzyme	  and	  substrate	  constant	  
for	   all	   kinetic	   assays,	   the	   poor	   catalytic	   efficiency	   of	  MtuDAH7PSY131A	   gave	   a	   low	   baseline	   activity,	  
approximately	  one	  third	  of	  MtuDAH7PSWT	  under	  the	  same	  conditions.	  	  
	  
The	  most	   prominent	   observation	   from	   the	   feedback	   inhibition	   studies	   of	  MtuDAH7PSY131A	   was	   the	  
~70	  %	   increase	   in	   activity	   caused	  by	  Phe	   (Figure	  5.17).	   The	   combination	  of	  Phe	  and	  Tyr	   caused	   the	  
greatest	   increase	   in	   MtuDAH7PSY131A	   of	   ~95	   %.	   Since	   the	   absolute	   activity	   of	   MtuDAH7PSY131A	  
(1.7	  ±	  0.1	  µMmin-­‐1mg-­‐1)	  was	   less	  than	  MtuDAH7PSWT	  (5.6	  ±	  0.1	  µMmin-­‐1mg-­‐1),	  Phe	  and	  Tyr	  (and	  to	  a	  
lesser	   extent	   Trp),	   binding	  may	  mitigate	   or	   even	   restore	   the	   loss	   of	   activity	   due	   to	   the	   Tyr131Ala	  
substitution.	  	  
	  




Figure	   5.17	   Remaining	   activity	   of	  MtuDAH7PSWT	   (blue)	  MtuDAH7PSY131A	   (orange)	   in	   the	   presence	   of	   various	  
single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  Assays	  conducted	  in	  the	  presence	  of	  150	  µM	  E4P	  and	  PEP.	  Error	  bars	  depict	  the	  standard	  deviation	  
of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
MtuDAH7PSY131A	   does	   not	   exhibit	   significant	   inhibitory	   sensitivity	   to	   any	   individual	   or	   binary	  
combination	  of	  aromatic	  amino	  acids.	  The	  presence	  of	  all	   three	  aromatic	  amino	  acids,	  Trp,	  Phe	  and	  
Tyr,	   reduced	  MtuDAH7PSY131A	   activity	   to	   ~42	  %.	  Without	   the	   tyrosyl	   group	   of	   Tyr131	   there	  was	   no	  
effective	  inhibitory	  response	  to	  any	  binary	  combination	  of	  aromatic	  amino	  acids	  and	  a	  poor	  response	  
to	   the	   presence	   of	   all	   three	   aromatic	   amino	   acids.	   It	   is	   likely	   the	   tyrosyl	   side	   chain	   of	   Tyr131	  
contributes	  to	  the	  signalling	  pathway	  between	  the	  allosteric	  binding	  sites	  and	  the	  active	  sites.	  	  
 Thermal	  stability	  5.6.3.
The	   thermal	   stability	   of	   MtuDAH7PSY131A	   was	   measured	   by	   DSF	   under	   the	   standard	   experimental	  
conditions	  detailed	  in	  Section	  9.8.1.	  The	  Tm	  of	  MtuDAH7PS
Y131A	  was	  ~6.5	  ˚C	  less	  than	  MtuDAH7PSWT,	  
indicating	   the	   introduction	   of	   the	   Tyr131Ala	   substitution	   decreased	   the	   thermal	   stability	   of	   the	  
protein	  (Figure	  5.18).	  The	  Tm	  determined	  in	  the	  presence	  of	  either	  Trp	  or	  Tyr	  (and	  combinations	  which	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included	  Trp	  or	  Tyr)	  had	  higher	  Tm	  values.	  Like	  MtuDAH7PS
V103A	  the	  addition	  of	  Tyr	  to	  MtuDAH7PSY131A	  
caused	   a	   big	   increase	   of	   ~4.5	   ˚C	   in	   the	   Tm	   compared	   to	   the	   ~1	   ˚C	   increase	   for	  MtuDAH7PS
WT.	   The	  
increases	  in	  Tm	  suggest	  MtuDAH7PS
Y131A	  was	  able	  to	  bind	  both	  Trp	  and	  Tyr	  and	  gain	  thermal	  stability	  
from	  doing	  so.	  	  
	  
	  
Figure	   5.18	   The	  effect	   of	   individual,	   binary	   and	   ternary	   combinations	  of	   aromatic	   amino	  acids	  on	   the	   thermal	  
stability	   of	  MtuDAH7PSWT	   (blue)	   and	  MtuDAH7PSY131A	   (orange).	   The	   aromatic	   amino	   acids	   are	   represented	   by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
Phe	  does	  not	  cause	  a	  positive	  thermal	  shift,	  instead	  a	  slight	  decrease	  of	  ~2	  ˚C	  is	  observed	  for	  the	  Tm	  
determined	  when	  Phe	  is	  added	  to	  the	  conditions.	  As	  a	  change	  in	  stability	   is	  observed	  it	   is	   likely	  Phe	  
does	   bind	   to	  MtuDAH7PSY131A,	   but	   this	   was	   better	   confirmed	   with	   ITC	   (Section	   5.6.4).	   This	   loss	   in	  
stability	  shows	  Phe	  does	  not	  act	  to	  stabilise	  the	  protein	  as	  previously	  observed	  for	  MtuDAH7PSWT.	  Trp	  
or	  Tyr	  binding	  appeared	  to	  counteract	  the	  destabilising	  effect	  of	  Phe	  binding.	  When	  Phe	  was	  added	  in	  
combination	  with	  Trp	  or	  Tyr	  to	  MtuDAH7PSY131A	  the	  calculated	  Tm.	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Overall	  the	  DSF	  results	  indicate	  the	  tyrosyl	  group	  of	  Tyr131	  is	  instrumental	  for	  MtuDAH7PS	  to	  acquire	  
an	  increase	  in	  thermal	  stability	  upon	  Phe	  binding.	  As	  site	  1	  was	  shown	  to	  be	  the	  Phe-­‐selective	  site	  in	  
Chapter	   3,	   Tyr131	   is	   most	   probably	   involved	   in	   signal	   transmission	   between	   site	   1	   and	   the	   other	  
allosteric	  binding	  sites	  and	  the	  active	  site.	  	  
 Binding	  affinities	  5.6.4.
ITC	  was	   used	   to	   quantify	   the	   binding	   affinity	   of	  MtuDAH7PSY131A	   for	   Trp	   and	   Phe.	   ITC	   experiments	  
were	   conducted	   under	   similar	   conditions	   as	  MtuDAH7PSWT,	  with	   protein	   and	   ligand	   concentrations	  
optimised	  for	  each	  experiment	  as	  detailed	  Section	  9.8.2.	  
	  
The	  Kd	  between	  Phe	  and	  MtuDAH7PS
Y131A	  was	  found	  to	  be	  ~50	  µM,	  more	  than	  double	  the	  Kd	  between	  
MtuDAH7PSWT	  and	  Phe	  (Figure	  5.19B,	  Table	  5.8).	  Thus	  the	  loss	  of	  the	  tyrosyl	  group	  of	  Tyr131	  has	  had	  
a	  detrimental	  affect	  on	  the	  affinity	  of	  MtuDAH7PSY131A	  for	  Phe,	  but	  does	  not	  prevent	  Phe	  binding.	  	  
	  
As	  seen	  previously	   for	  MtuDAH7PSR171A	  and	  MtuDAH7PSG190P	   the	   ITC	  thermogram	  for	  Trp	  binding	  to	  
MtuDAH7PSY131A	   displayed	   two	   binding	   events	   of	   opposite	   enthalpy	   change	   (Figure	   5.19C).	   The	   Kd	  
values	   (of	   5.5	   and	   0.5	   µM)	   determined	   for	   each	   binding	   event	   revealed	   Trp	   bound	   tightly	   to	  
MtuDAH7PSY131A	   (Figure	   5.19A).	   Furthermore	   the	   observed	   Kd	   between	   Trp	   and	   MtuDAH7PS
Y131A	  
decreased	  by	  five-­‐fold	  when	  MtuDAH7PSY131A	  was	  incubated	  with	  Phe.	  A	  similar	  five-­‐fold	  decrease	  in	  
the	  Kd	  between	  Trp	  and	  MtuDAH7PS
WT	  was	  observed	  when	  MtuDAH7PSWT	  was	   incubated	  with	  Phe.	  
The	  loss	  of	  the	  tyrosyl	  group	  of	  Tyr131	  has	  not	  prevented	  Trp	  binding.	  However,	  the	  substitution	  may	  
have	   altered	   communication	   between	   the	   Trp	   sites	   of	   each	   monomeric	   unit	   resulting	   in	   the	  
identification	  of	  two	  Trp	  binding	  events.	  




Figure	   5.19	   ITC	   data	   for	   the	   interaction	   of	   A.	   38	   µM	  MtuDAH7PSY131A	   with	   0.5	   mM	   Trp	   titrant;	   B.	   38	   µM	   of	  
MtuDAH7PSY131A	  with	  1	  mM	  Phe	  titrant	  and	  C.	  38	  µM	  MtuDAH7PSY131A	  and	  a	  background	  of	  100	  µM	  Phe	  present	  
in	  the	  cell	  with	  a	  0.5	  mM	  Trp	  titrant.	  
	  
Table	   5.8	   Dissociation	   constants	   determined	   by	   ITC	   for	   MtuDAH7PSY131A.	   *	   Indicates	   results	   determined	  
previously	   by	   Richard	   Hutton	   and	   —	   Indicates	   no	   background	   ligand	   present.	   Values	   are	   from	   a	   single	   ITC	  









Wild	  type	   Y131A	  
Kd	  (µM)	   Kd	  (µM)	  
Trp	   —	   4.7	  ±	  0.1*	   5.5	  ±	  0.2	  and	  0.5	  ±	  0.3	  
Phe	   	   —	   21	  ±	  1*	   52	  ±	  3	  
Trp	   Phe	   1.08	  ±	  0.03*	   1.1	  ±	  0.1	  and	  0.12	  ±	  0.09	  
	  
 Activation	  of	  MtuCM	  5.6.5.
An	  activation	  profile	  of	  MtuCM	  activity	  by	  MtuDAH7PSY131A	  was	  obtained	  to	  gain	  insight	  into	  whether	  
the	   interaction	   between	   the	   two	   enzymes	   had	   been	   compromised	   by	   the	   Tyr131Ala	   substitution.	  
Kinetic	  assays	  were	  conducted	  under	  the	  standard	  conditions	  outlined	  in	  Section	  9.9.1.	  	  
	  
A.	   B.	   C.	  




Figure	  5.20	  Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  either	  equimolar,	  ten-­‐fold	  or	  200-­‐fold	  molar	  excess	  of	  
MtuDAH7PSWT	  (blue	  hash)	  and	  MtuDAH7PSY131A	  (orange	  hash).	  The	  burgundy	  line	  indicates	  the	  activity	  of	  MtuCM	  
alone.	  Assays	  conducted	  with	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  for	  reactions	  requiring	  a	  200-­‐fold	  
excess	   of	  MtuDAH7PS	   where	   10	   nM	   of	  MtuCM	   and	  MtuCM	   alone	   where	   90	  nM	   were	   used	   and	   the	   results	  
normalised.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	  
	  
MtuDAH7PSY131A	   is	   able	   to	   enhance	   the	   activity	   of	  MtuCM.	   The	   level	   of	   enhancement	   achieved	   by	  
MtuDAH7PSY131A	  is	  abysmal	  in	  comparison	  with	  MtuDAH7PSWT	  (Figure	  5.20).	  This	  indicates	  one	  of	  two	  
things;	  either	  MtuDAH7PSY131A	  has	  a	  reduced	  affinity	  for	  MtuCM	  and	  a	  smaller	  proportion	  of	  complex	  
is	   formed,	   or	   on	   the	   formation	   of	   the	   complex	   MtuDAH7PSY131A	   is	   unable	   to	   cause	   the	   same	  
rearrangement	  of	   the	  MtuCM	  active	  site	  essential	   for	   the	  observed	  activity	  boost.	  Both	  hypotheses	  
could	  account	  for	  the	  reduced	  enhancement	  of	  MtuCM	  activity	  observed	  for	  MtuDAH7PSY131A.	  
 Regulation	  of	  MtuCM	  by	  MtuDAH7PSY131A	  5.6.6.
Kinetic	   assays	   for	   the	   inhibition	   studies	   of	   MtuCM	   in	   the	   presence	   of	   a	   ten-­‐molar	   excess	   of	  
MtuDAH7PSY131A	   were	   conducted	   under	   the	   standard	   conditions	   outlined	   in	   Section	   9.9.3.	   The	  
inhibition	   studies	   showed	   the	  MtuCM	   activity	   of	   a	   mixture	   of	  MtuCM	   and	  MtuDAH7PSY131A	   was	  
insensitive	   to	   Phe,	   yet	   sensitivity	   to	   Tyr	   was	   preserved	   (Figure	   5.21).	   These	   results	   offer	   further	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support	  that	  Tyr131	  is	  critical	  to	  signal	  transmission	  of	  Phe	  binding,	  without	  side	  chain	  of	  Tyr131	  the	  
binding	  of	  Phe	   is	  not	  adequately	   communicated	   to	  MtuCM	  and	  consequently	  does	  not	   significantly	  
affect	  MtuCM	  activity.	  
	  
Synergistic	  inhibition	  of	  MtuCM	  activity	  by	  MtuDAH7PSY131A	  was	  observed	  in	  the	  presence	  of	  Phe	  and	  
Tyr	  and	   suggests	  both	  Phe	  and	  Tyr	   can	  bind	   simultaneously	   to	   their	  preferred	   sites.	  The	   synergistic	  
inhibition	  of	  MtuCM	  by	  MtuDAH7PSY131A	  was	  poor	  for	  combinations	  of	  Trp	  with	  either	  Phe	  or	  Tyr.	  The	  
Tyr131Ala	  substitution	  may	  have	  disrupted	  the	  communication	  of	  Trp	  binding	  to	  sites	  1	  and	  2	  and	  to	  
the	  MtuCM•MtuDAH7PS	   interface	   preventing	   synergistic	   regulation	   from	   occurring.	   Curiously,	   the	  
combination	  of	  Phe,	  Tyr	  and	  Trp	  was	  resulted	  in	  the	  greatest	  reduction	  in	  activity.	  Thus,	  Tyr	  and	  Phe	  
binding	  may	   help	   to	   re-­‐establish	   the	   communication	   pathways	   between	   the	   allosteric	   binding	   sites	  
and	   the	  MtuCM•MtuDAH7PS	   interface	   allowing	  MtuCM	   activity	   to	   be	   regulated.	   Alternatively	   Trp	  
binding	  may	  shift	  the	  MtuDAH7PSY131A	  population	  ensemble	  toward	  a	  species	  that	  exhibits	  a	  greater	  
affinity	  and	  ability	  to	  activate	  MtuCM	  than	  unliganded	  MtuDAH7PSY131.	  	  
	  




Figure	   5.21	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  (blue	  hash)	  or	  MtuDAH7PSY131A	  (orange	  hash).	  The	  
aromatic	   amino	   acids	   are	   represented	   by	   their	   one	   letter	   code;	   Trp,	   W;	   Phe,	   F	   and	   Tyr,	   Y.	   Each	   letter	   also	  
represents	   200	   µM	  of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	   presence	   of	   150	   µM	  
chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  at	  least	  duplicate	  measurements.	  
P-­‐values	  provided	  in	  appendix	  V.	  
	  
Native	  PAGE	  also	  illustrated	  the	  failure	  of	  Phe	  binding	  to	  MtuDAH7PSY131A	  to	  inhibit	  MtuCM	  activity.	  A	  
protein	  band	  observed	  on	  the	  native	  gel	  at	  ~300	  kDa	  when	  MtuDAH7PSY131A	  and	  MtuCM	  were	  both	  
present	   confirms	   MtuDAH7PSY131A	   can	   form	   a	   complex	   with	   MtuCM	   Figure	   5.22).	   This	   higher	  
molecular	  weight	  band	  associated	  with	  the	  formation	  of	  the	  complex	  MtuCM•MtuDAH7PSY131A	  is	  just	  
as	   strong,	   if	   not	   stronger	   in	   the	   presence	   of	   Phe.	   The	   retention	   of	   the	  MtuCM•MtuDAH7PSY131A	  
complex	   band	   in	   the	   presence	   of	   Phe	   is	   further	   evidence	   MtuDAH7PSY131A	   can	   not	   effectively	  








Figure	   5.22	   Amersham	   ECL	   Native	   PAGE	   with	   50	   mM	   Tris-­‐	   175	   mM	   Alanine	   running	   buffer	   pH	   9.2;	   Lane	   M	  
molecular	   weight	   marker;	   Lane	   1	   MtuDAH7PSY131A;	   Lane	   2	   MtuDAH7PSY131Awith	   MtuCM	   and	   Lane	   3	  
MtuDAH7PSY131A	  with	  MtuCM	   and	   1	  mM	  Phe.	   The	   concentration	   of	  MtuCM	   is	   approximately	   four-­‐fold	   	  molar	  
excess	  of	  MtuDAH7PS.	  
	  
 Summary	  of	  findings	  for	  MtuDAH7PSY131A	  5.6.7.
The	   SAXS	   parameters	   determined	   for	  MtuDAH7PSY131A	   suggest	   that	   although	  MtuDAH7PSY131A	   was	  
tetrameric	   it	   may	   not	   be	   identical	   to	   MtuDAH7PSWT.	   Native	   PAGE	   also	   showed	   the	   quaternary	  
structure	   equilibrium	   of	  MtuDAH7PSY131A	   had	   changed	   in	   comparison	   with	  MtuDAH7PSWT,	   the	   gel	  
showing	   MtuDAH7PSY131A	   existed	   mainly	   as	   a	   mixture	   of	   dimer	   and	   tetramer.	   Structural	  
characterisation	  of	  MtuDAH7PSG190P	  and	  MtuDAH7PSV103A	  also	  suggested	  these	  proteins	  may	  adopt	  a	  
different	   quaternary	   structure	   conformation	   than	   MtuDAH7PSWT.	   The	   catalytic	   ability	   of	  
MtuDAH7PSG190P,	  MtuDAH7PSV103A	   and	  MtuDAH7PSN237A	   are	   comparable	   to	  MtuDAH7PSWT	   and	   their	  
interaction	   with	  MtuCM	   has	   not	   been	   significantly	   impaired.	   Conversely	   the	   catalytic	   efficiency	   of	  
MtuDAH7PSY131A	   has	   been	   impaired,	   especially	   with	   respect	   to	   PEP,	   and	   the	   activation	   of	  MtuCM	  
activity	   by	  MtuDAH7PSY131A	   was	   also	   quite	   poor.	   Hence	  MtuDAH7PSY131A	   has	   probably	   adopted	   a	  
different	  conformation	  to	  the	  wild	  type	  enzyme	  and	  forms	  weaker	  interactions	  with	  MtuCM	  resulting	  
in	  poor	  activation	  of	  MtuCM	  activity.	  However,	   it	   is	  unclear	  whether	   it	   is	  the	  possible	  change	   in	  the	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conformation	   of	  MtuDAH7PSY131A	   or	   the	   substitution	   of	   Tyr131,	   which	   is	   responsible	   for	   the	   poor	  
activity	  of	  MtuDAH7PSY131A.	  
	  
DSF	  and	  ITC	  confirmed	  Trp,	  Phe	  and	  Tyr	  were	  all	  able	  to	  bind	  MtuDAH7PSY131A.	  It	  should	  also	  be	  noted	  
that	  Phe	  binding	  reduced	  the	  thermal	  stability	  of	  MtuDAH7PSY131A	  and	  may	  be	  linked	  to	  any	  change	  in	  
conformation	   or	   quaternary	   structure.	   	   ITC	   also	   provided	   evidence	   that	   Phe	   binding	   enhanced	   the	  
affinity	  of	  MtuDAH7PSY131A	   for	  Trp.	  Nonetheless	  the	   loss	  of	  the	  tyrosyl	  group	  of	  Tyr131	  has	  severely	  
disrupted	   the	   synergistic	   regulation	   of	  MtuDAH7PSWT.	   Phe,	   Tyr	   and	   Trp	   activated	  MtuDAH7PSY131A	  
activity	   and	   only	   the	   addition	   of	   all	   three	   aromatic	   amino	   acids	   could	   elicit	   a	   synergistic	   inhibitory	  
response	   that	   was	   still	   much	   less	   effective	   than	   the	   ternary	   inhibition	   of	   MtuDAH7PSWT.	   The	  
Tyr131Ala	  substitution	  may	  have	  led	  to	  MtuDAH7PSY131A	  adopting	  a	  slightly	  different	  conformation	  to	  
MtuDAH7PSWT	  with	  an	   inferior	  catalytic	  ability.	   If	   this	   is	   true	   then	   the	  activation	  of	  MtuDAH7PSY131A	  
activity	   on	  binding	   any	  of	   the	   aromatic	   amino	   acids	  may	  be	  due	   to	   the	  occupancy	  of	   the	   allosteric	  
binding	  sites	  partially	  restoring	  the	  MtuDAH7PSWT	  conformation.	  	  
	  
MtuDAH7PSY131A	  endowed	  MtuCM	  activity	  with	  regulatory	  sensitivity	  to	  Tyr,	  but	  not	  Phe,	  as	  shown	  by	  
the	  MtuCM	   inhibition	   studies	   and	   native	   PAGE.	  MtuDAH7PSY131A	   did	   not	   significantly	   synergistically	  
regulate	  MtuCM	  activity	   in	   the	  presence	  of	  Trp	  with	  either	  Phe	  or	  Tyr,	  but	   the	  combination	  of	  Phe,	  
Trp	   and	   Tyr	   showed	   evidence	   for	   synergy.	   The	   loss	   in	   synergy	   suggests	   Tyr131	  may	   play	   a	   role	   in	  
communicating	  Trp	  binding	  between	  all	  three	  allosteric	  bindings	  sites.	  
	  
It	   is	  unclear	  from	  the	  available	  crystallographic	  coordinates	  of	  the	  MtuDAH7PSWT	  how	  the	  loss	  of	  Tyr131	  had	  
such	  a	  dramatic	   impact	  on	  MtuDAH7PS	  activity.	  An	  aromatic	  amino	  acid	  residue,	  either	  Phe	  or	  Tyr,	   typically	  
occupies	   the	  position	  of	  Tyr131	  as	  shown	  by	   the	  multiple	  sequence	  alignment	  conducted	  as	  part	  of	   the	  SCA	  
analysis.115	  Hence	  the	  hydrophobic	  interaction	  of	  the	  tyrosyl	  group	  of	  Tyr131	  with	  the	  benzyl	  ring	  with	  Phe94	  
may	  be	  a	  critical	  interaction	  and	  may	  help	  to	  control	  the	  flexibility	  of	  the	  long	  β2-­‐α2	  loop	  (	  
Figure	   5.1C).	   Substitution	   of	   Tyr131	   for	   Ala,	   a	   residue	  with	   a	  much	   smaller	   side	   chain,	  may	   create	  
space	  for	  water	  to	  bind	  and	  may	  disrupt	  the	  site	  of	  substitution	  and	  thus	  allosteric	  communication.	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Comprehensive	   crystallographic	   studies	   may	   be	   conducted	   to	   determine	   if	   MtuDAH7PSY131A	   has	  
adopted	  a	  different	  conformation,	  providing	  crystal	  packing	  effects	  do	  not	  hide	  any	  small	  changes	  in	  
conformation.	  Obtaining	  crystal	  structures	  of	  MtuDAH7PSY131A	  with	  and	  without	  the	  aromatic	  amino	  
acids	   present	   may	   provide	   insight	   into	   how	   the	   ligands	   are	   causing	   activation	   of	  MtuDAH7PSY131A	  
activity.	  Crystal	  coordinates	  of	  MtuDAH7PSY131A	  may	  also	  help	  to	  clarify	  the	  role	  of	  the	  tyrosyl	  group	  of	  
Tyr131	  in	  controlling	  the	  flexibility	  or	  conformation	  of	  the	  β2-­‐α2	  loop	  and	  whether	  this	  is	  linked	  to	  the	  
changes	   in	  MtuDAH7PS	  conformation.	  Alternatively	  MD	  simulations	  can	  be	  used	  to	  gain	   insight	   into	  
how	   the	   Tyr131Ala	   substitution	   may	   have	   affected	   the	   molecular	   motion	   and	   conformation	   of	  
MtuDAH7PSY131A.	  
	  
 Investigating	  the	  role	  of	  Asn175	  5.7.
 Kinetic	  parameters	  5.7.1.
	  The	  kinetic	  parameters	  of	  MtuDAH7PSN175A	  were	  derived	  from	  the	  Michaelis-­‐Menten	  kinetics	  under	  
standard	  assay	  conditions	  detailed	  in	  Section	  9.9.1.	  The	  kinetic	  parameters	  of	  MtuDAH7PSN175A	  were	  
interesting	  because	  the	  increase	  in	  kcat	  was	  accompanied	  by	  an	  increase	  in	  the	  Km	  values	  for	  both	  E4P	  
and	  PEP	  ultimately	  resulting	   in	  only	  a	  small	  difference	   in	  the	  determined	  catalytic	  efficiency	  of	  each	  
substrate	   compared	   to	  MtuDAH7PSWT	   (Table	   5.9).	   Thus	   the	   substitution	   of	   Asn175	   to	   Ala	   has	   not	  
seriously	  harmed	  the	  catalytic	  efficiency	  of	  the	  enzyme.	  
	  
Table	   5.9	   Kinetic	   parameters	   determined	   from	   a	   single	   set	   of	  Michaelis-­‐Menten	   kinetics	   of	  MtuDAH7PSN175A.	  
Michaelis-­‐Menten	  plots	  are	  shown	  in	  Appendix	  I.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  
squares	  fit.	  










E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
N175A	   61	  ±	  8	   89	  ±	  7	   7.6	  ±	  0.2	   150	  ±	  20	   100	  ±	  10	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 Disruption	  of	  feedback	  regulation	  	  5.7.2.
Feedback	   inhibition	   studies	  were	   conducted	   under	   the	   standard	   conditions	   stated	   in	   Section	  9.9.3.	  
The	   changes	   in	  both	  MtuDAH7PSR171A	   and	  MtuDAH7PSN175A	   are	   located	  at	   the	  Phe-­‐selective	  binding	  
site,	   site	   1.	   Thus	   it	   was	   unsurprising	   to	   find	   that,	   like	  MtuDAH7PSR171A,	  MtuDAH7PSN175A	   activity	  
showed	   significantly	   reduced	   sensitivity	   to	   the	   combination	  of	   Trp	  and	  Phe	   (Figure	  5.23).	  However,	  
unlike	  MtuDAH7PSR171A,	   which	   showed	   reduced	   sensitivity	   to	   all	   combinations	   of	   aromatic	   amino	  
acids,	  MtuDAH7PSN175A	  activity	  showed	  increased	  sensitivity	  to	  Trp	  and	  Tyr.	  The	  ternary	  combination	  
of	  all	  three	  aromatic	  amino	  acids	  greatly	  reduced	  the	  MtuDAH7PSN175A	  activity,	  but	  the	  reduction	  was	  
not	  as	  severe	  as	  observed	  for	  MtuDAH7PSWT.	  Asn175	  appears	  to	  be	  critical	   for	   the	  signalling	  of	  Phe	  
binding	   to	   the	   active	   site.	   Furthermore	   as	   MtuDAH7PSN175A	   has	   improved	   sensitivity	   to	   the	  
combination	  of	  Trp	  and	  Tyr,	  this	  suggests	  Asn175	  may	  play	  a	  role	  in	  distinguishing	  between	  Phe	  and	  
Tyr	  binding	  at	  site	  1.	  	  
	  
Figure	   5.23	   Remaining	   activity	   of	  MtuDAH7PSWT	   (blue)	  MtuDAH7PSN175A	   (yellow)	   in	   the	   presence	   of	   various	  
single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  Assays	  conducted	  in	  the	  presence	  of	  150	  µM	  E4P	  and	  PEP.	  Error	  bars	  depict	  the	  standard	  deviation	  
of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	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 Thermal	  stability	  in	  the	  presence	  of	  ligand	  5.7.3.
Unfortunately,	   due	   to	   limitations	   on	   time	   and	   available	   protein	   and	   the	   stability	   of	   the	   protein,	  
studying	   ligand	   binding	   to	  MtuDAH7PSN175A	   by	   isothermal	   titration	   calorimetry	   was	   impractical.	   To	  
gain	   some	   insight	   into	   whether	   the	   aromatic	   amino	   acids,	   particularly	   Phe,	   could	   bind	   to	  
MtuDAH7PSN175A	   DSF	   was	   used.	   All	   assays	   were	   conducted	   under	   equivalent	   standard	   conditions	  
outline	  in	  Section	  9.8.1.	  	  
	  
As	   seen	   for	   some	   previous	  MtuDAH7PS	   variants,	  MtuDAH7PSN175A	   displayed	   an	   unexpected	   loss	   of	  
thermal	  stability	  of	  ~6	   ˚C	  due	  to	   the	  substitution	  of	  Asn175	   (Figure	  5.24).	  Trp	  and	  Tyr	  binding	  were	  
clearly	  evident	  by	  the	  observed	  increases	  in	  the	  thermal	  melting	  temperature	  (Tm)	  when	  compared	  to	  
the	   unliganded	   enzyme.	   Tyr	   caused	   a	   shift	   in	   the	   Tm	  of	  MtuDAH7PS
N175A,	   of	   ~5	   ˚C	   greater	   than	   the	  
~1	  ˚C	  shift	  observed	  for	  MtuDAH7PSWT.	  The	  bigger	  increase	  in	  Tm	  suggests	  the	  substitution	  of	  Asn175	  
does	  not	  negatively	  impact	  Tyr	  binding	  and	  may	  have	  even	  improved	  it.	  	  
	  
Figure	   5.24	   The	  effect	   of	   individual,	   binary	   and	   ternary	   combinations	  of	   aromatic	   amino	  acids	  on	   the	   thermal	  
stability	   of	  MtuDAH7PSWT	   (blue)	   and	  MtuDAH7PSN175A	   (yellow).	   The	   aromatic	   amino	   acids	   are	   represented	   by	  
their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  
amino	  acids.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  
V.	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The	  presence	  of	  Phe	  however	  causes	   little	  change	  to	  the	  thermal	  stability	  of	  MtuDAH7PSN175A,	  even	  
when	  combined	  with	  Trp	  or	  Tyr.	  The	  lack	  of	  change	  in	  thermal	  stability	  suggests	  at	  a	  concentration	  of	  
200	  µM	  Phe	  does	  not	  bind	  to	  MtuDAH7PSN175A	  or	  at	  least	  Phe	  binding	  does	  not	  offer	  MtuDAH7PSN175A	  
any	  gain	   in	   thermal	   stability.	  Thus	  Asn175	  appears	   to	  be	  a	  critical	   residue	   for	  either	  Phe	  binding	   to	  
occur	  at	  site	  1	  or	  for	  signal	  transmission	  from	  site	  1.	  	  
 Activation	  of	  MtuCM	  5.7.4.
The	   ability	   of	   MtuDAH7PSN175A	   to	   activate	   MtuCM	   was	   very	   similar	   to	   MtuDAH7PSWT	   until	   the	  
concentration	  of	  MtuDAH7PSN175A	  reached	  a	  200-­‐fold	  molar	  excess	  (Figure	  5.25).	  At	  a	  200-­‐fold	  molar	  
excess	  of	  MtuDAH7PSN175A,	  MtuCM	  activity	   reached	  ~120	  mM	  min-­‐1	  mg-­‐1,	  nearly	  double	   the	  activity	  
boost	   achieved	   by	  MtuDAH7PSWT.	   The	   enhanced	   activation	   of	  MtuCM	   by	  MtuDAH7PSN175A	   at	   high	  
molar	  excess	   implies	  Asn175	  may	  be	  part	  of	   the	  signalling	  pathway	   from	  site	  1	   to	   the	   inter-­‐protein	  
interface	   and	   across	   to	   the	  MtuCM	  active	   site.	   The	   substitution	   of	   Asn175	  may	   have	   unexpectedly	  
improved	  the	  interaction	  between	  MtuCM	  and	  MtuDAH7PS.	  
	  	  
Figure	  5.25	  Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  either	  equimolar,	  ten-­‐fold	  or	  200-­‐fold	  molar	  excess	  of	  
MtuDAH7PSWT	  (blue	  hash)	  and	  MtuDAH7PSN175A	  (yellow	  hash).	  The	  burgundy	  line	  indicates	  the	  activity	  of	  MtuCM	  
alone.	  Assays	  conducted	  with	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  for	  reactions	  requiring	  a	  200-­‐fold	  
excess	   of	  MtuDAH7PS	   where	   10	   nM	   of	  MtuCM	   and	  MtuCM	   alone	   where	   90	   nM	   were	   used	   and	   the	   results	  
normalised.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	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 Regulation	  of	  MtuCM	  activity	  by	  5.7.5.
MtuDAH7PSN237A	  
	  
To	   understand	   how	   the	   Asn175Ala	   substitution	   affected	   the	   ability	   of	  MtuDAH7PSN175A	   to	   regulate	  
MtuCM	   activity,	   further	   inhibition	   studies	   were	   carried	   out	   using	   a	   mixture	   of	   MtuCM	   and	  
MtuDAH7PSN175A.	   All	   the	  MtuCM	   kinetic	   assays	   were	   conducted	   in	   accordance	   with	   the	   standard	  
protocol	  outlined	  in	  Section	  9.9.3.	  	  
	  
MtuCM	  activity	  showed	  a	  poor	  response	  to	  the	  presence	  of	  either	  Phe	  or	  Tyr	  despite	  the	  fact	  that	  Tyr	  
(with	   Trp)	   was	   able	   to	   regulate	  MtuDAH7PSN175A	   activity	   (Figure	   5.26).	   The	   insensitivity	   of	  MtuCM	  
activity	   to	   Tyr	   and	   Phe	  was	   also	   seen	   for	  MtuDAH7PSR171A,	   and	   confirmed	   site	   1	   of	  MtuDAH7PS	   is	  
essential	  for	  the	  regulation	  of	  MtuCM	  by	  Tyr	  and	  Phe	  alone.	  The	  combination	  of	  Phe	  and	  Tyr	  resulted	  
in	  a	  greater	   loss	  of	  MtuCM	  activity	   than	  either	  amino	  acid	  could	  achieve	  on	   its	  own.	  The	   improved	  
inhibition	   for	   the	   combination	   of	   Tyr	   and	   Phe	   suggests	   both	   amino	   acids	   are	   able	   to	   bind	  
simultaneously	  thus	   it	   is	  highly	  probable	  Phe	  is	  still	  able	  to	  bind	  to	  site	  1	  of	  MtuDAH7PSN175A,	  as	  Tyr	  
would	  preferentially	  bind	  to	  site	  2,	  the	  Tyr-­‐selective	  site.	  
	  
The	  most	   surprising	   result	   from	   the	   inhibition	   studies	  was	   that	   Trp	   inhibited	  MtuCM	   activity	   for	   a	  
mixture	  of	  MtuCM	  and	  MtuDAH7PSN175A	   incredibly	  well,	   reducing	  activity	   to	  ~5	  %.	  The	  sensitivity	   to	  
Trp	   is	   further	   evidence	   that	   site	   1	   is	   able	   to	   communicate	   to	   both	   the	   Trp	   site	   and	   the	  
MtuCM•MtuDAH7PS	   interface.	  Curiously	   the	  addition	  of	  Trp	  and	  Tyr	   to	   the	  mixture	  of	  MtuCM	  and	  
MtuDAH7PSN175A	  resulted	  in	  less	  effective	  MtuCM	  inhibition.	  Addition	  of	  Trp	  and	  Phe	  did	  not	  display	  
any	   synergistic	   inhibitory	   effect	   on	   MtuCM	   activity;	   further	   proof	   Asn175	   is	   essential	   for	  
communication	  between	  site	  1	  and	  the	  Trp	  site.	  	  
	  




Figure	   5.26	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSWT	  (blue	  hash)	  or	  MtuDAH7PSN175A	  (yellow	  hash).	  The	  
aromatic	   amino	   acids	   are	   represented	   by	   their	   one	   letter	   code;	   Trp,	   W;	   Phe,	   F	   and	   Tyr,	   Y.	   Each	   letter	   also	  
represents	   200	   µM	  of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	   presence	   of	   150	   µM	  
chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  at	  least	  duplicate	  measurements.	  
P-­‐values	  provided	  in	  appendix	  V.	  
	  
Native	  PAGE	  confirmed	  the	  MtuDAH7PSN175A	  was	  less	  susceptible	  to	  inhibition	  by	  Phe,	  and	  is	  unable	  
to	   cause	   the	  dissociation	  of	  MtuCM•MtuDAH7PSN175A	   complex.	  The	  ~300	  kDa	  molecular	  mass	  band	  
observed	  only	  when	  both	  MtuCM	  and	  MtuDAH7PSN175A	  are	  present	  corresponds	  to	  the	  formation	  of	  
the	  MtuCM•MtuDAH7PSN175A	  complex.	  This	  higher	  molecular	  mass	  band	  diminished	  in	  the	  presence	  
of	  Phe	  for	  the	  wild	  type	  enzyme	  (Section	  4.8.1)	  but	  for	  a	  mixture	  of	  MtuCM	  and	  MtuDAH7PSN175A	   in	  
the	   presence	   of	   Phe	   the	   ~300	   kDa	   band	   remained	   (Figure	   5.27).	   The	   native	   gel	   provides	   evidence	  
Asn175	  is	  essential	  for	  effective	  regulation	  of	  MtuCM	  activity	  by	  Phe.	  It	  is	  clear	  the	  loss	  of	  the	  amide	  
group	   of	   Asn175	   is	   fundamental	   to	   the	   signalling	   between	   the	   allosteric	   binding	   sites	   of	  
MtuDAH7PSN175A	  but	  also	  from	  the	  allosteric	  sites	  to	  MtuCM•MtuDAH7PS	  inter-­‐protein	  interface.	  	  




Figure	   5.27	   Amersham	   ECL	   Native	   PAGE	   with	   50	   mM	   Tris-­‐	   175	   mM	   Alanine	   running	   buffer	   pH	   9.2;	   Lane	   M	  
molecular	   weight	   marker;	   Lane	   1	   MtuDAH7PSY131A;	   Lane	   2	   MtuDAH7PSY131Awith	   MtuCM	   and	   Lane	   3	  
MtuDAH7PSY131A	   with	  MtuCM	   and	   1	  mM	   Phe.	   The	   concentration	   of	  MtuCM	   is	   approximately	   four-­‐fold	  molar	  
excess	  of	  MtuDAH7PS.	  
	  
 Summary	  of	  findings	  for	  MtuDAH7PSN175A	  5.7.6.
The	  quaternary	  structure	  of	  MtuDAH7PSN175A	  was	  shown	  to	  be	  unaffected	  by	  SAXS	  and	  native	  PAGE.	  
The	  activity	  of	  MtuDAH7PSN175A	  was	  not	  notably	  affected	  by	  the	  introduced	  substitution.	  The	  ability	  of	  
MtuDAH7PSN175A	   to	   activate	  MtuCM	   was	   impressively	   enhanced,	   with	   a	   200-­‐fold	   molar	   excess	   of	  
MtuDAH7PSN175A	   doubling	   the	   MtuCM	   activity	   achieved	   by	   MtuDAH7PSWT.	   Interestingly	  
MtuDAH7PSR171A,	   another	  MtuDAH7PS	   variant	   with	   a	   substitution	   located	   at	   site	   1,	   also	   roughly	  
doubled	   the	   MtuCM	   activity	   in	   comparison	   to	   MtuDAH7PSWT.	   The	   superior	   ability	   of	   both	  
MtuDAH7PSN175A	  and	  MtuDAH7PSR171A	   to	  boost	  MtuCM	  activity	  suggest	  site	  1	   is	   inherently	   linked	  to	  
the	  MtuCM•MtuDAH7PS	  interface,	  about	  45	  Å	  away.	  
	  
DSF	   showed	   that	   Trp	  and	  Tyr	  were	  able	   to	  bind	  MtuDAH7PSN175A.	   Phe	  did	  not	   cause	  an	   increase	   in	  
thermal	  stability	  of	  MtuDAH7PSN175A,	  but	  ITC	  analysis	  is	  required	  to	  verify	  whether	  Phe	  is	  able	  to	  bind	  
with	  any	  significant	  affinity	  to	  the	  enzyme.	  The	  sensitivity	  of	  MtuDAH7PSN175A	  activity	  to	  Trp	  and	  Tyr	  
had	   improved	   slightly.	   The	   sensitivity	   of	  MtuDAH7PSN175A	   activity	   to	   Trp	   and	   Phe	   was	   significantly	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diminished	   but	   had	   not	   been	   eliminated	   suggesting	   Phe	   may	   still	   be	   able	   to	   bind	   to	   the	   enzyme.	  
Assuming	  Phe	  can	  bind	  with	  a	  reasonable	  affinity	  to	  MtuDAH7PSN237A,	  the	  diminished	  sensitivity	  to	  the	  
combination	  of	  Trp	  and	  Phe,	  means	  Asn175	  must	  contribute	  to	  the	  communication	  pathway	  between	  
site	  1	  and	  the	  active	  site	  and/or	  between	  site	  1	  and	  the	  Trp	  site.	  ITC	  is	  needed	  to	  identify	  whether	  Phe	  
can	   bind	   to	  MtuDAH7PSN175A	   and	   if	   so	   whether	   it	   influences	   or	   is	   influenced	   by	   Trp	   binding.	   This	  
information	   is	   required	   to	   fully	   understand	   the	   impact	   the	   Asn175Ala	   substitution	   has	   had	   on	   the	  
regulatory	  network	  of	  MtuDAH7PS.	  
	  
The	  interaction	  between	  the	  amide	  of	  Asn175	  and	  the	  bound	  ligand	  at	  site	  1	  may	  not	  be	  absolutely	  essential	  
for	  an	  inhibitory	  response	  to	  Trp	  in	  combination	  with	  Phe	  or	  Tyr	  as	  proposed	  previously.126	  Instead	  it	  appears	  
from	   this	   study	   the	   interaction	   of	   Asn175	  with	   the	   bound	   ligand	   at	   site	   1	  may	   allow	   the	   site	   to	   distinguish	  
between	  Phe	  and	  Tyr	  binding.	  It	  should	  be	  noted	  that	  the	  amide	  group	  of	  Asn175	  coordinates	  to	  the	  amine	  and	  
carbonyl	  groups	  of	  the	  bound	  ligand,	  for	  both	  Tyr	  and	  Phe	  (	  
Figure	   5.1A).	   Thus	   it	   is	   not	   obvious	   exactly	   how	   Asn175	   may	   enable	   the	   enzyme	   to	   differentiate	  
between	  Phe	  and	  Tyr	  binding.	  It	  is	  probable	  to	  some	  degree	  that	  all	  the	  residues,	  which	  contribute	  to	  
the	  formation	  of	  Site	  1,	  collectively	  distinguish	  between	  Phe	  and	  Tyr	  binding.	  ITC	  may	  be	  able	  to	  show	  
if	  Asn175	  is	  truly	  critical	  for	  distinguishing	  between	  Phe	  and	  Tyr	  binding.	  	  
	  
Native	  PAGE	  and	  MtuCM	  inhibition	  studies	  showed	  MtuDAH7PSN175A	  could	  not	  inhibit	  MtuCM	  activity	  
in	   the	   presence	   of	   Phe	   or	   Tyr	   very	  well.	   The	   loss	   of	   the	   amide	   group	   of	   Asn175	   has	   disrupted	   the	  
signal	   transmission	   of	   ligand	   binding	   at	   site	   1	   to	   the	   MtuCM•MtuDAH7PS	   interface.	   Rather	  
unexpectedly,	   inhibition	   studies	   also	   showed	   MtuDAH7PSN175A	   endowed	   MtuCM	   activity	   with	  
sensitivity	   to	   Trp.	   The	   addition	   of	   Tyr	   somewhat	   reduced	   the	   inhibitory	   affect	   of	   Trp,	   making	  
combinations	   of	   allosteric	   amino	   acids	   including	   Trp	   and	   Tyr	   less	   effective	   than	   Trp	   alone.	   These	  
findings	  suggest	  the	   interactions	  of	  the	   ligand	  with	  the	  amide	  group	  of	  Asn175	  are	  essential	   for	  the	  
correct	   signal	   transmission	   between	   the	   allosteric	   binding	   sites	   and	   to	   the	   MtuCM•MtuDAH7PS	  
interface.	  





The	  SCA	  and	  MD	  analyses	  of	  MtuDAH7PS	  predicted	  a	   cluster	  of	   coevolved	   residues,	  believed	   to	  be	  
inherently	   involved	   in	   signal	   transmission	  between	  both	   the	  different	  allosteric	  binding	  sites	  and	   to	  
the	   MtuDAH7PS	   active	   site.	   This	   network	   of	   residues	   is	   thought	   to	   transmit	   subtle	   changes	   in	  
flexibility	  or	  molecular	  motion	  across	  the	  enzyme	  ultimately	  providing	  entropic	  control	  of	  the	  affinity	  
of	  each	  binding	  site	  for	  its	  ligand.71,115	  
	  
From	  the	  residues	  identified	  from	  the	  SCA	  and	  MD	  analysis,	  four	  MtuDAH7PS	  variants	  were	  generated	  
to	  verify	  experimentally	  whether	   the	   residues	  were	   readily	   involved	   in	   the	  communication	  network	  
between	   allosteric	   binding	   sites	   and	   to	   the	   active	   site.	   These	   variants,	   MtuDAH7PSG190P,	  
MtuDAH7PSV103A,	  MtuDAH7PSY131A	  and	  MtuDAH7PSN175A	  were	  all	  successfully	  expressed	  and	  purified.	  
CD	  revealed	  the	  secondary	  structure	  of	  all	  the	  variants	  to	  be	  similar	  to	  MtuDAH7PSWT	  but	  SAXS,	  AUC	  
and	  native	  PAGE	   revealed	  more	   subtle	   changes	   to	   the	  quaternary	   structure	  equilibrium	  of	   some	  of	  
the	  MtuDAH7PS	   variants.	   All	   four	   variants	   were	   catalytically	   active,	   but	   for	  MtuDAH7PSG190P	   and	  
MtuDAH7PSY131A	  the	  kinetic	  parameters	  varied	  widely	  from	  MtuDAH7PSWT.	  
	  
Gly190	  is	  absolutely	  essential	  for	  inhibition	  of	  MtuDAH7PS	  activity	  and	  synergy	  between	  the	  Trp	  site	  and	  sites	  
1	  and	  2	  as	  demonstrated	  by	  the	  kinetic	  analysis	  of	  MtuDAH7PSG190P.	  This	  Gly190Pro	  substitution	  was	  intended	  
to	   reduce	   the	   flexibility	  of	  α2-­‐α2a	   loop,	  and	   these	   results	   therefore	   imply	   that	   this	   flexibility	   is	  essential	   for	  
allosteric	   communication	   to	   and	   from	   the	   Trp	   site.	   However,	   the	   substitution	   may	   also	   prevent	   Ala192,	  
another	  residue	  also	  located	  on	  the	  α2-­‐α2a	  loop	  (	  
Figure	  5.1B)	  from	  hydrogen	  bonding	  to	  the	  bound	  Trp	  ligand	  at	  the	  Trp	  site.	  The	  Ala192	  contact	  with	  
the	  bound	  Trp	   ligand	  may	  be	  necessary	   for	  Trp	  binding	   to	  be	  communicated	   to	   the	  other	  allosteric	  
binding	  sites	  and	  the	  active	  site.	  Gly190	  does	  not	  play	  a	  role	   in	  the	  communication	  in	  the	  inhibitory	  
response	  of	  Phe	  and	  Tyr	  to	  MtuCM.	  	  
	  
Substitution	   of	   Val103	   for	   Ala	   also	   disrupted	   the	   synergistic	   inhibition	   of	  MtuDAH7PS	   and	  MtuCM	  
activities.	   Illustrating	   the	   SCA	   correctly	   identified	   Val103	   as	   a	   critical	   member	   of	   the	   signal	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transmission	   network	   of	   residues	   responsible	   for	   communicating	   ligand	   binding	   between	   allosteric	  
binding	   sites	   and	   the	   active	   site.	   The	   hydrophobic	   contacts	   formed	   between	   Val103	   and	   Leu194,	  
which	   is	  also	   located	  on	  the	  α2-­‐α2a	   loop,	  may	  ensure	  the	  α2-­‐α2a	   loop	   is	   in	   the	  correct	  position	  for	  
Ala192	   to	   form	  a	  hydrogen	  bond	   to	   the	  bound	  Trp	   ligand.	  Val103	  also	   forms	  hydrophobic	   contacts	  
with	  Leu107,	  which	  contributes	  to	  the	  formation	  of	  the	  hydrophobic	  pocket	  for	  Trp	  binding	  at	  the	  Trp	  
site.	   The	   interactions	   of	   Val103	   with	   Leu194	   and	   Leu107	   are	   just	   two	   interactions	   that	   could	   be	  
affected	   by	   the	   Val103	   substitution	   that	   in	   turn	   may	   effect	   Trp	   binding	   or	   communication	   of	   Trp	  
binding	  from	  the	  Trp	  site.	  
	  
MtuDAH7PSY131A	  had	  poor	  catalytic	  efficiency	  and	  poorly	  activated	  and	  regulated	  MtuCM	  activity.	   It	  
was	   proposed	   that	   the	   substitution	   of	   Tyr131	   may	   result	   in	   a	   pseudo	   Phe-­‐bound	   species	   of	  
MtuDAH7PS,	  which	  was	  catalytically	  unfavourable	  and	  weakened	  the	  interaction	  of	  MtuDAH7PSY131A	  
with	  MtuCM.	  The	   loss	  of	   the	  tyrosyl	  side	  chain	  of	  Tyr131	  correlated	  with	  a	  severe	   loss	  of	   inhibitory	  
sensitivity	  of	  MtuDAH7PS	  and	  MtuCM	  activity.	  However,	  all	  three	  aromatic	  amino	  acids	  were	  able	  to	  
activate	  MtuDAH7PS	  activity.	  Tyr131	  is	  located	  near	  the	  tight	  dimer	  interface	  on	  the	  β2-­‐α2	  loop	  and	  
may	   influence	   the	   conformation	   of	   the	   dimer/tetramer	   as	   part	   of	   the	   mechanism	   of	   inhibition	   of	  
MtuDAH7PS.	  
	  
Finally	  substitution	  of	  Asn175	  at	  the	  Phe-­‐selective	  binding	  site,	  site	  1,	  unsurprisingly	  resulted	  in	  both	  
MtuDAH7PS	   and	   MtuCM	   activity	   displaying	   decreased	   sensitivity	   to	   Phe.	   More	   interestingly	  
MtuDAH7PSY131A	   showed	   increased	   sensitivity	   to	   Trp	   and	   Tyr	   and	   MtuCM	   activity	   maintained	  
sensitivity	   to	   Tyr	   in	   the	   presence	   of	  MtuDAH7PSN175A.	   Thus	   Asn175	   may	   play	   a	   significant	   role	   in	  
distinguishing	   between	   Tyr	   and	   Phe	   binding	   at	   site	   1.	   Intriguingly	  MtuCM	   activity	   became	   highly	  
sensitive	  to	  the	  addition	  of	  Trp	   in	  the	  presence	  of	  MtuDAH7PSN175A,	  but	   the	  MtuCM	  activity	  was	  no	  
longer	   synergistically	   inhibited.	  Thus	   the	   loss	  of	   the	  amide	  group	  of	  Asn175	  has	   interfered	  with	   the	  
signal	   transmission	   between	   allosteric	   binding	   sites	   and	   between	   allosteric	   binding	   sites	   and	   the	  
MtuCM•MtuDAH7PS	  interface.	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This	   work	   proved	   far	   more	   successful	   than	   first	   anticipated,	   the	   dramatic	   changes	   in	   regulatory	  
response	  to	  the	  aromatic	  amino	  acids	  observed	  were	  not	  expected	  from	  single	  residue	  substitutions.	  
All	  four	  residues	  identified	  by	  the	  SCA	  and	  MD	  studies	  were	  found	  to	  disrupt	  the	  synergistic	  inhibition	  
of	  MtuDAH7PS	  and	  MtuCM	  to	  varying	  degrees.	  Each	  residue	  was	  shown	  to	  be	  critical	   to	  the	  proper	  
signal	  transmission	  of	  aromatic	  amino	  acid	  binding	  across	  the	  enzyme	  to	  the	  other	  allosteric	  binding	  
sites,	  the	  active	  site	  and	  the	  MtuCM•MtuDAH7PS	  interface.	  This	  work	  has	  successfully	  validated	  the	  
SCA	  and	  MD	  analysis	  by	  providing	  evidence	  that	   four	  of	   the	  residues	   identified	   in	   the	  analysis	  were	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6. MtuDAH7PS	   variants	   used	   to	   examine	   Trp	  
site	  residues.	  
6.1. Introduction	  
The	   sophisticated	   feedback	   regulation	   of	  MtuDAH7PS	   activity	   is	   reliant	   on	   the	   presence	   of	   Trp	   in	  
combination	   with	   either	   Phe	   or	   Tyr	   to	   elicit	   an	   inhibitory	   response.	   Crystallographic	   studies	   have	  
shown	  the	  allosteric	   ligand	  binding	  site	  near	   the	  weak	  dimer	   interface	   is	   the	  only	  site	  Trp	  has	  been	  
observed	   to	   occupy,	   and	   accordingly	   the	   site	   is	   identified	   as	   the	   Trp	   site.48,70,126	   As	   Trp	   binding,	  
presumably	   at	   the	   Trp	   site,	   is	   essential	   for	   inhibition	   of	  MtuDAH7PS	   activity	   there	   is	   a	   need	   for	   a	  
better	  understanding	  of	  the	  interactions	  between	  Trp	  and	  MtuDAH7PS.	  
	  
The	   work	   described	   within	   this	   chapter	   investigated	   some	   of	   the	   critical	   interactions	   that	   form	  
between	  MtuDAH7PS	   and	   the	   bound	   Trp	   at	   the	   Trp	   site	   and	   explores	   how	   Trp	   binding	   may	   be	  
communicated	  to	  the	  active	  site	  and	  the	  other	  allosteric	  binding	  sites,	  sites	  1	  and	  2.	  SDM	  was	  used	  to	  
substitute	  key	  binding	  site	  residues	  to	  prevent	  critical	  interactions	  between	  the	  Trp	  ligand	  and	  the	  Trp	  
site.	   These	   variant	   enzymes	   were	   characterised	   by	   a	   range	   of	   kinetic,	   structural	   and	   biophysical	  
techniques.	  
6.1.1. Formation	  of	  the	  Trp	  site	  
The	  Trp	  site	  is	  located	  near	  the	  weak	  dimer	  interface	  of	  MtuDAH7PS	  (Figure	  6.1A).	  Inspection	  of	  the	  
Trp-­‐	  and	  Phe-­‐bound	  MtuDAH7PS	  crystal	   structure	   (PDB	  code:	  3NV8)	   reveals	   that	  Trp	  binds	  within	  a	  
pocket	  formed	  between	  the	  inserted	  helices	  α2a	  and	  α2b	  and	  the	  core	  barrel.	  The	  carbonyl	  oxygen	  of	  
Trp	  forms	  hydrogen	  bonds	  with	  the	  amine	  group	  of	  Lys123	  (β2	  beta	  sheet).	  The	  α-­‐amino	  group	  of	  Trp	  
forms	  hydrogen	  bonds	  with	  both	  Thr240	  and	  Asn237	  (α2b-­‐β3	  loop).	  The	  backbone	  carbonyl	  oxygen	  of	  
Ala192	   forms	  a	  polar	  contact	   to	   the	  nitrogen	  of	   the	   indole	   ring	  of	   the	  bound	  Trp	  molecule.	  Several	  
hydrophobic	   residues,	   Val111,	   Leu107,	   Leu194,	   Val197	   and	   Ala241	   (α1	   helix	   and	   α2a-­‐α2b	   loop)	  
contribute	   to	   the	   formation	   of	   a	   hydrophobic	   cavity	   into	   which	   the	   indole	   ring	   of	   Trp	   is	   buried.	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Alignment	   of	   the	   tetrameric	   Trp-­‐bound	   crystal	   structure	   (PDB	   code:	   3NUE)	  with	   the	   Trp-­‐	   and	   Phe-­‐
bound	  crystal	  structure	  does	  not	  reveal	  any	  significant	  changes	  to	  the	  positions	  of	  residues	  at	  the	  Trp	  
site	  as	  a	  result	  of	  Phe	  binding	  at	  the	  site	  1	  and	  site	  2	  (Cα	  RMSD	  0.189	  Å)	  (Figure	  6.1D).	  
	  
Alignment	  of	   the	   tetrameric	  Trp-­‐	  and	  Phe-­‐bound	  crystal	   structure	  of	  MtuDAH7PS	   (PDB	  code:	  3KGF)	  
with	  the	  tetrameric	  unliganded	  crystal	  structure	  (PDB	  code:	  3NV8,	  Cα	  RMSD	  0.271	  Å)	  shows	  that	  Trp	  
binding	  causes	  some	  rearrangement	  of	  the	  residues	  of	  the	  Trp	  site	  (Figure	  6.1B).	  The	  α2-­‐β3	  loop	  has	  
moved,	  most	  notably	  moving	  Gln239,	  Thr	  240	  and	  Asn237	  (Cα)	  6.8,	  2.1	  and	  4.6	  Å	  respectively	  toward	  
the	   bound	   Trp	   ligand	  when	   Trp	   binds.	   The	   residues,	  which	   form	   the	   hydrophobic	   pocket,	   undergo	  
minor	  repositioning	  on	  Trp	  binding	  to	  create	  more	  room	  for	  the	  indole	  group	  of	  the	  Trp	  ligand.	  
	  




Figure	  6.1	  Critical	  residues	  involved	  in	  ligand	  binding	  at	  the	  Trp	  site.	  A.	  MtuDAH7PS	  Trp	  and	  Phe	  soaked	  crystal	  
structure	  (PDB	  code:	  3KGF,	  2.00	  Å	  resolution).	  Backbone	  carbons	  are	  shown	  in	  cartoon	  form	  with	  the	  core	  barrel,	  
inserted	  helices	  and	  N-­‐terminal	  extension	  coloured	  blue,	  yellow	  and	  red	  respectively	  and	  key	  residues	  shown	  in	  
stick	   form.	   The	   carbons	   of	   the	   bound	   Trp	   ligand	   are	   shown	   in	   orange,	   coordinated	   waters	   are	   shown	   as	   red	  
spheres	  and	  the	  dashed	  grey	  lines	  represent	  hydrogen	  bonding	  interactions.	  B.	  Alignment	  of	  A.	  with	  non-­‐liganded	  
crystal	  structure	  (PDB	  code:	  3NV8,	  2.25	  Å	  resolution,	  Cα	  RMSD	  0.271	  Å).	  Key	  residues	  of	  3NV8	  are	  shown	  as	  sticks	  
in	   light	   blue	   and	  wheat	   (coloured	   by	   core	   and	   inserted	   helices	   respectively).	   C.	   Alignment	   of	   A.	   with	   the	   low	  
concentration	  Trp	  soaked	  crystal	  structure	  (PDB	  code:	  3NUE,	  2.50	  Å	  resolution,	  Cα	  RMSD	  0.189	  Å).	  Key	  residues	  
of	   3NUE	  are	   shown	  as	   sticks	   in	   hot	   pink	   and	  dark	  purple	   (coloured	  by	   core	   and	   inserted	  helices	   respectively),	  
carbons	  of	  the	  Trp	  ligand	  are	  coloured	  dark	  green	  and	  hydrogen	  bonds	  are	  shown	  in	  red.	  D.	  Alignment	  of	  A.	  with	  
the	  high	  concentration	  Phe	  soaked	  crystal	  structure	  (PDB	  code:	  3NUD,	  3.00	  Å	  resolution,	  Cα	  RMSD	  0.303	  Å).	  Key	  
residues	  of	  3NUD	  are	  shown	  as	  sticks	  in	  grey	  and	  light	  green	  (coloured	  by	  core	  and	  inserted	  helices	  respectively),	  
carbons	  of	  the	  bound	  Tyr	  ligand	  are	  coloured	  red	  and	  hydrogen	  bonds	  are	  shown	  in	  red.	  
	  
One	  crystal	  structure	  of	  MtuDAH7PS	  was	  found	  to	  have	  Phe	  bound	  at	  all	   the	  allosteric	  binding	  sites	  
including	  the	  Trp	  site	  when	  the	  crystal	  was	  soaked	  at	  very	  high	  concentrations	  of	  Phe	  (>2mM)	  (PDB	  
code:	  3NUD).	  Alignment	  of	   this	  Phe-­‐bound	  tetrameric	  MtuDAH7PS	  structure	  with	  the	  Trp-­‐	  and	  Phe-­‐
A.	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bound	  MtuDAH7PS	  structure	  (PDB	  code:	  3KGF)	  (Cα	  RMSD	  0.303	  Å)	  revealed	  some	  minor	  changes	  in	  
the	   interactions	  between	  MtuDAH7PS	  and	   the	  bound	   ligand	   (Figure	  6.1C).	   The	  phenyl	   group	  of	   the	  
Phe	   ligand	  was	   buried	   in	   the	   hydrophobic	   pocket	   causing	   similar	   repositioning	   of	   the	   hydrophobic	  
residues	  that	  form	  the	  pocket	  as	  observed	  for	  Trp	  binding.	  The	  most	  notable	  differences	  between	  Trp	  
and	  Phe	  binding	  at	  the	  Trp	  site	  were	  changes	  to	  the	  polar	  contacts	  they	  formed	  with	  MtuDAH7PS.	  As	  
Phe	   lacks	  an	   indole	  ring	   it	  cannot	  hydrogen	  bond	  to	  the	  main	  chain	  carbonyl	  moiety	  of	  Ala192.	  The	  
Phe-­‐bound	   structure	   shows	   Lys123	   is	   positioned	   so	   as	   to	   only	   form	   one	   hydrogen	   bond	   to	   the	  
carboxyl	  group	  of	  the	  bound	  Phe	   ligand,	  compared	  to	  the	  two	  hydrogen	  bonds	  Lys123	  forms	  to	  the	  
carboxyl	   group	   of	   the	   bound	   Trp	   ligand.	   The	   amide	   nitrogen	   of	   Gln239	   can	   position	   to	   form	   a	  
hydrogen	   bond	   with	   the	   carboxyl	   group	   of	   the	   bound	   Phe	   ligand	   and	   was	   not	   observed	   for	   Trp	  
binding.	  Asn237	  is	  able	  to	  form	  two	  polar	  contacts	  between	  its	  amide	  group	  and	  the	  α-­‐amino	  group	  of	  
the	  bound	  Phe	  ligand.	  Asn237	  forms	  only	  a	  single	  polar	  contact	  to	  the	  bound	  Trp	  ligand.	  It	  should	  be	  
noted	   the	   side	   chain	   positions	   of	   Asn237	   and	   Gln239	   are	   less	   certain	   in	   the	   Phe-­‐bound	   crystal	  
coordinates	  (PDB	  code:	  3NUD)	  with	  two	  possible	  rotamers	  existing	  for	  each.	  	  
6.1.2. Chapter	  aims	  
The	  work	  in	  this	  chapter	  was	  designed	  to	  probe	  key	  interactions	  between	  MtuDAH7PS	  and	  the	  bound	  
Trp	   ligand	  at	   the	  Trp	  site.	  Site	  directed	  mutagenesis	  was	  used	  to	  produce	  MtuDAH7PS	  variants	  that	  
lacked	   key	   interactions	   between	   specific	   residues	   (Lys123	   and	   Asn237)	   and	   the	   bound	   Trp	   ligand.	  
Generating	  MtuDAH7PS	  variants	   that	  did	  not	  completely	  disrupt	  the	  quaternary	  structure	  and	  were	  
soluble	  proved	   to	  be	  very	   challenging.	   Investigation	  of	   these	   two	  variants	   aimed	   to	   reveal	  whether	  
Lys123	  or	  Asn237	  were	  critical	  for	  Trp	  binding	  or	  the	  communication	  of	  Trp	  binding	  to	  other	  allosteric	  
binding	  sites	  (site	  1	  and	  site	  2)	  and	  the	  active	  site.	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6.2. Preparation	  of	  variants	  
6.2.1. Selection	  of	  residues	  for	  mutagenesis	  
Inspection	  of	  the	  Trp	  site	  highlighted	  several	  residues	  that	  form	  contacts	  with	  the	  bound	  Trp	  ligand,	  
which	  made	   those	   residues	   good	   candidates	   for	   targeted	  mutagenesis	   (Figure	   6.1A).	   Preventing	   or	  
altering	  these	  interactions	  could	  disrupt	  or	  prevent	  Trp	  binding	  to	  the	  Trp	  site.	  
	  
Residues	   identified	   for	   investigation	   were	   Leu194,	   Thr240,	   Lys123	   and	   Asn237.	   The	   side	   chain	   of	  
Leu194	  reorganises	  upon	  Trp	  binding	  to	  help	  create	  a	  hydrophobic	  binding	  pocket	  for	  the	  indole	  ring.	  
Removal	  of	   the	  branched	  side	  chain	  by	  substitution	   to	  Ala,	  or	   replacement	  of	   the	  side	  chain	  with	  a	  
longer	   side	   chain	   with	   a	   polar	   or	   charged	   group	   (Asn	   or	   Asp)	   could	   prevent	   formation	   of	   the	  
hydrophobic	   pocket	   for	   the	   indole	   group	   and	   discourage	   Trp	   binding.	   Unfortunately	   no	   change	  
attempted	   to	   Leu194	   resulted	   in	   a	   sufficient	   yield	   of	   protein	   for	   investigation.	   The	   amino	   group	  of	  
Lys123	  forms	  a	  hydrogen	  bond	  to	  the	  carbonyl	  group	  of	  the	  bound	  Trp	  ligand.	  Initially	  the	  substitution	  
of	  Lys123	  for	  Ala	  was	  prepared	  to	  remove	  the	  side	  chain	  of	  Lys123,	  but	  this	  protein	  was	  insoluble.	  The	  
substitution	   of	   Lys123	   to	   Met	   proved	   to	   be	   a	   successful	   alternative	   that	   replaced	   the	   positively	  
charged	  amino	  side	  chain	  of	  Lys123	  with	  a	  hydrophobic	  side	  chain	  of	   similar	   length.	  Substitution	  of	  
Thr240	  or	  Asn237	  for	  Ala	  may	  prevent	  either	  residue	  hydrogen	  bonding	  to	  the	  α-­‐amino	  group	  of	  the	  
bound	  Trp	   ligand	  via	  their	  hydroxyl	  and	  amide	  group	  respectively,	  which	  would	  disrupt	  Trp	  binding.	  
Attempts	   to	   generate	   MtuDAH7PST240A	   were	   unsuccessful.	   MtuDAH7PSN237A	   and	   MtuDAH7PSK123M	  
were	   successfully	   purified	   with	   reasonable	   yields	   for	   a	   thorough	   investigation	   and	   are	   discussed	  
within	  this	  chapter.	  
6.2.2. Mutagenesis,	  expression	  and	  purification	  
SDM	   was	   carried	   out	   using	   a	   QiuikChange®	   Lightning	   Site-­‐Directed	   Mutagenesis	   Kit	   and	   the	  
QuikChange®	   Primer	   Design	   tool	   was	   used	   to	   design	   the	   primers	   required	   for	   each	  mutation.	   The	  
recommended	   protocol	   was	   followed	   and	   is	   detailed	   in	   Section	  9.2.	   Prior	   to	   electroporation	   into	  
Bl21(DE3)	  PGroESL	  cells	  the	  DNA	  sequences	  of	  the	  SDM	  products	  were	  checked	  to	  ensure	  the	  desired	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substitution	   was	   present	   and	   no	   anomalies	   had	   occurred.	   Following	   selection	   of	   colonies	   in	   the	  
presence	  of	  ampicillin	  ad	  chloramphenicol	  cells	  were	  grown	  and	  purified	  in	  accordance	  with	  standard	  
procedure	  for	  MtuDAH7PSWT,	  detailed	  in	  Section	  9.5.	  
6.2.3. Confirmation	  of	  product	  
The	  successfully	  purified	  protein	   for	  both	  MtuDAH7PS	  variants	  were	  run	  on	  SDS-­‐PAGE	  gels	   to	  verify	  
their	   purity	   and	   confirm	   their	   molecular	   weight.	   The	   gels	   of	   both	   MtuDAH7PSN237A	   and	  
MtuDAH7PSK123M	  produced	   a	   single	   band	   of	   ~50	   kDa	  mass,	   consistent	  with	   the	   expected	  molecular	  
weight	  of	  monomeric	  MtuDAH7PS	  (Figure	  6.2).	  	  
	  
Figure	  6.2	  SDS-­‐PAGE	  gel	  showing	  size	  and	  purity	  of	  each	  purified	  MtuDAH7PS	  variant.	  Lane	  M	  molecular	  weight	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6.2.4. Comparison	  of	  secondary	  structure	  
CD	   was	   carried	   out	   to	   assess	   the	   secondary	   structure	   of	   the	  MtuDAH7PS	   variants	   (experimental	  
details	  are	  described	  in	  section	  9.7.4).	  The	  CD	  spectra	  of	  both	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  
are	  similar	  to	  the	  wild	  type	  enzyme	  (Figure	  6.3).	  	  
	  
Figure	  6.3	  CD	  spectra	  for	  MtuDAH7PSWT	  (blue),	  MtuDAH7PSN237A	  (gold)	  and	  MtuDAH7PSK123M	  (silver).	  
6.3. Kinetic	  parameters	  
The	   introduction	   of	   the	  Asn237Ala	   or	   Lys123Met	   substitution	   to	   the	   Trp	   site	   has	   had	   a	   substantial	  
impact	   on	   the	   kinetic	   parameters,	   particularly	   on	   substrate	   affinity	   (Table	   6.1).	   Kinetic	   assays	  were	  
carried	  out	  as	  detailed	  in	  Section	  9.9.1.	  MtuDAH7PSK123M	  has	  an	  increased	  Km	  for	  E4P,	  but	  the	  Km	  value	  
for	  PEP	  remained	  unchanged.	  This	   reduced	  affinity	   for	  E4P	  gives	  a	  decreased	  catalytic	  efficiency	   for	  
E4P.	   The	   unchanged	   affinity	   for	   PEP	   coupled	   with	   an	   increase	   in	   the	   kcat	   results	   in	   an	   improved	  
catalytic	  efficiency	  for	  PEP.	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The	  Asn237Ala	  substitution	  severely	  affected	  the	  enzyme	  kinetics	  of	  MtuDAH7PSN237A.	  The	  affinity	  for	  
PEP	   was	   greatly	   reduced,	   as	   implied	   by	   the	   huge	   increase	   in	   the	   Km	   value	   for	   PEP	   (Table	   6.1).	  
Intriguingly	  the	  decrease	  in	  substrate	  affinity	  has	  been	  accompanied	  by	  a	  significant	  boost	  in	  turnover	  
number,	  overall	  resulting	   in	  a	  very	   low	  catalytic	  efficiency	  being	  determined	  with	  respect	  to	  PEP	  for	  
MtuDAH7PSN237A.	  
	  
Table	   6.1	   Kinetic	   parameters	   for	  MtuDAH7PSN237A	   and	  MtuDAH7PSK123M	   determined	   from	   a	   single	   set	   of	   data	  
fitted	  to	  the	  Michaelis-­‐Menten	  equation.	  ND	  Not	  determined	  as	  MtuDAH7PSN237A	  E4P	  data	  was	  fitted	  to	  the	  Hill	  
equation.	  Michaelis-­‐Menten	  plots	  are	  shown	  in	  Appendix	  I.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  
by	  least	  squares	  fit.	  
MtuDAH7PS	   Km	  
E4P	   Km	  
PEP	   kcat	   Catalytic	  Efficiency	  
kcat/Km	  
E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
N237A	   ND	   460	  ±	  50	   10.0	  ±	  0.5	   ND	   22	  ±	  3	  
K123M	   60	  ±	  4	   37	  ±	  2	   6.3	  ±	  0.1	   105	  ±	  9	   170	  ±	  10	  
	  
Close	  inspection	  of	  the	  increase	  in	  MtuDAH7PSN237A	  activity	  with	  respect	  to	  E4P	  concentration	  reveals	  
a	   sigmoidal	   curve.	  The	  data	   fits	  poorly	   to	   the	  Michaelis-­‐Menten	  equation,	  but	  quite	  well	   to	   the	  Hill	  
equation	  (Figure	  6.4A	  and	  B).	  The	  [E4P]0.5	  was	  determined	  to	  be	  116	  µM	  from	  the	  Hill	  equation,	  which	  
also	  suggests	  the	  affinity	  for	  E4P	  has	  been	  compromised.	  The	  Hill	  coefficient	  was	  found	  to	  be	  1.7	  ±	  0.1	  
and	  means	   that	   positive	   cooperativity	   occurs	  when	   E4P	  binds	   to	  MtuDAH7PSN237A.	   The	   cooperative	  
E4P	  binding	  observed	  for	  MtuDAH7PSN237A	  is	  reminiscent	  of	  the	  cooperative	  E4P	  binding	  exhibited	  by	  
MtuDAH7PSWT	   in	  the	  presence	  of	  aromatic	  amino	  acid	  combinations	   including	  Trp.48	  The	   loss	  of	   the	  
amide	   group	   of	   Asn237	   may	   have	   resulted	   in	   an	   inhibited-­‐like	   MtuDAH7PS	   state,	   producing	   an	  
enzyme	  with	  similar	  kinetic	  behaviour	  to	  the	  synergistically	  inhibited	  MtuDAH7PSWT.	  	  




Figure	   6.4	   Kinetic	   data	   for	   MtuDAH7PSN237A	   with	   varying	   E4P	   concentration	   fitted	   to	   A.	   Michaelis-­‐Menten	  
equation	  with	  Lineweaver-­‐Burke	  inset	  and	  B.	  the	  Hill	  equation.	  PEP	  concentration	  was	  held	  constant	  at	  1	  mM.	  
	  
6.4. Feedback	  regulation	  
6.4.1. Disruption	  to	  feedback	  regulation	  
The	  inhibition	  studies	  were	  carried	  out	  under	  the	  standard	  conditions	  outlined	  in	  Section	  9.9.3.	  For	  all	  
assays,	   across	   all	   variants,	   the	   substrate	   concentrations	   were	   kept	   at	   150	   µM	   and	   the	   enzyme	  
concentration	  between	  0.01-­‐0.02	  mg/mL.	  Due	  to	  the	  low	  catalytic	  efficiency	  of	  MtuDAH7PSN237A	  the	  
rates	   determined	   for	   the	   enzyme	  were	   very	   low	  which	   inherently	   resulted	   in	   greater	   error	   in	   their	  
measurement.	  MtuDAH7PSN237A	  showed	  remarkable	  sensitivity	  to	  the	  presence	  of	  the	  aromatic	  amino	  
acids	  (Figure	  6.5).	  The	  addition	  of	  either	  Phe	  or	  Tyr	  alone	  caused	  a	  substantial	  loss	  (~78	  %	  and	  ~61	  %	  
respectively)	   in	  MtuDAH7PSN237A	   activity.	   Addition	   of	   Trp	   did	   not	   inhibit	  MtuDAH7PSN237A	   activity.	  
Nonetheless,	  the	  combination	  of	  Trp	  and	  Phe	  acted	  synergistically,	  further	  reducing	  MtuDAH7PSN237A	  
activity	  to	  ~3	  %.	  These	  results	  indicate	  that	  it	  is	  highly	  likely	  Trp	  can	  bind	  to	  MtuDAH7PSN237A	  and	  this	  
binding	   can	   be	   communicated	   to	   site	   1	   (the	   Phe-­‐selective	   site)	   and	   the	   active	   site.	   Trp	   does	   not	  
display	  a	   synergistic	  effect	  on	  MtuDAH7PSN237A	  activity	   in	   combination	  with	  Tyr.	  The	   lack	  of	   synergy	  
for	  Trp	  and	  Tyr	  suggests	  Asn237	  may	  be	   important	  for	  the	  signal	  transmission	  of	  Trp	  binding	  to	  the	  
Tyr-­‐selective	  binding	  site,	  site	  2.	  	  
A.	   B.	  




Figure	  6.5	  Remaining	  activity	  of	  MtuDAH7PSWT	  (blue),	  MtuDAH7PSN237A	  (gold)	  and	  MtuDAH7PSK123M	  (silver)	  in	  the	  
presence	  of	  various	  single,	  binary	  and	  ternary	  combinations	  of	  aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  
are	   represented	  by	   their	  one	   letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  Y.	  Each	   letter	  also	   represents	  200	  µM	  of	   the	  
corresponding	   aromatic	   amino	   acid.	   Error	   bars	   depict	   the	   standard	   deviation	   of	   triplicate	   measurements.	   P-­‐
values	  provided	  in	  appendix	  V.	  
	  
Similar	   increases	   in	   sensitivity	   to	   Phe	   and	   Tyr	   alone	  were	   also	   observed	   for	  MtuDAH7PSK123M,	  with	  
activity	   reduced	   to	   respectively	  30	  %	  and	  38	  %	   respectively	   (Figure	  6.5).	   The	  presence	  of	  Trp	  has	  a	  
negligible	  effect	  on	  MtuDAH7PSK123M	  activity.	  Trp	  in	  combination	  with	  Phe	  or	  Tyr	  causes	  little	  change	  
in	   activity	   compared	   to	  MtuDAH7PSK123M	   activity	   in	   the	   presence	   of	   Phe	   or	   Tyr	   alone.	   The	   loss	   of	  
synergy	   could	   indicate	   the	   amine	   group	   of	   Lys123	   is	   essential	   for	   any	   synergistic	  mechanism	   to	   be	  
employed	   by	   MtuDAH7PS.	   Alternatively	   it	   may	   simply	   imply	   Trp	   does	   not	   bind	   very	   well	   to	  
MtuDAH7PSK123M.	  Thus	  further	  investigation	  of	  Trp	  binding	  to	  MtuDAH7PSK123M	  is	  required.	  
	  
The	   loss	   of	   the	   functional	   groups	   of	   Asn237	   or	   Lys123	  may	   have	  mimicked	   the	   signal	   that	   Trp	   has	  
bound	   at	   the	   Trp	   site	   to	   the	   other	   allosteric	   bindings	   sites	   (sites	   1	   and	   2)	   and	   the	   active	   site.	   This	  
‘pseudo-­‐Trp	   bound’	   MtuDAH7PS	   state	   could	   explain	   the	   potent	   inhibition	   observed	   for	  
MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  in	  the	  presence	  of	  Phe	  or	  Tyr	  alone.	  At	  the	  very	  least	  the	  loss	  
Trp	  site	   6	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of	   amide	   of	   Asn237	   and	   the	   amine	   of	   Lys123	   has	   severely	   disrupted	   the	   synergistic	   inhibition	  
mechanism	  that	  normally	  operates	  within	  MtuDAH7PS.	  
6.4.2. Effect	  of	  ligand	  on	  kinetic	  parameters	  
To	   further	   ascertain	   the	   effect	   the	   inhibitors	   have	   on	   each	   variant	   enzyme,	   their	   E4P-­‐dependent	  
kinetic	  parameters	  were	  determined	  under	  the	  standard	  conditions	  detailed	  in	  Section	  9.9.1,	  but	  with	  
the	  addition	  of	  200	  µM	  of	  the	  stated	  ligand	  to	  the	  assay	  conditions.	  	  
	  
For	  MtuDAH7PSK123M	  the	  kinetic	  parameters	  were	  determined	  in	  the	  presence	  of	  Phe	  and	  were	  fitted	  
to	  Michaelis-­‐Menten	  kinetics.	   If	  MtuDAH7PSK123M	  did	  adopt	  a	   ‘pseudo-­‐Trp	  bound’	  MtuDAH7PS	  state	  
then	  the	  E4P-­‐dependent	  kinetics	  of	  MtuDAH7PSK123M	  in	  the	  presence	  of	  Phe	  should	  show	  a	  sigmoidal	  
curve,	  evidence	  of	  cooperativity.	  A	  sigmoidal	  curve	  was	  observed	  for	  E4P-­‐dependent	  kinetics	  of	   the	  
wild	   type	  enzyme	   in	   the	  presence	  of	   Trp	  with	  either	  Phe	  or	   Tyr.48,91	   The	  E4P-­‐dependent	   kinetics	  of	  
MtuDAH7PSK123M	  obeyed	  Michaelis-­‐Menten	  kinetics	  in	  the	  presence	  or	  absence	  of	  Phe,	  providing	  no	  
evidence	  of	  cooperative	  E4P	  binding.	  	  
	  
The	   lack	  of	  cooperative	  E4P	  binding	  displayed	  by	  MtuDAH7PSK123M	  suggests	   if	  a	   ‘pseudo-­‐Trp	  bound’	  
MtuDAH7PS	  state	  has	  been	  adopted	  by	  MtuDAH7PSK123M	  the	  substitution	  of	  Lys123	  was	  insufficient	  to	  
trigger	   all	   the	   changes	   that	   occur	   on	   Trp	   binding	   to	   the	   active	   site.	   To	   discern	  whether	   the	   lack	   of	  
cooperative	   E4P	   binding	   displayed	   by	  MtuDAH7PSK123M	   is	   due	   to	   the	   cooperative	  mechanism	  being	  
disabled	  by	  the	  Lys123Met	  substitution,	  the	  kinetic	  analysis	  needs	  to	  be	  repeated	  in	  the	  presence	  of	  
both	  Trp	  and	  Phe.	  If	  no	  cooperativity	  is	  observed	  for	  MtuDAH7PSK123M	  in	  the	  presence	  of	  Trp	  and	  Phe	  
it	  would	   suggest	   that	   the	   amino	   group	  of	   Lys123	   is	   essential	   for	   Trp	   binding	   to	   be	   signalled	   to	   the	  
active	  site	  and	  stimulate	  cooperative	  E4P	  binding.	  
	  
The	  Km	  for	  E4P	  increased	  when	  MtuDAH7PS
K123M	  was	  in	  the	  presence	  of	  Phe	  (Table	  6.2).	  Phe	  had	  little	  
effect	  on	  the	  kcat	  of	  MtuDAH7PS
K123M.	  Thus	  Phe	  alone	  can	  act	  as	  a	  K-­‐type	  inhibitor,	  achieving	  inhibition	  
primarily	  by	  reducing	  the	  affinity	  of	  the	  MtuDAH7PSK123M	  for	  E4P.	  The	  combination	  of	  Trp	  with	  either	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Phe	   or	   Tyr	   also	   acted	   to	   reduce	   the	   affinity	   of	  MtuDAH7PSWT	   for	   E4P.	  Unlike	  MtuDAH7PSK123M,	   the	  
activity	  of	  the	  wild	  type	  enzyme	  displayed	  a	  sigmoidal	  response	  to	  increasing	  concentrations	  of	  E4P	  in	  
the	  presence	  of	  Trp	  with	  either	  Phe	  or	  Tyr.	  	  
	  
Table	   6.2	   The	   kinetic	   parameters	   determined	   for	   the	   E4P-­‐dependent	   kinetics	   of	   MtuDAH7PSN237A	   and	  
MtuDAH7PSK123M.	  Data	  for	  MtuDAH7PSN237A	  was	  fitted	  to	  the	  Hill	  equation	  and	  the	  data	  for	  MtuDAH7PsK123M-­‐	  was	  
fitted	   to	   the	   Michaelis-­‐Menten	   equation.	   –	   indicates	   not	   applicable.	   Michaelis-­‐Menten	   plots	   are	   shown	   in	  
Appendix	   I.	  A	  single	  data	  set	  was	  collected	  to	  the	  appropriate	  kinetic	  equation.	  Error	  represents	  error	  of	  curve	  
fitting	  to	  the	  data	  set	  by	  least	  squares	  fit.	  





Hill	   kcat	  
	  
Catalytic	  Efficiency	  
Coefficient	   kcat/Km	  
E4P	  
	   (µM)	   (µM)	   	   (s-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   –	   –	   4.7	  ±	  0.1	   170	  ±	  20	  
N237A*	   –	   116	  ±	  7	  	   1.6	  ±	  0.1	   5.9	  ±	  0.2	   –	  
N237A	  200W*	   –	   104	  ±	  6	   1.6	  ±	  0.1	   7.7	  ±	  0.3	   –	  
K123M	   60	  ±	  4	   –	   –	   6.3	  ±	  0.1	   105	  ±	  9	  
K123M	  200F	   320	  ±	  50	   –	   –	   7.7	  ±	  0.8	   24	  ±	  6	  
	  
The	   kinetic	   parameters	   of	  MtuDAH7PSN237A	  were	   determined	   in	   the	   presence	   of	   200	   µM	   of	   Trp	   to	  
ascertain	   if	   the	   addition	   of	   Trp	   somehow	   restored	   more	   wild	   type-­‐like	   kinetic	   behaviour	   to	  
MtuDAH7PSN237A.	   The	   kinetic	   data	   for	  MtuDAH7PS
N237A	   determined	   with	   the	   addition	   of	   Trp	   was	  
inconsistent	  with	  Michaelis-­‐Menten	  kinetics,	   and	  was	  better	   fitted	   to	   the	  Hill	   equation	   (Figure	  6.6).	  
The	   presence	   of	   Trp	   caused	  minor	   changes	   in	   [E4P]0.5	   and	   kcat,	   resulting	   in	   a	   slight	   increase	   in	   E4P	  
catalytic	  efficiency.	  A	  Hill	  coefficient	  of	  1.6	  was	  determined	  for	  MtuDAH7PSN237A	  in	  both	  the	  presence	  
and	   absence	   of	   Trp.	   The	   lack	   of	   significant	   variation	   in	   kinetic	   parameters	   determined	   for	  
MtuDAH7PSN237A	  makes	   it	  difficult	   to	  draw	  any	  conclusions	  with	  regards	  of	   the	  means	  by	  which	  the	  
activation	  of	  MtuDAH7PSN237A	  occurs	  in	  the	  presence	  of	  Trp.	  The	  use	  of	  a	  higher	  concentration	  of	  Trp	  
in	  the	  kinetic	  assays	  may	  reveal	  more	  information.	  




Figure	   6.6	   E4P-­‐dependent	   kinetic	   data	   for	  MtuDAH7PSN237A	   with	   varying	   E4P	   concentration	   fitted	   to	   the	   Hill	  
equation	  with	  (gold)	  and	  with	  out	  200	  µM	  Phe	  (purple).	  PEP	  concentration	  was	  held	  constant	  at	  1	  mM.	  
	  
6.5. Thermal	  stability	  
The	   thermal	   stability	  was	   determined	   by	  DSF	   and	  was	   carried	   out	   as	   detailed	   in	   section	   9.8.1.	   The	  
thermal	  stability	  of	  MtuDAH7PSN237A	   in	  the	  absence	  of	   ligand	   is	  similar	  to	  wild	  type	  (Figure	  6.7).	  Trp	  
increased	  the	  Tm	  of	  MtuDAH7PS
N237A	  by	  ~0.8	  ˚C,	  much	  less	  than	  the	  marked	  change	  of	  ~9.2	  ˚C	  seen	  for	  
MtuDAH7PSWT.	  The	  small	  increase	  in	  Tm	  suggests	  Trp	  binds	  poorly	  to	  MtuDAH7PS
N237A.	  The	  addition	  of	  
Phe	  or	  Tyr	  to	  MtuDAH7PSN237A	  caused	  a	  large	  shift	  in	  the	  Tm,	  ~4	  ˚C	  and	  ~5	  ˚C	  respectively,	  confirming	  
Phe	  and	  Tyr	  are	  still	  able	  to	  bind	  the	  variant	  protein.	  All	  combinations	  of	  allosteric	  amino	  acids	  with	  
the	  exception	  of	  Phe	  and	  Tyr	  produce	  smaller	  shifts	  in	  Tm	  when	  compared	  to	  MtuDAH7PS
WT.	  	  
	  
MtuDAH7PSK123M	   has	   a	   lower	   thermal	   stability	   than	   the	   wild	   type	   enzyme	   (Figure	   6.7).	  
MtuDAH7PSK123M	  also	  showed	  no	  change	  in	  Tm	  in	  the	  presence	  of	  Trp	  suggesting	  the	  ligand	  may	  not	  
be	   able	   to	   bind.	   Alternatively	   if	   the	   Trp	   can	   bind	  MtuDAH7PSK123M	   it	   is	   unable	   to	   elicit	   the	   same	  
response	   from	   the	   enzyme,	   failing	   to	   increase	   the	   thermal	   stability	   of	   the	   enzyme.	   The	   Tm	   in	   the	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presence	  of	  Tyr	  dropped	  by	  1	  ˚C.	  The	  presence	  of	  Phe	  improved	  the	  thermal	  stability,	  increasing	  the	  
Tm	   by	   ~3.5	  ˚C.	   Interestingly,	   combinations	   including	   Tyr	   and	   Phe	   resulted	   in	   increases	   in	   Tm	   greater	  
than	  3.5	  ˚C.	  Thus	  when	  Phe	  binds	  to	  site	  1	  it	  mitigates	  any	  loss	  in	  stability	  caused	  by	  Tyr	  binding	  at	  site	  
2,	   resulting	   in	   an	   overall	   greater	   increase	   in	   thermal	   stability.	   The	   addition	   of	   Trp	  with	   Phe	   or	   Tyr	  
showed	  no	  extra	  increase	  in	  thermal	  stability	  of	  MtuDAH7PSK123M.	  
	  
Figure	   6.7	   Thermal	   melting	   points	   determined	   by	   DSF	   for	  MtuDAH7PSWT	   (blue),	  MtuDAH7PSN237A	   (gold)	   and	  
MtuDAH7PSK123M	  (silver).	  Error	  bars	  depict	  the	  standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  
in	  appendix	  V.	  
6.6. Binding	  affinities	  
To	  quantify	  the	  ability	  of	  Trp	  to	  bind	  MtuDAH7PS	  ITC	  was	  carried	  out	  as	  detailed	  in	  Section	  9.8.2.	  Due	  
to	  constraints	  on	  time	  and	  enzyme	  stocks,	   ITC	  was	  only	  carried	  out	  on	  MtuDAH7PSN237A.	  The	  amide	  
functionality	   of	   Asn237	   forms	   a	   hydrogen	   bond	   to	   the	   bound	   Trp	   ligand	   and	   the	   substitution	   of	  
Asn237	  for	  Ala	  was	  expected	  to	  prevent	  this	  bond	  and	  disrupt	  Trp	  binding.	  In	  a	  fascinating	  twist,	  the	  
Asn237Ala	  substitution	  improved	  the	  affinity	  of	  MtuDAH7PS	  for	  Trp.	  The	  Kd	  between	  MtuDAH7PS
N237A	  
and	   Trp	   was	   lower	   than	   that	   with	   MtuDAH7PSWT	   (Table	   6.3,	   Figure	   6.8A).	   The	   affinity	   of	  
MtuDAH7PSN237A	  for	  Phe	  and	  Tyr	  has	  also	  improved	  compared	  to	  the	  wild	  type	  enzyme	  as	  illustrated	  
Trp	  site	   6	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by	   the	   decrease	   in	   the	   Kd	   values	   determined	   between	   MtuDAH7PS
N237A	   and	   either	   Phe	   or	   Tyr	  
compared	  to	  MtuDAH7PSWT	  (Figure	  6.8B-­‐C,	  Table	  6.3).	  	  
	  
Crystallography	  has	  previously	  shown	  the	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  can	  be	  promiscuous,	  
albeit	   Trp	   has	   never	   been	   observed	   to	   occupy	   allosteric	   binding	   site	   other	   than	   the	   Trp	   site.48,63,91	  
Given	  the	  Asn237Ala	  was	  intended	  to	  disrupt	  Trp	  binding	  and	  the	  promiscuity	  of	  the	  allosteric	  binding	  
sites	  there	  was	  a	  small	  possibility	  Trp	  may	  be	  able	  to	  bind	  sites	  1	  or	  2	  further	  ITC	  experiments	  were	  
conducted	  to	  assess	  this	  possibility.	  Thus	  to	  investigate	  which	  allosteric	  binding	  sites	  Trp	  was	  binding	  
ITC	  experiments	  were	  setup	  to	   identify	   if	  Trp	  competed	  with	  Phe	  to	  occupy	  site	  1.	  MtuDAH7PSN237A	  
was	   pre-­‐incubated	  with	   50	  µM	  Phe	   or	   20	   µM	  Tyr	   in	   the	   cell	   prior	   to	  measuring	   the	   binding	   of	   the	  
alternative	  titrated	  ligand	  (Figure	  6.8D-­‐E).	  Pre-­‐incubation	  of	  MtuDAH7PSN237A	  with	  Phe	  caused	  a	  small	  
change	   in	   the	   Kd	   determined	   between	   Trp	   and	   MtuDAH7PS
N237A	   and	   similarly	   preincubation	   of	  
MtuDAH7PSN237A	   with	   Trp	   caused	   a	   small	   change	   in	   the	   Kd	   determined	   between	   Phe	   and	  
MtuDAH7PSN237A	   (Table	   6.3).	   Neither	   change	   was	   great	   enough	   to	   confidently	   confirm	   whether	  
competition	  was	  occurring	  and	  therefore	  gave	  no	  reason	  to	  believe	  Trp	  is	  binding	  to	  site	  1.	  Moreover,	  
these	   studies	   also	   showed	   Phe	   and	   Trp	   could	   not	   improve	   the	   binding	   of	   the	   other	   amino	   acid	   to	  
MtuDAH7PSN237A,	  indicating	  cooperativity	  between	  the	  two	  sites	  has	  been	  disrupted.	  	  
	  
Table	   6.3	   Dissociation	   constants	   determined	   for	  MtuDAH7PSWT	   and	  MtuDAH7PSN237A	   by	   ITC.	   A	   background	  
concentrations	   of	   Phe,	   Trp	   and	   Tyr	   were	   50,	   20	   ad	   400	   µM	   respectively.	   —	   Denotes	   no	   background	   ligand	  
present.	   *	   Denotes	   values	   determined	   by	   Richard	   Hutton.71,91	   Values	   are	   determined	   from	   a	   single	   ITC	  









Wild	  type	   N237A	  
Kd	  (µM)	   Kd	  (µM)	  
Trp	   —	   4.7	  ±	  0.1*	   2.9	  ±	  0.2	  
Trp	   Phe	   1.08	  ±	  0.03*	   3.6	  ±	  0.2	  
Phe	   	   —	   21	  ±	  1*	   10	  ±	  2	  
Phe	   Trp	   5	  ±	  1*	   9	  ±	  1	  
Tyr	   —	   39	  ±	  1	   21.2	  ±	  0.7	  
Tyr	   Trp	   40	  ±	  2	   18.1	  ±	  0.6	  
	  




Figure	   6.8	   ITC	   data	   for	   the	   interaction	   of	   MtuDAH7PSN237A	   ITC	   data	   for	   the	   interaction	   of	   A.	   38	  µM	  
MtuDAH7PSN237A	   with	   800	   µM	   Trp	   titrant;	   B.	   41	  µM	   of	   MtuDAH7PSN237A	   with	   1	   mM	   Phe	   titrant,	   C.	   40µM	  
MtuDAH7PSN237A	  with	  2.5	  mM	  Tyr	  titrant;	  D.	  38	  µM	  MtuDAH7PSN237A	  preincubated	  with	  50	  µM	  Phe	  and	  with	  800	  
µM	  Trp	  titrant;	  E.	  41	  µM	  MtuDAH7PSN237A	  preincubated	  with	  20	  µM	  Trp	  and	  with	  1	  mM	  Phe	  titrant	  and	  F.	  40	  µM	  
MtuDAH7PSN237A	  preincubated	  with	  20	  µM	  Trp	  with	  2.5	  mM	  Tyr	  titrant.	  
	  
The	   Kd	   for	   Tyr	   binding	   to	   MtuDAH7PS
N237A	   decreased	   to	   18.1	   µM	   by	   the	   preincubation	   of	  
MtuDAH7PSN237A	  with	  Trp,	  suggesting	  Trp	  and	  Tyr	  are	  not	  competing	  for	  the	  same	  allosteric	  binding	  
sites	   (Figure	  6.8F,	  Table	  6.3).	  The	   lack	  of	  competition	  between	  Trp	  and	  Tyr	  to	  bind	  MtuDAH7PSN237A	  
means	  Trp	  is	  not	  binding	  to	  site	  2,	  the	  Tyr-­‐selective	  site.	  	  
A.	   B.	   C.	  
D.	   E.	   F.	  
Trp	  site	   6	  
	  
183	  
As	  there	  is	  no	  evidence	  Trp	  competes	  with	  Tyr	  or	  Phe	  to	  bind	  MtuDAH7PSN237A	  it	  is	  highly	  likely	  Trp	  is	  
able	   to	  bind	   to	   the	  Trp	   site	  of	  MtuDAH7PSN237A.	   This	   retention	  of	  Trp	  binding	   implies	   the	  hydrogen	  
bonds	  formed	  between	  the	  amide	  of	  Asn237	  and	  the	  α-­‐amino	  group	  of	  the	  bound	  Trp	  ligand	  are	  not	  
essential	  for	  Trp	  binding.	  The	  disruption	  to	  the	  cooperative	  binding	  between	  Trp	  and	  Phe	  suggests	  the	  
substitution	  of	  Asn237	   to	  Ala	  has	  disrupted	   the	   communication	  pathway	  between	   the	   Trp	   site	   and	  
site	  1.	  The	  loss	  of	  the	  polar	  contacts	  formed	  between	  the	  bound	  Trp	  ligand	  and	  Asn237	  at	  the	  Trp	  site	  
would	  allow	  the	  α2-­‐β3	   loop	  more	  flexibility	  and/or	  to	  adopt	  a	  different	  position,	  and	   it	   is	   likely	  that	  
this	  change	   in	   flexibility	  or	  position	  of	   the	  α2-­‐β3	   loop	  that	  has	  disrupted	  the	  synergistic	  mechanism	  
between	  the	  Trp	  site	  and	  site	  1.	  
6.7. Quaternary	  Structure	  
6.7.1. SAXS	  analysis	  
The	  quaternary	   structure	  of	  both	  Trp	  site	  variants	  were	  analysed	  by	  SAXS	  and	  were	   found	   to	  differ	  
considerably	  from	  MtuDAH7PSWT	  (Figure	  6.9A-­‐B).	  The	  experimental	  conditions	  and	  analysis	  is	  detailed	  
in	   Sections	   9.7.5	   and	   9.7.6.	   The	   SAXS	   profile	   of	  MtuDAH7PSN237A	   closely	   resembled	   the	   theoretical	  
scattering	  profile	  for	  the	  tetrameric	  MtuDAH7PSWT	  predicted	  by	  CRYSOL	  using	  the	  crystal	  coordinates	  
PDB	  code:	  3NV8,	  except	  between	  0.07	  and	  0.11	  s	   (Figure	  6.9A,	  Table	  6.4).69,70,103	  This	  divergence	  of	  
the	   scattering	   profile	   of	   MtuDAH7PSN237A	   from	   the	   theoretical	   scattering	   of	   MtuDAH7PSWT	   is	   an	  
indication	  the	  shape	  of	  the	  protein	  has	  changed.	  The	  similarity	  of	  the	  Dmax	  and	  the	  Rg	  determined	  for	  
MtuDAH7PSN237A	   and	  MtuDAH7PSWT	   suggest	   a	   very	   subtle	   change	   in	   the	   average	   conformation	   of	  
MtuDAH7PSN237A	   has	   occurred.	   The	   Asn237Ala	   substitution	   altered	   the	   quaternary	   structure	   of	  
MtuDAH7PSN237A	  most	  probably	  by	  altering	  the	  flexibility	  of	  the	  α2-­‐β3	  loop	  where	  Asn237	  is	  located.	  	  




Figure	  6.9	  SAXS	  scattering	  profiles	  of	  MtuDAH7PSWT	  (blue	  dots)	  and	  A.	  MtuDAH7PSN237A	  with	  (purple	  dots)	  and	  
with	  out	  200	  µM	  Trp	  (gold	  dots)	  and	  B.	  MtuDAH7PSK123M	  with	  (pink	  dots)	  and	  without	  (silver	  dots)	  200	  µM	  Phe.	  
Also	   shown	   are	   the	   theoretical	   scattering	   profiles	   for	   the	  MtuDAH7PSWT	   tetramer	   (solid	   black	   line)	   and	   dimer	  
(dashed	  black	  line)	  (PDB	  code:	  3NV8)	  predicted	  by	  CRYSOL.103	  C.	  The	  SAXS	  scattering	  profile	  of	  MtuDAH7PSK123M	  
(silver	  dots),	  and	  the	  theoretical	  scattering	  profiles	  MtuDAH7PS	  consisting	  of	  a	  mixture	  of	  77	  %	  dimer	  and	  23	  %	  
monomer	   (green	   line),	   a	  mixture	   of	   49	  %	   tetramer	   and	   51	  %	   dimer	   (blue	   line)	   and	   77	  %	   tetramer	   and	   23	  %	  
monomer	  (burgundy	  line),	  as	  predicted	  by	  OLIGOMER.101	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Table	   6.4	   SAXS	   parameters	   determined	   from	   PRIMUS,	   GNOM,	   CRYSOL	   and	   SAXS	   MoW	   for	  MtuDAH7PSWT,	  
MtuDAH7PSN237A	  with	  and	  without	  200	  µM	  Trp,	  and	  MtuDAH7PSK123M	  with	  and	  without	  200	  µM	  Phe.	  Analysis	  was	  
conducted	  with	  data	  from	  a	  single	  SAXS	  experiment.	  
MtuDAH7PS	   Wild	  type	   N237A	   N237A	  	  
200W	  
K123M	   K123M	  	  
200F	  
Guinier	  analysis	   	   	  
Rg	  (Å)	   41.6	  ±	  0.3	   42.81	  ±	  0.05	   42.0	  ±	  0.1	   38.1	  ±	  0.4	   41.7	  ±	  0.1	  










Pair	  distribution	  analysis	  
Real	  Space	  Rg	  (Å)	   40.9	  ±	  0.2	   42.1	  ±	  0.2	   41.5	  ±	  0.07	   38.7	  ±	  0.1	   41.6	  ±	  0.1	  
Dmax	  (Å)	   127	   128	   130	   125.5	   127	  
Vp,	  (Da)	   282700	   350000	   289800	   199300	   338700	  
Molecular	  weight	  estimates	  from	  SAXS	  MoW	  analysis	  
Mw	  from	  Vp	  (Da)	   199	  100	   210700	   200900	   133900	   209400	  
Nō	  of	  Subunits	   4	   4	   4	   3	   4	  
CRYSOL	  analysis	  with	  tetrameric	  3NV8	  
RgE	  (Å)	   42.4	  ±	  0.2	   41.6	  ±	  0.2	   41.9	  ±	  0.2	   37.2	  ±	  0.2	   41.8	  ±	  0.2	  
RgT	  (Å)	   40.6	   41.5	   41.4	   31.9	   41.3	  
𝜒2	   0.996	   8.605	   1.879	   3.83	   0.519	  
CRYSOL	  analysis	  with	  dimeric	  3NV8	  
RgE	  (Å) 41.7	  ±	  0.2	   ND	   ND	   37.2	  ±	  0.2	   41.7	  ±	  0.2	  
RgT	  (Å) 30.7	   ND	   ND	   31.9	   31.9	  
𝜒2 13.3	   ND	   ND	   3.83	   11.58	  
CRYSOL	  analysis	  with	  monomeric	  3NV8	  
RgE	  (Å) 40.9	  ±	  0.2	   ND	   ND	   36.0	  ±	  0.2	   41.5	  ±	  0.2	  
RgT	  (Å) 25.0	   ND	   ND	   25.01	   25.06	  
𝜒2 22.0	   ND	   ND	   8.89	   21.32	  
	  
Attempts	  were	  made	  to	  fit	   the	  SAXS	  scattering	  profile	  of	  MtuDAH7PSN237A	   to	  mixtures	  of	  monomer,	  
dimer	   and	   tetramer	   ensembles	   of	   the	  MtuDAH7PSWT	   3NV8	   crystal	   coordinates	   using	  OLIGOMER.101	  
OLIGOMER	  did	  not	  indicate	  a	  mixture	  of	  oligomeric	  species	  was	  present	  in	  solution,	  instead	  indicating	  
the	  solution	  most	  likely	  consisted	  of	  100%	  tetramer.	  Thus	  the	  change	  in	  the	  SAXS	  scattering	  profile	  of	  
MtuDAH7PSN237A	  was	  most	  likely	  due	  to	  a	  subtle	  change	  in	  conformation	  of	  the	  tetramer.	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The	   addition	   of	   200	   µM	   Trp	   to	   MtuDAH7PSN237A	   changed	   the	   SAXS	   scattering	   profile	   to	   better	  
correlate	   with	   the	   theoretical	   scattering	   of	   the	   MtuDAH7PSWT	   tetramer	   (PDB	   code:	   3NV8),	   as	  
demonstrated	  by	  the	  decrease	  in	  the	  𝜒2	  value	  (Figure	  6.9A,	  Table	  6.4).	  Hence	  Trp	  binding	  caused	  the	  
conformation	   of	   tetrameric	   MtuDAH7PSN237A	   to	   become	   more	   like	   MtuDAH7PSWT,	   possibly	   by	  
restricting	  the	  flexibility	  or	  position	  of	  the	  α2-­‐β3	  loop.	  As	  the	  binding	  of	  Trp	  alters	  the	  conformation	  of	  
the	   MtuDAH7PsN237A	   tetramer	   it	   is	   evidence	   the	   change	   in	   tetrameric	   conformation	   due	   to	   the	  
Asn237Ala	   substitution	   is	   reversible.	   The	   change	   in	   the	   tetramer	   conformation	   of	  MtuDAH7PSN237A	  
due	  to	  the	  presence	  of	  Trp	  binding	  illustrates	  the	  interactions	  of	  the	  MtuDAH7PS	  subunits	  are	  flexible	  
and	  will	   tolerate	  changes	   in	  conformation,	  without	  disrupting	   the	   formation	  of	   the	  homotetrameric	  
MtuDAH7PS	  complex.	  	  
	  
The	   SAXS	   scattering	   profile	   of	  MtuDAH7PSK123M	   varied	   extensively	   from	   the	   predicted	   dimeric	   and	  
tetrameric	  theoretical	  scattering	  profiles	  for	  the	  MtuDAH7PSWT	  crystal	  coordinates	  3NV8	  predicted	  by	  
CRYSOL	   (Figure	   6.9B,	   Table	   6.4).103	   Instead,	   OLIGOMER	   was	   used	   to	   assess	   if	   a	   combination	   of	  
oligomeric	   states	   were	   present	   in	   solution	   (Figure	   6.9C).101	   Theoretical	   scattering	   for	   various	  
combinations	   of	   monomeric,	   dimeric	   and	   tetrameric	   MtuDAH7PSWT	   were	   generated	   from	   the	  
MtuDAH7PSWT	  crystal	  coordinates	  of	  3NV8	  and	  compared	  to	  the	  experimental	  SAXS	  scattering	  profile	  
of	  MtuDAH7PSK123M.	   Evaluation	   of	   the	   OLIGOMER	   results	   suggested	  MtuDAH7PSK123M	   fitted	   best,	  
based	   on	   𝜒2	   values,	   to	   models	   of	   a	   solution	   containing	   23	   %	  MtuDAH7PS	   monomer	   and	   77	   %	  
MtuDAH7PS	   tetramer	   (Table	   6.5).	   The	   Rg	   determined	   from	   the	   Guinier	   plot	   or	   Rg,	   Dmax	   and	   the	  
Vρ)determined	   from	   the	   pair	   wise	   distribution	   were	   both	   lower	   than	   values	   determined	   for	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Table	  6.5	  SAXS	  parameters	  determined	  for	  MtuDAH7PSK123M	  by	  OLIGOMER	  calculated	  for;	  analysis	  1	  a	  mixture	  of	  
MtuDAH7PS	  tetramer	  and	  dimer;	  analysis	  2	  a	  mixture	  of	  MtuDAH7PS	  tetramer	  and	  monomer	  and	  analysis	  3	  for	  a	  
mixture	   of	  MtuDAH7PS	   tetramer,	   dimer	   and	  monomer.	  Analysis	  was	   conducted	  with	   data	   from	   a	   single	   SAXS	  
experiment.	  
	   Analysis	  1	   Analysis	  2	   Analysis	  3	  
Tetramer	  (%)	   48.5	  ±	  0.8	   76.6	  ±	  0.4	   76.6	  ±	  0.4	  
Dimer	  (%)	   51.5	  ±	  0.7	   n/a	   0.0	  ±	  0.0	  
Monomer	  (%)	   n/a	   23.4	  ±	  0.3	   23.4	  ±	  0.3	  
Mw	  (Da)	   132700	   124900	   124900	  
Rg	  (Å)	   36.02	   36.99	   36.99	  
𝜒2	   2.45	   0.76	   0.76	  
	  
The	  addition	  of	  Phe	  to	  MtuDAH7PSK123M	  gave	  a	  SAXS	  scattering	  profile	  that	  closely	  followed	  the	  SAXS	  
scattering	   profile	   of	   MtuDAH7PSWT	   (Figure	   6.9B).	   CRYSOL	   confirmed	   SAXS	   scattering	   profile	   of	  
MtuDAH7PSK123M	   fitted	   very	   closely	   to	   the	   predicted	   theoretical	   scattering	   profile	   of	  MtuDAH7PSWT	  
(PDB	   code:	   3NV8)	   as	   indicated	   by	   𝜒2	   of	   ~0.5	   (Table	   6.4).	   The	   Rg,	   Dmax	   and	   Vρ	   determined	   for	  
MtuDAH7PSK123M	   in	   the	   presence	   of	   Phe	   all	   increased,	   and	   became	   more	   consistent	   with	   values	  
expected	  for	  tetrameric	  MtuDAH7PS.	  	  
	  
The	   OLIGOMER	   results	   imply	   MtuDAH7PSK123M	   exists	   as	   an	   ensemble	   of	   oligomeric	   states	   in	  
equilibrium.	  The	  addition	  of	  Phe	  to	  MtuDAH7PSK123M	  showed	  the	  quaternary	  structure	  equilibrium	  of	  
MtuDAH7PSK123M	   was	   dynamic,	   shifting	   to	   almost	   completely	   favour	   the	   formation	   of	   the	  
MtuDAH7PSK123M	   tetramer	   in	   the	   presence	   of	   Phe.	   The	   substitution	   of	   Lys123	   for	   Met	   has	   most	  
probably	  altered	  the	  interactions	  of	  tight	  dimer	  interface,	  weakening	  the	  interactions	  that	  encourage	  
the	  formation	  of	  the	  tight	  dimer	  and	  consequently	  displacing	  the	  quaternary	  structure	  equilibrium.	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6.7.2. Native	  PAGE	  
Blue	  native	  PAGE	  was	  used	  to	  assess	  the	  oligomeric	  species	  present	  in	  a	  low	  concentration	  solution	  of	  
MtuDAH7PS	  and	  was	  carried	  out	  as	  detailed	  in	  Section	  9.7.2.	  MtuDAH7PSN237A	  produces	  a	  single	  band	  
a	   little	  over	   ~200	   kDa	   in	  mass,	   the	  expected	  molecular	  weight	  of	   the	  MtuDAH7PS	   tetramer	   (Figure	  
6.10).	   The	   presence	   of	   tetrameric	  MtuDAH7PSN237A	   was	   in	   agreement	   with	   the	   findings	   from	   the	  
analysis	   of	   SAXS	   data	   for	  MtuDAH7PSN237A	   conducted	   at	   high	   concentrations	   of	   the	   enzyme	   (~8.8	  
mg/mL).	  The	  presence	  of	  a	  single	  ~200	  kDa	  for	  MtuDAH7PSN237A	  contrasted	  with	  MtuDAH7PSWT	  which	  
exhibited	   two	   bands	   at	   ~50	   and	   ~100	  kDa,	   representing	   monomeric	   and	   dimeric	   MtuDAH7PS	  
respectively.	   Therefore,	   the	   Asn237Ala	   substitution	   introduced	   to	   MtuDAH7PSN237A	   stabilises	   the	  
formation	  of	  the	  tetramer	  even	  at	  very	  low	  concentrations.	  
	  
	  
Figure	   6.10	   Blue	   native	   PAGE.	   Lane	   M	   displays	   the	   molecular	   weight	   marker;	   Lane	   1	  MtuDAH7PSWT;	   Lane	   2	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Conversely,	   MtuDAH7PSK123M	   exhibits	   a	   strong	   band	   of	   ~50	   kDa	   mass,	   the	   correct	   mass	   for	   an	  
MtuDAH7PS	  monomer,	  and	  there	  was	  also	  evidence	  of	  a	  fainter	  higher	  molecular	  band	  at	  ~100	  kDa,	  
evidence	  some	  dimeric	  MtuDAH7PSK123M	  was	  also	  present	  at	  low	  concentrations	  of	  MtuDAH7PSK123M.	  
The	  quaternary	  structures	  identified	  for	  a	  solution	  of	  low	  concentration	  of	  MtuDAH7PSK123M	  by	  native	  
PAGE	  differed	  from	  the	  mixture	  of	  monomeric	  and	  tetrameric	  MtuDAH7PSK123M	  identified	  by	  SAXS	  of	  
at	   a	   high	   concentration	   of	   MtuDAH7PSK123M.	   Thus	   the	   quaternary	   structure	   equilibrium	   of	  
MtuDAH7PSK123M	  was	  dynamic	  and	  showed	  concentration	  dependence;	  at	   lower	  concentrations	   the	  
MtuDAH7PSK123M	   monomer	   is	   favoured	   and	   at	   high	   concentrations	   the	   formation	   of	   the	  
MtuDAH7PSK123M	  tetramer	  is	  favoured.	  	  
6.7.3. AUC	  analysis	  
AUC	   experiments	   were	   carried	   out	   on	  MtuDAH7PSK123M	   as	   described	   for	  MtuDAH7PSWT	   in	   Section	  
9.7.7.	  Ali	  Nazmi	  performed	  the	  AUC	  experiments	  and	  assisted	  with	  the	  data	  analysis.	  Sedimentation	  
velocity	   experiments	   were	   carried	   out	   at	   three	   concentrations	   of	  MtuDAH7PSK123M	   (0.3,	   0.6	   and	  
1.0	  mg/mL)	   and	   confirmed	   the	   quaternary	   structure	   equilibrium	   of	   MtuDAH7PSK123M	   was	  
concentration	  dependent.	   In	   order	   to	  determine	   the	   s	   and	  molecular	  mass	  of	  MtuDAH7PSK123M	   the	  
AUC	   data	   for	  MtuDAH7PSK123M	   was	   fitted	   to	   a	   continuous	   size	   c(s)	   distribution	   model.	   At	   0.3	   and	  
0.6	  mg/mL	  there	   is	  a	  single	  distribution	  peak	   for	  MtuDAH7PSK123M	  at	  ~3.5	  S,	  which	  gave	  a	  predicted	  
molecular	   mass	   of	   74	  kDa,	   the	   expected	   molecular	   mass	   of	   an	  MtuDAH7PS	   monomer	   is	   ~50	   kDa	  
(Figure	   6.11).	   As	   the	   concentration	   of	  MtuDAH7PSK123M	   increased	   the	   tail	   of	   the	   distribution	   peak	  
became	   more	   noticeable.	   At	   a	   concentration	   of	   1.0	   mg/mL	   MtuDAH7PSK123M	   two	   further	   peaks	  
become	  more	  defined	  at	  ~5.7	  S	  and	  8.3	  S,	  which	  corresponded	  to	  molecular	  masses	  of	  ~120	  kDa	  and	  
~220	  kDa	  respectively.	  As	  the	  concentration	  of	  MtuDAH7PSK123M	  in	  solution	  was	  increased	  from	  0.3	  to	  
1.0	  mg/mL	  the	  amount	  of	  dimeric	  and	  tetrameric	  MtuDAH7PSK123M	  in	  solution	  also	  increased,	  but	  the	  
monomeric	  species	  remained	  the	  dominant	  oligomeric	  species	  in	  solution	  at	  all	  three	  concentrations	  
analysed.	  A	  concentration	  of	  1	  mg/mL	  was	  not	  enough	  to	  drive	  the	  equilibrium	  towards	  favouring	  the	  
MtuDAH7PSK123M	  tetramer.	  	  




Figure	  6.11	  Continuous	  size	  c(s)	  distribution	  plots	  from	  sedimentation	  velocity	  experiments	  of	  MtuDAH7PSK123M	  
analysed	  at	  0.3	  (violet),	  0.6	  (purple)	  and	  1.0	  (pink)	  mg/mL.	  AUC	  data	  and	  fits	  shown	  in	  Appendix	  II.	  
	  
6.8. Activation	  of	  MtuCM	  
Kinetic	   assays	  monitoring	  MtuCM	  activity	   in	   the	  presence	  of	   the	  MtuDAH7PS	   variants	  were	   carried	  
out	   to	  determine	   if	   changes	   in	   the	  average	  quaternary	   structure	  of	   the	  variants	   compromised	   their	  
interaction	  with	  MtuCM.	   Assays	  were	   conducted	   under	   the	   conditions	   stated	   in	   Section	   9.9.1.	   The	  
ability	   of	   both	   variants	   to	   activate	   MtuCM	   has	   been	   severely	   compromised	   compared	   to	   the	  
MtuDAH7PSWT	  (Figure	  6.12).	  MtuDAH7PSN237A	  achieved	  a	  34-­‐fold	  maximum	  enhancement	  of	  MtuCM	  
activity,	  and	  MtuDAH7PSK123M	  activated	  MtuCM	  activity	  by	  19-­‐fold.	  	  
	  
The	   change	   in	   conformation	   of	   the	  MtuDAH7PSN237A	   tetramer	  must	   disrupt	   the	   interface	   to	   which	  
MtuCM	   binds.	   This	   change	   at	   the	  MtuCM	   binding	   face	   of	  MtuDAH7PSN237A	   either	   weakened	   the	  
interaction	  between	  MtuDAH7PSN237A	  and	  MtuCM	  or	  did	  not	  allow	  the	  optimal	   interactions	  to	  occur	  
with	  the	  MtuCM	  C-­‐terminal	  tail	  that	  were	  required	  for	  the	  MtuCM	  activation,	  resulting	  in	  the	  reduced	  
ability	   of	   MtuDAH7PSN237A	   to	   boost	   MtuCM	   activity.	   The	   poor	   activation	   of	   MtuCM	   activity	   by	  
MtuDAH7PSN237A	   offers	   evidence	   that	   a	   change	  or	   twist	   in	   the	   tetramer	   conformation	   is	   enough	   to	  
weaken	   or	   alter	   the	   interaction	   between	  MtuCM	   and	  MtuDAH7PS,	   in	   turn	   altering	   the	   ability	   of	  
MtuDAH7PS	  to	  activate	  MtuCM	  activity.	  	  
	  




Figure	  6.12	  Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  either	  equimolar,	  ten-­‐fold	  or	  200-­‐fold	  molar	  excess	  of	  
MtuDAH7PSWT	   (blue	   hash),	  MtuDAH7PSN237A	   (gold	   hash)	   and	  MtuDAH7PSK123M	   (silver	   hash).	   The	   burgundy	   line	  
indicates	  the	  activity	  of	  MtuCM	  alone.	  Assays	  conducted	  with	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  
for	  reactions	  requiring	  a	  200-­‐fold	  excess	  of	  MtuDAH7PS	  where	  10	  nM	  of	  MtuCM	  and	  MtuCM	  alone	  where	  90	  nM	  
were	  used	  and	  the	  results	  normalised.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	  
	  
The	  Lys123Met	  substitution	  has	  disrupted	  the	  quaternary	  structure	  equilibrium	  of	  MtuDAH7PSK123M	  to	  
favour	   the	  monomer.	   The	   dramatically	   reduced	   ability	   of	  MtuDAH7PSK123M	  most	   likely	   reflects	   the	  
much	  lower	  affinity	  of	  MtuCM	  for	  the	  MtuDAH7PS	  monomer	  compared	  to	  the	  MtuDAH7PS	  tetramer.	  
At	   a	   200-­‐fold	   molar	   excess	   of	  MtuDAH7PSK123M	   the	   quaternary	   structure	   equilibrium	   would	   shift	  
slightly	   toward	   the	   formation	   of	   the	  MtuDAH7PSK123M	   tetramer,	   which	   is	   better	   able	   to	   activate	  
MtuCM	  activity.	  
6.9. Regulation	  of	  MtuCM	  
	  
Both	  MtuDAH7PS	  variants	  were	  able	  to	  regulate	  MtuCM	  activity,	  despite	  their	  changes	  in	  quaternary	  
structure/conformation.	  Assays	  to	  determine	  MtuCM	  activity	  of	  a	  mixture	  of	  MtuCM	  and	  a	  ten-­‐fold	  
molar	  excess	  of	  variant	  MtuDAH7PS	  in	  the	  presence	  of	  various	  aromatic	  amino	  acids	  were	  carried	  out	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as	  outlined	  in	  Section	  9.9.3.	  It	  should	  be	  noted	  the	  MtuCM	  activity	  being	  measured	  was	  very	  low	  due	  
to	   the	  poor	   ability	   of	   both	  MtuDAH7PS	   variants	   to	   boost	  MtuCM	  activity,	   and	   inherently	   there	   are	  
greater	  errors	  associated	  with	  these	  measurements.	  The	  addition	  of	  Trp	  to	  a	  mixture	  of	  MtuCM	  and	  
MtuDAH7PSN237A	  dramatically	  boosted	  the	  activity	  of	  MtuCM	  by	  ~96	  %	  (Figure	  6.13).	  SAXS	  showed	  the	  
MtuDAH7PSN237A	  tetramer	  became	  more	   like	  the	  MtuDAH7PSWT	  tetramer	  when	  Trp	  was	  added.	  This	  
change	   in	   conformation	   most	   likely	   strengthened	   or	   improved	   the	   interactions	   between	  
MtuDAH7PSN237A	   and	   MtuCM	   facilitating	   better	   activation	   of	   MtuCM	   activity.	   The	   regulation	   of	  
MtuCM	  activity	  in	  the	  presence	  of	  MtuDAH7PSN237A	  showed	  greater	  sensitivity	  to	  Phe	  or	  Tyr	  than	  for	  a	  
mixture	  of	  MtuCM	  and	  MtuDAH7PSWT.	  The	  improved	  inhibition	  of	  MtuCM	  activity	  by	  Phe	  and	  Tyr	  may	  
be	   in	  part	  due	  to	  the	  ability	  of	  MtuDAH7PSN237A	  to	  bind	  both	  Phe	  and	  Tyr	  more	  tightly	  as	  shown	  by	  
ITC.	  
	  
Due	  to	  the	  very	  small	  rates	  measured	  for	  the	  inhibited	  MtuCM	  activity	  and	  the	  large	  errors	  associated	  
with	  these	  measurements	  it	  was	  difficult	  to	  determine	  if	  MtuDAH7PSN237A	  was	  able	  to	  synergistically	  
inhibit	  MtuCM	  activity	   in	  the	  presence	  of	  combinations	  of	  aromatic	  amino	  acids.	  The	  exception	  was	  
the	  addition	  of	  Trp	  in	  combination	  with	  Tyr,	  which	  appeared	  to	  synergistically	  inhibit	  MtuCM	  activity	  
in	  the	  presence	  of	  MtuDAH7PSN237A.	  The	  synergistic	  inhibition	  of	  MtuCM	  activity	  by	  Trp	  and	  Tyr	  in	  the	  
presence	  of	  MtuDAH7PSN237A	  suggests	  Asn237	  is	  not	  important	  for	  communicating	  allosteric	  inhibitor	  
binding	  to	  the	  MtuCM•MtuDAH7PS	  interface.	  




Figure	   6.13	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	   amino	   acids	   and	   a	   ten-­‐fold	   excess	   of	  MtuDAH7PSWT	   (blue	   hash),	   	  MtuDAH7PSN237A	   (gold	   hash)	   and	  
MtuDAH7PSK123M	  (silver	  hash).	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  
and	  Tyr,	  Y.	  Each	  letter	  also	  represents	  200	  µM	  of	  the	  corresponding	  aromatic	  amino	  acids.	  Assays	  conducted	  in	  
the	  presence	  of	  150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  at	   least	  
duplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	  addition	  of	  Trp	  to	  a	  mixture	  of	  MtuCM	  and	  MtuDAH7PSK123M	  also	  boosts	  MtuCM	  activity	  by	  ~22	  %	  
(Figure	  6.13).	  The	  improved	  activation	  of	  MtuCM	  activity	   in	  the	  presence	  of	  MtuDAH7PSN237A	  by	  Trp	  
was	  most	  likely	  due	  to	  Trp	  binding	  shifting	  the	  quaternary	  structure	  equilibrium	  toward	  the	  tetramer,	  
which	  in	  turn	  has	  a	  higher	  affinity	  for	  MtuCM	  and	  results	  in	  greater	  enhancement	  of	  MtuCM	  activity.	  
The	   improved	   activation	   of	  MtuCM	   activity	   in	   the	   presence	   of	  MtuDAH7PSN237A	   by	   Trp	   was	   also	  
significant	  as	  this	  was	  the	  first	  evidence	  to	  indicate	  Trp	  can	  still	  bind	  to	  MtuDAH7PSK123M.	  The	  very	  low	  
rates	  and	  their	  large	  associated	  errors	  made	  it	  difficult	  to	  identify	  whether	  synergistic	  inhibition	  was	  
occurring.	  Ideally,	  the	  inhibition	  assays	  need	  to	  be	  repeated	  using	  a	  higher	  concentration	  of	  chorismic	  
acid	   in	  order	   to	   increase	  the	  absolute	  rates	  of	   the	   inhibited	  MtuCM	  activity.	  Faster	   rates	  may	  allow	  
differences	  between	  the	  single	  and	  multiple	  aromatics	  acids	  combinations	  to	  be	  identified,	  and	  allow	  
insight	  into	  whether	  synergistic	  inhibition	  of	  MtuCM	  activity	  is	  occurring	  in	  the	  presence	  of	  these	  two	  
MtuDAH7PS	   variants.	  As	   the	   allosteric	   binding	   sites	  of	  MtuDAH7PS	  are	   located	  near	   the	  dimer	   and	  
tetramer	  interface	  it	   is	  highly	   likely	  the	  MtuDAH7PS	  is	  the	  tetramer	  species	   is	  regulated	  species	  and	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also	   the	   species,	  which	   regulates	  MtuCM	  activity.	  Hence	   the	  MtuDAH7PSK123M	   tetramer	   is	   probably	  
responsible	  for	  both	  the	  activation	  and	  any	  inhibition	  of	  MtuCM	  activity.	  	  
6.10. Effect	  of	  MtuCM	  on	  the	  E4P	  kinetics	  of	  
MtuDAH7PSK123M	  
	  
Evaluation	  of	   the	  quaternary	   structure	  of	  MtuDAH7PSK123M	  has	   shown	   that	   at	   low	   concentrations	   a	  
mixture	   of	   oligomer	   species	   is	   present,	   predominately	   monomer.	   The	   crystal	   structure	   of	   the	  
MtuCM•MtuDAH7PSWT	   complex	   shows	   the	   dimeric	  MtuCM	   binds	   to	  MtuDAH7PS	   across	   the	   weak	  
dimer	  interface.85	  The	  kinetics	  of	  MtuDAH7PSK123M	  were	  analysed	  in	  the	  presence	  of	  a	  ten-­‐fold	  molar	  
excess	   of	  MtuCM	  as	   outlined	   in	   Section	   9.9.1.	   The	   data	  was	   fitted	   to	  Michaelis-­‐Menten	   kinetics	   to	  
determine	  the	  kinetics	  parameters.	  	  
	  
The	   addition	   of	  MtuCM	   caused	   the	   E4P	   catalytic	   efficiency	   of	  MtuDAH7PSK123M	   to	   half,	   whereas	  
MtuDAH7PSWT	  exhibits	  no	  catalytic	  penalty	   for	  being	  associated	  to	  MtuCM	  (Table	  6.6).	   It	   is	  possible	  
MtuCM	   encourages	   the	   association	   of	   the	   tetramer	  MtuDAH7PSK123M	   to	   occur,	   either	   by	   enabling	  
favourable	  contact	  between	  subunits	  or	  by	   simply	  bringing	   them	   into	  close	  proximity.	   If	  a	   tetramer	  
has	  been	  formed,	  it	  could	  be	  the	  tetrameric	  form	  of	  MtuDAH7PSK123M	  rather	  than	  the	  interaction	  with	  
MtuCM	  itself	  that	  is	  responsible	  for	  the	  loss	  in	  catalytic	  ability.	  The	  loss	  in	  E4P	  catalytic	  efficiency	  of	  
MtuDAH7PSK123M	   would	   infer	   the	   MtuDAH7PSK123M	   tetramer	   was	   a	   poorer	   catalyst	   than	   the	  
MtuDAH7PSK123M	  monomer.	  
	  
Table	   6.6	  E4P-­‐dependent	  kinetic	  parameters	   for	  MtuDAH7PSK123M	  with	  and	  without	  a	   ten-­‐fold	  molar	  excess	  of	  
MtuCM.	  Michaelis-­‐Menten	  plots	  are	  shown	   in	  Appendix	   I.	  Values	  were	  determined	   from	  a	  single	  set	  of	  kinetic	  
data.	  Errors	  represent	  the	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  squares	  fit.	  








	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	  
K123M	   60	  ±	  4	   6.3	  ±	  0.1	   105	  ±	  9	  
K123M-­‐CM	   67	  ±	  4	   3.5	  ±	  0.1	   52	  ±	  5	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6.11. Chapter	  summary	  
Two	  Trp	  site	  MtuDAH7PS	  variants,	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M,	  were	  prepared	  and	  purified	  
successfully.	   CD	   showed	   the	   secondary	   structures	   of	   both	   variant	   enzymes	   were	   similar	   to	  
MtuDAH7PSWT.	  SAXS	  revealed	  the	  substitution	  of	  Asn237	  for	  Met	  altered	  the	  tetrameric	  conformation	  
of	   MtuDAH7PSN237A.	   Native	   PAGE	   showed	   MtuDAH7PSN237A	   was	   tetrameric	   even	   at	   low	  
concentrations,	   suggesting	   the	   loss	   of	   the	   amide	   of	   Asn237	   has	   stabilised	   the	   MtuDAH7PSN237A	  
tetramer.	  On	  the	  other	  hand,	  AUC,	  native	  PAGE	  and	  SAXS	  showed	  MtuDAH7PSK123M	  existed	  in	  solution	  
as	  a	  mixture	  of	  monomer,	  dimer	  and	  tetramer.	  As	  expected,	  this	  equilibrium	  showed	  concentrations	  
dependence;	  AUC	  showed	  at	  low	  concentrations	  the	  equilibrium	  favours	  the	  monomeric	  species,	  and	  
at	  high	  concentrations	  the	  equilibrium	  shifted	  to	  favour	  the	  tetramer.	  Substitution	  of	  residues	  at	  or	  
near	  the	  Trp	  site	  appears	  to	  correlate	  strongly	  with	  changes	  in	  quaternary	  structure.	  	  
	  
Both	  MtuDAH7PSN237A	   and	  MtuDAH7PSK123M	   were	   catalytically	   active.	   The	   catalytic	   efficiency	   with	  
respect	   to	   PEP	   of	   MtuDAH7PSN237A	   was	   severely	   compromised,	   but	   this	   catalytic	   efficiency	   of	  
MtuDAH7PSK123M	  showed	  some	  improvement.	  The	  E4P	  concentration	  required	  for	  effective	  catalysis	  
increased	  for	  both	  MtuDAH7PS	  variants.	  Intriguingly,	  the	  kinetic	  data	  for	  the	  E4P-­‐dependent	  kinetics	  
of	  MtuDAH7PSN237A	   displayed	   cooperativity,	   behaviour	   that	   had	   only	   previously	   been	   observed	   for	  
MtuDAH7PSWT	  in	  the	  presence	  of	  Trp	  and	  Phe.48	  Molecular	  modelling	  studies	  found	  the	  occupation	  of	  
the	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  correlated	  with	  the	  increased	  flexibility	  of	  the	  E4P	  binding	  
loop	  (β2-­‐α2	   loop).71	  The	  mechanism	  of	  MtuDAH7PS	   inhibition	  proposed	  was	  that	  the	  binding	  of	  Trp	  
and	  Phe	   to	   the	  allosteric	  binding	   sites	  entropically	  disfavoured	  E4P	  binding	  at	   the	  active	   site.71	   The	  
change	  in	  E4P-­‐dependent	  kinetics	  of	  both	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  is	  evidence	  the	  Trp	  
site	   is	   intrinsically	   linked	   to	   the	   active	   site.	   The	   change	   in	   the	   substrate	   catalytic	   efficiencies	   of	  
MtuDAH7PSK123M	   could	   also	   in	   part	   be	   due	   to	   the	   disruption	   of	   the	   quaternary	   structure.	   The	  
monomer	   may	   have	   different	   catalytic	   properties	   to	   the	   tetramer.	   To	   investigate	   the	   kinetic	  
properties	  of	  monomeric	  MtuDAH7PS,	  a	  variant	  would	  need	  to	  be	  produced	  that	  disrupted	  the	  tight	  
dimer	  interface	  sufficiently	  that	  the	  variant	  could	  not	  form	  higher	  oligomeric	  states.	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Inhibition	   studies	   showed	   both	  MtuDAH7PSN237A	   and	  MtuDAH7PSK123M	  were	   activated	   by	   Trp.	   SAXS	  
showed	   Phe	   binding	   drives	   the	   MtuDAH7PSK123M	   quaternary	   structure	   equilibrium	   towards	   the	  
tetramer.	   It	   is	   in	   all	   likelihood	   Trp	   binding	   also	   shifts	   the	   quaternary	   structure	   equilibrium	   of	  
MtuDAH7PSK123M	  toward	  the	  tetramer.	  If	  the	  tetramer	  is	  more	  catalytically	  active	  than	  the	  monomer	  
it	   could	   explain	   the	   improvement	   of	  MtuDAH7PSK123M	   activity	   in	   the	   presence	   of	   Trp.	   SAXS	   also	  
showed	   the	   conformation	   of	   the	  MtuDAH7PSN237A	   tetramer	   became	   more	   like	   the	  MtuDAH7PSWT	  
tetramer	   in	   the	   presence	   of	   Trp,	   yet	   the	   E4P-­‐dependent	   kinetic	   parameters	   did	   not	   reveal	   any	  
significant	   changes.	   The	   change	   in	  MtuDAH7PSN237A	   tetramer	   conformation	   may	   instead	   improve	  
MtuDAH7PSN237A	   activity	   by	   improving	   PEP	   catalytic	   efficiency.	   Investigation	   of	   the	   PEP-­‐dependent	  
kinetic	   parameters	   in	   the	   presence	   of	   Trp	   is	   required	   to	   determine	   if	   Trp	   improves	   PEP	   catalytic	  
efficiency	  of	  MtuDAH7PSN237A.	  
	  
The	   ITC	   of	  MtuDAH7PSN237A	   revealed	   the	   affinity	   for	   all	   three	   aromatic	   amino	   acids	   had	   improved	  
compared	  to	  MtuDAH7PSWT.	  ITC	  did	  not	  reveal	  any	  evidence	  to	  suggest	  Trp	  was	  competing	  with	  Phe	  
or	  Tyr	  to	  occupy	  sites	  1	  or	  2,	  so	  it	  is	  highly	  probably	  Trp	  binds	  to	  the	  Trp	  site	  of	  MtuDAH7PSN237A.	  The	  
loss	  of	  Asn237	  was	  not	  detrimental	   to	  Trp	  binding	   to	  MtuDAH7PSN237A	   therefore	   the	  polar	   contacts	  
between	  the	  amide	  of	  Asn237	  and	  the	  α-­‐amino	  group	  of	  the	  bound	  Trp	   ligand	  are	  not	  essential	   for	  
the	  tight	  binding	  of	  Trp	  at	  the	  Trp	  site.	  ITC	  also	  showed	  no	  evidence	  that	  the	  presence	  of	  Trp	  or	  Phe	  
could	   improve	   the	   binding	   of	   the	   other	   ligand	   to	  MtuDAH7PSN237A.	   The	   lack	   of	   cooperative	   binding	  
between	   the	   allosteric	   binding	   sites	   of	   MtuDAH7PSN237A	   suggests	   the	   contacts	   formed	   between	  
Asn237	  and	  the	  bound	  Trp	  ligand	  are	  responsible	  for	  triggering	  the	  correct	  signal	  transmission	  of	  Trp	  
binding	  to	  the	  active	  site	  and	  the	  other	  allosteric	  binding	  sites.	  
	  
DSF	   and	   the	   inhibition	   studies	  with	   and	  without	  MtuCM	   confirmed	   all	   three	   aromatic	   amino	   acids	  
could	  bind	  to	  both	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M.	  The	  binding	  of	  Trp	  to	  MtuDAH7PSK123M	  may	  
have	  been	   significantly	  weakened	  by	   substitution	  of	   Lys123	   as	   Trp	   caused	   very	   little	   change	   to	   the	  
thermal	   stability	   of	   MtuDAH7PSK123M	   and	   there	   is	   no	   synergistic	   regulation	   of	   MtuDAH7PSK123M	  
activity.	   ITC	   of	  MtuDAH7PSK123M	  with	   a	   Trp	   titrant	   could	   identify	   if	  MtuDAH7PSK123M	   has	   a	   reduced	  
affinity	  for	  Trp.	  The	  activity	  of	  both	  variant	  enzymes	  showed	  sensitivity	  to	  both	  Phe	  and	  Tyr,	  but	  did	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not	  show	  strong	  evidence	  of	  synergistic	  regulation	  in	  the	  presence	  of	  multiple	  aromatic	  amino	  acids.	  
The	  loss	  of	  synergistic	  inhibition	  and	  change	  in	  sensitivity	  to	  Phe	  and	  Tyr	  showed	  Asn237	  and	  Lys123	  
are	   intimately	   involved	   in	   the	   signal	   transmission	   networks	   between	   the	   Trp	   site	   and	   the	   other	  
allosteric	   binding	   sites	   and	   the	   active	   site.	   The	   substitution	  of	   these	   two	   residues	  may	  have	   falsely	  
signalled	  Trp	  has	  bound	  to	  the	  Trp	  site	  at	   least	  partially	  to	  the	  other	  allosteric	  binding	  sites	  and	  the	  
active	  site.	  	  
	  
Both	  MtuDAH7PSK123M	   and	  MtuDAH7PSN237A	   were	   poor	   activators	   of	  MtuCM	   activity.	   The	  MtuCM	  
activity	  in	  the	  presence	  of	  MtuDAH7PSN237A	  and	  MtuDAH7PSK123M	  also	  exhibited	  heightened	  sensitivity	  
to	  Tyr	  and	  Phe.	  For	  MtuDAH7PSK123M	  the	  poor	  activation	  was	  most	  probably	  due	  to	  the	  predominance	  
of	  the	  MtuDAH7PSK123M	  monomer	  in	  solution.	  Since	  MtuCM	  binds	  across	  the	  weak	  dimer	  interface	  of	  
MtuDAH7PS,	  it	  is	  highly	  likely	  the	  affinity	  of	  MtuCM	  for	  the	  MtuDAH7PS	  monomer	  is	  very	  much	  less	  
than	   the	  MtuDAH7PS	   tetramer.	   Furthermore	   the	   monomer	   may	   not	   be	   able	   to	   form	   the	   proper	  
contacts	   with	   the	  MtuCM	   C-­‐terminal	   tail,	   thus	   fail	   to	   properly	   activate	  MtuCM	   activity.	   The	   poor	  
activation	  of	  MtuCM	  activity	  by	  MtuDAH7PSN237A	  is	  likely	  to	  be	  mostly	  due	  to	  the	  change	  in	  tetramer	  
conformation,	   as	   demonstrated	   by	   the	   improvement	   of	   the	   ability	   of	  MtuDAH7PSN237A	   to	   activate	  
MtuCM	  activity	   in	   the	  presence	  of	  Trp.	  As	  stated	  previously,	  SAXS	  showed	  Trp	  binding	  changed	  the	  
MtuDAH7PSN237A	   tetramer	   conformation	   to	   a	   conformation	   that	   was	   similar	   to	   the	  MtuDAH7PSWT	  
tetramer.	  Therefore	  the	  change	   in	  conformation	  of	  MtuDAH7PSN237A	  must	  disrupt	  the	   interaction	  of	  
MtuDAH7PSN237A	   with	   MtuCM	   by	   either	   preventing	   the	   key	   interactions	   that	   facilitate	   the	  
rearrangement	  of	  the	  MtuCM	  active	  site	  residues	  or	  by	  weakening	  the	  polar	  and	  non-­‐polar	  contacts	  
required	  for	  MtuCM	  binding	  to	  MtuDAH7PSN237A.	  	  
	  
The	  proposed	  mechanism	  of	   inhibition	  of	  the	  MtuCM•MtuDAH7PS	  complex	  (Section	  4.8)	   is	  that	  the	  
binding	  of	  Phe	  causes	  a	  subtle	  change	  in	  the	  conformation	  of	  MtuDAH7PS	  tetramer,	  such	  as	  a	  slight	  
twist	   in	   the	   tetramer	   plane.	   This	   twist	   in	   turn	   disrupts	   the	   contacts	   at	   the	  MtuCM•MtuDAH7PS	  
interface	   resulting	   in	   dissociation	   of	   the	   complex,	   preventing	   activation	   of	   MtuCM	   activity.	  
MtuDAH7PSN237A	  has	  illustrated	  the	  MtuDAH7PS	  tetramer	  is	  flexible	  and	  can	  change	  conformation	  on	  
ligand	  binding.	  Furthermore	  the	  tetramer	  conformation	  of	  MtuDAH7PS	  affects	  the	  enzyme’s	  ability	  to	  
6	   Trp	  site	  	  
	  
198	  
activate	  MtuCM.	   These	   are	   significant	   findings	   that	   give	   credence	   to	   the	   proposed	   mechanism	   of	  
MtuCM	  inhibition	  of	  the	  MtuCM•MtuDAH7PS	  complex.	  
	  
In	   Section	   2.6.2,	   it	   was	   shown	   that	   Trp	   and	   Phe	   shift	   the	   quaternary	   structure	   equilibrium	   of	  
MtuDAH7PSWT	   toward	   the	   tetramer.	  The	  quaternary	  structure	  of	  MtuDAH7PSN237A	  was	  shown	  to	  be	  
predominantly	   tetrameric	   and	   suggests	   this	   variant	   enzyme	   may	   mimic	   the	   conformation	   of	  
MtuDAH7PS	   in	   the	   presence	   of	   Trp	   and	   Phe,	   i.e.	   the	   inhibited	   state.	   The	   catalytic	   ability	   of	  
MtuDAH7PSN237A	   was	   severely	   impaired	   as	   would	   be	   expected	   for	   an	   inhibited-­‐like	   MtuDAH7PS	  
species.	   Cooperative	   E4P	   binding	   has	   previously	   only	   been	   described	   for	   MtuDAH7PSWT	   in	   the	  
presence	  of	  Trp	  and	  Phe	  or	  Trp	  and	  Tyr.48	  Therefore	  the	  E4P	  binding	  loop	  of	  MtuDAH7PSN237A	  is	  most	  
likely	  mimicking	   the	   changes	   in	   flexibility	   that	  occur	  on	  Trp	  and	  Phe	  binding	   to	  MtuDAH7PSWT.	   Like	  
MtuDAH7PSWT	   bound	   with	   Trp	   and	   Phe	   or	   Trp	   and	   Tyr	  MtuDAH7PSN237A	   poorly	   activates	  MtuCM	  
activity.	   The	   dissociation	   constants,	   determined	   by	   ITC,	   between	   the	   aromatic	   amino	   acids	   and	  
MtuDAH7PSWT	   decreased	   when	   MtuDAH7PSWT	   was	   preincubated	   with	   Trp	   (Section	   2.5.2),	   the	  
dissociation	   constants	   determined	   between	   the	   aromatic	   amino	   acids	   and	  MtuDAH7PSN237A	   were	  
lower	   than	   for	  MtuDAH7PSWT.	   Phe	   and	  Tyr	  were	  only	   able	   to	   inhibit	  MtuDAH7PSWT	  when	  added	   in	  
combination	  with	  Trp,	  whereas	  MtuDAH7PSN237A	  displayed	  sensitivity	  to	  the	  presence	  of	  Phe	  and	  Tyr	  
alone.	  The	   improved	  binding	  of	   the	  aromatic	  amino	  acids	   to	  MtuDAH7PSN237A	  and	  sensitivity	   to	  Phe	  
and	   Tyr	   are	   also	   consistent	   with	  MtuDAH7PSN237A	   adopting	   an	   inhibited-­‐like	  MtuDAH7PS	   species,	  
which	  has	  at	  least	  partially	  signalled	  to	  sites	  1	  and	  2	  and	  the	  active	  site	  Trp	  binding	  has	  occurred.	  
	  
Overall	   the	   substitutions	   of	   Asn237	   and	   Lys123	   caused	   remarkable	   changes	   to	   almost	   every	  
measureable	  property	  of	  MtuDAH7PS.	  The	  relatively	  small	  change	  of	  removing	  the	  amide	  side	  chain	  
from	  Asn237	  at	  the	  Trp	  site	  shifted	  the	  quaternary	  equilibrium,	  changed	  the	  tetramer	  conformation,	  
decreased	   the	   enzymes	   catalysis,	   altered	   the	   regulatory	   sensitivity,	   the	   enzymes	   ability	   to	   bind	   the	  
aromatic	  amino	  acids	  and	   interfered	  with	   the	  enzymes	   interaction	  with	  MtuCM.	  Similarly	   switching	  
the	   positively	   charged	   amino	   group	   of	   Lys123	   to	   the	   hydrophobic	   thiol	   ether	   Met,	   shifted	   the	  
quaternary	   structure	   equilibrium	   to	   favour	   the	  monomer,	   altering	   the	   enzyme’s	   catalytic	   efficiency	  
and	  regulatory	  sensitivity	  as	  well	  as	  impairing	  the	  ability	  of	  the	  enzyme	  to	  interact	  with	  and	  regulate	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MtuCM.	  The	  binding	  of	  Trp	  at	  the	  Trp	  site	  and	  the	  polar	  contacts	  Trp	  forms	  with	  Asn237	  and	  Ly123	  
are	  an	  integral	  part	  of	  the	  signalling	  network	  that	  relays	  to	  the	  other	  allosteric	  binding	  sites	  and	  the	  
active	   site.	   Any	   disruption	   to	   the	   residues	   of	   the	   Trp	   site	   involved	   in	   the	   signalling	   pathway	   alters	  
almost	  every	  measurable	  characteristic	  of	  MtuDAH7PS.	  The	  sensitivity	  of	  MtuDAH7PS	  to	  substitution	  
at	  the	  Trp	  site	  highlights	  the	  central	  role	  the	  Trp	  site	  plays	  in	  the	  allosteric	  regulation	  of	  MtuDAH7PS.	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7. The	   regulatory	   consequences	  of	  disrupting	   the	  
quaternary	  structure	  of	  MtuDAH7PS.	  	  
 Introduction	  7.1.
The	  work	  described	  in	  chapter	  2	  demonstrated	  that	  MtuDAH7PSWT	  exists	  in	  solution	  as	  an	  ensemble	  
of	   different	   oligomers	   in	   equilibrium	   (Section	   2.6).	   This	   quaternary	   structure	   equilibrium	  moves	   in	  
response	  to	  MtuDAH7PSWT	  concentration	  and	  the	  presence	  of	  ligand.	  Later	  work	  outlined	  in	  chapters	  
5	  and	  6	  provided	  several	  examples	  which	  demonstrate	  that	  the	  substitution	  of	  a	  single	  residue	  could	  
disrupt	   the	   quaternary	   structure	   equilibrium	   of	   the	   variant	   MtuDAH7PS	   to	   favour	   a	   particular	  
oligomeric	  state.	  	  
	  
Based	   on	   SCA	   and	  MD	   simulations	   clusters	   of	   residues	   believed	   to	   be	   part	   of	   the	   communication	  
pathways	  between	  the	  allosteric	  sites	  and	  the	  active	  site	  have	  been	  identified.115	  Work	  described	  in	  
chapter	  5	  aimed	  to	  validate	  computational	  studies	  with	  experimental	   results.	   115	  The	  preparation	  of	  
several	   variants,	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	   and	  MtuDAH7PST114V	   (not	   covered	   in	   this	  
thesis	   as	   the	   properties	   of	   MtuDAH7PST114V	   were	   very	   similar	   to	   MtuDAH7PSG232P	   and	  
MtuDAH7PSG190P/G232P)	   disrupted	   the	   quaternary	   structure	   of	   the	   variants	   so	   severely	   that	   these	  
variant	   enzymes	   exist	   as	   dimers	   rather	   than	   tetramers	   in	   solution.	   The	   serendipitous	   formation	   of	  
these	  dimers	  presented	  a	  unique	  opportunity	  to	  study	  the	  MtuDAH7PS	  dimer;	   the	  findings	  of	   these	  
studies	  are	  discussed	  within	  this	  chapter.	  
	  
 Subunit	  interfaces	  7.1.1.
Crystal	  coordinates	  of	  MtuDAH7PS	  with	  and	  without	  ligand	  bound	  consistently	  identify	  two	  subunits	  
in	  the	  asymmetric	  unit	  that	  interact	  to	  form	  a	  dimer.	  The	  interface	  of	  this	  dimer	  is	  formed	  principally	  
by	  residues	  of	  the	  α2	  helix	  from	  the	  core	  (β/α)8	  barrel	  structure	  and	  the	  residues	   located	  on	  the	  N-­‐
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terminal	   extension,	   more	   specifically	   the	   α0b-­‐α0c	   loop,	   β0	   beta	   strand	   and	   the	   N-­‐terminal	   tail	  
(residues	   1-­‐3)	   (Figure	   7.1A).	   The	   β0	   strand	   of	   each	   subunit	   associates	   to	   form	   an	   inter-­‐subunit	  
antiparallel	  β-­‐sheet.	  Evaluation	  of	  the	  dimer	  interface	  of	  unliganded	  MtuDAH7PS	  (PDB	  code:	  3NV8)	  by	  
PDBsum127	   revealed	   the	   average	   buried	   surface	   area	   of	   each	   subunit	   to	   be	   1875	   Å2.	   PDBsum	   also	  
found	  a	  total	  of	  170	  hydrophobic	  contacts,	  13	  hydrogen	  bonds	  and	  1	  salt	  bridge	  between	  Asp10	  and	  
Arg171	  (Appendix	  III).	  	  
	  
The	  binding	  of	  Trp	  and	  Phe	  at	  the	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  subtly	  alters	  the	  interactions	  
between	   the	   two	   subunits	   at	   the	   dimer	   interface	   (Figure	   7.1B).	   PDBsum	   found	   198	  hydrophobic	  
contacts	  and	  18	  hydrogen	  bonds	  were	  formed	  across	  the	  dimer	  interface	  of	  MtuDAH7PS	  bound	  with	  
Trp	  and	  Phe	  (PDB	  code:	  3KGF),	  burying	  an	  average	  surface	  area	  of	  1825	  Å2	  for	  each	  subunit	  (Appendix	  
III).	   The	   loss	   of	   the	   salt	   bridge	   between	   Asp10	   and	   Arg171	   is	   associated	   with	   the	   β0-­‐α0a	   loop	  
becoming	  disordered	  in	  the	  Trp	  and	  Phe	  bound	  MtuDAH7PS	  structure.	  
	  




Figure	   7.1	   The	   dimer	   present	   in	   the	   crystallographic	   asymmetric	   unit,	   with	   schematic	   of	   the	   dimer	   interface	  
interactions	  between	  the	  two	  subunits	  designated	  chain	  A	  and	  chain	  B	  below.	  A.	  unliganded	  MtuDAH7PS	  (PDB	  
code	  3nv8)	  with	  the	  core	  (β/α)8	  barrel	  coloured	  cyan,	  the	  N-­‐terminal	  extension	  magenta	  and	  the	  inserted	  helices	  
yellow	   orange,	   and	   B.	   Trp-­‐	   and	   Phe-­‐bound	  MtuDAH7PS	   (PDB	   code:	   3KGF).	   The	   core	   (β/α)8	   barrel	   structure	   is	  
coloured	  blue,	  the	  N-­‐terminal	  extension	  is	  coloured	  red	  and	  the	  additional	  helices	  to	  the	  α2-­‐β3	  loop	  are	  coloured	  
yellow.	  
	  
When	  crystallographic	  symmetry	  is	  applied	  to	  the	  asymmetric	  unit,	  a	  homotetramer	  is	  generated.	  The	  
interface	  between	  the	  two	  asymmetric	  dimers	  is	  denoted	  here	  as	  the	  tetramer	  interface.	  The	  residues	  
of	  the	  inserted	  α2b	  helix,	  the	  α2-­‐β3	  loop	  and	  the	  α1	  helix	  from	  the	  core	  (β/α)8	  barrel	  are	  principally	  
involved	   in	   forming	  the	  contacts	  across	   the	  tetramer	   interface	   (Figure	  7.2A).	  The	   interface	  between	  
two	   subunits	   across	   the	   tetramer	   interface	   was	   found	   to	   bury	   an	   average	   surface	   area	   for	   each	  
subunit	   of	   990	   Å2	   in	   the	   unliganded	  MtuDAH7PS	   crystal	   structure	   (PDB	   code:	   3NV8)	   according	   to	  
PDBsum.	  PDB	  sum	  identified	  2	  hydrogen	  bonds	  and	  71	  hydrophobic	  contacts	  between	  two	  subunits	  
of	  the	  tetramer	  interface	  (Appendix	  III).	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The	   crystal	   structure	   of	   Trp-­‐	   and	   Phe-­‐bound	  MtuDAH7PS	   (PDB	   doe:	   3KGF)	   revealed	   Trp	   and	   Phe	  
binding	  to	  MtuDAH7PS	  caused	  subtle	  changes	  at	  the	  tetramer	  interface	  of	  MtuDAH7PS	  (Figure	  7.2B).	  
Evaluation	  of	  the	  Trp-­‐	  and	  Phe-­‐bound	  MtuDAH7PS	  crystal	  structure	  by	  PDBsum	  revealed	  only	  a	  slight	  
increase	   of	   the	   average	   buried	   surface	   of	   each	   subunit	   at	   the	   tetramer	   interface	   to	   1055	   Å2.	  
Additionally	   PDBsum	   identified	   4	   hydrogen	   bonds	   and	   100	   hydrophobic	   contacts	   between	   the	   two	  
subunits	   of	   the	   tetramer	   interface	   (Appendix	   III).	   The	   increased	   number	   of	   contacts	   between	   the	  
subunits	  at	  the	  tetramer	  interface	  when	  Trp	  and	  Phe	  have	  bound	  to	  MtuDAH7PS	  would	  contribute	  to	  
the	   stabilisation	   of	   the	   interface,	   and	   promote	   formation	   of	   the	   tetramer.	   This	   observation	   is	  
consistent	  with	  experimental	  data	  from	  AUC	  that	  found	  Trp	  and	  Phe	  cause	  the	  quaternary	  structure	  
equilibrium	  of	  MtuDAH7PSWT	  to	  shift	  toward	  the	  MtuDAH7PS	  tetramer	  (Section	  2.6.2).	  




Figure	  7.2	  The	  tetramer	  interface	  formed	  by	  the	  interaction	  between	  chain	  A	  of	  the	  adjacent	  asymmetric	  dimers.	  
For	   clarity	   chain	   A	   of	   the	   second	   dimer	   has	   been	   designated	   chain	   C,	   schematic	   to	   the	   right	   represents	   the	  
interactions	  between	  chains	  A	  and	  C	  at	  the	  tetramer	  interface.	  A.	  unliganded	  MtuDAH7PS	  (PDB	  code	  3NV8)	  with	  
the	  core	  (β/α)8	  barrel	  coloured	  cyan,	  the	  N-­‐terminal	  extension	  magenta	  and	  the	  inserted	  helices	  yellow	  orange,	  
and	  B.	  Trp-­‐	  and	  Phe-­‐bound	  MtuDAH7PS	  (PDB	  code:	  3KGF).	  The	  core	  (β/α)8	  barrel	  structure	  is	  coloured	  blue,	  the	  
N-­‐terminal	  extension	  is	  coloured	  red	  and	  the	  additional	  helices	  to	  the	  α2-­‐β3	  loop	  are	  coloured	  yellow.	  
 Serendipitous	  dimeric	  MtuDAH7PS	  variants	  	  7.1.2.
From	  the	  SCA	  and	  MD	  simulations	  it	  was	  proposed	  that	  restricting	  the	  flexibility	  of	  the	  inserted	  α2a	  
and	   a2b	   helices	   may	   disrupt	   the	   regulation	   of	  MtuDAH7PS	   by	   restricting	   fluctuations	   in	   flexibility	  
being	  transmitted	  throughout	  the	  enzyme	  (previously	  discussed	  in	  Section	  5.1).	  Two	  residues,	  Gly190	  
and	  Gly232,	   located	  on	  the	   loops	  preceding	  and	  succeeding	  the	   inserted	  α2a	  and	  α2b	  helices,	  were	  
identified	   as	   potentially	   critical	   residues	   that	   control	   the	   flexibility	   of	   the	   α2a	   and	   α2b	   helices	   and	  
their	   associated	   loops.	   Gly190,	   located	   along	   the	   α2-­‐α2a	   loop,	   forms	   interactions	   with	   a	   water	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residues	  Met228	  and	  Ser229	  of	  the	  α2a	  helix	  (Figure	  7.3).	  The	  substitution	  of	  Gly190	  and	  Gly232	  for	  
Pro	   enforces	   limitations	   on	   the	   backbone,	   reducing	   flexibility.	   The	   successful	   preparation	   and	  
purification	   of	   MtuDAH7PSG190P	   showed	   the	   substitution	   of	   Gly190	   for	   eliminated	   the	   effective	  
synergistic	   regulation	   of	   MtuDAH7PS	   activity	   (Section	   5.4.2).	   Preparation	   and	   purification	   of	  
MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P	  were	  also	  successful,	  but	  it	  was	  immediately	  obvious	  from	  
the	   size	  exclusion	   chromatography	   that	   these	  enzymes	  were	  not	   tetrameric,	   as	   they	  eluted	  ~20	  mL	  
later	  than	  typically	  seen	  for	  MtuDAH7PS.	  
	  
Figure	   7.3	   Interactions	   of	   Gly190	   and	   Gly232	   (coloured	  magenta	   and	   show	   as	   sticks)	   from	   the	   Trp-­‐	   and	   Phe-­‐
bound	  MtuDAH7PS	  crystal	  structure	  (PDB	  code:	  3KGF).	  The	  core	  (β/α)8	  barrel	  structure	  is	  coloured	  blue,	  the	  N-­‐
terminal	  extension	  is	  coloured	  red,	  the	  additional	  helices	  to	  the	  α2-­‐β3	  loop	  are	  coloured	  yellow	  and	  the	  bound	  
Trp	   ligand	   is	   shown	  with	   carbon	   atoms	   coloured	  orange.	  Hydrogen	   bonds	   are	   shown	   a	   grey	   dashed	   lines	   and	  
waters	  at	  red	  spheres.	  
 Chapter	  aims	  7.1.3.
The	   primary	   goal	   of	   this	   chapter	  was	   to	   take	   full	   advantage	   of	   the	   serendipitous	   formation	   of	   two	  
dimeric	  MtuDAH7PS	   variants,	  MtuDAH7PSG232P	   and	  MtuDAH7PSG190P/G232P,	   thoroughly	   characterising	  
these	  proteins	  to	  gain	  a	  better	  understanding	  of	  the	  role	  of	  quaternary	  structure	  in	  the	  regulation	  and	  
activity	   of	   MtuDAH7PS.	   Both	   Gly190Pro	   and	   Gly232Pro	   were	   changes	   intended	   to	   disrupt	   the	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properties	   of	   the	   variant	   enzymes	   were	   due	   to	   the	   substitution(s)	   or	   the	   change	   in	   quaternary	  
structure.	  To	  address	  this	  concern,	  another	  MtuDAH7PS	  variant	  was	  required,	  deliberately	  engineered	  
to	   disrupt	   the	   tetramer	   interface	   of	   MtuDAH7PS	   and	   prevent	   tetramer	   formation.	   The	   variant	  
MtuDAH7PSF227D	  was	  successfully	  prepared	  by	  site	  directed	  mutagenesis	  and	  characterised	  alongside	  
MtuDAH7PSG232P	   and	   MtuDAH7PSG190P/G232P	   using	   a	   range	   of	   structural,	   kinetic	   and	   biophysical	  
techniques.	  
 Preparation	  of	  variants	  7.2.
 Choice	  of	   aromatic	   amino	  acid	   substitution	   to	  7.2.1.
disrupt	  the	  MtuDAH7PS	  tetramer	  interface	  
	  
Inspection	  of	  the	  tetramer	   interface	  revealed	  a	  small	  hydrophobic	  grove	  (Figure	  7.4).	  Residues	  from	  
the	  core	  α1	  helix	  (Val111	  and	  Tyr115),	  the	  α2-­‐α2a	  loop	  (Leu194)	  and	  the	  inserted	  helices	  α2a	  (His198)	  
and	  α2b	  (Ile221,	  Leu225	  and	  Met228)	  form	  this	  hydrophobic	  grove.	  Phe227,	  located	  on	  the	  α2b	  helix	  
of	  the	  subunit	  across	  the	  tetramer	  interface	  protrudes	  into	  this	  grove,	  forming	  hydrophobic	  contacts	  
with	   Tyr115,	  Met228,	   and	   Thr114	   (contacts	   identified	   by	   PDBsum).127	   Substitution	   of	   Phe227	   for	   a	  
charged	   residue,	   such	   as	   Asp,	   was	   proposed	   to	   disturb	   these	   interactions	   and	   prevent	   stable	  
formation	  of	  the	  tetramer	  interface.	  
	  




Figure	   7.4	   Hydrophobic	   grove	   located	   on	   tetramer	   interface	   of	   MtuDAH7PS	   (PDB	   code:	   3KGF)	   A.	   Surface	  
representation	  of	  chain	  A	  depicting	  cavity	  created	  by	  the	  hydrophobic	  residues.	  Residues	  of	  the	  opposite	  chain	  
are	   shown	   in	  cartoon	   form,	  and	  Phe227	  as	   sticks	   coloured	  magenta.	  B.	  Diagram	  depicting	   secondary	   structure	  
elements	   and	   the	   residues	   important	   for	   the	   formation	   of	   the	   grove	   shown	   as	   sticks.	   The	   core	   (β/α)8	   barrel	  
structure	  is	  coloured	  blue,	  the	  N-­‐terminal	  extension	  is	  coloured	  red,	  the	  additional	  helices	  to	  the	  α2-­‐β3	  loop	  are	  
coloured	  yellow,	  Phe227	  as	  sticks	  coloured	  magenta,	  and	  the	  bound	  ligand	  Trp	  as	  sticks	  coloured	  orange.	  
	  
 Preparation,	  expression	  and	  purification	  7.2.2.
SDM	  was	  performed	  using	  the	  QuikChange®	  Lightning	  Site-­‐Directed	  Mutagenesis	  Kit	  (Stratagene),	  as	  
described	   in	   Section	  9.2.	  All	   primers	  were	  designed	   to	   incorporate	   the	  desired	  mutations	  using	   the	  
QuikChange®	   Primer	   Design	   tool	   (Agilent	   technologies).	   To	   generate	   the	   vector	   for	  
MtuDAH7PSG190P/G232P	  two	  rounds	  of	  SDM	  were	  required.	  The	  SDM	  product	  for	  MtuDAH7PSG190P	  was	  
formed	   in	   the	   first	   round,	   sequence	   verified	   and	   used	   as	   the	   template	   in	   the	   second	   round.	   The	  
second	  round	  of	  SDM	  followed	  the	  same	  protocol	  as	  the	  first	  but	  used	  the	  primers	  to	  introduce	  the	  
substitution	  of	  Gly232Pro.	  DNA	  sequencing	  of	  all	  SDM	  products	  confirmed	  the	  correct	  incorporation	  
of	  the	  desired	  mutations.	  SDM	  products	  were	  electroporated	  into	  BL21(DE3)	  PGroESL	  cells,	  expressed	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 Confirmation	  of	  product	  7.2.3.
SDS-­‐PAGE	  was	  used	  to	  assess	  enzyme	  purity	  and	  molecular	  mass.	  Analysis	  of	  the	  purified	  MtuDAH7PS	  
variants	  by	  SDS-­‐PAGE	  showed	  all	   three	  variants	  produce	  a	  strong	  band	  at	  ~50	  kDa	  (Figure	  7.5).	  This	  
mass	  is	  in	  agreement	  with	  the	  expected	  monomeric	  mass	  of	  MtuDAH7PS	  of	  ~51	  kDa.	  MtuDAH7PSF227D	  
and	  MtuDAH7PSG232P	   are	   highly	   pure.	   There	   is	   a	   small	   amount	   of	   contamination	   present	   in	   the	  
MtuDAH7PSG190P/G232P	   sample,	   but	   this	   is	   relatively	   insignificant	   compared	   to	   the	   amount	   of	  
MtuDAH7PSG190P/G232P	  present.	  
	  
Figure	   7.5	   SDS-­‐PAGE	  gel	   illustrating	   the	   size	  and	  purity	  of	  each	  MtuDAH7PS	  variant.	   Lane	  M	  molecular	  weight	  
marker;	  Lane	  1	  MtuDAH7PSF227D;	  Lane	  2	  MtuDAH7PSG232P	  and	  Lane	  3	  MtuDAH7PSG190P/G232P.	  
	  
 Comparison	  of	  secondary	  structure	  	  7.3.
The	   secondary	   structure	   of	   all	   purified	  MtuDAH7PS	   variants	   was	   assessed	   by	   CD	   to	   detect	   if	   the	  
variation	   to	   their	   aromatic	   amino	   acid	   sequence	   due	   to	   the	   substitution(s)	   has	   caused	   a	   change	   in	  
their	   secondary	   structure.	   Assays	   were	   carried	   out	   as	   detailed	   in	   Section	  9.7.4.	   Comparison	   of	   the	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MtuDAH7PSF227D	  showed	  no	  variation	  (Figure	  7.6).	  Thus	  the	  substitution(s)	  introduced	  to	  each	  variant	  
have	  not	  obviously	  affected	  the	  secondary	  structure.	  	  
	  
Figure	  7.6	  CD	  spectra	  for	  MtuDAH7PSWT	  (blue),	  MtuDAH7PSG232P	  (purple),	  MtuDAH7PSG190P/G232P	  (light	  purple)	  and	  
MtuDAH7PSF227D	  (pink).	  
 Quaternary	  structure	  analysis	  7.4.
The	   first	   variant	   of	  MtuDAH7PS	   to	   be	   purified	   was	  MtuDAH7PSG232P.	   During	   the	   final	   step	   of	   the	  
purification,	   SEC,	   it	  was	  noted	   that	  MtuDAH7PSG232P	  eluted	  at	   	  ~180	  mL,	  approximately	  20	  mL	   later	  
than	   MtuDAH7PSWT.	   As	   SEC	   separates	   different	   species	   by	   size,	   this	   means	   the	   molecular	   mass	  
MtuDAH7PSG232P	   is	   lower	   than	   typically	   observed	   under	   the	   same	   conditions	   for	  MtuDAH7PSWT.	   A	  
higher	  elution	  volume	  and	   lower	  molecular	  mass	  are	  most	   likely	  due	  to	  MtuDAH7PSG232P	  adopting	  a	  
different	  oligomeric	  structure	  to	  MtuDAH7PSWT.	  MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  were	  also	  
found	  to	  elute	  from	  the	  SEC	  column	  at	  ~180	  mL.	  In	  order	  to	  verify	  whether	  the	  quaternary	  structure	  
of	   the	  MtuDAH7PS	   variants	   truly	   differed	   from	  MtuDAH7PSWT	   the	   variants	  were	   analysed	   by	   SAXS,	  
native	  PAGE	  and	  AUC.	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 SAXS	  analysis	  7.4.1.
SAXS	  analysis	  was	  carried	  out	  on	  all	  three	  MtuDAH7PS	  variants	  under	  the	  standard	  conditions	  stated	  
for	   the	  wild	   type	   enzyme,	   detailed	   in	   Section	  9.7.5The	   SAXS	   scattering	  profiles	   of	  MtuDAH7PSG232P,	  
MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  were	  almost	  identical	  to	  each	  other	  when	  overlaid	  (Figure	  
7.7).	  The	  scattering	  profiles	  of	  the	  MtuDAH7PS	  variants	  varied	  greatly	  from	  the	  SAXS	  scattering	  profile	  
of	   MtuDAH7PSWT	   and	   the	   theoretical	   scattering	   profile	   predicted	   by	   CRYSOL	   for	   tetrameric	  
MtuDAH7PS	  (PDB	  code:	  3NV8).103	  	  
	  
Figure	   7.7	   SAXS	  profiles	  of	  MtuDAH7PSWT	   (blue),	  MtuDAH7PSG232P	   (purple),	  MtuDAH7PSG190P/G232P	   (light	  purple)	  
and	  MtuDAH7PSF227D	  (pink).	  Also	  shown	  is	  the	  theoretical	  scattering	  for	  the	  tetrameric	  (black)	  and	  dimeric	  (black	  
dash)	  MtuDAH7PS	  from	  PDB	  code	  3NV8.	  Inset	  pair-­‐wise	  distribution	  profiles.	  
	  
Comparison	   of	   the	   SAXS	   scattering	   profiles	   of	   the	   variant	   enzymes	   with	   the	   theoretical	   scattering	  
profile	  predicted	  by	  CRYSOL	  for	  the	  dimer	  of	  MtuDAH7PS	  showed	  they	  were	  in	  good	  agreement.	  The	  
dimer	   formed	   in	   the	   asymmetric	   unit	   of	   the	  MtuDAH7PS	   crystal	   coordinates	   (PDB	   code:	   3nv8)	  was	  
used	  for	  the	  CRYSOL	  analysis,	  as	  the	  substitutions	   introduced	  to	  the	  variants	  most	   likely	  disrupt	  the	  
tetramer	   interface.	   The	   𝜒2	   values	   calculated	   by	   CRYSOL	   for	   the	   fit	   of	   MtuDAH7PSG232P	   and	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MtuDAH7PSG190P/G232P	   to	   the	   predicted	   scattering	   of	   the	  MtuDAH7PS	   dimer	   were	   0.986	   and	   0.806	  
respectively,	  indicating	  a	  very	  good	  fit	  to	  the	  dimeric	  crystal	  structure.	  Thus	  the	  average	  structure	  of	  
MtuDAH7PSG232P	   and	  MtuDAH7PSG190P/G232P	   in	   solution	   is	   a	   dimeric	   at	   the	  measured	   concentrations	  
(Table	   7.1).	   The	   𝜒2	   for	  MtuDAH7PSF227D	   was	   2.36,	   suggesting	   that	   there	   is	   some	   deviation	   of	   the	  
average	   structure	   of	   MtuDAH7PSF227D	   in	   solution	   from	   the	   crystallographic	   coordinates	   of	   the	  
MtuDAH7PS	  dimer.	  	  
	  
The	   parameters	   determined	   from	   the	   SAXS	   experimental	   data	   for	   the	   three	  MtuDAH7PS	   variants	  
differed	  from	  the	  wild	  type	  enzyme,	  but	  were	  remarkably	  similar	  to	  each	  other.	  The	  Dmax	  of	  the	  three	  
variant	   enzymes	   was	   smaller	   than	  MtuDAH7PSWT,	   as	   was	   the	   Rg,	   the	   real	   space	   Rg	   and	   the	   Porod	  
volume	  (Table	  7.1).	  Analysis	  by	  SAXS	  MoW	  showed	  the	  Porod	  volume	  of	  the	  MtuDAH7PS	  variants	  was	  
consistent	   with	   the	   mass	   of	   the	   MtuDAH7PS	   dimer.	   The	   analysis	   of	   the	   SAXS	   data	   for	   the	  
MtuDAH7PSG232P,	   MtuDAH7PSG190P/G232P	   and	   MtuDAH7PSF227D	   showed	   the	   average	   quaternary	  
structure	   of	   all	   three	   variants	   was	   dimeric.	   There	   was	   no	   convincing	   evidence	   to	   suggest	   other	  
oligomeric	  species	  were	  present	  in	  solution	  at	  the	  concentrations	  (4.5	  –	  6	  mg/mL)	  analysed.	  
	  
The	  quaternary	  structure	  of	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  collected	  at	  
the	  concentrations	  required	  for	  SAXS	  was	  shown	  to	  be	  almost	  exclusively	  dimeric	  in	  solution.	  The	  lack	  
of	  evidence	  of	  tetramer	  formation	  at	  the	  high	  concentrations	  of	  the	  variant	  enzymes	  required	  for	  the	  
SAXS	  analysis	  of	  MtuDAH7PS	  indicates	  the	  introduced	  substitutions,	  Gly232Pro	  and	  Phe227Asp,	  most	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Table	   7.1	   SAXS	   parameters	   calculated	   from	   analysis	   of	   the	   scattering	   profiles	   of	  MtuDAH7PS	   variants	   using	  
PRIMUS,	  GNOM,	  MoW,	  and	  CRYSOL.	  Values	  were	  obtained	  by	  analysis	  of	  one	  set	  of	  SAXS	  data.	  




Rg	  (Å)	   41.6	  ±	  0.3	   29.8	  ±	  0.1	   30.7	  ±	  0.2	   29.8	  ±	  0.1	  
I	  (0)	  (cm-­‐1)	   0.168	  ±	  0.001	   0.074	  ±	  0.001	   0.053	  ±	  0.001	   0.066	  ±	  0.001	  
Pair	  distribution	  analysis	  
Real	  Space	  Rg	  (Å)	   40.9	  ±	  0.2	   29.6	  ±	  0.1	   30.2	  ±	  0.1	   28.83	  ±	  0.07	  
Dmax	  	  (Å)	   127	   98	   99	   96	  
Vp,	  (Da)	   282700	   144500	   137500	   150518	  
Molecular	  weight	  estimates	  from	  SAXS	  MoW	  analysis	  
Mw	  from	  Vp	  (Da)	   199	  100	   89800	   92900	   91800	  
Nō	  of	  Subunits	   4	   2	   2	   2	  
CRYSOL	  analysis	  with	  Tetrameric	  3NV8	  
RgE	  (Å)	   42.4	  ±	  0.2	   41.6	  ±	  0.2	   41.9	  ±	  0.2	   29.8	  ±	  0.2	  
RgT	  (Å)	   40.6	   29.6	  ±	  0.2	   30.4	  ±	  0.2	   39.8	  
𝜒2	   0.996	   40.0	   39.9	   51.4	  
CRYSOL	  analysis	  with	  dimeric	  3NV8	  
RgE	  (Å)	   41.7	  ±	  0.2	   29.6	  ±	  0.2	   30.2	  ±	  0.2	   29.9	  ±	  0.2	  
RgT	  (Å)	   30.7	   29.1	   29.4	   29.3	  
𝜒2	   13.3	   0.986	   0.806	   2.36	  
	  
 Native	  PAGE	  7.4.2.
To	  evaluate	  the	  quaternary	  structure	  of	  the	  MtuDAH7PS	  variants	  at	  low	  concentrations	  (<	  250	  ng/mL)	  
blue	  native	  PAGE	  was	  employed.	  The	  blue	  native	  PAGE	  was	  carried	  out	  under	  the	  conditions	  stated	  in	  
Section	   9.7.2.	   All	   three	  MtuDAH7PS	   variants	   display	   a	   protein	   band	   at	   ~100	  kDa	   and	   a	   second	   at	  
~50	  kDa	  (Figure	  7.8),	  consistent	  with	  the	  molecular	  masses	  of	  the	  MtuDAH7PS	  dimer	  and	  monomer	  
respectively.	  The	  result	  is	  similar	  to	  MtuDAH7PSWT.	  This	  shows	  despite	  the	  MtuDAH7PS	  variants	  being	  
dimeric	   at	   high	   concentrations,	   at	   low	   concentrations	   they	   exist	   as	   both	   monomeric	   and	   dimeric	  
species	   in	   solution.	   Furthermore	   the	   ratio	   present	   of	   the	   two	   oligomeric	   species	   in	   each	   variant	  
enzyme	  is	  approximately	  the	  same	  as	  the	  wild	  type	  enzyme	  in	  solution	  at	  low	  concentration.	  	  





Figure	   7.8	   Blue	   native	   PAGE	   gel;	   Lane	  M	   displays	   the	  molecular	  weight	  marker;	   Lane	   1	  MtuDAH7PSWT;	   Lane2	  
MtuDAH7PSF227D;	  Lane	  3	  MtuDAH7PSG232P	  and	  Lane	  4	  MtuDAH7PSG190P/G232P.	  
	  
 AUC	  analysis	  7.4.3.
AUC	  was	   used	   to	   gain	   better	   insight	   into	   the	   quaternary	   structure	   of	  MtuDAH7PSG232P	   in	   solution.	  
Sedimentation	   velocity	   experiments	   were	   carried	   out	   at	   the	   three	   concentrations	   0.09,	   0.6	   and	  
0.9	  mg/mL,	  under	  the	  conditions	  previously	  described	  for	  the	  wild	  type	  enzyme	  in	  Section	  9.7.7.	  The	  
AUC	  data	  was	  fitted	  to	  a	  continuous	  distribution	  c(s)	  model,	  which	  showed	  the	  quaternary	  structure	  
of	  MtuDAH7PSG232P	   varied	   with	   concentration	   (Figure	   7.9A).	   At	   the	   lowest	   analysed	   concentration,	  
0.09	  mg/mL,	  the	  sedimentation	  coefficient	  (s)	  of	  the	  peak	  was	  4.0	  ±	  0.4	  S,	  which	  corresponded	  to	  a	  
molecular	  mass	  of	  ~54	  kDa,	   in	  good	  agreement	  with	  monomeric	  mass	  of	  MtuDAH7PS	  (~51	  kDa).	  At	  
0.6	  mg/mL	  the	  peak	  had	  an	  s	  value	  of	  5.0	  ±	  0.6	  S	  and	  had	  broadened.	  At	  0.9	  mg/mL	  the	  main	  peak	  
had	   an	   s	   value	   of	   5.7	  ±	  0.1	  S	   (with	   a	   calculated	   molecular	   mass	   of	   ~75	   kDa)	   and	   a	   shoulder	   at	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solution,	  with	  portion	  of	   dimer	   increasing,	   and	   the	  portion	  of	  monomer	  decreasing	  with	   increasing	  
concentration.	  
	  
Figure	   7.9	   Normalised	   c(s)	   distribution	   functions	   from	   AUC	   data	   for	  MtuDAH7PSG232P	   in	   the	   absence	   (A.)	   and	  
presence	  (B.)	  of	  100	  µM	  Trp	  and	  100	  µM	  Phe.	  MtuDAH7PSG232P	  was	  analysed	  at	  0.09	  mg/mL	  (violet),	  0.6	  mg/mL	  
(purple)	  and	  0.9	  mg/mL	  (pink).	  AUC	  data,	  fits	  and	  residuals	  are	  provided	  in	  Appendix	  II.	  
	  
When	  samples	  were	  spiked	  with	  100	  µM	  each	  of	  Trp	  and	  Phe	  analysis	  showed	  only	  one	  peak	  at	  ~6.1	  S	  
for	   all	   concentrations	   (Figure	   7.9B).	   This	   peak	   gave	   a	   calculated	   molecular	   mass	   of	   ~92	  kDa.	   The	  
molecular	  mass	  of	  dimeric	  MtuDAH7PS	  	   is	  expected	  to	  be	  ~102	  kDa.	  Hence,	  the	  addition	  of	  Trp	  and	  
Phe	  had	  stabilised	  the	  dimeric	  structure	  of	  MtuDAH7PSG232P.	  As	  Phe	  binds	  at	  the	  dimer	  interface,	  Phe	  
was	   most	   likely	   primarily	   responsible	   for	   the	   stabilisation	   of	   the	   MtuDAH7PSG232P	   dimer	   by	  
strengthening	   the	   interactions	   between	   the	   two	   subunits.	   The	   effect	   of	   Trp	   and	   Phe	   alone	   on	   the	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 Kinetic	  parameters	  7.5.
	  
The	  substitutions	  introduced	  to	  the	  three	  dimeric	  MtuDAH7PS	  variants	  had	  devastating	  consequences	  
on	   their	   catalytic	   ability.	   The	   E4P-­‐dependent	  Michaelis-­‐Menten	   kinetics	   was	   determined	   using	   the	  
standard	  kinetic	  assays	  conditions	  initially	  used	  for	  the	  wild	  type	  enzyme	  in	  Section	  9.9.1.	  	  
	  
The	  E4P-­‐dependent	  Michaelis-­‐Menten	  kinetics	  displayed	  a	  huge	  rise	  in	  the	  Michaelis	  constant	  (Km)	  for	  
all	   three	  dimeric	  variants	  of	  MtuDAH7PS	   (Table	  7.2).	  For	  MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P	  
the	  Km
E4P	  had	  to	  330	  µM	  and	  390	  µM	  respectively.	  MtuDAH7PSF227D	  was	   the	  most	  severely	  affected	  
with	   the	   Km
E4P	   increasing	   to	   590	   ±	   60	   µM.	   All	   three	   dimeric	   enzymes	   showed	   that	   a	   considerably	  
higher	  concentration	  of	  E4P	  was	  required	  for	  effective	  catalysis	  than	  by	  MtuDAH7PSWT.	  	  
	  
There	  was	  also	  an	  unanticipated	  improvement	  in	  the	  kcat	  of	  all	  three	  dimeric	  variants	  (Table	  7.2).	  The	  
improvement	   in	  kcat	   indicates	   the	  maximum	  rate	  of	  catalysis	  at	  high	  substrate	  concentrations	   is	  not	  
adversely	  affected;	   in	   fact	   it	  may	  have	   improved.	   If	  any	   improvement	  to	  catalysis	  has	  occurred	  as	  a	  
result	  of	  preventing	  tetramer	  formation	  it	  was	  insufficient	  to	  compensate	  for	  the	  decreased	  affinity	  of	  
the	   variant	   enzymes	   for	   E4P.	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	   and	  MtuDAH7PSF227D	   were	   all	  
found	  to	  have	  very	  low	  catalytic	  efficiencies	  with	  respect	  to	  E4P.	  	  
	  
Table	   7.2	   Kinetic	   parameters	   of	  MtuDAH7PSWT,	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	   and	  MtuDAH7PSF227D	  
determined	   from	   Michaelis-­‐Menten	   kinetics.	   Data	   for	   Km
E4P	   was	   obtained	   using	   the	   ternary	   complex	   rate	  
equation.	  Michaelis-­‐Menten	  plots	  are	   shown	   in	  Appendix	   I.	  Values	  have	  been	  determined	   from	  a	   single	   set	  of	  
kinetic	  data.	  Error	  represents	  error	  of	  curve	  fitting	  to	  the	  data	  set	  by	  least	  squares	  fit.	  










E4P	   kcat	  /Km	  
PEP	  
	   (µM)	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   37	  ±	  4	   4.7	  ±	  0.1	   170	  ±	  20	   130	  ±	  20	  
G232P	   330	  ±	  10	   90	  ±	  20	   14.3.	  ±	  0.2	   43	  ±	  2	   160	  ±	  40	  
G190P/G232P	   390	  ±	  30	   60	  ±	  20	   12.3	  ±	  0.4	   32	  ±	  4	   210	  ±	  70	  
F227D	   590	  ±	  60	   80	  ±	  20	   8.0	  ±	  0.4	   14	  ±	  2	   100	  ±	  30	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For	  the	  determination	  of	  Michaelis-­‐Menten	  kinetics	  of	  enzyme	  systems	  involving	  two	  substrates	  the	  
alternate	  substrate	  ideally	  needs	  to	  be	  held	  in	  excess,	  usually	  at	  a	  concentration	  between	  three	  and	  
ten	  times	  the	  estimated	  Km.	  For	  the	  dimeric	  MtuDAH7PS	  variants	  this	  would	  require	  unworkable	  E4P	  
concentrations	   in	   excess	   of	   1.5	  mM	   to	   determine	   the	  Km
PEP.	   As	   an	   alternative	   the	   ternary	   complex	  
equation	   provided	   by	   GraFit	   5.0	   (Erthicus)	  was	   used	   (Equation	   7.1).	   Derived	   from	   the	   general	   rate	  
equation	   of	   Alberty	   the	   ternary	   complex	   rate	   equation	   from	   Grafit	   models	   a	   generalised	   two-­‐
substrate	   irreversible	   enzyme	   reaction	   with	   a	   mechanism	   involving	   the	   formation	   of	   a	   ternary	  
complex	  between	  the	  two	  substrates	  and	  the	  enzyme	  in	  non-­‐saturating	  substrate	  conditions.128	  Three	  
sets	  of	  Michaelis-­‐Menten	   kinetics	  were	  used	   to	  determine	   the	  determine	  Km
PEP,	   each	  at	   a	  different	  
E4P	   concentration,	   150,	   300	   and	   500	   µM	   (Figure	   7.10)	   When	   this	   data	   was	   fitted	   to	   the	   ternary	  
complex	   rate	   equation	   the	   Km
PEP	   could	   be	   determined,	   without	   needing	   excessively	   high	   and	  
problematic	  E4P	  concentrations.	  The	  Km
PEP	  was	  determined	  for	  each	  dimeric	  variant	  and	  found	  to	  be	  
greater	   than	  MtuDAH7PSWT.	   Indicating	   greater	   PEP	   concentrations	   were	   required	   by	   the	   dimeric	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Equation	  7.1	  The	  ternary	  complex	  equation	   from	  GraFit	  5.0.	  Vmax	   the	  maximum	  possible	   rate,	  υ	   the	  measured	  
rate.	  A	   is	   the	  variable	   substrate	   (PEP)	  and	  B	   is	   substrate	  held	  constant	   (E4P)	   for	  each	  set	  of	  Michaelis-­‐Menten	  
kinetics.[A]	   and	   [B]	   represents	   the	   concentration	   of	   the	   relative	   substrate	   and	   KA	   and	   KB	   are	   the	   Michaelis	  
constants	  determined	  for	  the	  respective	  substrate	  (concentration	  of	  specified	  substrate	  that	  gives	  ½	  Vmax.	  KA’	  is	  
the	  apparent	  dissociation	  constant	  of	  substrate	  A.	  
	  




Figure	   7.10	   Ternary	   complex	   kinetics	   used	   to	   determine	   the	   Km
PEP	   for	   A.	   MtuDAH7PSG232P;	   B.	  
MtuDAH7PSG190P/G232P	   and	   C.	   MtuDAH7PSF227D.	   Michaelis-­‐Menten	   kinetics	   is	   shown	   in	   the	   top	   plot,	   and	  




Overall	  the	  dimeric	  MtuDAH7PS	  variants	  were	  much	  poorer	  catalysts	  than	  MtuDAH7PSWT	  or	  any	  other	  
MtuDAH7PS	   variant	   produced.	   As	   all	   three	   dimeric	  MtuDAH7PS	   variants	   displayed	   poor	   catalytic	  
activity,	   the	   dimeric	   quaternary	   structure	   of	   the	   enzymes	  was	  most	   likely	   responsible	   for	   the	   poor	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MtuDAH7PSG190P/G232P	   and	  MtuDAH7PSF227S	   to	   form	   the	  MtuDAH7PS	   tetramer	   in	   solution	   severely	  
handicapped	   their	   ability	   to	   bind	   E4P,	   and	   to	   a	   lesser	   extent	   PEP.	   Intriguingly	   dimeric	  MtuDAH7PS	  
variants	  were	  able	  to	  turnover	  the	  substrates	  to	  product	  faster	  than	  MtuDAH7PSWT.	  
 Feedback	  regulation	  of	  dimeric	  MtuDAH7PS	  variants	  7.6.
 Disruption	  of	  feedback	  inhibition	  7.6.1.
The	   initial	   set	   of	   inhibition	   studies	   were	   conducted	   using	   the	   standard	   conditions,	   for	   which	   the	  
substrate	  concentrations	  are	  held	  at	  150	  µM,	  as	  outline	  in	  Section	  9.9.3.	  These	  conditions	  have	  been	  
used	   previously	   for	   all	  MtuDAH7PS	   variants.48,91	   All	   three	   dimeric	  MtuDAH7PS	   variants	   showed	   an	  
increased	   sensitivity	   to	   Phe,	   reducing	   activity	   to	   50-­‐60	   %	   (Figure	   7.11A).	   Interestingly	   only	  
MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P	  showed	  heightened	  sensitivity	  to	  Tyr.	  Thus	  the	  Gly232Pro	  
(and	  Gly190Pro)	  substitution(s)	  have	  affected	  the	  enzymes	  sensitivity	  to	  Tyr.	  Whereas	  the	  disruption	  
to	   the	   quaternary	   structure	   of	   the	   MtuDAH7PS	   variants	   may	   be	   responsible	   for	   the	   change	   in	  
sensitivity	   to	   Phe,	   due	   to	  MtuDAH7PSF227D	   also	   exhibiting	   increased	   sensitivity	   to	   Phe.	   The	   dimeric	  
MtuDAH7PS	   variants	   also	   showed	   no	   evidence	   of	   synergistic	   regulation	   when	   multiple	   aromatic	  
amino	  acids	  were	  present.	  The	  lack	  of	  synergistic	  regulation	  in	  all	  three	  dimeric	  MtuDAH7PS	  variants	  
illustrated	  that	  the	  tetrameric	  structure	  of	  MtuDAH7PS	  is	  essential	  for	  synergistic	  regulation.	  The	  fine-­‐
tuning	  of	  the	  molecular	  dynamics	  of	  MtuDAH7PS	  in	  response	  to	  the	  aromatic	  amino	  acids	  is	  believed	  
to	   be	   responsible	   for	   the	   inhibition	   of	  MtuDAH7PS	   activity.71,115The	  MtuDAH7PS	   tetramer	   probably	  
facilitates	   the	   correct	  molecular	  motion	   or	   conformational	   fluctuations	   of	   the	   subunits	   that	   allows	  
allosteric	  ligand	  binding	  and	  communication	  of	  allosteric	  binding	  within	  and	  between	  subunits.	  
	  





Figure	   7.11	   Remaining	   activity	   of	  MtuDAH7PSWT	   (blue),	  MtuDAH7PSG232P	   (purple),	  MtuDAH7PSG190P/G232P	   (light	  
purple)	   and	   MtuDAH7PSF227D	   (pink)	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids.	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	  letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  Tyr,	  
Y.	   Each	   letter	   also	   represents	   200	   µM	   of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	  
presence	   of	   A.	   150	   µM	   E4P	   and	   PEP	   and	   B.	   1800	   µM	   E4P	   and	   150	   µM	   PEP.	   Error	   bars	   depict	   the	   standard	  
deviation	  of	  at	  least	  duplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	   regulatory	   response	  of	  MtuDAH7PS	  has	  previously	  been	  shown	  to	  be	  highly	  dependent	  on	  E4P	  
concentration.48	   An	   absolute	   concentration	   of	   150	   µM	   E4P	   was	   originally	   chosen	   to	   illustrate	   the	  
A.	  
B.	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synergistic	   inhibition	   of	  MtuDAH7PS	   whilst	   conserving	   E4P	   stocks.	   However,	   the	   huge	   drop	   in	   the	  
affinity	  of	  the	  dimeric	  MtuDAH7PS	  variants	  for	  E4P	  (Section	  7.5)	  complicated	  the	  interpretation	  of	  the	  
inhibition	  studies.	  The	  concentration	  of	  150	  µM	  E4P	  used	  in	  these	  assays	  was	  less	  than	  half	  the	  Km
E4P	  
determined	   for	   any	   of	   the	   dimeric	   MtuDAH7PS	   variants.	   For	   MtuDAH7PSWT	   and	   most	   other	  
MtuDAH7PS	  variants	  150	  µM	  E4P	  was	  equivalent	  to	  three-­‐five	  times	  the	  Km
E4P.	  Consequently,	  assays	  
conducted	   at	   a	   concentration	   of	   150	   µM	   E4P	   for	   the	   dimeric	  MtuDAH7PS	   variants	   evaluated	   the	  
inhibitory	   response	   at	   a	   completely	   different	   area	  of	   the	  Michaelis-­‐Menten	   curve	   compared	   to	   the	  
wild	   type	   enzyme.	   To	   address	   any	   possible	   discrepancies	   in	   inhibition	   due	   to	   surveying	   a	   different	  
portion	  of	  the	  Michaelis-­‐Menten	  curve	  the	  inhibition	  studies	  were	  also	  conducted	  at	  a	  concentration	  
of	  1800	  µM	  E4P,	  a	  value	  between	  three	  to	  five	  times	  the	  Km
E4P	  of	  the	  dimeric	  variants.	  
	  
To	  ensure	  such	  high	  concentrations	  of	  E4P	  did	  not	  adversely	  affect	  MtuDAH7PS	   inhibition,	  high	  E4P	  
concentration	   (1800	   µM)	   inhibition	   studies	  were	   also	   carried	   out	   on	   the	  wild	   type	   enzyme	   (Figure	  
7.11B).	  MtuDAH7PSWT	   displayed	   very	   similar	   regulatory	   behaviour	   at	   both	   E4P	   concentrations.	   The	  
only	  exception	  was	  MtuDAH7PSWT	  that	  the	  addition	  of	  Trp	  alone,	  with	  the	  remaining	  MtuDAH7PSWT	  
activity	  reduced	  to	  ~49	  %.	  All	  three	  dimeric	  MtuDAH7PS	  variants	  were	  insensitive	  to	  the	  presence	  of	  
any	  single,	  binary	  or	  ternary	  combination	  of	  aromatic	  amino	  acids	  at	  the	  higher	  E4P	  concentration	  of	  
1800	  µM.	  Hence	  the	  dimeric	  MtuDAH7PS	  variants	  appear	  to	  be	  poorly	  regulated.	  	  
	  
 Effect	  of	  ligand	  on	  dimeric	  MtuDAH7PS	  kinetic	  7.6.2.
parameters	  
	  
The	  E4P-­‐dependent	  kinetics	  of	  MtuDAH7PSWT	  displayed	  cooperativity,	  only	  in	  the	  presence	  of	  Trp	  and	  
Phe	   (or	   Tyr).48	   To	   ascertain	   if	   the	   dimeric	  MtuDAH7PS	   variants	   were	   capable	   of	   cooperative	   E4P	  
binding	  the	  E4P-­‐dependent	  kinetics	  of	  MtuDAH7PSG190P/G232P	  were	  determined	  in	  the	  presence	  of	  Trp	  
and	   Phe.	   Assays	   were	   conducted	   under	   standard	   assay	   conditions	   detailed	   in	   Section	   Inhibition	  
studies,	  with	  and	  the	  addition	  of	  200	  µM	  Trp	  and	  200	  µM	  Phe.	  PEP	  concentration	  was	  held	  at	  300	  µM	  
for	   the	   collection	   of	   the	   E4P-­‐dependent	   kinetic	   data.	   Only	   one	   set	   of	   kinetic	   data	  was	   required	   to	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identify	  if	  the	  plot	  was	  sigmoidal	  shape	  and	  to	  see	  how	  the	  kinetic	  parameters	  changed	  with	  respect	  
to	  unliganded	  enzyme.	  	  
	  
The	   E4P-­‐dependent	   kinetics	   of	   MtuDAH7PSG190P/G232P	   in	   the	   presence	   of	   Trp	   and	   Phe	   fitted	   the	  
standard	  Michaelis-­‐Menten	  equation	  and	   showed	  no	   sign	  of	   cooperative	  E4P	  binding	   (Figure	  7.12).	  
Hence	   it	   is	   likely	   that	   the	   formation	   of	   the	   MtuDAH7PS	   tetramer	   is	   essential	   for	   effective	  
communication	   of	   ligand	   binding	   at	   the	   allosteric	   binding	   sites	   to	   the	   active	   site.	   The	   E4P	   catalytic	  
efficiency	  of	  MtuDAH7PSG190P/G232P	  was	  harmed	  by	  the	  presence	  of	  Trp	  and	  Phe.	  The	  Km
E4P	  increased	  to	  
~990	  µM	   	   and	   the	  kcat	   roughly	   halved	   to	   ~6.8	   s
-­‐1	   (Table	   7.3).	   As	  MtuDAH7PSG190P/G232P	   only	   showed	  
sensitivity	  to	  Phe	   in	  the	   inhibition	  studies,	  Phe	   is	  most	   likely	  responsible	  for	  the	  observed	   inhibitory	  
effect.	   The	   Gly190Pro/Gly232Pro	   substitutions	   disrupted	   the	   quaternary	   structure	   of	  
MtuDAH7PSG190P/G232P	  and	  possibly	  the	  flexibility	  of	  the	   loops	  that	  precede	  and	  succeed	  the	  α2a	  and	  
α2b	  helices.	  As	  two	  changes	  may	  have	  occurred	  to	  MtuDAH7PSG190P/G232P	  it	  was	  difficult	  to	  absolutely	  
define	  which	  was	  responsible	  for	  the	  loss	  of	  E4P	  cooperativity.	  But	  given	  cooperativity	  has	  long	  been	  
associated	  with	  multi-­‐subunit	  complexes	   it	   is	  highly	   likely	  that	  the	  change	   in	  quaternary	  structure	   is	  
the	  primary	  cause.2,128	  Analysis	  of	  E4P-­‐dependent	  kinetics	  of	  MtuDAH7PSF227D	   in	  the	  presence	  of	  Trp	  
and	  Phe	  would	  help	  to	  confirm	  if	  tetramer	  formation	  is	  necessary	  for	  E4P	  cooperativity.	  
	  
	  
Figure	  7.12	  Michaelis-­‐Menten	  plot,	  with	  Lineweaver	  burke	  insert,	  of	  the	  E4P-­‐dependent	  kinetics	  of	  
MtuDAH7PSG190P/G232P	  in	  the	  presence	  of	  200	  µM	  of	  Trp	  and	  200	  µM	  Phe.	  The	  concentration	  of	  PEP	  was	  held	  at	  
300	  µM.	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Table	   7.3	   E4P-­‐dependent	   kinetic	   parameters	   for	  MtuDAH7PSWT	   and	  MtuDAH7PSG190P/G232P	   with	   and	   without	  
200	  µM	   Trp	   and	   200	   µM	   Phe,	   determined	   from	   the	   Michaelis-­‐Menten	   kinetics	   (Appendix	   I).	   Values	   were	  
determined	  from	  a	  single	  set	  of	  kinetic	  data	  with	  error	  bars	  depicted	  the	  error	  of	  of	  curve	  fitting	  to	  the	  data	  set	  
by	  least	  squares	  fit.	  
	  
 Thermal	  stability	  7.7.
	  
DSF	  was	  used	   to	  assess	   the	   thermal	   stability	  of	   the	  MtuDAH7PS	  variants	   in	   the	  presence	  of	  various	  
combinations	  of	  ligands,	  Section	  9.8.1.	  The	  dimeric	  variants	  have	  lower	  Tm	  than	  MtuDAH7PS
WT	  (Figure	  
7.13).	   The	  MtuDAH7PS	   tetramer	   has	   additional	   interactions	   across	   the	   tetramer	   interface,	   which	  
needs	   to	   be	   broken,	   compared	   to	   the	  MtuDAH7PS	   dimer.	   The	  more	   interactions	   to	   be	   broken	   the	  
more	   energy	   (heat)	   is	   required	   to	   thermally	   denature	   the	   protein.	   If	   a	   substantial	   portion	   of	  
MtuDAH7PSWT	  can	  access	  the	  MtuDAH7PS	  tetramer	  under	  the	  DSF	  assay	  conditions	  it	  would	  explain	  
the	  higher	  Tm	  of	  MtuDAH7PS
WT	  compared	  to	  the	  dimeric	  MtuDAH7PS	  variants.	  MtuDAH7PSF227D	  was	  
less	   thermally	   stable	   than	   MtuDAH7PSG232P	   or	   MtuDAH7PSG190P/G232P.	   The	   introduction	   of	   the	  
negatively	  charged	  Asp	  residue	  in	  place	  of	  the	  neutral	  Phe	  may	  repel	  dimeric	  units	  from	  each	  other,	  
preventing	   or	   reducing	   transient	   interactions	   across	   the	   tetramer	   interface	   and	   reducing	   thermal	  
stability	  further.	  Gly190Pro	  was	  previously	  shown	  to	  stabilise	  the	  MtuDAH7PS	  tetramer	  stability	  and	  
increased	   the	   enzymes	   thermal	   stability	   (Section	   5.4.3).	   The	   ~2	   ˚C	   difference	   in	   Tm	   between	  
MtuDAH7PSG232P	   and	   MtuDAH7PSG190P/G232P	   suggests	   the	   Gly190Pro	   substitution	   may	   also	   offer	  










	   (µM)	   (s-­‐1)	   (s-­‐1mM-­‐1)	  
Wild	  type	   28	  ±	  2	   4.7	  ±	  0.1	   170	  ±	  20	  
G190P/G232P	   390	  ±	  30	   12.3	  ±	  0.4	   32	  ±	  4	  
G190P/G232P	  WF	   990	  ±	  90	   6.8	  ±	  0.3	   7.0	  ±	  0.9	  




Figure	   7.13	   The	  effect	   of	   individual,	   binary	   and	   ternary	   combinations	  of	   aromatic	   amino	  acids	  on	   the	   thermal	  
stability	   of	   MtuDAH7PSWT	   (blue)	   and	   MtuDAH7PSG232P	   (purple),	   MtuDAH7PSG190P/G232P	   (light	   purple)	   and	  
MtuDAH7PSF227D	  (pink).	  The	  aromatic	  amino	  acids	  are	  represented	  by	  their	  one	   letter	  code;	  Trp,	  W;	  Phe,	  F	  and	  
Tyr,	   Y.	   Each	   letter	   also	   represents	   200	   µM	   of	   the	   corresponding	   aromatic	   amino	   acids.	   Error	   bars	   depict	   the	  
standard	  deviation	  of	  triplicate	  measurements.	  P-­‐values	  provided	  in	  appendix	  V.	  
	  
The	  addition	  of	  Trp	  to	  the	  assay	  buffer	  had	   little	  effect	  on	  the	  determined	  Tm	  of	  any	  of	   the	  dimeric	  
MtuDAH7PS	   variants	   (Figure	   7.13).	   The	   increase	   in	   Tm	   determined	   for	   MtuDAH7PS
G232P	   and	  
MtuDAH7PSG190P/G232P	  was	  less	  than	  0.3	  ˚C.	  A	  DSF	  assay	  was	  conducted	  with	  the	  addition	  of	  1	  mM	  Trp	  
to	   the	   assay	   buffer	   and	  MtuDAH7PSG190P/G232P	   Tm	   was	   51.1	   ±	   0.4	   ˚C,	   less	   than	   a	   ~2	   ˚C	   increase	   in	  
thermal	  stability.	  The	  small	  shift	   in	  Tm
	  means	  Trp	  either	  binds	  very	  weakly	  or	  Trp	  binding	  offers	  little	  
improvement	   in	   thermal	   stability	   to	   the	   dimeric	  MtuDAH7PS	   variants.	  MtuDAH7PSF227D	   showed	   a	  
modest	  ~0.9	   ˚C	   increase	   in	  Tm	   in	   the	  presence	  of	  200	  mM	  Trp.	  The	  behaviour	  of	  MtuDAH7PS
F227D	   is	  
similar	  to	  MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P,	  thus	  the	  change	  in	  quaternary	  structure	  of	  the	  
MtuDAH7PS	  variants	  was	  most	  likely	  responsible	  for	  their	  poorer	  response	  to	  Trp.	  	  
	  
The	  addition	  of	  either	  Phe	  or	  Tyr	  caused	  an	   increase	   in	  thermal	  stability	  between	  2-­‐3.5	  ˚C,	   for	  each	  
dimeric	  MtuDAH7PS	  variant,	  MtuDAH7PSWT	  displayed	  an	  increase	  in	  thermal	  stability	  of	  ~2.6	  ˚C.	  The	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increase	   in	  Tm	   in	   the	  presence	  of	  Phe	  or	  Tyr	  suggests	   that	   the	  Phe-­‐	  and	  Tyr-­‐selective	  bindings	  sites,	  
sites	   1	   and	   2,	   are	   intact	   in	   the	  MtuDAH7PS	   dimeric	   variants.	   Interestingly	   the	   increase	   in	   thermal	  
stability	  in	  the	  presence	  of	  Phe	  was	  lower	  for	  MtuDAH7PSG190P/G232P	  than	  MtuDAH7PSG232P,	  which	  may	  
be	  an	  indication	  that	  the	  substitution	  of	  Gly190	  has	  affected	  Phe	  binding.	  The	  thermal	  stability	  gained	  
from	  Phe	  and	  Tyr	  binding	   to	   the	  dimeric	  MtuDAH7PS	  variants	  was	  additive	  when	  both	  Phe	  and	  Tyr	  
were	  present.	   Although	   the	   additive	   effect	   of	   Tyr	   and	  Phe	  was	   seen	   for	   the	  wild	   type	   enzyme	  and	  
MtuDAH7PSF227D	  (each	  showed	  an	  increase	  of	  ~4.4	  ˚C	  and	  ~3.7	  ˚C	  respectively),	  the	  gain	  in	  stability	  for	  
MtuDAH7PSG232P	   and	   MtuDAH7PSG190P/G232P	   was	   much	   more	   dramatic,	   ~8.5	   ˚C	   and	   ~11.1	   ˚C	  
respectively.	   The	   increased	   Tm	   in	   the	   presence	   of	   Phe	   and	   Tyr	   suggests	   that	   the	   Gly232Pro	  
substitution	  influences	  ligand	  binding.	  	  
 Binding	  affinities	  7.8.
ITC	  was	  used	  to	  gain	  a	  more	  detailed	  insight	  into	  the	  dimeric	  MtuDAH7PS	  variants	  ability	  to	  bind	  the	  
aromatic	  amino	  acids.	  The	  experimental	  protocol	  is	  detailed	  in	  Section	  9.8.2.	  Trp	  and	  Phe	  were	  shown	  
to	   bind	   to	  MtuDAH7PSG232P	   (Figure	   7.14A-­‐B)	   and	  MtuDAH7PSF227D	   (Figure	   7.15G-­‐H)	   and	   all	   three	  
aromatic	   amino	   acids	  were	   shown	   to	  bind	  MtuDAH7PSG190P/G232P	   (Figure	   7.14D-­‐F,	   Table	   7.4).	   The	  Kd	  
determined	  between	  Tyr	  and	  MtuDAH7PSG190P/G232P	  was	  42	  ±	  9	  µM,	   indicating	  the	   loss	  of	  tetrameric	  
structure	   has	   not	   negatively	   impacted	   Tyr	   binding.	   Tyr	   binding	   was	   only	   evaluated	   for	  
MtuDAH7PSG190P/G232P.	  As	  MtuDAH7PSG190P/G232P	  shares	  a	  similar	  dimeric	  structure	  to	  MtuDAH7PSG232P	  
and	  MtuDAH7PSF227D	  and	  DSF	  showed	  a	  change	  in	  thermal	  stability	  in	  the	  presence	  of	  Tyr	  for	  all	  there	  
dimeric	  MtuDAH7PS	  variants	  it	  is	  not	  unreasonable	  to	  assume	  Tyr	  binding	  is	  also	  largely	  unaffected	  in	  
these	  variants.	  Ideally	  ITC	  should	  be	  carried	  out	  to	  verify	  this	  assumption.	  The	  Kd	  values	  between	  Phe	  
and	  MtuDAH7PSG232P	  or	  MtuDAH7PSF227D	  were	  17	  ±	  2	  µM	  and	  15.9	  ±	  0.9	  µM	  respectively,	  whereas	  the	  
Kd	  of	  Phe	  in	  MtuDAH7PS
G190P/G232P	  was	  slightly	  lower.	  The	  ability	  of	  the	  three	  MtuDAH7PS	  variants	  to	  
bind	  Phe	  has	  therefore	  not	  been	  adversely	  affected	  by	  the	  inability	  of	  the	  variant	  enzymes	  to	  form	  the	  
tetrameric	   MtuDAH7PS	   structure.	   As	   Tyr	   and	   Phe	   can	   bind	   to	   the	   dimeric	  MtuDAH7PS	   variants	  
without	  penalty	   it	   is	  highly	   likely	  the	  Phe-­‐	  and	  Tyr-­‐selective	  sites,	  site	  1	  and	  site	  2,	  remain	  relatively	  
intact	  in	  the	  MtuDAH7PS	  dimer.	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Most	   remarkably	  all	   three	  dimeric	  MtuDAH7PS	  variants	  have	   retained	   the	  ability	   to	  bind	  Trp,	  albeit	  
weakly,	  with	  the	  Kd
	  for	  Trp	  binding	  to	  the	  variant	  enzymes	  ranging	  between	  150-­‐200	  µM	  (Table	  7.4).	  
Unfortunately,	  although	  ITC	  may	  have	  shown	  that	  Trp	  can	  bind	  it	  does	  not	  reveal	  which	  of	  the	  three	  
distinct	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  Trp	  occupies.	  In	  an	  attempt	  to	  establish	  if	  Trp	  bound	  to	  
the	  Phe-­‐selective	  site,	  site	  1,	  the	  variant	  enzymes	  were	  pre-­‐incubated	  with	  Phe.	  As	  Phe	  preferentially	  
binds	   to	   site	   1,	   Trp	  would	  have	   to	   compete	  with	  Phe	   to	  occupy	   site	   1	   and	   this	   competition	   should	  
have	  been	  reflected	   in	   increased	  Kd	   for	  Trp	   in	  the	  variant	  enzyme	  in	  the	  presence	  of	  Phe.	  However,	  
the	  small	  increase	  in	  Kd	  observed	  between	  Trp	  and	  MtuDAH7PS
F227D	  preincubated	  with	  Phe	  was	  within	  
error	   of	   the	   determined	   Kd	   in	   the	   absence	   of	   a	   Phe.	   The	   Kd	   between	   Trp	   and	  MtuDAH7PS
G232P	  
preincubated	  with	  Phe	  increased	  to	  210	  ±	  30	  µM	  (Figure	  7.14C,	  Figure	  7.15I,	  Table	  7.4).	  Given	  site	  1	  is	  
known	   to	  be	   the	  Phe	  binding	   site	  a	  more	  dramatic	   increase	   in	   the	  Kd	   I	  was	  expected	   if	  we	  were	   to	  
confidently	  identify	  competition	  between	  Trp	  and	  Phe.	  
	  
The	  lack	  of	  unequivocal	  evidence	  for	  competition	  between	  the	  Trp	  and	  Phe	  suggest	  Trp	  does	  not	  bind	  
to	  site	  1.	  It	  is	  most	  probable	  the	  Trp	  site	  can	  still	  bind	  Trp.	  The	  huge	  reduction	  in	  the	  affinity	  for	  Trp	  by	  
the	   dimeric	  MtuDAH7PS	   variants	   is	   likely	   due	   to	   the	   disruption	   of	   the	   tetramer	   interface	   directly	  
affecting	  the	  Trp	  site.	  However,	  Trp	  may	  instead	  bind	  to	  the	  Tyr-­‐selective	  site,	  site	  2.	  This	  possibility	  is	  
yet	   to	   be	   discounted	   experimentally	   and	   cannot	   be	   ruled	   out.	   It	   should	   also	   be	   noted	   that	  
preincubation	  of	  MtuDAH7PSG232P	  or	  MtuDAH7PSF227D	  with	  Phe	  did	  not	   improve	  Trp	  binding	  as	  seen	  
previously	   for	   MtuDAH7PSWT.	   The	   loss	   of	   tetramer	   structure	   appears	   to	   have	   prevented	  
communication	  between	  site	  1	  and	  the	  Trp	  site,	  resulting	  in	  the	  loss	  of	  cooperative	  Trp	  binding	  in	  the	  
presence	  of	  Phe.	  




Figure	   7.14	   ITC	   data	   for	   the	   interaction	   of	   A.	   30	   µM	  MtuDAH7PSG232P	   with	   3	   mM	   Trp	   titrant;	   B.	   28	   µM	   of	  
MtuDAH7PSG232P	  with	  900	  µM	  Phe	  titrant;	  C.	  24	  µM	  MtuDAH7PSG232P	  and	  a	  background	  of	  50	  µM	  Phe	  present	  in	  
the	   cell	   with	   a	   5	   mM	   Trp	   titrant;	   D.	   37	  µM	   MtuDAH7PSG190P/G232P	   with	   3	   mM	   Trp	   titrant;	   E.	   33	   µM	   of	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Figure	  7.15	  (Figure	  7.14	  cont.)	  ITC	  data	  for	  the	  interaction	  of	  G.	  32	  µM	  MtuDAH7PSF227D	  with	  5	  mM	  Trp	  titrant;	  H.	  
32	  µM	  of	  MtuDAH7PSF227D	  with	  600	  µM	  Phe	  titrant	  and	   I.	  28	  µM	  MtuDAH7PSF227D	  and	  a	  background	  of	  50	  µM	  
Phe	  present	  in	  the	  cell	  with	  a	  5	  mM	  Trp	  titrant.	  
	  
Table	   7.4	   Dissociation	   constants	   determined	  by	   ITC	   for	  MtuDAH7PSWT,	  MtuDAH7PSG232P,	  MtuDAH7PSG190P/G232P	  
and	   MtuDAH7PSF227D.	   *	   Indicates	   results	   determined	   previously	   by	   Richard	   Hutton	   and	   —	   Indicates	   no	  
background	   ligand	   or	   analysis	   not	   conducted.	   Values	   were	   determined	   from	   a	   single	   ITC	   experiment.	   Error	  








Wild	  type	   G232P	   G190P/G232P	   F227D	  
Kd	  (µM)	   Kd	  (µM)	   Kd	  (µM)	   Kd	  (µM)	  
Trp	   —	   4.7	  ±	  0.1*	   150	  ±	  10	   180	  ±	  10	   200	  ±	  20	  
Trp	   Phe	   1.08	  ±	  0.03*	   210	  ±	  30	   —	   220	  ±	  20	  
Phe	   —	   21	  ±	  1*	   17	  ±	  2	   11.3	  ±	  0.2	   15.9	  ±	  0.9	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 Activation	  of	  MtuCM	  activity	  	  7.9.
	  
In	  the	  interest	  of	  determining	  how	  effectively	  the	  dimeric	  MtuDAH7PS	  variants	  interact	  with	  MtuCM	  
kinetic	  assays	  were	  conducted	  monitoring	  MtuCM	  activity,	  under	  the	  standard	  conditions	  detailed	  in	  
Section	   9.9.1.	   MtuDAH7PSG232P,	   MtuDAH7PSG190P/G232P	   and	   MtuDAH7PSF227D	   were	   all	   very	   poor	  
enhancers	  of	  MtuCM	  activity	  (	  
Figure	  7.16A).	  A	  200-­‐fold	  molar	  excess	  of	  a	  dimeric	  MtuDAH7PS	  variant	  resulted	  in	  the	  MtuCM	  activity	  
being	  activated	  by	  a	  maximum	  of	  approximately	  ten-­‐fold.	  This	  level	  of	  activation	  was	  considerably	  less	  
than	  the	  activation	  of	  MtuDAH7PSWT	  achieved	  under	  the	  same	  conditions.	  	  
	  
	  
Figure	  7.16	  A.	  Activation	  of	  MtuCM	  activity	  in	  the	  presence	  of	  either	  equimolar,	  ten-­‐fold	  or	  200-­‐fold	  molar	  excess	  
of	  MtuDAH7PSWT	   (blue	  hash)	  and	  MtuDAH7PSG232P	   (purple	  hash),	  MtuDAH7PSG190P/G232P	   (light	  purple	  hash)	  and	  
MtuDAH7PSF227D	   (pink	  hash).	   The	  burgundy	   line	   indicates	   the	   activity	  of	  MtuCM	  alone.	  Assays	   conducted	  with	  
150	  µM	  chorismic	  acid	  and	  60	  nM	  MtuCM	  except	  for	  reactions	  requiring	  a	  200-­‐fold	  excess	  of	  MtuDAH7PS	  where	  
10	   nM	  of	  MtuCM	  was	   used	   and	  MtuCM	  alone	  where	   90	  nM	  was	   used	   and	   the	   results	   normalised.	   Error	   bars	  
depict	   the	   standard	   deviation	   of	   duplicate	   measurements.	   B.	  MtuCM	   activity	   in	   the	   presence	   of	   increasing	  
concentration	  of	  MtuDAH7PSWT	  (blue	  dots)	  or	  MtuDAH7PSG232P	  (purple	  dots).	  Single	  point	  assays	  were	  conducted	  




	  To	  ascertain	  if	  this	  poor	  activation	  could	  be	  overcome	  by	  increasing	  the	  concentration	  of	  the	  dimeric	  
MtuDAH7PS	  variants	   the	  MtuCM	  activation	  profile	   for	  MtuDAH7PSG232P	  was	  examined	  more	  closely.	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The	  activation	  of	  MtuCM	  with	   increasing	  MtuDAH7PSG232P	  concentration	  was	  plotted	  (Figure	  7.16B).	  
The	   kinetic	   assays	  were	   conducted	   in	   the	   standard	   kinetic	   buffer	   of	   50	  mM	  BTP	  1mM	  TCEP	  pH	  7.5	  
with	  10	  nM	  MtuCM,	  150	  µM	  PEP	  and	  initiated	  with	  150	  µM	  chorismic	  acid	  and	  varying	  concentrations	  
of	   either	  MtuDAH7PSG232P	   or	  MtuDAH7PSWT.	   The	   experimental	   data	   showed	  MtuDAH7PSG232P	   was	  
incapable	  of	  enhancing	  MtuCM	  activity	  to	  the	  same	  extent	  as	  the	  wild	  type	  enzyme.	  	  
	  
The	  MtuCM	   binding	   site	   is	   located	   across	   the	   tetramer	   interface	   of	  MtuDAH7PS.	  MtuDAH7PSG232P,	  
MtuDAH7PSG190P/G232P	   and	  MtuDAH7PSF227D	  have	  all	   been	   shown	   to	  be	  primarily	  dimeric	   in	   solution.	  
The	  dimeric	  MtuDAH7PS	  variants	  would	  not	  be	  able	  to	  interact	  appropriately	  with	  MtuCM,	  resulting	  
in	   the	   observed	   loss	   in	   their	   ability	   to	   activate	  MtuCM	   activity	   and	   form	   the	  MtuCM•MtuDAH7PS	  
complex.	   The	  MtuDAH7PS	  dimer	  may	  not	   be	   able	   to	   induce	   the	  MtuCM	  active	   site	   conformational	  
changes	  required	  for	  optimal	  catalysis.	  	  
 Regulation	  of	  MtuCM	  7.10.
The	  MtuCM	  inhibition	  studies	  in	  the	  presence	  of	  a	  ten-­‐fold	  molar	  excess	  of	  MtuDAH7PS	  variant	  were	  
conducted	   using	   the	   standard	   protocol	   outlined	   in	   Section	   9.9.3,	   except	   that	   the	   chorismic	   acid	  
concentration	  was	  adjusted	  to	  250	  µM	  due	  to	  the	  poor	  activation	  of	  MtuCM	  activity	  in	  the	  presence	  
of	   the	   dimeric	  MtuDAH7PS	   variants.	  MtuDAH7PSG190P/G232P	   was	   not	   analysed	   as	   protein	   stocks	   had	  
been	   exhausted.	  MtuDAH7PSG232P	   and	  MtuDAH7PSF227D	   displayed	   no	   evidence	   of	   inhibition	   in	   the	  
presence	  of	   any	   single	  or	   combination	  of	   aromatic	   amino	  acids	   (Figure	  7.17).	   The	   lack	  of	   inhibition	  
may	  mean	  the	  transmission	  of	  ligand	  binding	  across	  the	  MtuCM•MtuDAH7PS	  interface	  is	  dependent	  
on	  MtuDAH7PS	  accessing	  the	  tetramer	  structure.	  However,	  the	  lack	  of	   inhibition	  was	  more	  likely	  an	  
indication	  that	  very	  little	  MtuCM•MtuDAH7PS	  complex	  had	  formed	  in	  solution.	  Further	  insight	  could	  
be	  gained	  by	  repeating	  the	  MtuCM	  inhibition	  studies	  with	  a	  higher	  molar	  excess	  of	  MtuDAH7PS,	  i.e.	  
200-­‐fold	  to	  force	  more	  complex	  formation.	  





Figure	   7.17	   Remaining	  MtuCM	   activity	   in	   the	   presence	   of	   various	   single,	   binary	   and	   ternary	   combinations	   of	  
aromatic	  amino	  acids	  and	  a	  ten-­‐fold	  excess	  of	  MtuDAH7PSG232P	  (purple	  hash)	  or	  MtuDAH7PSF227D	  (pink	  hash).	  The	  
aromatic	   amino	   acids	   are	   represented	   by	   their	   one	   letter	   code;	   Trp,	   W;	   Phe,	   F	   and	   Tyr,	   Y.	   Each	   letter	   also	  
represents	   200	  µM	   of	   the	   corresponding	   aromatic	   amino	   acids.	   Assays	   conducted	   in	   the	   presence	   of	   250	  µM	  
chorismic	  acid	  and	  60	  nM	  MtuCM.	  Error	  bars	  depict	  the	  standard	  deviation	  of	  duplicate	  measurements.	  P-­‐values	  
provided	  in	  appendix	  V.	  
	  
Intriguingly	  MtuDAH7PSG232P	  was	  a	  better	  activator	  of	  MtuCM	  activity	   in	  the	  presence	  of	  Trp.	  As	  the	  
Trp	   site	   is	   located	   at	   the	   tetramer	   interface	   it	   is	   possible	   Trp	   binding	   would	   encourage	   tetramer	  
formation.	   It	   is	   tempting	   to	  attribute	   the	   improved	  activation	  of	  MtuCM	  activity	   to	  Trp	   shifting	   the	  
quaternary	   structure	   equilibrium	   of	  MtuDAH7PSG232P	   towards	   tetramer	   formation	   however	   further	  
evidence,	  such	  as	  AUC,	  is	  required	  to	  support	  this	  conclusion.	  
 Chapter	  summary	  7.11.
MtuDAH7PSG232P,	   MtuDAH7PSG190P/G232P	   and	   MtuDAH7PSF227D	   were	   all	   successfully	   prepared	   and	  
purified.	   AUC,	   native	   PAGE	   and	   SAXS	   all	   showed	   the	   quaternary	   structure	   of	   the	   three	   variant	  
enzymes	   had	   been	   disrupted.	   At	   high	   concentrations	   (>1	   mg/mL)	   the	   MtuDAH7PS	   dimer	   was	  
7	   MtuDAH7PS	  dimer	  
	  
232	  
favoured,	   and	   at	   low	   concentration	   (<	   0.6	   mg/mL)	   the	  MtuDAH7PS	   monomer	   was	   favoured.	   The	  
Gly232Pro	   substitution	   located	   on	   the	   α2b-­‐β3	   loop	   had	   unintentionally	   disturbed	   the	   tetramer	  
interface,	   preventing	  MtuDAH7PS	   tetramer	   formation.	   Conversely	   the	   Phe227Asp	   substitution	   was	  
successfully	   engineered	   to	   disrupt	   the	   tetramer	   interface	   by	   causing	   repulsion	   between	   the	  
hydrophobic	  pocket	  that	  would	  normally	  bind	  Phe227	  and	  the	  Asp	  that	  replaced	  it.	  CD	  showed	  there	  
was	  no	  change	  to	  the	  secondary	  structure	  of	  any	  of	  the	  variant	  enzymes	  as	  a	  result	  of	  the	  introduced	  
substitutions.	   Successful	   preparation	   of	  MtuDAH7PSF227D	   helped	   to	   distinguish	   which	   properties	   of	  
MtuDAH7PSG232P	  and	  MtuDAH7PSG190P/G232P	  are	  due	  to	  their	  introduced	  substitution(s)	  and	  which	  are	  
due	  to	  the	  disruption	  of	  their	  quaternary	  structure.	  
	  
All	   three	   dimeric	   MtuDAH7PS	   variants	   were	   active	   with	   similar	   kinetic	   parameters.	   The	   variant	  
enzymes	  all	  exhibited	  poor	  activity,	  primarily	  because	  the	  concentration	  of	  E4P	  required	  for	  effective	  
catalysis	  had	  increased	  by	  over	  ten-­‐fold.	  The	  concentration	  of	  PEP	  required	  for	  effective	  catalysis	  had	  
also	   increased	   but	   more	   modestly.	   Intriguingly	   the	   turnover	   number	   for	   the	   dimeric	   variants	   was	  
significantly	   higher	   than	  MtuDAH7PSWT,	   which	   helped	   to	   compensate	   for	   the	   poor	   affinity	   of	   the	  
enzymes	  for	  E4P.	  As	  all	   three	  variant	  enzymes	  share	  similar	  kinetic	  parameters	   it	   is	  highly	   likely	   the	  
change	  in	  quaternary	  structure	  is	  responsible	  for	  the	  loss	  in	  E4P	  affinity.	  The	  E4P-­‐dependent	  kinetics	  
of	   MtuDAH7PSG190P/G232P	   showed	   no	   cooperativity	   in	   the	   presence	   of	   Trp	   and	   Phe.	   The	   lack	   of	  
cooperative	   E4P	   binding	   suggests	   the	   tetrameric	   MtuDAH7PS	   structure	   may	   be	   important	   for	  
signalling	  between	  the	  allosteric	  binding	  sites	  and	  the	  active	  site.	  	  
	  
DSF,	  ITC,	  AUC	  and	  inhibition	  studies	  collectively	  showed	  all	  three	  aromatic	  amino	  acids	  could	  bind	  to	  
the	  three	  variant	  enzymes.	  Phe	  and	  Tyr	  binding	  had	  not	  been	  adversely	  affected,	  whilst	  Trp	  binding	  
was	   significantly	   weakened.	   The	   Trp	   binding	   site	   is	   located	   very	   near	   the	   tetramer	   interface,	   with	  
several	  residues	  contributing	  to	  both	  the	  Trp	  binding	  site	  and	  the	  tetramer	   interface.	  Consequently,	  
changes	  to	  the	  quaternary	  structure	  may	  affect	  the	  conformation	  of	  the	  binding	  site	  and	  the	  flexibility	  
of	   the	   regions	   near	   the	   Trp	   binding	   site,	   ultimately	   discouraging	   Trp	   binding.	   Furthermore	   the	  
Gly232Pro	   and	   Phe227Asp	   substitutions	   are	   located	   close	   to	   both	   the	   Trp	   binding	   site	   and	   the	  
tetramer	  interface	  and	  may	  have	  inadvertently	  contributed	  to	  the	  disruption	  of	  Trp	  binding	  to	  the	  Trp	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site.	   Phe	   and	   Tyr	   bind	   at	   sites	   1	   and	   2	   at	   the	   dimer	   interface	   and	   the	   disruption	   of	   the	   tetramer	  
interface	   is	   less	   likely	   to	   affect	   these	  binding	   sites	   directly.	  Additionally,	   AUC	   revealed	   Trp	   and	  Phe	  
stabilised	  the	  dimer	  formation	  of	  MtuDAH7PSG232P.	  As	  the	  Phe-­‐selective	  binding	  site,	  site	  1,	  is	  located	  
at	   the	   dimer	   interface	   it	   is	   understandable	   that	   Phe	   binding	   may	   help	   strengthen	   interactions	  
between	  the	  two	  subunits.	  ITC	  also	  revealed	  that	  Phe	  did	  not	  improve	  Trp	  binding	  to	  MtuDAH7PSG232P	  
or	   MtuDAH7PSF227D;	   evidence	   that	   the	   MtuDAH7PS	   tetramer	   is	   required	   for	   signal	   transmission	  
between	  the	  allosteric	  binding	  sites.	  	  
	  
Inhibition	   studies	   of	   MtuDAH7PS	   activity	   conducted	   at	   150	   µM	   E4P	   showed	   MtuDAH7PSG232P,	  
MtuDAH7PSG190P/G232P	  and	  MtuDAH7PSF227D	  were	  sensitive	  to	  the	  presence	  of	  Phe	  and	  Tyr,	  but	  showed	  
no	   evidence	   of	   synergistic	   inhibition.	   The	   lack	   of	   synergy	   is	   consistent	   with	   the	   lack	   of	   synergy	  
observed	  by	  ITC	  for	  MtuDAH7PSG232P	  and	  MtuDAH7PSF227D.	  Due	  to	  the	  huge	  increase	  in	  the	  Km
E4P	  the	  
standard	   inhibition	   studies	   of	   the	   dimeric	   MtuDAH7PS	   variants	   were	   conducted	   at	   an	   E4P	  
concentration	   less	   than	   half	   the	   Km
E4P	   for	   the	   dimeric	   variants.	   For	   MtuDAH7PSWT	   the	   E4P	  
concentration	   in	  the	   inhibition	  studies	  was	  roughly	   five	  times	  the	  MtuDAH7SWT	  Km
E4P.	  To	  correct	   for	  
the	   difference	   in	   relative	   E4P	   concentrations	   the	   inhibition	   assays	   were	   also	   conducted	   at	   an	   E4P	  
concentration	  three	  to	  five	  times	  the	  Km
E4P	  of	  the	  dimeric	  MtuDAH7PS	  variants	  (1800	  µM).	  At	  this	  high	  
concentration	   of	   E4P	   MtuDAH7PSG232P,	   MtuDAH7PSG190P/G232P	   and	   MtuDAH7PSF227D	   all	   showed	   no	  
sensitivity	  to	  any	  single	  or	  combination	  of	  aromatic	  amino	  acids.	  Thus	  the	  sensitivity	  to	  Phe	  and	  Tyr	  
demonstrated	  by	  the	  dimeric	  MtuDAH7PS	  variants	  in	  the	  standard	  inhibition	  study	  was	  most	  likely	  an	  
artefact	   of	   the	   relatively	   low	   E4P	   concentration	   (150	   µM)	   at	   which	   the	   inhibition	   studies	   were	  
conducted.	   Therefore	   the	   MtuDAH7PS	   tetramer	   quaternary	   structure	   is	   required	   for	   effective	  
regulation	  of	  MtuDAH7PS.	  
	  
MtuDAH7PSG232P,	   MtuDAH7PSG190P/G232P	   and	   MtuDAH7PSF227D	   poorly	   boosted	   MtuCM	   activity	   and	  
showed	   little	   evidence	   of	   regulatory	   sensitivity.	   Two	   MtuCM	   dimers	   bind	   across	   the	   tetramer	  
interface	   of	   MtuDAH7PS	   (Figure	   7.18).	   The	   dimeric	  MtuCM	   binds	   across	   the	   interface	   with	   one	  
MtuCM	  subunit	  bound	  to	  each	  MtuDAH7PS	  asymmetric	  dimer	  and	  this	  binding	  mode	  is	  repeated	  at	  
the	   opposite	   side	   of	   MtuDAH7PS.	   The	   disruption	   of	   the	   tetramer	   interface	   by	   Gly232Pro	   and	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Phe227Asp,	   has	  most	   probably	   inadvertently	   disrupted	   the	  MtuCM	   binding	   site.	   Since	   the	   dimeric	  
MtuDAH7PS	  variants	  do	  not	  form	  an	  appreciable	  amount	  of	  tetramer	  the	  MtuCM	  dimer	  can	  only	  form	  
half	  the	  number	  of	  contacts,	  resulting	  in	  a	  much	  weaker	  interaction.	  This	  weaker	  interaction	  between	  
MtuCM	  and	  MtuDAH7PSWT	  may	  result	  in	  a	  transient	  MtuCM•MtuDAH7PSdimer	  complex,	  with	  the	  short	  
time	  span	  of	  the	  association	  most	  likely	  limiting	  the	  benefits	  of	  the	  interaction	  from	  being	  exploited.	  
Moreover,	  the	  restricted	  interactions	  between	  the	  dimeric	  MtuDAH7PS	  variants	  and	  MtuCM	  may	  not	  
invoke	  the	  active	  site	  rearrangement	  of	  MtuCM	  required	  for	  activation.	  The	  proposed	  mechanism	  of	  
inhibition	   of	   MtuCM	   activity	   is	   via	   breaking	   or	   weakening	   the	   interaction	   between	   MtuCM	   and	  
MtuDAH7PS	  preventing	  proper	  activation.	  Hence,	   it	   is	  unlikely	  MtuCM	  and	  the	  dimeric	  MtuDAH7PS	  
variants	  form	  a	  sufficient	  amount	  of	  the	  MtuCM•MtuDAH7PSdimer	  complex	  to	  detect	  inhibition.	  
	  
	  
Figure	  7.18	  Cartoon	  and	  surface	  depiction	  of	  the	  MtuCM	  bound	  MtuDAH7PS	  crystallographic	  coordinates	  (PDB	  
code:	   2W19).	   For	  MtuDAH7PS	   the	   core	   (β/α)8	   barrel	   structure	   is	   coloured	   blue,	   the	   N-­‐terminal	   extension	   is	  
coloured	  red	  and	  the	  additional	  helices	  to	  the	  α2-­‐β3	  loop	  are	  coloured	  yellow.	  One	  subunit	  of	  the	  MtuCM	  dimer	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MtuDAH7PSG232P,	   MtuDAH7PSG190P/G232P	   and	   MtuDAH7PSF227D	   exist	   as	   a	   mixture	   of	   monomer	   and	  
dimer	  in	  solution.	  Therefore	  the	  introduction	  of	  the	  Gly232Pro	  or	  Phe227Asp	  substitution	  has	  clearly	  
disrupted	  the	  quaternary	  structure	  of	  the	  MtuDAH7PS	  variants.	  The	  similarity	  in	  the	  properties	  of	  the	  
three	  variant	  enzymes	  showed	  it	  is	  the	  change	  in	  quaternary	  structure,	  which	  is	  largely	  responsible	  for	  
the	   changes	   in	   their	   observed	   kinetic	   and	   biophysical	   properties.	   These	   dimeric	   variants	   have	  
highlighted	   the	   necessity	   of	  MtuDAH7PS	   to	   be	   able	   to	   access	   the	   tetrameric	   structure	   for	   proper	  
catalytic	   and	   regulatory	   function.	   Thus,	   in	   all	   likelihood	   the	   tetrameric	  MtuDAH7PS	   structure	   is	   the	  
most	  biologically	  relevant	  form	  of	  the	  enzyme.	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8. Thesis	  summary	  and	  future	  directions	  
The	  functional	  and	  structural	  studies	  of	  MtuDAH7PS	  presented	  within	  this	  thesis	  have	  expanded	  upon	  
previous	  work	  on	  the	  enzyme	  by	  the	  Parker	  research	  group.48,64,69,71,115,126	  The	  work	  described	  in	  this	  
thesis	   largely	  utilised	   the	   technique	  of	  SDM	  to	  generate	  variant	  proteins	   in	  order	   to	   investigate	   the	  
regulation	  of	  MtuDAH7PS	   so	   as	   to	   better	   understand	  how	   the	   complex	   allostery	   is	   achieved	   in	   the	  
absence	   of	   significant	   conformational	   change.	   This	   thesis	   also	   describes	   investigations	   into	   the	  
interactions	  between	  MtuDAH7PS	  and	  MtuCM	  first	  described	  in	  2009.85	  	  
 MtuDAH7PS	  is	  subject	  to	  ternary	  synergistic	  allostery	  8.1.
	  
Enzymes	   located	   at	   critical	   points	   in	  metabolic	   pathways	   are	   generally	   tightly	   regulated	   to	   control	  
metabolic	   flux	   into	   the	   pathway.	   Enzymes	   such	   as	   DAH7PS,	   that	   are	   located	   within	   branched	  
pathways	  present	  particular	  challenges	  in	  order	  to	  tune	  enzyme	  activity	  to	  meet	  cellular	  requirements	  
without	  causing	  a	  build	  up	  of	  harmful,	  unstable	  or	  unnecessary	  metabolites.	  DAH7PS	  enzymes	  from	  
different	   organisms	   employ	   different	   strategies	   to	   control	   entry	   into	   aromatic	   amino	   acid	  
biosynthesis.	   It	   is	   speculated	   that	   in	   plants	   DAH7PS	   activity	   is	   controlled	   primarily	   at	   the	  
transcriptional	  level,	  although	  the	  exact	  mechanism	  remains	  unclear.70,129-­‐131	  Some	  organisms	  such	  as	  
E.	  coli	   and	   S.	   cerevisiae	  utilise	  multiple	   DAH7PS	   isozymes,	   with	   each	   isozyme	   being	   regulated	   by	   a	  
particular	   aromatic	   amino	   acid.49,50,132,133	   Other	   organisms	   encode	   for	   a	   single	   DAH7PS,	   which	   is	  
subject	  to	  feedback	  regulation	  by	  specific	  individual	  aromatic	  amino	  acids.	  One	  example	  is	  T.	  maritima	  
DAH7PS,	   which	   is	   sensitive	   to	   Phe	   or	   Tyr	   but	   is	   never	   completely	   inhibited	   by	   either	   amino	   acid,	  
presumably	  to	  allow	  basal	  levels	  of	  synthesis	  of	  Trp	  and	  other	  metabolites	  even	  when	  Phe	  or	  Tyr	  are	  
in	   excess.47,134	   M.	   tuberculosis	   also	   encodes	   a	   single	   DAH7PS	   but	   this	   enzyme	   has	   developed	  
synergistic	  allostery,	  with	  a	  far	  more	  sophisticated	  strategy	  to	  allow	  DAH7PS	  activity	  to	  be	  fine-­‐tuned	  
to	  meet	  cellular	  needs.	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Prior	  to	  the	  commencement	  of	  this	  work	  it	  had	  been	  established	  that	  MtuDAH7PS	  was	  insensitive	  to	  
individual	   aromatic	   amino	   acids,	   but	   synergistically	   inhibited	   by	   binary	   combinations	   of	   aromatic	  
amino	   acids	   that	   included	   Trp.48,63,70	   Crystallographic	   studies	   had	   identified	   three	   distinct	   allosteric	  
binding	  sites;	  the	  Trp	  site,	  site	  1	  and	  site	  2.48,71,91	  The	  Trp	  site	  is	  the	  only	  allosteric	  site	  Trp	  has	  been	  
observed	  to	  occupy.	  The	  selectivity	  of	  sites	  1	  and	  2	  was	  more	  ambiguous	  as	  both	  Phe	  and	  Tyr	  have	  
been	  observed	  to	  occupy	  both	  sites.48,71,91	  Moreover,	  it	  was	  uncertain	  whether	  both	  sites	  1	  and	  2	  or	  if	  
only	  one	  of	  the	  sites	  played	  a	  part	  in	  the	  allosteric	  regulation	  of	  MtuDAH7PS.	  	  
	  
SDM,	  kinetic	  analysis	  and	   ITC	  showed	   that	   site	  1	  was	  able	   to	  bind	  both	  Phe	  and	  Tyr,	  but	  had	   to	  be	  
occupied	  by	  Phe,	  in	  combination	  with	  Trp	  bound	  to	  the	  Trp	  site,	  to	  elicit	  an	  inhibitory	  response.	  These	  
findings	  have	  now	   led	   to	  site	  1	  being	  designated	  the	  Phe-­‐selective	  site.	  Site	  2	  was	   found	  to	  show	  a	  
higher	  affinity	  for	  Tyr	  than	  Phe.	  Furthermore	  Tyr,	  must	  occupy	  site	  2,	  in	  combination	  with	  Trp	  at	  the	  
Trp	   site,	   to	   elicit	   an	   inhibitory	   response,	   leading	   site	   2	   to	   be	   designated	   the	   Tyr-­‐selective	   site.	  
Additionally,	   it	   was	   found	   the	   binary	   synergistic	   inhibitory	   response	   caused	   by	   Trp	   and	   Phe	   was	  
augmented	  by	  the	  addition	  of	  Tyr,	  which	  almost	  completely	  abolished	  MtuDAH7PS	  activity.	  	  
	  
The	   presence	   of	   three	   distinct	   allosteric	   binding	   sites,	   each	   specific	   to	   a	   particular	   aromatic	   amino	  
acid,	   allows	   M.	   tuberculosis	   to	   finely	   tune	   MtuDAH7PS	   activity	   in	   response	   to	   the	   cellular	  
concentrations	  of	  all	   three	  aromatic	  amino	  acid	  end	  products.	   Synergistic	   regulation	  of	  enzymes	  by	  
two	   effectors	   is	   not	   uncommon.	  Glutamine	   phophoribosylpyrophosphate	   amidotransferase	   from	  B.	  
subtilis	   is	   synergistically	   feedback	   regulated	   by	   the	   end	   products	   of	   the	  de	   novo	   purine	   nucleotide	  
synthesis,	   adenine	   diphosphate	   (ADP)	   and	   guanine	   monophosphate	   (GMP).135	   Aspartate	  
transcarbamoylase	   from	   E.	   coli	   is	   synergistically	   regulated	   by	   the	   allosteric	   effectors	   pyrimidine	  
cytidine	   and	   uracil	   triphosphates	   (CTP	   and	   UTP),	   the	   end	   products	   of	   pyrimidine	   biosynthetic	  
pathways.119	  However,	   the	  highly	  sophisticated	  ternary	  synergistic	  allosteric	   regulation	  observed	  for	  
MtuDAH7PS	  is	  unique	  amongst	  characterised	  regulatory	  enzymes.	  Although,	  the	  lack	  of	  examples	  of	  
ternary	   synergistic	   allosteric	   regulation	   in	   the	   literature	   is	   perhaps	   a	   reflection	   of	   the	   difficulty	   in	  
identifying	  the	  necessary	  conditions	  to	  observe	  the	  phenomena,	  as	  opposed	  to	  a	  lack	  of	  its	  prevalence	  
in	  nature.	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 The	   synergistic	   allosteric	   regulation	   of	   MtuDAH7PS	  8.2.
involves	   a	   highly	   evolved	   network	   of	   residues	   to	  
communicate	  between	  remote	  sites	  
	  
Traditionally	   the	   transmission	   of	   signals	   between	   remote	   allosteric	   binding	   sites	   and	   between	  
allosteric	   binding	   sites	   and	   active	   sites	   have	   largely	   been	   understood	   in	   terms	   of	   conformational	  
change.	  For	  instance	  the	  binding	  of	  Tyr	  to	  the	  DAH7PS	  from	  T.	  maritime	  causes	  the	  regulatory	  domain	  
favour	  a	  closed	  form	  of	  the	  enzyme	  rather	  than	  an	  open	  form,	  effectively	  blocking	  the	  active	  site.47,62	  
The	   allosteric	   regulation	   of	   proteins	   that	   undergo	   significant	   structural	   change	   is	   considered	   to	   be	  
enthalpically	   driven,	  whereas	   the	   allosteric	   regulation	  of	   proteins	   that	  do	  not	  undergo	  any	  obvious	  
change	   in	   conformation	   is	   considered	   to	   be	   entropically	   driven.3,6,24	   The	   binding	   of	   Trp	   and	   Phe	   to	  
MtuDAH7PS	  does	  not	  cause	  any	  significant	  conformational	  changes	  and	  there	  are	  very	  few	  structural	  
differences	  between	  the	   liganded	  and	  unliganded	  structures.48,71	  Furthermore,	  the	  allosteric	  binding	  
sites	  of	  MtuDAH7PS	  are	  remote	  from	  the	  active	  site	  and	  each	  other.	  There	  are	  very	  few	  known	  well-­‐
studied	   examples	   of	   allostery	   not	   associated	   with	   changes	   in	   conformation.	   One,	   commonly	   cited	  
example	  is	  the	  interaction	  of	  the	  catabolite	  activator	  protein	  from	  E.	  coli	  with	  the	  allosteric	  effector	  
cyclic	   adenine	  monophosphate	   (cAMP),	  which	   results	   in	   changes	   in	   the	   enzymes	   intrinsic	   motions	  
without	  significantly	  altering	  the	  structure	  of	  the	  enzyme.25,136	  MD	  simulations	  indicate	  the	  synergistic	  
allosteric	  regulation	  of	  MtuDAH7PS	  is	  largely	  entropically	  driven.71,115	  Upon	  binding	  of	  Trp	  or	  Phe	  the	  
rigidity	   of	   the	   alternative	   allosteric	   binding	   pockets	   changes,	   improving	   the	   binding	   of	   Phe	   or	   Trp	  
respectively.71,115	  Similarly,	  upon	  binding	  of	  Trp	  and	  Phe,	  the	  flexibility	  of	  the	  E4P	  binding	  loop	  (the	  β2-­‐
α2	   loop)	  was	   predicted	   to	   increase,	   increasing	   the	   entropic	   cost	   of	   E4P	   binding,	   reducing	   catalytic	  
activity.71,115	  	  
	  
The	   subtle	   changes	   in	   enzyme	   dynamics	   that	   occur	   upon	   Trp	   and	   Phe	   binding	   to	  MtuDAH7PS	   are	  
becoming	   increasingly	   well	   understood,	   but	   exactly	   how	   occupancy	   at	   one	   allosteric	   site	   is	  
communicated	  to	  the	  other	  allosteric	  sites,	  and	  how	  the	  occupancy	  of	  two	  or	  more	  distinct	  allosteric	  
sites	  is	  communicated	  to	  the	  active	  site	  is	  a	  more	  challenging	  problem	  to	  solve.	  The	  current	  general	  
view	  on	  allosteric	  communication	  is	  that	  multiple	  propagation	  pathways	  exist,	  major	  and	  minor,	  as	  a	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result	   of	   proteins	   existing	   as	   population	   ensembles	   of	   different	   states.3,18,71,125,136,137	   Local	   stress(s)	  
applied	   to	   the	   allosteric	   binding	   sites	   by	   ligand	   binding	   or	   by	   covalent	   modification	   triggers	  
propagation	   of	   a	   signal	   along	  multiple	   pathways	   to	   other	   allosteric	   binding	   sites	   and/or	   the	   active	  
site.3,18,125,137	  	  
	  
Computational	   techniques	   such	   as,	   anisotropic	   thermal	   diffusion,	   SCA	   and	   MD	   simulations	   are	  
frequently	   employed	   to	   identify	   potential	   clusters	   or	   residues	   that	   may	   be	   involved	   in	   the	  
communication	  pathways	  of	  a	  protein.25,115,122,123,125,138,139	  A	  combination	  of	  SCA	  and	  MD	  simulations	  
were	  used	  to	  identify	  a	  cluster	  of	  coevolved	  residues	  that	  could	  potentially	  be	  critical	  to	  the	  allosteric	  
regulation	   of	  MtuDAH7PS.71,115	   This	   network	   or	   cluster	   of	   residues	   is	   thought	   to	   transmit	   subtle	  
changes	  in	  flexibility	  or	  molecular	  motion	  across	  the	  enzyme,	  ultimately	  providing	  entropic	  control	  of	  
the	   affinity	   of	   each	   binding	   site	   for	   its	   ligand.23,71	   Although	   insightful,	   such	   findings	   are	   more	  
meaningful	   when	   accompanied	   by	   experimental	   validation.	   Hence,	   the	   roles	   of	   four	   residues	  
belonging	   to	   the	   cluster	   of	   residues	   identified	   by	   computational	   techniques	   were	   examined	   as	  
described	   in	   chapter	   5.	   Substitution	   of	   any	   one	   of	   the	   four	   residues	   was	   surprisingly	   effective	   at	  
disrupting	  the	  synergistic	  regulation	  of	  MtuDAH7PS	  and/or	  MtuCM	  as	  shown	  by,	  kinetic	  analysis,	  ITC,	  
and	  DSF.	   The	   substitution	   of	  Gly190	   for	   Pro	   had	   the	  most	   radical	   effect	   and	   rendered	  MtuDAH7PS	  
insensitive	  to	  any	  combination	  of	  allosteric	  amino	  acids.	  Gly190	  is	  located	  along	  the	  α2-­‐α2a	  loop,	  and	  
the	  substitution	   to	  Pro	  was	   intended	   to	   restrict	   the	   flexibility	  of	   the	   loop	  and	   the	  adjacent	   inserted	  
α2a	  and	  to	  a	  lesser	  extent	  the	  α2b	  helices.	  Changes	  in	  the	  flexibility	  of	  the	  α2	  α2a	  loop	  may	  impact	  on	  
the	  ability	  of	   the	  backbone	   carbonyl	  moiety	  of	  Ala192,	   also	   located	  along	   the	   loop,	   from	  hydrogen	  
bonding	   with	   the	   bound	   Trp	   ligand.	   The	   substitution	   of	   Gly190	   highlights	   the	   importance	   of	   the	  
flexibility	   of	   the	   secondary	   and	   tertiary	   structure,	   and	   therefore	   molecular	   dynamics,	   for	   the	  
transmission	  of	  signals	  between	  allosteric	  and/or	  the	  active	  site	  of	  MtuDAH7PS.	  	  
	  
These	  results	   imply	  that	  the	  SCA	  and	  MD	  simulations	  have	  successfully	   identified	  residues	  critical	  to	  
the	  proper	  function	  of	  the	  synergistic	  allosteric	  regulation	  of	  MtuDAH7PS.	  Furthermore,	  three	  of	  the	  
residues	   targeted	   were	   not	   directly	   located	   at	   either	   the	   allosteric	   binding	   sites	   or	   the	   active	   site	  
therefore,	  these	  residues	  must	  form	  part	  of	  the	  communication	  network	  responsible	  for	  transmitting	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occupancy	  of	  an	  allosteric	  binding	  site	  to	  other	  allosteric	  binding	  sites	  and	  the	  active	  site.	  The	  drastic	  
changes	  to	  the	  regulation	  of	  MtuDAH7PS	  (and	  MtuCM)	  due	  to	  a	  single	  residue	  substitution	  highlights	  
how	  highly	  evolved	  this	  communication	  pathway	  is.	  	  
	  
Additional	  residues	  involved	  in	  the	  signalling	  network	  could	  potentially	  be	  found	  by	  the	  continuation	  
of	   this	   work.	   SCA	   and	   MD	   analysis	   provided	   a	   series	   of	   residues	   that	   are	   candidates	   for	   further	  
investigation	   using	   SDM	   and	   the	   same	   kinetic	   and	   biophysical	   techniques	   described	   here.	   The	  
continuation	   of	   this	   work	   could	   lead	   to	   a	   map	   of	   the	   molecular	   pathways	   within	   MtuDAH7PS	  
responsible	  for	  the	  signal	  transfer	  between	  allosteric	  sites,	  to	  the	  active	  site	  and	  to	  MtuCM.	  A	  greater	  
understanding	  of	  how	  allostery	  is	  communicated	  within	  MtuDAH7PS	  could	  potentially	  be	  exploited	  to	  
develop	  novel	  anti-­‐TB	  drugs.	  
	  
This	  work	  not	  only	  validates	  the	  computational	  studies	  on	  MtuDAH7PS,	  but	  also	  provides	  a	  successful	  
example	   of	   how	   computational	   techniques	   can	   be	   used	   to	   successfully	   identify	   allosteric	  
communication	   networks	   in	   enzymes	   that	   show	   little	   or	   no	   conformational	   change.	   Discoveries	   of	  
allosteric	   systems	   such	   as	  MtuDAH7PS	   that	   are	  mediated	  by	   subtle	   changes	   in	  molecular	   dynamics	  
force	   the	   traditional	   views	   of	   allostery	   to	   be	   reassessed	   and	   evolve	   into	  more	   flexible	   and	   robust	  
paradigms.	  	  
 The	  MtuDAH7PS	  tetramer	  is	  the	  regulated	  quaternary	  8.3.
structure	  
	  
Not	   all	   residues	   identified	   as	   part	   of	   the	   MtuDAH7PS	   allosteric	   communication	   network	   were	  
amenable	   to	   substitution	   without	   adversely	   affecting	   protein	   solubility	   or	   quaternary	   structure.	  
Chapter	   7	   describes	   the	   characterisation	   of	  MtuDAH7PS	   variants	   where	   the	   residue	   substitution	  
disrupted	   quaternary	   structure,	   destabilising	   the	   homotetramer.	   The	   substitution	   of	   Gly232	   to	   Pro	  
proved	  to	  be	  of	  particular	  interest.	  Gly232	  is	  located	  on	  the	  α2b-­‐β3	  loop	  succeeding	  the	  inserted	  α2a	  
and	  α2b	  helices.	  Substitution	  of	  Gly232	  to	  Pro	  was	  intended	  to	  limit	  the	  flexibility	  of	  this	  loop	  and	  the	  
preceding	   helices.	   However,	   an	   unintended	   consequence	   of	   the	   Gly232Pro	   substitution	   was	   the	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disruption	   to	   the	  quaternary	   structure,	  MtuDAH7PSG232P	   (and	  MtuDAH7PSG190P/G232P)	   could	  not	   form	  
the	   tetramer.	  AUC,	  SAXS	  and	  native	  PAGE	  show	  these	  MtuDAH7PS	  variants	  are	  primarily	  dimeric	   in	  
solution.	  There	  is	  a	  link	  between	  the	  allosteric	  network	  responsible	  for	  signalling	  ligand	  occupancy	  at	  
the	   allosteric	   sites	   and	   the	   control	   of	   quaternary	   structure	   and	   these	   findings	   imply	   quaternary	  
structure	  is	  important	  to	  the	  regulation	  of	  MtuDAH7PS.	  	  
	  
The	  serendipitous	  formation	  of	  the	  dimeric	  MtuDAH7PS	  variants	  provided	  an	  unexpected	  opportunity	  
to	  characterise	  the	  properties	  of	  the	  MtuDAH7PS	  dimer.	  Kinetic	  and	  biophysical	  analysis	  showed	  that	  
all	  dimeric	  MtuDAH7PS	  variants	  possessed	  a	  significantly	  reduced	  catalytic	  efficiency	  and	  showed	  very	  
poor	   regulatory	   sensitivity.	   The	   engineering	   of	   another	   MtuDAH7PS	   variant	   (MtuDAH7PSF227D)	  
intended	  to	  only	  disrupt	   the	   tetramer	   interface	  of	  MtuDAH7PS,	  also	  prevented	  tetramer	   formation,	  
and	   this	   confirmed	   that	   the	   changes	   in	   properties	   observed	   of	  MtuDAH7PSG232P	   were	   due	   to	   the	  
change	  in	  quaternary	  structure	  and	  not	  the	  substitution	  of	  Gly232.	  	  
	  
In	   chapter	   2	   AUC	   results	   showed	   that	  MtuDAH7PSWT	   exists	   as	   a	   mixture	   of	   oligomeric	   states	   in	  
solution,	  with	   increases	   in	  protein	   concentration	   favouring	   tetramer	   formation.	  The	  addition	  of	   the	  
allosteric	   ligands,	   Trp	   and/or	   Phe,	   stabilised	   the	   formation	   of	   the	   tetramer	   at	   all	   protein	  
concentrations	   analysed.	   This	   stabilisation	   is	   understandable	   given	   the	   allosteric	   binding	   sites	   are	  
located	   at	   the	   dimer	   and	   tetramer	   interfaces.48,69	   Similarly	   in	   chapter	   6	   AUC	   and	   SAXS	   analyses	  
demonstrated	  that	  MtuDAH7PSK123M	  exists	  as	  a	  mixture	  of	  primarily	  monomer	  and	  tetramer,	  but	  the	  
addition	  of	  Phe	  promoted	  formation	  of	  the	  tetramer.	  The	  stabilisation	  of	  the	  MtuDAH7PS	  tetramer	  in	  
the	   presence	   of	   ligand	   and	   the	   poor	   activity	   and	   regulation	   of	   the	   dimeric	  MtuDAH7PS	   variants,	  
described	  in	  chapter	  7,	  suggests	  the	  tetramer	  is	  the	  regulated	  species.	  	  
	  
Previous	   work	   has	   shown	   that	  MtuCM	   binds	   to	  MtuDAH7PS	   across	   the	   tetramer	   interface,	   which	  
infers	   the	   necessity	   for	   the	   formation	   of	   the	  MtuDAH7PS	   tetramer	   for	   the	  MtuCM•MtuDAH7PS	  
complex	  to	  form.85	  The	  dimeric	  MtuDAH7PS	  variants	  were	  found	  to	  be	  very	  poor	  activators	  of	  MtuCM	  
activity	  and	  in	  chapter	  3	  AUC	  analyses	  are	  presented	  that	  show	  that	  MtuCM	  stabilised	  the	  formation	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of	  the	  MtuDAH7PSWT	  tetramer	  at	  all	  protein	  concentrations	  used.	  These	  findings	  are	  consistent	  with	  
the	  formation	  of	  the	  MtuCM•MtuDAH7PS	  complex	  being	  accessed	  via	  the	  MtuDAH7PS	  tetramer.	  	  
	  
In	   chapter	   3	   it	   was	   hypothesised	   that	  MtuDAH7PS	   inhibited	   the	   activity	   of	  MtuCM	   by	   causing	   the	  
MtuCM•MtuDAH7PS	   complex	   to	   dissociate	   when	   Phe	   bound	  MtuDAH7PS.	   Native	   PAGE	   and	   AUC	  
studies	   support	   this	   proposed	   hypothesis.	   This	   hypothesis	   implies	   that	   the	   unliganded	  MtuDAH7PS	  
species	   is	   not	   equivalent	   to	   the	   liganded	   (Phe-­‐bound)	  MtuDAH7PS	   species.	   Hence	   either	   a	   small	  
conformational	  change,	  such	  as	  a	  twist	  across	  the	  tetramer	   interface	  or	  a	  significant	   increase	   in	  the	  
molecular	   motion	   of	   the	   α2b,	   α7	   and	   α8	   helices	   (and	   their	   associated	   loops)	   located	   at	   the	  
MtuCM•MtuDAH7PS	   interface	  must	   weaken	   the	   interactions	   between	  MtuCM	   and	  MtuDAH7PS.	   It	  
should	  be	  noted	  that	  Trp	  alone	  does	  not	  cause	  the	  same	  changes	  to	  the	  MtuDAH7PS	  tetramer	  as	  Phe,	  
as	   indicated	   by	   the	   insensitivity	   of	   the	  MtuCM•MtuDAH7PS	   complex	   to	   Trp.	   This	   different	   kinetic	  
behaviour	   suggests	   Trp	   may	   stabilise	   a	   tetramer	   species,	   with	   similar	   affinity	   for	  MtuCM	   as	   the	  
unliganded	  MtuDAH7PS,	  but	  with	  an	  increased	  affinity	  for	  other	  allosteric	  ligands.	  
	  
As	   stated	   previously	   the	   AUC	   showed	   unliganded	  MtuDAH7PSWT	   exists	   as	   a	   mixture	   of	   monomer,	  
dimer	  and	  tetramer.	  The	  stability	  of	  the	  dimeric	  MtuDAH7PS	  variants,	  their	  regulatory	  properties,	  and	  
their	   catalytic	   abilities	   calls	   into	   question	   the	   biological	   relevance	   of	   the	  MtuDAH7PS	   dimer.	   The	  
tetramer	  is	  clearly	  the	  relevant	  regulatory	  structure,	  has	  a	  higher	  catalytic	  efficiency,	  and	  is	  required	  
to	   interact	   with	  MtuCM.	   The	   observation	   of	   the	   dimer	   may	   simply	   be	   an	   artefact	   of	   an	   in	   vitro	  
environment.	  The	  localised	  cellular	  concentration	  within	  the	  bacterium	  cells,	  salt	  concentrations,	  pH,	  
ancillary	   proteins	   and	   cofactors	   can	   all	   influence	   the	  quaternary	   structure	   a	   protein	   adopts	   in	   vivo,	  
factors	   that	   are	   hard	   to	   predict	   and	  mimic	   in	   a	   laboratory	   setting.	   However,	   the	   existence	   of	   two	  
distinct	   tetrameric	   MtuDAH7PS	   species	   does	   not	   preclude	   the	   possibility	   that	   these	   different	  
conformations	  are	  accessed	  via	  the	  dimer	  or	  even	  via	  the	  monomer.	  These	  possibilities	  are	  more	  akin	  
to	   the	  morpheein	  model	   of	   allostery.5,12,94	   The	   stability	   of	   the	  MtuDA7PS	   dimer	   and	   the	   ease	  with	  
which	   the	   tetramer	   interface	   can	   be	   disrupted	   to	   prevent	   tetramer	   formation	   (even	   accidently)	  
supports	  the	  viability	  of	  a	  morpheein-­‐like	  model	  of	  allostery	  via	  a	  dimeric	  intermediate.	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The	  original	  MWC	  view	  has	  now	  been	  expanded	  and	  enzymes	  are	  now	  generally	  considered	  to	  exist	  
as	  protein	  ensemble	  of	  conformational	  states.3,20,140	  The	  binding	  of	  an	  allosteric	  effectors	  to	  a	  protein	  
that	   exists	   at	   equilibrium	  may	   vary	   the	   overall	   amplitude	   and	   frequency	   of	   fluctuations	   about	   the	  
mean	   species	   or	   alter	   the	   average	   conformation	   of	   the	   equilibrium.3,17,20,22,137	   The	   current	  model	   is	  
more	  robust	  and	  does	  not	  restrict	  or	  require	  the	  shift	   in	  the	  population	  ensemble	  of	  a	  protein	  from	  
occurring	   via	   dissociation	   and	  of	   a	   proteins	   oligomeric	   state	   and	   reassembly	   into	   a	   new	  oligomeric	  
state/different	   conformation.	   A	   complex	  model	   of	   different	   species	   where	   the	   distribution	   can	   be	  
altered	   by	   ligand,	   protein	   partner	   or	   substrate	   binding	   is	   better	   suited	   to	   modelling	   the	   allosteric	  
regulation	  of	  MtuDAH7PS.	  The	  experimental	   findings	   from	  this	  and	  previous	  studies	  have	  helped	  to	  
shape	   our	   current	   understanding	   of	   how	   allosteric	   function	   is	   communicated	   within	  MtuDAH7PS.	  
Molecular	   dynamics	   and	   quaternary	   structure	   clearly	   play	   a	   significant	   role	   in	   the	   transmission	   of	  
occupancy	  at	  one	  or	  more	  allosteric	  site	  to	  other	  allosteric	  sites	  and	  the	  active	  site.	  
 CM	  complex	  and	  dissociation	  8.4.
	  
Our	   understanding	   of	   how	   the	   thousands	   of	   enzyme-­‐catalysed	   reactions	  within	   the	   in	   vivo	   cellular	  
environment	   are	   interconnected	   and	   regulated	   to	   meet	   the	   cells	   overall	   needs	   is	   continuously	  
developing	   but	   is	   still	   not	   well	   understood.141	   Cells	   were	   once	   thought	   to	   consist	   of	   collection	   of	  
soluble	  proteins,	  substrates,	  cofactors	  and	  products	  within	  the	  cellular	  matrix	  that	  relied	  primarily	  on	  
diffusion	   for	   the	   right	   components	   to	   come	   together	  and	   react.2	  However,	   as	  our	  understanding	  of	  
cellular	   organisation	   advances,	   the	   number	   of	   examples	   of	   strategic	   use	   of	   compartmentalisation,	  
membrane-­‐bound	  systems	  and	  formation	  of	  multimolecular	  complexes	  by	  cells	   in	  order	   to	  organise	  
and	  control	  the	  enzymes	  of	  particular	  pathways	  is	  growing.2,141-­‐143	  An	  excellent	  example	  of	  the	  highly	  
organised	  nature	  of	  the	  cellular	  environment	  is	  the	  respiratory	  enzymes	  of	  eukaryotic	  cells	  that	  form	  
multimolecular	   complexes,	   most	   of	   which	   are	   membrane	   bound	   and	   localised	   within	   the	  
mitrochondria.2,144,145	  	  
	  
Enzymes	   from	   a	   vast	   array	   of	  metabolic	   pathways	   including	   glycolysis,	   Krebs	   cycle,	  de	   novo	   purine	  
biosynthesis,	   DNA	   repair	   and	   replication	   have	   been	   shown	   to	   form	   multimolecular	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complexes.2,140,141,143	   There	   are	   several	   obvious	   advantages	   to	   the	   formation	   of	   multimolecular	  
complexes.	   Complex	   formation	   may	   offer	   a	   kinetic	   advantage	   to	   the	   enzymes	   by	   permitting	   the	  
channelling	   of	  metabolites	   between	   sequential	   enzymes.2,141	   Complex	   formation	  may	   also	   increase	  
the	  overall	  stability	  of	  each	  enzyme	  and	  reduce	  the	  risk	  of	  enzyme	  degradation	  via	  proteolysis.1,2,146	  
Furthermore	  the	  formation	  of	  multienzyme	  complexes	  affords	  the	  cell	  another	  mechanism	  by	  which	  
to	  regulate	  and	  control	  enzyme	  activity:	  through	  the	  association	  and	  dissociation	  of	  the	  complex.147,148	  
Complex	   formation	  may	  be	  required	   for	   the	  proper	   function	   for	  some	  enzymes,	  whereas	   for	  others	  
complex	  formation	  may	  inhibit	  enzyme	  activity.147,148	  	  
	  
In	   2009	   Sasso	   et	   al.	   showed	   MtuDAH7PS	   formed	   a	   non-­‐covalent	   complex	   with	   MtuCM,	   which	  
dramatically	  boosted	  the	  catalytic	  efficiency	  of	  MtuCM	  and	  bestowed	  it	  with	  regulatory	  sensitivity	  to	  
Phe	   and	   Tyr.85	   In	   chapter	   4	   studies	   were	   detailed	   that	   demonstrated	   that	  MtuDAH7PS	   boosted	  
MtuCM	   activity	   by	   over	   100	   fold	   and	   endowed	  MtuCM	  with	   regulatory	   sensitivity	   to	   Phe	   and	   Tyr,	  
consistent	  with	  previous	  work.85	  This	  study	  additionally	  showed	  MtuDAH7PS	  synergistically	  regulated	  
MtuCM	  activity	  when	  Trp	  was	  present	  in	  combination	  with	  either	  Phe	  and/or	  Tyr.	  The	  work	  described	  
in	  chapter	  4	  further	  expanded	  upon	  the	  findings	  reported	  previously	  by	  showing	  conclusively	  that	  the	  
allosteric	   sites	   of	   MtuDAH7PS	   were	   responsible	   for	   the	   synergistic	   regulation	   of	   MtuCM.	   The	  
MtuDAH7PS	  variants	  generated	  in	  chapter	  3,	  engineered	  to	  disrupt	  ligand	  binding	  at	  site	  1	  or	  site	  2,	  
were	  utilised	  in	  these	  experiments	  to	  show	  that	  site	  1,	  and	  to	  a	  lesser	  extent	  site	  2,	  were	  essential	  for	  
the	  inhibitory	  response	  on	  MtuCM	  activity	  by	  Phe	  and	  Tyr	  respectively.	  
	  
Arguably	  one	  of	   the	  most	  exciting	   findings	  of	   this	  work	  was	   that	   the	  binding	  of	  Phe	   to	  MtuDAH7PS	  
weakens	  or	  alters	  the	  interaction	  between	  MtuCM	  and	  MtuDAH7PS,	  encouraging	  the	  dissociation	  of	  
MtuCM	   from	  MtuDAH7PS.	   The	  disruption	   to	   the	  MtuCM•MtuDAH7PS	  was	   revealed	  by	   a	   variety	   of	  
techniques	   including	   kinetic	   analysis,	   native	   PAGE	   and	   AUC.	   Control	   of	   enzyme	   activity	   or	   protein	  
function	  of	  a	  multienzyme	  complex	  via	  association	  and	  dissociation	   is	  not	  unprecedented.	  One	  well	  
known	  example	  is	  the	  suppression	  of	  protein	  synthesis	  by	  dissociation	  of	  the	  ribosome	  in	  response	  to	  
cell	  stress,	  such	  as	  a	  limited	  supply	  of	  adenosine	  triphosphate	  (ATP).2,149	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As	  stated	  in	  Section	  0,	  the	  fact	  that	  the	  Phe-­‐bound	  MtuDAH7PS	  and	  unliganded	  MtuDAH7PS	  exhibit	  
different	  affinities	  for	  MtuCM	  suggests	  their	  tetramer	  properties	  are	  not	  the	  same.	  One	  possibility	  is	  
that	  Phe	  binding	  causes	  changes	  to	  the	  molecular	  dynamics	  of	  the	  residues	  of	  MtuDAH7PS	  located	  at	  
the	  MtuCM•MtuDAH7PS	   interface,	   and	   this	   change	   discourages	  MtuCM	   binding.	   MD	   simulations	  
predicted	   that	   Phe	   binding	   leads	   to	   increased	   flexibility	   of	   the	   β7-­‐α7	   and	   β8-­‐α8	   loops,	   which	   are	  
involved	  in	  forming	  the	  MtuCM•MtuDAH7PS	  interface.71	  However,	  the	  binding	  of	  Trp	  and	  Phe,	  which	  
synergistically	  inhibit	  MtuCM	  activity,	  reduces	  the	  flexibility	  of	  these	  loops,	  resulting	  in	  similar	  or	  less	  
flexibility	  of	  the	  β7-­‐α7	  and	  β8-­‐α8	  loops,	  as	  is	  predicted	  for	  the	  unliganded	  enzyme.71	  	  
	  
Alternatively	  Phe	  binding	  may	  alter	   the	  MtuDAH7PS	   tetramer	  species,	  by	  altering	   the	  nature	  of	   the	  
interactions	  between	  MtuCM	  and	  MtuDAH7PS	  at	  the	  MtuCM•MtuDAH7PS	  interface,	  disfavouring	  the	  
interaction	   with	  MtuCM	   and/or	   activation	   of	  MtuCM	   activity.	   The	   crystallographic	   coordinates	   for	  
MtuDAH7PS	  show	  no	  obvious	  evidence	  of	  a	  twist	  in	  the	  conformation	  of	  the	  MtuDAH7PS	  tetramer	  as	  
a	   result	  of	  Phe	  binding,	  but	   subtle	  changes	   in	   conformation	  could	  be	  hidden	  due	   to	  crystal	  packing	  
effects.48,69,91	  Phe	  binding	  does	  cause	  a	  small	  shift	  in	  the	  β0-­‐strand	  of	  one	  subunit	  relative	  β0-­‐strand	  of	  
the	  other	  subunit	  across	  the	  dimer	  interface	  of	  MtuDAH7PS	  on	  Phe	  binding,	  which	  is	  best	  illustrated	  
by	  the	  relative	  positions	  of	  Trp3	  in	  each	  subunit	  (Figure	  8.1A).	  This	  shift	  may	  reflect	  a	  slight	  twist	  of	  
the	  two	  subunits	  across the	  dimer	  interface	  in	  the	  plane	  of	  the	  tetramer	  interface	  (Figure	  8.1B).	  48,69,91	  
Any	  twisting,	  even	  if	  only	  slight,	  at	  the	  dimer	  interface	  would	  probably	  change	  the	  interactions	  of	  the	  
tetramer	  interface	  and	  the	  overall	  tetramer	  conformation	  slightly.	  If	  substantial	  enough,	  this	  change	  
could	  be	  responsible	  for	  the	  reduced	  affinity	  of	  Phe-­‐bound	  MtuDAH7PS	  for	  MtuCM.	  	  
	  
However,	  the	  SAXS	  data	  presented	  in	  chapter	  2	  showed	  no	  evidence	  of	  MtuDAH7PSWT	  undergoing	  any	  
conformational	  change	  due	  to	  the	  addition	  of	  200	  µM	  Trp,	  Phe	  and	  Tyr.	  The	  change	  that	  occurred	  to	  
the	  SAXS	  profile	  for	  MtuDAH7PSN237A	  on	  the	  addition	  of	  Trp	  was	  described	  in	  Chapter	  6,	  prove	  that	  the	  
MtuDAH7PS	   tetramer	   is	   flexible	   and	   can	   change	   on	   ligand	   binding.	   The	   lack	   of	   change	   observed	  
between	  the	  SAXS	  profile	  for	  MtuDAH7PSWT	  with	  and	  without	  Trp,	  Phe	  and	  Tyr	  does	  not	  eliminate	  the	  
possibility	  a	  small	  conformational	  change	  is	  occurring.	  SAXS	  data	  with	  a	  better	  signal	  to	  noise	  may	  be	  
required	  to	  visualise	  such	  subtle	  changes	  in	  conformation.	  





Figure	  8.1	  A.	  The	  antiparallel	  β-­‐sheet	  formed	  between	  the	  β0-­‐strands	  of	  the	  two	  subunits	  of	  the	  dimer	  interface	  
of	  MtuDAH7PS	  shown	  in	  cartoon	  form.	  Phe	  binding	  causes	  the	  β0-­‐strand	  of	  one	  subunit	  to	  move	  by	  about	  one	  
peptide	  unit	  relative	  to	  the	  β0-­‐strand	  of	  the	  other	  subunit	  as	  illustrated	  by	  considering	  the	  relative	  positions	  of	  
Trp3	   on	   each	   β0-­‐strand.	   The	   dimer	   interface	   is	   located	   between	   the	   two	   subunits	   of	   the	   crystallographic	  
asymmetric	   unit.	   The	   side	   chain	   of	   Trp3	   shown	   in	   Teal	   has	   been	   modelled	   in	   by	   PyMol.	   Hypothetically	   this	  
movement	  could	  cause	  the	  dimer	  interface	  to	  twist	  slightly.	  The	  crystal	  structure	  from	  MtuDAH7PS	  bound	  with	  
Trp-­‐	  and	  Phe-­‐bound	  (PDB	  code:	  3KGF)	  has	  each	  subunit	  coloured	  red	  and	  blue	  and	  the	  unliganded	  MtuDAH7PS	  
crystal	  structure	  (PDB	  code:	  3NV8)	  has	  each	  subunit	  coloured	  orange	  and	  purple.	  Phe	  is	  shown	  as	  green	  spheres.	  
B.	  A	  schematic	  representation	  of	  the	  slight	  twist	  that	  may	  occur	  at	  the	  dimer	   interface	   in	  either	   in	  response	  to	  
Phe	  binding	  or	  in	  order	  for	  Phe	  to	  bind.	  This	  twist	  changes	  the	  dimer	  conformation,	  and	  therefore	  the	  tetramer	  
conformation,	   reducing	   MtuDAH7PS	   affinity	   for	   MtuCM.	   The	   dimeric	   subunit	   shown	   in	   orange	   an	   purple	  
represents	   unliganded	  MtuDAH7PS	   and	   the	   dimeric	   subunit	   shown	   in	   red	   and	  blue	   represents	   the	   Phe-­‐bound	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 Future	  directions	  8.5.
There	   are	   various	   options	   that	   could	   be	   pursued	   in	   order	   expand	   upon	   the	   research	   into	   the	  
regulation	   of	   MtuDAH7PS	   presented	   in	   this	   thesis.	   The	   three	   questions	   below	   are	   particularly	  
pertinent,	  and	  addressing	   these	  could	   significantly	  enhance	   the	  extent	  of	  our	  understanding	  of	   this	  
sophisticated	  regulatory	  system.	  
 Does	   a	   twist	   at	   the	   dimer	   interface	   of	  8.5.1.
MtuDAH7PS	  occur?	  
	  
The	  hypothesis	  that	  the	  dimeric	  interface	  of	  MtuDAH7PS	  undergoes	  a	  slight	  twist	  on	  Phe	  binding	  has	  
been	   proposed	   within	   this	   body	   of	   work.	   As	   yet	   no	   convincing	   evidence	   exists	   to	   support	   this	  
hypothesis,	   but	   there	   are	   several	   techniques	   that	   could	   be	   used	   in	   order	   to	   observe	   the	   twist	  
including	  19F,	  2H,	  and/or	  a	  combination	  of	  15N,	  13C	  and	  1H	  nuclear	  magnetic	  resonance	  (NMR),	  pulsed	  
electron-­‐electron	  double	  resonance	  (PELDOR)	  and	  fluorescence	  resonance	  energy	  transfer	  (FRET).150-­‐
152	   PELDOR	   is	   an	  electron	  paramagnetic	   resonance	   technique	  used	   to	  measure	   the	   strength	  of	   spin	  
coupling	  between	  spin	  labels	  to	  determine	  the	  distance	  between	  the	  spin-­‐labels.152	  A	  spin-­‐label	  would	  
need	  to	  be	  covalently	  attached	  to	  each	  MtuDAH7PS	  subunit	  near	  the	  dimer	  interface	  before	  PELDOR	  
could	  be	  carried	  out.	  FRET	  is	  a	  phenomenon	  that	  occurs	  when	  the	  emission	  and	  absorption	  spectra	  of	  
two	   different	   chromophores	   overlap.153,154	   The	   amount	   of	   FRET	   signal	   depends	   on	   the	   relative	  
orientation	  and	  distance	  between	  the	  chromophores,	  enabling	  the	  technique	  to	  be	  used	  as	  a	  highly	  
sensitive	   ‘spectroscopic	   ruler’.153,154	   FRET	   also	   requires	   each	   MtuDAH7PS	   subunit	   to	   be	   labelled,	  
covalently	  or	  non-­‐covalently,	  near	  the	  dimer	  interface	  with	  either	  a	  chromophore	  donor	  or	  acceptor.	  
The	   necessity	   of	   subunit	   labelling	   for	   both	   PELDOR	   and	   FRET	   is	   a	   distinct	   disadvantage,	   as	   this	  
modification	   risks	   disrupting	   or	   preventing	   ligand	   binding	   or	   the	  MtuDAH7PS	   quaternary	   structure	  
itself.	   The	   choice	   of	   label(s)	   and	   their	   placement	   will	   need	   to	   be	   carefully	   considered	   for	   either	  
technique.	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FRET	  and	  PELDOR	  could	  also	  be	  used	  to	  measure	  the	  interaction	  between	  MtuCM	  and	  MtuDAH7PS.	  
Monitoring	   changes	   that	   occur	   across	   the	  MtuCM•MtuDAH7PS	   on	   Phe	   binding	   could	   also	   reveal	   a	  
change	   in	  MtuDAH7PS	   tetramer	   conformation	   and	   confirm	   that	   Phe	  binding	  does	   cause	  MtuCM	   to	  
dissociate	  from	  MtuCM.	  
 How	  is	  the	  allosteric	  regulation	  of	  MtuDAH7PS	  8.5.2.
transmitted	   across	   the	   MtuCM•MtuDAH7PS	  
interface	  to	  MtuCM?	  
	  
This	  work	  has	  clearly	  established	  that	   the	  allosteric	  binding	  sites	  of	  MtuDAH7PS	  are	   responsible	   for	  
the	   regulation	   of	   MtuCM,	   and	   that	   occupancy	   at	   the	   allosteric	   binding	   sites	   of	   MtuDAH7PS	   is	  
transmitted	   along	   a	   network	   of	   residues	   to	   other	   allosteric	   sites	   and	   to	   the	  MtuCM•MtuDAH7PS	  
interface	   (MtuCM	  binding	   site).	   It	   is	   still	  unclear	  exactly	  which	   residues	  of	  MtuDAH7PS	  and	  MtuCM	  
are	   responsible	   for	   the	   transmission	   of	   the	   allosteric	   signal	   across	   the	   interface.	   The	  most	   obvious	  
candidates	   for	   investigation	   are	   the	   six	   residue	   pairs	   that	   form	   polar	   contacts	   across	   the	  
MtuCM•MtuDAH7PS	  interface.	  SDM	  and	  kinetic	  analysis	  could	  be	  used	  to	  evaluate	  the	  role	  of	  these	  
residues.	   However,	   changes	   in	   these	   residues	   risks	   completely	   disrupting	  MtuCM	  binding.	   SCA	   and	  
MD	  simulations	   could	  be	  used	   to	   identify	   alternative	   targets	   that	  perhaps	  do	  not	   form	  such	   crucial	  
interactions	  between	  MtuCM	  and	  MtuDAH7PS.	  
 Is	   the	   highly	   sophisticated	   allostery	   of	  8.5.3.
MtuDAH7PS	   a	   common	   feature	   of	   microbial	  
type	  II	  DAH7PS	  enzymes?	  
	  
MtuDAH7PS	   is	   currently	   the	   only	   structurally	   characterised	   type	   II	   DAH7PS	   and	   is	   by	   far	   the	   best	  
functionally	  characterised	  type	  II	  enzyme.	  A	  broader	  question	  to	  be	  considered	  is	  whether	  all	  type	  II	  
DAH7PS	   enzymes	   demonstrate	   synergistic	   allostery	   or	   form	   multienzyme	   complexes	   with	   other	  
enzymes	  of	   the	  aromatic	  amino	  acid	  biosynthetic	  pathway.	  This	  question	   is	  complicated	  by	  the	   fact	  
that	   many	   microbial	   organisms	   possess	   a	   combination	   of	   type	   I	   and	   type	   II	   DAH7PS,	   and/or	   may	  
possess	  multiple	  open	   reading	   frames	  encoding	   the	   type	   II	  DAH7PSs.70	  Often	   these	  organisms	  have	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DAH7PS	  enzymes	  that	  are	  associated	  with	  the	  production	  of	  secondary	  metabolites	  as	  well	  as	  for	  the	  
primary	   metabolism	   of	   the	   aromatic	   amino	   acids.70	   Thus	   investigation	   of	   a	   broad	   range	   of	   type	   II	  
DAH7PS	   enzymes	   from	   a	   variety	   of	   organisms,	   such	   as	   those	   listed	   below,	   is	   required	   to	   better	  
understand	  the	  functional	  and	  structural	  characteristics	  of	  the	  type	  II	  DAH7PS	  family	  and	  lead	  to	  the	  
classification	  of	  new	  sub-­‐types	  within	  the	  type	  II	  DAH7PS	  family.	  	  
	  
One	   of	   two	  DAH7PSs	   from	  C.	  glutamicum	   (CglDAH7PS)	   is	   a	   type	   II	   DAH7PS,	   and	   is	   reportedly	   only	  
inhibited	  by	  Trp.	  However,	  when	  CglDAH7PS	  forms	  a	  complex	  with	  the	  CM	  from	  the	  same	  organism	  
the	  CglDAH7PS	   activity	   is	   boosted	   and	   it	   is	   bestowed	  with	   additional	   sensitivity	   to	   prephenate.88-­‐90	  
This	   response	   appears	   to	   be	   a	   variation	   of	   the	   symbiotic	   regulation	   observed	   for	  MtuDAH7PS	   and	  
MtuCM.	  	  
	  
The	  type	  II	  DAH7PS	  from	  Helicobacter	  pylori	  (HpyDAH7PS)	  has	  also	  been	  functionally	  characterised	  by	  
members	   of	   the	   Parker	   research	   group.63	   Despite	   sharing	   a	   67	   %	   sequence	   similarity	   with	  
MtuDAH7PS,	  HpyDAH7PS	  is	  insensitive	  to	  the	  presence	  of	  any	  individual	  or	  combination	  of	  aromatic	  
amino	  acids.	   If	  HpyDAH7PS	   is	   allosterically	   inhibited,	   the	   right	  allosteric	   inhibitor	  or	   combination	  of	  
inhibitors	   is	   yet	   to	   be	   found.	   Further	   investigation	   of	   HpyDAH7PS	   is	   needed	   to	   assess	   whether	   a	  
binding	   partner	   is	   required	   for	   allosteric	   regulation	   such	   as	   HpyCM.	   Structural	   characterisation	   of	  
HpyDAH7PS	   could	   also	   determine	   whether	   it	   has	   allosteric	   binding	   sites	   that	   are	   similar	   to	  
MtuDAH7PS	  and	  therefore	  whether	  allosteric	  regulation	  would	  be	  expected.	  	  
	  	  
The	  genome	  of	  Pseudomonas	  aeruginosa	  also	  encodes	  for	  at	  least	  two	  DAH7PS	  enzymes,	  one	  of	  these	  
is	   a	   type	   II	   DAH7PS	   (PaeDAH7PS).70	   Sequence	   alignment	   shows	   PaeDAH7PS	   is	   missing	   part	   of	   the	  
sequence	   that	   aligns	   with	   the	   Trp	   binding	   site	   of	   MtuDAH7PS.70	   Functional	   and	   structural	  
characterisation	   of	   this	   PaeDAH7PS	   is	   yet	   to	   be	   undertaken.	   It	   is	   unlikely	   that	   PaeDAH7PS	   will	   be	  
synergistically	   regulated	   if	   it	   is	   truly	   lacking	   a	   Trp	   binding	   site,	   but	   could	   still	   form	   a	  multienzyme	  
complex	   as	   seen	   for	   CglDAH7PS	   and	   CglCM	   that	   bestows	   PaeDAH7PS	   with	   regulatory	   sensitivity.	  
PaeDAH7PS	   could	   also	   be	   involved	   with	   the	   biosynthesis	   of	   secondary	   metabolites	   and	   may	   be	  
subject	  to	  feedback	  regulation	  from	  different	  metabolites.	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 Concluding	  remarks	  8.6.
MtuDAH7PS	  exhibits	  a	  remarkably	  sophisticated	  regulatory	  mechanism	  that	  tightly	  controls	  not	  only	  
the	  activity	  of	  MtuDAH7PS	  itself,	  but	  also	  of	  its	  partner	  enzyme	  MtuCM.	  These	  studies	  have	  furthered	  
our	  understanding	  of	  the	  mechanism	  of	  allosteric	  regulation	  employed	  by	  MtuDAH7PS.	  Importantly,	  
these	  studies	  have	  started	  to	  address	  how	  MtuDAH7PS	   is	   regulated	  and	  how	  allosteric	  regulation	   is	  
communicated	  between	  the	  allosteric	   sites,	   to	   the	  active	  site	  and	   to	  MtuCM.	  This	  knowledge	  could	  
eventually	   contribute	   to	   the	   rational	   design	   of	   drugs	   that	  mimic	   allosteric	   effectors	   or	   disrupt	   the	  
allosteric	  regulation	  of	  the	  target	  enzyme.	  For	  MtuDAH7PS	  this	  could	  mean	  the	  development	  of	  anti-­‐
TB	  drugs	  that	  target	  its	  allosteric	  binding	  sites	  designed	  to	  inhibit	  both	  MtuDAH7PS	  and	  MtuCM.	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9. Experimental	  details	  
 General	  experimental	  9.1.
 Water	  9.1.1.
All	  buffers	  and	  solutions	  made	  using	  water	  filtered	  by	  Millipore	  Milli-­‐Q	  water	  system.	  Any	  water	  used	  
for	  the	  purpose	  of	  PCR	  was	  autoclaved	  prior	  to	  use.	  
 pH	  measurement	  9.1.2.
The	   pH	   of	   solutions	  was	   determined	   using	   a	   Denver	   Instruments	   UB-­‐10	  Ultra-­‐Basic	   pH	  meter	  with	  
either	  a	  standard	  or	  micro-­‐probe.	  The	  addition	  of	  either	  HCl	  or	  NaOH	  solution	  was	  used	  to	  adjust	  the	  
pH	  of	  the	  solutions	  if	  necessary,	  with	  the	  exceptions	  of	  buffers	  for	  CD	  where	  H2SO4	  was	  used	  in	  place	  
of	  HCl.	  
 Centrifugation	  9.1.3.
Centrifugation	  was	  performed	  by	  either	  Sorvall	  Evolution	  RC	  (Thermo	  Scientific),	  Heraeus	  Multifuge	  1	  
S-­‐R	  (Thermo	  Scientific)	  Heraeus	  Fresco	  17	  (Thermo	  Scientific)	  or	  a	  Minispin®	  Centrifuge	  (Eppendorf).	  
 Culture	  media	  9.1.4.
All	  E.	   coli	   cells	  were	   grown	   in	   Lysogeny-­‐Broth	   (LB).	   LB	  media	  was	   prepared	   by	   dissolving	   20	   g/L	   LB	  
(Lennox	   L)	   base	   in	   Milli-­‐Q	   water	   and	   sterilised	   by	   autoclaving	   at	   121	   ˚C,	   15	   psi	   for	   20	   min.	   The	  
appropriate	  antibiotics	  were	  added	  just	  prior	  to	  use.	  	  
	  
LB-­‐agar	  plates	  were	  prepared	  by	  dissolving	  20	  g/L	  LB	  (Lennox	  L)	  base	  and	  15	  g/L	  agar	  in	  Milli-­‐Q	  water	  
and	  sterilising	  by	  autoclaving	  at	  121	  ˚C,	  15	  psi	  for	  20	  min.	  The	  LB-­‐agar	  mixture	  was	  then	  heated	  in	  a	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microwave	  until	  boiling	  and	  left	  to	  cool	  in	  a	  60	  ˚C	  oven.	  The	  mixture	  was	  allowed	  to	  cool	  to	  ~50	  ˚C	  on	  
the	  bench	  and	  the	  appropriate	  antibiotics	  were	  added	  just	  prior	  to	  pouring	  the	  plates	  into	  round	  petri	  
dishes	  and	  allowing	  to	  set.	  Plates	  were	  stored	  for	  up	  to	  a	  week	  at	  4	  ˚C.	  
 Antibiotic	  stocks	  9.1.5.
Stock	  solutions	  of	  ampicillin	  and	  chloramphenicol	  were	  prepared	  and	  stored	  at	  -­‐80	  ˚C.	  Ampicillin	  (100	  
mg/mL)	  was	  prepared	  in	  Milli-­‐Q	  water	  and	  chloramphenicol	  (50	  mg/mL)	  was	  made	  in	  ~95	  %	  ethanol	  
(analytical	  grade).	  
 	  Generation	  of	  protein	  structure	  figures	  9.1.6.
Figures	  of	  protein	  structures	  were	  created	  using	  PyMOL	  (version	  1.5,	  Schrödinger	  LLC).155 
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 Site-­‐directed	  mutagenesis	  and	  transformations	  9.2.
 Primers	  9.2.1.
Primers	  were	  designed	  using	  the	  QuikChange®	  Primer	  Design	  Tool	  (Agilent	  technologies)	  (Table	  9.1)	  
and	  synthesised	  by	  Invitrogen.	  Primers	  were	  stored	  at	  300	  mM	  in	  autoclaved	  Milli-­‐Q	  water. 
Table	  9.1	  Sequence	  of	  primers	  designed	  for	  site-­‐directed	  mutagenesis.	  
Substitution	   Strand	   Primer	  Sequence	  5’g3’  
Arg171Ala	   sense	   gtcgcggctggtcgcggcttacgctaac	  
	   antisense	   gttagcgtaagccgcgaccagccgcgac	  
Arg256Ala	   sense	   gtgctcgactacgaggccgccatgttgaggtt	  
	   antisense	   aacctcaacatggcggcctcgtagtcgagcac	  
Gly190Pro	   sense	   gctgacttcgtcgcccctggcgtcgctg	  
	   antisense	   cagcgacgccaggggcgacgaagtcagc	  
Val103Ala	   sense	   catattcggggcaatgcccgtgccttgttgcag	  
	   antisense	   ctgcaacaaggcacgggcattgccccgaatatg	  
Tyr131Ala	   sense	   catcgccggtcaggccgcgaagcctcgg	  
	   antisense	   ccgaggcttcgcggcctgaccggcgatg	  
Asn175Ala	   sense	   gctggtccgggcttacgctgccgccagtgcg	  
	   antisense	   cgcactggccggcagcgtaagcccggaccagc	  
Lys123Met	   sense	   cagcatgccagtggtgatggtggcccg	  
	   antisense	   cgggccaccatcaccactggcatgctg	  
Asn237Ala	   sense	   ggcggtctgtagagcgcggtcggccacc	  
	   antisense	   ggtggccgaccgcgctctacagaccgcc	  
Gly232Pro	   sense	   gcggttcatgagtgcctgtccggtggccgac	  
	   antisense	   gtcggccaccggacaggcactcatgaaccgc	  
Phe227Asp	   sense	   ccacaggcactcatgtcccgcagcccacgatc	  
	   antisense	   gatcgtgggctgcgggacatgagtgcctgtgg	  
 Site-­‐directed	  mutagenesis	  9.2.2.
Site-­‐directed	   mutagenesis	   (SDM)	   was	   used	   to	   introduce	   amino	   acid	   substitutions	   into	   the	  
pProExHta-­‐MtuDAH7PS	  plasmid.	  The	  mutagenesis	  was	  performed	  using	  the	  QuickChange®	  Lightning	  
Site-­‐Directed	  Mutagenesis	   Kit	   (Stratagene)	   following	   the	  manufacturers	   recommended	   protocol	   for	  
50	   µL	   reactions.	   For	   MtuDAH7PS	   containing	   a	   single	   amino	   acid	   substitution	   the	   pProExHta-­‐
MtuDAH7PS	  plasmid	  was	  used	  as	  the	  DNA	  template.	  To	  generate	  the	  double	  amino	  acid	  substituted	  
MtuDAH7PSG190P/G232P	   the	  pProExHta-­‐MtuDAH7PSG190P	  plasmid	  was	  used	  as	   the	   template.	   The	   single	  
amino	   acid	   substitutions	   were	   introduced	   using	   synthetic	   oligonucleotide	   primers.	   These	   primers	  
were	  used	   to	   amplify	   the	  whole	  plasmid	   via	   a	   thermocycling	   reaction	  performed	  using	   a	  Veriti®96-­‐
well	   Thermal	   Cycler	   (Applied	   Biosystems).	   After	   thermocycling	   the	   SDM	   product	   was	   treated	   with	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Dpn1	  (Stratagene)	  for	  5	  min	  at	  37	  ˚C	  to	  digest	  the	  template	  DNA.	  The	  Dpn1	  treated	  SDM	  product	  was	  
then	  transformed	  into	  E.	  coli	  OneShot	  Top10	  cells	  (Invitrogen)	  for	  storage.	  For	  protein	  expression	  the	  
SDM	  products	  for	  the	  MtuDAH7PS	  variants	  were	  transformed	  into	  E.	  coli	  BL21(DE3)	  pGroESL	  cells. 
 Agarose	  gel	  electrophoresis	  9.2.3.
Either	  pre-­‐cast	  E-­‐Gel®	  1.2	  %	  (w/v)	  agarose	  gels	  (Invitrogen)	  or	  self-­‐cast	  1	  %	  agarose	  gels	  were	  used	  for	  
agarose	   gel	   electrophoresis.	   Reaction	  products	  were	   loaded	  on	   to	   E-­‐Gel’s®	  without	   dye	   and	   run	   as	  
directed	  by	   the	  manufacturer.	  The	  E-­‐Gel®	  was	   run	  and	  monitored	  with	  an	  E-­‐Gel	  R	   iBaseTM	  and	  Safe	  
ImagerTM	  (Invitrogen).	  
	  
	  Self-­‐cast	  1	  %	  agarose	  gels	  were	  prepared	  by	  heating	  0.3	  g	  of	  agarose	   in	  30	  mL	  of	  tris-­‐acetate-­‐EDTA	  
(TAE)	  buffer	  until	  dissolved.	  The	  solution	  was	  then	  cooled	  ~50	  ˚C	  before	  adding	  SYBR	  Safe®	  DNA	  stain,	  
poured	  into	  a	  mould	  and	  allowed	  to	  set.	  For	  the	  self-­‐cast	  gels	  samples	  were	  prepared	  by	  adding	  a	  6x	  
sample	  loading	  buffer.	  Electrophoresis	  performed	  using	  a	  Mini-­‐Sub®	  Cell	  GT	  (Bio-­‐Rad).	  Samples	  were	  
run	  in	  TAE	  buffer	  for	  60	  min	  at	  80	  V.	  Gel	  bands	  were	  visualised	  and	  photographed	  under	  UV	  light	  with	  
a	  Molecular	  Imager®	  Gel	  DocTM	  XR	  (BioRad).	  
	  
TAE	  buffer:	  
	   60	  mM	  Tris-­‐HCl,	  1	  mM	  EDTA,	  20	  mM	  acetic	  acid.	  
Sample	  loading	  dye	  (6x):	  
	   60	  mM	  Tris-­‐HCl,	  60	  mM	  EDTA,	  0.2	  %	  (w/v)	  orange	  G,	  0.05	  %	  (w/v)	  xylene	  cyanol	  ff	  and	  60	  %	  
(v/v)	  glycerol.	  
 Chemical	  transformation	  of	  E.	  coli	  cells	  9.2.1.
Prior	   to	   the	   transformation	   the	   chemically	   competent	   cells	   were	   allowed	   to	   thaw	   on	   ice.	  
Transformations	   were	   carried	   out	   by	   gently	   mixing	   2	   µL	   of	   Dpn1	   treated	   mutagenesis	   product	  
(40-­‐80	  ng/µL))	  with	  50	  µL	  of	   chemically	   competent	   cells	   and	   incubating	  on	   ice	   for	  30	  min.	   The	   cells	  
were	  heat-­‐shocked	  at	  42	  ˚C	  for	  ~35	  s	  and	  then	  incubated	  on	  ice	  for	  a	  further	  2	  min.	  200	  µL	  of	  super	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optimal	  broth	  (SOC)	  medium	  was	  added	  to	  the	  cells,	  mixed	  gently	  and	  incubated	  at	  37	  ˚C	  for	  1	  h.	  The	  
cells	   were	   then	   spread	   on	   LB-­‐agar	   plates	   containing	   the	   appropriate	   antibiotics	   for	   antibiotic-­‐
resistance	   selection.	   The	   plates	   were	   incubated	   overnight	   at	   37	   ˚C.	   E.	  coli	   Oneshot	   Top10	   cells	  
(Invitrogen)	  were	  used	  for	  plasmid	  storage	  and	  propagation,	  and	  E.coli	  BL21(DE3)	  cells	  were	  used	  for	  
the	  expression	  of	  MtuCM.	  
	  
SOC	  medium:	  
	   2	  %	  (w/v)	  tryptone,	  0.5%	  (w/v)	  yeast	  extract,	  10	  mM	  NaCl,	  2.5	  mM	  KCl,	  10	  mM	  MgSO4	  and	  20	  
mM	  glucose.	  
 Preparation	  of	  chemically	  competent	  cells	  9.2.2.
Chemically	  competent	  cells	  were	  prepared	  by	  inoculating	  a	  5	  mL	  LB	  culture	  from	  a	  glycerol	  stock	  of	  
the	  desired	  cell	  line	  and	  grown	  overnight	  at	  37	  ˚C	  with	  the	  appropriate	  antibiotics	  if	  applicable.	  2	  mL	  
from	  this	  culture	  was	  used	  to	  inoculate	  a	  100mL	  LB	  culture,	  with	  the	  appropriate	  antibiotics	  added,	  
grown	  at	  37	  ˚C	  until	  the	  culture	  reached	  an	  optical	  density	  at	  600	  nm	  (OD600)	  between	  0.3-­‐0.4.	  The	  
culture	  was	  then	  transferred	  to	  a	  sterile	  50	  mL	  tube	  and	  centrifuged	  at	  2000	  g,	  4	  ˚C	  for	  15	  min.	  All	  
plasticware	  and	  solutions	  used	  here	  on	  were	  pre-­‐chilled	  and	  kept	  on	  ice	  in	  order	  to	  maintain	  cell	  
health	  until	  the	  cells	  were	  flash	  frozen.	  After	  centrifugation	  the	  media	  was	  poured	  off	  and	  discarded.	  
The	  cells	  were	  carefully	  resuspended,	  on	  ice,	  in	  50	  mL	  of	  sterile	  0.1	  M	  CaCl2	  and	  incubated	  on	  ice	  for	  
30	  min.	  Cells	  were	  then	  centrifuged	  again	  at	  4000	  rpm,	  4	  ˚C	  for	  15	  min	  and	  the	  supernatant	  discarded.	  
The	  cell	  pellet	  was	  gently	  resuspended	  in	  5	  mL	  0.1	  M	  CaCl2	  and	  incubated	  for	  a	  further	  2	  h	  on	  ice	  
before	  being	  gently	  mixed	  with	  pre-­‐	  chilled	  sterile	  60%	  (v/v)	  glycerol	  to	  a	  final	  concentration	  of	  15%	  
(v/v).	  The	  cells	  were	  then	  pipetted	  into	  50	  µL,	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  ˚C.	  
 Electroporation	   of	   E.coli	   BL21	   (DE3)	   pGroESL	  9.2.1.
cells	  
	  
Prior	  to	  electroporation	  the	  electro-­‐competent	  E.	  coli	  BL21	  (DE3)	  pGroESL	  cells	  were	  thawed	  on	  ice.	  
Once	  thawed	  the	  cells	  were	  gently	  mixed	  with	  2	  µL	  (40-­‐80	  ng/mL)	  of	  the	  Dpn1	  treated	  mutagenesis	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product	  and	  transferred	  into	  a	  chilled	  0.2	  cm	  gap	  electroporation	  cuvette	  (BioRad).	  The	  mixture	  was	  
incubated	  on	  ice	  for	  2	  min	  before	  electroporation	  was	  performed	  using	  a	  BioRad	  Gene	  Pulser	  (200	  Ω,	  
25	  µF	  2.5	  kV)	  with	  a	  time	  constant	  of	  ~4.6	  ms.	  500	  µL	  of	  SOC	  media	  was	   immediately	  added	  to	  the	  
cuvette	   and	   gently	  mixed.	   The	   cells	  were	   then	   transferred	   to	   a	   sterile	   1.5	  mL	   Eppendorf	   tube	   and	  
incubated	   at	   37	   ˚C	   for	   1	   h.	   The	   cells	   were	   then	   spread	   onto	   pre-­‐warmed	   LB-­‐agar	   plates	   with	   the	  
appropriate	  antibiotics	  (100	  µg/mL	  ampicillin	  and	  25	  µg/mL	  chloramphenicol)	  and	  incubated	  at	  37	  ˚C	  
overnight.	  
 Preparation	   of	   E.coli	   BL21	   (DE3)	   pGroESL	  9.2.2.
electro-­‐competent	  cells	  
	  
Electro-­‐competent	  BL21	  (DE3)	  pGroESL	  cells	  were	  prepared	  by	  inoculating	  a	  5	  mL	  preculture	  (with	  25	  
µg/mL	   chloramphenicol)	   with	   a	   scraping	   from	   a	   BL21	   (DE3)	   pGroESL	   cell	   glycerol	   stock	   and	   left	   to	  
grow	  overnight	  at	  37	  ˚C.	  2	  mL	  from	  this	  culture	  was	  then	  used	  to	  inoculate	  a	  100	  mL	  LB	  culture	  (with	  
25	  µg/mL	  chloramphenicol),	  which	  was	  grown	  at	  37	  ˚C	  until	  the	  OD600	  reached	  ~0.5.	  The	  culture	  was	  
then	  transferred	  to	  a	  sterile	  falcon	  tube	  and	  centrifuged	  at	  6400	  g,	  4	  ˚C	  for	  5	  min.	  All	  plasticware	  and	  
solutions	  used	  here	  on	  were	  pre-­‐chilled	  and	  kept	  on	  ice	  in	  order	  to	  maintain	  cell	  health	  until	  the	  cells	  
were	  flash	  frozen.	  	  The	  supernatant	  was	  discarded,	  and	  the	  cells	  gently	  resuspended	  in	  100	  mL	  chilled	  
and	  sterile	  1	  mM	  HEPES	  pH	  7.0	  buffer.	  The	  cells	  were	  centrifuged	  again	  at	  6400	  g,	  4	  ˚C	  for	  5	  min,	  the	  
supernatant	  discarded	  and	  the	  cell	  pellet	  resuspended	  in	  50	  mL	  chilled	  HEPES	  buffer.	  The	  cells	  were	  
centrifuged	  again	  at	  6400	  g,	  4	  ˚C	  for	  5	  min,	  the	  supernatant	  discarded	  and	  the	  cell	  pellet	  resuspended	  
in	  4	  mL	  cold	  sterile	  glycerol	  (10	  %	  (v/v)).	  The	  cells	  were	  centrifuged	  for	  the	  final	  time	  at	  7700	  g,	  4	  ˚C	  
for	  10	  min	  and	  the	  supernatant	  discarded.	  The	  cell	  pellet	  was	  resuspended	  in	  500	  µL	  of	  glycerol	  (10	  %	  
(v/v))	  and	  pipetted	  into	  50	  µL	  aliquots,	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  ˚C.	  
 Plasmid	  preparation	  and	  isolation	  9.2.3.
When	  required	  for	  DNA	  sequencing	  or	  for	  transformations	  plasmids	  were	  extracted	  and	  purified	  from	  
5	  mL	  LB	  cultures.	  The	  5	  mL	  cultures	  were	  inoculated	  with	  E.	  coli	  OneShot	  Top10	  cells	  containing	  the	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target	  plasmid	  and	  grown	  overnight	  at	  37	  ˚C.	  3	  mL	  of	  the	  incubated	  cultures	  were	  harvested	  for	  the	  
cells	  by	  centrifuging	  in	  sterile	  1.5	  mL	  Eppendorf	  tubes	  at	  17000	  g	  for	  1	  min	  at	  room	  temperature.	  The	  
supernatant	  was	  discarded.	  The	  plasmids	  were	  extracted	  and	  purified	  from	  the	  cells	  using	  a	  High	  Pure	  
Plasmid	   Isolation	   Kit	   (Roche)	   by	   following	   the	   manufacturer’s	   procedure.	   Isolated	   plasmids	   were	  
stored	  at	  -­‐20	  ˚C.	  
 DNA	  sequencing	  9.2.4.
DNA	  sequencing	  services	  were	  provided	  by	  Canterbury	  Sequencing,	  and	  performed	  using	  an	  ABI3100	  
Genetic	   Analyser	   (Applied	   Systems	   Inc.)	   and	   following	   a	   procedure	   derived	   from	   the	   Sanger	   chain	  
termination	   protocol.	   Double	   stranded	   plasmid	   samples	   were	   prepared	   in	   6	   µL	   aliquots	   at	   40-­‐50	  
ng/mL	  per	  sequencing	  run.	  Generic	  pPro	  (sense	  and	  antisense)	  primers	  were	  used	  for	  sequencing	  at	  
concentration	  of	  3.2	  mM.	  
 Glycerol	  stocks	  9.2.5.
In	   order	   to	   maintain	   a	   viable	   cell	   stock,	   E.	   coli	   cells	   transformed	   with	   MtuDAH7PS	   or	   MtuCM	  
containing	   plasmids	   were	   stored	   at	   -­‐80	   ˚C	   as	   glycerol	   stocks.	   Glycerol	   stocks	   were	   prepared	   by	  
inoculating	  a	  5	  mL	  culture,	  with	  appropriate	  antibiotics,	  with	  the	  desired	  E.	  coli	  cells.	  The	  5	  mL	  culture	  
was	   incubated	   overnight	   at	   37	   ˚C.	   800	   µL	   of	   this	   culture	  was	  mixed	  with	   400	   µL	   sterile	   50	  %	   (v/v)	  
glycerol	  in	  a	  sterile	  1.5	  mL	  Eppendorf	  tube	  and	  flash	  frozen	  with	  liquid	  nitrogen	  prior	  to	  storage.	  
 E.	  coli	  cell	  growth,	  induction	  and	  harvesting	  9.3.
 Growth	  of	  E.	  coli	  cells	  9.3.1.
E.	  coli	  BL21	  (DE3)	  cells	  containing	  the	  plasmid	  encoding	  the	  gene	  for	  MtuCM	  were	  ampicillin	  resistant,	  
whist	   E.	   coli	   BL21	   (DE3)	   pGroESL	   cells	   containing	   the	   pPro	   Ex-­‐Hta	   plasmid	   encoding	   the	   gene	   for	  
MtuDAH7PS	  were	  resistant	  to	  ampicillin	  and	  chloramphenicol.	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100	   mL	   LB	   cultures	   containing	   the	   appropriate	   antibiotics	   (ampicillin	   (100	   µg/mL)	   and/or	  
chloramphenicol	  (25	  µg/mL))	  were	  inoculated	  with	  scraping	  from	  the	  appropriate	  glycerol	  stock	  and	  
grown	   overnight	   at	   37	   ˚C	   with	   shaking	   at	   170-­‐180	   rpm.	   25	  mL	   of	   this	   small	   culture	   was	   used	   to	  
inoculate	  1L	  of	  LB	  media	  cultures	  containing	  ampicillin	  (100	  µg/mL)	  and	  chloramphenicol	  (25	  µg/mL)	  
in	  2-­‐3	  L	  baffled	  flasks.	  Typically	  4L	  of	  culture	  was	  prepared	  and	  grown	  at	  37	  ˚C,	  with	  shaking	  at	  170-­‐
180	  rpm	  until	  the	  OD600	  reached	  0.4-­‐0.6,	  which	  usually	  took	  about	  3	  h.	  The	  temperature	  was	  lowered	  
to	  23	  ˚C	  20-­‐30	  min	  before	  induction.	  
 Induction	  of	  protein	  expression	  9.3.2.
A	   physiological	   analogue	   of	   lactose	   isopropyl	   β-­‐D-­‐1-­‐thiogalactopyranoside	   (IPTG)	  was	   added	   to	   the	  
cell	   culture	   to	   activate	   the	   lac	   promoter,	   thereby	   activating	   gene	   expression	   of	   the	   target	   protein	  
(MtuCM	  or	  MtuDAH7PS).	  IPTG	  was	  added	  to	  the	  1L	  cultures	  to	  give	  a	  final	  concentration	  of	  0.1	  mM	  
for	  the	  expression	  of	  MtuDAH7PS	  from	  E.	  coli	  BL21	  (DE3)	  pGroESL	  cells	  and	  0.5	  mM	  for	  the	  expression	  
of	  MtuCM	  from	  E.	  coli	  BL21	  (DE3)	  cells.	  The	  induced	  cultures	  were	  incubated	  at	  23	  ˚C	  overnight,	  with	  
shaking	  at	  170-­‐180	  rpm,	  overnight.	  
 Cell	  harvesting	  	  9.3.3.
Cell	   cultures	   were	   harvested	   in	   1	   L	   flasks	   by	   centrifugation	   at	   14000	   g	   for	   20	   min	   at	   4	   ˚C.	   The	  
supernatant	  was	  discarded	  and	  the	  cell	  pellet	  scraped	  out	  of	  the	  flasks	  and	  either	  immediately	  lysed	  
or	  stored	  at	  -­‐80	  ˚C	  until	  needed.	  
 General	  purification	  experimental	  9.4.
 Fast	  protein	  liquid	  chromatography	  (FPLC)	  9.4.1.
FPLC	   was	   carried	   out	   using	   either	   the	   Bio-­‐Rad	   Biologic	   Duoflow	   or	   GE	   Healthcare	   AKTApurifierTM	  
protein	  chromatography	  systems	  at	  4	  ˚C	  unless	  otherwise	  stated.	  All	  buffers,	  solvents	  and	  samples	  for	  
FPLC	  were	  filtered	  through	  a	  0.2	  µM	  filter	  just	  prior	  to	  use.	  Samples	  were	  applied	  to	  columns	  using	  a	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10	  or	  50	  mL	  SuperloopTM	  (GE	  Healthcare).	  Sample	  elution	  was	  monitored	  at	  both	  260	  and	  280	  nm	  and	  
identified	  peaks	  assessed	  by	  SDS-­‐PAGE	  to	  determine	  if	  the	  protein	  of	  interest	  was	  present.	  	  
 Preparation	  of	  TEV	  protease	  9.4.2.
Recombinant	   Tobacco	   etch	   virus	   (TEV)	   protease	   156	   was	   purified	   from	   E.	   coli	   BL21	   (DE3)	   cells	  
containing	   the	   plasmids	   pRIL	   and	   pRK793.	   pRIL	   allows	   E.	   coli	   to	   better	   produce	   rare	   codons	   and	  
pRK793	   encodes	   for	   TEV	   protease.	   A	   scraping	   of	   these	   cells	  was	   used	   to	   grow	   a	   50	  mL	   LB	   culture,	  
containing	  ampicillin	  (100	  µg/mL)	  and	  chloramphenicol	  (25	  µg/mL),	  overnight	  at	  37	  ˚C	  with	  shaking	  at	  
170-­‐180	   rpm.	   1	  L	   of	   LB,	   containing	   ampicillin	   (100	   µg/mL)	   and	   chloramphenicol	   (25	   µg/mL),	   was	  
inoculated	  with	  about	  20	  mL	  of	   this	   small	   culture	  and	  grown	  at	  37	   ˚C	  with	   shaking	  at	  170-­‐180	   rpm	  
until	  the	  OD600	  was	  ~0.6.	  The	  E.	  coli	  cells	  were	  then	  induced	  IPTG	  (final	  concentration	  0.5	  mM),	  and	  
incubated	  overnight	  at	  23	  ˚C	  with	  shaking	  at	  170-­‐180	  rpm.	  
	  
Cells	  were	  then	  harvested,	  resuspended	  in	  TEV	  HisTrap	  A	  buffer	  and	  lysed	  by	  sonication	  as	  described	  
later	   for	  MtuDAH7PS	   (Section	   9.5.1).	   The	   TEV	   protease	   was	   then	   purified	   from	   the	   soluble	   E.	  coli	  
proteins	  by	  a	  single	  IMAC	  step	  using	  a	  5	  mL	  HisTrapTM	  HP	  column	  (GE	  Healthcare).	  The	  procedure	  for	  
the	   IMAC	  was	   the	   same	   as	   previously	   described	   for	  MtuDAH7PS	  using	   a	   linear	   gradient	   for	   elution	  
except	   TEV	  HisTrap	  A	   and	  B	  buffers	  were	  used.	   The	   eluted	   fractions	   containing	   TEV	  protease	  were	  
pooled	  and	  buffer	  exchanged	   into	  TEV	  storage	  buffer	  and	  concentrated	   to	  ~	  1	  mg/mL	  before	  being	  
flash	  frozen	  in	  liquid	  nitrogen	  in	  1	  mL	  aliquots	  and	  stored	  at	  -­‐80	  ˚C.	  
	  
TEV	  HisTrap	  A	  buffer:	  
50	  mM	  potassium	  phosphate,	  500	  mM	  KCl,	  25	  mM	  imidazole	  and	  10	  %	  (v/v)	  glycerol	  at	  pH	  
8.0	  
	  
TEV	  HisTrap	  B	  buffer:	  
	   50	  mM	  potassium	  phosphate,	  500	  mM	  KCl,	  500	  mM	  imidazole	  and	  10	  %	  (v/v)	  glycerol	  at	  pH	  
8.0	  
	  
TEV	  storage	  buffer:	  
	   25	   mM	   potassium	   phosphate,	   200	   mM	   KCl,	   10	   mM	   dithiothreitol	   (DTT),	   2	   mM	  
ethylenediaminetetraacetic	  acid	  (EDTA)	  and	  10	  %	  (v/v)	  glycerol	  at	  pH	  8.0	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 Determination	  of	  MtuDAH7PS	  concentration	  9.4.3.
	  
The	  concentration	  of	  protein	  samples	  was	  measured	  using	  a	  Nanodrop	  ND-­‐1000	  spectrophotometer.	  
The	   concentration	   was	   calculated	   from	   the	   absorbance	   at	   280	   nm	   using	   the	   molar	   extinction	  
coefficient	   determined	   for	   each	   protein.	   The	   molar	   extinction	   coefficients	   for	   each	   protein	   were	  
determined	  from	  the	  protein	  sequences	  using	  the	  ProtParam	  tool	  on	  the	  ExPASy	  Proteomics	  Server	  
(Table	  9.2).157	  The	  molar	  extinction	  coefficient	  determined	  for	  MtuDAH7PSWT	  was	  used	  to	  assess	  the	  
concentration	  of	  all	  MtuDAH7PS	  variants,	  as	  the	  single	  or	  double	  residue	  substitutions	  were	  found	  to	  
have	  a	  negligible	  effect	  on	  the	  calculated	  molar	  extinction	  coefficient.	  	  
	  
Table	   9.2	  Molar	  extinction	  coefficients	  determined	   for	  MtuDAH7PS	  and	  MtuCM	  at	  280	  nm	  measured	   in	  water	  
using	  the	  ProtParam	  tool	  on	  the	  ExPASy	  Proteomics	  Server.157	  
Protein	   Molar	  extinction	  coefficient	  
M-­‐1cm-­‐1	  
MtuDAH7PS	   41160	  
MtuCM	   1490	  
	  
 Determination	  of	  MtuCM	  concentration	  9.4.4.
Due	   to	   the	   low	   molar	   extinction	   coefficient	   of	   MtuCM	   there	   is	   a	   large	   error	   associated	   with	  
spectroscopic	  determination	  of	  protein	  concentration.	  As	  an	  alternative	  the	  concentration	  of	  MtuCM	  
samples	  were	  determined	  by	  the	  method	  of	  Bradford,	  using	  bovine	  serum	  albumin	  as	  a	  standard.158	  
20	  µL	  of	  protein	  sample	  was	  added	  to	  1	  mL	  of	  Bradford	  agent	  pre-­‐equilibrated	  to	  room	  temperature.	  
Samples	  were	  then	  gently	  shaken	  and	  incubated	  at	  room	  temperature	  for	  5	  min	  prior	  to	  absorbance	  
readings	  at	  595	  nm	  being	  taken	  in	  triplicate.	  The	  absorbance	  readings	  of	  the	  standards	  were	  plotted	  
by	  Cary	  UV	  software,	  the	  software	  also	  calculated	  the	  protein	  concentration	  of	  the	  sample	  by	  fitting	  
to	  the	  curve	  produced	  by	  bovine	  serum	  albumin.	  
	  
Contamination	   of	  MtuCM	   samples	  with	   a	   small	   portion	   of	   GST-­‐tag	   results	   in	   the	   Bradford	  method	  
overestimating	   the	  concentration	  of	  MtuCM.	  To	  adjust	   for	   this	  contamination	   the	  kinetic	  activity	  of	  
each	   purification	   batch	   of	  MtuCM	   was	   also	   determined	   and	   the	   concentration	   normalised	   to	   the	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activity	  of	  a	  highly	  pure	  preparation	  of	  MtuCM	  (as	  shown	  by	  SDS-­‐PAGE)	  used	  as	  a	  standard.	  Kinetic	  
assays	  were	   conducted	  with	   a	   final	   concentration	  of	  MtuCM	  of	  1	  ng/mL	   in	   kinetic	   assay	  buffer	   (50	  




NuPAGE®	   10%	   Bis-­‐Tris	   1mm	   x	   12-­‐well	   pre-­‐cast	   gels	   (Invitrogen)	   were	   used	   for	   Sodium	   dodecyl	  
sulphate-­‐polyacrylamide	   (SDS-­‐PAGE).	   SDS-­‐PAGE	   was	   performed	   using	   an	   XCell	   SureLockTM	  
Electrophoresis	  Cell	  (Invitrogen).	  Protein	  samples	  were	  mixed	  with	  NuPAGE®	  LDS	  Sample	  Buffer	  (4x)	  
and	   DTT,	   centrifuged	   to	   mix	   and	   placed	   in	   boiling	   water	   for	   5	   min	   before	   loading	   onto	   a	   gel.	  
Electrophoresis	   of	   MtuDAH7PS	   protein	   samples	   was	   conducted	   in	   NuPAGE®	   MOPS	   SDS	   Running	  
Buffer	   (Invitrogen)	   and	   run	   at	   200	   V	   for	   50	   min.	   Electrophoresis	   of	  MtuCM	   protein	   samples	   was	  
conducted	  in	  NuPAGE®	  MES	  SDS	  Running	  Buffer	  (Invitrogen)	  and	  run	  at	  200	  V	  for	  35	  min.	  A	  sample	  of	  
the	   Novex®	   Sharp	   Pre-­‐Stained	   Protein	   Standards	   was	   included	   on	   each	   SDS-­‐PAGE	   gel	   for	   the	  
determination	  of	  the	  molecular	  weight	  of	  protein	  bands.	  
 Visualisation	  of	  PAGE	  gels	  9.4.6.
Gels	  were	  stained	  by	  heating	   in	  microwave	  oven	  on	  high	   for	  ~1	  min	   in	  a	  staining	  solution	  and	  then	  
shaken	  for	  15-­‐30	  min	  at	  room	  temperature.	  Gels	  were	  then	  rinsed	  in	  water	  and	  placed	  in	  destaining	  
solution,	  heated	  for	  1	  min	  in	  the	  microwave	  oven	  on	  high	  for	  ~	  1	  min	  and	  shaken	  for	  1-­‐2	  hours	  or	  until	  
sufficiently	  destained	  at	  room	  temperature	  before	  being	  rinsed	  with	  water	  and	  stored	  in	  water.	  Gels	  
were	  viewed	  and	  imaged	  with	  a	  Molecular	  Imager	  Gel	  Doc	  XR	  (Bio-­‐Rad).	  
	  
Staining	  solution:	  




	   40	  %	  (v/v)	  methanol	  and	  10	  %	  (v/v)	  glacial	  acetic	  acid.	  
9	   Experimental	  
	  
264	  
 Protein	  concentration	  and	  buffer	  exchange	  9.4.7.
MtuDAH7PS	  protein	  solutions	  were	  concentrated	  using	  10000	  Da	  molecular	  weight	  cut-­‐off	   (MWCO)	  
devices,	   and	  MtuCM	   protein	   solutions	   were	   concentrated	   using	   5000	  Da	   MWCO	   (Vivaspin	   2	   (GE	  
Healthcare)	  or	  Vivaspin	  500	  or	  Vivaspin	  20	  (Sartorius	  Stedim	  Biotech)	  or	  Amicon®	  Ultra-­‐4	  (Millipore)).	  
Concentrators	  were	  rinsed	  with	  Milli-­‐Q	  water	  prior	  to	  use.	  
	  
Buffer	  exchange	  of	  protein	  solutions	  was	  achieved	  by	  concentrating	  a	  sample	  volume	  to	  ~5	  mL	  and	  
diluting	  to	  ~18	  mL	  with	  desired	  buffer	  and	  repeating	  until	  the	  percentage	  of	  old	  buffer	  in	  solution	  was	  
less	  than	  5	  %.	  
 Purification	  of	  MtuDAH7PS	  and	  MtuDAH7PS	  variants	  9.5.
 Cell	  lysis	  9.5.1.
Harvested	  cells	  were	  thoroughly	  resuspended	   in	  10	  mL	  of	  cold	   lysis	  buffer	  per	  1	  g	  of	  cell	  pellet	  and	  
then	  either	  lysed	  by	  sonication	  or	  cell	  disruption.	  Cell	  disruption	  was	  found	  to	  achieve	  more	  reliable	  
and	   complete	   cell	   lysis	   and	  was	   used	  preferentially	   for	   the	   lysis	   of	  E.	   coli	   BL21	   (DE3)	   pGroESL	   cells	  
containing	  the	  plasmid	  for	  MtuDAH7PS.	  
	  
Sonication	   was	   performed	   on	   ice,	   using	   an	   Omni-­‐Ruptor	   4000	   Ultrasonic	   Homogenizer	   (Omni	  
International).	   Sonication	   was	   conducted	   for	   5	   min	   intervals	   at	   ~35	   %	   pulse,	   80-­‐90	   %	   power	   and	  
repeated	   4-­‐6	   times	   with	   a	   2-­‐5	   5	   min	   wait	   between	   cycles	   to	   reduce	   the	   risk	   of	   over-­‐heating	   the	  
sample.	  
	  
Prior	  to	  cell	  disruption	  the	  resuspended	  cells	  were	  incubated	  with	  2	  µL	  of	  benzonase	  for	  5	  min.	  Cell	  
disruption	   was	   performed	   by	   passing	   the	   resuspended	   cells	   through	   an	   M-­‐110P	   Microfluidiser®	  
(Microfluidics)	  2-­‐3	   times	  at	  a	  pressure	  of	  18000	  psi.	  The	   interaction	  chamber	  of	   the	  Microfluidiser®	  
was	  packed	  with	  ice,	  and	  the	  samples	  were	  collected	  and	  kept	  on	  ice	  between	  reapplication	  to	  reduce	  
the	  risk	  of	  over-­‐heating	  the	  sample	  and	  denaturing	  the	  target	  protein.	  




The	  soluble	  fraction	  of	  the	  cell	  lysate	  was	  separated	  by	  centrifugation	  at	  24000	  g,	  4	  ˚C	  for	  60	  min.	  The	  
cell	  pellet	  was	  discarded.	  The	   supernatant	  was	   then	   filtered	   through	  a	  0.2	  µm	   filter	   (Millipore)	  and	  
stored	  until	  ready	  to	  be	  purified.	  To	  reduce	  the	  risk	  of	  proteolysis	  chromatography	  was	  carried	  out	  as	  
soon	  as	  possible,	  and	  protease	  inhibitors	  were	  included	  in	  the	  lysis	  buffer.	  
Lysis	  buffer:	  
	   50	  mL	  HisTrap	  A	  buffer	   (Section	  9.5.2)	  and	  a	  CompleteTM	  Protease	   Inhibitor	  Cocktail	  Tablet	  
(Roche).	  
 Immobilised	  metal	  affinity	  chromatography	  	  9.5.2.
	  
The	   purification	   of	  MtuDAH7PS	   and	  MtuDAH7PS	   utilised	   IMAC	   to	   isolate	   the	   polyhistidine	   tagged	  
MtuDAH7PS	  (MtuDAH7PSH6)	  from	  other	  soluble	  E.	  coli	  proteins	  (Section	  2.3,Figure	  2.3).	  Following	  the	  
separation	   of	   the	  MtuDAH7PSH6,	   the	   polyhistidine	   tag	   was	   cleaved	   and	   removed	   from	   the	   protein	  
sample	  by	  IMAC.	  
	  
The	   first	   round	   of	   IMAC	   was	   performed	   using	   a	   5	   mL	   HisTrapTM	   HP	   column	   prepacked	   with	  
pre-­‐charged	  Ni	  SepharoseTM	  High	  Performance	  resin.	  The	  column	  was	  washed	  with	  5	  column	  volumes	  
of	  water	  prior	   to	  use.	  Thereafter	   the	  column	  was	  equilibrated	  with	  5	  column	  volumes	  of	  HisTrap	  A	  
buffer	   before	   sample	   application.	   Weakly	   bound	   proteins	   and	   contaminants	   were	   washed	   off	   the	  
column	  with	  3-­‐5	  columns	  of	  HisTrap	  A	  buffer.	  Proteins	  bound	  to	  the	  column	  were	  eluted	  with	  steadily	  
increasing	   imidazole	   concentration	   i.e.	   a	   linear	   gradient.	   The	   proportion	   of	   HisTrap	   B	   buffer	  mixed	  
with	   HisTrap	   A	   buffer	   increased	   from	   0	   to	   100	   %	   over	   10	  column	   volumes.	   The	   column	   was	   then	  
washed	  with	  3-­‐5	  columns	  volumes	  of	  HisTrap	  B	  buffer.	  The	  columned	  was	  then	  washed	  with	  5	  column	  
volumes	   of	   HisTrap	   A	   buffer	   ready	   for	   the	   next	   stage	   of	   IMAC.	   The	   eluted	   protein	   of	   interest	  
(MtuDAH7PSH6)	  was	  immediately	  collected	  and	  pooled	  ready	  for	  treatment	  with	  TEV	  protease.	  
	  
After	   TEV	  protease	   cleavage	   the	  protein	   sample	  was	   reapplied	   to	  a	  5	  mL	  HisTrapTM	  HP	   column	   (GE	  
Healthcare),	  to	  remove	  the	  cleaved	  polyhistidine	  tag	  and	  the	  TEV	  protease.	  Prior	  to	  application	  of	  the	  
sample	   the	   column	  was	  pre-­‐equilibrated	  with	  5	   column	  volumes	  of	  HisTrap	  A	  buffer.	   The	  unbound	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protein,	   including	  MtuDAH7PS,	  was	  washed	   off	   the	   column	  with	   3-­‐5	   column	   volumes	   of	   HisTrap	   A	  
buffer.	  The	  unbound	  fraction	  was	  collected	  and	  pooled	  ready	  for	  the	  next	  stage	  of	  purification.	  Any	  
bound	  protein	  was	  washed	  off	  the	  column	  with	  3-­‐5	  column	  volumes	  of	  HisTrap	  B	  buffer.	  The	  column	  
was	  then	  washed	  with	  5	  column	  volumes	  of	  HisTrap	  A	  buffer	  and	  5	  column	  volumes	  of	  water	  prior	  to	  
storage	  in	  20	  %	  ethanol.	  	  
	  
HisTrap	  A	  buffer:	  
	   20	   mM	   1,3-­‐	   bis[tris(hydroxymethyl)methylamino]propane	   (BTP),	   150	   mM	   NaCl,	   100	   µM	  
MnSO4,	   100	   µM	   phophoenolpyruvate	   (PEP),	   200	   µM	   tris(2-­‐carboxyethyl)phosphine	   (TCEP)	  
and	  20	  mM	  imidazole	  at	  pH	  7.5.	  
	  
HisTrap	  B	  buffer:	  
	   20	   mM	   BTP,	   150	   mM	   NaCl,	   100	   µM	   MnSO4,	   100	   µM	   PEP,	   200	   µM	   TCEP	   and	   500	   mM	  
imidazole	  at	  pH	  7.5.	  
 Cleavage	  of	  the	  polyhistidine	  tag	  9.5.3.
TEV	  protease	  was	  used	  to	  cleave	  the	  N-­‐terminal	  polyhistidine	  tag	  from	  MtuDAH7PSH6.	  The	  fractions,	  
containing	  MtuDAH7PS,	  eluted	  from	  the	  first	  IMAC	  were	  pooled.	  This	  pooled	  fraction	  typically	  had	  a	  
total	  volume	  between	  15-­‐20	  mL,	  and	  was	  diluted	  to	  50	  mL	  with	  SEC	  buffer	  (Section	  9.5.4)	  to	  reduce	  
the	   concentration	   of	   imidazole,	   permitting	   better	   TEV	   protease	   activity.	   Typically	   1	   mg	   of	   TEV	  
protease	  (1/10th	  –	  1/100th	  of	  the	  concentration	  (mg/mL)	  of	  the	  protein	  of	  interest)	  was	  added	  to	  the	  
pooled	   fractions,	   gently	   mixed	   and	   incubated	   overnight	   at	   4	   ˚C.	   The	   pooled	   fraction	   was	   then	  
reapplied	  to	  the	  IMAC	  column	  to	  remove	  the	  cleaved	  polyhistidine	  tag	  and	  TEV	  protease.	  
 Size	  exclusion	  chromatography	  	  9.5.4.
SEC	  was	  used	  as	  a	  polishing	  step	  to	  separate	  any	  remaining	  E.	  coli	  proteins	  in	  the	  protein	  sample	  from	  
MtuDAH7PS	  based	  on	  size.	  The	  pooled	  fractions	  containing	  the	  cleaved	  protein	  from	  the	  second	  IMAC	  
step	  was	  concentrated	  to	  a	  volume	  of	  less	  than	  13	  mL	  or	  until	  a	  maximum	  concentration	  of	  5	  mg/mL	  
was	  reached.	  A	  HiLoadTM	  26/60	  SuperdexTM	  200	  prep	  grade	  column	  (GE	  Healthcare)	  was	  equilibrated	  
with	  1	  column	  volume	  of	  SEC	  buffer	  prior	  to	  loading	  the	  cleaved	  protein	  sample	  onto	  the	  column.	  The	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sample	  was	  eluted	  with	  1	  column	  volume	  of	  SEC	  buffer	  and	  the	  fractions	  containing	  MtuDAH7PS	  were	  
pooled	  and	  concentrated	  to	  between	  3-­‐5	  mg/mL.	  The	  SEC	  column	  was	  stored	  in	  20	  %	  ethanol.	  	  
SEC	  buffer:	  
	   10	  mM	  BTP,	  150	  mM	  NaCl,	  200	  µM	  MnSO4,	  200	  µM	  PEP	  and	  200	  µM	  TCEP	  at	  pH	  7.5.	  
 Storage	  of	  purified	  MtuDAH7PS	  9.5.5.
The	  pooled	   fractions	  of	  MtuDAH7PS	   from	  SEC	  were	   concentrated	   to	  between	  2-­‐5	  mg/mL	  and	   then	  
pipetted	  into	  100	  or	  200	  µL	  aliquots,	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  ˚C.	  
 Purification	  of	  MtuCM	  9.6.
 Cell	  lysis	  9.6.1.
Harvested	  cells	  were	  thoroughly	  resuspended	  in	  10	  mL	  cold	  lysis	  buffer	  per	  1	  g	  of	  cell	  pellet	  and	  lysed	  
by	  sonication.	  Sonication	  was	  performed	  on	  ice,	  using	  an	  Omni-­‐Ruptor	  4000	  Ultrasonic	  Homogeniser	  
(Omni	  International).	  Sonication	  was	  conducted	  for	  5	  min	  intervals	  at	  ~35	  %	  pulse,	  70-­‐80	  %	  power	  and	  
repeated	   4-­‐5	   times	   with	   5-­‐10	   min	   breaks	   between	   cycles	   to	   reduce	   the	   risk	   of	   over-­‐heating	   the	  
sample.	  
	  
The	  soluble	  fraction	  of	  the	  cell	  lysate	  was	  separated	  by	  centrifugation	  at	  24000	  g,	  4	  ˚C	  for	  35	  min.	  The	  
cell	  pellet	  was	  discarded.	  The	   supernatant	  was	   then	   filtered	   through	  a	  0.2	  µm	   filter	   (Millipore)	  and	  
stored	  until	  ready	  to	  be	  purified.	  To	  reduce	  the	  risk	  of	  proteolysis	  chromatography	  was	  carried	  out	  as	  
soon	  as	  possible,	  and	  protease	  inhibitors	  were	  included	  in	  the	  lysis	  buffer.	  
	  
Lysis	  buffer:	  
	   50	  mL	  GSTrap	  A1	  buffer	  and	  a	  CompleteTM	  Protease	  Inhibitor	  Cocktail	  Tablet	  (Roche).	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 Affinity	  chromatography	  9.6.2.
The	   purification	   of	   MtuCM	   also	   utilised	   affinity	   chromatography	   to	   separate	   the	   glutathione	  
S-­‐transferase	  (GST)	  tagged	  MtuCM	  (MtuCMGST)	  from	  other	  soluble	  E.	  coli	  proteins	  (Section	  4.2,	  Figure	  
4.4).	  Once	  isolated	  MtuCMGST,	  was	  treated	  with	  TEV	  protease	  to	  cleave	  the	  GST	  tag.	  IMAC	  was	  used	  to	  
remove	  the	  cleaved	  GST	  tag.	  	  
	  
The	  first	  round	  of	  IMAC	  was	  performed	  using	  a	  5	  mL	  GSTrapTM	  HP	  column	  prepacked	  with	  Glutathione	  
SepharoseTM	  High	  Performance	  resin.	  The	  column	  was	  washed	  with	  5	  column	  volumes	  of	  water	  prior	  
to	  use.	  Thereafter	   the	  column	  was	  equilibrated	  with	  5	  column	  volumes	  of	  GSTrap	  A1	  buffer	  before	  
sample	  application.	  Weakly	  bound	  proteins	  and	  contaminants	  were	  washed	  off	  the	  column	  with	  3-­‐5	  
columns	  of	  GSTrap	  A1	  buffer.	   Proteins	  bound	   to	   the	   column	  were	  eluted	  with	   increasing	   imidazole	  
concentration	  i.e.	  a	   linear	  gradient.	  The	  proportion	  of	  GSTrap	  B	  buffer	  mixed	  with	  GSTrap	  A1	  buffer	  
increased	  from	  0	  to	  100	  %	  over	  10	  column	  volumes.	  The	  column	  was	  then	  washed	  with	  3-­‐5	  columns	  
volumes	  of	  GSTrap	  B	  buffer.	  The	  columned	  was	   then	  washed	  with	  5	  column	  volumes	  of	  GSTrap	  A2	  
buffer	  ready	  for	  the	  next	  stage	  of	  IMAC.	  The	  eluted	  protein	  of	  interest	  (MtuCMGST)	  was	  immediately	  
collected	  and	  pooled	  ready	  for	  treatment	  with	  TEV	  protease.	  
	  
Separation	  of	  the	  cleaved	  GST	  tag	  proved	  to	  be	  problematic	  due	  to	  an	  affinity	  between	  MtuCM	  and	  
the	  cleaved	  GST	  tag.	  To	  overcome	  this	  glycerol	  was	  added	  to	  the	  GSTrap	  A1	  buffer	  (GSTrap	  A2	  buffer),	  
FPLC	  was	  conducted	  at	  room	  temperature	  and	  the	  four	  GSTraps	  were	  connected	  in	  series	  to	  maximise	  
GST	  tag	  recovery	  during	  each	  IMAC	  step.	  After	  each	  round	  of	  IMAC	  the	  protein	  washed	  off	  the	  column	  
was	   inspected	   by	   SDS-­‐PAGE	   to	   ascertain	   the	   amount	   of	   GST	   tag	   present	   in	   the	   protein	   samples.	   If	  
significant	  contamination	  was	  present	  the	  MtuCM	  protein	  solution	  would	  undergo	  another	  round	  of	  
IMAC.	  	  
	  
After	  TEV	  protease	  cleavage	  the	  protein	  sample	  was	  reapplied	  to	  a	  4x	  5	  mL	  GSTrapTM	  HP	  columns	  (GE	  
Healthcare)	  connected	  in	  series	  (for	  a	  total	  column	  volume	  of	  20	  mL),	  pre-­‐equilibrated	  with	  5	  column	  
volumes	  of	  GSTrap	  A2	  buffer,	  to	  remove	  the	  cleaved	  GST	  tag.	  The	  unbound	  protein,	  including	  MtuCM,	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was	  washed	  off	  the	  column	  with	  3-­‐5	  column	  volumes	  of	  GSTrap	  A2	  buffer.	  The	  unbound	  fraction	  was	  
collected	   and	   pooled.	   Any	   bound	   protein	  was	  washed	   off	   the	   column	  with	   3-­‐5	   column	   volumes	   of	  
GSTrap	  B	  buffer.	   The	   column	  was	   then	  washed	  with	  5	   column	  volumes	  of	  GSTrap	  A.	   If	   the	  MtuCM	  
protein	   sample	   contained	   significant	   GST	   tag	   contamination	   it	   was	   concentrated	   to	   ~10	   mL	   and	  
underwent	  further	  iterations	  of	  IMAC	  until	  the	  sample	  appeared	  to	  be	  sufficiently	  pure.	  The	  MtuCM	  
sample	  was	  then	  concentrated	  to	  ~5	  mL	  ready	  for	  SEC.	  Meanwhile,	  the	  column	  was	  then	  washed	  with	  
5	  column	  volumes	  of	  GSTrap	  A1	  or	  GSTrap	  A2	  buffer	  and	  5	  column	  volumes	  of	  water	  prior	  to	  storage	  
in	  20	  %	  ethanol.	  	  
	  
In	   some	   instances	   SEC	   did	   not	   sufficiently	   remove	   the	   remaining	   cleaved	   GST	   tag	   and	   the	  MtuCM	  
sample	   underwent	   another	   1	   or	   2	   iterations	   of	   IMAC	   using	   4	   x	   5	   mL	   GSTtapTMs	   in	   series.	   	   When	  
analysed	  by	  SDS-­‐PAGE	  and	  found	  to	  be	  sufficiently	  pure	  the	  MtuCM	  sample	  was	  concentrated	  to	  ~3-­‐6	  
mL	  before	  being	  desalted	  to	  remove	  any	  glycerol	  in	  the	  buffer.	  
	  
GSTrap	  A1	  buffer:	  
	   10	  mM	  phosphate	  buffer	  and	  5	  mM	  KCl	  at	  pH	  7.5.	  
	  
GSTrap	  A2	  buffer:	  
	   10	  mM	  phosphate	  buffer	  and	  5	  mM	  KCl	  and	  1	  %	  (v/v)	  glycerol	  at	  pH	  7.5.	  
	  
GSTrap	  B	  buffer:	  
	   50	  mM	  Tris-­‐HCl,	  150	  mM	  NaCl,	  and	  10	  mM	  reduced	  glutathione	  at	  pH	  7.5	  
 Cleavage	  of	  GST-­‐tag	  9.6.3.
TEV	  protease	  was	  used	   to	   cleave	   the	  N-­‐terminal	  GST	   tag	   from	  MtuCMGST.	   The	   fractions,	   containing	  
MtuDAH7PS,	  eluted	  from	  the	  first	  IMAC	  were	  pooled.	  This	  pooled	  fraction	  typically	  had	  a	  total	  volume	  
between	   10-­‐15	   mL,	   and	   was	   diluted	   to	   ~50	   mL	   with	   SEC	   buffer	   (Section	   9.6.4)	   to	   reduce	   the	  
concentration	   of	   reduced	   glutathione.	   Typically	   0.5	   mg	   of	   TEV	   protease	   (1/10th	   –	   1/100th	   of	   the	  
concentration	   (mg/mL)	   of	   the	  protein	  of	   interest)	  was	   added	   to	   the	  pooled	   fractions,	   gently	  mixed	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and	   incubated	   overnight	   at	   4	   ˚C.	   The	   pooled	   fraction	   was	   then	   reapplied	   to	   the	   IMAC	   column	   to	  
remove	  the	  cleaved	  GST	  tag	  as	  described	  above	  in	  Section	  9.6.2.	  
 Size	  exclusion	  chromatography	  9.6.4.
The	  pooled	  fractions	  containing	  the	  cleaved	  protein	  from	  the	  IMAC	  step	  to	  remove	  the	  cleaved	  GST	  
tag	  was	  concentrated	  to	  a	  volume	  of	  less	  than	  5	  mL.	  The	  protein	  sample	  was	  applied	  to	  a	  SEC	  column	  
to	  remove	  any	  remaining	  GST	  tag	  and	  the	  TEV	  protease.	  A	  HiLoadTM	  16/60	  SuperdexTM	  75	  prep	  grade	  
column	   (GE	  Healthcare)	  was	   equilibrated	  with	   1	   column	   volume	   of	   SEC	   buffer	   prior	   to	   loading	   the	  
cleaved	  protein	  sample	  onto	  the	  column.	  The	  sample	  was	  eluted	  with	  1	  column	  volume	  of	  SEC	  buffer	  
and	  the	  fractions	  containing	  MtuCM	  were	  pooled.	  The	  SEC	  column	  was	  stored	   in	  20	  %	  ethanol.	  The	  
pooled	  MtuCM	   fractions	   were	   concentrated	   to	   between	   0.5-­‐2	   mg/mL	   and	   purity	   was	   verified	   by	  
SDS-­‐PAGE.	   If	   sufficiently	   pure	   the	  MtuCM	   sample	   was	   prepared	   for	   storage.	   If	   significant	   GST	   tag	  
contamination	  was	  present	  in	  the	  sample	  the	  MtuCM	  sample	  underwent	  further	  rounds	  of	  IMAC.	  
	  
SEC	  buffer:	  
	   10	  mM	  BTP,	  150	  mM	  NaCl,	  200	  µM	  MnSO4,	  200	  µM	  PEP	  and	  200	  µM	  TCEP	  at	  pH	  7.5.	  
 Desalting	  9.6.5.
MtuCM	  samples	   that	  were	   insufficiently	  purified	  by	  SEC	  were	  subjected	   to	   further	   IMAC	  to	   remove	  
any	   remaining	  GST	   tag.	  The	  GSTrap	  A2	  buffer	   required	   for	   IMAC	  contains	  glycerol	  and	   reintroduces	  
glycerol	  to	  the	  MtuCM	  sample.	  This	  glycerol	  must	  be	  removed	  from	  the	  buffer	  prior	  to	  storage	  as	   it	  
was	   shown	   to	   interfere	   in	   the	   inhibition	   studies	   of	  MtuCM•MtuDAH7PS	   activity.	   The	  MtuCM	  was	  
desalted	  with	  a	  PD-­‐10	  SephadexTM	  G-­‐25	  column	  (GE	  Healthcare)	  using	  the	  manufacturer’s	  gravity-­‐fed	  
protocol.	   The	   column	   was	   equilibrated	   with	   5	   column	   volumes	   of	   SEC	   buffer	   before	   the	   protein	  
sample	   was	   applied.	   The	   protein	   was	   eluted	   with	   2	   column	   volumes	   of	   SEC	   buffer,	   and	  MtuCM	  
containing	  fractions	  collected	  and	  pooled	  (MtuCM	  was	  usually	  eluted	  in	  a	  single	  block	  from	  2.5-­‐6	  mL).	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The	   column	   was	   then	   washed	   with	   5	   column	   volumes	   of	   water	   and	   stored	   in	   20%	   ethanol.	   The	  
collected	  MtuCM	  sample	  was	  then	  pooled	  and	  concentrated	  to	  0.5-­‐2	  mg/mL	  ready	  for	  storage.	  
 Storage	  of	  purified	  MtuCM	  9.6.6.
MtuCM	  samples	  ready	  for	  storage	  were	  concentrated	  to	  between	  0.5-­‐2	  mg/mL	  before	  being	  pipetted	  
into	  10,	  50	  or	  100	  µL	  aliquots,	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  ˚C.	  
 Structural	  characterisation	  9.7.
 Mass	  spectrometry	  9.7.1.
The	  mass	  of	  the	  purified	  proteins	  was	  measured	  by	  electrospray	  ionisation	  using	  a	  Bruker	  maXisTM	  3G	  
(Bruker	  Daltonics).	  Protein	  samples	  were	  buffer	  exchanged	  into	  Milli-­‐Q	  water	  and	  diluted	  to	  1	  mg/mL	  
for	  analysis.	   
 Blue	  native	  PAGE	  of	  MtuDAH7PS	  9.7.2.
Blue	  native	  PAGE	  was	  performed	  using	  NativePAGETM	  Novex®	  4-­‐16	  %	  Bis-­‐Tris	  Protein	  1	  mm	  10	  wells	  
Gels.	   Native	   PAGE	   was	   performed	   using	   an	   XCell	   SureLockTM	   Electrophoresis	   Cell	   (Invitrogen).	   The	  
manufacturer’s	  experimental	   setup	  and	  protocol	  was	  used	   including	   the	  20x	  NativePAGETM	  Running	  
Buffer	  and	  20x	  NativePAGETM	  cathode	  buffer	  additive	  for	  electrophoresis.	  Samples	  were	  prepared	  by	  
mixing	   with	   4x	   NativePAGETM	   Sample	   Buffer	   prior	   to	   loading	   on	   the	   gels.	   NativeMarkTM	   Unstained	  
Protein	  Standard	  was	  mixed	  with	  the	  4x	  NativePAGETM	  Sample	  Buffer	  and	   loaded	  on	  the	  gel	   for	   the	  
determination	   of	   the	   native	   molecular	   weight	   of	   the	   target	   protein.	   The	   gels	   were	   stained	   and	  
destained	  as	  described	  for	  SDS-­‐PAGE	  gels	  (Section	  9.4.6)	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 Native	   PAGE	   of	   the	   MtuCM•MtuDAH7PS	  9.7.3.
complex	  
	  
Native	   PAGE	  was	   performed	   using	   AmershamTM	   ECLTM	   12	  %	   15-­‐well	   gels	   (GE	   Healthcare).	   The	   gels	  
were	  run	  in	  50	  mM	  Tris	  buffer	  with	  175	  mM	  alanine	  at	  pH	  9.2	  using	  an	  EDLTM	  Gel	  Box	  at	  160	  V	  90	  min.	  
Samples	  were	  prepared	   to	  give	  a	   final	   concentration	  of	  ~	  6	  µM	  MtuDAH7PS	  and	  18-­‐24	  µM	  MtuCM	  
when	  mixed	  with	  a	  2x	  loading	  dye.	  The	  samples	  were	  allowed	  incubate	  for	  5	  min	  before	  being	  loaded	  
onto	  the	  gel.	  NativeMarkTM	  Unstained	  Protein	  Standard	  was	  mixed	  with	  the	  2x	  loading	  dye	  and	  also	  
loaded	  onto	   the	   gel	   as	   native	  molecular	  weight	   standards.	   The	   gels	  were	   stained	   and	  destained	   as	  
described	  for	  SDS-­‐PAGE	  gels	  (Section	  9.4.6)	  
Loading	  dye:	  
	   125	  mM	  Tris-­‐HCl,	   20	  %	   (v/v)	   glycerol	   and	   2	  mg	  bromophenol	   blue	   at	   pH	   6.5	   and	  made	   to	  
10	  mL	  with	  Milli-­‐Q	  water.	  
	  
 Circular	  dichroism	  	  9.7.4.
CD	  experiments	  were	  carried	  out	  using	  a	  JASCO	  J-­‐815	  Spectropolarimeter.	  The	  CD	  spectrum	  of	  each	  
protein	   was	   collected	   from	   260	   to	   195	   nm,	   with	   a	   0.5	   nm	   data	   pitch,	   1	   s	   response	   and	   1	   nm	  
bandwidth.	  Samples	  were	  prepared	  at	  0.03	  mg/mL	  in	  a	  3	  mL	  quartz	  cuvette	  with	  a	  1	  cm	  path	  length.	  
Data	  was	  collected	  at	  25	  ˚C	  in	  10	  mM	  Tris	  buffer	  at	  pH	  7.5	  pH	  adjusted	  with	  H2SO4.	  The	  CD	  spectrum	  
of	   each	   protein	   had	   the	   spectrum	   of	   the	   buffer	   subtracted	   and	   was	   smoothed	   by	   performing	   a	  
five-­‐point	  moving	  average.	  	  
 Small	  angle	  X-­‐ray	  scattering	  data	  collection	  9.7.5.
	  
SAXS	  data	  was	  collected	  at	  the	  Australian	  Synchrotron	  SAXS/WAXS	  beamline	  equipped	  with	  a	  Pilatus	  
Synchrotron	  detector	  (1	  M,	  170	  x	  170	  mm,	  effective	  pixel	  size,	  172	  x	  172	  µm).	  The	  wavelength	  of	  the	  
X-­‐rays	  was	  1.0332	  Å.	   The	   sample-­‐detector	  distance	  was	   set	   to	  1.6	  m,	  which	  provides	  an	   s	   range	  of	  
0.0126-­‐0.6014	   Å-­‐1.	   s	   is	   defined	   as	   the	   magnitude	   of	   the	   scattering	   vector	   and	   is	   related	   to	   the	  
scattering	   angle	   (2θ)	   and	   the	  wavelength	   (λ)	   by	   s=(4π/λ)sinθ.	   Protein	   samples	  were	   analysed	   at	   ~6	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mg/mL	   in	   SEC	   buffer	   (Section	   9.5.4)	   and	   filtered	   through	   a	   0.2	   µM	   filter	   just	   prior	   to	   analysis	   to	  
minimise	  the	  amount	  of	  aggregates	  in	  the	  protein	  solution.	  SAXS	  data	  was	  collected	  for	  each	  protein	  
following	   it’s	   elution	   from	   a	   SuperdexTM	   200	   5/150	   column,	   equilibrated	   previously	   with	   1	   column	  
volume	   of	   SEC	   buffer.	   The	   SAXS	   data	   was	   collected	   from	   a	   1.5	  mm	   glass	   capillary	   at	   27	   ˚C	   at	   2	   s	  
intervals.	   For	   some	   experiments	   SEC	   buffer	   and	   the	   protein	   sample	   were	   supplemented	   with	   the	  
stated	   concentration	   of	   aromatic	   amino	   acids	   (200	   µM	   or	   1	  mM).	   Two-­‐dimensional	   intensity	   plots	  
from	   the	   tip	   of	   the	   peak	   of	   the	   SEC	   analysis	   were	   radially	   averaged,	   normalised	   to	   sample	  
transmission	   and	   background	   subtracted	   in	   ScatterBrain	   (www.synchrotron.org.au/	  
index.php/aussyncbeamlines/saxswaxs/software-­‐saxswaxs).	  
 SAXS	  data	  analysis	  9.7.6.
Scattering	   intensity	   (I)	   was	   plotted	   against	   s.	   All	   samples	   were	   checked	   for	   non-­‐linearity	   in	   the	  
increase	  of	  intensity	  at	  low	  s	  to	  check	  for	  aggregation	  or	  concentration	  dependent	  scattering.	  Guinier	  
fits	   were	   linear	   for	   s·∙Rg<1.3	   (Rg	   is	   the	   radius	   of	   gyration)	   as	   calculated	   by	   PRIMUS.
101	   An	   indirect	  
Fourier	  transform	  was	  performed	  by	  GNOM	  to	  provide	  the	  pair	  wise	  distribution	  function	  (P(r))	  which	  
determined	  both	  the	  relative	  probabilities	  of	  distance	  between	  scattering	  centres	  and	  the	  maximum	  
dimension	  of	  the	  scattering	  particle	  (Dmax).
102	  
	  
Theoretical	   scattering	   profiles	   were	   generated	   from	   atomic	   coordinates	   and	   compared	   with	   the	  
experimental	   scattering	   profile	   using	   CRYSOL.103	   For	   scattering	   profiles	   that	   possibly	   consist	   as	  
mixtures	  of	  quaternary	  structures	  theoretical	  scattering	  profiles	  were	  generated	  and	  compared	  to	  the	  
experimental	   scattering	   profile	   by	   OLIGOMER.159	   OLIGOMER	   was	   used	   to	   predict	   the	   approximate	  
proportion	   of	   each	   oligomeric	   structure	   in	   present.	   To	   assess	   and	   compare	   the	   quality	   of	   fits	  
determined	  by	  CRYSOL	  or	  OLIGOMER	  the	  χ2	  values	  for	  the	  fits	  were	  compared.160	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 Analytical	  ultracentrifugation	  	  9.7.7.
Sedimentation	  velocity	  experiments	  were	  performed	  using	  a	  Beckman	  Coulter	  model	  XL-­‐I	  analytical	  
ultracentrifuge	  equipped	  with	  UV-­‐visible	  scanning	  optics.	  Reference	  samples	  (i.e.	  buffer)	  were	  400	  µL	  
and	  protein	  samples	  were	  380	  µL.	  Samples	  were	  loaded	  into	  12	  mm	  double-­‐sector	  cells	  with	  quartz	  
windows,	  and	  the	  cells	  were	  mounted	  in	  an	  An-­‐50	  Ti	  eight-­‐hole	  rotor.	  All	  MtuDAH7PS	  samples	  were	  
prepared	  by	  dialysis	  overnight	  into	  the	  AUC	  buffer	  whilst	  samples	  containing	  a	  mixture	  of	  MtuCM	  and	  
MtuDAH7PS	  were	  dialysed	   for	   2-­‐4	   h	   into	   the	  AUC	  buffer	   due	   to	   the	   instability	   of	  MtuCM.	   Samples	  
collected	  in	  the	  presence	  of	  100	  µM	  of	  any	  of	  the	  aromatic	  amino	  acids	  were	  spiked	  with	  the	  amino	  
acid	  (both	  the	  protein	  sample	  and	  the	  buffer	  reference	  sample)	  just	  prior	  to	  analysis.	  
	  
All	  AUC	  experiments	  were	  carried	  out	  by	  Ali	  Nazmi,	  I	  performed	  all	  sample	  preparation.	  Ali	  was	  also	  
kind	  enough	  to	  assist	  with	  the	  analysis	  of	  the	  experimental	  data.	  
	  
Protein	  samples	  were	  prepared	  at	   three	  different	  concentrations	  between	  0.09	  and	  1.0	  mg/mL	  and	  
centrifuged	  at	  50000	  rpm	  at	  20	  ˚C.	  Absorbance	  data	  was	  collected	  in	  continuous	  mode	  at	  278	  or	  279	  
nm	  without	  averaging.	  AUC	  data	  was	  fitted	  to	  a	  continuous	  distribution	  c(s)	  model	  using	  SEDFIT.107,161	  
The	   ratios	   of	   the	   frictional	   coefficients	   (f/f0)	   calculated	   by	   SEDFIT	   from	   fitting	   the	   c(s)	   models	   are	  
tabulated	  below	  (Table	  9.3).	  The	  partial	  specific	  volume	  (ν)	  of	  the	  proteins,	  buffer	  density	  (1.005	  gmL-­‐
1)	   and	   buffer	   viscosity	   (1.021	   cp)	   were	   calculated	   using	   the	   program	   SEDNTERP.162	   The	   ν	   of	   the	  





Equation	  9.1	  Equation	  to	  calculate	  the	  partial	  specific	  volume	  for	  AUC.	  Where	  v1	  and	  Mw1	  are	  the	  partial	  specific	  
volume	   and	  molecular	   weight	   of	  MtuDAH7PS	   and	   v2	   and	  Mw2	   are	   the	   partial	   specific	   volume	   and	  molecular	  
weight	  of	  MtuCM	  respectively.	  
	  
AUC	  Buffer:	  
50	  mM	  Tris	  buffer	  with	  150	  mM	  NaCl	  and	  200	  µM	  MnSO4	  at	  pH	  7.5.	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Table	  9.3	  Frictional	  coefficient	  ratios	  (f/f0)	  calculated	  from	  fitting	  the	  continuous	  size	  (c(s))	  distribution	  model	  to	  
the	  AUC	  data	  by	  SEDFIT.	  	  
Sample	   [MtuDAH7PS]	  
(mg/mL)	  
f/f0	   Sample	   [MtuDAH7PS]	  
(mg/mL)	  
f/f0	  
Chapter	  2	   	   	   Chapter	  4	  cont.	   	   	  
MtuDAH7PSWT	   0.2	   1.13	   MtuDAH7PSWT	  +	  	  MtuCM	  
+100	  µM	  Phe	  
0.2	   1.28	  
MtuDAH7PSWT	   0.4	   1.19	   MtuDAH7PSWT	  +	  	  MtuCM	  
+100	  µM	  Phe	  
0.4	   1.33	  
MtuDAH7PSWT	   1.0	   1.23	   MtuDAH7PSWT	  +	  	  MtuCM	  
+100	  µM	  Phe	  
0.6	   1.21	  
MtuDAH7PSWT+	  100	  µM	  Phe	   0.2	   1.18	   MtuDAH7PSWT	   0.6	   1.23	  
MtuDAH7PSWT+	  100	  µM	  Phe	   0.4	   1.15	   Chapter5	   	   	  
MtuDAH7PSWT+	  100	  µM	  Phe	   1.0	   1.12	   MtuDAH7PSG190P	   0.1	   1.24	  
MtuDAH7PSWT+	  100	  µM	  Trp	   0.2	   1.25	   MtuDAH7PSG190P	   0.25	   1.34	  
MtuDAH7PSWT+	  100	  µM	  Trp	   0.4	   1.18	   MtuDAH7PSG190P	   1.0	   1.34	  
MtuDAH7PSWT+	  100	  µM	  Trp	   1.0	   1.18	   MtuDAH7PSV103A	   0.1	   1.25	  
MtuDAH7PSWT	  
+	  100	  µM	  Phe	  +	  100	  µM	  Trp	  
0.2	   1.35	   MtuDAH7PSV103A	   0.3	   1.40	  
MtuDAH7PSWT	  
+	  100	  µM	  Phe	  +	  100	  µM	  Trp	  
0.4	   1.23	   MtuDAH7PSV103A	   1.0	   1.32	  
MtuDAH7PSWT	  
+	  100	  µM	  Phe	  +	  100	  µM	  Trp	  
1.0	   1.13	  
Chapter	  6	  
	   	  
Chapter	  4	   	   	   MtuDAH7PS
K123M	   0.3	   1.20	  
MtuDAH7PSWT	  +	  4x	  MtuCM	   0.2	   1.23	   MtuDAH7PSK123M	   0.6	   1.18	  
MtuDAH7PSWT	  +	  4x	  MtuCM	   0.4	   1.25	   MtuDAH7PSK123M	   1.0	   1.19	  
MtuDAH7PSWT	  +	  4x	  MtuCM	   0.6	   1.23	   Chapter	  7	   	   	  
MtuDAH7PSWT	  +	  	  MtuCM	   0.2	   1.30	   MtuDAH7PSG232P	   0.09	   1.38	  
MtuDAH7PSWT	  +	  	  MtuCM	   0.4	   1.26	   MtuDAH7PSG232P	   0.6	   1.28	  
MtuDAH7PSWT	  +	  	  MtuCM	   0.6	   1.35	   MtuDAH7PSG232P	   0.9	   1.26	  
MtuDAH7PSWT	  
+	  0.5x	  MtuCM	  
0.2	   1.46	   MtuDAH7PSG232P	  
+	  100	  µM	  Phe	  +	  100	  µM	  
Trp	  
0.09	   1.25	  
MtuDAH7PSWT	  
+	  0.5x	  MtuCM	  
0.4	   1.10	   MtuDAH7PSG232P	  
+	  100	  µM	  Phe	  +	  100	  µM	  
Trp	  
0.6	   1.23	  
MtuDAH7PSWT	  
+	  0.5x	  MtuCM	  
0.6	   1.29	   MtuDAH7PSG232P	  
+	  100	  µM	  Phe	  +	  100	  µM	  
Trp	  
0.9	   1.24	  
MtuDAH7PSWT	  +	  	  4x	  MtuCM	  
+100	  µM	  Phe	  
0.4	   1.32	   	   	   	  
	  
 IMAC	  pull	  down	  assay	  9.7.8.
A	  pull-­‐down	  assay	  is	  an	  in	  vitro	  method	  to	  determine	  whether	  a	  physical	  interaction	  occurs	  between	  
two	  proteins	  in	  this	  case	  MtuDAH7PS	  and	  MtuCM	  by	  utilising	  the	  affinity	  of	  one	  binding	  partner	  for	  a	  
particular	   resin	   or	   surface.	   MtuDAH7PS	   was	   purified	   without	   cleavage	   of	   the	   polyhistidine	   tag	  
allowing	  the	  enzyme	  to	  retain	  an	  affinity	  for	  resin	  of	  a	  HisTrapTM	  HP	  column.	  MtuCM	  has	  no	  inherent	  
9	   Experimental	  
	  
276	  
affinity	   for	   the	   HisTrapTM	   HP	   resin	   and	   therefore	   can	   only	   bind	   to	   the	   HisTrapTM	   HP	   column	   via	  
MtuDAH7PSH6.	  
	  
A	   200	  µL	  mixture	  of	  MtuDAH7PS	   and	  MtuCM	  was	  prepared	   to	   give	   a	   final	   concentration	  of	   10	  µM	  
MtuDAH7PS	  and	  ~30	  µM	  MtuCM.	  The	  mixture	  was	  gently	  mixed	  and	  incubated	  for	  15	  min	  at	  4	  ˚C.	  A	  
200	  µL	  sample	  of	  each	  separate	  protein	  was	  also	  prepared.	  In	  this	  control,	  MtuDAH7PS	  was	  applied	  to	  
the	  column	  at	  ~10	  µM.	  The	  sample	  concentration	  of	  MtuCM	  was	   increased	  to	  ~60	  µM	  to	  allow	  the	  
elution	  of	  MtuCM	  from	  the	  column	  to	  be	  more	  easily	  identified	  by	  monitoring	  the	  UV	  absorbance	  at	  
280	  nm.	  
	  
The	  pull	  down	  assay	  protocol	  is	  similar	  to	  that	  of	  an	  IMAC	  purification	  step.	  The	  protein	  samples	  were	  
applied	   (~200	   µL)	   to	   a	   5mL	   HisTrapTM	   HP	   column	   (GE	   Healthcare)	   previously	   equilibrated	   with	   5	  
column	  volumes	  of	  Histrap	  A	  buffer	  (Section	  9.5.2).	  The	  column	  was	  washed	  with	  2-­‐3	  column	  volumes	  
of	   Histrap	   A	   buffer	   to	   remove	   any	   unbound	   protein.	   Any	   bound	   protein	   was	   then	   eluted	   off	   the	  
column	  with	  2-­‐3	  column	  volumes	  of	  Histrap	  B	  buffer	  (Section	  9.5.2).	  	  
	  
To	  assess	   if	  Phe	  prevented	  the	  complex	  from	  forming	  a	  second	  mixture	  of	  the	  same	  concentrations	  
was	   also	   prepared	   and	   spiked	   to	   a	   final	   concentration	   of	   1	   mM	   Phe	   and	   allowed	   to	   incubate	   for	  
15	  min	  at	  4	  ˚C	  prior	  to	  application	  to	  the	  column.	  The	  HisTrap	  A	  buffer	  for	  this	  pull	  down	  assay	  was	  
also	  spiked	  to	  a	  final	  concentration	  of	  	  1	  mM	  Phe.	  
	  
Fractions	  were	  collected	  during	  both	  the	  wash	  and	  elution	  steps	  and	  analysed	  on	  an	  SDS-­‐PAGE	  gel	  to	  
identify	  the	  whether	  MtuCM	  and/or	  MtuDAH7PS	  was	  present.	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 Biophysical	  characterisation	  9.8.
 Differential	  scanning	  fluorimetry	  	  9.8.1.
DSF	   was	   performed	   using	   a	   Bio-­‐Rad	   iCycler	   iQ5TM	   Multicolour	   Real-­‐Time	   PCR	   Detection	   System.	  
Samples	  were	  prepared	  in	  a	  96-­‐well	  plate	  to	  give	  a	  final	  volume	  of	  25	  µL.	  Each	  well	  contained	  20	  µL	  
SEC	  buffer	  (supplemented	  with	  the	  appropriate	  amino	  acid(s)	  to	  give	  a	  final	  amino	  acid	  concentration	  
of	  either	  200	  µM,	  500	  µM	  or	  1	  mM),	  4	  µL	  of	  protein	  at	  1	  mg/mL	  and	  1	  µL	  of	  250x	  SYPRO	  Orange	  dye.	  
The	  plate	  was	  sealed	  and	  subjected	  to	  a	  thermal	  cycling	  program	  that	  heated	  the	  plated	  from	  20	  to	  95	  
˚C	  in	  0.2	  ˚C	  increments	  over	  4	  h.	  Each	  protein	  sample	  was	  measured	  in	  triplicate	  and	  compared	  to	  a	  
negative	   control	   in	   which	   no	   protein	   sample	   was	   present.	   Melting	   temperatures	   were	   manually	  
calculated	  at	  the	  temperature	  at	  which	  the	  maximum	  inflection	  occurred	  along	  the	  generated	  melting	  
curve	  of	  each	  protein	  sample.	  Statistical	  analysis	  way	  performed	  via	  a	  two-­‐tailed	  student	  t-­‐test	  with	  a	  
95	  %	  confidence	  interval.	  
 Isothermal	  titration	  calorimetry	  	  9.8.2.
The	   affinity	   between	  MtuDAH7PS	   variants	   and	   the	   aromatic	   amino	   acids	   was	   assessed	   by	   ITC	   and	  
performed	  using	  a	  VP-­‐ITC	  unit	  (MicroCal;	  GE	  Healthcare).	  All	  solutions	  were	  filtered	  through	  a	  0.2	  µm	  
filter	  (Millipore)	  and	  degassed	  under	  vacuum.	  All	  protein	  samples	  were	  analysed	  in	  SEC	  buffer	  at	  25	  
˚C.	   The	   experimental	   set-­‐up	   for	   each	   experiment	   is	   detailed	   in	   Table	   9.4.	   Heats	   of	   dilution	  
experiments	   were	   carried	   out	   for	   each	   run	   and	   subtracted	   from	   the	   integrated	   data	   before	   curve	  
fitting	   was	   carried	   out.	   Iterative	   curve	   fitting	   to	   either	   the	   one-­‐	   or	   two-­‐site	   models	   provided	   by	  
MicroCal	  was	  performed	  by	  Origin	  7.0	  software.	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Table	  9.4	  ITC	  experimental	  set-­‐up.	  *	  Number	  of	  injection	  excludes	  the	  first	  small	  volume	  injection.	  –indicates	  no	  









Chapter	  2	   	   	   	  
38	  µM	  MtuDAH7PSWT	  	   20	  µM	  Trp	   3	  mM	  Tyr	   28	  x	  10	  µL	  
49	  µM	  MtuDAH7PSWT	   400	  µM	  Tyr	   250	  µM	  Trp	   28	  x	  10	  µL	  
40	  µM	  MtuDAH7PSWT	   400	  µM	  Tyr	   1	  mM	  Phe	   28	  x	  10	  µL	  
Chapter	  3	  
	   	   	  
30	  µM	  MtuDAH7PSR171A	   –	   2	  mM	  Phe	   28	  x	  10	  µL	  
30	  µM	  MtuDAH7PSR171A	   –	   3	  mM	  Tyr	   56	  x	  5	  µL	  
30	  µM	  MtuDAH7PSR171A	   50	  µM	  Phe	   3	  mM	  Tyr	   28	  x	  10	  µL	  
40	  µM	  MtuDAH7PSR171A	   –	   3	  mM	  Trp	   56	  x	  5	  µL	  
30	  µM	  MtuDAH7PSR256A	   –	   900	  µM	  Phe	   28	  x	  10	  µL	  
60	  µM	  MtuDAH7PSR256A	   –	   2	  mM	  Tyr	   28	  x	  10	  µL	  
50	  µM	  MtuDAH7PSR256A	   50	  µM	  Phe	   3	  mM	  Tyr	   28	  x	  10	  µL	  
30	  µM	  MtuDAH7PSR256A	   –	   300	  µM	  Trp	   28	  x	  10	  µL	  
Chapter	  5	   	   	   	  
81	  µM	  MtuDAH7PSG190P	   –	   1	  mM	  Trp	   28	  x	  10	  µL	  
49	  µM	  MtuDAH7PSG190P	   –	   2	  mM	  Phe	   28	  x	  2	  µL	  
38	  µM	  MtuDAH7PSG190P	   100	  µM	  Phe	   1	  mM	  Trp	   28	  x	  10	  µL	  
38	  µM	  MtuDAH7PSY131A	   –	   500	  µM	  Trp	   28	  x	  10	  µL	  
38	  µM	  MtuDAH7PSY131A	   –	   1	  mM	  Phe	   28	  x	  10	  µL	  
38	  µM	  MtuDAH7PSY131A	   100	  µM	  Phe	   500	  µM	  Trp	   28	  x	  10	  µL	  
Chapter	  6	  
	   	   	  
38	  µM	  MtuDAH7PSN237A	   –	   800	  µM	  Trp	   28	  x	  10	  µL	  
41	  µM	  MtuDAH7PSN237A	   –	   1	  mM	  Phe	   28	  x	  10	  µL	  
40	  µM	  MtuDAH7PSN237A	   –	   2.5	  mM	  Tyr	   28	  x	  10	  µL	  
38	  µM	  MtuDAH7PSN237A	   50	  µM	  Phe	   800	  µM	  Trp	   28	  x	  10	  µL	  
41	  µM	  MtuDAH7PSN237A	   20	  µM	  Trp	   1	  mM	  Phe	   28	  x	  10	  µL	  
38	  µM	  MtuDAH7PSN237A	   20	  µM	  Trp	   2.5	  mM	  Tyr	   28	  x	  10	  µL	  
Chapter	  7	   	   	   	  
30	  µM	  MtuDAH7PSG232P	   –	   3	  mM	  Trp	   28	  x	  10	  µL	  
28	  µM	  MtuDAH7PSG232P	   –	   900	  µM	  Phe	   28	  x	  10	  µL	  
24	  µM	  MtuDAH7PSG232P	   50	  µM	  Phe	   5	  mM	  Trp	   28	  x	  10	  µL	  
37	  µM	  MtuDAH7PSG190P/G232P	   –	   3	  mM	  Trp	   28	  x	  10	  µL	  
33	  µM	  MtuDAH7PSG190P/G232P	   –	   900	  µM	  Phe	   28	  x	  10	  µL	  
32	  µM	  MtuDAH7PSG190P/G232P	   –	   3	  mM	  Tyr	   28	  x	  10	  µL	  
32	  µM	  MtuDAH7PSF227D	   –	   5	  mM	  Trp	   28	  x	  10	  µL	  
32	  µM	  MtuDAH7PSF227D	   –	   600	  µM	  Phe	   28	  x	  10	  µL	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 Kinetic	  analysis	  9.9.
 Standard	  kinetic	  assays	  9.9.1.
	  
Measurement	  of	  MtuDAH7PS	  activity	  
The	  assays	  used	  to	  measure	  MtuDAH7PS	  activity	  were	  based	  on	  the	  assay	  developed	  by	  Celia	  Webby	  
and	   further	   improved	   by	   Richard	   Hutton.48,69,70	   The	   kinetic	   parameters	   and	   measurements	   of	  
MtuDAH7PS	  activity	  were	  measured	  by	  monitoring	  the	  loss	  of	  PEP	  at	  232	  nm	  (ε	  =	  2.8	  x	  103	  M-­‐1	  cm-­‐1	  at	  
30	   ˚C)	   in	   the	   presence	   of	   E4P	   using	   a	   Varian	   Cary	   100	   UV-­‐visible	   spectrophotometer	   using	   quartz	  
cuvettes	   with	   a	   1	   cm	   or	   1	   mm	   pathlength	   and	   standard	   assay	   conditions.	   The	   reaction	   mixtures	  
contained	  100	  µM	  MnSO4,	  300	  µM	  PEP	  (unless	  stated	  otherwise	  or	  varied	  to	  determine	  the	  Km
PEP)	  and	  
E4P	  at	  300	  µM	  (unless	   stated	  otherwise	  or	  varied	   to	  determine	   the	  Km
E4P).	  Reactions	  were	   initiated	  
with	  enzyme.	  For	  assays	  not	  intended	  to	  determine	  Km	  values	  PEP	  and	  E4P	  concentrations	  were	  held	  
at	  150	  µM.	  PEP	  and	  E4P	  solutions	  were	  made	  up	  in	  assay	  buffer.	  
	  
Measurement	  of	  MtuCM	  activity	  
The	  assays	  used	  to	  measure	  MtuCM	  activity	  were	  developed	  by	  Richard	  Hutton	  based	  on	  the	  assays	  
performed	  by	  Sasso	  et.	  al..85	  Kinetic	  parameters	  of	  MtuCM	  activity	  were	  determined	  by	  monitoring	  
the	  loss	  of	  chorismic	  acid	  (Sigma)	  at	  274	  nm	  (ε	  =	  2.630	  M-­‐1	  cm-­‐1	  at	  30	  ˚C)	  in	  the	  same	  assay	  buffer	  as	  
MtuDAH7PS	  and	  in	  the	  presence	  of	  MnSO4	  (100	  µM),	  PEP	  (150	  µM)	  and	  25	  µM	  or	  150	  µM	  chorismic	  
acid.	  For	  the	  determination	  of	  the	  chorismic	  acid	  Km	  the	  chorismic	  acid	  concentration	  was	  varied.	  	  
	  
Measurement	  of	  MtuCM	  or	  MtuDAH7PS	  activity	  of	  the	  MtuCM•MtuDAH7PS	  complex	  
For	   study	   of	   the	   complexes,	   MtuCM	   activity	   was	   determined	   with	   a	   1:10	   ratio	   for	   MtuCM	   to	  
MtuDAH7PS	   and	  MtuDAH7PS	   activity	  was	   determined	  with	   a	   10:1	   ratio	   of	  MtuCM	   to	  MtuDAH7PS,	  
and	   allowed	   to	   incubate	   at	   303	   K	   in	   the	   presence	   of	   all	   assay	   components	   (except	   the	   initiating	  
substrate,	  chorismic	  acid,	  or	  E4P	  respectively)	   for	   five	  min.	  Assays	  were	  also	  conducted	  to	  measure	  
MtuCM	  activity	   in	   the	  presence	  of	   1:1	  or	   1:200	   ratios	   of	  MtuCM	   to	  MtuDAH7PS	  or	   as	  MtuDAH7PS	  
concentration	  was	  varied	  between	  10	  nm	  and	  4	  µM	  under	  the	  standard	  assay	  conditions.	  The	  effect	  
of	  NaCl	   on	   the	  MtuCM	  activity	  of	   a	   1:10	  mixture	  of	  MtuCM	   to	  MtuDAH7PS	  was	  determined	  under	  
standard	  assays	  conditions	  with	  the	  addition	  of	  the	  NaCl	  to	  give	  a	  final	  concentration	  between	  0-­‐1.5	  
mM.	  Reactions	  were	  initiated	  with	  150	  µM	  chorismic	  acid.	  
	  
Determination	  of	  Michaelis-­‐Menten	  kinetics	  in	  the	  presence	  of	  aromatic	  amino	  acids	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For	  Michaelis-­‐Menten	  kinetics	  determined	  in	  the	  presence	  of	  one	  or	  a	  combination	  of	  aromatic	  amino	  
acids	   the	  amino	  acid	   solutions	  were	  added	   to	   the	   standard	  assay	   conditions	   to	  a	   concentrations	   to	  
give	   a	   final	   concentration	   of	   200	   µM	   (unless	   stated	   otherwise).	   Kinetic	   measurements	   were	   then	  
conducted	  as	  described	  in	  the	  absence	  of	  aromatic	  amino	  acids.	  
	  
Chorismic	   acid,	   PEP,	   and	  E4P	   solutions	  were	  made	  up	   in	   assay	  buffer	   and	   the	  MnSO4	   solution	  was	  
made	  up	  in	  Milli-­‐Q	  water.	  All	  assay	  solutions	  were	  filtered	  through	  a	  0.2	  µM	  (Millipore)	  filter	  prior	  to	  
use.	  Initial	  reaction	  rates	  were	  determined	  by	  a	  least-­‐squares	  fit	  of	  the	  initial-­‐rate	  data.	  Km	  and	  kcat	  
values	  were	  determined	  by	  fitting	  the	  data	  to	  the	  Michaelis-­‐Menten	  equation	  (Equation	  9.2),	  ternary	  
complex	   equation	   (Equation	   9.3)	   or	   the	   Hill	   equation	   (Equation	   9.4)	   using	   the	   software	   GraFit	   5.0	  
(Erithacus	  software)	  or	  Kaleidagraph	  (Synergy).	  	  
	  
	   	  










	   Ternary	  complex	  kinetic	  equation	  
𝑣 =
𝑉!"# A [B]
𝐾𝐾! + 𝐾! A + 𝐾![B] + A [B]
	  
Equation	   9.2	   The	   Michaelis-­‐Menten	   kinetic	   equation,	   Equation	   9.3	   The	   Hill	   equation	   and	   Equation	   9.4	   The	  
ternary	   complex	   kinetic	   equation.	   υ	   is	   the	   reaction	   velocity,	   Vmax	   is	   the	  maximum	   velocity	   of	   an	   enzyme,	   [S]	  
substrate	   concentration,	   Km	   is	   the	   Michaelis	   constant,	   n	   is	   the	   Hill	   coefficient,	   K	   is	   the	   apparent	   association	  
constant.	  For	  the	  ternary	  complex	  kinetic	  equation	  A	  and	  B	  refer	  to	  alternate	  substrates.	  
 Determination	  of	  substrate	  concentrations	  9.9.2.
The	   concentration	   of	   substrates	   (PEP,	   E4P	   and	   chorismic	   acid)	  was	   determined	   enzymatically	   using	  
the	  appropriate	  assay	  conditions	  and	  the	  relevant	  enzyme.	  Assays	  were	  conducted	  in	  the	  presence	  of	  
100	   µM	   MnSO4.	   A	   known	   volume	   of	   substrate	   solutions,	   typically	   5	   µL,	   for	   which	   substrate	  
concentration	  was	  to	  be	  determined,	  was	  added	  to	  the	  assay.	  For	  the	  measurement	  of	  PEP	  and	  E4P	  
the	  other	  substrate	  was	  held	  in	  excess.	  Reaction	  was	  imitated	  with	  enzyme	  and	  allowed	  to	  progress	  
until	  complete	  consumption	  of	  the	  limiting	  substrate	  had	  taken	  place.	  To	  ensure	  the	  desired	  substrate	  
was	  limiting	  more	  of	  the	  limited	  substrate	  was	  added	  to	  the	  cuvette.	  For	  efficiency	  MtuDAH7PS	  was	  
used	  to	  activate	  MtuCM	  activity	  for	  the	  measurement	  of	  chorismic	  acid	  concentration.	  	  




The	   change	   in	   absorbance	   was	   noted	   between	   the	   start	   and	   end	   of	   the	   reactions.	   The	   change	   in	  
absorbance	  caused	  by	  the	  addition	  of	  enzyme	  to	  initiate	  the	  reactions	  was	  allowed	  for	  and	  the	  total	  
change	   in	   absorbance	  was	  used	   to	  determine	   the	   concentration	  of	   substrate	  by	   applying	   the	  Beer-­‐
Lambert	   law	   using	   the	   appropriate	   substrate	   extinction	   coefficient.	   All	   measurements	   for	   the	  
determination	  of	  substrate	  concentration	  were	  conducted	  in	  triplicate.	  
 Inhibition	  studies	  9.9.3.
Solutions	  of	  L-­‐Phe,	  L-­‐Tyr	  and	  L-­‐Trp	  were	  made	  up	  in	  Milli-­‐Q	  water	  and	  filtered	  through	  a	  0.2	  µm	  filter	  
(Millipore).	   The	   appropriate	   amino	   acid	   solution(s)	   were	   added	   to	   the	   standard	   assay	   reaction	  
mixtures	   to	   give	   a	   final	   concentration	   of	   200	   µM	   unless	   stated	   otherwise	   for	   all	   inhibitor	   studies.	  
Steady-­‐state	  kinetics	  were	  conducted	  in	  the	  presence	  of	  one,	  two	  or	  all	  three	  aromatic	  amino	  acids.	  
The	  assay	  conditions	  contained	  150	  µM	  PEP,	  150	  or	  1800	  µM	  E4P	  and	  100	  µM	  MnSO4	  in	  assay	  buffer	  
for	  measurements	  of	  MtuDAH7PS	  activity.	  	  
	  
For	  the	  measurement	  of	  the	  inhibition	  of	  MtuCM	  activity	  the	  assay	  conditions	  contained	  150	  µM	  PEP,	  
150	  µM	  chorismic	  acid	  and	  100	  µM	  MnSO4	  in	  assay.	  The	  final	  concentration	  of	  MtuCM	  in	  each	  cuvette	  
was	  ~3	  µM.	  Reactions	  were	  initiated	  with	  chorismic	  acid.	  
	  
For	  reactions	  measuring	  the	  inhibition	  of	  MtuCM	  activity	  of	  the	  MtuCM•MtuDAH7PS	  complex	  activity	  
was	  determined	  with	  a	  1:10	  ratio	  of	  MtuCM	  to	  MtuDAH7PS	  with	  MtuCM	  concentration	  held	  a	  60	  nM.	  
When	   measuring	   the	   inhibition	   of	  MtuDAH7PS	   activity	   of	   the	   complex	   a	   10:1	   ratio	   of	  MtuCM	   to	  
MtuDAH7PS	  was	  used	  MtuDAH7PS	  was	  held	  at	  40	  nM.	  
	  
Statistical	  analysis	  way	  performed	  via	  a	  two-­‐tailed	  student	  t-­‐test	  with	  a	  95	  %	  confidence	  interval.	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 Kinetic	   determination	  of	   dissociation	   constant	  9.9.4.
between	  MtuCM	  and	  MtuDAH7PS	  
	  
The	   kinetic	   parameters	   were	   determined	   by	   measuring	   CM	   activity	   at	   various	   concentrations	   of	  
MtuDAH7PS	  under	  the	  standard	  assay	  conditions	  described	  above	  either	  in	  the	  presence	  or	  absence	  
of	  200	  µM	  Phe.	  The	  MtuCM	  concentration	  was	  held	  at	  10	  nM	  (90	  nM	  in	  the	  absence	  of	  MtuDAH7PS).	  
For	   each	  MtuDAH7PS	   concentration	   at	   least	   seven	   points	   were	   used	   to	   determine	   the	   Michaelis-­‐
Menten	  kinetic	  parameters	  used	  to	  find	  the	  catalytic	  efficiency	  (kcat/Km)	  of	  MtuCM	  activity.	  Each	  set	  of	  
Michaelis-­‐Menten	   kinetics	   was	   conducted	   in	   duplicate.	   The	   Kd	   app	   was	   derived	   using	   an	   equation	  
(Equation	   9.5)	   adapted	   from	   Taira	   and	   Benkovic	   as	   outlined	   by	   Sasso	   et	   al.	   and	   assumes	   a	   1:1	  
stoichiometry	  of	  MtuCM	  to	  MtuDAH7PS.85,114	  The	  program	  KaleidaGraph	  (Synergy	  Software)	  was	  used	  
to	  iteratively	  fit	  the	  derived	  equation,	  shown	  below:	  
	  
𝜐 = 𝜐!" + CM ! + DS ! + 𝐾!,!"" − ( CM ! + DS ! + 𝐾!,!"")! − 4 CM ! DS ! •
!!"•!"!!!"
![!"]!
	  	  	  	  	  	  
Equation	   9.5	   Equation	   for	   the	  determination	  of	   the	  apparent	  dissociation	  constant	   if	   the	  MtuCM•MtuDAH7PS	  
complex	   υ,	   υCM	   and	   υCM•DS	   are	   the	   corresponding	   catalytic	   efficiencies,	   [CM]0	   and	   [DS]0	   are	   the	   total	  
concentrations	   of	  MtuCM	   and	  MtuDAH7PSWT	   respectively.	   Kd,app	   is	   the	   apparent	   dissociation	   constant	   of	   the	  
complex.	  
	  
The	  data	  was	  fitted	  to	  Equation	  9.5,	  using	  υCM•DS	  and	  Kd,app	  as	  the	  fitting	  parameters,	  by	  the	  iterative	  
curve	   fitting	   software	   KaleidaGraph	   (Synergy	   Software).	   Sasso	   et	   al.	   adapted	   work	   by	   Taira	   and	  
Benkovic	   to	   derive	   this	   equation	   allowing	   the	   determination	   of	   the	   apparent	  MtuCM•MtuDAH7PS	  
dissociation	  constant	  for	  a	  1:1	  stoichiometry.85,114	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Appendix	  I	  –	  Michaelis-­‐Menten	  plots	  of	  kinetic	  data	  
	  
In	  this	  section	  the	  kinetic	  data	  for	  the	  each	  enzyme	  is	  presented	  as	  Michaelis-­‐Menten	  plots	  with	  the	  
Lineweaver-­‐Burke	   plot	   inset.	   The	   data	   has	   been	   fitted	   to	   Michaelis-­‐Menten	   kinetics	   using	   the	  
software	  GraFit	  5.0	  (Erithicus).	  
	  
	  
	   	  















MtuCM	  +	  10	  x	  MtuDAH7PS	   MtuCM	  +	  200	  x	  MtuDAH7PS	  
MtuCM	  +	  10	  x	  MtuDAH7PS	  
+	  200	  µM	  Phe	  
MtuCM	  +	  10	  x	  MtuDAH7PS	  
+	  100	  µM	  Phe	  +	  100	  µM	  Tyr	  
MtuCM	  alone	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MtuCM	  +	  10	  x	  MtuDAH7PS	  
+	  200	  µM	  Phe	  +	  200	  µM	  Tyr	  
MtuCM	  +	  10	  x	  MtuDAH7PS	  
+	  200	  µM	  Tyr	  
MtuDAH7PS	  +	  10	  x	  MtuCM	  
	  
MtuCM	  +	  	  
10	  x	  MtuDAH7PSR171A	  
+	  
MtuCM	  +	  	  
10	  x	  MtuDAH7PSR256A	  




MtuDAH7PSR171A	  +	  10	  x	  MtuCM	  
	  































+	  200	  µM	  Trp*	  
MtuDAH7PSK123M	  
+	  200	  µM	  Phe	  
*	  
	  
*	  Kinetic	  data	  was	  also	  fitted	  to	  the	  Hill	  equation,	  data	  plot	  and	  fit	  shown	  in	  chapter	  6.	  














+	  200	  µM	  Trp	  +	  200	  µM	  Phe	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Appendix	  II	  –	  AUC	  distribution	  and	  residual	  data	  
	  
In	   this	   section	   the	   data	   for	   the	   sedimentation	   velocity	   experiments	   is	   presented.	   Plotted	   is	   the	  
continuous	  distribution	  c(s)	  model	  fitted	  (coloured	  lines)	  to	  the	  experimental	  data	  (black	  dots)	  using	  

















A.	   D.	  
E.	  
F.	  
MtuDAH7PSWT	   MtuDAH7PSWT	  
+	  100	  µM	  Phe	  
Figure	  AII.1	  Left	  MtuDAH7PSWT	  at	  0.2	  mg/mL	  (A.)	  0.4	  mg/mL	  (B.)	  and	  1.0mg/mL	  (C.).	  Right	  MtuDAH7PSWT	  +	  
100	  µM	  Phe	  at	  0.2	  mg/mL	  (D.)	  0.4	  mg/mL	  (E.)	  and	  1.0	  mg/mL	  (F.)	  
Chapter	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Figure	  AII.2	  Left	  MtuDAH7PSWT	  +	  100	  µM	  Trp	  at	  0.2	  mg/mL	  (A.)	  0.4	  mg/mL	  (B.)	  and	  1.0	  mg/mL	  (C.).	  Right	  








+	  100	  µM	  Trp	  +	  100	  µM	  Phe	  
MtuDAH7PSWT	  
+	  100	  µM	  Trp	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A.	   D.	  
B.	   E.	  
C.	   F.	  
MtuDAH7PSWT	  
+	  4	  x	  MtuCM	  
MtuDAH7PSWT	  
+	  MtuCM	  
Figure	  AII.3	  Left	  MtuDAH7PSWT	  +	  four-­‐fold	  molar	  excess	  of	  MtuCM	  at	  0.2	  mg/mL	  (A.)	  0.4	  mg/mL	  (B.)	  and	  
0.6	  mg/mL	  (C.).	  Right	  MtuDAH7PSWT	  +	  equimolar	  amount	  of	  MtuCM	  at	  0.2	  mg/mL	  (D.)	  0.4	  mg/mL	  (E.)	  and	  
0.6	  mg/mL	  (F.).	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C.	  
B.	  






+	  0.5	  x	  MtuCM	  
Figure	  AII.4	  Left	  MtuDAH7PSWT	  +	  half	  the	  molar	  amount	  of	  MtuCM	  at	  0.2	  mg/mL	  (A.)	  0.4	  mg/mL	  (B.)	  and	  
0.6	  mg/mL	  (C.).	  Right	  MtuDAH7PSWT	  at	  0.2	  mg/mL	  (D.)	  0.4	  mg/mL	  (E.)	  and	  0.6	  mg/mL	  (F.).	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C.	  
B.	  




+	  MtuCM	  +	  100	  µM	  Phe	  
MtuDAH7PSWT;	  	  
MtuDAH7PSWT	  +	  4x	  MtuCM;	  
MtuDAH7PSWT	  +	  4x	  MtuCM	  +	  100	  µM	  Phe	  
Figure	  AII.5	  Left	  MtuDAH7PSWT	  +	  equimolar	  amount	  of	  MtuCM	  +	  100	  µM	  Phe	  at	  0.2	  mg/mL	  (A.)	  0.4	  mg/mL	  
(B.)	  and	  0.6	  mg/mL	  (C.).	  Right	  MtuDAH7PSWT	  at	  0.4	  mg/mL	  (D.)	  MtuDAH7PSWT	  +	  four-­‐fold	  molar	  excess	  of	  
MtuCM	   at	   0.4	  mg/mL	   (E.)	   and	  MtuDAH7PSWT	   +	   four-­‐fold	  molar	   excess	  of	  MtuCM	   +	   100	  µM	  Phe	   at	   0.4	  
mg/mL	  (F.).	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Figure	   AII.6	   Left	   MtuDAH7PSG190P	   at	   0.1	   mg/mL	   (A.)	   0.25	   mg/mL	   (B.)	   and	   1.0	   mg/mL	   (C.).	   Right	  
MtuDAH7PSV103A	  at	  0.1	  mg/mL	  (D.)	  0.3	  mg/mL	  (E.)	  and	  1.0	  mg/mL	  (F.).	  
MtuDAH7PSG190P	   MtuDAH7PSV103A	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  5	  









Figure	  AII.7	  MtuDAH7PSK123M	  at	  0.3	  mg/mL	  (A.)	  0.6	  mg/mL	  (B.)	  and	  1.0	  mg/mL	  (C.).	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  6	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Appendix	  III	  –	  Protein-­‐Protein	  interface	  interactions	  
	  
In	  this	  section	  the	  PDBsum	  analysis,	  which	  schematically	  depicts	  the	  interactions	  between	  residues	  at	  
a	  protein-­‐protein	   interface.	  Dashed	  orange	   lines	  represent	  a	  hydrogen	  bond,	  and	  the	  solid	  blue	   line	  
represents	   a	   hydrogen	   bond	   between	   residue	   pairs.	   The	   four	   subunits	   of	  MtuDAH7PS	   have	   been	  
identified	  as	  chains	  A-­‐D	  and	  the	  two	  subunits	  of	  MtuCM	  as	  chains	  E	  and	  F	  as	  shown	  in	  the	  schematic	  
below	  (Figure	  AIII.1).	  
	   	  
Tetramer	  interface	  
Chain	  A	  
Chain	  D	  Chain	  C	  
Chain	  B	  
Dimer	  interface	  
Chain	  E	  Chain	  F	  
MtuCM•MtuDAH7PS	  	  
interface	  
Figure	  AIII.1	  Schematic	  of	  the	  dimer,	  tetramer	  and	  MtuCM•MtuDAH7PS	  interfaces.	  The	  subunits	  of	  
MtuDAH7PS	   have	   been	   identified	   as	   chains	   A-­‐D,	   and	   the	   two	   subunits	   of	   MtuCM	   have	   been	  
identified	  as	  chains	  E	  and	  F.	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MtuDAH7PSWT+	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Interactions	  at	  the	  dimer	  interface	  





	   	  
Interactions	  at	  the	  tetramer	  interface	  
MtuDAH7PSWT+	  Trp	  +	  Phe	  
(PDB	  code:	  3KGF)	  
MtuDAH7PSWT	  
(PDB	  code:	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Interactions	  at	  the	  MtuCM•MtuDAH7PS	  interface	  
MtuDAH7PSWT+	  MtuCM	  
(PDB	  code:	  2W19)	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Appendix	  IV	  –	  ITC	  heats	  of	  dilution	  
	  
In	  this	  section	  an	  example	  of	  the	  heat	  of	  dilution	  (HOD)	  for	  each	  ligand,	  Trp,	  Phe	  and	  Tyr,	  used	  in	  the	  
ITC	  analysis	  of	  MtuDAH7PSWT	  and	  the	  MtuDAH7PS	  variants	  are	  shown	  	  
	   	  




HOD	  for	  300	  µM	  Trp	   HOD	  for	  900	  µM	  Phe	  
HOD	  for	  2	  mM	  Tyr	  
Bibliography	   	  
	  
305	  
Appendix	  V	  –	  Student	  t-­‐test	  analysis	  of	  DSF	  and	  kinetic	  data	  
	  
In	   this	   section	   the	   p-­‐values	   determined	   via	   a	   two-­‐tailed	   student	   t-­‐test	   performed	   on	   the	   DSF	   and	  
kinetic	  data	  have	  been	  tabulated.	  A	  95	  %	  confidence	  interval	  was	  used.	  	  
	   	  










MtuD	  WT	   None	   51.5	   0.1	   	  
MtuD	  WT	   W	   60.1	   0.6	   0.00	  
MtuD	  WT	   F	   54.1	   0.5	   0.01	  
MtuD	  WT	   Y	   52.5	   0.1	   0.01	  
MtuD	  WT	   WF	   60.4	   0.7	   0.00	  
MtuD	  WT	   WY	   58.1	   0.4	   0.00	  
MtuD	  WT	   YF	   55.9	   0.6	   0.00	  
MtuD	  WT	   WFY	   62.1	   0.6	   0.00	  
MtuD	  WT	   500W	   63.6	   0.5	   0.00	  
MtuD	  WT	   1000W	   66.5	   0.1	   0.00	  
MtuD	  WT	   500F	   58.9	   0.1	   0.00	  
MtuD	  WT	   1000F	   62.5	   0.1	   0.00	  
MtuD	  WT	   500Y	   49.5	   0.4	   0.02	  
MtuD	  WT	   1000Y	   42.7	   0.8	   0.00	  
	   	   	   	   	  






MtuD	  R171A	   None	   51.1	   0.1	   	  
MtuD	  R171A	   W	   58.6	   0.0	   0.00	  
MtuD	  R171A	   F	   51.2	   0.0	   0.18	  
MtuD	  R171A	   Y	   51.6	   0.0	   0.02	  
MtuD	  R171A	   WF	   57.7	   0.1	   0.00	  
MtuD	  R171A	   WY	   58.8	   0.0	   0.00	  
MtuD	  R171A	   FY	   51.7	   0.1	   0.04	  
MtuD	  R171A	   WFY	   58.5	   0.1	   0.00	  
	   	   	   	   	  
MtuD	  R256A	   None	   50.8	   0.0	   	  
MtuD	  R256A	   W	   58.2	   0.5	   0.00	  
MtuD	  R256A	   F	   53.2	   0.5	   0.02	  
MtuD	  R256A	   Y	   50.9	   0.1	   0.18	  
MtuD	  R256A	   WF	   60.7	   0.1	   0.00	  
MtuD	  R256A	   WY	   58.3	   0.8	   0.00	  
MtuD	  R256A	   YF	   52.7	   0.6	   0.03	  
MtuD	  R256A	   WFY	   60.1	   0.3	   0.00	  
	   	   	   	   	  






MtuCM	   None	   54.7	   0.4	   	  
MtuCM	   W	   52.9	   1.2	   0.20	  
MtuCM	   F	   52.8	   0.0	   0.02	  
MtuCM	   Y	   48.1	   0.8	   0.01	  
MtuCM	   YF	   50.3	   0.5	   0.01	  
MtuCM	  	   WFY	   51.9	   1.2	   0.03	  
	   	   	   	   	  






MtuD	  G190P	   None	   52.6	   0.0	   	  
MtuD	  G190P	   W	   57.4	   0.0	   ND	  
MtuD	  G190P	   F	   58.5	   0.1	   0.00	  
MtuD	  G190P	   Y	   53.6	   0.0	   ND	  
MtuD	  G190P	   WF	   60.4	   0.0	   ND	  
MtuD	  G190P	   WY	   58.2	   0.2	   0.00	  
MtuD	  G190P	   YF	   61.7	   0.1	   0.00	  
MtuD	  G190P	   WFY	   63.2	   0.0	   0.00	  
MtuD	  G190P	   500W	   64.6	   0.2	   0.00	  
MtuD	  G190P	   1000W	   67.1	   0.1	   0.00	  
DSF	  student	  t-­‐test	  analysis	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MtuD	  Y131A	   None	   44.9	   0.5	   	  
MtuD	  Y131A	   W	   52.3	   0.1	   0.00	  
MtuD	  Y131A	   F	   42.7	   0.6	   0.00	  
MtuD	  Y131A	   Y	   49.4	   0.0	   0.00	  
MtuD	  Y131A	   WF	   53.1	   0.8	   0.00	  
MtuD	  Y131A	   WY	   53.8	   0.2	   0.00	  
MtuD	  Y131A	   YF	   49.4	   0.0	   0.00	  
MtuD	  Y131A	   WFY	   53.9	   0.1	   0.00	  
	   	   	   	   	  
MtuD	  V103A	   None	   40.2	   0.0	   	  
MtuD	  V103A	   W	   51.2	   0.3	   0.00	  
MtuD	  V103A	   F	   44.2	   0.5	   0.01	  
MtuD	  V103A	   Y	   48.4	   0.0	   ND	  
MtuD	  V103A	   WF	   54.4	   0.0	   ND	  
MtuD	  V103A	   WY	   51.6	   0.0	   ND	  
MtuD	  V103A	   YF	   54.1	   0.1	   0.00	  
MtuD	  V103A	   WFY	   57.2	   0.3	   0.00	  
	   	   	   	   	  
MtuD	  N175A	   None	   44.1	   0.5	   	  
MtuD	  N175A	   W	   51.3	   0.1	   0.00	  
MtuD	  N175A	   F	   44.3	   0.6	   0.46	  
MtuD	  N175A	   Y	   49.3	   0.5	   0.01	  
MtuD	  N175A	   WF	   51.4	   0.0	   0.00	  
MtuD	  N175A	   WY	   54.5	   0.1	   0.00	  
MtuD	  N175A	   YF	   48.9	   0.3	   0.00	  
MtuD	  N175A	   WFY	   54.3	   0.1	   0.00	  
	   	   	   	   	  






MtuK123M	   None	   47.8	   0.0	   	  	  
MtuK123M	   W	   48.0	   0.0	   0.00	  
MtuK123M	   F	   51.3	   0.4	   0.00	  
MtuK123M	   Y	   46.9	   0.3	   0.03	  
MtuK123M	   WF	   51.7	   0.1	   0.00	  
MtuK123M	   WY	   47.5	   0.1	   0.04	  
MtuK123M	   YF	   54.7	   0.6	   0.00	  
MtuK123M	   WFY	   55.1	   0.5	   0.00	  
	   	   	   	   	  
MtuD	  N237A	   None	   51.2	   0.2	   	  	  
MtuD	  N237A	   W	   52.6	   0.7	   0.04	  
MtuD	  N237A	   F	   55.9	   0.5	   0.01	  
MtuD	  N237A	   Y	   56.9	   0.8	   0.01	  
MtuD	  N237A	   WF	   56.2	   0.3	   0.00	  
MtuD	  N237A	   WY	   56.5	   0.1	   0.00	  
MtuD	  N237A	   YF	   59.2	   0.3	   0.00	  
MtuD	  N237A	   WFY	   59.1	   0.2	   0.00	  
	   	   	   	   	  






MtuD	  G232P	   None	   47.9	   0.3	   	  	  
MtuD	  G232P	   W	   48.1	   0.8	   0.53	  
MtuD	  G232P	   F	   52.0	   0.3	   0.00	  
MtuD	  G232P	   Y	   50.7	   0.6	   0.01	  
MtuD	  G232P	   WF	   51.9	   0.1	   0.00	  
MtuD	  G232P	   WY	   51.5	   0.2	   0.00	  
MtuD	  G232P	   YF	   59.0	   0.9	   0.00	  
MtuD	  G232P	   WFY	   59.3	   0.4	   0.00	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MtuD	  G190P/G232P	   None	   49.3	   0.4	   	  	  
MtuD	  G190P/G232P	   W	   49.6	   0.0	   0.30	  
MtuD	  G190P/G232P	   F	   51.0	   0.0	   0.02	  
MtuD	  G190P/G232P	   Y	   52.9	   0.1	   0.01	  
MtuD	  G190P/G232P	   WF	   53.5	   0.1	   0.01	  
MtuD	  G190P/G232P	   WY	   51.4	   0.0	   0.01	  
MtuD	  G190P/G232P	   YF	   57.8	   0.5	   0.00	  
MtuD	  G190P/G232P	   WFY	   59.4	   0.2	   0.00	  
MtuD	  G190P/G232P	   500W	   49.9	   0.6	   0.33	  
MtuD	  G190P/G232P	   1000W	   51.1	   0.4	   0.02	  
	   	   	   	   	  
MtuD	  F227D	   None	   43.0	   1.2	   	  	  
MtuD	  F227D	   W	   43.9	   0.2	   0.38	  
MtuD	  F227D	   F	   46.7	   0.7	   0.02	  
MtuD	  F227D	   Y	   46.1	   0.4	   0.08	  
MtuD	  F227D	   WF	   46.6	   0.0	   0.04	  
MtuD	  F227D	   WY	   46.3	   0.8	   0.11	  
MtuD	  F227D	   YF	   51.5	   0.1	   0.01	  
































MtuD	  WT	   None	   100.0	   1.1	   	  	  
MtuD	  WT	   W	   90.6	   3.4	   0.03	  
MtuD	  WT	   F	   88.1	   4.6	   0.06	  
MtuD	  WT	   Y	   77.5	   1.5	   0.00	  
MtuD	  WT	   YF	   85.9	   5.4	   0.06	  
MtuD	  WT	   WY	   26.7	   2.8	   0.00	  
MtuD	  WT	   WF	   6.9	   0.1	   0.00	  
MtuD	  WT	   WFY	   0.6	   0.3	   0.00	  
MtuD	  WT	   WFF	   1.9	   0.2	   0.00	  
MtuD	  WT	   WYY	   11.7	   4.7	   0.00	  
	   	   	   	   	  






MtuD	  R171A	   None	   100.0	   1.9	   	  
MtuD	  R171A	   W	   95.8	   0.9	   0.02	  
MtuD	  R171A	   F	   94.6	   3.3	   0.02	  
MtuD	  R171A	   Y	   73.1	   3.1	   0.00	  
MtuD	  R171A	   YF	   79.0	   2.3	   0.01	  
MtuD	  R171A	   WY	   76.8	   0.6	   0.00	  
MtuD	  R171A	   WF	   60.9	   2.6	   0.00	  
MtuD	  R171A	   WFY	   23.7	   2.7	   0.00	  
MtuD	  R171A	   WFF	   86.8	   3.6	   0.03	  
MtuD	  R171A	   WYY	   54.9	   7.0	   0.01	  
	   	   	   	   	  
MtuD	  R256A	   None	   100.0	   2.2	   	  
MtuD	  R256A	   W	   99.8	   0.5	   0.89	  
MtuD	  R256A	   F	   84.4	   2.7	   0.00	  
MtuD	  R256A	   Y	   90.0	   2.0	   0.01	  
MtuD	  R256A	   YF	   82.0	   5.6	   0.03	  
MtuD	  R256A	   WY	   98.4	   3.1	   0.58	  
MtuD	  R256A	   WF	   17.6	   1.6	   0.00	  
MtuD	  R256A	   WFY	   15.3	   0.6	   0.00	  
MtuD	  R256A	   WFF	   12.9	   2.2	   0.00	  
MtuD	  R256A	   WYY	   99.5	   4.3	   0.90	  
	   	   	   	   	  






MtuD	  MtuCM	   None	   100.0	   5.5	   	  
MtuD	  MtuCM	   W	   225.8	   1.7	   0.01	  
MtuD	  MtuCM	   F	   139.9	   1.8	   0.02	  
MtuD	  MtuCM	   Y	   155.8	   0.1	   0.03	  
MtuD	  MtuCM	   YF	   106.1	   4.5	   0.37	  
MtuD	  MtuCM	   WY	   48.2	   3.2	   0.00	  
MtuD	  MtuCM	   WF	   6.1	   0.2	   0.02	  
MtuD	  MtuCM	   WFY	   4.1	   1.5	   0.02	  
	   	   	   	   	  
MtuD	  H6	   None	   100.0	   3.2	   	  
MtuD	  H6	   W	   96.6	   3.6	   0.45	  
MtuD	  H6	   F	   95.4	   1.7	   0.15	  
MtuD	  H6	   Y	   89.3	   6.7	   0.16	  
MtuD	  H6	   YF	   75.0	   1.9	   0.01	  
MtuD	  H6	   WY	   66.4	   1.4	   0.00	  
MtuD	  H6	   WF	   19.3	   0.5	   0.00	  
MtuD	  H6	   WFY	   7.2	   1.7	   0.00	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MtuD	  G190P	   None	   100.0	   2.3	   	  	  
MtuD	  G190P	   W	   93.5	   3.1	   0.03	  
MtuD	  G190P	   F	   106.8	   4.3	   0.15	  
MtuD	  G190P	   Y	   88.8	   5.2	   0.11	  
MtuD	  G190P	   YF	   87.9	   3.4	   0.06	  
MtuD	  G190P	   WY	   90.6	   1.8	   0.00	  
MtuD	  G190P	   WF	   99.8	   4.3	   0.87	  
MtuD	  G190P	   WFY	   83.6	   0.5	   0.01	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  Y131A	   None	   100.0	   0.9	   	  	  
MtuD	  Y131A	   W	   116.4	   1.7	   0.05	  
MtuD	  Y131A	   F	   168.6	   6.5	   0.04	  
MtuD	  Y131A	   Y	   112.9	   2.0	   0.08	  
MtuD	  Y131A	   YF	   194.4	   1.7	   0.01	  
MtuD	  Y131A	   WY	   90.5	   5.2	   0.22	  
MtuD	  Y131A	   WF	   114.6	   0.4	   0.02	  
MtuD	  Y131A	   WFY	   41.6	   4.4	   0.03	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  V103A	   None	   100.0	   3.9	   	  	  
MtuD	  V103A	   W	   104.8	   2.8	   0.54	  
MtuD	  V103A	   F	   99.9	   3.0	   0.28	  
MtuD	  V103A	   Y	   103.4	   0.7	   0.26	  
MtuD	  V103A	   YF	   83.0	   0.2	   0.04	  
MtuD	  V103A	   WY	   75.8	   3.1	   0.08	  
MtuD	  V103A	   WF	   19.5	   7.5	   0.05	  
MtuD	  V103A	   WFY	   3.6	   0.0	   0.01	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  N175A	   None	   100.0	   4.5	   	  
MtuD	  N175A	   W	   84.2	   5.2	   0.22	  
MtuD	  N175A	   F	   94.8	   4.5	   0.43	  
MtuD	  N175A	   Y	   98.7	   1.6	   0.52	  
MtuD	  N175A	   YF	   97.8	   0.1	   0.36	  
MtuD	  N175A	   WY	   11.7	   0.9	   0.00	  
MtuD	  N175A	   WF	   59.4	   3.7	   0.08	  
MtuD	  N175A	   WFY	   15.2	   0.1	   0.02	  
	   	   	   	   	  






MtuD	  K123M	   None	   100.0	   3.1	   	  	  
MtuD	  K123M	   W	   84.5	   5.0	   0.08	  
MtuD	  K123M	   F	   30.3	   2.3	   0.00	  
MtuD	  K123M	   Y	   38.0	   3.4	   0.00	  
MtuD	  K123M	   YF	   26.1	   3.9	   0.00	  
MtuD	  K123M	   WY	   35.4	   1.6	   0.00	  
MtuD	  K123M	   WF	   29.6	   0.6	   0.00	  
MtuD	  K123M	   WFY	   24.6	   3.4	   0.00	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  N237A	   None	   100.0	   3.5	   	  	  
MtuD	  N237A	   W	   121.1	   0.7	   0.00	  
MtuD	  N237A	   F	   22.4	   0.3	   0.01	  
MtuD	  N237A	   Y	   28.9	   2.9	   0.02	  
MtuD	  N237A	   YF	   21.0	   1.0	   0.01	  
MtuD	  N237A	   WY	   30.2	   3.3	   0.02	  
MtuD	  N237A	   WF	   3.2	   0.8	   0.00	  
MtuD	  N237A	   WFY	   1.9	   0.4	   0.00	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MtuD	  G232P	   None	   100.0	   4.9	   	  	  
MtuD	  G232P	   W	   91.2	   1.6	   0.12	  
MtuD	  G232P	   F	   60.1	   3.8	   0.00	  
MtuD	  G232P	   Y	   65.7	   2.9	   0.00	  
MtuD	  G232P	   YF	   64.4	   1.2	   0.01	  
MtuD	  G232P	   WY	   60.5	   2.1	   0.00	  
MtuD	  G232P	   WF	   65.9	   4.4	   0.01	  
MtuD	  G232P	   WFY	   60.6	   5.9	   0.02	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  G190P/G232P	   None	   100.0	   4.5	   	  	  
MtuD	  G190P/G232P	   W	   99.3	   3.0	   0.86	  
MtuD	  G190P/G232P	   F	   58.9	   2.7	   0.01	  
MtuD	  G190P/G232P	   Y	   51.5	   2.5	   0.00	  
MtuD	  G190P/G232P	   YF	   37.9	   0.3	   0.00	  
MtuD	  G190P/G232P	   WY	   58.5	   4.7	   0.02	  
MtuD	  G190P/G232P	   WF	   54.1	   4.2	   0.01	  
MtuD	  G190P/G232P	   WFY	   50.8	   3.7	   0.01	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  F227D	   None	   100.0	   4.7	   	  	  
MtuD	  F227D	   W	   92.7	   3.4	   0.53	  
MtuD	  F227D	   F	   46.4	   4.0	   0.01	  
MtuD	  F227D	   Y	   77.5	   2.9	   0.06	  
MtuD	  F227D	   YF	   51.9	   1.9	   0.04	  
MtuD	  F227D	   WY	   61.8	   1.4	   0.09	  
MtuD	  F227D	   WF	   52.4	   6.5	   0.00	  
MtuD	  F227D	   WFY	   47.1	   3.0	   0.02	  
	  1800	  µM	  E4P	   	  	   	  	   	  	   	  	  
MtuD	  G232P	   None	   100.0	   1.0	   	  	  
MtuD	  G232P	   W	   98.6	   5.6	   0.74	  
MtuD	  G232P	   F	   93.8	   1.2	   0.01	  
MtuD	  G232P	   Y	   81.8	   2.5	   0.04	  
MtuD	  G232P	   YF	   88.4	   0.7	   0.07	  
MtuD	  G232P	   WY	   95.3	   0.7	   0.16	  
MtuD	  G232P	   WF	   83.7	   6.5	   0.20	  
MtuD	  G232P	   WFY	   76.0	   5.1	   0.08	  
	  	   	  	   	  	   	  	   	  	  
G190P/G232P	   None	   100.0	   4.2	   	  	  
G190P/G232P	   W	   84.4	   4.6	   0.01	  
G190P/G232P	   F	   92.9	   8.9	   0.58	  
G190P/G232P	   Y	   95.9	   4.6	   0.05	  
G190P/G232P	   YF	   101.0	   3.2	   0.88	  
G190P/G232P	   WY	   76.4	   3.0	   0.02	  
G190P/G232P	   WF	   79.8	   1.6	   0.13	  
G190P/G232P	   WFY	   96.5	   3.2	   0.62	  
	  	   	  	   	  	   	  	   	  	  
MtuD	  F227D	   None	   100.0	   3.1	   	  
MtuD	  F227D	   W	   97.5	   0.8	   0.38	  
MtuD	  F227D	   F	   100.4	   1.8	   0.75	  
MtuD	  F227D	   Y	   86.0	   2.3	   0.17	  
MtuD	  F227D	   YF	   88.1	   4.7	   0.28	  
MtuD	  F227D	   WY	   101.0	   2.0	   0.05	  
MtuD	  F227D	   WF	   96.0	   0.7	   0.38	  
MtuD	  F227D	   WFY	   84.8	   0.2	   0.03	  
	  	   	  	   100.0	   2.4	   0.02	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MtuD	  WT	   None	   100.0	   0.6	   	  	  
MtuD	  WT	   W	   49.9	   1.1	   0.02	  
MtuD	  WT	   F	   96.5	   0.3	   0.04	  
MtuD	  WT	   Y	   87.3	   0.2	   0.02	  
MtuD	  WT	   YF	   88.6	   0.4	   0.04	  
MtuD	  WT	   WY	   13.6	   1.0	   0.00	  
MtuD	  WT	   WF	   4.9	   0.1	   0.00	  












MtuCM	   None	   100.0	   2.2	   	  	  
MtuCM	   F	   102.2	   2.3	   0.47	  
MtuCM	   W	   99.9	   3.1	   0.97	  
MtuCM	   Y	   98.1	   0.6	   0.52	  
MtuCM	   WF	   99.1	   1.4	   0.60	  
MtuCM	   FY	   99.4	   1.8	   0.17	  
MtuCM	   WY	   97.2	   0.0	   0.44	  
MtuCM	   WFY	   98.0	   2.2	   0.35	  
150	   	  	   	  	   	  	   	  
MtuCM	  -­‐DWT	   None	   100.0	   0.2	   	  
MtuCM	  -­‐DWT	   F	   63.1	   0.1	   0.06	  
MtuCM	  -­‐DWT	   W	   94.0	   3.0	   0.46	  
MtuCM	  -­‐DWT	   Y	   88.1	   0.4	   0.19	  
MtuCM	  -­‐DWT	   WF	   38.8	   1.2	   0.05	  
MtuCM	  -­‐DWT	   FY	   35.1	   0.5	   0.05	  
MtuCM	  -­‐DWT	   WY	   60.6	   2.7	   0.04	  
MtuCM	  -­‐DWT	   WFY	   29.5	   2.6	   0.05	  
25	   	  	   	  	   	  	   	  
MtuCM	  -­‐DWT	   None	   100.0	   3.9	   	  
MtuCM	  -­‐DWT	   F	   16.4	   2.0	   0.00	  
MtuCM	  -­‐DWT	   W	   93.1	   10.0	   0.12	  
MtuCM	  -­‐DWT	   Y	   59.5	   9.1	   0.03	  
MtuCM	  -­‐DWT	   WF	   2.2	   1.8	   0.00	  
MtuCM	  -­‐DWT	   FY	   6.4	   2.2	   0.00	  
MtuCM	  -­‐DWT	   WY	   23.1	   7.9	   0.00	  
MtuCM	  -­‐DWT	   WFY	   1.0	   0.7	   0.00	  
	   	   	   	   	  
MtuCM	  -­‐DR171A	   None	   100.0	   7.7	   	  
MtuCM	  -­‐DR171A	   F	   83.8	   5.2	   0.00	  
MtuCM	  -­‐DR171A	   W	   109.4	   5.5	   0.42	  
MtuCM	  -­‐DR171A	   Y	   118.6	   3.8	   0.34	  
MtuCM	  -­‐DR171A	   WF	   79.3	   8.9	   0.01	  
MtuCM	  -­‐DR171A	   FY	   79.8	   2.5	   0.01	  
MtuCM	  -­‐DR171A	   WY	   93.3	   10.8	   0.21	  
MtuCM	  -­‐DR171A	   WFY	   92.1	   11.7	   0.06	  
Student	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  on	  CM	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  data	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MtuCM	  -­‐DR256A	   None	   100.0	   1.2	   	  
MtuCM	  -­‐DR256A	   F	   20.9	   2.7	   0.00	  
MtuCM	  -­‐DR256A	   W	   90.7	   3.7	   0.04	  
MtuCM	  -­‐DR256A	   Y	   97.7	   2.8	   0.47	  
MtuCM	  -­‐DR256A	   WF	   19.4	   5.6	   0.00	  
MtuCM	  -­‐DR256A	   FY	   27.8	   12.2	   0.00	  
MtuCM	  -­‐DR256A	   WY	   86.8	   1.3	   0.01	  
MtuCM	  -­‐DR256A	   WFY	   17.2	   0.9	   0.00	  
	   	   	   	   	  






MtuCM	  -­‐DG190P	   None	   100.0	   1.0	   	  
MtuCM	  -­‐DG190P	   F	   24.1	   1.8	   0.00	  
MtuCM	  -­‐DG190P	   W	   136.8	   7.7	   0.03	  
MtuCM	  -­‐DG190P	   Y	   88.6	   6.4	   0.01	  
MtuCM	  -­‐DG190P	   WF	   105.2	   5.7	   0.03	  
MtuCM	  -­‐DG190P	   FY	   16.3	   3.3	   0.00	  
MtuCM	  -­‐DG190P	   WY	   123.5	   1.7	   0.50	  
MtuCM	  -­‐DG190P	   WFY	   51.3	   4.1	   0.00	  
	   	   	   	   	  
MtuCM	  -­‐DY131A	   None	   100.0	   14.1	   	  
MtuCM	  -­‐DY131A	   F	   74.9	   3.4	   0.07	  
MtuCM	  -­‐DY131A	   W	   82.8	   5.9	   0.08	  
MtuCM	  -­‐DY131A	   Y	   57.3	   8.6	   0.01	  
MtuCM	  -­‐DY131A	   WF	   54.5	   3.8	   0.02	  
MtuCM	  -­‐DY131A	   FY	   21.3	   3.3	   0.01	  
MtuCM	  -­‐DY131A	   WY	   71.0	   0.9	   0.06	  
MtuCM	  -­‐DY131A	   WFY	   16.4	   0.6	   0.01	  
	   	   	   	   	  
MtuCM	  -­‐DV103A	   None	   100.0	   5.2	   	  
MtuCM	  -­‐DV103A	   F	   45.9	   1.7	   0.03	  
MtuCM	  -­‐DV103A	   W	   110.0	   4.4	   0.03	  
MtuCM	  -­‐DV103A	   Y	   93.4	   8.7	   0.59	  
MtuCM	  -­‐DV103A	   WF	   59.9	   9.2	   0.16	  
MtuCM	  -­‐DV103A	   FY	   16.8	   2.7	   0.01	  
MtuCM	  -­‐DV103A	   WY	   77.0	   0.0	   0.10	  
MtuCM	  -­‐DV103A	   WFY	   28.4	   2.0	   0.00	  
	   	   	   	   	  
MtuCM	  -­‐DN175A	   None	   100.0	   2.3	   	  
MtuCM	  -­‐DN175A	   F	   70.1	   1.2	   0.05	  
MtuCM	  -­‐DN175A	   W	   4.6	   1.3	   0.00	  
MtuCM	  -­‐DN175A	   Y	   76.9	   8.8	   0.12	  
MtuCM	  -­‐DN175A	   WF	   3.2	   2.2	   0.02	  
MtuCM	  -­‐DN175A	   FY	   41.3	   3.8	   0.01	  
MtuCM	  -­‐DN175A	   WY	   39.8	   18.8	   0.35	  
MtuCM	  -­‐DN175A	   WFY	   29.2	   0.4	   0.01	  
	   	   	   	   	  






MtuCM	  -­‐DK123M	   None	   100.0	   9.6	   	  
MtuCM	  -­‐DK123M	   F	   11.3	   2.5	   0.01	  
MtuCM	  -­‐DK123M	   W	   126.6	   5.7	   0.00	  
MtuCM	  -­‐DK123M	   Y	   4.4	   4.7	   0.01	  
MtuCM	  -­‐DK123M	   WF	   0.0	   9.2	   0.01	  
MtuCM	  -­‐DK123M	   FY	   2.5	   7.3	   0.00	  
MtuCM	  -­‐DK123M	   WY	   2.4	   0.4	   0.00	  
MtuCM	  -­‐DK123M	   WFY	   6.3	   0.2	   0.00	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MtuCM	  -­‐DN237A	   None	   100.0	   9.8	   	  
MtuCM	  -­‐DN237A	   F	   4.3	   3.8	   0.00	  
MtuCM	  -­‐DN237A	   W	   196.0	   12.8	   0.01	  
MtuCM	  -­‐DN237A	   Y	   26.0	   9.7	   0.00	  
MtuCM	  -­‐DN237A	   WF	   3.2	   8.5	   0.01	  
MtuCM	  -­‐DN237A	   FY	   12.8	   7.5	   0.00	  
MtuCM	  -­‐DN237A	   WY	   10.1	   1.2	   0.02	  
MtuCM	  -­‐DN237A	   WFY	   2.5	   0.5	   0.01	  
	   	   	   	   	  






MtuCM	  -­‐DG232P	   None	   100.0	   6.1	   	  
MtuCM	  -­‐DG232P	   F	   80.6	   5.0	   0.35	  
MtuCM	  -­‐DG232P	   W	   144.0	   4.1	   0.00	  
MtuCM	  -­‐DG232P	   Y	   94.5	   2.5	   0.23	  
MtuCM	  -­‐DG232P	   WF	   118.4	   11.8	   0.03	  
MtuCM	  -­‐DG232P	   FY	   108.6	   8.3	   0.07	  
MtuCM	  -­‐DG232P	   WY	   107.4	   4.1	   0.01	  
MtuCM	  -­‐DG232P	   WFY	   108.6	   1.2	   0.01	  
	   	   	   	   	  
MtuCM	  –DF227D	   None	   100.0	   2.0	   	  
MtuCM	  –DF227D	   F	   92.0	   5.5	   0.20	  
MtuCM	  –DF227D	   W	   99.7	   9.1	   0.98	  
MtuCM	  –DF227D	   Y	   92.0	   4.5	   0.14	  
MtuCM	  –DF227D	   WF	   88.0	   0.1	   0.08	  
MtuCM	  –DF227D	   FY	   89.4	   2.0	   0.17	  
MtuCM	  –DF227D	   WY	   90.7	   2.0	   0.25	  
MtuCM	  –DF227D	   WFY	   84.4	   0.1	   0.04	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